Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.42659305810911996,-2.0048557098820976,0.0,0.3484708749746943,0.251,59/110,21.66%,DCP1A;EIF3E;RPS24;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;UPF3B;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;SMG6;ETF1;RPL7A;EIF4A3;RPL31;NCBP2;PPP2CA;RBM8A;HELZ2;RPL36A
prerank,cellular response to copper ion (GO:0071280),-0.6907009687354349,-1.9972257980788235,0.0,0.18730309529889821,0.262,9/16,10.34%,HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,response to copper ion (GO:0046688),-0.6144203818688193,-1.8868559348383054,0.0,0.4951190348598782,0.688,9/20,10.34%,HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A
prerank,skeletal muscle contraction (GO:0003009),0.7749452487037092,1.8410005664452476,0.0,1.0,0.557,4/19,4.00%,TNNI3;TNNC1;TNNI1;MYH14
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7992823605790118,1.818557809260319,0.0013623978201634877,0.847112427921754,0.708,4/15,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.53817156832763,-1.80882208406204,0.0,0.8676380301127742,0.92,17/24,32.79%,SEC31A;TAPBP;ERAP1;SAR1B;CALR;SEC24C;TAP2;SEC24A;ACE;ABCB9;SEC13;IDE;MFSD6;TAP1;HFE;TAPBPL;FCER1G
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5369306143087622,-1.7999487819709976,0.009950248756218905,0.7531326785390581,0.934,13/26,15.95%,ITSN2;GAK;PICALM;INPP5F;AP2A2;CLTA;GPR107;SGIP1;CLTB;ITSN1;FNBP1L;AP2M1;PIP5K1C
prerank,visual system development (GO:0150063),-0.4788119070938897,-1.7846540143749612,0.0,0.7292479039835009,0.958,19/37,31.41%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;CHRDL1;C1QA
prerank,gonad development (GO:0008406),0.6560253982334016,1.7838748345958677,0.0,1.0,0.897,8/41,8.37%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;NR2F2;WNT4;SOX9
prerank,body fluid secretion (GO:0007589),0.7873364387751023,1.782519505442367,0.0013869625520110957,0.811917912739777,0.905,6/15,10.20%,APLN;GUCA1B;SLC22A4;GPAT4;ZBTB7B;PRLR
prerank,negative regulation of vascular permeability (GO:0043116),-0.6825092030864383,-1.7766361040519645,0.0031746031746031746,0.6745400508438727,0.968,9/12,25.93%,FERMT2;ANGPT1;SLIT2;CLDN5;RAMP2;PTPRJ;VEGFA;PDE2A;CEACAM1
prerank,regulation of phospholipase activity (GO:0010517),0.8395674583935642,1.7704134569482375,0.0074962518740629685,0.7979378692091583,0.942,4/10,3.62%,PLA2G5;PDPK1;FGFR2;FGFR1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.8343637544195994,1.7676265223998284,0.0,0.6954175499846214,0.95,4/11,4.87%,MST1R;SIRT2;RAC1;NRP1
prerank,cytoplasmic translation (GO:0002181),-0.40003101034626876,-1.7662221010895778,0.0,0.6509327047378861,0.976,44/91,17.70%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;EIF4A2;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;FTSJ1;RPL39;RPL12;RPL27;RPS17;TMA7;RPS26;RPS27;RPL10A;RPS10;ETF1;RPL7A
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.548121115624552,-1.7646209042174652,0.003937007874015748,0.5876816110250312,0.979,12/22,18.68%,CYRIB;SLIT2;PRKCD;TMSB4X;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1;TMSB10
prerank,sodium-independent organic anion transport (GO:0043252),-0.7191978443755953,-1.7628645144810684,0.0,0.5366451474610292,0.981,4/10,5.80%,SLCO3A1;SLC16A2;SLCO1C1;SLCO2A1
prerank,granulocyte differentiation (GO:0030851),-0.5652711926830118,-1.7504352768240805,0.0071174377224199285,0.5528015243916742,0.988,11/18,29.51%,LEF1;LBR;PML;EP300;RARA;CBFA2T3;JAGN1;CDK2;CDK4;TAL1;CDKN1A
prerank,male gonad development (GO:0008584),0.6552454137765918,1.7335754815864823,0.0011918951132300357,1.0,0.99,7/34,8.37%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,myotube cell development (GO:0014904),0.8108251735181526,1.7204874513477868,0.004524886877828055,1.0,0.997,2/10,1.18%,MYORG;IGF1
prerank,development of primary male sexual characteristics (GO:0046546),0.6482279241991205,1.7147701081509463,0.003579952267303103,1.0,0.998,7/34,8.37%,FSHR;FGF9;WNT2B;WNT5A;MAMLD1;WNT4;SOX9
prerank,positive regulation of cyclase activity (GO:0031281),-0.6240522419192206,-1.7082957970223056,0.011029411764705883,0.7431322904082739,0.999,4/14,6.90%,MAPK8;CACNA1D;NOS3;CACNA1C
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6891363412069708,1.7034461252401583,0.0037735849056603774,1.0,1.0,3/22,3.17%,IL10RA;OCIAD2;IL10RB
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.616343842388136,-1.7021291232817628,0.019933554817275746,0.7222393951999554,0.999,3/13,3.43%,AXL;LAMP1;ZBTB1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.6201421984895423,-1.7005909182170482,0.014760147601476014,0.6792848551683048,1.0,6/15,17.60%,GRM7;GRM1;GRM3;DAGLB;HOMER3;GRIK3
prerank,retina homeostasis (GO:0001895),-0.5408479370891168,-1.6999389506182636,0.013824884792626729,0.6371209164120661,1.0,8/23,17.73%,POTEF;ACTB;CCDC66;POC1B;WHRN;BBS4;ACTG1;HSPB1
prerank,bicarbonate transport (GO:0015701),0.6720413239118659,1.6995246432514557,0.0038461538461538464,1.0,1.0,3/25,0.31%,CYB5R2;SLC4A4;SLC4A5
prerank,cellular response to zinc ion (GO:0071294),-0.5886692676643581,-1.695752935132087,0.009933774834437087,0.6190122281044619,1.0,9/15,15.35%,MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;GLRA2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.8181930960344134,1.6932013313434364,0.00741839762611276,1.0,1.0,6/10,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;SDHAF3
prerank,regulation of glucose metabolic process (GO:0010906),0.645529794216242,1.6859361836386104,0.0024183796856106408,1.0,1.0,11/34,10.40%,GPLD1;SIRT7;SELENOS;PDK1;MLYCD;USP7;RORA;OGT;ZNF692;SDHAF3;IRS2
prerank,respiratory tube development (GO:0030323),0.6575354254840022,1.683062799048211,0.0037128712871287127,1.0,1.0,6/28,6.59%,FGF9;STRA6;FGFR2;HECA;PCSK5;ZIC3
prerank,regulation of hormone secretion (GO:0046883),0.7406394075251961,1.680355777773306,0.004189944134078212,0.9875320259950311,1.0,5/15,9.55%,EDN3;ANXA1;VAMP3;SNX6;SOX11
prerank,negative regulation of myotube differentiation (GO:0010832),0.7630319043266138,1.6779886966865907,0.005657708628005658,0.9514739416905333,1.0,6/12,12.36%,HDAC3;TMEM119;XBP1;HDAC5;HDAC4;HDAC1
prerank,lipid catabolic process (GO:0016042),0.7077889534767574,1.6768395377276006,0.0053475935828877,0.9075814356241215,1.0,2/18,1.59%,LPL;SIRT2
prerank,neuron projection fasciculation (GO:0106030),0.8054087365906456,1.6746776698011392,0.0030911901081916537,0.8837190687128845,1.0,2/10,1.72%,AMIGO1;EPHB2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.7056693623178992,1.6697286450535327,0.014175257731958763,0.8908740290361861,1.0,8/18,12.36%,HDAC3;TMEM119;XBP1;HDAC5;FRS2;HDAC4;SOX6;HDAC1
prerank,leukotriene biosynthetic process (GO:0019370),0.745262918781902,1.667277760151701,0.012345679012345678,0.8718952323623962,1.0,2/14,0.56%,PLA2G5;ALOX5AP
prerank,histone methylation (GO:0016571),0.658076233892343,1.6669892852592254,0.007653061224489796,0.8335420559964283,1.0,15/26,19.80%,SIRT7;PRMT6;FBL;EZH2;EHMT2;PRMT5;NTMT1;NSD3;SUV39H1;PRMT1;EHMT1;PRMT8;NSD1;PRMT2;CARM1
prerank,positive regulation of heart contraction (GO:0045823),0.7087144085486383,1.6652278170895958,0.006570302233902759,0.8124956004889761,1.0,5/19,7.53%,APLN;ADM;EDN3;ATP2A2;ATP1A2
prerank,response to insulin (GO:0032868),0.5765022432031766,1.6625334215405054,0.0010504201680672268,0.8045007111706284,1.0,33/80,16.50%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;OGT;CAPN10;PIK3R1;ZBTB7B;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;ZBED3;PRKCI;RAB31;RAB8A;RAB8B;SLC27A1
prerank,establishment of endothelial barrier (GO:0061028),-0.47308353527112607,-1.6593413802590296,0.010416666666666666,0.7774615826411516,1.0,14/29,23.91%,RDX;RAPGEF6;RAPGEF3;PECAM1;TJP1;EZR;F11R;RAB1A;MYADM;RAP2C;MSN;PDE2A;RAB1B;ROBO4
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6683115424346129,-1.656106535827754,0.011764705882352941,0.7510273336694192,1.0,5/10,16.60%,BICD1;UBXN2B;MARK4;NSFL1C;CEP250
prerank,lung development (GO:0030324),0.6292484168646026,1.6536649288686185,0.004819277108433735,0.8585180578418392,1.0,8/33,9.55%,FGF9;STRA6;FGFR2;FGF10;ERRFI1;ZIC3;RCN3;SOX11
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6971578403293346,1.6513595186873538,0.0136986301369863,0.8465063001602866,1.0,2/17,4.97%,PLA2G5;CRLS1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.6016404075601414,-1.6508274226302404,0.020338983050847456,0.7417615236714629,1.0,7/15,20.22%,STAT3;APPL1;HIF1A;TLR4;IL17RA;GBP5;IL17D
prerank,negative regulation of bone remodeling (GO:0046851),0.7548853687238569,1.650503035461431,0.022590361445783132,0.822070176734578,1.0,3/11,4.85%,TMEM119;SFRP1;TNFAIP3
prerank,regulation of spindle organization (GO:0090224),0.7169859810602875,1.6498934974254023,0.006802721088435374,0.7981044276143405,1.0,5/18,11.26%,PSRC1;FSD1;RAE1;MAP9;GPSM2
prerank,natural killer cell activation (GO:0030101),-0.5026999958343417,-1.6459137838857936,0.009569377990430622,0.7327689117827244,1.0,8/23,22.73%,AXL;TOX;KAT7;ELF4;PTPRC;BAG6;PBX1;PIK3CD
prerank,cardiac conduction system development (GO:0003161),-0.49602158739586144,-1.6453752929115824,0.01485148514851485,0.70103835696174,1.0,9/24,17.80%,SMAD4;GJA1;MAML1;SMAD1;BMPR1A;CACNA1G;TBX18;BMP4;NOTCH2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.37420666993835827,-1.6437393301064454,0.0,0.6777362528627152,1.0,43/91,17.70%,RPS24;SSR1;ARL6IP1;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;TRAM1;RPS10;RPL7A
prerank,embryonic hemopoiesis (GO:0035162),-0.6161942766258445,-1.6433345417517973,0.012903225806451613,0.6506841351599489,1.0,8/12,18.53%,KITLG;KIT;TGFBR2;KDR;THOC5;FLT3LG;SH2B3;ATF4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.750131657848673,1.6411964004248554,0.013062409288824383,0.8507086928659441,1.0,4/13,7.49%,IGF1;IL33;ABCA2;SOAT1
prerank,positive regulation of transport (GO:0051050),0.5594506220865492,1.6410170971407787,0.0,0.8231268938681365,1.0,27/85,19.12%,PLA2G5;CALY;FCGR2B;BAX;GPLD1;TUB;CHCHD10;KCTD7;ANXA1;MLC1;ZNF205;CAPN10;CD151;SIRPA;ABCA7;CLIP3;CD47;LRP1;IL15RA;NUMA1;CAMK1D;ANXA2;FMR1;APOE;KMT2A;FLOT1;SMPD1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5230710441351782,-1.638579873171099,0.007662835249042145,0.647030556919159,1.0,14/19,27.22%,HIPK2;PML;USP28;SIRT1;HIPK1;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;BCL3;RPS27L
prerank,"wound healing, spreading of cells (GO:0044319)",0.6541890063737358,1.6381220952976856,0.014066496163682864,0.8231606050895751,1.0,6/24,5.68%,CARMIL2;MMP12;LCP1;DDR1;MRTFA;CD151
prerank,response to prostaglandin E (GO:0034695),0.7842783351576372,1.6362328758478033,0.01188707280832095,0.8137627865194774,1.0,3/10,6.64%,SFRP1;PTGER4;GNG2
prerank,negative regulation by host of viral process (GO:0044793),-0.6552886885852796,-1.6353933669267096,0.01366120218579235,0.6360464645475609,1.0,6/10,26.41%,EIF2AK4;VAPA;CCNK;PSMC3;ZC3H12A;PRKN
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5989423973241599,-1.6337249793128417,0.02287581699346405,0.6189546382663501,1.0,8/13,16.00%,NR3C1;MED1;AR;ABHD2;BMP7;ESR1;PGR;BMP4
prerank,negative regulation of GTPase activity (GO:0034260),-0.5093593402528559,-1.6337050789513783,0.024154589371980676,0.5962320537906141,1.0,7/22,8.37%,LRCH1;DAB2IP;RDX;SH3BP4;CPEB2;LRRK2;F11R
prerank,response to purine-containing compound (GO:0014074),-0.5553001790349358,-1.6336872866516767,0.008403361344537815,0.5749380518695208,1.0,12/17,37.99%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;P2RY1;RYR2;TRPM2;P2RY6;VGF;P2RX4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.7143713806421135,1.6333548553944899,0.012096774193548387,0.8126511318060681,1.0,5/16,5.73%,SFRP2;CDKN2D;CXCL12;SNAI1;FBH1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.5551449410382088,-1.632964978955859,0.033582089552238806,0.5572529940328086,1.0,8/18,19.70%,MFHAS1;ENSA;URI1;INPP5K;PPP1R8;PTPA;SH3RF2;ZCCHC9
prerank,renal absorption (GO:0070293),0.7787755553469111,1.6315753498710366,0.015503875968992248,0.8034895966040257,1.0,1/10,0.03%,MAGED2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6590279763195176,1.6309870567650446,0.011421319796954314,0.7848606915091884,1.0,9/23,23.39%,TNNI3;TNNC1;FGFR2;TPM1;TGFB1;TGFBR3;SMAD7;ID2;FKBP1A
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3472442101271308,-1.6240212556061209,0.0,0.57472285036191,1.0,35/103,16.22%,RAPGEF5;RAPGEF6;KRAS;ARHGEF18;RALBP1;RB1;RAB18;ARHGAP18;RREB1;PLCE1;ABR;USP28;PRKD1;TIAM2;NRAS;TNK2;RRAGC;RHEB;NUCB1;RGL1;USP8;RASGRP3;RALB;ARL3;TP53;RIT1;PLD2;SHC3;ARHGAP1;ARHGAP31;JUN;RGL2;ARFIP2;PLK2;DNMT1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6930651852078445,1.623002840392767,0.013966480446927373,0.8344172635168265,1.0,8/17,15.32%,PPIF;PARP1;FIS1;FLCN;PID1;HDAC4;GIT1;NUPR1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.42125393087232715,-1.6205659092839049,0.008928571428571428,0.5719207979297377,1.0,11/49,9.78%,LRCH1;DAB2IP;RDX;SH3BP4;SLC39A14;CPEB2;URI1;CST3;LRRK2;F11R;ECM1
prerank,regulation of membrane repolarization (GO:0060306),-0.5952348690468445,-1.6163789833004503,0.019543973941368076,0.5714037560253997,1.0,5/13,13.21%,CAV1;CACNA2D1;KCNJ2;AKAP9;NEDD4L
prerank,triglyceride biosynthetic process (GO:0019432),0.6788662338579992,1.614816899666164,0.021333333333333333,0.8896119775049285,1.0,7/18,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,B cell activation involved in immune response (GO:0002312),0.7186092957372046,1.6147454027697736,0.01775147928994083,0.8664931913496672,1.0,4/13,8.82%,FCGR2B;EXOSC3;RNF8;RNF168
prerank,regulation of gluconeogenesis (GO:0006111),0.6332663374289558,1.608541560439022,0.016069221260815822,0.9037117944424773,1.0,9/27,10.15%,SIRT7;SELENOS;USP7;OGT;ZNF692;DDB1;SIK1;NNMT;SDHAF3
prerank,epiboly involved in wound healing (GO:0090505),0.6940396515857179,1.6081215147790353,0.010854816824966078,0.8854027569391828,1.0,5/16,5.68%,CARMIL2;LCP1;DDR1;MRTFA;CD151
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6879789618103936,1.6070409427966712,0.012747875354107648,0.8730928235040053,1.0,1/17,0.14%,PLA2G5
prerank,innate immune response in mucosa (GO:0002227),-0.6475783810015054,-1.607009941648269,0.037463976945244955,0.5925324840005314,1.0,3/10,14.64%,RNASE3;DEFA6;RPL39
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5891867637769131,1.605507221797604,0.006904487917146145,0.8659376784205148,1.0,6/44,2.88%,CARMIL2;SPIRE2;CDC42EP5;CDC42EP4;BIN1;WHAMM
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6865989856002227,1.6031105250879638,0.021768707482993196,0.8672235794543125,1.0,4/17,4.87%,FGF9;VTN;IGF1;NRP1
prerank,axonal fasciculation (GO:0007413),0.7393698987971653,1.6021060506080487,0.01188707280832095,0.8558769535048626,1.0,2/12,1.72%,AMIGO1;EPHB2
prerank,rRNA 3'-end processing (GO:0031125),0.766493200488812,1.5996756128683842,0.013719512195121951,0.8588661517419977,1.0,4/10,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,regulation of cell division (GO:0051302),0.552966979711496,1.5949486019033516,0.00211864406779661,0.882578505720876,1.0,28/72,21.79%,SFRP2;CCP110;FSD1;SIRT2;RAB11FIP4;MYO19;FGFR2;CALM3;FLCN;PLK5;ENTR1;ORC6;RACK1;GIT1;CSPP1;PRPF40A;KLHL13;TXNIP;PIK3C3;CALM1;PIK3R4;NCOA3;MLLT3;PRDM15;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,protein kinase B signaling (GO:0043491),0.6506431706742775,1.5932071074935203,0.017632241813602016,0.8794803304713621,1.0,5/23,4.02%,IGF1;SIRT2;TSC2;THEM4;ZFP36L1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.7601112885542975,1.5920127472156387,0.017266187050359712,0.872000275093879,1.0,3/11,0.80%,SFRP2;WNT2B;WNT5A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6443839640972584,1.5911550293534464,0.019975031210986267,0.8614101997144322,1.0,5/23,10.20%,IL10RA;OCIAD2;IL10RB;PIBF1;PRLR
prerank,phospholipid metabolic process (GO:0006644),0.5546759218269182,1.590947797905115,0.0,0.8455262805538588,1.0,20/71,19.12%,PLA2G5;LPL;PIP4K2B;SMPD2;PCYT2;ABCA2;AGPAT1;AGPAT5;PLPPR2;AGPAT3;GPAM;FADS1;ENPP2;PLPP3;PIP4K2A;PLPPR5;GPX4;GDE1;PIP5K1A;SMPD1
prerank,vacuolar acidification (GO:0007035),0.6534559264987759,1.5906140518243408,0.02929936305732484,0.8316463937501185,1.0,7/21,12.68%,CLN3;ATP6AP2;CLN6;ATP6V0A2;ATP6V0E2;TCIRG1;ATP6V0A4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.6288519881577279,1.5890402356986328,0.004895960832313341,0.8284129455905893,1.0,4/27,2.19%,PLA2G5;MAPK9;LPL;NFKB1
prerank,regulation of myotube differentiation (GO:0010830),0.630017614097056,1.588676977603449,0.015267175572519083,0.8155088061157159,1.0,8/24,12.36%,HDAC3;TMEM119;DMPK;XBP1;HDAC5;SIK1;HDAC4;HDAC1
prerank,lung epithelium development (GO:0060428),0.7615781044592802,1.5886044316368635,0.027737226277372264,0.8006383288646307,1.0,4/10,7.81%,STRA6;FGF10;ERRFI1;RCN3
prerank,muscle filament sliding (GO:0030049),0.5942732824999153,1.5870305426372275,0.011890606420927468,0.7848732385734244,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,actin-myosin filament sliding (GO:0033275),0.5942732824999153,1.5870305426372275,0.011890606420927468,0.7848732385734244,1.0,7/38,10.81%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;TPM1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5496424869037745,1.5869782456213413,0.0031746031746031746,0.7711718817701666,1.0,19/72,14.97%,FGF20;FGF9;FGFRL1;FGFR2;FGFR1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.4633220798576185,-1.5868421475398409,0.005128205128205128,0.6650733197471992,1.0,15/29,19.82%,SMAD4;CYRIB;TJP1;SLIT2;PRKCD;KANK3;MYADM;KANK4;SHANK3;PIK3CA;TWF2;PFN1;KANK1;TWF1;FKBP4
prerank,actin filament network formation (GO:0051639),0.7413726138562093,1.5864090779452573,0.01608187134502924,0.7622734077718272,1.0,3/11,0.97%,CARMIL2;SPIRE2;LCP1
prerank,phagosome-lysosome fusion (GO:0090385),0.7666626373118326,1.584663217286248,0.01726844583987441,0.7633906094788038,1.0,3/10,4.78%,PLA2G5;CLN3;RAB34
prerank,lipid phosphorylation (GO:0046834),-0.6343098887655372,-1.58318040103175,0.014925373134328358,0.6634325417040542,1.0,7/10,19.02%,DGKH;DGKB;DGKE;DGKZ;DGKD;DGKG;DGKQ
prerank,response to organophosphorus (GO:0046683),-0.5612869268682814,-1.5828146707467223,0.039568345323741004,0.6462743267217312,1.0,11/16,37.99%,NDUFS4;STAT1;TRPC3;ABCC9;P2RX7;DGKQ;TRIM16;TYMS;RFC3;VGF;P2RX4
prerank,positive regulation of integrin activation (GO:0033625),-0.6043494316376077,-1.581865169830962,0.04113924050632911,0.6329278856698313,1.0,5/11,18.46%,FERMT2;PLEK;RASIP1;SRC;P2RY12
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6892026394282569,1.581040919326234,0.022191400832177532,0.777311629803073,1.0,4/16,11.52%,MYORG;IGF1;IGFBP3;BMP5
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6359698939109385,1.5805069184678375,0.02295918367346939,0.7683972877161376,1.0,5/24,5.09%,SFRP2;CDKN2D;TAF9B;CXCL12;SNAI1
prerank,icosanoid biosynthetic process (GO:0046456),0.7609990034674734,1.5778357279329625,0.02225519287833828,0.776891677343506,1.0,2/10,0.56%,PLA2G5;ALOX5AP
prerank,fatty acid metabolic process (GO:0006631),0.5194244515230723,1.5744406829516946,0.005149330587023687,0.7898740362951516,1.0,26/115,15.47%,SLC27A6;FASN;ALOX5AP;NDUFAB1;LPL;MLYCD;SLC27A4;THEM4;PON2;XBP1;LPIN1;PON3;ACOT11;SGPL1;LPIN3;MSMO1;GPAM;ELOVL4;CROT;CPT2;ACADSB;LPIN2;MECR;PTGS2;ACSL6;ABCD2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49988864568960645,-1.5735001650272553,0.039647577092511016,0.6537267763094348,1.0,9/21,22.71%,FOXP1;PRKCH;PTPRC;IKBKG;SLC39A10;NECTIN2;RAB29;CD81;BCL10
prerank,digestive tract morphogenesis (GO:0048546),0.6928866737218838,1.5697963645750934,0.019525801952580194,0.8120342967185532,1.0,6/14,11.29%,STRA6;FGFR2;NIPBL;BBS7;SOX11;PDGFRA
prerank,regulation of lysosomal lumen pH (GO:0035751),0.7197152881491438,1.5693122693315218,0.027656477438136828,0.8029512545749243,1.0,3/12,2.20%,CLN3;ATP6AP2;CLN6
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6077277916843753,-1.5663688636566404,0.03225806451612903,0.669298627655723,1.0,6/11,23.57%,RAPGEF6;TJP1;F11R;RAB1A;RAP2C;RAB1B
prerank,regulation of stem cell population maintenance (GO:2000036),-0.5108416980293128,-1.5663407690710118,0.02734375,0.6527022833998668,1.0,8/18,25.65%,CNOT1;WDR43;REST;TAF5L;CNOT2;ELAVL1;TAF6L;HMGA2
prerank,vesicle transport along actin filament (GO:0030050),0.6538141697784665,1.5641543782730032,0.03474903474903475,0.832275082098241,1.0,3/19,5.26%,MYO1A;MYO19;MYO1B
prerank,regulation of oxidative phosphorylation (GO:0002082),0.6708082678832779,1.5626164342411566,0.032303370786516857,0.8320184839106284,1.0,7/16,15.32%,PPIF;SLC25A33;COX7A2;VCP;AK4;UQCC2;NUPR1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6388440716241177,1.561704876174973,0.024934383202099737,0.8274942580784007,1.0,8/23,10.71%,SLC4A4;IGF1;NFKB1;ARNT;PRXL2C;EGF;ZBTB20;APP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4633660519210516,-1.5607162421347984,0.011111111111111112,0.6600760811639561,1.0,9/27,10.78%,MAPK8;KAT7;IKBKB;CUL1;TAOK2;SKP1;MAP3K8;UBB;IKBKG
prerank,neurotransmitter uptake (GO:0001504),0.7158103210860629,1.5603798655455199,0.037821482602118005,0.8258778286881837,1.0,5/12,13.89%,SLC29A1;ATP1A2;GLUL;SNAP25;SLC1A3
prerank,positive regulation of double-strand break repair (GO:2000781),0.5702209768679185,1.5565029256734153,0.019675925925925927,0.8440732880237934,1.0,10/39,9.77%,SPIRE2;KDM4D;FOXM1;PARP1;ACTR2;MGMT;SLF2;FUS;WRAP53;MRNIP
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6897134560075051,1.5541333914842859,0.02880658436213992,0.8516234709391264,1.0,5/15,14.28%,CARMIL2;DDR1;DDR2;LRP1;TGFB1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.6019443786719187,1.5509705692662439,0.02530120481927711,0.8652398063400142,1.0,8/29,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.6524677349929979,1.5505354797862558,0.03042328042328042,0.8565356507366815,1.0,9/19,11.98%,CAMK2B;CUL7;CDKL5;OBSL1;DBN1;LRP8;DHX36;DBNL;IL1RAPL1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.49974132700133184,-1.5503043987520524,0.018779342723004695,0.6909005510007946,1.0,16/19,25.30%,MORC3;TAPT1;HK1;PML;SKP1;ARL2BP;TAF8;BBS4;TAF3;PINK1;HSPA5;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,nucleoside salvage (GO:0043174),0.7366150383314319,1.5493891049833286,0.023255813953488372,0.8541232074871136,1.0,6/10,13.10%,DCK;TK1;TK2;UPP2;UCKL1;HPRT1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.5291760165152518,-1.5484783470894945,0.03879310344827586,0.6834688934460066,1.0,5/18,3.85%,SMAD4;IL6R;FER;STAT3;STAT1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7289332591920307,1.5472555869074236,0.019230769230769232,0.8599272476389154,1.0,1/11,0.14%,PLA2G5
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.6531693885342107,1.5467901096757652,0.03994490358126722,0.8523068776625015,1.0,4/18,4.44%,BAX;CHCHD10;FZD9;ZNF205
prerank,regulation of catecholamine secretion (GO:0050433),0.6096846941130578,1.546456588222404,0.024783147459727387,0.8436907389457284,1.0,3/29,0.87%,FGF20;SYT3;SYT10
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.7202497596649415,1.5460973461872534,0.032448377581120944,0.8356538961931342,1.0,3/11,3.32%,EXOSC3;EXOSC2;FBL
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.614462189991676,-1.5446036619828267,0.056074766355140186,0.6845918233433962,1.0,6/10,28.14%,HK1;GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5678500064510698,1.544122663346102,0.025056947608200455,0.8395044967552797,1.0,18/42,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;EARS2;AARS1;EPRS1;SARS1;TARS2;NARS1;HARS1
prerank,regulation of dopamine secretion (GO:0014059),0.6231261411697802,1.5438010949816101,0.021573604060913704,0.8311919835540981,1.0,3/25,0.87%,FGF20;SYT3;SYT10
prerank,response to hexose (GO:0009746),0.6200645792106779,1.5410967343284305,0.020757020757020756,0.8420532163643449,1.0,7/25,13.32%,LPL;GPLD1;SELENOS;TCF7L2;SELENOT;IRS2;ZBED3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.690856458903113,1.5400951732170616,0.03212290502793296,0.8394422926686175,1.0,7/14,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,female gonad development (GO:0008585),0.6505024657826494,1.539435801462848,0.02875816993464052,0.8346655871866645,1.0,2/19,2.96%,FSHR;NR2F2
prerank,tRNA aminoacylation (GO:0043039),0.5813127495871451,1.5389899757499232,0.02240566037735849,0.8280369535786443,1.0,17/37,12.81%,FARSB;YARS1;AIMP2;WARS1;YARS2;GATB;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;SARS1;NARS1;HARS1
prerank,pancreas development (GO:0031016),0.7073398722957382,1.5379162386167737,0.03812316715542522,0.8264659100868244,1.0,4/12,8.63%,NKX6-1;TCF7L2;ZIC3;SELENOT
prerank,mitochondrial fusion (GO:0008053),0.6566358646281623,1.5372240372040806,0.018944519621109608,0.8224820180321448,1.0,8/18,13.20%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.7037806772851771,1.5357658519566157,0.036827195467422094,0.8241041272989111,1.0,1/12,0.02%,DPYSL4
prerank,substantia nigra development (GO:0021762),0.5725249764312963,1.5348596838131048,0.02237926972909305,0.8214525698700156,1.0,8/37,8.88%,FGF9;NDRG2;SIRT2;INA;CALM3;ATP5PF;SEC16A;YWHAH
prerank,autophagosome maturation (GO:0097352),0.5796688071773498,1.531858210287436,0.014510278113663845,0.8354475791398487,1.0,15/32,16.15%,UBQLN1;CLN3;VPS16;ATP2A2;SNX14;LIX1L;ATG14;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;VMP1;STX17;VAMP8
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.34989343837549436,-1.5316106663697497,0.0,0.7275539483412627,1.0,46/87,22.59%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;RPS5;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;RPS26;RPS27;RPL10A;RPS10;RPL7A;SEC61A1;RPL31;RPL36A;SEC61B;SRP14;RPL29
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3453061988032924,-1.5294451639240823,0.0,0.7213489151734993,1.0,23/87,10.84%,PARD3;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;FMOD;TWSG1;FNTA;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22
prerank,protein localization to mitochondrion (GO:0070585),-0.5922038405149053,-1.529359750276956,0.06774193548387097,0.7065107972475634,1.0,9/11,21.99%,HK1;LRRK2;PINK1;RALA;HK2;COX18;MAIP1;AKT1;DNAJA1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3692509833821388,-1.5291702510323788,0.012048192771084338,0.6923816818588995,1.0,29/63,23.88%,ANO4;GABRB1;SLC12A7;SLC26A2;GABRG2;CLCN3;SLC25A3;SLC37A3;ANO6;ANO1;SLC20A1;SLC25A14;GABRA5;SLC12A4;SLC5A6;SLC5A5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;SLC25A30;GLRA3;SLC25A11;SLC12A8
prerank,somite development (GO:0061053),0.7000564136940349,1.528221668622257,0.04451038575667656,0.8539173599302542,1.0,3/11,9.55%,SFRP2;PTCH1;SOX11
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6185539685300125,1.527846390239504,0.03280839895013123,0.8473405405201558,1.0,8/21,15.68%,PTGER4;IGF1;ZFP36L1;FGF10;SOX9;EGF;MAP2K2;CTSH
prerank,neural tube development (GO:0021915),0.6617805062767662,1.527378811761318,0.04843304843304843,0.8413702214612025,1.0,8/15,19.15%,ARL13B;ALDH1A2;DVL1;PTCH1;SOX11;TGFB1;PKD2;SOX4
prerank,positive regulation of cellular respiration (GO:1901857),0.7334455359793879,1.5269568089856858,0.033093525179856115,0.8352002746853421,1.0,6/11,15.32%,IFNAR1;IL10RB;PRELID1;VCP;PARK7;NUPR1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.6272026134887272,1.5261961436787956,0.03137254901960784,0.8316859192510397,1.0,5/21,7.92%,SFRP1;STK36;DCDC2;RAB34;TUBD1
prerank,phagolysosome assembly (GO:0001845),0.705919419162696,1.525955152718064,0.046686746987951805,0.8247934475492591,1.0,3/12,4.78%,PLA2G5;CLN3;RAB34
prerank,megakaryocyte differentiation (GO:0030219),-0.5867903391237695,-1.525408742017324,0.057692307692307696,0.6943637766396269,1.0,3/11,4.62%,MED1;KIT;UBA5
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5931017094983385,1.524037528225435,0.037758830694275276,0.8297467131938049,1.0,10/30,10.18%,SFRP2;SFRP1;SH3BP5;NTF3;THY1;DMTN;PIBF1;SH3BP5L;MVP;SRCIN1
prerank,regulation of immunoglobulin production (GO:0002637),0.6127993633657637,1.5237880006194726,0.034482758620689655,0.8229467495285737,1.0,4/23,6.58%,FCGR2B;EPHB2;XBP1;VAMP3
prerank,regulation of histone deacetylation (GO:0031063),0.6948523186212807,1.5226664130208558,0.028409090909090908,0.8225962027842514,1.0,7/13,16.05%,PRMT6;NIPBL;AKAP8L;ZBTB7B;CAMK2D;SAP30BP;CTBP1
prerank,mucosal immune response (GO:0002385),-0.5407219021629102,-1.5218064660353807,0.056338028169014086,0.6964190436369266,1.0,3/15,14.64%,RNASE3;DEFA6;RPL39
prerank,response to cadmium ion (GO:0046686),-0.4476337516451748,-1.5207214807196234,0.018433179723502304,0.6873118256470855,1.0,12/26,13.89%,MAPK8;EGFR;HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;JUN
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5164452017223743,1.5202838652205914,0.007246376811594203,0.8324380708263208,1.0,23/87,16.76%,FGF20;FGF9;SFRP1;FGFRL1;FGFR2;FGFR1;ZFP36L1;FGF10;POLR2B;TIA1;FLRT2;FRS2;FLRT1;HNRNPM;KL;RBFOX2;POLR2K;TIAL1;SETX;FGFBP1;CBL;NDNF;ITGB1BP1
prerank,epidermis development (GO:0008544),0.5431646889061846,1.5199639578686452,0.012048192771084338,0.8260836063504801,1.0,8/56,5.53%,ATP2C1;EDAR;FGFR2;SCEL;PTHLH;EDA2R;ATP2A2;PLOD1
prerank,regulation of protein kinase A signaling (GO:0010738),0.6309733343910752,1.5196493991482138,0.043824701195219126,0.8202375050786276,1.0,3/20,7.66%,FSHR;TCIM;ADGRV1
prerank,positive regulation of receptor internalization (GO:0002092),0.6128353189210642,1.5196051120781418,0.04287515762925599,0.8124841611276057,1.0,9/22,16.79%,APLN;NTF3;PICK1;CD63;ARRB1;EGF;MAGI2;AHI1;FMR1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.516441792363872,1.5192137402056556,0.006237006237006237,0.8070872930089175,1.0,33/102,15.66%,CPEB1;GPLD1;SELENOS;PDPK1;NFKB1;ADCY7;PARP1;USF1;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;SLC30A10;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;RAB10;IRS2;DENND4C;PIK3R2;MYO5A;ENPP1;LPIN2;RAB13;PRKCI;ADCY1;RAB31;RAB8A;RAB8B
prerank,GPI anchor metabolic process (GO:0006505),0.6069331188745213,1.5185494212049002,0.03934010152284264,0.8040541975757349,1.0,8/26,10.68%,PIGG;GPLD1;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1
prerank,regulation of mitotic spindle organization (GO:0060236),0.5873566560626488,1.5181062533591176,0.021634615384615384,0.7993027847017926,1.0,14/35,21.47%,PSRC1;FSD1;RAE1;CEP97;DRG1;CHMP3;MAP9;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5532734921563353,-1.5180167917391383,0.06209150326797386,0.686135802143683,1.0,7/13,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,P-body assembly (GO:0033962),-0.5661304237041761,-1.5173631253276605,0.05501618122977346,0.6764567580655579,1.0,4/12,10.42%,EIF4ENIF1;PATL1;LIMD1;RC3H1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4588011175186042,-1.5172596419092015,0.034653465346534656,0.6643129376977072,1.0,8/26,13.21%,CACNA1D;CAB39;ATP1B3;AKAP9;ACTN2;VAMP2;ATP1B1;NEDD4L
prerank,snRNA 3'-end processing (GO:0034472),0.6329014142154774,1.5172359439469556,0.042328042328042326,0.7979564906457625,1.0,6/19,6.42%,EXOSC3;TOE1;EXOSC7;EXOSC2;USB1;EXOSC8
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.53513336336662,1.5128951798192318,0.01670378619153675,0.820974782212707,1.0,18/62,14.52%,IGF1;RAC1;FGF10;RASGEF1A;ARRB1;GPR4;RAPGEF1;PRAG1;IRS2;PIK3CB;ADGRG1;ROBO1;ALS2;AKAP13;LPAR1;AUTS2;STK19;LPAR6
prerank,lipoxygenase pathway (GO:0019372),0.6783492463233459,1.5102753353599763,0.0332409972299169,0.8324252048804693,1.0,5/14,17.75%,ALOX5AP;PON2;PON3;PTGS2;GPX4
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3091935427146601,-1.5079812751230268,0.0,0.6918532831954968,1.0,76/168,23.01%,CNOT1;DCP1A;EIF3E;CSDE1;RPS24;PATL1;RPL11;SMG5;RPS15A;RPS23;RPL5;RPL37A;DCPS;RPL6;RPL18A;RPL24;RPS19;NCBP1;RPS20;RPL38;TENT2;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;LSM1;RC3H1;RPL28;RPL22;RPL34;RPS13;RPLP0;PARN;UPF3B;RPL36;RPL10;ERI1;CNOT8;RPL32;RPS28;UPF1;RPS5;RPL15;RPS2;PYM1;RNPS1;RPL39;RPL12;RPL27;RPS17;UPF3A;SMG9;RPS26;RPS27;RPL10A;RPS10;CNOT7;SMG6;ETF1;RPL7A;EXOSC9;EIF4A3;RPL31;NCBP2;PPP2CA;TUT1;RBM8A;HELZ2;RPL36A;TUT4;CNOT2;RPL29;CNOT11
prerank,diacylglycerol metabolic process (GO:0046339),-0.4570690618544588,-1.5071257812356402,0.03864734299516908,0.6828629043309914,1.0,11/23,21.92%,DGKH;PLCE1;DGKB;DGKE;DGKZ;DGKD;DGKG;PGS1;DGKQ;DGAT1;LIPE
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5015408642891424,-1.5063844613485102,0.04597701149425287,0.6737867773359385,1.0,8/17,25.22%,CAV1;ADIPOR1;PRKAB2;PPARD;PRKAA2;ADIPOR2;PPARG;PPARA
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5757675818286795,1.5054091532593281,0.04700352526439483,0.8601926939808993,1.0,8/31,6.42%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;DCP1B;EXOSC8
prerank,presynapse organization (GO:0099172),0.6957354745644484,1.5047101638221025,0.03828483920367534,0.8575120304583246,1.0,4/10,14.38%,WNT5A;DVL1;NLGN3;NLGN2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.46817689839276194,-1.5037847927925052,0.03773584905660377,0.6725713191456627,1.0,6/23,21.26%,LAMP1;CADM1;LGALS9;NECTIN2;PIK3R6;PVR
prerank,actin filament-based transport (GO:0099515),0.6107910755741354,1.5032551004976733,0.05486284289276808,0.8610035964140345,1.0,3/21,5.26%,MYO1A;MYO19;MYO1B
prerank,acylglycerol metabolic process (GO:0006639),-0.42141735219570986,-1.5028237412827405,0.03076923076923077,0.6651770054667907,1.0,13/37,12.91%,DGKH;CAV1;DGKB;GK5;MGLL;DGKE;DGKZ;ABHD6;ABHD2;DGKD;DGKG;LMF1;PGS1
prerank,regulation of B cell activation (GO:0050864),0.5883350130670097,1.5023041089376108,0.05408805031446541,0.8606802834367279,1.0,3/25,4.85%,FCGR2B;ZFP36L1;TNFAIP3
prerank,diterpenoid metabolic process (GO:0016101),0.5337653105075796,1.500269363675368,0.018909899888765295,0.8676425617779073,1.0,15/55,17.19%,LPL;RDH10;STRA6;GPC6;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;GPC4;LRP1;HSPG2;ALDH3A2;APOE
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6701231568669367,1.4993686365405214,0.04329608938547486,0.866963414914145,1.0,3/13,3.62%,APLN;PDPK1;FGFR1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4159526274138505,-1.4989971590438622,0.010869565217391304,0.6694089209214402,1.0,20/32,28.54%,HIPK2;FHIT;PML;USP28;SIRT1;HIPK1;JMY;TP53;EP300;MSH2;TMEM109;BAG6;DYRK2;DDIT4;RRP8;BCL3;MYBBP1A;RPS27L;BOK;PDK2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6950042160459629,1.4986581030907558,0.047619047619047616,0.8648297447750593,1.0,4/12,6.18%,GMPS;ADSL;PAICS;GART
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.5816827713734853,1.4975457049012653,0.03400503778337532,0.8648754567799041,1.0,6/30,15.47%,SLC27A6;ELOVL1;SLC27A4;ELOVL4;ACSL6;ABCD2
prerank,regulation of lamellipodium organization (GO:1902743),0.6704993940423362,1.496953867498169,0.04120879120879121,0.8617178146100601,1.0,3/14,6.44%,CARMIL2;RAC1;DMTN
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.520166827620848,-1.4949033467108477,0.06451612903225806,0.6745910565340034,1.0,7/15,21.33%,CNOT1;TNRC6A;EIF4ENIF1;AGO2;CPEB3;CNOT7;BTG2
prerank,positive regulation of cell killing (GO:0031343),0.6690186394208371,1.4944005222939187,0.0371900826446281,0.8728607419135067,1.0,3/13,2.78%,WNT5A;DVL2;RAC1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.6047099508788036,1.4943788979381758,0.03553299492385787,0.8656210312448559,1.0,6/25,6.18%,GMPS;ADSL;PRPSAP2;DCK;PAICS;GART
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6508067128591817,1.494292416661641,0.03443526170798898,0.8590123474458189,1.0,5/15,8.95%,AATK;DDR1;ABL1;SRMS;TEC
prerank,glycolipid biosynthetic process (GO:0009247),0.5538153944272525,1.4935921351700874,0.026869158878504672,0.8570271790737137,1.0,10/38,10.43%,PIGG;A4GALT;PGAP4;ST8SIA3;DPM2;ST3GAL2;PIGM;PIGU;ST3GAL5;PIGA
prerank,DNA modification (GO:0006304),0.6159370786609184,1.4918982121868256,0.04066073697585769,0.8624837697798147,1.0,5/22,4.96%,EXOSC3;PARP1;NTHL1;MPG;PARP2
prerank,organelle fusion (GO:0048284),0.610597270845221,1.4912401614971997,0.041005291005291,0.8598055317578769,1.0,9/22,16.00%,BAX;FIS1;USP30;MIEF2;MFN1;MFN2;AFG3L2;GDAP1;VPS18
prerank,leukotriene metabolic process (GO:0006691),0.6306785193481582,1.4910744346270612,0.052702702702702706,0.8538882463934423,1.0,2/19,0.56%,PLA2G5;ALOX5AP
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.43730288716615795,-1.4904710363709806,0.03431372549019608,0.6819947381246172,1.0,8/27,9.22%,EGFR;PUM1;EIF4ENIF1;STAT3;RIPK1;AGO2;TP53;LIMD1
prerank,sensory perception of taste (GO:0050909),0.7043648073199948,1.4881822487238043,0.047619047619047616,0.8679106203612825,1.0,1/10,1.86%,ASIC1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6787632756410563,1.4859853182664462,0.05485232067510549,0.8770551393382426,1.0,5/12,10.28%,DCK;TK1;TK2;UPP2;UCKL1
prerank,regulation of osteoblast proliferation (GO:0033688),0.6267770086219442,1.484924256795629,0.04341926729986431,0.8776127892930837,1.0,4/17,4.87%,TMEM119;SFRP1;FGFR2;NELL1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.7054597398909055,1.4828105729595924,0.0487062404870624,0.8791372981817432,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,regulation of pseudopodium assembly (GO:0031272),0.7054597398909055,1.4828105729595924,0.0487062404870624,0.8791372981817432,1.0,2/10,1.42%,CDC42EP5;CDC42EP4
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4261682338490719,-1.4823451733439936,0.024509803921568627,0.7043571271995942,1.0,11/30,9.79%,GJA1;JAM2;PECAM1;TJP1;ACTB;CLDN5;ESAM;DMD;F11R;OCLN;LSR
prerank,cellular response to cadmium ion (GO:0071276),-0.4531331725366493,-1.4821901139344007,0.036036036036036036,0.6940661846236698,1.0,12/24,13.89%,MAPK8;EGFR;HSF1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;JUN
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.4976396875353253,-1.4821536658412073,0.056,0.6836395444335277,1.0,10/18,22.86%,PREPL;RIMS2;SYN1;LRRK2;DTNBP1;NLGN1;SLC4A8;RAB5A;RAB3GAP1;SNAPIN
prerank,positive regulation of secretion (GO:0051047),0.6855587468251613,1.480829329002016,0.05271317829457364,0.8864182748191106,1.0,2/11,3.80%,GPLD1;XBP1
prerank,histone H3 deacetylation (GO:0070932),0.65117415225358,1.4790340103389061,0.05758426966292135,0.8929630602004964,1.0,6/15,12.36%,HDAC3;SIRT2;SIRT7;PER1;HDAC4;HDAC1
prerank,regulation of double-strand break repair (GO:2000779),0.5414966413544479,1.4783858683880642,0.0344418052256532,0.8908107917148131,1.0,14/39,19.07%,SPIRE2;FOXM1;SIRT7;ACTR2;MGMT;SLF2;WRAP53;MRNIP;TWIST1;SPIRE1;UBR5;TERF2IP;FMN2;PPP4C
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6324903409339597,1.477301769264092,0.05630026809651475,0.8918017596995422,1.0,1/16,0.02%,DPYSL4
prerank,regulation of wound healing (GO:0061041),0.5469999032952139,1.476224955993464,0.03214695752009185,0.8924470503914372,1.0,7/42,6.44%,VTN;EPHB2;AJAP1;CASK;ANXA1;TNFAIP3;DMTN
prerank,cellular senescence (GO:0090398),-0.4364497195782362,-1.4757426784888548,0.04591836734693878,0.6997466764998478,1.0,16/27,38.23%,SMC5;PRKCD;PML;SIRT1;CALR;TBX3;TBX2;HMGA2;NSMCE2;ECRG4;KAT6A;CDKN1A;SMC6;ULK3;HRAS;SRF
prerank,response to UV-A (GO:0070141),-0.5325818383213007,-1.4737390329611926,0.07291666666666667,0.6974456024271972,1.0,7/14,28.73%,EGFR;MME;MMP2;AKT1;MMP1;CERS1;CCND1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.6894581449885901,1.473444970811616,0.07246376811594203,0.8924498068540926,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.6894581449885901,1.473444970811616,0.07246376811594203,0.8924498068540926,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.6894581449885901,1.473444970811616,0.07246376811594203,0.8924498068540926,1.0,4/11,7.50%,DCAKD;PANK4;COASY;ACAT1
prerank,actin nucleation (GO:0045010),0.5962259499090854,1.4721838640551559,0.04743083003952569,0.8949696898982198,1.0,4/21,3.87%,SPIRE2;WHAMM;ACTR2;ARPC1A
prerank,digestive tract development (GO:0048565),0.5567157168520042,1.471909354858167,0.04529201430274136,0.8905671694930599,1.0,8/32,6.59%,STRA6;FGFR2;PCSK5;NIPBL;CHD8;CLMP;BBS7;ZIC3
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5867134407496519,1.4718713946559299,0.05667506297229219,0.8844134093901025,1.0,6/26,6.55%,SIRT2;TNFAIP3;PPM1B;CARD16;DHX58;TRAFD1
prerank,protein deacylation (GO:0035601),0.6040464396238544,1.471477243504458,0.04648241206030151,0.8808265388936956,1.0,8/23,12.36%,HDAC3;SIRT2;SIRT7;ABHD10;LYPLAL1;HDAC5;HDAC4;HDAC1
prerank,regulation of nuclear division (GO:0051783),0.6089850966958307,1.4712716117515756,0.061598951507208385,0.8761395827305302,1.0,6/20,12.64%,CUL7;OBSL1;CDK13;FBXO5;PRMT5;RCC1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.6471918271189971,1.4705067139757682,0.055632823365785816,0.8752363705114208,1.0,6/16,14.84%,SP7;SOX9;DHX36;NUDT21;SOX6;SOX5
prerank,cardiac muscle contraction (GO:0060048),0.5622469947257289,1.4699186430482423,0.04523809523809524,0.873306636336623,1.0,8/34,14.61%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1;CAMK2D;GRK2
prerank,cellular response to insulin stimulus (GO:0032869),0.4915865372509105,1.4698518271414698,0.009211873080859774,0.8677579758901939,1.0,42/124,16.91%,CPEB1;GPLD1;SELENOS;PDPK1;PARP1;USF1;SLC27A4;ATP6V0A2;XBP1;ZFP36L1;SLC25A33;LPIN1;CAPN10;PIK3R1;GAB1;ATP6V0E2;HDAC5;RAB12;INSIG1;EPRS1;LPIN3;BAIAP2;RAB10;IRS2;DENND4C;ATP6V1G1;PIK3R2;TCIRG1;MYO5A;ENPP1;LPIN2;ATP6V0A4;RAB13;PRKCI;ATP6V1D;RAB31;FOXC2;RAB8A;RAB8B;ATP6V1B2;SLC27A1;PHIP
prerank,pseudouridine synthesis (GO:0001522),0.6639055617870372,1.4695946460543252,0.06524822695035461,0.8635399061288205,1.0,4/13,9.92%,NHP2;TRUB2;PUS10;PUS7
prerank,genitalia development (GO:0048806),0.674082251457397,1.4689122705103346,0.07320644216691069,0.8623593668618913,1.0,2/12,2.18%,WNT5A;STRA6
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3987352438681982,-1.467522657511269,0.03614457831325301,0.7118510507123225,1.0,22/32,39.57%,SORBS1;ASAH1;CREBL2;ADIPOR1;PRKAB2;CREB1;PRKAA2;ADIPOR2;AKT1;PPARA;AVIL;CEACAM1;SIRT4;MID1IP1;GPER1;ASXL3;EIF6;MLXIPL;FITM2;STAR;C3;PDK4
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.497460791680559,-1.4662423264897728,0.06859205776173286,0.7067267111126273,1.0,7/18,9.67%,SMAD4;CD46;HIF1A;TGFB2;LGALS9;CD34;FN1
prerank,regulation of multicellular organism growth (GO:0040014),0.6331124746394956,1.4643038597102447,0.05333333333333334,0.8880230590899196,1.0,4/15,10.71%,IGF1;PTCH1;PPIB;APP
prerank,ovarian follicle development (GO:0001541),-0.5383947253793013,-1.4638217186138314,0.1033210332103321,0.7058246459141453,1.0,12/13,44.45%,KIT;CEBPB;VEGFA;EIF2B5;INHBA;EIF2B2;EIF2B4;INHBB;INHA;FOXL2;ANG;LHCGR
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6221712298843071,1.4634471043773425,0.055408970976253295,0.8882717792916676,1.0,4/18,8.86%,ZFP36L1;PRELID1;ABL1;XRCC6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.6376247731622379,1.4631345322057905,0.0504774897680764,0.8842129846138662,1.0,4/16,6.18%,GMPS;ADSL;PAICS;GART
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5733973771073246,1.4628307016594597,0.060459492140266025,0.8804559723052716,1.0,3/29,2.97%,TNNI3;TNNC1;FGFR2
prerank,arachidonic acid secretion (GO:0050482),0.7009928005894264,1.4621859397562522,0.0471841704718417,0.8733217936685662,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,arachidonate transport (GO:1903963),0.7009928005894264,1.4621859397562522,0.0471841704718417,0.8733217936685662,1.0,3/10,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.7049620415883529,1.4613953873872867,0.07982583454281568,0.8730961781010405,1.0,4/10,13.34%,CBARP;BIN1;ATP1A2;VDAC1
prerank,acidic amino acid transport (GO:0015800),-0.495645772583654,-1.4602089438583483,0.07114624505928854,0.7097640057363097,1.0,5/17,5.58%,SLC6A6;GJA1;ARL6IP5;SLC25A13;LRRC8D
prerank,endothelial cell proliferation (GO:0001935),-0.5079659110947122,-1.459022076548732,0.05693950177935943,0.7044133042999745,1.0,8/17,23.62%,BMPER;ERN1;TEK;CD34;PRKX;BMP4;DLG1;SEMA5A
prerank,response to amyloid-beta (GO:1904645),0.5258954855833476,1.4584275010096672,0.03953488372093023,0.8883567939277616,1.0,10/44,10.71%,MMP12;FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6984149362905056,1.458349966562787,0.06859756097560976,0.8832309568087776,1.0,2/10,4.88%,EPB41L4B;FGF10
prerank,regulation of actomyosin structure organization (GO:0110020),0.66434090377164,1.4573922062234252,0.07449856733524356,0.8846256700655066,1.0,5/13,14.18%,PTGER4;RAC1;ALMS1;AKAP13;ROCK2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5963473705604746,-1.4563510823924422,0.06666666666666667,0.7055789347357905,1.0,4/10,9.08%,KAT7;SIRT1;KAT2B;EP300
prerank,triglyceride catabolic process (GO:0019433),0.6101567598820642,1.4560551237146633,0.059379217273954114,0.8886552814314073,1.0,1/19,0.96%,LPL
prerank,protein K11-linked ubiquitination (GO:0070979),0.5782320124412544,1.4556947437341488,0.03865336658354115,0.8854563819623152,1.0,13/27,18.59%,CDC23;UBE2S;UBE2E2;CDC16;FZR1;ANAPC2;UBE2A;ANAPC11;ANAPC4;CDC26;UBE2L3;ANAPC10;ANAPC5
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5966787434310753,1.4537378959853915,0.06394557823129252,0.8932360574880714,1.0,9/21,14.68%,MED24;MED12;MED14;MED13;MED4;DHX36;TWIST1;SETX;BCLAF1
prerank,ncRNA catabolic process (GO:0034661),0.5751440870326234,1.4523525322957078,0.0480295566502463,0.8969224431584688,1.0,11/28,16.22%,EXOSC3;EXOSC7;EXOSC2;ZCCHC8;EXOSC8;LIN28B;MTREX;SND1;XRN1;DIS3L2;NUDT16L1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.613958767451918,1.4500353549258564,0.05748663101604278,0.9068295534492133,1.0,4/19,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,urogenital system development (GO:0001655),0.6806424355680749,1.44794158834497,0.07604017216642754,0.9156065546905195,1.0,3/11,8.37%,EPHB2;ANXA1;SOX9
prerank,dicarboxylic acid transport (GO:0006835),-0.42290896069137185,-1.4451047420978178,0.08602150537634409,0.7424430989959155,1.0,7/28,14.41%,GJA1;ARL6IP5;SLC26A7;SLC25A13;SLC25A32;SLC22A6;GIPC1
prerank,histone H2A ubiquitination (GO:0033522),0.612704167698529,1.445010752217059,0.06869220607661823,0.9309453072598735,1.0,7/17,12.70%,RNF8;PCGF1;DDB1;RNF168;CUL4B;KDM2B;UBE2A
prerank,embryonic digestive tract development (GO:0048566),0.6037043961540741,1.444523624459396,0.07957559681697612,0.9287143449824052,1.0,6/18,11.29%,STRA6;FGFR2;PCSK5;NIPBL;SOX11;PDGFRA
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5613545721742161,1.442364743369561,0.04975124378109453,0.9387100049345107,1.0,9/30,14.52%,RAC1;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6
prerank,regulation of neuroinflammatory response (GO:0150077),0.6113419414355606,1.4408955504756698,0.06472919418758256,0.9435439860860265,1.0,5/19,15.32%,IGF1;IL33;CD200R1;PTGS2;NUPR1
prerank,cellular response to calcium ion (GO:0071277),0.5045848184774457,1.4402558969413466,0.03275109170305677,0.9422552852063653,1.0,28/67,23.24%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;PKD2;PRKAA1;KCNH1;SMPD1;SYT4;SYT11;SYT12;CPNE2;SYT7;SYT2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5634518023930641,1.4402358720244868,0.049689440993788817,0.9367455491763825,1.0,8/26,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;SARS1;PTGS2;TGFB1
prerank,response to interferon-beta (GO:0035456),-0.44433072240438604,-1.4400390832146879,0.05909090909090909,0.7532923943567548,1.0,13/22,23.52%,UBE2K;IFNAR2;STAT1;PLSCR1;IKBKE;AIM2;XAF1;IRGM;NDUFA13;BST2;IFITM2;IFITM1;UBE2G2
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6876352541211259,1.4395258468728025,0.07142857142857142,0.9359461840677158,1.0,1/10,0.06%,CARMIL2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5817328979528443,1.4391950978179389,0.06797385620915032,0.9328041715045384,1.0,1/21,0.14%,PLA2G5
prerank,regulation of exocytosis (GO:0017157),0.5209243693553158,1.438407335526886,0.043478260869565216,0.9331863433412239,1.0,16/46,17.01%,UNC13D;CPLANE2;ANXA1;RAB12;CPLX1;CHMP3;RAB10;RAB3B;RAB2B;IL1RAPL1;SYT1;RAB13;RAB8A;RAB8B;NSF;RAB21
prerank,negative regulation of B cell activation (GO:0050869),0.5786785896847174,1.4381427932509234,0.07601572739187418,0.9296478857637258,1.0,3/21,4.85%,FCGR2B;SFRP1;TNFAIP3
prerank,positive regulation of protein sumoylation (GO:0033235),0.6815064175478934,1.4360535063865092,0.08131241084165478,0.9388707677206225,1.0,7/10,22.92%,GNL3;RWDD3;SAE1;HDAC4;PIAS3;PIAS1;UBA2
prerank,protein heterotetramerization (GO:0051290),0.6392371094942271,1.4339178892004896,0.0707070707070707,0.9484595966402252,1.0,6/13,18.02%,FARSB;GRIN1;CPSF7;NUDT21;CPSF6;PKD2
prerank,positive regulation of neuron differentiation (GO:0045666),0.5314662825942941,1.4336412414214013,0.053613053613053616,0.9449168683262721,1.0,11/40,17.06%,FGF20;FGFR1;TCF4;ZEB1;BRINP3;MMD;GPRC5B;SOX11;IMPACT;TCF3;BRINP1
prerank,sensory perception of chemical stimulus (GO:0007606),0.6166477841474358,1.4324437971419621,0.06789250353606789,0.9478078463590774,1.0,4/15,10.58%,SYT10;SLC24A4;GNAS;UBR3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6471278095244705,1.4320768448322696,0.0700280112044818,0.9449937212044607,1.0,4/14,6.18%,GMPS;ADSL;PAICS;GART
prerank,negative regulation of immune effector process (GO:0002698),-0.5232702849955725,-1.4319791780565716,0.0979020979020979,0.7770384683337859,1.0,6/13,13.96%,FER;APPL1;RPS19;RC3H1;GRN;ENPP3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.6307028581787727,1.4316967172989208,0.0893371757925072,0.9421947386006534,1.0,6/14,13.47%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6526533385685634,1.4297447646685773,0.08333333333333333,0.9507434534215095,1.0,1/12,1.00%,B3GALNT1
prerank,negative regulation of protein processing (GO:0010955),-0.5444775061996531,-1.4288067668663074,0.11,0.7802268547678131,1.0,4/12,7.45%,TMEM59;SERPINE2;THBS1;LRRK2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.58108703067922,1.4275594636853763,0.07953063885267275,0.9607179331781452,1.0,5/22,6.42%,EXOSC3;NOP9;EXOSC7;EXOSC2;EXOSC8
prerank,negative regulation of cation channel activity (GO:2001258),0.5653043066927497,1.424448483816253,0.06918238993710692,0.9769340623073296,1.0,4/26,3.09%,UBQLN1;CBARP;EPHB2;CALM3
prerank,cellular response to pH (GO:0071467),0.6052295552245391,1.4243034396762353,0.06550802139037433,0.9727211799082242,1.0,3/17,4.43%,GPLD1;ASIC1;GPR68
prerank,regulation of exit from mitosis (GO:0007096),0.5254031556225194,1.4230477615130563,0.07771428571428571,0.9761456280504552,1.0,16/38,19.74%,CDC23;SIRT2;UBE2S;MAD2L1;CDC16;ANAPC2;CDC14B;PPP1R9B;ANAPC11;ANAPC4;CDC26;UBE2E1;UBE2D1;ANAPC10;ANAPC5;ZW10
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5023982556785674,1.4222754891562759,0.04661487236403995,0.9762280549503206,1.0,8/54,8.20%,AMIGO1;KCNAB2;BIN1;CD63;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,regulation of amyloid-beta clearance (GO:1900221),0.6092444362986406,1.4221772946028866,0.08762169680111266,0.9716804022651708,1.0,7/16,17.19%,LRPAP1;ABCA7;IFNGR1;HDAC1;CYP51A1;LRP1;APOE
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5477429676339157,-1.421504337562672,0.08359133126934984,0.8007849537980175,1.0,4/11,9.22%,PUM1;STAT3;XPO5;LIMD1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5629380041686388,-1.4214735349878342,0.10365853658536585,0.7908138487855305,1.0,3/11,3.57%,SMAD4;LMNA;GLRX3
prerank,renal filtration (GO:0097205),0.6833959051578657,1.4211447277823042,0.0880597014925373,0.9739672104661113,1.0,3/10,6.14%,XPNPEP3;SULF1;TMEM63C
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4257828820935904,-1.420364441969817,0.09183673469387756,0.7854751316226468,1.0,8/24,16.70%,PECAM1;EZR;F11R;SEMA4D;NT5E;ROCK1;ITGA4;MSN
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5995094322188125,1.4202701445673553,0.08677685950413223,0.9748232440422127,1.0,9/17,22.64%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,negative regulation of cholesterol transport (GO:0032375),0.6809739013567648,1.4199795755165232,0.08955223880597014,0.9715984649993765,1.0,2/10,4.31%,NFKB1;ABCA2
prerank,histone H4 deacetylation (GO:0070933),0.6822872495734242,1.4198522797864155,0.09720176730486009,0.9673474232403118,1.0,5/10,12.36%,HDAC3;SIRT2;HDAC4;RCOR1;HDAC1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5574656392643171,1.4197739251288808,0.0743073047858942,0.9628632778535898,1.0,7/27,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6801268845162873,1.4197150772000777,0.07981927710843373,0.9582264670183144,1.0,1/10,0.17%,RNF157
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6309765424957051,1.419411698482425,0.08426966292134831,0.9551604042182752,1.0,3/14,7.22%,APLN;SULF1;GPC1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5367201660409611,1.4186652118727467,0.05620608899297424,0.9554591582736393,1.0,10/38,10.71%,IL34;SH3BP5;DLG3;THY1;LRP8;GPRC5B;SH3BP5L;MVP;SRCIN1;APP
prerank,regulation of keratinocyte migration (GO:0051547),0.6585901427412779,1.418275403834222,0.09620991253644315,0.9531646289533561,1.0,2/12,4.88%,EPB41L4B;FGF10
prerank,acylglycerol biosynthetic process (GO:0046463),0.5723363751440613,1.4181675958705944,0.0897597977243995,0.9489935305243961,1.0,7/23,12.41%,MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.432131065810976,-1.4173164899530792,0.0663265306122449,0.7885363514618343,1.0,8/24,10.78%,UBE2N;IRAK2;IRAK1;NOD1;RNF34;CYLD;UBB;IKBKG
prerank,immunoglobulin mediated immune response (GO:0016064),0.6598326693616645,1.4170848223658608,0.08995502248875563,0.9511996080262748,1.0,1/10,0.85%,FCGR2B
prerank,negative regulation of histone modification (GO:0031057),0.6369881448507665,1.417062344870896,0.0890125173852573,0.9464902851942699,1.0,5/14,16.05%,AASS;PRMT6;TWIST1;JARID2;CTBP1
prerank,ketone body metabolic process (GO:1902224),0.6814813337537082,1.4170241565445143,0.08592592592592592,0.9419322188244881,1.0,4/10,7.50%,HMGCLL1;OXCT1;BDH1;ACAT1
prerank,peptidyl-amino acid modification (GO:0018193),0.6888768084067804,1.4168977641505383,0.0736196319018405,0.9380242231060195,1.0,4/10,13.29%,TTLL4;METAP1;METAP1D;METAP2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5904522079831181,1.4167221677131792,0.09428950863213811,0.9299503750364366,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,positive regulation of glycolytic process (GO:0045821),0.5904522079831181,1.4167221677131792,0.09428950863213811,0.9299503750364366,1.0,6/20,10.71%,SLC4A4;IGF1;ARNT;PRXL2C;ZBTB20;APP
prerank,regulation of protein sumoylation (GO:0033233),0.6177580214432411,1.4165796117501235,0.07951482479784366,0.9261548951868873,1.0,7/17,15.02%,GNL3;RWDD3;SAE1;HDAC4;ZMIZ1;PARK7;PIAS3
prerank,neuron projection extension (GO:1990138),0.5324873284928838,1.4163331910739057,0.07636363636363637,0.9232829327624411,1.0,14/32,15.90%,HSP90AA1;NRP1;CDK5;TMEM108;CYFIP1;FLRT1;IQGAP1;NLGN3;USP9X;ALCAM;AUTS2;IMPACT;SEMA3A;SLC9A6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5410139566645553,1.4156868178393276,0.0775,0.9229838282977156,1.0,8/31,11.07%,BAX;CHCHD10;TFDP1;ZNF205;NMT1;YWHAH;YWHAG;BCL2
prerank,regulation of cellular protein localization (GO:1903827),0.5136214192859939,1.4154106535842719,0.05281285878300804,0.9204081055761437,1.0,11/45,9.82%,TRIM67;KCNAB2;LCP1;PARP1;HSP90AA1;ABCA2;GPC6;DVL1;GPC1;EGF;VCP
prerank,regulation of blood circulation (GO:1903522),0.5452239973337569,1.4147242297816212,0.0583232077764277,0.9203394194613854,1.0,7/34,11.50%,KCNG2;DMPK;CELF2;DES;BDKRB2;TPM1;CAMK2D
prerank,Golgi ribbon formation (GO:0090161),0.6424844257296511,1.4144426303894841,0.08702064896755163,0.9178958144340837,1.0,5/13,15.63%,STX6;TRIP11;STX16;PRMT5;VTI1A
prerank,regulation of cellular localization (GO:0060341),0.5071279418987902,1.4140551379292934,0.0397196261682243,0.9161478230864013,1.0,19/46,23.25%,TRIM67;UNC13D;PARP1;HSP90AA1;DVL1;BRSK2;BRSK1;CAMK2D;NUMA1;ADCY5;EPHA5;WWC1;LYN;PARD6G;GSN;PPM1F;GOSR1;MAP2;STXBP4
prerank,membrane lipid catabolic process (GO:0046466),0.672381338214518,1.4124272092341261,0.0763582966226138,0.9222936939055828,1.0,4/10,10.25%,SMPDL3B;SMPD2;SGPL1;ENPP2
prerank,mesenchyme development (GO:0060485),0.6302920247112844,1.4115748315482939,0.07639836289222374,0.9234184197666994,1.0,2/15,2.97%,SFRP2;FGFR2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5816304977050644,1.4097336517780505,0.08545918367346939,0.9313109965295053,1.0,5/22,4.88%,EPB41L4B;FGFR2;CASK;ZFP36L1;FGF10
prerank,protein heterooligomerization (GO:0051291),0.5967145297255603,1.4087495724650623,0.09201623815967523,0.9335538832527499,1.0,8/17,18.44%,FARSB;GRIN1;KCNC2;CPSF7;NUDT21;CPSF6;PKD2;MAT2A
prerank,cellular response to amyloid-beta (GO:1904646),0.5187149705432768,1.4085992271376633,0.0706713780918728,0.9301715755470342,1.0,11/35,16.06%,FCGR2B;IGF1;GRIN1;ATP1A3;CDK5;SNX6;GRIN2A;CACNB1;APP;LRP1;ICAM1
prerank,retinoid metabolic process (GO:0001523),0.48721385776415094,1.4055148883370647,0.03965702036441586,0.9460307608962283,1.0,16/71,17.19%,LPL;RDH10;STRA6;GPC6;ALDH1A2;RDH11;GPC1;LRP8;RDH5;RBP1;AKR1B10;CYP26B1;GPC4;LRP1;HSPG2;APOE
prerank,respiratory system development (GO:0060541),0.5328614004048255,1.4052279868331878,0.07590361445783132,0.9436722634704459,1.0,4/32,6.59%,FGF9;STRA6;FGFR2;ZIC3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.6073813930381772,1.405136810683923,0.09517241379310344,0.9399008481565423,1.0,4/16,9.11%,KHSRP;PLEKHN1;ZFP36L1;DHX36
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6170110524240787,1.404236276822532,0.09825033647375504,0.9415614055884921,1.0,5/15,17.19%,GPLD1;NRDC;PACSIN3;SNX33;APOE
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.6549819462487797,1.404230974893198,0.08860759493670886,0.9372781927342964,1.0,8/12,21.94%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,glycosphingolipid metabolic process (GO:0006687),0.5152822350341726,1.4037759609367593,0.06825938566552901,0.9359982205455409,1.0,12/42,14.35%,B3GALNT1;A4GALT;CLN6;ST8SIA3;SMPD2;GBA2;GLB1;ABCA2;ST3GAL5;PSAP;SMPD4;ST6GALNAC6
prerank,rRNA catabolic process (GO:0016075),0.6037689401464408,1.4037162187059813,0.09491059147180192,0.9321525083557813,1.0,4/16,6.42%,EXOSC3;EXOSC7;EXOSC2;EXOSC8
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5503510098399295,1.4036359840535884,0.07990012484394507,0.924291991620369,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5503510098399295,1.4036359840535884,0.07990012484394507,0.924291991620369,1.0,8/29,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;ACAT1;CROT;ACSL6
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5234964204802133,1.4024648125056407,0.06984866123399301,0.9273851197801984,1.0,7/41,10.90%,SFRP2;TNNI3;TNNC1;FGFR2;SOX11;TPM1;RBPJ
prerank,response to zinc ion (GO:0010043),-0.4227117467450292,-1.4016752681332239,0.0730593607305936,0.8453871554549959,1.0,13/25,21.70%,SLC30A4;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;D2HGDH;GLRA2;CRIP1;MT2A
prerank,alanine transport (GO:0032328),-0.5655054288211607,-1.4013595490108417,0.10644257703081232,0.8366056228449316,1.0,5/10,27.20%,SLC6A6;SLC36A4;SLC1A4;SLC6A17;SLC36A1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5989923621530836,1.4012420168945736,0.09769335142469471,0.9312798665730968,1.0,9/17,17.69%,CPEB1;CDK9;RNF40;CPSF7;ZC3H14;NUDT21;ZC3H3;CCNT1;CPSF6
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.52560016758298,1.4009143152675672,0.06775700934579439,0.9291569258135667,1.0,10/39,17.25%,MYO1A;CLN3;MYO19;TANC2;MYO1B;MYO5A;BICDL1;HTT;TRAK1;KIF5B
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5677238694425473,1.4005902608300589,0.09783989834815757,0.9271825454264733,1.0,4/23,12.83%,IGF1;TNFAIP3;CARD16;GIT1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6683333052370771,1.4005680728207397,0.0995405819295559,0.9191780001273446,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,DNA dealkylation (GO:0035510),0.6683333052370771,1.4005680728207397,0.0995405819295559,0.9191780001273446,1.0,7/10,19.29%,MPG;MGMT;ASCC1;ALKBH3;ASCC2;FTO;ALKBH1
prerank,carbohydrate derivative transport (GO:1901264),0.5863722129979727,1.4004681057944783,0.08955223880597014,0.9157703355411313,1.0,4/18,8.89%,SLC29A1;CLN3;SLC25A19;VLDLR
prerank,regulation of protein neddylation (GO:2000434),-0.5689514864343683,-1.399529434763009,0.07861635220125786,0.8342947603793323,1.0,4/10,6.65%,DCUN1D4;RPL11;HIF1A;RPL5
prerank,sodium ion export across plasma membrane (GO:0036376),0.6297806987090138,1.399335995188221,0.09264705882352942,0.9189678964182906,1.0,3/13,7.53%,SLC4A4;ATP1A3;ATP1A2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.529378212255717,-1.3982075346428917,0.08681672025723473,0.829962819613442,1.0,6/13,24.20%,GJA1;GJC1;CACNA1C;CACNB2;KCNJ3;KCNQ1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4671116523151974,1.3975739273493757,0.020618556701030927,0.9263656853237856,1.0,48/129,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;FGF10;PPM1B;USP47;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.611190870838697,1.3972526439537172,0.1070460704607046,0.9243406223350795,1.0,3/15,15.38%,HGD;FAH;QDPR
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6314803440586227,1.3966619185172218,0.08885542168674698,0.9240825976589714,1.0,1/13,1.00%,B3GALNT1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4745143957461891,1.3962855858965217,0.03882476390346275,0.9224564315769979,1.0,13/85,8.37%,SFRP2;FGF9;EPB41L4B;SFRP1;IGF1;BMP6;FGFR2;ZFP36L1;FGF10;LAMC1;TCF7L2;MAGED1;SOX9
prerank,DNA catabolic process (GO:0006308),0.6491907309739028,1.3959737582049654,0.10271041369472182,0.9206069790402407,1.0,3/11,6.72%,DNASE1L2;FBH1;DFFB
prerank,regulation of axon guidance (GO:1902667),0.6683211135031287,1.3955324584233184,0.07819548872180451,0.9194567091291512,1.0,5/10,16.03%,ZSWIM6;NRP1;MYCBP2;YTHDF1;ZSWIM8
prerank,ncRNA metabolic process (GO:0034660),0.5362894003194894,1.395443719301941,0.07117852975495916,0.9161835202171847,1.0,5/37,4.08%,KHSRP;TARBP2;DGCR8;DDX17;ZCCHC8
prerank,positive regulation of lipid localization (GO:1905954),0.6468056976347891,1.3953518234845244,0.11363636363636363,0.9129255140848769,1.0,2/11,2.19%,LPL;NFKB1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4147955017268726,-1.3947098353110567,0.0776255707762557,0.8361908128889495,1.0,9/25,11.38%,HIPK2;CSNK2A1;PML;RPL11;HSP90AB1;RPL5;PSMF1;TRIM39;GABARAPL2
prerank,regulation of cell cycle process (GO:0010564),0.4712002945192494,1.394330425521852,0.036382536382536385,0.9157895911769613,1.0,34/104,22.07%,CCP110;FSD1;SFRP1;CUL7;CSNK2A2;RAB11FIP4;MYO19;CALM3;OBSL1;CDK13;FLCN;FBXO5;PLK5;SOX9;ENTR1;PRMT5;MAP9;USP19;RCC1;GIT1;SND1;PRPF40A;KLHL13;NUMA1;PIK3C3;KIF20B;CALM1;PIK3R4;YTHDF2;UVRAG;KLHL9;RAB11FIP3;CALM2;CUL9
prerank,tyrosine metabolic process (GO:0006570),0.6610162921285561,1.3938427804826696,0.09812409812409813,0.9151103494417473,1.0,1/11,0.55%,HGD
prerank,regulation of B cell differentiation (GO:0045577),0.5868971866755968,1.3934374251955524,0.09029649595687332,0.9140189212543889,1.0,3/17,4.02%,SFRP1;XBP1;ZFP36L1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6023474135534935,1.3933943969706233,0.08390646492434663,0.9104682109335708,1.0,5/17,9.08%,NTF3;NRP1;CDK5;ABL1;BAIAP2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5445454967919322,1.3912460620132858,0.09753086419753086,0.9202351886316333,1.0,6/27,13.55%,SELENOS;TNFAIP3;CD200R1;SIRPA;ARRB1;PTPN22
prerank,regulation of microtubule polymerization (GO:0031113),0.5162544103680352,1.3911166947290867,0.0587557603686636,0.9173451984846953,1.0,19/40,23.05%,PSRC1;RAC1;MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;DRG1;CLIP3;MAPT;EML2;TBCD;NUMA1;TUBB4A;RPS3;CAMSAP1;PAK1;MAP2;CDK5RAP2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5523019997618959,1.3904309817075018,0.08312342569269521,0.917922435763225,1.0,7/24,14.28%,EIF2AK3;RORA;CCBE1;SULF1;ARNT;PTGS2;TGFB1
prerank,protein targeting to ER (GO:0045047),-0.3193060987946442,-1.3901819614510225,0.0,0.8464437661382446,1.0,46/99,20.15%,RPS24;RPL11;RPS15A;RPS23;RPL5;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;RPL36;RPL10;RPL32;RPS28;SRPRB;RPS5;SPCS3;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;SGTA;RPS26;RPS27;RPL10A;RPS10;RPL7A;SGTB;SEC61A1;RPL31
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5167426735993795,-1.389473056891871,0.09717868338557993,0.8398073838834386,1.0,5/12,16.22%,TASOR;PPHLN1;APOBEC1;SETDB2;DNMT1
prerank,negative regulation of cilium assembly (GO:1902018),0.6435729463073205,1.3887878153707707,0.09523809523809523,0.9241858727545526,1.0,7/12,18.26%,CCP110;TBC1D7;CEP97;TCHP;EVI5L;MAP4;CDK10
prerank,isotype switching (GO:0045190),0.6583502292626003,1.388557079380581,0.11463046757164404,0.9216989148028568,1.0,4/10,15.53%,EXOSC3;RNF8;RNF168;HSPD1
prerank,positive regulation of phospholipase activity (GO:0010518),0.5717174538941052,1.3883388783900361,0.0847682119205298,0.9193108537234913,1.0,5/22,3.62%,PLA2G5;PDPK1;NTF3;FGFR2;FGFR1
prerank,secretion (GO:0046903),0.6208672483624872,1.3883347642508956,0.11475409836065574,0.9156345470888062,1.0,4/14,13.35%,GUCA1B;SLC22A4;FBLN5;PRKCI
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3357323341733629,-1.3882206783184425,0.012048192771084338,0.8357550251104808,1.0,18/65,16.00%,LEF1;FOXP1;KIT;SBNO2;PML;SIRT1;PIR;LGALS9;TGFBR2;EP300;RARA;MT1G;OSTM1;CBFA2T3;THOC5;GLO1;TNFRSF11A;BMP4
prerank,negative regulation of lymphocyte activation (GO:0051250),0.573670531436608,1.3876248882715803,0.08571428571428572,0.9162813817593997,1.0,5/21,13.55%,FCGR2B;TNFAIP3;PIBF1;SOX11;PTPN22
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.6408839622245106,1.3862311011780093,0.10775862068965517,0.9178312128922413,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6408839622245106,1.3862311011780093,0.10775862068965517,0.9178312128922413,1.0,4/12,14.41%,IGF1;CHERP;STIMATE;CAMTA1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.590363979997675,1.3856720116808379,0.10109289617486339,0.9175690805974873,1.0,2/17,0.87%,UNC13D;SYT10
prerank,cytoplasmic translational initiation (GO:0002183),-0.4757533585409786,-1.3854064861919533,0.0992063492063492,0.8378909590667571,1.0,9/17,26.18%,EIF2S2;EIF4B;MCTS1;RBM4;EIF4A2;EIF2D;EIF5;EIF3I;EIF3D
prerank,organic anion transport (GO:0015711),0.4740188688138237,1.3849274677638617,0.04310344827586207,0.9186830764135371,1.0,7/76,2.23%,CYB5R2;SLC4A4;SLC4A5;SLC35B2;SLC35B1;SLC25A19;LRRC8A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4800114382326795,1.3847090826732553,0.062023939064200215,0.9164260703218144,1.0,11/66,12.83%,WNT5A;LPL;IGF1;GSDMD;TNFAIP3;CARD16;TMEM106A;SIRPA;MALT1;APP;GIT1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5239132135956246,1.3846381217806891,0.07719298245614035,0.9133350936954807,1.0,9/35,15.44%,FASN;ALOX5AP;HMGCLL1;FAR2;BDH1;ACAT1;PAM;FAR1;SLC25A1
prerank,protein secretion (GO:0009306),0.49229454491040353,1.3830462750968886,0.06945975744211687,0.9197705383014938,1.0,20/56,18.19%,PTPRN;ANXA1;PCSK5;TVP23B;MIA3;RAB12;RCN3;RAB10;WLS;RAB3B;PORCN;PARK7;TANGO2;CAMK2G;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5559429821009497,1.3827129325451994,0.09293680297397769,0.9181266838461116,1.0,10/26,21.10%,SMPDL3B;GPR108;IRF1;LGR4;LRRC14;TLR3;GPS2;FLOT1;BIRC3;APPL2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3842613802072714,-1.382064358625463,0.07746478873239436,0.8428280286862189,1.0,13/34,13.78%,LATS1;MFHAS1;PICALM;GPM6B;UBXN2B;GOPC;NSFL1C;TTBK2;ILRUN;ACTN2;MAP1A;NEDD4L;SIN3A
prerank,regulation of secretion (GO:0051046),0.6267514956864054,1.3816755599602424,0.1,0.9209948649567634,1.0,6/13,16.96%,GPLD1;OPRK1;FGF10;EGF;NRG1;OAS2
prerank,regulation of dendrite extension (GO:1903859),0.586898628707185,1.3814865902112188,0.0938337801608579,0.9185618058584987,1.0,3/18,3.59%,RNF157;SYT3;UNC13A
prerank,sensory perception of smell (GO:0007608),0.6427850687539587,1.3814838469491189,0.09186746987951808,0.9150611404226752,1.0,3/11,10.58%,SYT10;SLC24A4;UBR3
prerank,axon development (GO:0061564),0.4764616961531442,1.380727472276118,0.035181236673773986,0.9161059166531743,1.0,28/78,21.89%,AMIGO1;EPHB2;ATL1;FGFR2;NEFH;CDK5;PAK3;BRSK2;CAMSAP2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;MAPK8IP3;DOCK7;MAPT;RAB8A;DCC;ZDHHC17;SLITRK1;SLITRK5;SPTBN4;LLGL1;RYK;ARHGAP35
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5334728897290218,1.3798051569233096,0.08812729498164015,0.9180869183766632,1.0,6/30,9.79%,SFRP2;CDKN2D;CXCL12;SNAI1;FBXO5;TWIST1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.550203875359066,1.37937643356218,0.08618504435994931,0.9171422550057575,1.0,10/25,17.62%,STUB1;ZYG11B;NGLY1;AUP1;POMT2;KLHL15;VCP;UGGT2;DERL1;OMA1
prerank,T cell homeostasis (GO:0043029),-0.5479462763363923,-1.378856333501831,0.11363636363636363,0.8471251216096781,1.0,5/10,24.61%,PPP2R3C;FAS;AKT1;NCKAP1L;ZC3H8
prerank,mammary gland development (GO:0030879),0.5813678554078467,1.378843539065716,0.096,0.9169536191342906,1.0,6/21,14.04%,APLN;GPAT4;ZBTB7B;WNT4;PRLR;NRG1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.48586876563372156,1.3761762216302167,0.06347438752783964,0.929949643636727,1.0,11/59,12.08%,NDUFAB1;LPL;CYP27A1;MLYCD;XBP1;ALDH1A2;CYP7B1;HSD17B4;ELOVL4;AMACR;PARK7
prerank,regulation of protein polymerization (GO:0032271),0.5185988510544066,1.375954719841049,0.09449760765550239,0.9278617246930537,1.0,11/35,9.63%,ABITRAM;HSP90AA1;MAPRE3;GBA2;ABL1;PAK3;DBN1;TPPP3;CAMSAP2;PRUNE1;DBNL
prerank,regulation of mitotic nuclear division (GO:0007088),0.49204833005542775,1.375780192049439,0.06363636363636363,0.9255157980301946,1.0,10/55,9.18%,IGF1;CUL7;LCMT1;EDN3;OBSL1;CDK13;FBXO5;AURKAIP1;EGF;PRMT5
prerank,positive regulation of dendrite extension (GO:1903861),0.588637863399221,1.373948037156054,0.10526315789473684,0.9334323915054724,1.0,3/17,3.59%,RNF157;SYT3;UNC13A
prerank,negative regulation of protein phosphorylation (GO:0001933),0.453461767178114,1.3738107449305974,0.029441624365482234,0.9309202724075608,1.0,49/150,18.99%,SFRP2;SFRP1;SIRT2;TARBP2;EPHB2;GSKIP;TSC2;PDPK1;NTF3;GPD1L;CALM3;PRKRIP1;WARS1;FBLN1;PMEPA1;ERRFI1;THY1;ATG14;DMTN;DVL1;CNKSR3;SIRPA;PID1;CDK5RAP3;TWIST1;MVP;YWHAG;IGFBP3;ENPP1;PARK7;RACK1;PLPP3;ZBED3;TGFB1;FKBP8;PPM1E;IMPACT;SMAD6;ITGB1BP1;SPRY2;GNAQ;DNAJC10;CAMK2N1;RASSF2;TAB1;TERF2IP;TRIM27;CALM1;PRKAG2
prerank,miRNA metabolic process (GO:0010586),0.5773264191913934,1.3731689618209095,0.11870967741935484,0.9312910271954158,1.0,7/20,15.03%,KHSRP;TARBP2;DGCR8;DDX17;LIN28B;SND1;DIS3L2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4782786942875809,1.3718317504805515,0.059734513274336286,0.9363207476538488,1.0,23/65,19.03%,CPEB1;UBQLN1;SFRP1;SIRT2;STUB1;PICK1;RORA;ZFP36L1;CARD16;FAM162A;TBL2;MDM4;NDRG1;TWIST1;SUV39H1;AK4;EGLN2;PTGS2;NDNF;HP1BP3;MDM2;PGK1;FMN2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.6283937731692688,1.3716664677086743,0.10863509749303621,0.9338578836106654,1.0,8/13,21.94%,HEXIM1;EAPP;RNF8;RNF168;NELFA;RECQL5;HNRNPU;TCERG1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5309685904365486,1.3714872916304874,0.09587378640776699,0.9316698909486879,1.0,11/32,16.50%,CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5135325399837806,-1.3712287234152578,0.1289198606271777,0.8703341127392163,1.0,4/14,12.55%,ATP1B3;AKAP9;ACTN2;ATP1B1
prerank,positive regulation of cell adhesion (GO:0045785),0.47406895463855936,1.371145864246804,0.0455531453362256,0.9304007813501329,1.0,13/74,12.46%,SFRP2;EPB41L4B;DUSP26;RAC1;CXCL12;PRKCA;FLCN;RHOD;TPM1;ADGRG1;FBLN2;CD47;ECM2
prerank,presynapse assembly (GO:0099054),0.5843169973338935,1.369895528573982,0.11675824175824176,0.935084547392324,1.0,5/16,14.38%,WNT5A;DVL1;IL1RAPL1;NLGN3;NLGN2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.615908897808916,1.3694919631429283,0.11189801699716714,0.9342393231323315,1.0,5/13,11.52%,NFKB1;SCAP;DKK3;ERLIN2;BMP5
prerank,response to glucose (GO:0009749),0.4972812829121946,1.3692975709772166,0.0744920993227991,0.9320427572742649,1.0,12/46,13.42%,LPL;GPLD1;SELENOS;NKX6-1;XBP1;TCF7L2;SELENOT;IRS2;ZBTB20;RACK1;ZBED3;TRA2B
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5774312854655022,1.3692799467906298,0.106353591160221,0.9288002151758203,1.0,6/17,14.84%,BAX;FIS1;FZD9;BCL2;SOD2;DNM1L
prerank,regulation of glucose import (GO:0046324),0.5225056384164514,1.3690419550993622,0.09057971014492754,0.926918086008505,1.0,9/30,13.35%,RTN2;IGF1;SELENOS;CAPN10;PIK3R1;PID1;IRS2;ENPP1;PRKCI
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.5187128954291896,-1.3689302060510944,0.13194444444444445,0.8705168536643436,1.0,3/12,5.12%,WAPL;RB1;HDAC8
prerank,negative regulation of blood pressure (GO:0045776),0.617239274247425,1.3689242099594094,0.12283236994219653,0.9243152639385258,1.0,1/13,0.18%,APLN
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4858484916299148,1.368703354146038,0.08200455580865604,0.9223479843125408,1.0,14/50,16.45%,SFRP1;STK36;FGFR2;DCDC2;GLIS2;RORA;RAB34;TUBD1;PTCH1;VCP;RACK1;SUFU;TULP3;MEGF8
prerank,positive regulation of ossification (GO:0045778),0.5068101661735952,1.3680476757159037,0.0892018779342723,0.9227713083946704,1.0,11/39,9.70%,WNT5A;TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;SOX11;KL
prerank,cellular lipid catabolic process (GO:0044242),0.5390122167807083,1.3679562148335733,0.09494451294697903,0.9200246957297995,1.0,6/27,12.41%,SMPDL3B;SIRT2;LPIN1;LPIN3;ENPP2;LPIN2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.49813364600825294,1.367818387213448,0.07234539089848308,0.9176198024157061,1.0,7/41,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;ANK3;GABBR1
prerank,peptide catabolic process (GO:0043171),-0.42075467555321255,-1.367780489507212,0.08849557522123894,0.8662710843285395,1.0,12/23,23.93%,NPEPPS;LNPEP;LTA4H;ERAP1;TPP1;GGT5;XPNPEP1;ACE;ENPEP;IDE;CHAC2;TRHDE
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.4706503594519694,-1.366063389983836,0.11397058823529412,0.864609328172076,1.0,9/17,22.95%,MAML3;MAML1;STAT1;NOTCH3;KAT2B;EP300;HEYL;PBX1;NOTCH4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.492402480087313,1.365671939928594,0.08906426155580609,0.9272537846079869,1.0,12/48,16.59%,GMPS;ADSL;SLC35B2;ADCY7;DCAKD;PANK4;COASY;ACAT1;AK5;ADCY1;NPR2;ADCY5
prerank,amino acid import (GO:0043090),-0.4234648861116188,-1.365608608485018,0.0970464135021097,0.8572899943844259,1.0,6/21,5.29%,SLC6A6;SLC16A2;SH3BP4;SLC47A1;SLC7A1;SFXN2
prerank,photoperiodism (GO:0009648),0.5322225240909749,1.364331340522108,0.09523809523809523,0.9321845745934814,1.0,7/28,10.14%,CRTC1;RBM4B;FBXL12;SIK1;PER1;PPP1CC;USP2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4541926767060719,-1.3637968804277638,0.09701492537313433,0.8562316094124703,1.0,8/20,17.09%,PDCD4;THBS1;ANO6;PLCG1;SFRP4;ITGA4;PIAS4;RGCC
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4659214120187495,1.3637437248156696,0.045168067226890755,0.9325324491446776,1.0,30/75,21.78%,ATL1;ABITRAM;FGFR2;DCDC2;MINK1;NEFH;CDK5;PAK3;DVL1;BRSK2;BAIAP2;RAB10;NTNG2;BRSK1;AFG3L2;APP;ANK3;DOCK7;FARP1;RAB8A;BTBD3;TBCD;DCC;ZDHHC17;SLITRK1;SLITRK5;MAP6;SPTBN4;LLGL1;RYK
prerank,cellular response to sterol (GO:0036315),0.6100234549179735,1.3628582922345422,0.12342215988779803,0.9345760752965724,1.0,5/13,8.42%,GPLD1;RORA;MLC1;INSIG1;PTCH1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4766666968004436,1.3618830138768712,0.06566200215285253,0.9373000586366422,1.0,15/68,15.29%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;FZD9;FZD3;TCF7L2;DVL1;WNT4;DIXDC1;PORCN;PLPP3;CSNK1A1;TCF7L1
prerank,positive regulation of nuclear division (GO:0051785),0.5435223206718551,1.3604914084035815,0.09603072983354674,0.9426727932418903,1.0,4/25,9.15%,IGF1;SIRT2;EDN3;EGF
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5472395008480972,-1.3602011585802436,0.12994350282485875,0.8627074092255453,1.0,4/10,3.95%,PRKG1;RDX;SERPINE2;PRKCD
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4782381904285638,1.359751061366388,0.0784313725490196,0.9438404281236661,1.0,14/62,12.60%,SFRP2;CDKN2D;PPIF;SELENOS;SYVN1;XBP1;DDX3X;CXCL12;SNAI1;BCL2;RTKN2;PARK7;SOD2;CREB3
prerank,regulation of T cell migration (GO:2000404),0.5807733487087288,1.3593305978563535,0.1218872870249017,0.943091554435516,1.0,5/18,10.71%,CXCL12;CD200R1;RIPOR2;DOCK8;APP
prerank,sympathetic nervous system development (GO:0048485),0.5951628910430194,1.3589727456282232,0.13399153737658676,0.9420385262683055,1.0,6/15,19.15%,FZD3;NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6295858220312185,1.3585621368737006,0.13314037626628075,0.9414234552575633,1.0,6/12,21.25%,HGS;NDRG4;IFT20;CBL;F3;CBLB
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45115679406330667,-1.3585425554269948,0.10810810810810811,0.8611695394960562,1.0,6/18,13.96%,DOCK2;SBNO2;LBP;PLCG2;DYSF;ENPP3
prerank,glycoprotein catabolic process (GO:0006516),0.5803386222180651,1.3577473183555473,0.13043478260869565,0.9430848586798143,1.0,4/17,8.34%,MMP12;EDEM1;NGLY1;MANBA
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.4304217617236123,-1.3573296786066542,0.08878504672897196,0.8579262373951547,1.0,7/23,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.5497998839269914,-1.3570143139086357,0.1308411214953271,0.850646872100451,1.0,7/10,34.88%,MTHFR;MTHFS;MTHFD1;MTHFD1L;MTHFD2;DHFR;TYMS
prerank,cellular response to interleukin-6 (GO:0071354),-0.414037409852692,-1.3553531251326285,0.09947643979057591,0.8494929105989596,1.0,7/26,4.13%,SMAD4;ST3GAL6;IL6R;FER;STAT3;STAT1;SBNO2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.495363249512016,1.354906786558654,0.10329171396140749,0.9570854128611727,1.0,20/45,22.11%,MAD2L1;HECA;ZFP36L1;FZD3;SCRIB;WEE1;TRIM35;BRINP3;AURKAIP1;CHFR;PTPN3;TGFB1;BCL6;ZWINT;BRINP1;NABP2;ZW10;TOM1L2;ANGEL2;SMAD3
prerank,negative regulation of neuron differentiation (GO:0045665),-0.43237907046649915,-1.3548601637927202,0.12857142857142856,0.8433455893092496,1.0,9/22,24.88%,EIF2AK4;MED1;CALR;REST;BMP7;HES1;DTX1;SOX2;NEPRO
prerank,base conversion or substitution editing (GO:0016553),-0.532993198579948,-1.3544986686516673,0.1270718232044199,0.8368071731609579,1.0,3/11,13.01%,ADARB2;APOBEC1;METTL3
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.5117156272240435,1.3544315183509892,0.08419838523644751,0.956826276843348,1.0,12/40,14.63%,BAX;SLC25A33;PRELID1;ABL1;PPA2;SLC25A36;PID1;VCP;BCL2;PARK7;MAPT;RNF122
prerank,regulation of ion transport (GO:0043269),0.47130640583662786,1.354406297353285,0.061621621621621624,0.9537406267193242,1.0,13/76,12.73%,FGF20;SYT3;SYT10;NKAIN4;VAMP3;SNX6;SIK1;KCNJ10;YWHAH;PER1;GDNF;ANK3;SYT1
prerank,positive regulation of cell differentiation (GO:0045597),0.4393313175652992,1.3533959994552018,0.006012024048096192,0.9567368252108012,1.0,59/237,16.48%,SFRP2;PLA2G5;MAPK9;LPL;TMEM119;SFRP1;IGF1;SP7;FBN2;NFKB1;LRRC8A;BMP6;EDN3;FGFR1;XBP1;GLIPR2;ZFP36L1;NELL1;SNAI1;OLFM1;DDR2;TCF4;ABL1;FBXO5;SUCO;EZH2;ZEB1;RANBP3L;GPC1;RIPOR2;TGFB1I1;WDFY2;BRINP3;WNT4;SOX9;MMD;GPRC5B;SDCBP;DHX36;SOX11;TWIST1;GDNF;IGFBP3;BNIP2;NUDT21;SOX6;AXIN2;RPS6KA3;TGFB1;AAMDC;IMPACT;SOX5;LMO3;TCF3;CTNNBIP1;RPS6KA1;CDS1;MEDAG;AGTR1
prerank,lipoprotein localization (GO:0044872),0.6214178804265222,1.352181406339006,0.1318051575931232,0.9610934835270248,1.0,5/11,17.86%,MIA3;ZDHHC3;LRP1;VMP1;ZDHHC17
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5040926195356805,-1.3519955710847689,0.14864864864864866,0.8382820299582874,1.0,8/13,18.49%,GOT2;IDH1;IDH2;PHYH;D2HGDH;GPT2;L2HGDH;GOT1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.44844427057475095,-1.3516455203790558,0.1417624521072797,0.831740136019477,1.0,8/19,11.89%,PRKCH;IKBKB;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,peptide hormone secretion (GO:0030072),0.526506597431827,1.3514894752920616,0.12437810945273632,0.9619931264848521,1.0,5/26,12.18%,PTPRN;EDN3;ANXA1;PARK7;CAMK2G
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6372086266641434,1.3510987628477924,0.12951807228915663,0.9610574133369642,1.0,4/11,5.91%,IGF1;TSC2;EIF2AK3;PIK3R1
prerank,neurotransmitter transport (GO:0006836),0.4694909462717706,1.3497693533276993,0.05477980665950591,0.9657041801481583,1.0,16/73,14.29%,SLC29A1;PPFIA4;GLS2;CASK;UNC13A;DVL1;ATP1A2;GLUL;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1;SLC6A4;SLC1A3;SLC6A15
prerank,regulation of interleukin-13 production (GO:0032656),-0.5132535967636045,-1.3494160271094637,0.11920529801324503,0.8334967574662371,1.0,3/13,9.42%,LEF1;LGALS9;RARA
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6389242284272472,1.348990732780811,0.16366366366366367,0.9673299041656194,1.0,3/10,6.42%,EMC1;EMC8;MMGT1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5584762624421598,1.348660951899595,0.1218872870249017,0.9662070123842231,1.0,6/20,18.02%,APLN;SULF1;GPC1;NPTN;SPRY2;PRKD2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5616506874594915,1.34820082214546,0.11879895561357702,0.9659034700038099,1.0,6/20,18.98%,RNF157;APLP1;GRK3;GRK2;MRAP2;GPRASP1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.38724689535551576,-1.3478739613642503,0.10112359550561797,0.8321940064117571,1.0,10/28,17.15%,UBE2N;IRAK2;IRAK1;NOD1;OTULIN;CYLD;UBB;IKBKG;IRGM;AAMP
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5336659303216775,1.347017984707733,0.10625,0.9700043871840742,1.0,8/27,13.59%,FCGR2B;FBXO7;BRSK2;NTNG2;BRSK1;IL1RAPL1;CAMK2G;DISC1
prerank,positive regulation of protein processing (GO:0010954),0.5632966851245543,1.3469468439324874,0.13438735177865613,0.9673429536937697,1.0,2/19,4.19%,CLEC3B;CCBE1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5592136583159956,1.3459821208932745,0.1272965879265092,0.9702143902988576,1.0,8/20,15.76%,GMPS;ADSL;PAICS;GART;AK4;HPRT1;AK3;GMPR2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5096725589028791,1.345935792719385,0.10628019323671498,0.96739336143958,1.0,6/34,14.67%,WNT5A;EPHB2;XBP1;VAMP3;PTPN22;LACC1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4602603322359679,-1.3457542827290916,0.10588235294117647,0.8331027844494439,1.0,4/16,21.26%,LAMP1;CADM1;NECTIN2;PVR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5503677270344121,1.345657045723649,0.1397712833545108,0.9659847856905097,1.0,7/21,15.91%,SIRT2;SLC30A10;PARK7;COA8;ABCB7;ABCD2;SIRT5
prerank,negative regulation of hormone secretion (GO:0046888),-0.5372786242659832,-1.3450532830385424,0.15060240963855423,0.828334498500517,1.0,3/10,18.74%,GJA1;RAB11FIP5;RAB11FIP1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4469783612142377,1.3446051800692407,0.03076923076923077,0.9693015503193875,1.0,52/152,20.13%,SFRP2;TMEM198;ATP6AP2;SFRP1;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DDX3X;FZD9;TNFAIP3;FGF10;PPM1B;USP47;SULF1;PSMB10;PSMD11;XIAP;GPRC5B;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;JUP;AXIN2;ZBED3;CDC73;DISC1;CSNK1D;RNF220;TGFB1;LYPD6;PSMD1;USP34;ADGRA2;TNKS;PTK7;UBR5;PSMD6;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;PRDM15;LRRK1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3634428193853274,-1.3445707004283007,0.0547945205479452,0.8230388140550475,1.0,20/37,21.70%,HIPK2;WAC;FHIT;CSNK2A1;PML;RPL11;HSP90AB1;UCHL5;RPL5;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;PDCL3;UBXN1;NOP53
prerank,regulation of leukocyte migration (GO:0002685),0.5798683918153726,1.3442012308327091,0.12083333333333333,0.9687894314450065,1.0,3/16,6.68%,RAC1;ANXA1;MIA3
prerank,triglyceride metabolic process (GO:0006641),0.48598518976270016,1.3433263287900337,0.08409090909090909,0.9709123938257642,1.0,8/48,12.41%,LPL;MOGAT3;LPIN1;GPAT4;LPIN3;GPAM;AGMO;LPIN2
prerank,regulation of cell junction assembly (GO:1901888),-0.39899802113705163,-1.3431372458380122,0.07,0.8212965113065086,1.0,9/27,11.89%,MEF2C;PRKCH;PDLIM5;TJP1;CLDN5;PRKACA;F11R;OCLN;ROCK1
prerank,activation of adenylate cyclase activity (GO:0007190),0.5158363800606601,1.342392377485171,0.10216346153846154,0.9734519511712615,1.0,2/35,2.40%,FSHR;ADCY7
prerank,nuclear membrane disassembly (GO:0051081),0.6044908174023599,1.341245053996966,0.14439946018893388,0.9773787023722553,1.0,4/14,6.66%,LPIN1;PRKCA;NEK9;AKAP8L
prerank,heart contraction (GO:0060047),0.5031607061607031,1.341059439610924,0.09414466130884042,0.9753197013873366,1.0,6/41,10.81%,TNNI3;TNNC1;TNNI1;ATP1A2;SCN2B;TPM1
prerank,regulation of neuron apoptotic process (GO:0043523),0.4551410510099185,1.3408966153606714,0.05219206680584551,0.9732245749955915,1.0,23/96,17.19%,FGF20;CLN3;EPHA7;BAX;NTF3;FZD9;CDK5;SNX6;SLC30A10;DDIT3;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;LANCL1;PRKCI;EGLN2;NUPR1;NDNF;FAIM2;APOE
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5030050895722391,1.340444444738117,0.11229314420803782,0.9729389298562079,1.0,7/35,11.37%,IL10RA;OCIAD2;IL10RB;PIGU;HGS;EGF;LEPROT
prerank,positive regulation of cell growth (GO:0030307),0.4508090520237028,1.340253162448503,0.055613850996852045,0.9710104609241424,1.0,21/96,13.93%,SFRP2;RNF157;SYT3;SFRP1;IGF1;CDKN2AIP;EXOSC2;CDKL5;TAF9B;UNC13A;SLC25A33;DDX3X;USP47;DBN1;SDCBP;DBNL;BCL2;EIF4G2;SYT1;RPS6KA3;MAPT
prerank,myelin assembly (GO:0032288),0.6335550821710894,1.34010515890489,0.17620481927710843,0.9689178760399165,1.0,6/10,21.60%,ABCA2;GPC1;EPB41L3;TENM4;TPPP;CD9
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4498230819008163,1.339847628611381,0.06303418803418803,0.9674254289314874,1.0,31/84,22.70%,ILF3;RTN2;IGF1;PAIP2;BIN1;EIF2AK3;DDX3X;CNOT10;IGF2BP2;EPRS1;DHX36;ABCA7;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;SORL1;SAMD4B;RPS3;YBX1;NTRK2;IGFBP5;SAMD4A;GGA3;RTN1;RPL13A
prerank,axon extension (GO:0048675),0.5392519385448474,1.339444073619257,0.1411764705882353,0.9669560282302045,1.0,12/23,15.90%,HSP90AA1;NRP1;CDK5;CYFIP1;NLGN3;USP9X;ALCAM;AUTS2;SLIT1;SLIT3;SEMA3A;SLC9A6
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6327520515090018,1.3386904671637214,0.12927191679049035,0.9682642822988239,1.0,5/11,19.47%,ATL1;BNIP1;MOSPD3;VAPB;VCPIP1
prerank,chloride transmembrane transport (GO:1902476),-0.34700810592111286,-1.338448665255242,0.05660377358490566,0.8323276521154067,1.0,20/48,23.88%,ANO4;GABRB1;SLC12A7;GABRG2;CLCN3;ANO6;ANO1;GABRA5;SLC12A4;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;GABRA1;GLRA3;SLC12A8
prerank,sensory organ development (GO:0007423),-0.33221076505915337,-1.3373959240569577,0.07079646017699115,0.8296731699091792,1.0,21/51,30.11%,HIPK2;SMOC1;RAB18;RBP4;TGFB2;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMCHD1;SMG9;PBX2;PBX1;SOX2;ZDHHC16;FREM2;MEIS3;PAX8;MAFB;CHRDL1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5664473628600355,1.3372753149490684,0.13090418353576247,0.9738168809682531,1.0,1/17,0.11%,SFRP2
prerank,cardiolipin metabolic process (GO:0032048),0.6102392508980484,1.3367904176009742,0.1388101983002833,0.9738076001205507,1.0,6/13,16.50%,PLA2G5;PTPMT1;CRLS1;HADHB;LCLAT1;SLC27A1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4039750123497867,-1.336193370800844,0.09411764705882353,0.8275338388980139,1.0,9/26,10.78%,UBE2N;IRAK2;IRAK1;NOD1;IFIH1;CYLD;UBB;ALPK1;IKBKG
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5595238982074002,1.336032153991694,0.12924281984334204,0.9752737556918957,1.0,6/19,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,protein localization to phagophore assembly site (GO:0034497),0.6212578995871967,1.3358036011032755,0.13392857142857142,0.9736644044354008,1.0,6/11,18.15%,TRAPPC8;WIPI1;MFN2;ATG13;STX17;ATG9A
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.48809603354170633,-1.335725513624739,0.14516129032258066,0.8223130823721754,1.0,6/14,17.09%,PDCD4;THBS1;ANO6;PLCG1;ITGA4;RGCC
prerank,autophagy of peroxisome (GO:0030242),0.6094796198295973,1.3349422217242546,0.14507042253521127,0.9758182959420397,1.0,7/12,19.00%,TRAPPC8;USP30;SQSTM1;PEX5;MAP1LC3B;PIK3C3;PIK3R4
prerank,positive regulation of T cell migration (GO:2000406),0.5643695718640486,1.334753609807172,0.12467191601049869,0.9740339035559862,1.0,4/20,10.71%,WNT5A;CXCL12;DOCK8;APP
prerank,embryonic axis specification (GO:0000578),-0.45410775008586446,-1.3344317873990432,0.12177121771217712,0.8202262419723478,1.0,4/15,9.15%,TASOR;COBL;CXXC4;TBX3
prerank,positive regulation of cell projection organization (GO:0031346),0.4458537068231845,1.33413312716248,0.04766839378238342,0.9748073869969243,1.0,41/115,20.96%,CARMIL2;AMIGO1;WNT5A;CAMK2B;DVL2;CUL7;CDKL5;PLXNA2;OBSL1;TENM3;DVL1;PLXNA1;PLK5;RAPGEF1;ROBO2;ROBO1;MAGI2;IL1RAPL1;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SLITRK1;CUX1;SCARB2;CARMIL1;LYN;ATP1B2;PTK2B;MAP6;NTRK2;SCN1B
prerank,regulation of cell adhesion (GO:0030155),0.4419462950051626,1.3340249424278958,0.03802672147995889,0.9725905040091157,1.0,24/129,11.14%,EPB41L4B;DUSP26;DACT2;EPHA7;EPHB2;PLXNA2;FBLN1;CXCL12;MINK1;PRKCA;FLCN;NUAK1;ABL1;ADAM22;EPHA8;MIA3;RHOD;CXCR4;RIPOR2;DSCAM;PLXNA1;GPR4;TPM1;ADGRG1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5451687292688364,1.3335176847807422,0.12276214833759591,0.9726524109685769,1.0,7/22,19.24%,GPLD1;NRDC;PACSIN3;SNX33;PTPN3;APOE;TIMP2
prerank,mRNA splice site selection (GO:0006376),0.5228540849084278,1.3322356310576713,0.11699507389162561,0.97724312640742,1.0,14/30,17.68%,SRSF12;SRSF5;CELF2;CELF1;SRSF9;SF3A1;SRSF1;PSIP1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6309548092786268,1.3316506777334502,0.1436950146627566,0.9777592632971785,1.0,4/11,11.50%,BIN1;NOS1AP;CACNB1;CAMK2D
prerank,dendrite morphogenesis (GO:0048813),0.4947583250204091,1.331415259796252,0.10357142857142858,0.9762155524190436,1.0,7/35,6.49%,EPHB2;ABITRAM;DCDC2;CTNND2;MINK1;PAK3;DVL1
prerank,regulation of amyloid-beta formation (GO:1902003),0.49906080687481563,1.3308106572843914,0.11644657863145258,0.9769746355680728,1.0,16/34,23.03%,RTN2;IGF1;BIN1;ABCA2;ABCA7;IFNGR1;TMED10;ROCK2;APOE;SORL1;NTRK2;ABCG1;GGA3;RTN1;EPHA4;SP1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.38468672779629737,-1.3307949351707868,0.0962566844919786,0.8270052096661777,1.0,6/30,9.55%,CD46;STAT3;TLR4;LGALS9;CD34;PLCG2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4487023767304804,-1.3302571770287561,0.13524590163934427,0.822282367791849,1.0,4/17,21.26%,LAMP1;CADM1;NECTIN2;PVR
prerank,intraciliary retrograde transport (GO:0035721),-0.5010057515320013,-1.3299244754924782,0.13968253968253969,0.8167466127506058,1.0,8/12,24.23%,IFT43;DYNC2I1;IFT122;IFT140;WDR19;DYNC2LI1;DYNLT2B;DYNC2I2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.548301356211315,1.329579736954286,0.1384820239680426,0.9814292209288151,1.0,10/20,21.65%,VTN;IGF1;NRP1;IGFBP3;NDRG4;LRP1;SERPINE1;SORL1;S100A11;IGFBP5
prerank,B cell mediated immunity (GO:0019724),0.6273026997909852,1.328358114429555,0.13608562691131498,0.9856937068196762,1.0,1/10,0.85%,FCGR2B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.47789411806498033,1.3283547606602697,0.09518477043673013,0.9828289118694586,1.0,11/47,20.46%,VTN;BIN1;SERPING1;SPOCK1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;SORL1;TIMP2;SERPINF1
prerank,positive regulation of signaling (GO:0023056),0.5005537738396687,1.3280437275423524,0.11619718309859155,0.9819046768570162,1.0,13/37,18.43%,CDKN2AIP;EDN3;SCRIB;VAMP3;NMU;SOX11;WLS;CLSTN2;SYT1;NSF;ANXA2;ILK;CLSTN3
prerank,steroid metabolic process (GO:0008202),0.46345492646315806,1.3276665959438412,0.07626208378088077,0.9813278573566189,1.0,13/72,13.04%,CYP27A1;GBA2;CYP7B1;LSS;GC;HSD17B4;RDH5;MSMO1;PRLR;AMACR;STARD3;CYP26B1;CYP51A1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.43843445092797956,1.3269449338543848,0.06256410256410257,0.9827778487261822,1.0,8/116,3.71%,FSHR;FCGR2B;PTGER4;SELENOS;ADCY7;ADM;VIPR2;PTHLH
prerank,positive regulation of ATP metabolic process (GO:1903580),0.506613881322628,1.3263846076812362,0.1407766990291262,0.9832049708675852,1.0,8/32,10.71%,SLC4A4;IGF1;ARNT;PID1;PRXL2C;VCP;ZBTB20;APP
prerank,regulation of sodium ion transport (GO:0002028),0.5065503772874245,1.3263424563336876,0.11242603550295859,0.9806289356617304,1.0,10/34,11.41%,GPD1L;NKAIN4;CNKSR3;SIK1;YWHAH;PER1;WNK2;ANK3;SLMAP;FGF12
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4388538202724352,1.326057227307497,0.0629514963880289,0.9795553162860793,1.0,18/113,9.55%,FGF9;MMP12;WNT5A;PTPRN;SFRP1;IGF1;BMP6;FGFR2;XBP1;NRP1;FGF10;PRKCA;LAMC1;TCF7L2;ARNT;SOX9;EGF;SOX11
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.520016936857314,1.3250832913913628,0.12098765432098765,0.9824124151658776,1.0,7/28,9.17%,STMN4;MAPRE3;GBA2;ABL1;CAMSAP2;GAS2L1;PRUNE1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5407667891013874,1.3249672103700596,0.13392857142857142,0.980264169994542,1.0,7/21,12.60%,SELENOS;EIF2AK3;SYVN1;XBP1;DDIT3;PARK7;CREB3
prerank,regulation of fibroblast migration (GO:0010762),0.5440218324044495,1.3248867548073535,0.13618677042801555,0.9779187093481022,1.0,11/20,21.29%,CLN3;RAC1;DDR2;ARHGEF7;DMTN;RFFL;TGFB1;ITGB1BP1;ITGB1;APPL2;FGF2
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.5002314730424133,-1.3243121613596422,0.15282392026578073,0.8313583202937513,1.0,11/12,45.59%,MCM6;CDC7;MCM4;MUS81;MCMDC2;GINS4;CDC45;MCM3;MCM2;MCM7;MCM5
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6224238837333249,1.3239004508683792,0.15327380952380953,0.9808674615816538,1.0,4/11,14.61%,ADM;ARRB1;GRK3;GRK2
prerank,positive regulation of heart rate (GO:0010460),0.5774199636642317,1.3236768984720937,0.1392235609103079,0.9793668170040273,1.0,4/17,10.81%,ADM;EDN3;ATP2A2;TPM1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5352692362853736,1.323561265143893,0.13101604278074866,0.9772792370821659,1.0,7/22,10.46%,MED24;MED12;MED14;MED13;MED4;DHX36;PSMC5
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5327579257568744,1.3234167868002598,0.13248407643312102,0.975324964161433,1.0,5/24,8.36%,CARMIL2;RAC1;ACTR2;PIK3R1;CYFIP1
prerank,T cell migration (GO:0072678),-0.5033103322615221,-1.3227202995058898,0.1266233766233766,0.8309826302115043,1.0,5/13,22.73%,CXCL16;S1PR1;MSN;SLC12A2;PIK3CD
prerank,fatty acid transport (GO:0015908),0.5690897859241567,1.322064528491392,0.13288590604026845,0.9806436680939995,1.0,2/17,3.04%,SLC27A6;SLC27A4
prerank,icosanoid secretion (GO:0032309),0.6087019440386582,1.3219695326530543,0.1341991341991342,0.978457501785579,1.0,3/12,8.53%,PLA2G5;ANXA1;BDKRB2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5148649539477371,1.3216376050763874,0.13647342995169082,0.977737698030523,1.0,10/31,20.88%,TNNI3;TNNC1;FGFR2;TPM1;RBPJ;NRG1;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,ear morphogenesis (GO:0042471),0.5536603558599703,1.3213474927146962,0.15303430079155672,0.9766259499217251,1.0,4/20,9.79%,EPHB2;FGFR2;NIPBL;TWIST1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5659614096074557,1.3212255672431867,0.1440107671601615,0.9746544207881644,1.0,6/17,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,negative regulation of blood coagulation (GO:0030195),0.49388683316732335,1.3210086299654096,0.12514619883040937,0.9732070979406385,1.0,10/38,17.19%,VTN;C1QTNF1;SERPING1;PLAT;PDGFRA;TFPI;F3;F8;SERPINE1;APOE
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.45116837865258896,-1.3205357793584014,0.1453287197231834,0.8329753652053871,1.0,7/16,20.27%,NAA15;KAT2B;NAA40;EP300;NAA25;NAA60;NAA80
prerank,neuron projection morphogenesis (GO:0048812),0.4384162809270278,1.3203767842603484,0.036885245901639344,0.9740263519557465,1.0,51/137,21.78%,EPHB2;ATL1;ABITRAM;NTF3;FGFR2;DCDC2;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;DVL1;DBN1;BRSK2;FLRT1;BAIAP2;RAB10;DBNL;NTNG2;BRSK1;AFG3L2;APP;ANK3;ALS2;IQGAP1;DOCK7;FARP1;ALCAM;EPB41L3;IMPACT;CNTNAP2;RAB8A;TRIO;SLC9A6;BTBD3;DCC;ZDHHC17;SLITRK1;GAS7;KIF20B;SHANK1;NRK;SLITRK5;NBL1;MAP6;SPTBN4;MAP4K4;LLGL1;RYK
prerank,metal ion homeostasis (GO:0055065),-0.3409323882624096,-1.3198791847512903,0.08974358974358974,0.8286637406898231,1.0,18/40,30.30%,SLC12A7;CNNM2;CAV1;LETM1;TMTC2;LETM2;FAM20A;SLC12A4;COX11;SELENON;SLC12A9;SLC12A2;SLC12A8;CNNM4;SLC12A6;WFS1;SLC8A1;JPH2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.57079500742801,1.3190698627448263,0.1292517006802721,0.9789028162643324,1.0,7/17,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.5571386777171083,1.3184864517837664,0.14864864864864866,0.9797503430927657,1.0,5/18,11.50%,PPIF;CBARP;BIN1;ATP1A2;CAMK2D
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5270167644699628,1.318129022588089,0.12988650693568726,0.9791428897525547,1.0,6/24,6.13%,SFRP1;RAC1;NRP1;PIK3R1;ABL1;THY1
prerank,sterol transport (GO:0015918),-0.42338806326341594,-1.3180458435398357,0.11904761904761904,0.8289492932123718,1.0,6/19,18.44%,OSBPL2;CAV1;OSBPL5;OSBP;ARV1;LDLRAP1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.42886812816419995,-1.317946884091363,0.12345679012345678,0.8228165640396572,1.0,8/18,13.64%,RNF103;RNF185;AMFR;MAN1B1;EDEM2;OS9;UBB;RNF139
prerank,regulation of protein autophosphorylation (GO:0031952),0.4983098890697665,1.317757941770044,0.11506524317912219,0.97869679204676,1.0,15/36,18.96%,EPHA7;CALM3;DDX3X;ERRFI1;RAP2A;PPP2R5E;MVP;ENPP1;IMPACT;PPP2R5D;MRE11;RAD50;PPP2R5A;RASSF2;CALM1
prerank,cell-cell junction maintenance (GO:0045217),-0.5101692610352306,-1.3176404992808612,0.1394658753709199,0.8175623570146039,1.0,3/11,10.41%,FERMT2;TJP1;MYADM
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5078369265253566,-1.3171458997900505,0.15172413793103448,0.8130396167983946,1.0,9/12,35.55%,CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;MUL1;CGAS
prerank,purine nucleotide catabolic process (GO:0006195),-0.5090235933828681,-1.315451842468909,0.17687074829931973,0.8131685141386646,1.0,8/13,34.73%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,protein methylation (GO:0006479),0.4889955296728766,1.3153214500255324,0.12064965197215777,0.9898377261699767,1.0,19/40,19.80%,LCMT1;PRMT6;ETFBKMT;EZH2;EHMT2;PRMT5;NTMT1;NSD3;PRMT1;EHMT1;GSPT1;FAM98A;ATPSCKMT;PRMT8;PCMT1;NSD1;RAB6A;PRMT2;CARM1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4592070563274241,1.3144907485951172,0.087527352297593,0.9919488328730761,1.0,25/65,23.39%,ADAMTSL2;FBN2;PDPK1;STUB1;PMEPA1;SNX6;HTRA3;TGFB1I1;LTBP1;LEMD3;PEG10;FBN1;TGFB1;SMAD6;VASN;MTMR4;SPRY2;SMURF1;TGFBR1;PPM1A;SMAD7;SMAD2;SMAD3;DAND5;FKBP1A
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5330628997936826,-1.314094926743578,0.17971014492753623,0.812131657261515,1.0,6/10,27.10%,CSGALNACT1;XYLT1;DSEL;B3GAT2;XYLT2;B3GAT1
prerank,regulation of lipase activity (GO:0060191),0.5920241071755846,1.3127907665824556,0.16246498599439776,0.9989498762328878,1.0,2/13,4.57%,LPL;PCSK5
prerank,response to ethanol (GO:0045471),0.586661510787666,1.310755307414595,0.15007215007215008,1.0,1.0,4/14,14.46%,ADCY7;GRIN1;GRIN2A;GLRA1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.5069833658030466,1.3103337725704671,0.12302070645554203,1.0,1.0,9/30,15.21%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5024188735728463,1.309341567617656,0.13653136531365315,1.0,1.0,17/32,24.80%,MMP12;AJAP1;CASK;DMTN;SEMA3E;JAG1;SERPINE1;ITGB1BP1;DLC1;ARHGAP6;NF2;MAP4K4;CLASP2;HOXA7;PTEN;CORO1C;PHLDB2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5669641885138481,1.3092975313051132,0.15650969529085873,1.0,1.0,5/16,15.47%,CHID1;ADCY7;SIRPA;CUEDC2;ABCD2
prerank,regulation of chemotaxis (GO:0050920),0.5157340927670802,1.308900558961885,0.1342534504391468,1.0,1.0,10/30,16.26%,USP14;ZSWIM6;CXCR4;MYCBP2;EFNB2;PDGFRA;YTHDF1;TGFB1;ZSWIM8;ADGRA2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5192659848014773,-1.3081632338586882,0.1863905325443787,0.828426806894149,1.0,3/10,28.86%,BMP4;FZD7;PAX8
prerank,purine nucleotide biosynthetic process (GO:0006164),0.6112635529900885,1.3080925250521795,0.16220238095238096,1.0,1.0,4/12,13.10%,ADSL;PRPSAP2;GART;HPRT1
prerank,positive chemotaxis (GO:0050918),0.5395753347677711,1.3070777285206792,0.15696887686062247,1.0,1.0,4/17,5.37%,TSC2;NRP1;FGF10;SCRIB
prerank,coenzyme A metabolic process (GO:0015936),0.5910172952049042,1.3068300830832904,0.15527065527065528,1.0,1.0,5/14,10.94%,DCAKD;PANK4;COASY;ACAT1;CROT
prerank,positive regulation of neutrophil migration (GO:1902624),0.5528387795022569,1.3066253339990812,0.16133333333333333,1.0,1.0,6/18,16.52%,RAC1;MOSPD2;TIRAP;RIPOR2;DNM1L;CAMK1D
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.46015325896153086,1.3065913488873258,0.09913793103448276,1.0,1.0,23/71,19.04%,ADAMTS7;STUB1;ZYG11B;TNFAIP3;OTUD7A;NGLY1;DDB1;HM13;CAPN2;CUL4B;VCP;CHFR;MALT1;VPS4B;USP9X;RNF41;CTSZ;CTSH;NEDD8;MDM2;OMA1;CTSK;CTSO
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.5145682229985563,1.3065760659772092,0.14285714285714285,1.0,1.0,1/23,0.14%,PLA2G5
prerank,activation of protein kinase B activity (GO:0032148),0.51099387713161,1.3065372306076173,0.1560549313358302,1.0,1.0,4/29,2.60%,WNT5A;IGF1;PDPK1;NTF3
prerank,mitochondrion morphogenesis (GO:0070584),0.608952269513799,1.3059131692830084,0.15588235294117647,1.0,1.0,5/11,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5940492964688889,1.3052808689262283,0.17327459618208516,1.0,1.0,3/12,4.44%,GRIN1;SLC5A3;ZNF205
prerank,regulation of cellular pH (GO:0030641),0.5049795493173729,1.3051497859623094,0.14833127317676142,1.0,1.0,3/29,0.91%,SLC4A4;SLC4A5;CLN3
prerank,embryonic appendage morphogenesis (GO:0035113),-0.48840673163340464,-1.305106889847618,0.17350157728706625,0.8335053242845137,1.0,4/12,6.44%,LRP6;MBNL1;FBXW4;TGFB2
prerank,regulation of secretion by cell (GO:1903530),0.46053967402444945,1.3044798355074718,0.12458654906284454,1.0,1.0,18/54,17.84%,CPLANE2;ANXA1;VAMP3;RAB12;CPLX1;RAB10;RAB3B;MCTP2;SYT1;RAB13;RHBDF1;RAB8A;RAB8B;VAMP8;NSF;FMR1;RAB21;MCTP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.47142226843938906,1.3041715829260996,0.12331838565022421,1.0,1.0,12/47,16.69%,KHSRP;NFKB1;ABCA2;SNAI1;ERLIN2;SIRPA;SIK1;WNT4;ROCK2;SLC27A1;ACADL;ACADVL
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.606929859564579,1.3041025791608922,0.1694915254237288,1.0,1.0,3/12,5.13%,LPIN1;PRKCA;NEK9
prerank,positive regulation of leukocyte migration (GO:0002687),0.5078339574455824,1.3040360975170122,0.15671641791044777,0.998923509397386,1.0,4/27,8.46%,EDN3;THY1;MIA3;JAM3
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4278127442674118,-1.3033786491054256,0.15648854961832062,0.8338108375502237,1.0,9/18,19.69%,SLC25A13;MSRA;MTHFR;GOT2;FOLH1;MTHFD1;NAALAD2;GOT1;ASPG
prerank,apoptotic mitochondrial changes (GO:0008637),0.5013742367117037,1.3031285966283068,0.147239263803681,1.0,1.0,10/32,15.53%,BAX;THEM4;FIS1;AIFM2;FZD9;BCL2;SOD2;ATG3;DNM1L;HSPD1
prerank,positive regulation of cell communication (GO:0010647),0.5106764797867169,1.30258456500798,0.1329268292682927,1.0,1.0,10/28,18.43%,CDKN2AIP;EDN3;NMU;SOX11;WLS;CLSTN2;ANK3;SYT1;ILK;CLSTN3
prerank,protein polyglutamylation (GO:0018095),0.6110122303249843,1.3024175373353146,0.1645021645021645,1.0,1.0,4/11,16.03%,TTLL4;TPGS1;CFAP20;TTLL11
prerank,neutral amino acid transport (GO:0015804),-0.37905213012886446,-1.3023132530408201,0.1179245283018868,0.8316596222399527,1.0,17/28,39.44%,SLC6A6;SLC3A2;SLC6A9;SLC36A4;CTNS;SLC43A2;SLC38A5;SLC1A4;SLC6A17;SLC36A1;SLC43A1;SLC6A7;LLGL2;SLC38A2;SLC7A8;SLC38A1;SLC7A10
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5349342114563934,1.3010466232395446,0.16538461538461538,1.0,1.0,5/23,11.50%,CBARP;NOS1AP;ATP1A2;CACNB1;CAMK2D
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4436215011589371,1.3006947698619336,0.0867237687366167,1.0,1.0,15/86,10.71%,SFRP2;VTN;SFRP1;IGF1;EPHA7;BMP6;NTF3;NRP1;FGF10;ABL1;DMTN;LRP8;TEC;ENPP2;APP
prerank,negative regulation of interferon-beta production (GO:0032688),0.6161083808200215,1.2999768166679433,0.17331288343558282,1.0,1.0,6/10,23.35%,PPM1B;SIRPA;YY1;RELB;PTPRS;REL
prerank,regulation of synapse organization (GO:0050807),0.5181994105641813,1.2996636045975316,0.15613382899628253,1.0,1.0,5/26,6.07%,WNT5A;CLN3;CAMK2B;CDKL5;ABL1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5584477207339099,1.2993744850825062,0.15081521739130435,1.0,1.0,2/17,3.12%,PSRC1;MAPRE3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.6144293286884333,1.299193131344055,0.1699248120300752,1.0,1.0,4/10,18.96%,CBARP;CALM3;FMR1;CALM1
prerank,response to sterol (GO:0036314),0.605268032909821,1.2991847138529355,0.16338880484114976,1.0,1.0,6/11,21.52%,RORA;ABCA2;INSIG1;TGFB1;TGFBR1;SMAD2
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.535541810613112,1.2988367128412868,0.15958815958815958,1.0,1.0,5/21,7.42%,UBE2S;MAD2L1;FZR1;FBXO5;CDC14B
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2926524923689302,-1.2988154594039956,0.045454545454545456,0.8381156928877809,1.0,28/94,14.52%,UBE2N;IKBKB;PSMB7;IRAK2;CUL1;IL1R1;RPS6KA5;RBX1;SKP1;IRAK1;NOD1;PSMB2;PSMD7;NFKBIA;PELI1;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;MAP3K8;UBB;TOLLIP;IKBKG;PSMD9;PSMD2;IRAK4;PSMB3
prerank,positive regulation of proteolysis (GO:0045862),0.46973842014053235,1.2987467247158304,0.1171960569550931,0.9990596753286546,1.0,14/55,17.26%,GPLD1;CLN6;STUB1;NRDC;CCBE1;OGT;RCN3;PACSIN3;AURKAIP1;SNX33;CTSH;APOE;TANK;TNIP1
prerank,nuclear transport (GO:0051169),0.5652735250012221,1.2987331734464442,0.17403314917127072,0.996628015856299,1.0,5/16,12.27%,NXT2;NXT1;ANP32A;PSIP1;NPM1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.34646512207280367,-1.2981659270992527,0.125,0.8346052326977172,1.0,18/36,21.74%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;GABARAPL2;GIPC1;CCAR2;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,regulation of cell killing (GO:0031341),0.5624165942936292,1.2981643137840353,0.16120218579234974,0.9973559018662062,1.0,3/16,2.78%,WNT5A;DVL2;RAC1
prerank,ganglion development (GO:0061548),0.604498459035847,1.297770901221226,0.18361581920903955,0.997078222090618,1.0,4/11,15.56%,FZD3;NRP1;UNC5C;SEMA3A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6048990333135946,1.297671324012099,0.16642335766423358,0.9951523290961228,1.0,2/11,4.50%,SELENOS;CXCL12
prerank,mRNA metabolic process (GO:0016071),0.4373355087272511,1.2969306967848584,0.09875259875259876,0.9968609278534294,1.0,33/90,19.58%,LSM6;TBRG4;SLBP;U2AF1;SRSF2;GEMIN2;PRPF8;DHX15;CNOT10;SRSF5;SF3B2;CELF1;AKAP8L;SRSF9;SF3A1;SRSF1;AURKAIP1;KIN;NUDT12;NUDT21;CPSF3;HNRNPA0;AGO3;HNRNPA2B1;DIS3L2;DDX5;NUDT16L1;SON;CPSF6;PCBP2;NONO;YTHDF2;CSTF3
prerank,DNA conformation change (GO:0071103),0.557811169391516,1.2966423355252124,0.1586021505376344,0.9961061630270188,1.0,8/17,22.00%,HMGB3;ABL1;TOP1;HAT1;TOP3B;TOP3A;TOP2B;HMGB1
prerank,negative regulation of ATPase activity (GO:0032780),0.5718801160449568,1.2965363795019003,0.17204301075268819,0.9942546856684066,1.0,2/16,1.61%,TNNI3;PPIF
prerank,error-prone translesion synthesis (GO:0042276),-0.4052905935492194,-1.2953633384947194,0.145748987854251,0.8388394690117743,1.0,15/21,38.97%,REV3L;RPA1;UBB;REV1;PRIMPOL;RFC2;PCNA;POLE2;POLK;POLI;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.42811879549745363,-1.2953476979877314,0.10861423220973783,0.8328908302874252,1.0,6/19,7.34%,PRKCE;LBP;IRAK1;TLR4;LGALS9;RAB11FIP2
prerank,glucan catabolic process (GO:0009251),-0.45163220088167655,-1.2952083211782475,0.13970588235294118,0.8274783174454896,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,regulation of neuron projection arborization (GO:0150011),0.5631652712900774,1.2949502159344477,0.17275280898876405,1.0,1.0,4/15,10.01%,WNT5A;DVL2;DVL1;NTNG2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5215916458385734,1.2945495044915603,0.16971916971916973,1.0,1.0,12/25,21.94%,HEXIM1;EAPP;RNF8;CDK13;BRD4;RNF168;CDC73;NELFA;RECQL5;HNRNPU;EAF1;TCERG1
prerank,lipid biosynthetic process (GO:0008610),0.4460280189046712,1.2942773376115924,0.11645299145299146,0.9997785571947291,1.0,16/77,14.55%,NDUFAB1;LPL;MLYCD;PCYT2;XBP1;AGPAT5;GPAT4;LSS;AGPAT3;GPAM;ELOVL4;FADS1;PRLR;CYP51A1;PAM;ACSL6
prerank,striated muscle contraction (GO:0006941),0.46715235442439956,1.2939655790371993,0.12162162162162163,0.9991451032607012,1.0,7/53,10.81%,TNNI3;TNNC1;TNNI1;MYH14;ATP1A2;SCN2B;TPM1
prerank,positive regulation of endocytosis (GO:0045807),0.4722303610846243,1.2934622215650036,0.11963882618510158,0.999566095419785,1.0,17/45,22.07%,CALY;VTN;CLN3;CD151;HNRNPK;CLIP3;LRP1;CBL;RAB31;SERPINE1;RAB21;APOE;FLOT1;SMPD1;DAB2;APPL2;B2M
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.38720051786103216,-1.2934600358715735,0.13333333333333333,0.8285296659028204,1.0,10/25,18.44%,KAT7;WDR43;ELL;HTATSF1;EAF2;SCAF8;THOC5;CCNK;CCAR2;ERCC6
prerank,metanephros development (GO:0001656),0.5115103534376447,1.292834452778688,0.15018315018315018,1.0,1.0,9/26,18.92%,NIPBL;FGF10;PTCH1;GDNF;ROBO2;CTSH;OSR1;PKD2;FOXD1
prerank,placenta development (GO:0001890),0.5949814509822668,1.2926239610120187,0.17553956834532375,0.9993769955719483,1.0,1/12,1.38%,CUL7
prerank,regulation of viral life cycle (GO:1903900),-0.4256323355290847,-1.2922767849717047,0.14767932489451477,0.8269358036838967,1.0,9/21,21.33%,TSG101;AXL;TRIM25;KPNA6;TRIM5;TRIM14;VPS4A;NECTIN2;HS3ST5
prerank,RNA transport (GO:0050658),0.45396211436995165,1.291132275593957,0.09539121114683816,1.0,1.0,33/71,24.90%,SLBP;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;THOC7;SIDT1;HNRNPA2B1;THOC1;NUP214;FMR1;SRRM1;NUP153;FLOT1;RTRAF;YBX1;TPR;SARNP;U2AF2;SIDT2;NUP155;SRSF6;ATXN2;RBFOX1;CHTOP;PNPT1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5383943683410546,1.2904974593012966,0.16861219195849547,1.0,1.0,9/19,18.22%,SCRIB;MTCL1;DLG3;PATJ;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5059723955381678,1.2903139520461424,0.1903584672435105,1.0,1.0,10/24,23.37%,ADAMTS7;PTHLH;SOX9;SOX6;TRPS1;SOX5;TGFBR1;MBOAT2;ADAMTS12;EFEMP1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5403929374057184,1.288985373753864,0.19397116644823068,1.0,1.0,2/18,5.54%,CARMIL2;DDR2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.34392546644546595,-1.2883330721595925,0.125,0.835728500308082,1.0,26/39,28.94%,RIOK3;RPS24;RIOK2;NOL11;RPS19;RPS16;RPS6;NOM1;RPS28;RPS5;RPS17;NOB1;RPS27;NOP14;WDR3;METTL17;RRP36;SNU13;RPS14;ERAL1;LTV1;RRP7A;EMG1;RPS27L;SURF6;MRPS7
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.37237473094408396,-1.2883303101156367,0.10526315789473684,0.8299475170729763,1.0,3/29,6.13%,CYRIB;LAMP1;CADM1
prerank,myelin maintenance (GO:0043217),0.624360537688502,1.2882924470407993,0.1794071762870515,1.0,1.0,4/10,15.47%,MYRF;CXCR4;EPB41L3;ABCD2
prerank,positive regulation of potassium ion transport (GO:0043268),0.47625675166264964,1.2877362844904332,0.15105386416861827,1.0,1.0,5/38,8.20%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10
prerank,neuromuscular process controlling balance (GO:0050885),0.5976695706929201,1.287562474653865,0.1649782923299566,1.0,1.0,2/12,5.21%,CLN3;PCDH15
prerank,regulation of fat cell differentiation (GO:0045598),0.4430020909290305,1.2873914778847313,0.09860664523043944,1.0,1.0,19/74,18.39%,SFRP2;WNT5A;LPL;SFRP1;SIRT2;XBP1;RORA;ZFP36L1;WDFY2;ENPP1;RUNX1T1;TGFB1;AAMDC;LMO3;TRIO;CDS1;MEDAG;FTO;GPS2
prerank,cellular response to peptide (GO:1901653),0.44916762953425504,1.2871142782133096,0.13938053097345132,1.0,1.0,14/56,13.61%,FCGR2B;IGF1;GRIN1;XBP1;ATP1A3;ZFP36L1;CDK5;SNX6;GRIN2A;TRIM41;CACNB1;APP;PTPN22;LRP1
prerank,synaptic vesicle cycle (GO:0099504),0.4923287232284417,1.2870146049193867,0.14981729598051158,1.0,1.0,6/30,10.56%,SYT10;CDK5;DNAJC5;CPLX1;SNAP25;BRSK1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5848709718538578,1.2867911842207533,0.1827485380116959,1.0,1.0,3/12,5.91%,BAX;XBP1;PIK3R1
prerank,phospholipid biosynthetic process (GO:0008654),0.48577146145687466,1.2864085696978251,0.15568862275449102,1.0,1.0,10/36,9.95%,CLN3;PCYT2;AGPAT5;CRLS1;DHDDS;CPNE7;AGPAT3;DPAGT1;GPAM;FADS1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46319378536816025,1.2861313660636438,0.1354625550660793,1.0,1.0,11/52,11.48%,LSM6;EXOSC1;EXOSC3;LSM7;EXOSC7;EXOSC2;CNOT10;DCP1B;EXOSC8;RC3H2;CNOT9
prerank,positive regulation of sodium ion transport (GO:0010765),0.5841408149658394,1.2861308568849619,0.17988668555240794,1.0,1.0,6/12,22.71%,GPD1L;CNKSR3;ANK3;AHCYL1;SCN1B;WNK3
prerank,peptidyl-asparagine modification (GO:0018196),0.49391930185031185,1.2859146938683814,0.14855072463768115,1.0,1.0,9/31,15.21%,ALG5;DPM2;ALG8;UGGT2;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.6135084769518612,1.2853678086314806,0.17325227963525835,1.0,1.0,3/10,13.59%,SMARCD3;FZD3;DISC1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5450227458670687,1.2844360178930023,0.1686429512516469,1.0,1.0,4/17,7.15%,EMC1;EMC8;MMGT1;GET1
prerank,regulation of protein localization to membrane (GO:1905475),0.502916345474703,1.2844033564414346,0.15327564894932014,1.0,1.0,13/28,19.45%,CLN3;SLC5A3;CDK5;GPC6;GPC1;VTI1B;GPC4;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14;GPC5
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4336940493497422,1.2838311026967593,0.07621009268795056,1.0,1.0,16/110,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;PTHLH;GNG2;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;LPAR1;ADCY1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5386864502990538,1.2833498649128845,0.16781292984869325,1.0,1.0,5/18,8.54%,FCGR2B;BAX;XBP1;PIK3R1;DDIT3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4972615141820696,1.2833100058487756,0.1596130592503023,1.0,1.0,10/29,18.47%,CLN3;CAMK2B;EPHB2;DBN1;APP;NETO1;APOE;MCTP1;ZDHHC2;SHISA9
prerank,positive regulation of protein deacetylation (GO:0090312),0.5746220180672922,1.2829995978629838,0.1836734693877551,1.0,1.0,6/14,16.05%,NIPBL;AKAP8L;ZBTB7B;NNMT;SAP30BP;CTBP1
prerank,protein mannosylation (GO:0035268),0.5209752387836035,1.2823702383236488,0.17142857142857143,1.0,1.0,8/22,18.89%,TMTC4;DPM2;TMTC1;POMT2;DPY19L1;DPY19L3;DPM1;DPY19L4
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.603344344882307,1.2820659865677053,0.1906906906906907,1.0,1.0,2/10,6.69%,VTN;ARNT
prerank,positive regulation of lamellipodium organization (GO:1902745),0.49270026242236714,1.2814275165207165,0.15815085158150852,1.0,1.0,7/32,10.25%,CARMIL2;RAC1;ACTR2;PIK3R1;ARHGEF7;CYFIP1;ENPP2
prerank,glycogen catabolic process (GO:0005980),-0.4398047348239,-1.2813524623389811,0.15492957746478872,0.8504116277534378,1.0,5/15,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4333310307001698,1.280386454078144,0.09862142099681867,1.0,1.0,27/88,19.43%,ILF3;CLN3;PAIP2;NFKB1;EIF2AK3;DDX3X;NELL1;CNOT10;CDK5;IGF2BP2;EPRS1;DHX36;CDK5RAP3;PLAT;PUS7;EIF4E2;CNOT9;MALSU1;RACK1;DAPK1;MRPL13;FMR1;APOE;CAMK2N1;ATRAID;SAMD4B;RPS3
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5685026506799137,1.2795677568748205,0.1927877947295423,1.0,1.0,1/13,0.11%,SFRP2
prerank,import into cell (GO:0098657),0.4767134713662046,1.2791610941903142,0.13472706155632985,1.0,1.0,11/41,16.50%,IL10RA;SLC29A1;LRRC8A;SLC5A3;SLC22A4;ATP1A2;GLUL;SNAP25;SLC1A3;SLC6A13;SLC27A1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5274677252581307,1.278749961068797,0.18893387314439947,1.0,1.0,9/19,22.64%,RTN2;IGF1;BIN1;ABCA7;APOE;SORL1;NTRK2;GGA3;RTN1
prerank,histone H2A acetylation (GO:0043968),-0.4459639388426616,-1.2787420132082705,0.1519434628975265,0.8543354229741318,1.0,6/16,17.77%,EPC1;TRRAP;NAA40;MSL3;ACTL6A;ING3
prerank,positive regulation of phosphorylation (GO:0042327),0.41450889312689854,1.278355852964262,0.04321608040201005,1.0,1.0,49/240,14.28%,FGF20;FGF9;SLC4A4;HDAC3;TMEM119;MST1R;IGF1;IL34;DVL2;EPHA7;EPHB2;HSP90AA1;RAC1;FGFR2;FGFR1;ERP29;DDR1;NRP1;FGF10;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;EPHA8;ARNT;RAP2A;DSCAM;WDFY2;ARRB1;SOX9;PRXL2C;SDCBP;EGF;EPHA10;CLIP3;MUSK;ZBTB20;APP;PDGFRA;LEPR;AXIN2;RACK1;ROR2;NPTN;CSNK1D;ROCK2;TGFB1
prerank,positive regulation of chemokine production (GO:0032722),0.4692174204448,1.2780773977987996,0.1695108077360637,1.0,1.0,8/44,13.29%,WNT5A;LPL;IL33;DDX3X;TIRAP;TWIST1;APP;TLR3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5780634490150441,1.2780059750973052,0.16951566951566951,1.0,1.0,2/13,4.87%,SFRP2;NRP1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.5464065888945135,1.2778799501198124,0.16106442577030813,1.0,1.0,3/16,3.85%,PDK1;MLYCD;RORA
prerank,nucleocytoplasmic transport (GO:0006913),0.47398993332460415,1.2778481008135782,0.16060961313012895,1.0,1.0,11/40,12.27%,SMN1;NXT2;NXT1;GEMIN2;ANP32A;HTATIP2;ATXN1;MALT1;BACH2;NEMF;NPM1
prerank,plasma membrane invagination (GO:0099024),0.4924042602085242,1.2772269777920915,0.16852540272614622,1.0,1.0,2/29,0.85%,SPIRE2;FCGR2B
prerank,positive regulation of biomineral tissue development (GO:0070169),0.47281354811077536,1.2763626969578847,0.15384615384615385,1.0,1.0,10/40,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;FBXO5;ADGRV1;WNT4;ATP2B1;KL
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.45282944092449046,1.2755966166064319,0.12373453318335208,1.0,1.0,16/59,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;TWIST1;AGO3;SETX;CBFB;BCLAF1;MED23
prerank,GPI anchor biosynthetic process (GO:0006506),0.49790296729945305,1.2750222791416073,0.1597051597051597,1.0,1.0,10/30,18.41%,PIGG;PGAP4;DPM2;PIGM;PIGU;PIGA;PGAP1;PIGK;PIGX;DPM1
prerank,regulation of calcium ion import (GO:0090279),0.5187774770831474,1.2745950267165382,0.1880674448767834,1.0,1.0,7/21,22.71%,CXCL12;EGF;SLC30A1;PLPP4;PKD2;TRIM27;WNK3
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.46492977343126135,1.2737452125464175,0.1436651583710407,1.0,1.0,8/46,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5119368837023006,-1.2734579888631887,0.18980169971671387,0.8684436467720745,1.0,3/10,6.97%,CTTNBP2NL;INPP5K;THBS1
prerank,regulation of macrophage activation (GO:0043030),0.4876802378772611,1.2731231355048995,0.16951219512195123,1.0,1.0,4/30,4.92%,WNT5A;FCGR2B;IL33;IL31RA
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.41798962819868485,1.272861283931686,0.07987866531850354,1.0,1.0,27/150,15.02%,FGF20;MYORG;FGF9;MST1R;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;TCF7L2;PIK3R1;GAB1;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;PARK7;NRG2;NRG1;TGFB1;F3
prerank,regulation of NMDA receptor activity (GO:2000310),0.4894743701084138,1.2714707426349001,0.17654171704957677,1.0,1.0,10/32,14.09%,CAMK2B;EPHB2;NEFL;GRIN1;DLG3;GRIN2A;APP;GRIA1;DAPK1;GRIA2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4377436404347836,1.2708414467358158,0.12405609492988134,1.0,1.0,13/72,11.29%,FSHR;IGF1;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;IRS2;PIK3CB;MAZ;PDGFRA
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4413791180834115,1.2691375995471432,0.12311015118790497,1.0,1.0,14/70,16.50%,PLA2G5;GPLD1;CSNK2A2;LPIN1;CEPT1;GPAT4;LPIN3;PCYT1B;ENPP2;STARD7;LPIN2;CHKB;SLC44A2;SLC27A1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.4288434813636093,-1.268385674119268,0.16911764705882354,0.8822655659964246,1.0,5/16,16.32%,AGL;PYGB;PHKA1;PGM2;PHKG2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.5240674254534897,1.2681581985181587,0.18275418275418276,1.0,1.0,8/20,16.69%,ABCA2;ERLIN2;SIK1;WNT4;BMP5;SLC27A1;ACADL;ACADVL
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.44060303721239275,1.26808818091562,0.1285097192224622,1.0,1.0,13/69,13.35%,FGF20;CLN3;NTF3;FZD9;SNX6;SLC30A10;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,regulation of ERAD pathway (GO:1904292),-0.49738758651251813,-1.2678709637480108,0.20723684210526316,0.8783687843531598,1.0,7/11,21.74%,RNF185;USP13;HERPUD1;RNFT1;BAG6;UBXN1;AQP11
prerank,positive regulation of ruffle assembly (GO:1900029),0.5798875349390058,1.2678648320599657,0.1963276836158192,1.0,1.0,1/13,0.06%,CARMIL2
prerank,cellular response to estrogen stimulus (GO:0071391),0.5517470080230292,1.2676913982831908,0.19456366237482117,1.0,1.0,4/14,12.53%,WBP2;SFRP1;SRA1;NCOA4
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5405637057685301,1.267460500518101,0.18655692729766804,1.0,1.0,4/17,8.37%,AJAP1;MAFG;CD24;SOX9
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4661357345717824,1.2674182168502346,0.16455696202531644,1.0,1.0,14/40,17.01%,VTN;NTF3;PICK1;CD63;HNRNPK;ARRB1;EGF;MAGI2;CBL;AHI1;SERPINE1;ANXA2;FMR1;RAB21
prerank,negative regulation of cartilage development (GO:0061037),0.5831175143944389,1.2672438874170258,0.17963224893917965,1.0,1.0,3/13,8.37%,ADAMTS7;PTHLH;SOX9
prerank,synaptic vesicle exocytosis (GO:0016079),0.4690948328301385,1.2670822381423414,0.16530849825378346,1.0,1.0,9/40,14.94%,SYT10;UNC13A;CDK5;STX2;DNAJC5;CPLX1;SNAP25;SYT1;STX11
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4600516472983007,1.267040531525869,0.15977011494252874,1.0,1.0,10/43,9.55%,TMEM119;IGF1;FBN2;BMP6;NELL1;DDR2;FBXO5;SUCO;WNT4;SOX11
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.471962083538112,1.2667882063983222,0.16393442622950818,1.0,1.0,15/38,24.19%,KHSRP;HSP90AA1;RAC1;NOS1AP;SIRPA;CD47;ROCK2;PTGS2;PKD2;ASS1;KLF4;ATP2B4;SMAD3;INSR;JAK2
prerank,calcium-mediated signaling (GO:0019722),0.4317410436003687,1.2660037822250507,0.11869747899159663,1.0,1.0,15/93,11.17%,TNNI3;PDPK1;EIF2AK3;DMPK;CCR9;ACKR2;FIS1;RCAN2;ATP2A2;DMTN;CXCR4;RCAN3;PPP1R9B;STIMATE;MCTP2
prerank,regulation of exosomal secretion (GO:1903541),0.533704023740732,1.2659517429536586,0.1876675603217158,1.0,1.0,6/19,12.16%,ATP9A;SNF8;HGS;SDCBP;CHMP3;VPS4B
prerank,rRNA modification (GO:0000154),0.5309496388951014,1.265761506940707,0.1866151866151866,1.0,1.0,8/21,19.51%,NHP2;FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,ruffle organization (GO:0031529),0.5573979614710387,1.2657190986079299,0.20299727520435967,1.0,1.0,8/16,20.42%,AIF1L;RAC1;CYFIP1;TPM1;PIP5K1A;PLEKHA1;CARMIL1;LIMA1
prerank,axonogenesis (GO:0007409),0.4107279432945038,1.2651975937170545,0.03510531594784353,1.0,1.0,67/237,17.96%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;ATL1;HSP90AA1;FGFR2;CXCL12;NRP1;NEFH;PRKCA;CDK5;PIK3R1;GAB1;PAK3;EFNB3;EPHA8;BRSK2;CXCR4;GPC1;DSCAM;RAP1GAP;CYFIP1;FRS2;EFNB2;VLDLR;BAIAP2;EPHA10;RAB10;SEMA3D;NTNG2;GDNF;IRS2;GFRA2;BRSK1;AFG3L2;PIK3CB;APP;ROBO2;ANK3;ROBO1;KIF5C;DAG1;NLGN3;DOCK7;B4GALT5;USP9X;FEZ2;NPTN;UNC5D;AUTS2;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;RAB8A;SLC9A6;EPHA5;KIF5B;USP33;DAB1;DCC;ZDHHC17;SLITRK1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.43717773306420343,1.2651177763446169,0.1272923408845739,1.0,1.0,12/69,13.29%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,negative regulation of response to external stimulus (GO:0032102),0.4315983331777888,1.264753213719862,0.10410094637223975,1.0,1.0,14/105,7.34%,SMPDL3B;PTGER4;SIRT2;AJAP1;SELENOS;CASK;RORA;TNFAIP3;PPM1B;CARD16;DHX58;CERS2;TRAFD1;SIRPA
prerank,neuromuscular process (GO:0050905),0.5520038803431233,1.264506795478953,0.20218579234972678,1.0,1.0,7/16,19.92%,CLN3;STRA6;MYCBP2;KCNA1;SHANK1;AGTPBP1;PAFAH1B1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5602417655818933,1.2644208494306162,0.18579234972677597,1.0,1.0,6/16,9.68%,DDX17;RBM17;CDK13;SRSF9;SRSF1;HNRNPM
prerank,ubiquinone metabolic process (GO:0006743),0.5491166058420438,1.2641637406048667,0.21714285714285714,1.0,1.0,3/15,3.34%,COQ6;COQ8B;AIFM2
prerank,cellular response to alcohol (GO:0097306),0.4669608021301476,1.2638174923798633,0.14776632302405499,1.0,1.0,11/42,16.59%,SFRP1;PTGER4;GPLD1;ADCY7;MLC1;GNG2;PTCH1;JUP;GLRA1;ADCY1;ADCY5
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.41037388385846263,-1.2637207403249187,0.1940928270042194,0.8881506229719615,1.0,6/18,13.78%,LATS1;MDFIC;MFHAS1;ILRUN;RAB23;SIN3A
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5037429964746506,1.2636257607602452,0.1777509068923821,1.0,1.0,8/26,15.47%,GRIN1;SLC25A33;SLC5A3;SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,negative regulation of immune response (GO:0050777),0.4152860239445876,1.263529448609892,0.08502024291497975,1.0,1.0,13/154,6.64%,FSHR;FCGR2B;PTGER4;SIRT2;ADCY7;ADM;VIPR2;PTHLH;TNFAIP3;PPM1B;DHX58;TRAFD1;GNG2
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.4278414108437473,-1.2633437363544455,0.16205533596837945,0.8835525190066152,1.0,3/17,1.94%,FERMT2;GJA1;KAT7
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.498112072143025,1.2631582171008247,0.1705521472392638,1.0,1.0,7/25,11.37%,CCP110;TBC1D7;CEP97;TCHP;RAP1GAP;ARHGAP24;EVI5L
prerank,receptor clustering (GO:0043113),0.5008678432202744,1.262419054231526,0.17557251908396945,1.0,1.0,10/27,18.22%,PICK1;SCRIB;DLG3;THY1;DVL1;MUSK;MAGI2;ITGB1BP1;DLG2;SYNJ2BP
prerank,regulation of amyloid fibril formation (GO:1905906),0.5497815881254359,1.2610082628592663,0.19833564493758668,1.0,1.0,6/15,17.23%,PFDN4;VBP1;PFDN1;APP;APOE;PFDN2
prerank,regulation of adaptive immune response (GO:0002819),0.5313161207190835,1.2607295279198305,0.2047556142668428,1.0,1.0,3/18,5.88%,FCGR2B;ADCY7;IRF1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.522941025828943,1.2604982103746192,0.18863049095607234,1.0,1.0,5/20,11.50%,TNNI3;CALM3;ATP2A2;ATP1A2;CAMK2D
prerank,natural killer cell mediated immunity (GO:0002228),0.5563337071753881,1.260368201886711,0.2002840909090909,1.0,1.0,6/15,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;LYST
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5339993409469883,1.2603268319492171,0.20430107526881722,1.0,1.0,3/18,3.62%,APLN;PDPK1;FGFR1
prerank,protein-containing complex disassembly (GO:0032984),0.44630371019930976,1.2600999176336796,0.14634146341463414,1.0,1.0,15/54,16.15%,UBQLN1;CLN3;DVL2;VPS16;SNX14;LIX1L;DVL1;CHMP3;VCP;VPS33B;VTI1B;MAP1LC3B;CSNK1A1;STX17;VAMP8
prerank,metal ion export (GO:0070839),0.4822224238380769,1.260092101056808,0.17034313725490197,1.0,1.0,5/31,12.11%,SLC4A4;ATP1A3;KCNT2;ATP1A2;KCND3
prerank,regulation of interleukin-6 production (GO:0032675),0.4232152598461481,1.260054195528793,0.11917098445595854,1.0,1.0,16/96,13.55%,WNT5A;LPL;SELENOS;IL33;XBP1;TNFAIP3;TIRAP;TMEM106A;CD200R1;SIRPA;ARRB1;TWIST1;APP;CD47;TLR3;PTPN22
prerank,Notch signaling pathway (GO:0007219),-0.316387498144428,-1.2600398964496489,0.07446808510638298,0.8905637455716355,1.0,25/59,24.81%,MAML3;MIB1;MAML1;POFUT1;STAT1;NOTCH3;KAT2B;EP300;NCSTN;ADAM10;TRAF7;HES1;APH1A;HEYL;DTX1;NOTCH2;DTX3L;PBX1;JAG2;SORBS2;APH1B;NOTCH4;PSEN2;BMP2;MDK
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5327182697181776,1.2600202862159797,0.17914438502673796,1.0,1.0,4/17,10.30%,BMP6;PRKCA;CARD16;LY96
prerank,lamellipodium assembly (GO:0030032),0.5030993380211084,1.2598399807358112,0.18329177057356608,1.0,1.0,13/26,20.98%,RAC1;WHAMM;SRGAP2;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4495444341692157,1.259527193489892,0.1361079865016873,1.0,1.0,9/57,5.90%,BAX;PPIF;CHCHD10;FIS1;ZNF205;FBXO7;FAM162A;DCN;MIEF2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5977822290090159,1.2589733749103158,0.21357850070721357,1.0,1.0,3/10,12.01%,SELENOS;PID1;ENPP1
prerank,regulation of cation channel activity (GO:2001257),0.42832499741299945,1.2588814542926825,0.12671594508975711,1.0,1.0,32/89,22.19%,CAMK2B;NEFL;CACNG3;CACNB4;GRIN1;MINK1;DLG3;GRIN2A;CACNB1;APP;ANK3;SLMAP;FGF12;CAMK2D;GRIA1;FGF14;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;AHNAK;JPH1;DLG2;SHISA9;CALM1;SHANK1;PTK2B;ITGB1;FGF13;CALM2;GRIA4
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5909330563325781,1.2577387346925628,0.20211161387631976,1.0,1.0,2/10,10.25%,PLA2G5;ENPP2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.5562896429436539,1.2576455879968265,0.21095890410958903,1.0,1.0,3/15,6.02%,IGF1;PPIF;PRELID1
prerank,positive regulation of phagocytosis (GO:0050766),0.45639722818941586,1.2567979839648984,0.15695067264573992,1.0,1.0,9/47,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;IL15RA;RAB31;CAMK1D
prerank,heart trabecula morphogenesis (GO:0061384),-0.4209996516601938,-1.2567142667459164,0.16862745098039217,0.8974548522734714,1.0,8/18,13.00%,ADGRG6;TEK;RBP4;TGFB2;ENG;BMPR1A;S1PR1;BMP7
prerank,regulation of cellular respiration (GO:0043457),0.5447981283172441,1.2566273275673467,0.18479685452162517,1.0,1.0,4/17,9.82%,IFNAR1;IL10RB;PRELID1;VCP
prerank,ephrin receptor signaling pathway (GO:0048013),0.4244853892215981,1.2559968362995733,0.13368983957219252,1.0,1.0,17/82,10.04%,EPHA7;EPHB2;DNM1;RAC1;GRIN1;ACTR2;ARPC1A;ARHGEF7;PAK3;EFNB3;EPHA8;KALRN;SDCBP;EFNB2;EPHA10;AP2S1;VAV2
prerank,negative regulation of signal transduction (GO:0009968),0.4048516166650777,1.255708656264084,0.041082164328657314,1.0,1.0,49/249,14.49%,SFRP2;RNF157;APLN;DLK1;SMPDL3B;GPR108;SFRP1;TCIM;TSC2;PIP4K2B;CSNK2A2;SLC27A4;GLIS2;DKK3;BRAP;TNFAIP3;CARD16;SULF1;DCN;SRMS;EZH2;TMBIM1;HGS;GPC1;PID1;ARRB1;PTCH1;LRPAP1;EGF;LGR4;VCP;PIK3CB;IGFBP3;BCL2;MAZ;LEPROT;BMP5;ENPP1;NDRG4;CD47;LRRC14;RACK1;CYP26B1;PIP4K2A;SUFU;TNS2;LRP1;PIP4K2C;TULP3
prerank,regulation of aerobic respiration (GO:1903715),0.5440246054027325,1.255421992771313,0.1883289124668435,1.0,1.0,5/15,13.28%,SLC25A33;COX7A2;VCP;AK4;UQCC2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5392535333787221,1.2552034518690034,0.18276762402088773,1.0,1.0,6/18,16.48%,EDN3;ABL1;POR;GDNF;PARK7;AGTR1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.538791831866961,1.2550617798445676,0.22253129346314326,1.0,1.0,1/16,0.85%,FCGR2B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6061855070359913,1.2547894303460232,0.22580645161290322,1.0,1.0,4/10,15.82%,HGS;NDRG4;LRP1;PTPN12
prerank,regulation of T cell differentiation (GO:0045580),0.47865682104352236,1.2547890900142242,0.17569193742478942,1.0,1.0,8/33,17.44%,XBP1;PRELID1;ABL1;CLPTM1;ZMIZ1;CBFB;FANCA;TCF7
prerank,ethanol metabolic process (GO:0006067),0.5792217407731535,1.2547443873186606,0.21418439716312057,0.9985596920709704,1.0,1/12,0.66%,ADH5
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5080767248609893,1.2542214579606066,0.20730117340286833,0.9994270448295655,1.0,10/23,16.45%,GLIS2;PTCH1;VCP;RFX4;ENPP1;GPR161;RACK1;SUFU;TULP3;MEGF8
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4072369107675253,1.2542056820232859,0.04909819639278557,0.99754981119879,1.0,75/248,20.37%,SFRP2;TMEM198;WNT5A;BICC1;ATP6AP2;SFRP1;DVL2;PSMD4;GSKIP;NFKB1;ZEB2;FGFR2;SCEL;DKK3;DDX3X;FZD9;CTNND2;CHD8;FGF10;PPM1B;TCF7L2;USP47;KLHL12;PSMB10;DVL1;STK11;PSMD11;XIAP;SOX9;DDIT3;GPRC5B;RBMS3;EGF;WLS;LGR4;VCP;PSME2;WNK2;PSMC5;LZTS2;JUP;ZNRF3;HDAC1;AXIN2;KREMEN1;ZBED3;CSNK1D;RNF220;TGFB1;LYPD6;CSNK1A1;PSMD1;INVS;USP34;NKD1;ADGRA2;TNKS;PTK7;UBR5;PSMD6;SOX13;APOE;TLE5;GNAQ;TBL1XR1;ILK;SOX4;GPC5;PSMD5;PPM1A;MLLT3;PRDM15;LRRK1;DAB2;CDK14
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5624138363957532,1.2540158721955554,0.2033898305084746,0.9965867633158766,1.0,3/14,8.37%,ADAMTS7;PTHLH;SOX9
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5183082975989821,1.2534319022604874,0.19764397905759162,0.9977144784831733,1.0,5/19,6.13%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,heart process (GO:0003015),0.561595307774984,1.2533627129628142,0.2125,0.996084056877132,1.0,1/14,0.42%,TNNI3
prerank,organic acid transport (GO:0015849),-0.28731851787875645,-1.2532510842656404,0.03571428571428571,0.9051686544822584,1.0,21/94,14.75%,ABCG2;ABCC4;SLC6A6;ATP8B1;SLC25A17;SLC26A7;SLC3A2;SLC7A1;SLCO1C1;LRRC8D;SLC16A1;GOT2;SLC25A32;SLC7A6;SLC7A7;PPARD;SLC22A6;SLC25A14;SLC43A2;SLC16A10;SLC5A6
prerank,neuromuscular junction development (GO:0007528),0.5068448068895398,1.2531259495912146,0.19874213836477989,0.9954242907808669,1.0,7/24,11.13%,CACNB4;UNC13A;PDZRN3;DVL1;MUSK;CACNB1;ANK3
prerank,membrane raft organization (GO:0031579),0.5472474917419446,1.2531009243695652,0.21142857142857144,0.993626207507394,1.0,6/15,22.04%,CLN3;ABCA7;EMP2;ANXA2;FLOT1;NPC1
prerank,regulation of lipid catabolic process (GO:0050994),-0.4031254386235601,-1.252439575414122,0.16521739130434782,0.9027362836138794,1.0,5/19,21.92%,LONP2;PDE3B;ALK;BSCL2;ADRA2A
prerank,protein trimerization (GO:0070206),0.5581523306522502,1.2521418282930112,0.21237693389592124,0.9948709610757461,1.0,5/14,17.80%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,protein homotrimerization (GO:0070207),0.5581523306522502,1.2521418282930112,0.21237693389592124,0.9948709610757461,1.0,5/14,17.80%,ALOX5AP;ASIC1;SLC1A5;MLKL;SLC1A2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5007748536334129,1.252049935436151,0.1814720812182741,0.9934693703998727,1.0,3/24,9.52%,PLA2G5;CRLS1;GPAM
prerank,protein deneddylation (GO:0000338),0.6017676765920295,1.251907169187189,0.22895125553914328,0.992267198991416,1.0,2/10,8.17%,COPS7A;COPS7B
prerank,mitotic spindle assembly (GO:0090307),0.4589581056722405,1.2514520094974169,0.1695501730103806,0.9927334945849602,1.0,13/42,17.49%,CCDC61;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;OFD1;CHEK2;BCCIP
prerank,negative regulation of neuron death (GO:1901215),0.4238011395938309,1.2509963767762544,0.12631578947368421,0.9930985488377397,1.0,17/93,13.35%,FGF20;CLN3;NTF3;FZD9;CDK5;FBXO7;SNX6;SLC30A10;CD200R1;INPP5A;NRBP2;GDNF;KDM2B;BCL2;PARK7;SOD2;PRKCI
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5730342485739464,1.250828009534888,0.21397379912663755,0.9920669344167872,1.0,1/12,1.28%,IL34
prerank,phosphatidic acid metabolic process (GO:0046473),0.4551214073962568,1.2505989858091013,0.16103603603603603,0.9913065698316817,1.0,8/48,9.52%,PLA2G5;GPD1;GPD1L;AGPAT1;AGPAT5;GPAT4;AGPAT3;GPAM
prerank,positive regulation of fat cell differentiation (GO:0045600),0.45444372187443244,1.250521862966008,0.1637831603229527,0.9898028284536026,1.0,13/47,17.11%,SFRP2;LPL;SFRP1;XBP1;ZFP36L1;ZBTB7B;WDFY2;PTGS2;AAMDC;LMO3;CDS1;MEDAG;SOX13
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4606907648017452,1.2503857230853168,0.18337129840546698,0.9886511743349449,1.0,18/42,25.24%,RAC1;MINK1;THY1;DMTN;SPOCK1;PIK3CB;FBLN2;ECM2;EMP2;TBCD;NDNF;GCNT2;PPM1F;TSC1;CORO1C;JAK2;CX3CL1;ATXN3
prerank,DNA replication initiation (GO:0006270),-0.33525866615836897,-1.2501944211836897,0.08666666666666667,0.9054379056734305,1.0,28/37,45.78%,ORC4;RPA1;PURA;NOC3L;ORC5;MCM6;PRIM2;CDK2;POLA2;PRIM1;LRWD1;POLE2;CDC7;MCM4;DBF4;RPA3;ORC1;CDC34;MCM8;RPA2;CDC45;POLE;MCM3;MCM2;MCM7;POLE3;MCM5;MCM10
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.4476645916883613,1.2500746186282135,0.15028248587570622,0.9883365534808662,1.0,19/57,19.05%,CAMK2B;NPTXR;NEFL;CACNG3;GRIN1;MINK1;DLG3;GRIN2A;APP;GRIA1;DAPK1;NETO1;GRIA2;NLGN2;CACNG4;DLGAP1;DLG2;SHISA9;SHANK1
prerank,positive regulation of neuron death (GO:1901216),0.4487379934668515,1.2493299867054133,0.1657271702367531,0.9901100879230776,1.0,7/46,8.84%,WNT5A;FCGR2B;EPHA7;BAX;CDK5;DDIT3;EFNB2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43619287365564235,1.2493296359394725,0.16906077348066298,0.9882348794232234,1.0,14/60,15.24%,MED24;BAX;NFKB1;MED12;MED14;CCNC;TCF7L2;MED13;MED4;SOX9;DHX36;AGO3;CBFB;MED23
prerank,regulation of cytoplasmic transport (GO:1903649),0.5885336457855956,1.2490566227915123,0.21145374449339208,0.9877084544265252,1.0,5/11,14.89%,ATP9A;USP7;CHMP3;MAP2K2;DNAJC13
prerank,regulation of mRNA stability (GO:0043488),0.41259266857463295,1.2486581860993444,0.10040567951318459,0.9878462188192448,1.0,54/145,22.24%,KHSRP;EXOSC1;EXOSC3;PSMD4;TBRG4;EXOSC7;EXOSC2;PAIP1;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;CELF1;FUS;PSMD11;HNRNPD;DHX36;PABPC1;GDNF;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;NPM1;AXIN2;YTHDF1;CSDC2;ROCK2;XRN1;NUP214;PSMD1;TNPO1;FMR1;THRAP3;PSMD6;FASTKD1;FTO;TENT5A;SAMD4B;YTHDF2;PSMD5;CIRBP;HNRNPU;MAPKAPK2;YBX1;PSMA4;PSMA1;PSMC6;SAMD4A;METTL14
prerank,brain development (GO:0007420),0.4171492482518158,1.248546937980673,0.10061601642710473,0.9865547687938074,1.0,27/136,16.11%,AATK;AMIGO1;AFF2;POU6F1;EPHA7;SYNJ2;NKX2-2;GRIN1;NIPBL;CHD8;ATXN1;CXCR4;GRIN2A;PTCH1;ZFHX2;CDK5RAP3;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;SLC6A4;ZIC2;CNTNAP2;CIC;HSPG2
prerank,vasculature development (GO:0001944),0.5353966208749172,1.2479690061331161,0.19696969696969696,0.9875780895487363,1.0,4/16,11.29%,STRA6;ERRFI1;STK11;PDGFRA
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6138623330535953,1.2477715400859142,0.23123123123123124,0.9867138531749261,1.0,2/10,1.24%,SFRP1;SP7
prerank,positive regulation of bone mineralization (GO:0030501),0.4666482872815775,1.2473552888205737,0.1844888366627497,0.9870556624468438,1.0,9/35,9.70%,TMEM119;FBN2;BMP6;FZD9;NELL1;ADGRV1;WNT4;ATP2B1;KL
prerank,negative regulation of binding (GO:0051100),-0.28859548087226633,-1.247087648545065,0.07692307692307693,0.9120517667804036,1.0,25/81,16.01%,WAPL;MAPK8;LEF1;CAV1;ACTB;PRKCD;SP100;GNL3L;STYX;CSNK1E;NFKBIA;LRRK2;RALB;ARHGAP28;IFIT2;ILRUN;CAMK1;TMBIM6;ROCK1;DACT1;BTAF1;JUN;HABP4;EFHB;PEX19
prerank,positive regulation of lipid storage (GO:0010884),0.5103115065152329,1.2468687904554445,0.20341207349081364,0.9876045103720933,1.0,4/21,9.13%,LPL;NFKB1;OSBPL11;PLIN3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.565873102570134,1.2468522352743427,0.2323529411764706,0.9858549849730929,1.0,3/13,11.81%,LCMT1;MAD2L1;DYNC1LI1
prerank,regulation of myoblast differentiation (GO:0045661),0.47883487979705763,1.2468507263037278,0.17866004962779156,0.9840355131738794,1.0,9/32,16.48%,LRRC8A;ZFP36L1;RANBP3L;RIPOR2;SOX9;SRA1;IGFBP3;TGFB1;TRIP4
prerank,cellular response to fatty acid (GO:0071398),0.5711480279360843,1.2459356503625705,0.20704225352112676,0.9869492061804213,1.0,2/12,7.65%,LPL;PID1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5280951488289274,1.2458302635601552,0.20408163265306123,0.9857039813289102,1.0,6/17,19.75%,ANXA1;ARRB1;SSC5D;PTPN22;ANXA4;KLF4
prerank,regulation of regulated secretory pathway (GO:1903305),0.47040139439878126,1.2447743752188623,0.1890909090909091,0.9892446809004916,1.0,3/34,0.87%,UNC13D;SYT3;SYT10
prerank,negative regulation of protein polymerization (GO:0032272),-0.37140791943397483,-1.244692774957102,0.1625615763546798,0.9160662461533137,1.0,11/27,17.39%,CYRIB;MAPRE1;SLIT2;PRKCD;KANK3;MYADM;KANK4;TWF2;PFN1;KANK1;TWF1
prerank,chordate embryonic development (GO:0043009),0.4467617515609204,1.2437524063180427,0.17439293598233996,0.9924596677232723,1.0,10/55,8.42%,WNT5A;ZNF568;FGFR2;FGFR1;PCSK5;FLCN;SULF1;ALDH1A2;DVL1;PTCH1
prerank,positive regulation of innate immune response (GO:0045089),0.487127083277618,1.243541252666768,0.19730392156862744,0.9917504857022162,1.0,5/30,8.18%,PLA2G5;WNT5A;POLR3D;IFI35;TRIM62
prerank,cGMP-mediated signaling (GO:0019934),0.5517522065232743,1.2428762270622926,0.21857142857142858,0.9932440230722943,1.0,4/13,18.87%,KCNC2;HTR2C;APOE;PDE9A
prerank,actin filament depolymerization (GO:0030042),-0.49131300777010833,-1.2426475928613228,0.20648967551622419,0.9180440545250187,1.0,6/11,23.64%,CFL2;DSTN;TWF2;TWF1;MICAL2;MICAL1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.49956077485972294,1.2424286083110565,0.19852034525277434,0.9937382701244456,1.0,4/26,7.53%,UBQLN1;CBARP;CALM3;ATP1A2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4304562280731858,-1.2422393010104429,0.18681318681318682,0.9137695846162599,1.0,9/17,16.00%,NR3C1;MED1;AR;ATP1A1;URI1;ABHD2;BMP7;SRC;BMP4
prerank,hepaticobiliary system development (GO:0061008),0.5180022683430322,1.2419702390475076,0.2220795892169448,0.9943078371748165,1.0,6/20,12.40%,GFER;XBP1;NIPBL;WNT4;CDK5RAP3;CEBPG
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4126849002259281,1.2402079559372774,0.12086776859504132,1.0,1.0,18/112,13.55%,WNT5A;LPL;IGF1;DDT;EPHB2;SELENOS;IL33;TNFAIP3;TIRAP;TMEM106A;SIRPA;TWIST1;LY96;APP;IFNGR1;CD47;TLR3;PTPN22
prerank,cognition (GO:0050890),0.45761169531366636,1.2396924912386948,0.17471264367816092,1.0,1.0,11/42,15.65%,METTL23;STRA6;MGAT3;NIPBL;CYFIP1;TTC8;APP;JAKMIP1;LINS1;RP9;SOBP
prerank,chromatin disassembly (GO:0031498),0.5651227859242924,1.239455211722639,0.22527472527472528,0.9998258882654891,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.5651227859242924,1.239455211722639,0.22527472527472528,0.9998258882654891,1.0,4/14,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,histone H2A monoubiquitination (GO:0035518),0.5290660545743614,1.2393225807089032,0.2047244094488189,0.9986923608093026,1.0,6/17,10.68%,PCGF1;DDB1;PCGF6;RNF168;CUL4B;KDM2B
prerank,sterol metabolic process (GO:0016125),0.4388701426930706,1.2392521781839319,0.1710239651416122,0.9972169642018938,1.0,12/60,13.04%,CYP27A1;CLN6;SCAP;GBA2;CYP7B1;SOAT1;INSIG1;MSMO1;SC5D;STARD3;CYP26B1;CYP51A1
prerank,regulation of protein kinase B signaling (GO:0051896),0.40315018156317745,1.239012491807195,0.07823470411233702,0.9966005644178267,1.0,34/193,14.28%,FGF20;MYORG;FGF9;MST1R;TSC2;PDPK1;HSP90AA1;RAC1;FGFR2;THEM4;FGFR1;FGF10;FLCN;TCF7L2;PIK3R1;GAB1;RCN3;DDIT3;FRS2;EGF;KL;IRS2;PIK3CB;PIK3R2;MAZ;PDGFRA;MAGI2;PARK7;DAG1;RACK1;NRG2;NRG1;RNF41;TGFB1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4334686565585986,1.2389228704781678,0.15184381778741865,0.995183786438654,1.0,12/67,11.29%,AATK;EPHB2;FGFR2;FGFR1;DDR1;DDR2;ABL1;SRMS;PIBF1;TEC;PRLR;PDGFRA
prerank,amino acid transmembrane transport (GO:0003333),-0.3189537786739003,-1.238760073782566,0.11475409836065574,0.9214592620594431,1.0,12/45,10.86%,SLC6A6;SLC16A2;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SFXN2;LRRC8D;SLC7A6;SLC38A11;SLC7A7;SLC36A4
prerank,chromosome organization (GO:0051276),0.4222482347980264,1.2384513742088024,0.13547052740434332,0.995711492023435,1.0,23/99,15.29%,COPS7A;HDAC3;CENPT;PARP1;FAM50A;GATAD1;RAE1;TCF7L2;ABL1;DDB1;PHF1;SETD7;EZH2;HDAC5;COPS7B;CUL4B;SUV39H1;HDAC1;AXIN2;EHMT1;NUCKS1;SATB1;TCF7L1
prerank,reticulophagy (GO:0061709),-0.47700368622595235,-1.2384438922941114,0.2305194805194805,0.9169476000081612,1.0,7/12,22.06%,ATG2B;UBA5;DDRGK1;ULK2;UFC1;UFL1;UFM1
prerank,myeloid cell differentiation (GO:0030099),-0.3084436905799166,-1.2384423376479825,0.12403100775193798,0.9113221546093382,1.0,18/47,29.03%,HIPK2;MFHAS1;NCOA6;KMT2E;KIT;UBA5;RPS19;PRKX;UFL1;IKZF1;KAT8;CASP3;PRDX3;RPS14;INHBA;SLC25A5;KAT6A;TAL1
prerank,regulation of feeding behavior (GO:0060259),-0.48104618794294335,-1.2384081982489767,0.21929824561403508,0.9059445940938909,1.0,3/11,5.04%,EIF2AK4;STAT3;SGIP1
prerank,chondrocyte differentiation (GO:0002062),0.47538866437698307,1.2383014435354305,0.18973747016706444,0.9947030405749026,1.0,9/32,17.12%,WNT2B;GPLD1;EIF2AK3;SULF1;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4536373700910171,1.2369110416808684,0.1676300578034682,0.9999455244254234,1.0,15/43,19.82%,TSC2;PIP4K2B;SLC27A4;SNX5;OGT;ZBTB7B;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;NUCKS1;SORL1;PTPRE;PRKCZ
prerank,nucleotide biosynthetic process (GO:0009165),0.5320328525049209,1.2367938631628732,0.2074468085106383,0.9987330039866195,1.0,5/18,13.10%,ADSL;PRPSAP2;GART;RRM2B;HPRT1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.590764705798607,1.2364789266741614,0.20478325859491778,0.9985234791235483,1.0,1/10,0.49%,NHP2
prerank,synaptic membrane adhesion (GO:0099560),0.5494960257187362,1.2360022939602269,0.23140495867768596,0.9990737189881215,1.0,6/14,20.04%,LRRC4;GPC6;PTPRF;GPC4;SLITRK1;PTPRS
prerank,negative regulation of immune system process (GO:0002683),0.5358602357059079,1.2354012434410828,0.23265306122448978,1.0,1.0,2/16,8.37%,FCGR2B;SOX9
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5664308298035949,1.23505949861317,0.21503759398496242,1.0,1.0,4/12,7.40%,CCT8;GNL3;CCT6A;WRAP53
prerank,myelination (GO:0042552),0.4471265900825708,1.2349978218834772,0.17321016166281755,0.9987156897161631,1.0,13/46,17.90%,AMIGO1;SIRT2;MYRF;ARHGEF10;MARVELD1;CXCR4;GPC1;PLLP;B4GALT5;EPB41L3;ABCD2;TPPP;BCAS1
prerank,long-chain fatty acid transport (GO:0015909),0.4779413314665892,1.2349964065721175,0.19899244332493704,0.9969487178013686,1.0,8/30,18.99%,SLC27A6;SLC27A4;CPT2;ABCD2;SLC27A1;APOE;SLC25A20;PRKAG2
prerank,ribosomal large subunit assembly (GO:0000027),-0.3731994195169381,-1.2344496105154075,0.19473684210526315,0.9153762300447951,1.0,18/24,36.65%,RPL11;RPL5;RPL6;RPL24;RPL3;RPLP0;RPL10;TRAF7;MRPL20;FASTKD2;NOP53;RPF2;NOP2;BOP1;RRS1;RSL24D1;NLE1;PPAN
prerank,histone H4-K8 acetylation (GO:0043982),-0.43889128917414394,-1.2344275431472886,0.2246376811594203,0.9045114522733869,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),-0.43889128917414394,-1.2344275431472886,0.2246376811594203,0.9045114522733869,1.0,8/15,18.09%,KAT7;JADE2;JADE1;KANSL3;JADE3;WDR5;HCFC1;KAT8
prerank,regulation of supramolecular fiber organization (GO:1902903),0.4954635235571701,1.2342706363007583,0.2276843467011643,0.9989615765371371,1.0,9/22,17.19%,MAPRE3;GBA2;ABL1;CAMSAP2;PRUNE1;PARK7;AKAP13;MAPT;APOE
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4270331601486266,-1.2332596728279914,0.2,0.9035351972558145,1.0,14/16,55.68%,TGFB2;ENG;NOTCH2;BMP2;HEY2;ZFPM1;DLL4;BMPR2;TBX20;NOG;MYH6;PROX1;GATA4;ISL1
prerank,organelle disassembly (GO:1903008),-0.33758880193873353,-1.2330980303074446,0.1337579617834395,0.8987107682201468,1.0,12/33,16.75%,GBF1;ATG2B;MCTS1;KLC1;UBA5;DDRGK1;EIF2D;MTIF2;ULK2;ZFAND1;UFC1;UFL1
prerank,neutrophil activation (GO:0042119),-0.4740332044960197,-1.2330177355950542,0.23548387096774193,0.8937637371639559,1.0,2/12,3.95%,KMT2E;PRKCD
prerank,glycerol metabolic process (GO:0006071),-0.502820302554447,-1.2326112193966887,0.21823204419889503,0.8901927947590025,1.0,8/10,39.26%,GK5;COQ2;COQ3;GOT1;PGP;GK;ANGPTL3;TKFC
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.41699022527931073,-1.2323822202613441,0.18518518518518517,0.885814990179132,1.0,7/17,15.52%,AFG1L;COX4I1;COX5A;COX8A;NDUFA4;COX7A2L;COX6A1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.39363690904754145,-1.2320584335832923,0.1826086956521739,0.8818717686611217,1.0,4/19,23.38%,LRP6;MANF;VEGFA;NR4A2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4987949875589992,1.2312814920196071,0.21473951715374842,1.0,1.0,8/23,18.75%,RAC1;MOSPD2;TIRAP;RIPOR2;JAM3;DNM1L;CAMK1D;MPP1
prerank,central nervous system myelination (GO:0022010),0.5720757098656227,1.2312363530186685,0.23700305810397554,1.0,1.0,4/11,15.23%,MYRF;ABCA2;B4GALT5;TENM4
prerank,embryonic eye morphogenesis (GO:0048048),0.5710627572996827,1.230358922606985,0.2222222222222222,1.0,1.0,5/11,12.67%,FBN2;MFAP2;MFAP5;KDM2B;FBN1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4698648626421524,1.2303296172108824,0.2026378896882494,1.0,1.0,8/33,12.24%,APLN;TNFAIP3;MFN2;TAFA5;TPM1;IGFBP3;NDRG4;SOD2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.5367556564256695,1.2300863583446084,0.22612359550561797,1.0,1.0,6/16,15.49%,PARP1;FLCN;PID1;VCP;AK4;ATPSCKMT
prerank,xenobiotic transport (GO:0042908),-0.4080714404200129,-1.2297502011029802,0.21505376344086022,0.8856279642024787,1.0,4/17,4.18%,ABCG2;GJA1;ABCC1;SLC47A1
prerank,response to calcium ion (GO:0051592),0.41345812794354664,1.2295686024730303,0.1609907120743034,1.0,1.0,32/102,21.79%,ALOX5AP;SYT3;WNT5A;SYT10;GPLD1;PPIF;CALM3;CARF;SLC25A24;DMTN;RASGRP2;KCNMA1;ADGRV1;PEF1;CPNE7;CAMK2D;IQGAP1;SYT1;CPNE8;ADCY1;DPEP1;AHCYL1;PKD2;PRKAA1;CALM1;KCNH1;SMPD1;SYT4;PDCD6;SYT11;SYT12;CALM2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.42298544691055784,1.2295277609617221,0.16236559139784945,1.0,1.0,12/73,13.29%,WNT5A;LPL;DDT;EPHB2;IL33;TIRAP;TMEM106A;TWIST1;LY96;APP;IFNGR1;TLR3
prerank,I-kappaB phosphorylation (GO:0007252),-0.49437500651707744,-1.2294929777665955,0.2096317280453258,0.8815130824962532,1.0,3/10,7.06%,DAB2IP;ERC1;TLR4
prerank,protein-DNA complex disassembly (GO:0032986),0.5427374130078807,1.2292771464711911,0.2208994708994709,1.0,1.0,4/16,8.38%,SMARCD3;SMARCC2;SMARCB1;SMARCD1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3701343114183435,-1.228994965755187,0.143646408839779,0.8784411222240279,1.0,10/27,16.58%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28;SHANK3;PFN1;MET
prerank,endomembrane system organization (GO:0010256),0.4025623498211084,1.2289931437767594,0.09898989898989899,1.0,1.0,50/178,16.00%,SPTBN5;REEP4;CUL7;A4GALT;ATL1;DNM1;TJAP1;UBXN2A;EIF2AK3;DMPK;BNIP1;TRAPPC8;OBSL1;TLCD1;SQSTM1;SEC16A;ARHGEF7;MIA3;SNX10;TRIP11;SEC16B;ATP8B2;LMAN2L;ARHGAP21;TOR1B;HOOK3;TBC1D20;PLEKHM2;USP6NL;ANK3;RAB30;ALS2;SNX33;VPS33B;LEMD3;TANGO2;TMED10;SERP1;COG3;HTT;CSNK1D;SMPD4;VMP1;DNM1L;DNAJC13;CSNK1A1;SPTBN1;VAPB;STX17;VPS18
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5154280484670417,1.228728201774706,0.2232620320855615,1.0,1.0,6/20,11.50%,BAX;FIS1;RAP1GDS1;ATP2A2;BCL2;CAMK2D
prerank,cellular response to interleukin-7 (GO:0098761),-0.40061897150455195,-1.2282963746700133,0.16101694915254236,0.8710915379941507,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.40061897150455195,-1.2282963746700133,0.16101694915254236,0.8710915379941507,1.0,3/17,3.26%,BRWD1;STAT3;IRS1
prerank,glial cell differentiation (GO:0010001),0.4679250498999608,1.227995858707438,0.20838471023427868,1.0,1.0,7/28,9.55%,MYRF;PICK1;FGF10;CDK5;GPC1;SOX9;SOX11
prerank,regulation of intracellular pH (GO:0051453),0.46703532718579005,1.227879097776658,0.19784172661870503,1.0,1.0,3/34,0.91%,SLC4A4;SLC4A5;CLN3
prerank,macroautophagy (GO:0016236),0.4117303819308803,1.2278054505254385,0.1437371663244353,1.0,1.0,47/118,21.47%,UBQLN1;CLN3;MVB12A;PIP4K2B;CSNK2A2;VPS16;WIPI1;SNF8;SNX14;TOMM20;MTERF3;FUNDC1;LIX1L;SQSTM1;ATG14;MFN1;HGS;MFN2;VTA1;CHMP3;VCP;ATG13;TCIRG1;VPS33B;VPS4B;VTI1B;PIP4K2A;VDAC1;ATG3;MAP1LC3B;VPS39;VPS41;STX17;VAMP8;PIK3C3;STAM2;ARL8B;PRKAA1;PRKAG2;PIK3R4;YOD1;AMBRA1;DYNLL1;UVRAG;VAMP7;CHMP4A;CHMP4B
prerank,regulation of cytokinesis (GO:0032465),0.42626704803803567,1.2272390621337337,0.1774193548387097,1.0,1.0,24/78,21.79%,CCP110;FSD1;RAB11FIP4;MYO19;CALM3;FLCN;CDC14B;PLK5;CIT;ENTR1;MAP9;GIT1;SVIL;CSPP1;PRPF40A;KLHL13;PIK3C3;KIF20B;CALM1;PIK3R4;UVRAG;KLHL9;RAB11FIP3;CALM2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5300261883983292,1.22675292079943,0.21655172413793103,1.0,1.0,3/16,7.50%,FASN;MLYCD;ACAT1
prerank,regulation of lamellipodium assembly (GO:0010591),0.46735581762284695,1.2265807362682342,0.21930870083432658,1.0,1.0,6/34,8.36%,CARMIL2;RAC1;ACTR2;PIK3R1;DMTN;CYFIP1
prerank,peptidyl-methionine modification (GO:0018206),0.5612115757007007,1.2259316832269342,0.2332859174964438,1.0,1.0,4/12,13.29%,METAP1;NAA30;METAP1D;METAP2
prerank,regulation of heart contraction (GO:0008016),0.41836378463128876,1.2255885620699645,0.13522012578616352,1.0,1.0,13/90,11.50%,APLN;KCNG2;DMPK;CALM3;ATP1A3;ATP2A2;ITPR1;CELF2;ATP1A2;DES;ATP2B1;TPM1;CAMK2D
prerank,actin filament organization (GO:0007015),0.4051959025954601,1.2253254505735929,0.10010111223458039,1.0,1.0,29/151,17.61%,MYO1A;CARMIL2;SPIRE2;LCP1;MYO19;RAC1;WHAMM;NEB;MYO1B;DMTN;DBN1;RHOD;GAS2L1;PPP1R9B;BAIAP2;RHOBTB3;TPM1;MYO5A;MPRIP;ZBED3;EFS;SVIL;EMP2;FAT1;SPIRE1;VILL;TMOD2;RUFY3;ABI1
prerank,regulation of mast cell degranulation (GO:0043304),0.5491647509794377,1.2252704774025815,0.2300140252454418,1.0,1.0,1/14,0.21%,UNC13D
prerank,female gamete generation (GO:0007292),0.4795912316962256,1.2252632237141778,0.18585131894484413,1.0,1.0,2/29,6.03%,FSHR;SPO11
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4970393009650463,1.2251971444317906,0.21292775665399238,1.0,1.0,7/22,16.79%,CBARP;CACNB4;NOS1AP;CACNB1;PDE4B;AHNAK;FMR1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.25629196080965044,-1.2240281545643146,0.0,0.8817079675446478,1.0,33/128,16.00%,PARD3;HIVEP1;SMAD4;FERMT2;ARHGEF18;PTPRK;PXN;PDCD4;TWSG1;FNTA;SLC33A1;NLK;APPL1;SIRT1;CLDN5;SMAD1;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2;F11R;UBB;ZFYVE9;DUSP22;ACVR2B;BMP7;ZMIZ2;BMPR1B;JUN;SRC;ITGB5;BMP4
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.49933781269657884,1.2239746647474972,0.22121604139715395,1.0,1.0,7/22,15.78%,HEXIM1;EEF1E1;CHD5;CDK5RAP3;RPS15;ATR;DDX5
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.25227453438388775,-1.2232368425382099,0.0,0.879556218024235,1.0,41/153,12.83%,RICTOR;MAPK8;HIPK2;LATS1;PRKCH;CSNK1G3;CAB39;ERN1;MORC3;CSNK2A1;IKBKB;MARK2;STK38L;NLK;PRKCE;PRKCD;RIPK1;RPS6KA5;CSNK1G1;PRKD1;MARK1;CSNK1E;MKNK1;HIPK1;PRKACA;LRRK2;CSNK1G2;TGFBR2;NEK6;IKBKE;TTBK2;MAP3K10;MAP3K13;STK32A;LMTK2;VRK3;CAMK1;ROCK1;MAP3K12;AKT3;PRKX
prerank,sensory perception of mechanical stimulus (GO:0050954),0.42619718850678157,1.2227861284995178,0.1395101171458999,1.0,1.0,10/85,9.16%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.43545221337512324,1.2227400591247364,0.1995540691192865,1.0,1.0,13/50,16.81%,CDKN2D;DDX3X;CARD16;USP47;RFFL;XIAP;CAAP1;PARK7;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,regulation of trophoblast cell migration (GO:1901163),-0.43601517556332137,-1.2227272587369127,0.21794871794871795,0.8765859463559735,1.0,6/14,19.11%,GJA1;AGO2;CALR;SYDE1;ARHGDIB;VEGFA
prerank,regulation of protein kinase C signaling (GO:0090036),0.5395368280353279,1.2226881769055862,0.22707423580786026,1.0,1.0,3/14,7.66%,WNT5A;GPD1L;ADGRV1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.29053913414464183,-1.2222375299190624,0.12698412698412698,0.8734269307229734,1.0,20/72,12.74%,ELF1;AXL;IFNAR2;IKBKB;IRAK2;STAT1;RIPK1;IRAK1;HSP90AB1;HIPK1;OTULIN;CYLD;TRIM44;TAX1BP1;PTPRC;IKBKG;LIFR;MADD;TNFRSF1A;CDC37
prerank,ERBB2 signaling pathway (GO:0038128),0.4655402058498074,1.2217360360067684,0.19781553398058252,1.0,1.0,11/31,18.11%,HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;EGF;NRG2;CUL5;NRG1;PTPN12;ERBIN
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5087160709354286,1.221033576688605,0.2102496714848883,1.0,1.0,2/20,3.12%,PSRC1;MAPRE3
prerank,cellular response to misfolded protein (GO:0071218),0.5056193415981503,1.2206473753958667,0.22769640479360853,1.0,1.0,6/20,10.85%,STUB1;AUP1;POMT2;KLHL15;VCP;UGGT2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5654090349909364,1.2206317840073841,0.24561403508771928,1.0,1.0,5/12,17.23%,PFDN4;VBP1;PFDN1;APOE;PFDN2
prerank,nuclear body organization (GO:0030575),0.559481047999394,1.2204500995552787,0.22814814814814816,1.0,1.0,3/12,7.40%,AFF2;USPL1;WRAP53
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5024056083463072,1.2200481014658915,0.22251655629139072,1.0,1.0,7/19,17.00%,CD63;CCBE1;DCN;PIK3CB;ROBO1;ADAMTS3;SPRY2
prerank,mitochondrial transport (GO:0006839),0.43597597663564713,1.219522990913721,0.20658342792281498,1.0,1.0,13/53,13.20%,PPIF;BCS1L;HSP90AA1;FIS1;SLC25A24;TOMM20;FBXO7;TIMM13;MFN2;AIP;BCL2;STARD3;GDAP1
prerank,chemical homeostasis (GO:0048878),0.42761408570634424,1.2194978132275747,0.19978165938864628,1.0,1.0,13/61,15.48%,SLC4A4;SLC4A5;USF1;NR1D2;DDX3X;TLCD1;RBP1;IRS2;WNK2;ZBTB20;TLCD3B;AQP4;ACOX3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3807498430903263,-1.219213727142046,0.1651376146788991,0.8795914261186725,1.0,6/23,7.62%,LATS1;SMAD4;BCL9;TRIM33;ITGA3;ENG
prerank,protein polymerization (GO:0051258),0.4401285686408797,1.2189258553327078,0.1787280701754386,1.0,1.0,20/55,21.47%,SPIRE2;RAC1;UBE2S;TPPP3;TTC17;CHMP3;WASF1;MAPT;SPIRE1;TPPP;GPX4;GAS7;ARHGAP6;PSTPIP2;PREX1;FGF13;GSN;DIAPH1;CHMP4A;CHMP4B
prerank,negative regulation of kinase activity (GO:0033673),0.43137194883940955,1.218844780969151,0.17845484221980412,1.0,1.0,24/62,21.65%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;WARS1;THY1;DVL1;YWHAG;IRS2;PARK7;MAPT;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;PPP2R5A;TAB1;TRIM27;PRKAG2;RTRAF;HNRNPU;NPRL2;PPM1F
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3860255567662443,-1.2187897488942894,0.20276497695852536,0.8714597313894179,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3860255567662443,-1.2187897488942894,0.20276497695852536,0.8714597313894179,1.0,8/20,11.39%,BCKDHB;IVD;MCCC2;HIBCH;MCCC1;ACAD8;ALDH6A1;BCKDHA
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4920339002231515,1.2186317321768982,0.23232323232323232,1.0,1.0,1/24,0.17%,RNF157
prerank,myeloid dendritic cell activation (GO:0001773),-0.4585928409683235,-1.2183910606398587,0.2197452229299363,0.868121041658228,1.0,2/12,7.89%,DOCK2;TGFBR2
prerank,regulation of interferon-beta production (GO:0032648),0.44240844840999144,1.2181241182280582,0.21550741163055873,1.0,1.0,16/46,20.04%,HSP90AA1;POLR3D;DDX3X;TIRAP;PPM1B;IRF1;DHX58;TRIM56;SIRPA;IRF3;YY1;TLR3;OAS2;RELB;FLOT1;PTPRS
prerank,negative regulation of calcium ion transport (GO:0051926),0.5466381158316891,1.2180246628514029,0.20815752461322082,1.0,1.0,4/15,9.62%,CBARP;ATP1A2;PACSIN3;SLC30A1
prerank,Wnt signaling pathway (GO:0016055),0.41129491481144526,1.2178392163689693,0.16842105263157894,1.0,1.0,21/92,15.56%,SFRP2;WNT2B;WNT5A;SFRP1;DVL2;DDX3X;FZD9;FZD3;TCF7L2;KLHL12;DVL1;CD24;WNT4;WLS;DIXDC1;PORCN;GPC4;PLPP3;CSNK1A1;TCF7L1;USP34
prerank,mitochondrial membrane organization (GO:0007006),0.46257408724017207,1.2177894649999363,0.22569027611044418,1.0,1.0,9/32,13.79%,APOOL;PPIF;MICOS10;MFN1;MFN2;APOO;RCC1L;BCL2;MTX3
prerank,monocarboxylic acid transport (GO:0015718),-0.29879387816052266,-1.2177579587715786,0.1262135922330097,0.865761446899863,1.0,9/51,6.35%,ABCG2;SLCO3A1;ABCC4;ATP8B1;SLC16A2;SLC16A6;SLCO1C1;SLCO2A1;SLC16A1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.5332303864135158,1.2174957698038666,0.24512534818941503,1.0,1.0,3/15,9.13%,LPL;OSBPL11;PLIN3
prerank,positive regulation of immune effector process (GO:0002699),0.4754263968217657,1.2174623357168517,0.20609756097560974,1.0,1.0,3/27,5.93%,PLA2G5;XBP1;DHX58
prerank,positive regulation of developmental growth (GO:0048639),0.4386873689951571,1.2174163206346111,0.20993227990970656,1.0,1.0,11/49,17.44%,RNF157;SYT3;CDKL5;UNC13A;DBN1;PPIB;DBNL;SYT1;MAPT;SMURF1;RUFY3
prerank,negative regulation of defense response (GO:0031348),0.4231188047686213,1.2172385075753283,0.16864864864864865,1.0,1.0,10/77,7.34%,SMPDL3B;PTGER4;SIRT2;SELENOS;RORA;TNFAIP3;PPM1B;DHX58;TRAFD1;SIRPA
prerank,negative regulation of B cell proliferation (GO:0030889),0.5569419092776674,1.2171498168326387,0.24962630792227206,1.0,1.0,1/11,0.85%,FCGR2B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4867692180300479,1.216892631745899,0.22150259067357514,1.0,1.0,3/25,5.62%,B3GALNT1;HS2ST1;NDST2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5665522241551566,1.2167774850069752,0.2414814814814815,1.0,1.0,5/11,15.95%,UBN1;RBBP4;ASF1A;ATRX;HAT1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3863766357253038,-1.2162200230040054,0.17032967032967034,0.8668328863025765,1.0,7/24,8.93%,WASF2;ARHGEF18;TMEFF2;TJP1;INPP5K;F11R;ARHGAP28
prerank,calcium ion homeostasis (GO:0055074),0.4107815435628028,1.2161281692935957,0.16806722689075632,1.0,1.0,15/95,13.21%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;GRIN1;CXCL12;ATP2A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.4420476074302962,1.2159631908418582,0.21212121212121213,1.0,1.0,6/45,10.71%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP
prerank,liver development (GO:0001889),0.47126621345319286,1.2158893054220625,0.220462850182704,1.0,1.0,7/32,12.40%,GFER;ANXA1;XBP1;ZIC3;WNT4;CDK5RAP3;CEBPG
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.44091774316774207,1.2158528864526243,0.18977272727272726,1.0,1.0,14/49,15.32%,UBQLN1;BAX;PPIF;EIF2AK3;FIS1;PTPMT1;DDX3X;DDIT3;BCL2;RTKN2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,negative regulation of cell development (GO:0010721),0.48369914516538515,1.2156635467142594,0.2159383033419023,1.0,1.0,8/25,23.91%,IGF1;PTHLH;HOOK3;FBN1;SORL1;APPL2;B2M;FBXW7
prerank,lipoprotein transport (GO:0042953),0.5665913766411582,1.2153809760297414,0.24780058651026393,0.9999099028151003,1.0,4/10,17.86%,MIA3;LRP1;VMP1;ZDHHC17
prerank,striated muscle tissue development (GO:0014706),-0.35043239886776134,-1.2153503143143674,0.1657754010695187,0.8653520542588354,1.0,9/29,16.25%,MEF2C;PGM5;MYL6;CAV1;RBP4;SGCD;BMP7;SIX1;NDUFV2
prerank,positive regulation of neurogenesis (GO:0050769),0.4229133124629346,1.2146263683541774,0.1574973031283711,1.0,1.0,21/68,20.85%,AMIGO1;CUL7;SMARCD3;CDKL5;PLXNA2;FZD3;OBSL1;PLXNA1;SOX11;ROBO2;ROBO1;IL1RAPL1;NPTN;DISC1;SNW1;PLXNB3;SLITRK1;CUX1;SERPINF1;MAP6;NTRK2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.399588211064525,1.2143538635642905,0.13184584178498987,1.0,1.0,22/152,14.65%,FSHR;S1PR2;PTGER4;ADCY7;ADM;VIPR2;PTHLH;OPRK1;GPR37;GNAS;GPR4;LGR4;TBXA2R;PTH1R;ADGRG1;GPR161;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1
prerank,positive regulation of organelle organization (GO:0010638),0.46666583313208415,1.2143502390863223,0.22919179734620024,0.9999769929576615,1.0,9/32,21.24%,PLA2G5;ANXA1;KATNBL1;ANXA2;PFDN2;FYCO1;RAB3GAP2;UVRAG;ATL3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.42407737641732407,1.2143122318289359,0.1967391304347826,0.9985610658008969,1.0,18/68,16.33%,MLYCD;THEM4;PTHLH;ENTPD7;ACOT9;ACOT11;GPAT4;MFN1;ACAT1;CROT;AK4;ENPP1;HPRT1;ABHD14B;AK3;ACSL6;GMPR2;SULT1A1
prerank,ceramide catabolic process (GO:0046514),-0.4357888986680229,-1.2142005742140065,0.21180555555555555,0.8649528556896549,1.0,13/14,55.85%,ASAH1;GM2A;NAGA;NEU1;NEU3;HEXA;GLA;ACER2;NEU2;ASAH2;NEU4;ACER3;ACER1
prerank,positive regulation of organelle assembly (GO:1902117),0.4488640891422333,1.2138113342960544,0.1997703788748565,0.9993779796604375,1.0,14/44,18.17%,CCP110;LCP1;PIP4K2B;ENTR1;SDCBP;GPSM2;PIP4K2A;HTT;PIP4K2C;CEP120;CNOT6;NUMA1;IL5;CCDC88A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.42092640611153087,1.2136377674049992,0.16059957173447537,0.9986851026811716,1.0,17/80,14.58%,CARMIL2;CCP110;CDC42EP5;CDC42EP4;RAC1;ACTR2;NRP1;PIK3R1;RIPOR2;CYFIP1;ENTR1;ARAP1;HTT;FAM98A;AUTS2;PLPPR5;CEP120
prerank,negative regulation of response to wounding (GO:1903035),0.5132639849683552,1.2133828179210162,0.24611398963730569,0.9982994620398165,1.0,8/19,22.67%,AJAP1;CASK;CERS2;GIT1;SERPINE1;PTPRS;FGF2;EPHA4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5162369691582428,1.2132064929687862,0.24435590969455512,0.9975355599029412,1.0,6/17,12.60%,ALG6;ALG1;ALG8;DHDDS;DPAGT1;ALG9
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4955175763341098,1.2126863613643588,0.22710163111668757,0.9984003517359692,1.0,3/22,6.13%,FCGR2B;UBASH3A;THY1
prerank,negative regulation of viral transcription (GO:0032897),0.5553673661770842,1.212513382866674,0.2323529411764706,0.9976107006452508,1.0,3/13,8.18%,HEXIM1;TRIM11;TRIM62
prerank,establishment of spindle localization (GO:0051293),0.5265233620148378,1.2118521689610522,0.24759284731774414,0.9992124479255462,1.0,7/14,24.56%,KPNB1;ZBED3;MAP4;CFL1;CLASP2;LLGL1;DYNC1H1
prerank,protein N-linked glycosylation (GO:0006487),0.42204390424266996,1.21155368488276,0.19313304721030042,0.9990245559526026,1.0,17/66,15.21%,ALG5;TMEM258;ALG6;MGAT3;DPM2;MGAT4B;ALG1;ALG8;DPAGT1;MGAT4C;UGGT2;ALG9;OSTC;UBE2J1;DAD1;MCFD2;RPN2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.574694655347018,1.2113686050886345,0.23607038123167157,0.9983259815625082,1.0,2/11,5.61%,XBP1;TMEM106A
prerank,bile acid and bile salt transport (GO:0015721),-0.3592250620209664,-1.2111135647666122,0.16097560975609757,0.8710916661159795,1.0,3/24,4.79%,ABCC4;ATP8B1;SLCO1C1
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4281887967088583,-1.2108889860233563,0.22962962962962963,0.8673998176005844,1.0,8/14,38.46%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,steroid hormone biosynthetic process (GO:0120178),-0.34843390123054885,-1.2108556642372603,0.1797752808988764,0.8629901531169774,1.0,14/29,42.35%,MED1;AKR1B1;STARD3NL;FDX1;TSPO;SRD5A3;FDXR;HSD17B7;HSD17B8;DHCR7;STAR;SRD5A1;HSD17B2;TSPOAP1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5684161899833053,1.2106034010326425,0.24005681818181818,1.0,1.0,6/11,16.87%,ZFP36L1;BARD1;DHX36;CDC73;ZC3H3;AHCYL1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.41178208007802164,-1.2105730295477448,0.21453287197231835,0.8595577494341968,1.0,7/17,32.79%,LGALS9;RARA;CEBPB;CD86;SYK;HAVCR2;FCER1G
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.548184776931914,1.2100667254340627,0.2598870056497175,1.0,1.0,6/13,14.40%,PRPF8;SRSF12;PRPF6;SART3;USP4;AAR2
prerank,positive regulation of DNA repair (GO:0045739),0.43447368260936303,1.209986944163821,0.20819112627986347,1.0,1.0,18/46,22.00%,SPIRE2;FOXM1;PARP1;RNF8;FGF10;MGMT;SLF2;WRAP53;RNF168;CEBPG;EYA2;SPIRE1;FMN2;UIMC1;RPS3;EYA1;NPAS2;HMGB1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5669437361578352,1.2092445435763268,0.23931623931623933,1.0,1.0,5/11,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.48204310916240156,1.2089609357263689,0.21799746514575413,1.0,1.0,10/27,19.82%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ
prerank,sphingolipid catabolic process (GO:0030149),0.5298426704791346,1.2088839579082855,0.23676880222841226,1.0,1.0,6/15,19.67%,SMPD2;SGPL1;ENPP2;SMPD4;SMPD1;PDXDC1
prerank,regulation of chromosome organization (GO:0033044),-0.3749296181027867,-1.2087795439837374,0.16877637130801687,0.8615830694366313,1.0,7/22,17.46%,WAPL;RB1;HDAC8;SMG5;CENPV;UPF1;SMG6
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.32901475395774593,-1.2080198718101238,0.15862068965517243,0.8596485352432968,1.0,14/40,16.75%,RAD23B;HIPK2;LATS1;CSNK2A1;GNA12;PML;RPL11;RPL5;AXIN1;TRIM39;UBQLN4;RNF139;SGTA;UFL1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.4673889874587187,-1.207409738171618,0.2282958199356913,0.8572969468424868,1.0,4/11,16.22%,TASOR;PPHLN1;SETDB2;DNMT1
prerank,protein localization to cell-cell junction (GO:0150105),-0.4267541510105322,-1.2074010500716346,0.2111111111111111,0.8529836638506201,1.0,5/15,9.79%,ARHGEF18;TJP1;ACTB;F11R;LSR
prerank,vitamin transport (GO:0051180),-0.34928190384253915,-1.2066667806799851,0.192090395480226,0.8514060619454737,1.0,9/29,23.43%,ABCG2;TCN2;SLC35F3;SLC25A32;SLC52A1;SLC5A6;CUBN;SLC19A2;SLC2A10
prerank,regulation of water loss via skin (GO:0033561),-0.4124063539365022,-1.2064466648734415,0.21505376344086022,0.8435899098345725,1.0,6/15,34.09%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.4124063539365022,-1.2064466648734415,0.21505376344086022,0.8435899098345725,1.0,6/15,34.09%,LSR;MET;HRNR;CLDN1;UGCG;ALOX12
prerank,potassium ion transport (GO:0006813),0.399374026157435,1.2063490975112419,0.1695786228160329,1.0,1.0,19/120,15.90%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;KCNK2;KCNMA1;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,regulation of cilium assembly (GO:1902017),0.42744708317309205,1.2060322853561969,0.2052689352360044,1.0,1.0,22/62,18.26%,CCP110;DCDC2;CDKL5;TBC1D7;SGSM3;TBC1D13;CEP97;TCHP;ENTR1;TBC1D20;USP6NL;EVI5L;IFT20;HTT;RABGAP1;TBC1D24;ATG3;CEP120;TBC1D9B;TBC1D22B;CCDC88A;CDK10
prerank,dendritic spine morphogenesis (GO:0060997),0.5191917941344557,1.2060281410125282,0.23994452149791956,1.0,1.0,3/15,6.37%,EPHB2;CTNND2;PAK3
prerank,mesenchymal cell differentiation (GO:0048762),0.43162246256461845,1.2056499492621482,0.2026875699888018,1.0,1.0,13/51,15.78%,WNT5A;CUL7;DDX17;FGFR2;FGFR1;SNAI1;RANBP3L;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,stabilization of membrane potential (GO:0030322),0.5180714155832988,1.2055776707588162,0.24242424242424243,1.0,1.0,2/16,5.33%,CHCHD10;KCNK2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.39932281296809774,-1.2054035443910271,0.20955882352941177,0.8430957396065504,1.0,10/18,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;TGFBR2;BMP4;HEYL;TBX2;BMP2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.47628155290693486,1.2053965100637698,0.23163138231631383,1.0,1.0,11/28,21.10%,TSC2;PIP4K2B;SLC27A4;PID1;ENPP1;PIP4K2A;TNS2;PIP4K2C;PTPRE;PRKCZ;APPL2
prerank,cholesterol homeostasis (GO:0042632),0.4224351736079206,1.2048519894075276,0.18783930510314875,1.0,1.0,20/64,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,positive regulation of growth (GO:0045927),0.4200327455975008,1.2043519445013646,0.19111111111111112,1.0,1.0,12/64,12.97%,SFRP2;SFRP1;CDKN2AIP;EXOSC2;TAF9B;SLC25A33;DDX3X;USP47;SDCBP;BCL2;EIF4G2;RPS6KA3
prerank,external encapsulating structure organization (GO:0045229),0.3936434396039399,1.2043494288859546,0.11534603811434303,1.0,1.0,46/205,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.5737664978151389,1.2040840169999203,0.25696594427244585,1.0,1.0,1/10,1.59%,SIRT2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5492839326691594,1.203102834037364,0.25255474452554744,1.0,1.0,5/13,7.72%,SAR1A;SEC16A;BRSK2;SEC16B;INSIG1
prerank,neuron migration (GO:0001764),0.4303786757724247,1.2030110895613746,0.20068027210884354,1.0,1.0,20/48,21.28%,RAC1;DCDC2;CDKL5;FGFR1;NRP1;CDK5;TUBB2A;SPOCK1;LRP12;USP9X;DISC1;AUTS2;PEX13;SEMA3A;NDNF;TUBGCP2;PAFAH1B1;DCX;NTRK2;FGF13
prerank,cell-substrate junction assembly (GO:0007044),-0.33888998382519087,-1.2022283980940185,0.1875,0.8500039339957703,1.0,15/33,15.19%,DST;SORBS1;FERMT2;PTPRK;ITGA6;TAOK2;CTTN;TESK2;ACTN1;FN1;PLEC;ACTN2;LAMA3;ITGB4;SRC
prerank,positive regulation of calcium ion import (GO:0090280),0.5448279942865283,1.2019746110676024,0.25608011444921314,1.0,1.0,1/12,4.50%,CXCL12
prerank,sterol homeostasis (GO:0055092),0.42060985637258114,1.2018464834344058,0.20368364030335862,1.0,1.0,20/65,22.93%,LPL;XBP1;RORA;ABCA2;CNBP;CYP7B1;SOAT1;CD24;INSIG1;EPHX2;APOE;MTTP;TTC39B;ABCA5;LIMA1;EHD1;NPC2;ABCG1;NPC1;IL18
prerank,protein O-linked mannosylation (GO:0035269),0.5098275882604774,1.20152009205375,0.25034387895460797,1.0,1.0,4/18,9.40%,TMTC4;DPM2;TMTC1;POMT2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.4852603530792303,-1.201259674758682,0.25507246376811593,0.8492216005989459,1.0,5/10,28.20%,CD34;KDR;HIF1AN;CEACAM1;RRAS
prerank,response to alcohol (GO:0097305),0.4798037572352054,1.201105283632198,0.24133504492939667,1.0,1.0,10/27,21.75%,GRIN1;ABCA2;GRIN2A;TGFB1;GLRA1;SLIT3;TGFBR1;TGFBR3;SMAD2;SDF4
prerank,extracellular structure organization (GO:0043062),0.39216548645665206,1.200917372255952,0.11923847695390781,1.0,1.0,46/204,16.49%,ADAMTSL2;MMP12;MMP17;VTN;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;DDR2;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;MFAP5;APP;ST7;ADAM12;COL1A2;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;PXDN;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.43732140552794563,-1.200805722734367,0.21863799283154123,0.846683297124109,1.0,3/13,21.26%,CYRIB;NECTIN2;PVR
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4911495918927994,1.2005256648571518,0.23827629911280102,1.0,1.0,5/23,9.57%,COPS7A;PARP1;DDB1;COPS7B;CUL4B
prerank,establishment of protein localization to extracellular region (GO:0035592),0.444638674317742,1.199993368056648,0.22654462242562928,1.0,1.0,19/39,24.56%,TVP23B;MIA3;RAB12;RCN3;RAB10;RAB3B;TANGO2;MON1A;RAB13;RAB8A;RAB8B;MTTP;NECAB3;STEAP3;ARFGAP3;COPG1;OLFM2;ABCA1;SEL1L
prerank,positive regulation of signal transduction (GO:0009967),0.3863742843670332,1.1996620959121913,0.10040160642570281,1.0,1.0,59/238,18.56%,MYORG;VTN;ATP6AP2;SFRP1;IGF1;STK36;BAX;CDKN2AIP;BMP6;NTF3;FGFR2;DCDC2;GRIN1;XBP1;CD63;RWDD3;CCBE1;SNX5;AGPAT1;RAB34;TNFAIP3;NRP1;PRKCA;SULF1;PIK3R1;DMTN;ARNT;TMEM108;ZBTB7B;SMARCB1;TUBD1;WLS;LY96;RBPJ;ROBO1;ZMIZ1;NLGN3;NPTN;PRKCI;CDC73;EMP2;DISC1;HTT;ADAMTS3;NLGN2;F3;LMO3;MN1;SNW1;JAG1;ITGB1BP1;PHIP;LANCL2;ILK;SORL1;PRKD2;PKD2;GPS2;TGFBR1
prerank,negative regulation of protein kinase activity (GO:0006469),0.40828047210817814,1.1991743362600595,0.19032597266035753,1.0,1.0,26/88,18.99%,DUSP26;TARBP2;GSKIP;TSC2;PDPK1;SH3BP5;PRKRIP1;WARS1;ABL1;THY1;DVL1;SH3BP5L;CDK5RAP3;MVP;YWHAG;SRCIN1;PARK7;NPM1;PPM1E;ITGB1BP1;GNAQ;CAMK2N1;SORL1;TAB1;TRIM27;PRKAG2
prerank,positive regulation of macrophage activation (GO:0043032),0.5043193790186278,1.198776046981173,0.26141078838174275,1.0,1.0,2/17,2.68%,WNT5A;IL33
prerank,cellular response to dsRNA (GO:0071359),-0.42658416030399654,-1.198003344604601,0.21755725190839695,0.8524056450059843,1.0,11/15,35.55%,RIOK3;CAV1;IFIH1;RALB;MAVS;IFIT1;DHX9;PQBP1;PDE12;MUL1;CGAS
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.46872734052092113,1.1974721969231858,0.25404732254047324,1.0,1.0,12/29,20.76%,PAIP1;FUS;PABPC1;GDNF;AXIN2;FMR1;THRAP3;DHX34;TENT5A;CIRBP;HNRNPU;YBX1
prerank,interstrand cross-link repair (GO:0036297),0.43053091173890023,1.1971987040776386,0.21348314606741572,1.0,1.0,13/53,15.12%,RNF8;USP1;FANCE;FANCG;RNF168;VCP;DCLRE1A;FANCM;POLN;FAAP100;ATR;FANCA;NUCKS1
prerank,rRNA transcription (GO:0009303),-0.3947165895497996,-1.1970492086896938,0.22745098039215686,0.8516598724283403,1.0,5/17,3.81%,SPIN1;BRF1;CAVIN1;GTF3C3;GTF3C2
prerank,positive regulation of cilium assembly (GO:0045724),0.5059725982265371,1.1967910631048664,0.2543507362784471,1.0,1.0,6/18,18.17%,CCP110;WRAP73;ENTR1;HTT;CEP120;CCDC88A
prerank,RNA processing (GO:0006396),0.3923310329943243,1.1966832958372682,0.1398390342052314,1.0,1.0,46/176,14.92%,KHSRP;LSM6;DDX17;RBM3;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;DHX15;USB1;SRSF5;SF3B2;SF3B1;RBM39;CELF2;DHX8;ATXN1;CELF1;HNRNPK;AKAP8L;FUS;MPHOSPH10;SRSF9;SF3A1;PRPF6;SRSF1;AURKAIP1;PPP1R9B;PABPC4;KIN;HNRNPD;LIN28B;RBMS1;NUDT21;RBMS2;DHX16;HNRNPA0;HNRNPH3;SETX;HNRNPL;NOVA1;HNRNPA2B1;RP9;THOC1
prerank,C4-dicarboxylate transport (GO:0015740),-0.4241385844508404,-1.1963047097845232,0.24381625441696114,0.8501150130073009,1.0,9/14,36.90%,SLC25A13;LRRC8D;SLC25A14;SLC25A30;SLC25A11;SLC25A22;SLC25A18;SLC13A5;SLC1A6
prerank,sensory perception of sound (GO:0007605),0.4138416930339769,1.195922102803454,0.17989417989417988,1.0,1.0,10/88,9.16%,MYO1A;DCDC2;MYH14;NIPBL;PCDH15;TIMM13;RIPOR2;ADGRV1;LHFPL3;CCDC50
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3927772071079796,-1.1958400015722657,0.18518518518518517,0.8476679083116486,1.0,6/20,9.94%,KCNB2;CHRM3;CAV1;PLCE1;CTTN;SETD3
prerank,insulin secretion (GO:0030073),0.497685036670971,1.1958331869015695,0.24285714285714285,1.0,1.0,5/19,12.18%,PTPRN;ANXA1;SELENOT;PARK7;CAMK2G
prerank,aminoglycan biosynthetic process (GO:0006023),0.4270788829787451,1.1957579448388627,0.21428571428571427,1.0,1.0,13/49,20.33%,B3GALNT1;HS2ST1;SLC35D2;GPC6;NDST2;GPC1;HS6ST2;GPC4;HSPG2;EXT2;GPC5;HS3ST1;GCNT2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.45559525198499873,1.195535933457728,0.22342995169082125,1.0,1.0,9/34,18.59%,IGF1;CDC23;EDN3;CDC16;EGF;ANAPC11;ANAPC4;PHIP;ANAPC5
prerank,modification-dependent protein catabolic process (GO:0019941),0.39054821877016827,1.1954458916658726,0.11088709677419355,1.0,1.0,61/193,18.59%,UBQLN1;CDC23;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;CDC16;RNF215;FZR1;FBXL14;FBXO7;SQSTM1;ANAPC2;DDB1;FBXO45;RFFL;PSMD11;ARRB1;UBA1;UBE3B;RNF40;RNF168;KLHL15;RNF11;CHFR;UBR3;RC3H2;ZNRF3;NTAN1;RNF19A;UBE2A;ANAPC11;WDR91;ANAPC4;RNF19B;CDC26;ANKIB1;PCYOX1;RNF217;FEM1C;CBL;TRPC4AP;UBE2E1;UBE2D1;NDFIP2;ARIH2;NEDD8;UBE2L3;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;ANAPC10;RNF111;ANAPC5
prerank,regulation of endocytosis (GO:0030100),0.42179409609866786,1.1952953271879283,0.20693391115926327,1.0,1.0,21/61,20.27%,CALY;TSC2;CD151;ABL1;PACSIN3;LRPAP1;RAB5B;ABCA7;CLIP3;AP2S1;SNX33;SCAMP5;LRP1;RUFY1;RIT2;APOE;MCTP1;ZFYVE16;FLOT1;SMPD1;DAB2
prerank,regulation of protein kinase activity (GO:0045859),0.40256928477816206,1.1952309811817332,0.16649323621227888,1.0,1.0,31/106,20.58%,TARBP2;GSKIP;TSC2;PDPK1;PRKRIP1;MAPRE3;SMG8;WARS1;DDR2;THY1;DVL1;MMD;XRCC6;MRNIP;YWHAG;JTB;ALS2;IQGAP1;PARK7;PPM1E;DAXX;ITGB1BP1;GNAQ;CAMK2N1;RASSF2;TAB1;TRIM27;PRKAG2;RTRAF;UVRAG;PTK2B
prerank,regulation of hydrolase activity (GO:0051336),-0.2897830179811874,-1.1950921383530586,0.12162162162162163,0.8461152865624396,1.0,27/71,22.99%,PRKG1;DAB2IP;RDX;RAPGEF6;RALBP1;CAV1;FGD5;OCRL;ARHGAP44;PLXNA4;FGD1;SIPA1L1;TDG;ARHGEF5;PLXNB2;PLXNC1;RASIP1;TBC1D10B;ARHGAP27;CHN2;NF1;WRN;PLXNB1;NGEF;CAMK2A;RAB3GAP1;FGD3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.35930768387150036,-1.1949080428339467,0.18681318681318682,0.8428071578197942,1.0,13/30,31.18%,NIBAN2;DACH1;GNL3L;STN1;TP53;NAT10;SRC;CTC1;CERS1;TEN1;CDKN1A;TINF2;MEN1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.37981868106646305,-1.194907340685099,0.2024793388429752,0.8388316523583801,1.0,8/20,19.51%,CNOT1;TNRC6A;HELZ;AGO2;LIMD1;CNOT8;CNOT7;NRDE2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.4907153461263209,1.1945181246473524,0.2574385510996119,1.0,1.0,7/23,10.18%,SH3BP5;ERRFI1;THY1;SNX6;SH3BP5L;MVP;SRCIN1
prerank,regulation of peptide hormone secretion (GO:0090276),0.4198325450316876,1.1942706499761258,0.20955483170466885,1.0,1.0,12/67,17.24%,CACNA2D2;KCNG2;PICK1;ITPR1;PRKCA;KCNC2;SNAP25;HTR2C;UQCC2;RFX3;CLOCK;EIPR1
prerank,central nervous system neuron development (GO:0021954),0.5209659921141515,1.1941619755661108,0.2742382271468144,1.0,1.0,8/15,23.89%,HSP90AA1;GBA2;B4GALT5;MAPT;NTRK2;ARHGAP35;MAP2;PTEN
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38407777570391877,1.1939619032720123,0.054,1.0,1.0,80/390,14.32%,FGF20;FGF9;MST1R;IGF1;EPHA7;SIRT2;GPLD1;EPHB2;FGFRL1;DNM1;TSC2;NTF3;EIF2AK3;HSP90AA1;RAC1;FGFR2;SH2D2A;COL4A6;ATP6V0A2;FGFR1;GRIN1;ACTR2;ARPC1A;DDR1;NRP1;FGF10;POLR2B;IL31RA;ANGPTL1;DDR2;SULF1;PIK3R1;GAB1;SRMS;ARHGEF7;PAK3;EFNB3;EPHA8;TIA1;ATP6V0E2;KALRN;CYFIP1;BDKRB2;FLRT2;SDCBP;FRS2;EFNB2;FLRT1;BAIAP2;EPHA10;RAPGEF1;PLAT;HNRNPM;KL;MVP;AP2S1;MUSK;VAV2;SHC4;PRLR;IRS2;GFRA2;PIK3CB;RBFOX2;ATP6V1G1;PIK3R2;TCIRG1;PDGFRA;POLR2K;TIAL1;ATP6V0A4;GIT1;SETX;ROR2;EFS;FGFBP1;BLNK;NRG1;ROCK2;ATP6V1D
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5458554688678546,1.1938313703089602,0.2757619738751814,1.0,1.0,3/12,9.95%,ELOVL1;HSD17B4;FADS1
prerank,spindle assembly (GO:0051225),0.40882538231589927,1.1930953043570787,0.2086021505376344,1.0,1.0,21/67,17.49%,HDAC3;CCDC61;MAPRE3;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;RCC1;HAUS3;CSNK1D;STAG2;OFD1;CHEK2;NUMA1;TNKS;TUBGCP2;BCCIP
prerank,epithelial to mesenchymal transition (GO:0001837),0.4327730471294447,1.193059707051558,0.22525597269624573,1.0,1.0,12/47,15.78%,WNT5A;CUL7;DDX17;FGFR1;SNAI1;OLFM1;WNT4;SOX9;RBPJ;ROCK2;TGFB1;DDX5
prerank,regulation of vesicle-mediated transport (GO:0060627),0.40627279154223556,1.1928962592961654,0.18229166666666666,1.0,1.0,26/91,17.01%,CPLANE2;TSC2;ATP9A;USP7;NRP1;ABL1;RAB12;PACSIN3;RAB5B;CPLX1;CHMP3;RAB10;AP2S1;MBTPS1;SCFD1;RAB3B;SYT1;RAB13;MAP2K2;DNAJC13;RAB8A;RAB8B;RUFY1;NSF;RIT2;RAB21
prerank,negative regulation of DNA binding (GO:0043392),-0.3539162727491663,-1.1924746189641502,0.16759776536312848,0.8429968549417165,1.0,11/28,26.63%,LEF1;SP100;NFKBIA;ILRUN;SIN3A;JUN;HABP4;MDFI;SUMO3;HMGA2;HEY2
prerank,regulation of steroid metabolic process (GO:0019218),0.48238776353312346,1.192460208558389,0.2632258064516129,1.0,1.0,9/23,21.42%,STUB1;RORA;ABCA2;EPHX2;ACADL;ACADVL;APOE;TTC39B;ABCG1
prerank,calcium ion import (GO:0070509),-0.3436019968364051,-1.192419089021669,0.17525773195876287,0.8392357201146541,1.0,16/28,31.29%,MICU1;CACNA1D;CACNA1C;CACNA1G;MCU;MCUR1;TRPC4;CACNB2;MCUB;MAIP1;SMDT1;CACNA1B;TRPV4;MICU3;SLC8A1;CACNA1H
prerank,macrophage differentiation (GO:0030225),0.5435373948409898,1.1923075526614255,0.26571428571428574,1.0,1.0,2/13,4.92%,PARP1;IL31RA
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4794450788436305,-1.1921167192652242,0.27388535031847133,0.8363807497757453,1.0,5/10,21.34%,GABRG2;GABRA5;GABRA4;GABRG1;GABRA1
prerank,retinol metabolic process (GO:0042572),0.5330599669578997,1.1919873564956414,0.273876404494382,1.0,1.0,2/14,6.30%,RDH10;RDH11
prerank,regulation of insulin secretion (GO:0050796),0.405530968602843,1.1919239035168487,0.1711340206185567,1.0,1.0,21/101,17.24%,CACNA2D2;KCNG2;SFRP1;LRRC8A;PICK1;ITPR1;CAPN10;PRKCA;TCF7L2;BRSK2;KCNC2;SNAP25;IRS2;UQCC2;NLGN2;RFX3;CLOCK;TRH;ADCY5;EPHA5;EIPR1
prerank,intestinal absorption (GO:0050892),-0.43122935400092505,-1.1913339791607387,0.23308270676691728,0.8352562530589189,1.0,5/13,33.23%,F11R;ADRA2A;KCNQ1;SLC26A6;UGCG
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5157001120701703,1.1912511381520805,0.26005361930294907,1.0,1.0,4/16,10.43%,PIGG;DPM2;PIGM;PIGA
prerank,negative regulation of leukocyte activation (GO:0002695),0.5211421192541528,1.1911957929406334,0.26595744680851063,1.0,1.0,2/15,4.92%,FCGR2B;IL31RA
prerank,vesicle transport along microtubule (GO:0047496),0.4802214544474233,1.1909665385054928,0.2596899224806202,1.0,1.0,13/23,26.28%,CLN3;KIF3A;BICDL1;HTT;TRAK1;KIF5B;FYCO1;KIFAP3;PAFAH1B1;KIF3B;DYNC1H1;FBXW11;KIF5A
prerank,oligodendrocyte differentiation (GO:0048709),0.5003502465467472,1.1902718104064403,0.2617801047120419,1.0,1.0,6/19,17.11%,MYRF;CDK5;SOX9;SOX6;TPPP;SOX13
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5385971131921251,1.1901522153486759,0.2770745428973277,1.0,1.0,5/13,12.60%,ALG6;ALG1;ALG8;DPAGT1;ALG9
prerank,positive regulation of histone deacetylation (GO:0031065),0.5473999437102836,1.1901306009422603,0.2791728212703102,1.0,1.0,6/12,18.02%,NIPBL;AKAP8L;ZBTB7B;SAP30BP;CTBP1;PRKD2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4433427953720053,-1.1897832595436708,0.26644736842105265,0.8368469850216741,1.0,10/12,52.75%,INPP5K;PPP1R3B;AKT1;PPP1R3C;PPP1R3F;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,cellular metal ion homeostasis (GO:0006875),0.40203741055256026,1.1890682118119564,0.1786833855799373,1.0,1.0,18/102,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;ATP1A3;CXCL12;ATP2A2;KCNMA1;ATP1A2;ATP2B1;SLC24A4;SLC30A1;PTH1R;HTR2C;NPTN;SLC41A1
prerank,response to leucine (GO:0043201),-0.47318310886782944,-1.1887626296335463,0.25796178343949044,0.832516213507965,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,cellular response to leucine (GO:0071233),-0.47318310886782944,-1.1887626296335463,0.25796178343949044,0.832516213507965,1.0,6/10,33.98%,UBR1;LARS1;SESN2;RRAGD;KLHL22;SESN3
prerank,positive regulation of axon extension (GO:0045773),0.4739796238852047,1.1883302947996663,0.24489795918367346,1.0,1.0,8/22,17.44%,CDKL5;NRP1;DBN1;DSCAM;DBNL;MAPT;MEGF8;RUFY3
prerank,monocyte chemotaxis (GO:0002548),-0.33670560185963294,-1.1880954185062598,0.13043478260869565,0.8310881872034964,1.0,7/32,18.94%,FLT1;IL6R;CCL15;RPS19;PTPRO;TNFRSF11A;CCL13
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5038155449801426,1.188078893748452,0.27448275862068966,1.0,1.0,9/18,19.31%,CLN3;ABCA2;CDK5;VTI1B;SPTBN1;STX8;VAMP8;ZDHHC2;MMP14
prerank,defense response to tumor cell (GO:0002357),0.5591481198571607,1.188062791671549,0.2818181818181818,1.0,1.0,5/10,19.75%,PLK5;RBMS3;DAPK1;DLEC1;KLF4
prerank,mesoderm development (GO:0007498),-0.3982374002744187,-1.1878297678185445,0.21544715447154472,0.8282391896351311,1.0,7/18,19.11%,TBX3;TIE1;MESD;IKZF1;TBX1;BMX;VEGFA
prerank,autophagy of mitochondrion (GO:0000422),0.4448383884337477,1.1878259780568055,0.23792270531400966,1.0,1.0,15/38,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,zinc ion homeostasis (GO:0055069),-0.3439505084166431,-1.1872018378105254,0.18181818181818182,0.8267402834897235,1.0,11/28,12.57%,SLC39A14;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A8;SLC39A12
prerank,cellular zinc ion homeostasis (GO:0006882),-0.3609701605057501,-1.1860929982523811,0.21782178217821782,0.82682723667272,1.0,13/26,18.81%,SLC39A14;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A8;SLC39A12;SLC39A7;SLC39A10
prerank,response to exogenous dsRNA (GO:0043330),-0.40315446512388337,-1.1858907900928284,0.23770491803278687,0.8237826204706603,1.0,11/18,35.55%,CAV1;SLC3A2;IFIH1;RALB;MAVS;IFIT1;TICAM1;DHX9;PQBP1;MUL1;CGAS
prerank,regulation of ossification (GO:0030278),0.4483744289078484,1.1857117965765096,0.23345367027677497,1.0,1.0,10/36,14.82%,WNT5A;SFRP1;ANKH;DDR2;SOX9;SOX11;TWIST1;RBPJ;ENPP1;SMAD6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.55117667039417,1.1852141966679968,0.2782608695652174,1.0,1.0,3/12,7.42%,UBE2S;FZR1;CDC14B
prerank,positive regulation of glial cell differentiation (GO:0045687),0.5043010868769108,1.184921652506811,0.2613480055020633,1.0,1.0,5/17,15.23%,IL34;BIN1;CXCR4;TGFB1;TENM4
prerank,sodium ion transmembrane transport (GO:0035725),0.40499177511656925,1.1840991348097512,0.20588235294117646,1.0,1.0,17/84,16.34%,SLC4A4;ASIC1;NALCN;ATP1A3;SLC6A11;SCN7A;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC9A7;SLC9A6;SLC6A13
prerank,COPII-coated vesicle budding (GO:0090114),0.4131948432005993,1.1839526905803102,0.22698072805139186,1.0,1.0,28/68,20.41%,TRAPPC10;SCAP;SAR1A;KLHL12;SEC16A;MIA3;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;VAPB;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,organonitrogen compound catabolic process (GO:1901565),0.4218359754598868,1.1836816460708477,0.22026431718061673,1.0,1.0,9/57,10.25%,PLA2G5;ADO;CLN6;SMPD2;RENBP;ANPEP;UCHL3;SGPL1;ENPP2
prerank,fatty acid elongation (GO:0030497),0.5402464580733627,1.183629572067136,0.26706231454005935,1.0,1.0,7/13,27.47%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,cell part morphogenesis (GO:0032990),0.5294244749940492,1.183315953103856,0.2828854314002829,1.0,1.0,5/13,14.84%,FIS1;MYH14;PID1;WASF1;DNM1L
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.536150122965656,1.182923851300191,0.2708638360175695,1.0,1.0,2/13,2.68%,SELENOS;IL33
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4560866301052394,1.182846244710044,0.25458996328029376,1.0,1.0,10/32,18.42%,CUL7;CDKL5;OBSL1;KNDC1;RAP2A;YWHAH;IL1RAPL1;GORASP1;CUX1;ADGRB3
prerank,secondary alcohol metabolic process (GO:1902652),0.44204715082467616,1.1827206047997612,0.23723041997729852,1.0,1.0,6/42,7.49%,CYP27A1;CLN6;SCAP;IDH3B;GBA2;SOAT1
prerank,cellular response to metal ion (GO:0071248),0.3938715347980577,1.18263856508438,0.1767109295199183,1.0,1.0,31/123,19.12%,ALOX5AP;MAPK9;SYT3;WNT5A;SYT10;GPLD1;PPIF;ADCY7;BMP6;CARF;SLC25A24;DMTN;RASGRP2;ADGRV1;CPNE7;ANK3;CAMK2D;IQGAP1;SYT1;CPNE8;KCNA1;SLC41A1;GLRA1;ADCY1;DAXX;DPEP1;DLG2;PKD2;PRKAA1;KCNH1;SMPD1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.406248716722776,1.182325112138123,0.21536796536796537,1.0,1.0,24/74,22.11%,SFRP2;SFRP1;MCRIP1;GLIPR2;SNAI1;OLFM1;EZH2;TGFB1I1;SDCBP;TWIST1;BMP5;DAG1;AXIN2;TGFB1;VASN;PHLDB1;SPRY2;TGFBR1;DAB2;GCNT2;SMAD7;CLASP2;SMAD2;SMAD3
prerank,gland development (GO:0048732),0.4182758767065141,1.1820118876476111,0.22002200220022003,1.0,1.0,12/59,14.04%,GFER;STRA6;FGFR2;ANXA1;XBP1;DKK3;FGF10;WNT4;SOX9;CDK5RAP3;CEBPG;NRG1
prerank,regulation of gastrulation (GO:0010470),0.530197556682097,1.1813172880981602,0.2758132956152758,1.0,1.0,7/14,24.80%,DAG1;RACK1;TENM4;PHLDB1;OSR1;CLASP2;PHLDB2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4099184626247151,-1.1811119644478918,0.2517985611510791,0.8363300999392662,1.0,11/16,31.97%,CAV1;TRIM25;EXOC7;EXOC2;TRIM5;TRIM14;NECTIN2;HS3ST5;FUCA2;TRIM21;TRIM68
prerank,protein K63-linked ubiquitination (GO:0070534),0.4319602463976244,1.1809854617731645,0.25,1.0,1.0,14/41,22.05%,RNF8;UBE2S;STUB1;UBE2E2;TRIM56;RNF168;UBE2V2;RNF152;HECTD1;ARIH2;TRIM27;TRAF3IP2;UBE2V1;TRAF2
prerank,inositol lipid-mediated signaling (GO:0048017),0.42242634601651047,1.1803724625801806,0.24501108647450112,1.0,1.0,16/50,19.08%,IGF1;PLCH1;FGFR1;OGT;PLCL2;PIK3R1;ADAP2;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;KCNH1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.4154499192317804,-1.1802458747754672,0.2518248175182482,0.8354965067234116,1.0,5/15,11.10%,RAPGEF3;BAG3;ANP32B;TP53;CAMK1
prerank,negative regulation of macrophage activation (GO:0043031),0.5097979539848203,1.180058705564848,0.27903871829105475,1.0,1.0,2/16,4.92%,FCGR2B;IL31RA
prerank,synapse organization (GO:0050808),0.3956972827387201,1.1798516983782306,0.18042813455657492,1.0,1.0,27/125,14.94%,PPFIA4;LRRC4;CHCHD10;CACNB4;UNC13A;CTNND2;OBSL1;PDZRN3;CDK5;GPC6;PAK3;DVL1;DSCAM;CYFIP1;DBNL;MUSK;CACNB1;APP;ANK3;PTPRF;NLGN3;GPC4;SPOCK2;FARP1;MAPT;NLGN2;SEMA3E
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.42457954108242724,-1.179622297909944,0.24305555555555555,0.8338355397109233,1.0,5/13,19.19%,NIBAN2;DAB2IP;EPN2;CADM4;EMILIN1
prerank,skeletal system development (GO:0001501),0.38596652143231924,1.179603386691691,0.18529707955689828,1.0,1.0,37/148,20.34%,WNT5A;PTGER4;IGF1;BMP6;EIF2AK3;FGFR2;FGFR1;PTHLH;ANKH;PCSK5;SULF1;HAPLN4;TRIP11;SOX9;GNAS;PPIB;CDH11;SOX11;PTH1R;BMP5;COL1A2;SOX6;FBN1;AKAP13;RPS6KA3;SUFU;TRPS1;SOX5;BMP1;TGFBR1;WWOX;SOX4;MMP14;PAPSS1;CHD7;EVC;MMP16
prerank,cAMP metabolic process (GO:0046058),0.535329711912516,1.179122169964437,0.25742574257425743,1.0,1.0,4/13,16.59%,ADCY7;PTHLH;ADCY1;ADCY5
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5329530773938305,1.1787186561026886,0.28611898016997167,1.0,1.0,3/13,13.39%,SYT10;SYT1;SCAMP5
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5693993538722789,1.17857937247273,0.2844574780058651,1.0,1.0,1/10,0.80%,WNT5A
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4087741922209686,1.17842450768401,0.206163655685441,1.0,1.0,31/76,24.50%,HDAC3;UBQLN1;PHF23;GNL3;STUB1;TBC1D7;RWDD3;SAE1;MYCBP2;XIAP;CDK5RAP3;HDAC4;MALT1;PIAS3;UBE2D1;NDFIP2;DERL1;UBE2L3;TANK;TNIP1;DCUN1D5;BIRC3;PIAS1;SMAD7;COMMD1;UBA2;FKBP1A;FBXW7;UBE3A;TRAF6;CRY1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4521592254242641,-1.1778795456144802,0.26031746031746034,0.8362011427898102,1.0,2/11,3.85%,STAT3;STAT1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.449267633848568,1.177734875984579,0.25415676959619954,1.0,1.0,6/32,11.97%,TFDP1;CDK5;NPAT;BRD4;FBXO5;BACH1
prerank,regulation of autophagosome maturation (GO:1901096),0.5311458290888798,1.1776508867487987,0.26878612716763006,1.0,1.0,2/13,1.37%,CLN3;PHF23
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.5420279174455138,1.1775349057215683,0.2880354505169867,1.0,1.0,3/11,8.37%,WNT5A;FGFR2;SOX9
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4279020339201569,-1.1772243036621355,0.2604166666666667,0.8346847543778411,1.0,5/13,17.64%,IRAK2;IRAK1;UNC93B1;IRAK4;PIK3AP1
prerank,mitotic metaphase plate congression (GO:0007080),0.42345931525336955,1.1763995806106675,0.2677966101694915,1.0,1.0,7/51,13.49%,PSRC1;CDC23;KPNB1;PIBF1;CHMP3;VPS4B;CENPC
prerank,fatty acid catabolic process (GO:0009062),0.4140040878755238,1.1763030475745133,0.23060109289617486,1.0,1.0,21/67,16.83%,SLC27A4;ACAD10;LPIN1;PCCB;HADHB;ACAT1;HSD17B4;LPIN3;MCEE;CROT;CPT2;EHHADH;LPIN2;PCCA;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,embryonic limb morphogenesis (GO:0030326),-0.31747258104400233,-1.1762934669289398,0.17159763313609466,0.8342563194604767,1.0,9/34,11.93%,LRP6;MBNL1;RARG;WDPCP;FBXW4;TGFB2;CACNA1C;TBX3;INTU
prerank,signal release from synapse (GO:0099643),0.432977074073296,1.176082397232684,0.25204200700116686,1.0,1.0,9/43,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4466590319457757,1.1749625605875809,0.2613365155131265,1.0,1.0,11/35,18.68%,VTN;RAC1;SMAP1;HNRNPK;LRPAP1;PIK3CB;CBL;SNAP91;SERPINE1;RAB21;FLOT1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.510256414072762,1.1740534817050785,0.28818061088977426,1.0,1.0,5/17,9.82%,SELENOS;SYVN1;HM13;AUP1;VCP
prerank,monocarboxylic acid metabolic process (GO:0032787),0.39117307301537063,1.1735858898521185,0.19195046439628483,1.0,1.0,23/117,13.46%,FASN;LPL;IGF1;SLC27A4;THEM4;GBA2;ACOT11;PCCB;ALDH1A2;ABAT;SGPL1;MSMO1;GPAM;ALDH4A1;DLAT;CROT;AMACR;SLC6A8;ACADSB;PCCA;CYP26B1;VDAC1;MECR
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.26882434392708465,-1.173377590625111,0.15492957746478872,0.8400731447813916,1.0,27/70,19.67%,CRADD;DAB2IP;IL6R;CASP8AP2;BAG3;APPL1;RIPK1;MCL1;DEDD;BCL2L1;TGFB2;HIPK1;DELE1;FAS;BCL2L2;TNFRSF1A;NGF;GABARAP;DDX47;TNFRSF1B;SORT1;P2RX7;MLLT11;TNFSF12;GSK3A;DIABLO;CASP3
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4789095051743844,1.1731148530732343,0.2794871794871795,1.0,1.0,4/23,6.64%,APLP1;SIRT2;ABL1;GNG2
prerank,response to metal ion (GO:0010038),-0.27217798454217884,-1.1729806991084875,0.10989010989010989,0.8375692743869133,1.0,17/67,13.35%,SEC31A;CAV1;GPHN;SLC25A13;ANXA11;HIF1A;TRPC3;MTF1;TRPC1;THBS1;PLSCR1;ITPR3;SLC30A4;MT1X;MT1A;NEDD4L;D2HGDH
prerank,actin filament bundle organization (GO:0061572),0.44581543431655024,1.1728246994336153,0.25717703349282295,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,ganglioside metabolic process (GO:0001573),0.49168492685989323,1.1727414712717197,0.2619974059662776,1.0,1.0,5/20,14.35%,CLN6;ST8SIA3;ABCA2;ST3GAL5;ST6GALNAC6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.47860976284307466,1.1726200726204372,0.2859025032938076,1.0,1.0,5/21,9.16%,HS2ST1;EXTL3;SULF1;GPC1;HS6ST2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4564851749573958,-1.1722434326409548,0.26479750778816197,0.8362646681762614,1.0,7/11,25.44%,CD34;KDR;ADIPOR2;VEGFA;GATA2;MCAM;ITGB3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.40364077691350747,-1.1719188405196808,0.27137546468401486,0.8337472829572825,1.0,7/17,12.55%,GJA1;ATP1A1;GJC1;GJD3;CACNA1C;PRKACA;ATP1B1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.45477095548732654,1.1718275011147703,0.27350427350427353,1.0,1.0,3/31,1.68%,SYT3;SYT10;CBARP
prerank,negative regulation of defense response to virus (GO:0050687),0.5612204439052241,1.1717529588578965,0.2937595129375951,1.0,1.0,2/10,5.04%,TARBP2;PPM1B
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.45674406187053906,1.1714037743703232,0.27490996398559425,1.0,1.0,5/28,9.77%,KDM4D;SIRT7;ACTR2;WRAP53;MRNIP
prerank,regulation of T cell chemotaxis (GO:0010819),0.5524497420975586,1.1713967545176287,0.29411764705882354,1.0,1.0,1/11,0.80%,WNT5A
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.4754923661798698,-1.1712123660871068,0.26126126126126126,0.8324654096503183,1.0,6/10,25.53%,RARG;RARB;RARA;TBX1;PPARG;RXRB
prerank,positive regulation of lyase activity (GO:0051349),-0.42581965486274886,-1.1711483889506593,0.23595505617977527,0.8291410424285331,1.0,7/14,28.05%,CACNA1D;NOS3;CACNA1C;NF1;NOS1;FXN;ISCU
prerank,response to interleukin-1 (GO:0070555),0.4038712800281913,1.1710193644502314,0.23880597014925373,1.0,1.0,12/73,12.26%,SFRP1;ADAMTS7;GBP3;NFKB1;ANXA1;PRKCA;SIRPA;SOX9;USP10;HDAC4;APP;CD47
prerank,positive regulation of cellular process (GO:0048522),0.37549139605306275,1.171009292403101,0.056,1.0,1.0,98/565,15.68%,FGF20;SFRP2;PLA2G5;FGF9;S1PR2;FASN;WNT5A;FCGR2B;EPB41L4B;SFRP1;MST1R;IGF1;DUSP26;IL34;DVL2;FOXM1;SIRT2;TUB;EAPP;MYRF;CDKN2AIP;TBRG4;BMP6;NTF3;EDN3;RAC1;EXOSC2;TSPAN31;FGFR2;TAF9B;FGFR1;GRIN1;PTHLH;XBP1;ZFP36L1;SLC25A33;MLC1;DDX3X;CXCL12;AGPAT1;CDC123;FGF10;IL31RA;CDK13;CAPN10;PRKCA;FLCN;USP47;CNBP;FBXO5;CELF1;EZH2;RHOD;SIRPA;SOX9;SDCBP;EFNB2;DHX36;EGF;HDAC4;ABCA7;SOX11;GDNF;PRLR;IRS2;COX17;TPM1;BCL2;ADGRG1;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;EIF4G2;CD47;NPM1;HDAC1;AXIN2;UBE2A;PRMT1;RPS6KA3;EMP2;LRP1;FAM98A;MAPT;NRG1;CSPP1;TGFB1;BCLAF1;KMT2D;IL15RA;TENM4;NUPR1;FAF1;CNOT6;RPS6KA1;CTSH
prerank,regulation of developmental growth (GO:0048638),0.4609910284955775,1.1706772414334126,0.2708585247883918,1.0,1.0,6/29,10.71%,IGF1;NIPBL;OLFM1;ABL1;MUSK;APP
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.484160618541516,1.170676817309201,0.2754569190600522,1.0,1.0,3/21,4.16%,SMARCD3;FZD9;FZD3
prerank,macrophage activation involved in immune response (GO:0002281),-0.4357084428646766,-1.1703323927238396,0.2571428571428571,0.8283167401560931,1.0,5/13,13.96%,SBNO2;LBP;PLCG2;DYSF;GRN
prerank,ribosomal small subunit assembly (GO:0000028),-0.411724943547818,-1.1698568247191246,0.22996515679442509,0.8265339320910413,1.0,12/16,35.05%,RPS19;RPS28;RPS5;RPS27;RPS14;ERAL1;RRP7A;RPS27L;MRPS7;PRKDC;MRPS11;XRCC5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3942973824129061,1.1696282103693143,0.21816283924843424,1.0,1.0,14/101,9.15%,PSRC1;WNT5A;MST1R;IL34;TCIM;INCENP;EDN3;CALM3;MAPRE3;FGFR1;DDX3X;EZH2;CD24;EGF
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5550732630087102,1.169337559912215,0.28276877761413843,1.0,1.0,4/10,13.44%,CAMK2B;APP;NPTN;NETO1
prerank,endocrine system development (GO:0035270),0.4752136652209468,1.1688513153705373,0.26953125,1.0,1.0,3/21,8.19%,STRA6;DKK3;WNT4
prerank,eye morphogenesis (GO:0048592),0.49334135150076047,1.1683686485881815,0.2998678996036988,1.0,1.0,9/19,19.23%,FBN2;NIPBL;TENM3;MFAP2;MFAP5;FBN1;COL5A2;NKD1;AGTPBP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.42803764733006255,1.1681762644439413,0.2551487414187643,1.0,1.0,7/44,12.84%,AMIGO1;GNG2;NOS1AP;KCNMA1;KCNJ10;WNK2;GABBR1
prerank,histone deacetylation (GO:0016575),0.43491766702899787,1.1679978617893036,0.2623138602520046,1.0,1.0,10/43,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;PER1;HDAC4;RCOR1;MTA2;HDAC1
prerank,calcium ion import into cytosol (GO:1902656),-0.4052531738007171,-1.1677300007836995,0.25,0.8298418346939217,1.0,8/15,38.46%,CACNA2D1;SLC24A2;TRPV2;TRPV4;SLC8A1;SLC8A2;TRPM2;SLC8A3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.40537205314498514,-1.1675965633126957,0.23826714801444043,0.8267879873081234,1.0,2/16,10.73%,CYRIB;PTPRC
prerank,spermatid development (GO:0007286),0.4510193017332659,1.1666459790458614,0.2649164677804296,1.0,1.0,6/32,15.75%,IQCG;SYCP3;RNF8;CDYL;ACRBP;GALNTL5
prerank,negative regulation of platelet activation (GO:0010544),-0.41193553892680485,-1.166640304920246,0.2638888888888889,0.8265158009189728,1.0,5/16,6.80%,PRKG1;SERPINE2;PRKCD;THBD;NOS3
prerank,peroxisomal membrane transport (GO:0015919),0.46386850392804124,1.1661678422801922,0.2907975460122699,1.0,1.0,11/27,16.83%,FIS1;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4234374210216444,1.1660432904575784,0.2722095671981777,1.0,1.0,9/44,12.08%,CYP27A1;PSAT1;CYP7B1;INSIG1;HSD17B4;MSMO1;SC5D;AMACR;PARK7
prerank,ERBB signaling pathway (GO:0038127),0.4038948612183166,1.1659198038489418,0.2343921139101862,1.0,1.0,17/64,15.82%,PDPK1;HSP90AA1;STUB1;PRKCA;PIK3R1;GAB1;SLC30A10;SOX9;EGF;MVP;IQGAP1;NRG2;CUL5;NRG1;TGFB1;CBL;PTPN12
prerank,cellular response to purine-containing compound (GO:0071415),-0.48018982262930177,-1.1657661798980812,0.2996742671009772,0.8262188647111137,1.0,7/10,37.92%,P2RY1;RYR2;GSTM2;SLC8A1;TRPM2;P2RY6;CASQ2
prerank,regulation of myelination (GO:0031641),0.46003244994729864,1.1657586286310198,0.2748091603053435,1.0,1.0,3/25,2.65%,SIRT2;MYRF;EIF2AK3
prerank,negative regulation of wound healing (GO:0061045),0.4578044306162776,1.1657097405853893,0.2798552472858866,1.0,1.0,8/28,21.40%,VTN;AJAP1;CASK;TFPI;SERPINE1;APOE;FGF2;CLASP2
prerank,peptide biosynthetic process (GO:0043043),-0.252145111200588,-1.1656907422595126,0.15,0.8231055943830637,1.0,55/153,18.40%,RPS24;ABCF1;AGO2;RPL11;RPS15A;RPS23;RPL5;DMD;RPL37A;RPL6;RPL18A;RPL24;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;SRBD1;RPS16;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;GGT5;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;RPS5;MRPL42;RPL15;RPS2;RPL39;RPL12;RPL27;RPS17;MRPS21;RPS26;RPS27;RPL10A;MRPL52;DARS1;RPS10;PCSK1;MRPS18A;MRPS15;RPL7A;MRPS33;MRPS18C
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.39134050475925236,1.1655718360683927,0.21243523316062177,1.0,1.0,20/100,14.97%,FSHR;IGF1;TSC2;PIP4K2B;NTF3;FGFR1;DCN;PIK3R1;GAB1;SOX9;EGF;TWIST1;IRS2;PIK3CB;MAZ;PDGFRA;PIP4K2A;ROR2;PIP4K2C;CBL
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3404983311748086,-1.16540132024474,0.2233502538071066,0.8206381993704776,1.0,6/27,4.67%,ARL6IP5;SLC25A13;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,acyl-CoA metabolic process (GO:0006637),0.44499620194743394,1.165312954949592,0.2668269230769231,1.0,1.0,8/35,14.55%,MLYCD;THEM4;ACOT9;ACOT11;GPAT4;MCEE;OGDH;ACSL6
prerank,regulation of cell differentiation (GO:0045595),0.3839763398706772,1.1651683595082782,0.1955420466058764,1.0,1.0,37/148,18.56%,DDX17;MCRIP1;BIN1;NTF3;EDN3;FGFR2;FGFR1;NR1D2;PTHLH;ZFP36L1;CDK9;CASZ1;CD24;SIK1;ZFHX2;YWHAH;CDK5RAP3;FADS1;YWHAG;GDNF;ST7;DAG1;SPOCK2;RPS6KA3;UQCC2;CBFB;EMP2;TGFB1;TRPS1;BCL6;RPS6KA1;DDX5;PHLDB1;TRIP4;OCIAD1;GPS2;TGFBR1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.42337965753702617,-1.1650149924442235,0.2627986348122867,0.81857319757289,1.0,7/13,25.22%,NFIB;PPARD;REST;NFATC4;BMP4;PPARG;PPARA
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.44914016795993333,1.1650089742436596,0.2584541062801932,1.0,1.0,1/29,0.14%,PLA2G5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.38620243563773277,1.1645098197355717,0.172978505629478,1.0,1.0,30/138,15.88%,GUCA1B;MST1R;EPHA7;EPHB2;NTF3;FGFR2;FGFR1;DDR1;IL31RA;ANGPTL1;DDR2;SRMS;EPHA8;BDKRB2;FRS2;EPHA10;RAPGEF1;MUSK;SHC4;GFRA2;PIK3CB;PDGFRA;PTPRF;ROR2;EFS;BLNK;ACVR1B;TRIO;NPR2;AHI1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5222995379562942,1.16444636848048,0.2770083102493075,1.0,1.0,5/14,12.60%,SELENOS;SYVN1;XBP1;PARK7;CREB3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.42043723933831423,1.164141753022047,0.2513842746400886,1.0,1.0,17/54,21.21%,CLN6;HS2ST1;SLC35D2;GLB1;GPC6;NDST2;GPC1;HS6ST2;HGSNAT;GPC4;HSPG2;EXT2;GPC5;GUSB;HS3ST1;GCNT2;CHST9
prerank,positive regulation of embryonic development (GO:0040019),0.48273173763892896,1.1640892301988353,0.29906542056074764,1.0,1.0,8/19,21.38%,WNT4;RACK1;B4GALT5;ZBED3;NR2C2;TENM4;OSR1;CFL1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5139365968541553,1.1638153287754365,0.3173076923076923,1.0,1.0,4/15,9.82%,PPIF;DDX3X;DHX36;VCP
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5217387417242833,1.1637541859085763,0.2842712842712843,1.0,1.0,7/13,23.02%,FBN2;FSTL1;LTBP1;FBN1;GREM2;NBL1;DAND5
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4745345792634791,1.163661991346039,0.28287841191067,1.0,1.0,6/25,7.87%,KHSRP;GEMIN2;PRPF8;SF3B1;MPHOSPH10;PRPF6
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.31958438563670155,-1.1636101615953243,0.2222222222222222,0.8193713610923653,1.0,8/33,10.21%,PTPRG;DAB2IP;PTPRM;SLIT2;SP100;ADIPOR1;THBS1;DUSP10
prerank,positive regulation of leukocyte activation (GO:0002696),0.48860342900325393,1.1634996945031957,0.2878581173260573,1.0,1.0,2/18,2.68%,WNT5A;IL33
prerank,regulation of mitochondrion organization (GO:0010821),0.4236485933734812,1.1633741477177488,0.2733333333333333,1.0,1.0,14/47,17.62%,SIRT7;CSNK2A2;MYO19;PRMT6;FIS1;FLCN;MIEF2;SQSTM1;PID1;VDAC1;MAPT;DNM1L;PARL;OMA1
prerank,positive regulation of inflammatory response (GO:0050729),0.40160996476007343,1.1631448168518774,0.24109014675052412,1.0,1.0,17/86,17.70%,WNT5A;LPL;PTGER4;DDT;IL33;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;NUPR1;VAMP8;AGTR1;SERPINE1;TNIP1;SNX4
prerank,actin cytoskeleton reorganization (GO:0031532),0.41218097501529166,1.162841384841155,0.2524271844660194,1.0,1.0,21/63,19.18%,S1PR2;ATP2C1;WHAMM;ANXA1;MINK1;NRP1;FGF10;CAPN10;GAB1;DMTN;BRSK2;RAP2A;ANTXR1;EFS;AUTS2;FARP2;PTK7;THSD7B;PIP5K1A;CDC42BPB;NRK
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.47204446863824095,1.1624753625783666,0.2777777777777778,1.0,1.0,10/23,22.71%,S1PR2;CALM3;EGF;APP;TGFB1;CEMIP;CALM1;PRKAG2;CALM2;WNK3
prerank,organic cation transport (GO:0015695),0.47991020471482304,1.1624079593778034,0.2767052767052767,1.0,1.0,3/20,4.21%,SLC25A19;SLC22A18;SLC22A4
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3193807360154334,-1.1623678775586919,0.18292682926829268,0.8201410177921625,1.0,16/35,26.31%,MFHAS1;DAB2IP;PHLPP1;EZR;LGALS9;CYLD;DUSP10;MAP3K4;EMC10;VEGFA;DUSP1;DLG1;SASH1;ZC3H12A;BMP2;GADD45B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.44288047955532056,1.1616655787884906,0.26153846153846155,1.0,1.0,11/33,18.57%,NHP2;ZBTB48;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,cellular response to interferon-gamma (GO:0071346),0.3995011654980006,1.1614731869931105,0.2470960929250264,1.0,1.0,21/88,18.03%,WNT5A;CAMK2B;GBP3;IRF1;GBP7;SIRPA;TRIM62;IFNGR2;EPRS1;IFNGR1;IRF3;CAMK2D;CAMK2G;CD47;DAPK1;GBP6;AQP4;ICAM1;OAS2;CCL25;JAK1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.37614728751844906,-1.1612413009099454,0.24793388429752067,0.820346808798794,1.0,4/21,7.55%,CACNA1D;FLNA;CACNA2D1;AKAP9
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4039544848421465,1.16119386064153,0.25677139761646806,1.0,1.0,17/63,19.24%,IL10RA;SIRT2;GPLD1;NELL1;RRAGA;WDR6;CDK5RAP3;BCL2;LEPR;EIF4G2;PTPN3;PTPN22;NUPR1;EIF4G3;SORL1;ATRAID;TIMP2
prerank,actin filament polymerization (GO:0030041),0.4603287924310966,1.161046663327323,0.2800480769230769,1.0,1.0,11/29,21.43%,SPIRE2;RAC1;TTC17;WASF1;SPIRE1;GAS7;ARHGAP6;PSTPIP2;PREX1;GSN;DIAPH1
prerank,dendritic cell differentiation (GO:0097028),-0.3717644447630145,-1.1601343362315808,0.226890756302521,0.820555320245068,1.0,3/22,7.89%,AXL;LGALS9;TGFBR2
prerank,organic hydroxy compound transport (GO:0015850),-0.3077102418561338,-1.1600060485507404,0.20481927710843373,0.817730466987492,1.0,6/36,6.35%,ABCC4;ATP8B1;RALBP1;SLCO1C1;RBP4;SLC16A1
prerank,protein O-linked glycosylation (GO:0006493),0.39275880627479404,1.1599787519863827,0.24130663856691253,1.0,1.0,24/96,19.34%,TMTC4;C1GALT1C1;GALNT16;B3GLCT;DPM2;ST3GAL2;OGT;PLOD1;GALNT4;ST3GAL3;TMTC1;POMGNT1;POMT2;B4GALT5;GALNTL6;GXYLT1;GALNT14;GALNT15;GALNT18;TRAK1;GXYLT2;DPM1;B3GALNT2;TET1
prerank,regulation of response to external stimulus (GO:0032101),0.3874193548785958,1.159819376566126,0.22142121524201855,1.0,1.0,27/121,16.48%,GUCA1B;WNT5A;FCGR2B;EPHB2;USP14;NR1D2;ANXA1;TIRAP;METAP1;BRD4;IRF1;DHX58;CELF1;CXCR4;NMT1;XIAP;LRP8;EFNB2;PDGFRA;PARK7;METAP2;PTPN22;PTGS2;BCL6;LACC1;ADGRA2;AGTR1
prerank,negative regulation of organelle assembly (GO:1902116),0.44476345530488115,1.159438500574571,0.29432624113475175,1.0,1.0,10/35,15.32%,CCP110;PHF23;TBC1D7;MDM1;CEP97;TCHP;SCFD1;EVI5L;FEZ2;NUPR1
prerank,negative regulation of metabolic process (GO:0009892),0.4111811707499825,1.159236609175887,0.26145251396648045,1.0,1.0,13/54,15.42%,FIS1;NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4568246196434444,-1.1584006333999486,0.27299703264094954,0.8195182891757338,1.0,6/11,20.24%,MBTPS2;TP53;HSPA5;CEBPB;ATF4;CREB3L1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.37705707132085287,-1.1581098462976498,0.2398190045248869,0.8171348168708439,1.0,11/21,34.12%,LIMCH1;GPM6B;SLK;ROCK1;ACTG1;DAPK3;RHOA;PEAK1;MACF1;EPHA3;CLASP1
prerank,protein glycosylation (GO:0006486),0.38494027079293763,1.1579672089691475,0.22676200204290092,1.0,1.0,28/125,15.81%,ALG5;B3GALNT1;C1GALT1C1;ST8SIA3;TMEM258;ALG6;MGAT3;ST3GAL2;OGT;MGAT4B;ALG1;PLOD1;ST3GAL3;ALG8;ST3GAL5;POMGNT1;DPAGT1;MGAT4C;POMT2;ALG9;B4GALT5;SERP1;COG3;DAD1;RPN2;GALNT18;GALNTL5;TRAK1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.42120752507545367,-1.157852930535237,0.2875816993464052,0.814718535422864,1.0,6/15,23.62%,PRKD1;TMSB4X;THBS1;MET;HSPB1;SEMA5A
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.28802953983290147,-1.1577674144903114,0.18181818181818182,0.8118025178067585,1.0,25/52,24.63%,ME3;ME2;MTHFR;GCLM;MTHFS;GOT2;SLC25A32;IDH1;ACLY;MTHFD1;IDH2;PHYH;D2HGDH;ACOT8;GPT2;L2HGDH;GOT1;MTHFD1L;ALDH5A1;HOGA1;MTRR;ALDH1L1;ALDH1L2;MDH1;ALDH18A1
prerank,cellular response to oxygen levels (GO:0071453),0.5497024525976578,1.15762041779897,0.30092592592592593,1.0,1.0,4/10,10.79%,ATP6V0A2;PICK1;NDUFS2;ATP6V1G1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.46823357164603174,-1.1575459074537013,0.29819277108433734,0.8093321480815455,1.0,3/10,7.64%,PARD3;DGKH;DGKD
prerank,glutamate metabolic process (GO:0006536),0.48193100200992384,1.1574133547554344,0.2979002624671916,1.0,1.0,6/19,13.26%,GLS2;FPGS;OAT;GLUL;GCLC;DGLUCY
prerank,negative regulation of cell aging (GO:0090344),0.49820690040303084,1.15725685110958,0.30533333333333335,1.0,1.0,4/16,9.79%,FOXM1;FBXO5;SLC30A10;TWIST1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.41576655655892636,1.1569582840248192,0.2777142857142857,1.0,1.0,7/51,12.75%,WNT5A;LPL;GSDMD;TMEM106A;MALT1;APP;TMED10
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.35085188601254863,-1.1568494935860494,0.2361111111111111,0.808357144936415,1.0,9/24,19.50%,TOMM70;EIF2AK4;STAT1;TRIM44;AIM2;SIN3A;MAVS;DTX3L;PARP9
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.46837034721395565,-1.156775448530709,0.2852941176470588,0.8054363602816728,1.0,5/10,18.19%,FEM1B;THOC5;WDR76;CCAR2;ETAA1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3463015156094193,-1.156732723584431,0.2413793103448276,0.8024453593348956,1.0,13/29,16.11%,RAD23B;GTF2H1;ERCC5;RBX1;CHD1L;MNAT1;CUL4A;RPA1;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.38131540907834033,1.1563636123463041,0.18503538928210314,1.0,1.0,49/172,19.00%,PLA2G5;CLN3;GPD1;PIP4K2B;CSNK2A2;GPD1L;SYNJ2;PCYT2;LPIN1;CEPT1;AGPAT1;AGPAT5;CRLS1;INPP5E;PIK3R1;GPAT4;PLEKHA3;CPNE7;AGPAT3;LPIN3;GPAM;PCYT1B;PITPNM3;PIK3CB;PIK3R2;STARD7;LPIN2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;PTDSS1;FAR1;FIG4;DDHD2;SACM1L;CHKB;CDS1;PIK3C2B;SLC44A2;MTMR4;RUFY1;SLC27A1;PIK3C3;PTDSS2;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4
prerank,protein targeting to mitochondrion (GO:0006626),0.4152514691561823,1.1563226494632586,0.2571743929359823,1.0,1.0,11/52,13.20%,DNLZ;HSP90AA1;FIS1;TOMM20;FBXO7;TIMM13;PMPCA;MFN2;AIP;TIMM29;GDAP1
prerank,regulation of glycolytic process (GO:0006110),0.403308945958792,1.1561255725032813,0.2464864864864865,1.0,1.0,21/68,19.14%,SLC4A4;IGF1;OGT;RAE1;ARNT;PRXL2C;HDAC4;NUP188;PGAM1;ZBTB20;APP;NUP210;GIT1;NUP88;NUP214;NUPR1;NUP153;RANBP2;PRKAA1;PRKAG2;NUP35
prerank,base-excision repair (GO:0006284),0.4156006809217775,1.155851198725833,0.2595936794582393,1.0,1.0,7/48,6.98%,LIG1;PARP1;NTHL1;PRMT6;MPG;USP47;LIG3
prerank,kinetochore organization (GO:0051383),0.5250792546155294,1.1556239335652838,0.28815977175463625,1.0,1.0,2/13,13.49%,CENPT;CENPC
prerank,nitric oxide metabolic process (GO:0046209),-0.4171428558935352,-1.155389922790699,0.24834437086092714,0.8035810694713864,1.0,7/14,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,regulation of mitotic cell cycle (GO:0007346),0.38032568085545915,1.1551837548727866,0.1891348088531187,1.0,1.0,59/171,22.11%,CUL7;CDC23;PSMD4;UBE2S;MAD2L1;HECA;CDC16;OBSL1;FZR1;CDK13;PRKCA;CDK9;SCRIB;ANAPC2;FBXO5;PSMB10;DDB1;TRIM35;PSMD11;BRINP3;SIK1;SRA1;SDCBP;RNF40;PRMT5;CDK5RAP3;USP2;PSME2;PSMC5;TMEM8B;APP;IQGAP1;PTPN3;RCC1;ANAPC11;ANAPC4;CDC26;TGFB1;PSMD1;UBE2E1;UBE2D1;PSMD6;BRINP1;MDM2;MEIS2;ANAPC10;CDK10;ANAPC5;USP22;KIF20B;PSMD5;CDK11B;HNRNPU;PSMA4;ANGEL2;PSMA1;PSMC6;CUL9;SMAD3
prerank,histone acetylation (GO:0016573),-0.2713742726678776,-1.1550788654101467,0.1978021978021978,0.8015877212383639,1.0,29/69,23.87%,EPC1;TRRAP;LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;NAA40;EP300;JADE1;JADE3;WDR5;MSL3;ACTL6A;TAF5L;KAT6B;DR1;ING3;BRCA2;KAT8;PHF20L1;ING5;NAA60;APBB1;RUVBL1;TRIM16;SUPT7L;TAF6L
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.46089611480871495,1.1550085971082904,0.29198966408268734,1.0,1.0,6/24,18.05%,FIS1;MTCL1;MIEF2;ANK3;ITGB1BP1;CEMIP
prerank,regulation of bone mineralization (GO:0030500),0.4121371773337188,1.1549606043568459,0.26674107142857145,1.0,1.0,13/55,12.01%,TMEM119;FBN2;BMP6;FZD9;ANKH;NELL1;DDR2;ADGRV1;WNT4;ATP2B1;KL;TWIST1;ENPP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5037450252310638,1.1548909423778482,0.29624664879356566,1.0,1.0,2/17,4.57%,LPL;PCSK5
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5017924561860944,1.1548415543987776,0.29766803840877915,1.0,1.0,3/15,7.08%,NHP2;CCT8;CCT6A
prerank,negative regulation of lipid storage (GO:0010888),-0.3759144362027682,-1.1547559454190213,0.23828125,0.7997014384042705,1.0,10/19,32.34%,ABHD5;NFKBIA;PPARD;NR1H3;NR1H2;PPARG;PPARA;ITGB3;PNPLA2;PTPN2
prerank,plasma membrane organization (GO:0007009),0.4056585737553612,1.1543242399921618,0.25488069414316705,1.0,1.0,21/61,21.80%,CLN3;A4GALT;BIN1;WHAMM;TLCD1;CXCR4;STX2;PACSIN3;ABCA7;ANK3;SNX33;SERP1;EPB41L3;SPTBN1;ABCD2;NSF;ARL8B;SMPD1;CHMP4A;SYT11;MYH9
prerank,axon guidance (GO:0007411),0.3768043214206132,1.1542417120835053,0.15947843530591777,1.0,1.0,50/201,17.72%,SPTBN5;WNT5A;EPHA7;PDLIM7;EPHB2;RAC1;PLXNA2;CXCL12;NRP1;PRKCA;PIK3R1;GAB1;EFNB3;EPHA8;CXCR4;GPC1;DSCAM;RAP1GAP;PLXNA1;CYFIP1;FRS2;EFNB2;VLDLR;TMEFF1;EPHA10;SEMA3D;GDNF;IRS2;GFRA2;PIK3CB;ROBO2;ROBO1;KIF5C;DAG1;FEZ2;NPTN;ALCAM;UNC5D;UNC5C;SLIT1;SLIT3;SEMA3E;SPTBN1;SEMA3A;PLXNB3;EPHA5;KIF5B;USP33;DAB1;DCC
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5231547983804903,1.1538983407143075,0.2997159090909091,1.0,1.0,4/12,15.47%,MLYCD;TWIST1;IRS2;ABCD2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3852485934332401,1.153815939441121,0.20142421159715157,1.0,1.0,21/142,13.68%,WNT5A;CLN3;PTGER4;CCR9;ACKR2;FIS1;FZD9;C1QTNF1;ABL1;CXCR4;HCRTR2;ATP1A2;CD24;BDKRB2;ATP2B1;SELENOT;TBXA2R;HCRTR1;PDGFRA;NPTN;LPAR1
prerank,phasic smooth muscle contraction (GO:0014821),0.5499366710852193,1.1537165061512573,0.30627871362940273,1.0,1.0,2/10,10.19%,EDN3;GDNF
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5324636563654083,1.1536119465781403,0.30633284241531666,1.0,1.0,1/12,0.85%,FCGR2B
prerank,regulation of immune effector process (GO:0002697),0.4252008525473643,1.1532895759113868,0.2711471610660487,1.0,1.0,3/41,5.04%,VTN;FCGR2B;SERPING1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4718238591514463,1.1526353451416027,0.3064312736443884,1.0,1.0,5/23,9.82%,SELENOS;SYVN1;SEC16A;AUP1;VCP
prerank,detection of mechanical stimulus (GO:0050982),0.48308188947919495,1.152458853729367,0.2960969044414536,1.0,1.0,5/19,24.29%,PKD2L2;JUP;PKD2;CSRP3;CDH2
prerank,cholesterol efflux (GO:0033344),0.46936715891077313,1.152196338794162,0.3209718670076726,1.0,1.0,8/20,23.97%,SOAT1;ABCA7;APOE;ABCA5;NPC2;ABCG1;NPC1;ABCA1
prerank,regulation of cation transmembrane transport (GO:1904062),0.44784519567936254,1.1519284664035163,0.2767749699157641,1.0,1.0,6/29,16.89%,KCNAB2;CD63;SLMAP;FGF12;DPP10;SLC30A5
prerank,filopodium assembly (GO:0046847),0.4955933165814074,1.151051984598641,0.3006711409395973,1.0,1.0,4/16,8.63%,S1PR2;SRGAP2;ARHGEF4;PPP1R9B
prerank,regulation of postsynapse organization (GO:0099175),0.45167490444194075,1.1510350130933658,0.29044117647058826,1.0,1.0,7/28,11.98%,WNT5A;FCGR2B;CDKL5;TANC2;CDK5;SRCIN1;IL1RAPL1
prerank,cellular calcium ion homeostasis (GO:0006874),0.38255550075407113,1.15080803955955,0.21961184882533197,1.0,1.0,23/133,13.21%,TNNI3;CLN3;BAX;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;FZD9;CXCL12;ATP2A2;PDZD8;HCRTR2;ATP2B1;SLC24A4;SLC30A1;AFG3L2;PTH1R;HCRTR1;BCL2;CAMK2D;HTR2C;NPTN
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5141150382426476,1.150558583496299,0.3166904422253923,1.0,1.0,3/13,9.60%,GLS2;GLUL;ALDH4A1
prerank,regulation of spindle assembly (GO:0090169),0.4593083844258875,1.1505349322448981,0.2919254658385093,1.0,1.0,10/25,21.47%,CEP97;DRG1;CHMP3;GPSM2;VPS4B;NUMA1;EML3;HNRNPU;TPR;CHMP4B
prerank,regulation of epithelial cell migration (GO:0010632),-0.29271432860238317,-1.1504574936938274,0.23469387755102042,0.8099163068755237,1.0,16/51,15.19%,PTPRG;DAB2IP;BMPER;DOCK1;RREB1;PRKCE;HIF1A;TGFB2;ADIPOR1;PLCG2;DUSP10;PTPN23;PLCG1;PFN1;CAPN7;SRC
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5187293739596585,1.150327478775076,0.32456140350877194,1.0,1.0,4/13,7.54%,EDEM1;SAR1A;SEC16A;SEC16B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4750039609823067,1.1503136974567842,0.3055198973042362,1.0,1.0,9/22,24.09%,DUSP18;PPM1B;PPM1E;PPP5C;PPP2CB;PPM1A;PPM1F;DUSP16;PPM1D
prerank,regulation of biomineral tissue development (GO:0070167),0.452427890647496,1.1498143824283154,0.303970223325062,1.0,1.0,8/26,14.28%,ANKH;DDR2;FBXO5;SOX9;TWIST1;ENPP1;ROCK2;TGFB1
prerank,regulation of protein phosphorylation (GO:0001932),0.37273024237449864,1.149810933231967,0.16265060240963855,1.0,1.0,50/256,14.90%,FGF20;FGF9;HDAC3;TMEM119;IL34;KDM4D;DVL2;EPHA7;EPHB2;EIF2AK3;HSP90AA1;RAC1;SMG8;WARS1;ERP29;FBLN1;FGF10;FLCN;KNDC1;FBH1;BRD4;ABL1;ATG14;AKAP8L;RAP2A;SIRPA;WDFY2;PID1;ARRB1;SOX9;PPP2R5E;CDK5RAP3;CLIP3;MUSK;APP;IGFBP3;LEPR;PARK7;NPM1;AXIN2;RACK1;PLPP3;NPTN;ZBED3;CSNK1D;ROCK2;TGFB1;FKBP8;IMPACT;PPP2R5D
prerank,protein neddylation (GO:0045116),-0.4298376645452869,-1.1496522921975416,0.2996742671009772,0.8093625285429951,1.0,3/13,4.49%,DCUN1D4;UBA3;RBX1
prerank,regulation of organelle organization (GO:0033043),0.3988218316590582,1.1496272945284043,0.2515991471215352,1.0,1.0,15/80,11.49%,CLN3;CPLANE2;SIRT7;ZEB2;PRMT6;FIS1;TAOK1;SAR1A;MIEF2;SQSTM1;CAMSAP2;CAPN2;PDE4DIP;USP6NL;MYO5A
prerank,endoplasmic reticulum organization (GO:0007029),0.39539093459239655,1.149585997672455,0.2572347266881029,1.0,1.0,23/72,19.98%,REEP4;ATL1;EIF2AK3;BNIP1;SEC16A;MIA3;GET1;SEC16B;MOSPD3;LMAN2L;RAB10;TOR1B;APP;SERP1;ZBED3;SMPD4;DNM1L;SEC61G;VAPB;ALDH3A2;VCPIP1;STX5;TOR1AIP2
prerank,positive regulation of type I interferon production (GO:0032481),0.3985792349209227,1.149501105129949,0.26543878656554715,1.0,1.0,21/73,17.30%,NFKB1;HSP90AA1;POLR3D;STAT6;NFKB2;DDX3X;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;TLR3;PTPN22;MRE11;HSPD1;OAS2;POLR3K
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5002727386017204,1.1491184276258979,0.3170731707317073,1.0,1.0,5/14,15.48%,HSD17B4;CROT;AMACR;EHHADH;ACOX3
prerank,lipoprotein catabolic process (GO:0042159),0.5385510954520281,1.148584482534339,0.3056768558951965,1.0,1.0,2/11,2.89%,ABHD10;LYPLAL1
prerank,positive regulation of protein modification process (GO:0031401),0.37353971328917973,1.1484623245702292,0.18869828456104945,1.0,1.0,53/203,21.29%,FGF20;FGF9;HDAC3;TMEM119;IL34;DVL2;HSP90AA1;RAC1;CALM3;TAOK1;ERP29;DDX3X;FGF10;FLCN;KNDC1;FBH1;ABL1;ATG14;NOS1AP;RAP2A;WDFY2;ARRB1;SOX9;NNMT;CLIP3;MUSK;APP;LEPR;AXIN2;RACK1;NPTN;CSNK1D;ROCK2;TGFB1;CAMTA1;ASPSCR1;DAXX;FMR1;ILK;PPP2R5A;TERF2IP;FLOT1;CALM1;SMPD1;PELI2;DLC1;RAB3GAP2;DAB2;LYN;ACVR2A;NTRK2;PTBP1;FGF2
prerank,regulation of mRNA catabolic process (GO:0061013),0.3819305740264208,1.148389720982695,0.2410623084780388,1.0,1.0,31/121,17.01%,KHSRP;EXOSC1;EXOSC3;PSMD4;EXOSC7;EXOSC2;PCBP4;ANP32A;ZFP36L1;PRKCA;IGF2BP2;PSMB10;EXOSC8;PSMD11;HNRNPD;DHX36;PABPC1;PSME2;PSMC5;ZC3H14;RC3H2;YTHDF3;YTHDF1;CSDC2;XRN1;NUP214;PSMD1;TNPO1;ZC3HAV1;FMR1;PSMD6
prerank,negative regulation of peptidase activity (GO:0010466),0.41626378888311955,1.1481137344643573,0.2792281498297389,1.0,1.0,11/47,20.46%,VTN;SERPING1;SPOCK1;PARK7;SERPINA2;SPOCK2;LRP1;SERPINE1;SERPIND1;TIMP2;SERPINF1
prerank,actin filament bundle assembly (GO:0051017),0.4365641562209951,1.148062879304725,0.27672209026128264,1.0,1.0,8/33,15.37%,LCP1;AIF1L;MYO1B;DMTN;RHOD;BAIAP2;ADD2;PAWR
prerank,positive regulation of glucose metabolic process (GO:0010907),0.505051522318022,1.1475775368136711,0.3171428571428571,1.0,1.0,4/14,10.40%,GPLD1;DDB1;NNMT;IRS2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.522117077204254,1.1475675941350258,0.3079136690647482,1.0,1.0,4/12,12.71%,EPHB2;HSP90AA1;MYCBP2;B4GALT5
prerank,Golgi organization (GO:0007030),0.3881110277734377,1.1475612356105078,0.24173553719008264,1.0,1.0,37/112,19.74%,SPTBN5;CUL7;TJAP1;UBXN2A;TRAPPC8;OBSL1;STX6;SEC16A;ARHGEF7;TRIP11;STX16;SEC16B;ATP8B2;PLK5;LMAN2L;PRMT5;ARHGAP21;TBC1D20;PLEKHM2;USP6NL;RAB30;TANGO2;VTI1B;TMED10;COG3;HTT;CSNK1D;VMP1;CSNK1A1;STX17;VTI1A;STK25;GORASP1;VCPIP1;STX5;FAM174B;ZW10
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.43794224252720265,1.1473785159325032,0.3112745098039216,1.0,1.0,2/29,1.12%,SFRP2;SFRP1
prerank,skeletal muscle tissue development (GO:0007519),0.44187960035772156,1.1464757486580284,0.29876543209876544,1.0,1.0,2/32,4.00%,MYORG;MYH14
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5329833352900116,1.1461813247766157,0.3255131964809384,1.0,1.0,3/12,22.93%,IL33;NUPR1;IL18
prerank,regulation of receptor internalization (GO:0002090),0.4330350137782569,1.1461405772222177,0.2767962308598351,1.0,1.0,11/35,18.68%,NTF3;PICK1;CD63;ARRB1;LRPAP1;SDCBP;EGF;MAGI2;AHI1;FMR1;FLOT1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.45512306959328774,-1.146053509367092,0.29310344827586204,0.8172194753682702,1.0,2/10,1.89%,PRKCH;MED1
prerank,amino acid import across plasma membrane (GO:0089718),-0.3535286139156626,-1.1460520377456553,0.24170616113744076,0.8141479562704763,1.0,6/24,4.67%,SLC6A6;SLC16A2;SLC3A2;SLC47A1;SLC7A1;SLC6A9
prerank,response to hydrogen peroxide (GO:0042542),0.41471105236182365,1.1459833049077541,0.28325688073394495,1.0,1.0,13/45,19.43%,APTX;PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;STK25;PLEKHA1;RPS3
prerank,regulation of cellular metabolic process (GO:0031323),0.4217540054718279,1.1457457493492105,0.2702078521939954,1.0,1.0,7/45,8.80%,FASN;FOXM1;STUB1;ABCA2;AGPAT1;PID1;SSH1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5171759185881836,1.1456363557064437,0.3386396526772793,1.0,1.0,7/13,27.47%,ELOVL1;ELOVL4;ELOVL6;HACD2;HACD1;HACD3;HACD4
prerank,protein maturation (GO:0051604),0.3882013730747823,1.145055057367418,0.24532224532224534,1.0,1.0,26/95,21.26%,NDUFAB1;XPNPEP3;CPXM1;CLN3;STUB1;PCSK5;OGT;SDE2;PCSK2;CIAO2A;PTCH1;AFG3L2;CPXM2;METAP2;MMS19;ADAMTS3;F3;CASP2;HSPD1;SORL1;MMP14;NFU1;PCSK6;MMP16;NAA35;ISCA1
prerank,positive regulation of protein acetylation (GO:1901985),0.5256299332365779,1.1449438431722814,0.3190271816881259,1.0,1.0,3/12,4.17%,TAOK1;DDX3X;DIP2B
prerank,regulation of intracellular transport (GO:0032386),0.4267099188776823,1.1447922582141172,0.30760233918128654,1.0,1.0,10/38,16.13%,LCP1;ATP9A;MLC1;CAPN10;NEFH;SCFD1;TTC21B;NUP214;ATPSCKMT;NUMA1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.33382833288292635,-1.1446181340157644,0.2808988764044944,0.8156601111264463,1.0,10/30,15.08%,CACNA1D;GJA1;CACNA2D1;ATP1A1;GJC1;KCNJ2;CACNA1C;CACNA1G;NEDD4L;SNTA1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.553084287468982,1.1443713833108047,0.3226744186046512,1.0,1.0,1/10,0.80%,WNT5A
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4646607721344478,-1.1443304741766105,0.2829581993569132,0.8134494631343969,1.0,5/10,22.33%,CST3;TNFRSF1A;TNFRSF1B;EMILIN1;DPP4
prerank,cellular amide metabolic process (GO:0043603),0.38327819182941064,1.1439358202005006,0.2572614107883817,1.0,1.0,19/102,14.55%,CPXM1;MLYCD;SMPD2;THEM4;ABCA2;FPGS;ACOT9;ACOT11;PCCB;THOP1;GPAT4;DNPEP;SGPL1;NNMT;CPXM2;PCCA;PLPP3;NIT1;ACSL6
prerank,neuropeptide signaling pathway (GO:0007218),0.40501979709234875,1.143772937880646,0.27181208053691275,1.0,1.0,9/58,14.46%,LTB4R2;OPRK1;HCRTR2;GPR37;GPR149;NMU;NXPH2;HCRTR1;GLRA1
prerank,negative regulation of translation (GO:0017148),0.38492896388669856,1.1436537733102012,0.25874867444326616,1.0,1.0,31/87,22.70%,ILF3;CPEB1;PAIP2;EIF2AK3;DDX3X;CNOT10;IGF2BP2;CELF1;EPRS1;DHX36;PUS7;EIF4E2;CNOT9;MALSU1;YTHDF3;RACK1;DAPK1;YTHDF1;ROCK2;MRPL13;FMR1;FTO;SAMD4B;YTHDF2;RPS3;YBX1;TPR;IGFBP5;SAMD4A;METTL14;RPL13A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4447730549314152,1.1434957155851004,0.27898550724637683,1.0,1.0,10/29,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,activation of GTPase activity (GO:0090630),0.3869907474442321,1.1434216311695833,0.26365546218487396,1.0,1.0,20/89,14.05%,MTSS2;NTF3;SLC27A4;TBC1D7;SGSM3;RUNDC1;ARHGEF10;TBC1D13;SCRIB;SYDE2;RAP1GAP;ARHGAP42;RAP1GAP2;RABGAP1L;ARHGAP24;USP6NL;EVI5L;DOCK7;RABGAP1;ARHGAP29
prerank,global genome nucleotide-excision repair (GO:0070911),-0.34621836459747013,-1.1433931974829115,0.2590909090909091,0.8133194823438642,1.0,11/26,16.11%,RAD23B;USP45;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4671295860442724,1.1430379367557402,0.2994791666666667,1.0,1.0,6/20,12.60%,SMAD9;XBP1;CARF;CHD6;RBPJ;CREB3
prerank,keratinocyte differentiation (GO:0030216),0.44770397821322533,1.1430142150699811,0.2964376590330789,1.0,1.0,3/29,3.76%,WNT5A;SCEL;ANXA1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.42404128745587977,-1.1429786407508173,0.2964169381107492,0.811530697289464,1.0,7/13,26.97%,NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR
prerank,regulation of metal ion transport (GO:0010959),0.4974547329839481,1.1429127357426707,0.31752305665349145,1.0,1.0,4/16,12.18%,CAMK2B;SLC30A10;BCL2;CAMK2G
prerank,cellular response to interleukin-4 (GO:0071353),0.5443910293538827,1.142344936380285,0.3241167434715822,1.0,1.0,2/10,3.80%,STAT6;XBP1
prerank,regulation of membrane depolarization (GO:0003254),0.4802574559383256,1.141981155080457,0.30677290836653387,1.0,1.0,6/18,20.96%,GPD1L;SCN2B;CAMK2D;PTPN3;SMAD7;SCN1B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3011640229169191,-1.1415969370431027,0.2549019607843137,0.8129172130269041,1.0,13/35,22.05%,MEF2C;FLT1;CAV1;PTPRM;STAT1;THBS1;AIMP1;CAV2;SCG2;RGCC;NF1;ATOH8;PPARG
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5444867504722446,1.1414550624525688,0.32142857142857145,1.0,1.0,3/11,14.28%,IL34;PRKCA;TGFB1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4284465461232407,1.1412236359113461,0.28128724672228844,1.0,1.0,11/34,21.64%,SMPDL3B;GPR108;TNFAIP3;LGR4;LY96;LRRC14;TLR3;GPS2;PTPRS;LYN;RAB7B
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.4712980819602689,1.1411034029713476,0.3220779220779221,1.0,1.0,4/20,7.75%,BBS10;HSP90AA1;NDUFAF1;PSMG3
prerank,negative regulation of phosphorylation (GO:0042326),0.3891734433195535,1.140927004588375,0.26299045599151644,1.0,1.0,27/85,20.74%,CDKN2D;EPHB2;PRKRIP1;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;HDAC4;IRS2;IGFBP3;PARK7;GIT1;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;NUPR1;DNAJC10;TERF2IP;DYNLL1;LYN;HNRNPU;NPRL2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3859287140808634,1.1408752662738444,0.264859228362878,1.0,1.0,22/98,17.19%,FASN;NTF3;IFNAR1;IL10RB;PICK1;CD63;AGPAT1;SCRIB;PRELID1;VAMP3;PID1;ARRB1;EGF;MAGI2;RNF41;TGFB1;AHI1;AGTR1;NSF;ANXA2;FMR1;APOE
prerank,regulation of leukocyte activation (GO:0002694),-0.40981810783474615,-1.1406433439159618,0.2793103448275862,0.8129835157187524,1.0,8/14,35.72%,MFHAS1;PLSCR1;GPR137B;SHPK;GPER1;CD74;CD200;MIF
prerank,protein import (GO:0017038),0.38985035758988484,1.1404675354452956,0.27044025157232704,1.0,1.0,29/84,21.10%,MMP12;TSC2;HSP90AA1;NXT2;FIS1;NXT1;KPNB1;NUP188;PXMP4;PEX5;IPO11;SNX33;E2F3;PXMP2;NUP88;GDAP1;PEX13;IPO7;NUP214;TNPO1;ABCD2;RAB8B;ALDH3A2;APOE;NUP153;PPP1R10;HEATR3;TPR;APPL2
prerank,telomere maintenance via telomerase (GO:0007004),0.44912096978342786,1.140360673649007,0.28536585365853656,1.0,1.0,10/28,18.57%,NHP2;HSP90AA1;WRAP53;PPP6R3;SHQ1;MRE11;RAD50;TERF1;ANKRD28;TERF2IP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.4078147514025135,1.1402228863188029,0.29295154185022027,1.0,1.0,13/56,17.34%,SPIRE2;CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SPIRE1;SON
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.42611496519197933,-1.140117650348151,0.2996632996632997,0.8116801093921707,1.0,6/12,16.92%,KAT7;TIPIN;NBN;WRNIP1;METTL4;BLM
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3769008627828316,-1.1400709353078826,0.24427480916030533,0.8088664784397154,1.0,12/16,44.81%,RPA1;PURA;BLM;RECQL;MCM6;WRN;MCM4;MCMDC2;TWNK;RAD51;MCM2;MCM7
prerank,triglyceride homeostasis (GO:0070328),0.45067307255416555,1.1394899610216855,0.2869458128078818,1.0,1.0,3/26,3.85%,LPL;XBP1;RORA
prerank,establishment of protein localization to membrane (GO:0090150),-0.2548342152576193,-1.1394741868095026,0.1,0.8078260726203965,1.0,15/66,15.42%,PARD3;EGFR;SYNE3;TAOK2;REEP1;ZDHHC20;NACA;RAB3IP;VPS37B;ZDHHC15;BRAF;NECTIN3;GOLGA7;VPS37C;FRMPD1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.42516586229702735,1.1388030270339418,0.29952830188679247,1.0,1.0,5/40,6.02%,IGF1;BAX;PPIF;FAM162A;PRELID1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.4601102722456698,1.1385481145779535,0.32837670384138784,1.0,1.0,4/23,7.60%,DNASE1L2;FBH1;DFFB;KPNB1
prerank,mitochondrial fission (GO:0000266),0.49353812337247177,1.1382273513465462,0.3328671328671329,1.0,1.0,5/16,14.84%,DNM1;FIS1;MTFR1L;GDAP1;DNM1L
prerank,regulation of transposition (GO:0010528),0.5353007654516305,1.1380474436803005,0.3347826086956522,1.0,1.0,1/13,1.78%,SIRT7
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3985004988119174,1.1380390879259803,0.27705627705627706,1.0,1.0,18/69,19.08%,IGF1;SIRT2;PLCH1;FGFR1;ZFP36L1;OGT;PLCL2;PIK3R1;IRS2;PIK3CB;PIK3R2;PDGFRA;PI4KB;PIK3C2B;PIK3C3;PITPNM2;PLEKHA1;KCNH1
prerank,fatty acid biosynthetic process (GO:0006633),0.3977858912902745,1.1373641348912875,0.2888402625820569,1.0,1.0,9/63,14.72%,NDUFAB1;LPL;MLYCD;ELOVL1;XBP1;ELOVL4;FADS1;PTGS2;EPHX2
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.4847660037344487,1.1368657185854223,0.31413612565445026,1.0,1.0,6/18,25.17%,IGF1;CD24;RPS3;HMGB1;IL18;IGFBP2
prerank,glycoprotein biosynthetic process (GO:0009101),0.3912478665834749,1.1354768893665494,0.272145144076841,1.0,1.0,14/79,13.65%,ALG5;B3GALNT1;IGF1;ST8SIA3;ST3GAL2;ALG1;TMEM106A;CHST10;ST3GAL3;ST3GAL5;B4GALT5;SERP1;COG3;DAD1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5298999026316088,1.1354309720066327,0.3244444444444444,1.0,1.0,5/11,17.83%,PCBP4;IGF2BP2;ZNF445;NOVA1;PCBP2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4456459634319752,1.1353201798458952,0.31772151898734174,1.0,1.0,6/28,15.53%,FGF10;THY1;SIRPA;XRCC6;CD47;HSPD1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.46717183746113644,1.1349378789549858,0.3010610079575597,1.0,1.0,2/21,1.32%,IL34;DDT
prerank,positive regulation of chromosome organization (GO:2001252),0.49960962825685884,1.13470764197523,0.32724719101123595,1.0,1.0,7/15,19.61%,GNL3;DHX36;ATRX;MRE11;RAD50;RAD21;PPP1R10
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4224834728025598,1.134689345804062,0.3103448275862069,1.0,1.0,16/40,22.11%,GLIPR2;SNAI1;OLFM1;TCF7L2;EZH2;TGFB1I1;SDCBP;TWIST1;AXIN2;TGFB1;JAG1;TGFBR1;DAB2;GCNT2;SMAD2;SMAD3
prerank,lipid oxidation (GO:0034440),-0.41224318698788387,-1.134484062203852,0.27380952380952384,0.8203835975128675,1.0,3/12,22.13%,ADIPOR1;ADIPOR2;PPARGC1A
prerank,protein targeting to peroxisome (GO:0006625),0.44554307121478626,1.1344721717276012,0.3174019607843137,1.0,1.0,12/29,16.83%,FIS1;ZFAND6;PXMP4;PEX1;PEX5;PXMP2;GDAP1;PEX7;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,regulation of axonogenesis (GO:0050770),0.4076313654085165,1.134203050175802,0.29194630872483224,1.0,1.0,23/51,24.29%,AMIGO1;PLXNA2;THY1;PAK3;EFNB3;BRSK2;MCF2;PLXNA1;BRSK1;ROBO2;ROBO1;PLXNB3;RUFY3;SLITRK1;CHN1;MAP6;NTRK2;ARHGAP35;PAK1;EPHA4;LRP4;PTEN;CDH2
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5265074937492873,1.1341220072666287,0.32907801418439714,1.0,1.0,3/12,10.71%,CXCL12;DOCK8;APP
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.49306841323535855,1.1340691978107944,0.32647462277091904,1.0,1.0,7/16,23.73%,PLEKHM2;CEBPG;TUBB;KIF5B;ARL8B;VAMP7;LYST
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.35962153513750733,-1.1337883089936485,0.25116279069767444,0.8194707696769603,1.0,5/20,13.21%,CAB39;PRKCE;GOPC;ACTN2;NEDD4L
prerank,folic acid metabolic process (GO:0046655),-0.37963362006224904,-1.1337065028939384,0.2801724137931034,0.8167128880019501,1.0,10/18,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,second-messenger-mediated signaling (GO:0019932),0.389259316827138,1.1336164150202768,0.27825159914712155,1.0,1.0,16/82,17.84%,PDPK1;EIF2AK3;EDN3;CCR9;ACKR2;RCAN2;CXCR4;RCAN3;INPP5A;PPP1R9B;MCTP2;NDNF;AGTR1;APOE;HRH1;MCTP1
prerank,superoxide anion generation (GO:0042554),-0.41420830469434095,-1.1335475240659,0.3308550185873606,0.814272551636855,1.0,11/13,56.86%,NOX1;CYBA;NCF2;ALOX12;CYBB;NOX4;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,pinocytosis (GO:0006907),0.5432738597760677,1.1332495099409663,0.33781763826606875,1.0,1.0,5/10,20.61%,SNX5;RAB34;SNX33;CARMIL1;MAPKAPK2
prerank,cellular response to glucose starvation (GO:0042149),0.4185965804555997,1.1331468522449977,0.2975778546712803,1.0,1.0,15/41,19.00%,EIF2AK3;XBP1;PICK1;NUAK2;NUAK1;ATG14;BRSK2;TBL2;SIK1;BRSK1;IMPACT;PIK3C3;PRKAA1;PRKAG2;PIK3R4
prerank,regulation of humoral immune response (GO:0002920),0.41461083007417593,1.1331452375333542,0.30549199084668194,1.0,1.0,3/44,5.04%,VTN;FCGR2B;SERPING1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.514221073236141,1.13294731778956,0.3385939741750359,1.0,1.0,4/13,13.54%,EDEM1;ERLEC1;BRSK2;UBE2J1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3737507124602421,1.1327757228303936,0.26078028747433263,1.0,1.0,6/117,3.71%,FSHR;PTGER4;ADCY7;ADM;VIPR2;PTHLH
prerank,RNA metabolic process (GO:0016070),0.38153263749821287,1.1326602301501383,0.25869120654396727,1.0,1.0,36/127,17.85%,LAGE3;DDX17;TBRG4;EXOSC7;RNASE1;RBM3;DDX3X;POLR2B;RBM39;CELF2;DHX8;ATXN1;HNRNPK;MPHOSPH10;PABPC4;HNRNPD;DHX36;HNRNPM;MTREX;RBFOX2;RBMS1;RBMS2;POLR2K;HNRNPA0;AGO3;HNRNPH3;SETX;HNRNPL;SND1;NOVA1;HNRNPA2B1;THOC1;TP53RK;FASTKD1;PCBP2;FTO
prerank,positive regulation of protein polymerization (GO:0032273),0.39897318723574005,1.1323318837241427,0.29244249726177435,1.0,1.0,9/65,9.23%,PSRC1;CDC42EP5;CDC42EP4;BIN1;HSP90AA1;RAC1;TPPP3;BAIAP2;DRG1
prerank,retinal metabolic process (GO:0042574),0.5277668466214099,1.132139626733475,0.32763532763532766,1.0,1.0,2/12,6.30%,RDH10;RDH11
prerank,protein complex oligomerization (GO:0051259),0.3892723566019942,1.1319103535174773,0.28556149732620323,1.0,1.0,26/85,22.76%,TRMT61B;GSDMD;MPP2;KCNC1;ATL1;LRRC8A;FUS;TIFA;KCNC2;CPSF7;HGSNAT;ALS2;NUDT21;NACC2;PRMT1;DNM1L;PRMT8;CPSF6;PKD2;MAT2A;OXA1L;EHD1;ATL3;EHD3;WDCP;OPA1
prerank,negative regulation of secretion (GO:0051048),0.5417000543894938,1.131367750965115,0.33183856502242154,1.0,1.0,4/10,16.15%,VAMP3;EGF;NRG1;VAMP8
prerank,extracellular matrix organization (GO:0030198),0.36850113925093203,1.131327846610093,0.1961961961961962,1.0,1.0,77/276,21.42%,ADAMTSL2;MMP12;MMP17;VTN;LCP1;MMP11;APLP1;COL27A1;FBN2;ADAMTS7;P4HA1;COL4A6;DDR1;COL4A5;ITGA9;ADAMTS10;LAMC3;ADAMTS20;LAMC1;PLOD1;DDR2;CD151;DCN;MFAP2;COL22A1;ADAMTS5;SPARC;ADAMTS6;JAM3;FLRT2;MFAP5;CAPN2;PPIB;P4HA2;APP;ST7;ADAM12;COL1A2;CRTAP;DAG1;CD47;ECM2;FBN1;SPOCK2;FBLN5;LAMB1;ADAMTS3;TGFB1;PXDN;P3H2;COL5A2;LUM;ICAM1;HSPG2;NDNF;ADAMTS1;SERPINE1;CAPNS1;COL11A1;BMP1;TGFBR1;SCUBE1;FLOT1;COL5A3;COL8A2;CTSK;TIMP2;MMP14;QSOX1;LOXL1;MMP16;ITGAV;ITGB1;ADAMTSL5;FGF2;GFOD2;GSN
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4221056789266775,-1.1311346467636942,0.30618892508143325,0.8189377811793286,1.0,1/12,3.43%,ZBTB1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4403009207937469,1.1310893798111625,0.3181818181818182,1.0,1.0,8/31,17.91%,ARRDC4;UBE2S;FZR1;CDC14B;UBE2L3;TOPORS;GORASP1;DCUN1D5
prerank,phospholipid transport (GO:0015914),-0.273916399201614,-1.1310434035499597,0.22857142857142856,0.8162891354443489,1.0,11/52,8.39%,ATP8B1;ATP10A;OSBPL2;PITPNA;ABCC1;ABCA4;PITPNC1;TMEM30A;SCARB1;SCP2;OSBPL5
prerank,neurotransmitter secretion (GO:0007269),0.4152822310176645,1.1301340885033617,0.3048065650644783,1.0,1.0,9/44,12.73%,SYT10;UNC13A;CDK5;DVL1;DNAJC5;CPLX1;SNAP25;BRSK1;SYT1
prerank,inner ear morphogenesis (GO:0042472),0.4578318145112318,1.1300981794825196,0.32985658409387225,1.0,1.0,3/22,8.37%,EPHB2;FGFR2;SOX9
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.43091599648191403,1.1299705642366868,0.3137254901960784,1.0,1.0,7/32,18.96%,PDPK1;CALM3;THY1;HTT;PKD2;CEMIP;CALM1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.41974056332196097,1.1298250923707496,0.3080513418903151,1.0,1.0,5/37,8.75%,SIRT2;NFKB1;ABCA2;LRPAP1;SDCBP
prerank,aorta development (GO:0035904),0.4965750694422716,1.1296233152932842,0.31888111888111886,1.0,1.0,6/14,18.02%,ROBO2;ROBO1;LRP1;HECTD1;JAG1;PKD2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4429396173145342,1.1294859996163242,0.32961586121437425,1.0,1.0,12/27,24.06%,SYT3;SYT10;SYT1;ARL8B;SYT4;VAMP7;SYT11;SYT12;SDF4;SYT7;SYT2;PPP3CB
prerank,protein modification by small protein conjugation (GO:0032446),0.36821764881385827,1.1293350861887586,0.157,1.0,1.0,101/361,20.24%,ARRDC4;RNF157;CUL7;CDC23;SELENOS;RNF138;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;SYVN1;USP7;SAE1;CDC16;LZTR1;TRIM11;BRAP;PDZRN3;RAE1;SDE2;FBXO7;FBH1;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;MYCBP2;NFX1;ARRB1;TRIM62;UBA1;RNF40;RNF168;RNF103-CHMP3;CDK5RAP3;UBE2V2;TRIM41;TRIM17;CUL4B;VCP;NUP188;CHFR;UBE2Z;UBR3;PEX5;ZNRF3;RNF152;NUP210;RACK1;UBE2A;ANAPC11;NUP88;USP9X;CDC73;CUL5;PCNP;RNF220;PEX13;ATG3;RNF41;CBL;PIAS3;NUP214;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;NEDD8;UBE2L3;EIPR1;SMURF1;TOPORS;MDM2;FBXO9;DCUN1D5;URM1;KLHL20;NUP153;RNF111;HLTF;RANBP2;TRIM27;NUP35;VCPIP1;RNF38;DTX2;PIAS1;SUMO2;EYA1
prerank,muscle cell development (GO:0055001),0.43747804993971773,1.1291495746904596,0.3200962695547533,1.0,1.0,3/30,3.12%,IGF1;BIN1;NEB
prerank,cellular response to UV-A (GO:0071492),-0.4352493248152175,-1.1290447403152353,0.29357798165137616,0.8196234947122212,1.0,4/11,25.35%,MME;MMP2;MMP1;CERS1
prerank,sulfur compound catabolic process (GO:0044273),0.4272711619508254,1.1288517626670798,0.3009367681498829,1.0,1.0,9/38,16.81%,ADO;MLYCD;GLB1;DCN;ACAT1;OMD;ARSB;LUM;DPEP1
prerank,positive regulation of metabolic process (GO:0009893),0.3787546701907228,1.1287122467738733,0.2690721649484536,1.0,1.0,22/103,17.62%,FASN;HDAC3;STAT6;LPIN1;AGPAT1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;PIGA;CPT2;LEPR;EHMT1;ESRRG;CAMK1D;ACADL;KDM6B;OMA1
prerank,extracellular matrix assembly (GO:0085029),0.46226924976220185,1.1284573608088317,0.3128205128205128,1.0,1.0,7/23,14.59%,MFAP4;TNXB;NTNG2;FBLN5;LAMB1;TGFB1;PXDN
prerank,regulation of macrophage differentiation (GO:0045649),0.49761125963573183,1.1282124643385663,0.3230563002680965,1.0,1.0,2/15,5.06%,IL34;PRKCA
prerank,regulation of microtubule nucleation (GO:0010968),0.5459472177964396,1.1280267684852647,0.3431952662721893,1.0,1.0,5/10,22.50%,ARHGEF7;GIT1;EML2;MECP2;PAK1
prerank,spliceosomal complex assembly (GO:0000245),0.4142680846515189,1.1278896187118157,0.29828571428571427,1.0,1.0,17/46,18.52%,SMN1;SRSF5;SF3B1;CELF2;CELF1;SRSF9;SF3A1;PRPF6;SRSF1;SETX;LUC7L2;KHDC4;CELF5;YTHDC1;LUC7L3;GCFC2;SRPK1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.37529988954215804,-1.1272026372166062,0.2950191570881226,0.8225287379361684,1.0,4/18,8.15%,MTUS1;IL6R;SLIT2;SLC8B1
prerank,regulation of protein catabolic process (GO:0042176),0.38033528340968875,1.1271076065530479,0.28482328482328484,1.0,1.0,29/99,19.51%,WNT5A;SIRT2;AZIN2;ASB5;MAD2L1;FZR1;SNF8;TNFAIP3;DDB1;BARD1;HGS;MDM4;VCP;CYP51A1;WDR91;EGLN2;RNF41;FAF1;CHEK2;NKD1;NSF;TIPARP;SMURF1;MDM2;SORL1;ZDHHC2;BANP;FMN2;STX5
prerank,nuclear export (GO:0051168),0.386148159699349,1.1270210951371247,0.28854166666666664,1.0,1.0,30/80,23.13%,U2AF1;SRSF2;RAE1;SRSF5;ATXN1;SRSF3;THOC3;SRSF9;RANBP3L;SRSF1;NUP188;MALT1;STRADB;NEMF;THOC7;TGFB1;THOC1;NUP214;XPO6;SMURF1;SRRM1;XPO7;NUP153;RANBP3;TPR;SARNP;U2AF2;NUP155;SRSF6;CSE1L
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.4782348216131135,1.1269472245206666,0.30962343096234307,1.0,1.0,5/17,11.30%,GPLD1;NRP1;MIA3;EFNB2;ROBO1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3143022681793692,-1.1267601904461673,0.22085889570552147,0.8210229318667251,1.0,13/36,15.17%,CRADD;DAB2IP;RB1;CSNK2A1;TPD52L1;CYLD;TRIM39;FAS;TMBIM6;MADD;SGMS1;DAPK2;TRAF7
prerank,exit from mitosis (GO:0010458),0.5223995666955279,1.126671967610898,0.3222543352601156,1.0,1.0,2/12,2.85%,SIRT7;UBE2S
prerank,Golgi to endosome transport (GO:0006895),-0.3858647192184355,-1.1265185535109996,0.27037037037037037,0.8189909131364983,1.0,7/16,16.65%,GBF1;VPS13A;RAB14;VPS13C;EPS15;KIF16B;SORT1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.42438294558442746,1.1263679653190124,0.2992874109263658,1.0,1.0,5/35,6.98%,LIG1;PARP1;NTHL1;MPG;LIG3
prerank,central nervous system development (GO:0007417),0.3689869961999497,1.1262755978799928,0.20682730923694778,1.0,1.0,51/250,18.16%,AATK;AMIGO1;AFF2;ATP6AP2;SH3GL3;POU6F1;EPHA7;MYRF;SYNJ2;GBA2;NKX2-2;GLIS2;GRIN1;NIPBL;CHD8;CDK5;DHX30;ATXN1;HAPLN4;ADAM22;ZIC3;CXCR4;GRIN2A;SPOCK1;SOX9;PTCH1;ZFHX2;CDK5RAP3;SOX11;JARID2;POU6F2;COX7B;SETD1A;ROBO2;ADGRG1;SMARCA1;NDRG4;SOX6;RPS6KA3;ZIC2;CNTNAP2;CIC;AHI1;HSPG2;ADGRA2;TPPP;ALDH3A2;TUBGCP2;MEIS2;PKD2;ATN1
prerank,negative regulation of histone methylation (GO:0031061),0.5319529238729791,1.1261123550169594,0.32575757575757575,1.0,1.0,3/10,10.02%,AASS;PHF1;JARID2
prerank,lamellipodium organization (GO:0097581),0.44001570583197,1.1258424636437112,0.32885085574572126,1.0,1.0,13/29,20.98%,RAC1;WHAMM;ARHGEF7;ARHGEF4;DMTN;RHOD;CYFIP1;ABLIM2;WASF1;ARHGEF6;CCDC88A;CARMIL1;ITGB1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3757477568144075,1.1252902855942077,0.2756476683937824,1.0,1.0,23/108,17.54%,SFRP2;ATP6AP2;SFRP1;GSKIP;TSC2;FGFR2;DCDC2;CTNND2;TNFAIP3;SULF1;WLS;APP;RACK1;KREMEN1;CBFB;CDC73;DISC1;LRP1;TCF7L1;CTNNBIP1;NKD1;PTK7;GNAQ
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4793744990781171,1.1246443100130123,0.32669322709163345,1.0,1.0,9/18,18.37%,KMT2B;SETD7;EHMT2;SETD1A;SUV39H1;EHMT1;KMT2D;ASH1L;KMT2A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.42315413421827175,1.124619785836817,0.3025516403402187,1.0,1.0,6/33,16.76%,SFRP2;EPHA8;JAM3;FOXC2;SERPINE1;ITGB1BP1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3366020575450674,-1.1245991806411053,0.30456852791878175,0.8220282744455132,1.0,7/27,17.46%,NIBAN2;DACH1;SMG5;TOM1L1;RGCC;PDGFA;SMG6
prerank,negative regulation of mRNA processing (GO:0050686),0.49425951217848857,1.1232849119863078,0.34106412005457026,1.0,1.0,4/15,7.02%,PCBP4;SRSF12;BARD1;SRSF9
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.47185301527121337,1.1231294868375212,0.32614213197969544,1.0,1.0,3/21,5.55%,HKDC1;G6PC3;TKT
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4304960079007703,1.1231037673216053,0.3242924528301887,1.0,1.0,6/33,11.01%,IGF1;SIRT2;ZFP36L1;PIK3R1;PIK3CB;PIK3R2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5007447143395992,1.1230855409790221,0.337431693989071,1.0,1.0,9/14,26.21%,PKIB;HTT;PKIG;PRKAR1A;ATP2B4;PKIA;PRKAR1B;PRKAR2A;RAPGEF2
prerank,positive regulation of axonogenesis (GO:0050772),0.41593589465646796,1.1227737172319796,0.3229527104959631,1.0,1.0,12/43,17.96%,AMIGO1;CDKL5;PLXNA2;DBN1;PLXNA1;DBNL;ROBO2;ROBO1;MAPT;PLXNB3;RUFY3;SLITRK1
prerank,protein localization to synapse (GO:0035418),0.5155447195770545,1.1225649173787835,0.33236994219653176,1.0,1.0,1/12,0.27%,MPP4
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4835049566442485,1.122263625768989,0.3458333333333333,1.0,1.0,4/16,10.88%,LRRC8A;RANBP3L;RIPOR2;IGFBP3
prerank,negative regulation of secretion by cell (GO:1903531),0.42593156811953226,1.1218421215847467,0.31176470588235294,1.0,1.0,12/38,21.57%,ANXA1;ERP29;VAMP3;SLC30A1;IL1RAPL1;CYP51A1;RHBDF1;VAMP8;TRH;APOE;SYT4;SYT11
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5210199689846298,1.1216028491303995,0.3514705882352941,1.0,1.0,5/11,16.38%,AUP1;POMT2;VCP;UGGT2;DERL1
prerank,transepithelial transport (GO:0070633),0.49028983769024137,1.121399546266489,0.3403361344537815,1.0,1.0,2/15,1.59%,BEST1;GPLD1
prerank,negative regulation of protein metabolic process (GO:0051248),0.4094966092418325,1.12123825635195,0.31477272727272726,1.0,1.0,13/48,19.03%,PFDN4;SIRT2;AZIN2;NFKB1;MAD2L1;VBP1;PFDN1;MDM4;CYP51A1;APOE;PFDN2;BANP;FMN2
prerank,acute-phase response (GO:0006953),-0.43052356116528906,-1.120367664363926,0.3375,0.832179824002614,1.0,3/12,7.50%,IL6R;LBP;PLSCR1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4168865017277306,1.1203241010163207,0.33449074074074076,1.0,1.0,8/38,9.77%,NDUFAB1;NDUFA7;NDUFAF1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,response to amino acid (GO:0043200),0.42558509004414125,1.1202665189254222,0.330518697225573,1.0,1.0,8/31,14.46%,CPEB1;GRIN1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,endocardial cushion development (GO:0003197),-0.3579901695940244,-1.1201653967118828,0.2697095435684647,0.829872157548076,1.0,10/21,24.63%,TGFB2;NOS3;ACVR1;ENG;BMPR1A;BMP4;HEYL;CRELD1;TBX2;BMP2
prerank,cellular component disassembly (GO:0022411),0.40164934464136826,1.1199303408491639,0.2903225806451613,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,extracellular matrix disassembly (GO:0022617),0.40128914705446983,1.1197266089386988,0.3003337041156841,1.0,1.0,15/53,21.42%,MMP12;LCP1;MMP11;LAMC1;ADAMTS5;CAPN2;CAPNS1;BMP1;SCUBE1;FLOT1;CTSK;TIMP2;MMP14;MMP16;GSN
prerank,positive regulation of translational initiation (GO:0045948),0.475506648707742,1.1191308930665869,0.3347050754458162,1.0,1.0,7/18,24.24%,DDX3X;CDC123;YTHDF3;YTHDF1;YTHDF2;KHDRBS1;UHMK1
prerank,lipid homeostasis (GO:0055088),0.39284199082218924,1.1189437537306575,0.3093126385809313,1.0,1.0,11/57,12.73%,USF1;NR1D2;XBP1;DDX3X;ABCA2;TLCD1;RCN3;RBP1;IRS2;ZBTB20;TLCD3B
prerank,endothelial cell development (GO:0001885),-0.33928011251972556,-1.1188485906904775,0.26548672566371684,0.8311121115770151,1.0,8/25,16.70%,RDX;RAPGEF3;PECAM1;COL18A1;EZR;MYADM;MET;MSN
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3970715810244914,1.118601054480508,0.32146829810901,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3970715810244914,1.118601054480508,0.32146829810901,1.0,1.0,11/56,9.77%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.41760057881759416,1.118437569504253,0.3321995464852608,1.0,1.0,16/39,24.93%,AJAP1;CASK;FBLN1;DMTN;SPOCK1;SEMA3E;TBCD;JAG1;ITGB1BP1;GCNT2;NF2;MAP4K4;HOXA7;AP1AR;CORO1C;CX3CL1
prerank,ribosome assembly (GO:0042255),-0.2868916709997351,-1.1183106872731599,0.23255813953488372,0.8298867046515639,1.0,35/47,38.76%,EIF2A;RPL11;RPL5;RPL6;RPL24;RPS19;EFL1;RPL3;RPLP0;RPL10;RPS28;RPS5;TRAF7;RPS27;MRPL20;NOP53;RPF2;RPS14;ERAL1;RRP7A;RPS27L;NOP2;MRPS7;BOP1;EIF6;DHX37;MRPS11;MRPL22;RRS1;RSL24D1;NLE1;PPAN;MPV17L2;C1QBP;PWP2
prerank,negative regulation of mitochondrion organization (GO:0010823),0.42844874084493023,1.117889338331009,0.316747572815534,1.0,1.0,5/33,6.02%,IGF1;PPIF;FZD9;FLCN;PRELID1
prerank,cellular response to interferon-beta (GO:0035458),-0.39688319294679913,-1.1177562454110255,0.30689655172413793,0.8288875431052164,1.0,7/14,23.52%,UBE2K;STAT1;AIM2;IRGM;NDUFA13;IFITM2;UBE2G2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.536092220149011,1.1176402955409466,0.34850863422291994,1.0,1.0,1/10,0.85%,FCGR2B
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5170938580905942,1.1174131657634288,0.36,1.0,1.0,7/12,25.14%,ARHGEF7;CLIP3;EML2;TBCD;TUBB4A;MAP2;STMN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.47685687432083024,1.1168703280687198,0.34868421052631576,1.0,1.0,10/18,26.36%,UNC13A;GRIK5;GRIA2;NAPA;UNC13B;CDH8;GRIK2;GRIK1;GRID1;SLC17A6
prerank,regulation of cellular component biogenesis (GO:0044087),-0.2985543507095486,-1.116802135805527,0.21481481481481482,0.829092743064255,1.0,16/39,18.82%,LATS1;DAB2IP;RDX;TJP1;EZR;TIE1;PARP10;ROCK1;VPS11;HCFC1;SPTY2D1;IRGM;MSN;PINK1;ANKRA2;GFAP
prerank,regulation of lymphocyte proliferation (GO:0050670),0.4855824645780846,1.1166234568488596,0.3452544704264099,1.0,1.0,3/16,13.55%,FGF10;SOX11;PTPN22
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3458185679766165,-1.1166204019503037,0.27450980392156865,0.8268053288060753,1.0,8/24,7.89%,SMAD4;PARVA;NRP2;TGFB2;ACVR1;ENG;BMPR1A;TGFBR2
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5071836340595995,1.1163301233373653,0.34107402031930334,1.0,1.0,2/12,9.21%,GALT;EXTL2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5334368269527922,1.1153201658596974,0.36063218390804597,1.0,1.0,4/10,13.57%,CPEB1;DHX36;NUDT21;CDC73
prerank,fatty acid oxidation (GO:0019395),0.3951775499522272,1.1151207995274037,0.3292273236282195,1.0,1.0,15/57,16.83%,ADH5;ACAD10;HADHB;ACAT1;HSD17B4;CROT;CPT2;EHHADH;MECR;PEX13;ECHDC1;ABCD2;ACADL;ACADVL;ALDH3A2
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.43378622976378767,-1.115016761669622,0.34177215189873417,0.8288039318310778,1.0,5/11,13.21%,PICALM;GPM6B;GOPC;ACTN2;NEDD4L
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.36329928157067604,1.1147396374497567,0.2830957230142566,1.0,1.0,33/151,22.16%,FSHR;PLA2G5;DDT;FGFR2;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;SLC30A10;ARRB1;PRXL2C;ABCA7;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;ICAM1;SPRY2;APOE;CCL25;PRKD2;PRKCZ;GCNT2;PTK2B;NTRK2;FGF2;MTURN;HMGB1;ERBB4
prerank,kidney development (GO:0001822),0.39270230606793116,1.1146223629639316,0.3033226152197213,1.0,1.0,16/65,19.15%,STRA6;GREB1L;PCSK5;NIPBL;FGF10;SULF1;WNT4;GDNF;ROBO2;PYGO2;PYGO1;CTSH;AGTR1;OSR1;TGFBR1;SOX4
prerank,histone monoubiquitination (GO:0010390),0.4439051443987905,1.114198595528638,0.3421717171717172,1.0,1.0,8/24,15.71%,PCGF1;DDB1;RNF40;RNF168;CUL4B;KDM2B;CDC73;UBE2E1
prerank,regulation of protein targeting to membrane (GO:0090313),0.435149603986135,1.1139714470192281,0.34620174346201743,1.0,1.0,7/28,18.05%,FIS1;MTCL1;MIEF2;DMTN;ANK3;ITGB1BP1;CEMIP
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3595513264783899,1.1139665883620062,0.2,1.0,1.0,78/348,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;IGF1;EPHB2;BMP6;NTF3;EIF2AK3;IL33;WARS1;PICK1;ERP29;CD63;DDX3X;SNF8;C1QTNF1;FGF10;FUBP1;SCRIB;OLFM1;VAMP3;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;ARRB1;SOX9;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ANK3;MAZ;ROBO1;IFNGR1;MAGI2;PARK7;TADA3;AGO3;LAMTOR5;TLR3;PTPN22;FAM98A;ROCK2;TGFB1;EPHX2;F3;MED23;CTSH;AHI1;NSF;ANXA2;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;TGFBR1;PDCD5;MPHOSPH8;PRKAA1;FOXD1;RPS3;MITF;KLF4;GABPA
prerank,protein deacetylation (GO:0006476),0.4183261283888348,1.1138635697536823,0.32687927107061504,1.0,1.0,9/41,12.36%,HDAC3;SIRT2;SIRT7;MIER2;HDAC5;HDAC4;RCOR1;MTA2;HDAC1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4368937195444972,1.1137386092386374,0.3237139272271016,1.0,1.0,6/26,12.71%,ALG6;ST3GAL2;TKT;ALG8;RRM2B;B4GALT5
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4454107251004508,-1.11368486175992,0.3394495412844037,0.8302074133285822,1.0,4/10,26.68%,SLC8B1;HOMER3;EFHB;CD84
prerank,positive regulation of telomere maintenance (GO:0032206),0.43165823857729435,1.1136172615504212,0.31630170316301703,1.0,1.0,11/31,19.61%,GNL3;PKIB;HNRNPD;DHX36;ATRX;HNRNPA2B1;MRE11;RAD50;TNKS;NABP2;PPP1R10
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.39887117175081327,1.112952944011799,0.3188888888888889,1.0,1.0,13/56,13.22%,CDC23;UBE2E2;ANXA1;TFDP1;DDX3X;CDC16;FGF10;BRD4;FBXO5;CDC25A;VPS4B;ANAPC11;ANAPC4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.46958596457321516,1.1126765767997586,0.34893048128342247,1.0,1.0,3/18,7.08%,NHP2;CCT8;CCT6A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4047041745695931,1.1126459031037546,0.3449074074074074,1.0,1.0,12/46,15.42%,NRDC;FLCN;PLCL2;ACOT11;STK11;ADAMTS5;DDIT3;LGR4;RBPJ;DOCK7;NOVA1;FOXC2
prerank,cellular response to nutrient levels (GO:0031669),0.39464051081039864,1.112623116722017,0.31978021978021975,1.0,1.0,11/62,9.95%,LPL;SFRP1;XBP1;WIPI1;FLCN;ATG14;RRAGA;GAS2L1;EHMT2;RIPOR1;FADS1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.42913854385835387,1.112616764309357,0.3164400494437577,1.0,1.0,11/33,19.43%,PPIF;ANXA1;TNFAIP3;ABL1;SIRPA;OSER1;PARK7;SETX;IMPACT;PLEKHA1;RPS3
prerank,regulation of RNA metabolic process (GO:0051252),0.3960836330713247,1.1122022622574999,0.29418221734357847,1.0,1.0,26/59,23.96%,AFF2;FAM50A;PCBP4;IGF2BP2;CELF1;FUS;RC3H2;HNRNPH3;HNRNPL;TRA2B;NOVA1;HNRNPLL;GRSF1;AHNAK;CLK4;OAS2;SON;PCBP2;BRDT;YTHDF2;MITF;PTBP1;CLK2;RRP1B;SNRNP70;CLK1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5278043955496938,1.1116087074065732,0.37592867756315007,1.0,1.0,4/10,12.69%,FZD9;DCN;BCL2;RACK1
prerank,regulation of neutrophil migration (GO:1902622),0.5310308408598535,1.11159090113104,0.3523076923076923,1.0,1.0,2/10,8.46%,RAC1;JAM3
prerank,quinone biosynthetic process (GO:1901663),0.49339290555237914,1.111446091740066,0.34553440702781846,1.0,1.0,2/14,2.22%,COQ6;COQ8B
prerank,Golgi localization (GO:0051645),0.5190937783939042,1.1112987675892991,0.35823170731707316,1.0,1.0,7/11,22.64%,ARHGAP21;RIPOR1;HOOK3;STK25;UVRAG;TBCCD1;COPG1
prerank,regulation of small molecule metabolic process (GO:0062012),0.43139102011780084,1.1112912250807108,0.3453416149068323,1.0,1.0,9/28,18.70%,PDK1;MLYCD;RORA;EPHX2;ACADL;ACADVL;APOE;NCOR2;TTC39B
prerank,acylglycerol homeostasis (GO:0055090),0.4528162292473735,1.1110562958300765,0.32993630573248406,1.0,1.0,2/20,3.85%,LPL;RORA
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3567205879721605,1.1108619434468667,0.212,1.0,1.0,53/348,12.69%,FGF20;SFRP2;FGF9;S1PR2;HDAC3;VTN;TMEM119;IGF1;IL34;DVL2;ARAF;BMP6;NTF3;HSP90AA1;RAC1;CALM3;MAPRE3;ERP29;DDX3X;NRP1;FGF10;CDK9;FLCN;DDR2;KNDC1;FBH1;ABL1;ATG14;RAP2A;WDFY2;ARRB1;LRP8;SOX9;MMD;SDCBP;XRCC6;TEC;EGF;CLIP3;MRNIP;MUSK;JTB;ENPP2;APP;LEPR;ALS2;CNOT9;BMP5;IQGAP1;PARK7;DOCK7;AXIN2;RACK1
prerank,regulation of phosphate metabolic process (GO:0019220),0.48387662511666457,1.1107197629217374,0.3623789764868603,1.0,1.0,4/16,10.29%,SIRT2;BARD1;CD24;PGAM1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5162750901922696,1.1106904642536912,0.3516642547033285,1.0,1.0,5/11,20.27%,SFRP1;CSNK1D;NKD1;MLLT3;DAB2
prerank,camera-type eye development (GO:0043010),0.44632433338829286,1.1106440645338784,0.3354192740926158,1.0,1.0,3/25,5.55%,FBN2;STRA6;TENM3
prerank,DNA biosynthetic process (GO:0071897),0.47942771038305787,1.1105665688338937,0.3383356070941337,1.0,1.0,3/16,13.72%,CDKN2D;POLH;POLD3
prerank,negative regulation of inflammatory response (GO:0050728),0.36240663312919563,1.110551031400571,0.2674066599394551,1.0,1.0,14/182,7.34%,FSHR;SMPDL3B;PTGER4;IGF1;SELENOS;ADCY7;ADM;VIPR2;PTHLH;RORA;TNFAIP3;GNG2;CD200R1;SIRPA
prerank,blood vessel endothelial cell migration (GO:0043534),0.4489903333906874,1.1098703201626934,0.33722438391699094,1.0,1.0,6/22,13.57%,GPLD1;NRP1;MIA3;EFNB2;ROBO1;EMP2
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3460558403756465,-1.1097310740018982,0.2895927601809955,0.8401248887048807,1.0,13/23,38.01%,AXL;TLR4;LGALS9;RARA;VSIR;INHBA;ZC3H12A;CD274;HAVCR2;LAPTM5;NR1H4;INHA;C1QBP
prerank,purine ribonucleotide transport (GO:0015868),0.4823586049648071,1.1096482234725888,0.35041551246537395,1.0,1.0,3/16,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,negative regulation of cell population proliferation (GO:0008285),0.3590495317589152,1.1091473522560187,0.1961961961961962,1.0,1.0,96/351,22.50%,SFRP2;CDKN2D;WNT5A;SFRP1;SIRT2;GPLD1;TSC2;CHERP;CGRRF1;GNRH1;PTHLH;WARS1;TFDP1;FBLN1;TNFAIP3;NELL1;RBBP4;FLCN;CLMN;IRF1;DLG3;ALDH1A2;CELF1;EEF1E1;MAGED1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;MFN2;IFI35;SOX9;WDR6;MDM4;SOX11;WNK2;KDM2B;APP;IGFBP3;ADGRG1;IGFBP7;BMP5;NACC2;E2F3;MAGI2;SPEG;NDRG4;SOD2;NPM1;AXIN2;ROR2;TNS2;CDC73;FGFBP1;RNF41;TGFB1;SLURP1;P3H2;SMAD6;DIS3L2;MN1;NUPR1;CTNNBIP1;CTBP1;ADAMTS1;ITGB1BP1;ABI1;CAMK2N1;PKD2;ATRAID;CDK10;PDCD5;ATP8A2;SOX4;DLC1;KLF4;MTSS1;LYN;FTH1;CTCF;PTK2B;TGFBR3;S100A11;NF2;APPL2;DLG5;TES;IGFBP5;PRKRA;PEX2;B2M;ERBB4;ITGA1;PAK1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.22875434613558737,-1.1090787737748313,0.0,0.8392953398593423,1.0,28/149,10.78%,SLCO3A1;PRKCH;UBE2N;MTPN;IKBKB;CAV1;AR;FER;IRAK2;STAT3;RIPK1;RPS6KA5;PRKD1;IRAK1;NOD1;TRIM25;ERC1;NFKBIA;PSMA6;TLR4;EIF2AK2;LGALS9;EP300;DDRGK1;MAP3K13;UBB;AIM2;IKBKG
prerank,regulation of neuroblast proliferation (GO:1902692),0.47944298171375693,1.1089956622224217,0.3728813559322034,1.0,1.0,3/15,13.59%,SMARCD3;FZD3;DISC1
prerank,regulation of cytoplasmic translation (GO:2000765),0.48868673440150334,1.1088795158520268,0.34545454545454546,1.0,1.0,3/14,9.11%,CPEB1;CNBP;DHX36
prerank,tRNA modification (GO:0006400),0.3911683866495843,1.1088532740623835,0.3232432432432432,1.0,1.0,17/62,19.95%,TRMT61B;DTWD1;ANKRD16;TRDMT1;TYW1;PUS10;AARS1;WDR6;PUS7;TRMT1;METTL2B;METTL2A;TPRKB;QTRT2;URM1;ALKBH1;WDR4
prerank,positive regulation of vasoconstriction (GO:0045907),-0.41070040709494315,-1.1088488674344699,0.32673267326732675,0.8371660780484228,1.0,2/13,4.65%,CAV1;ADRA1B
prerank,glycerolipid catabolic process (GO:0046503),-0.3638501216528728,-1.1088044016184913,0.31020408163265306,0.834477386709273,1.0,6/19,8.66%,GPCPD1;PNPLA6;MGLL;ABHD6;ABHD2;GDPD1
prerank,primary alcohol metabolic process (GO:0034308),0.444283384014097,1.1086907917165547,0.34886649874055414,1.0,1.0,4/25,7.45%,IGF1;RDH10;RDH11;GDPD3
prerank,purine-containing compound catabolic process (GO:0072523),-0.43832797357048,-1.1083424335966,0.3107142857142857,0.8330668275314765,1.0,8/13,34.73%,NT5C2;NT5E;ITPA;GPX1;PNP;GDA;NT5C;NT5C1A
prerank,protein insertion into ER membrane (GO:0045048),0.4101641442838888,1.108070314763329,0.33951332560834296,1.0,1.0,13/37,22.53%,EMC1;EMC8;MMGT1;GET1;APP;SERP1;EMC7;SEC61G;ALDH3A2;STX5;EMC4;TRAM2;EMC2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.35475967976164813,1.107625685265319,0.159,1.0,1.0,90/509,15.32%,FSHR;FGF20;MYORG;FGF9;HDAC3;HEXIM1;WNT5A;MST1R;IGF1;SLC35B2;TCIM;BAX;PDPK1;MAP3K14;NTF3;ATP2C1;HSP90AA1;EDAR;RAC1;FGFR2;THEM4;FIS1;FGFR1;DDX3X;EDA2R;FGF10;TIRAP;CARD16;SLC38A9;FLCN;TCF7L2;TMEM106A;DCN;BRD4;PIK3R1;DHX58;GAB1;EPHA8;NOS1AP;RRAGA;DHX33;CHD5;CC2D1A;ADGRV1;TIFA;GPR37;IFI35;TRIM62;SOX9;DDIT3;GPRC5B;FRS2;DHX36;EGF;CDK5RAP3;SOX11;WLS;KL;MALT1;IRS2;PIK3CB;APP;USP15;PIK3R2;BCL2;TFG;MAZ;RPS15;PDGFRA;NFAT5;RTKN2;IQGAP1;PARK7;PLEKHG5;RACK1;LAMTOR5;AKAP13;NRG2;ROR2;TLR3;LPAR1;NRG1;ROCK2;TGFB1;BCLAF1;DNM1L;CBL;F3;PPP5C;NUPR1
prerank,wound healing (GO:0042060),0.38540047590379123,1.1070057553668402,0.32420591456736036,1.0,1.0,20/62,23.69%,MMP12;WNT5A;EPB41L4B;IGF1;FGF10;MIA3;TPM1;PPL;PDGFRA;NRG1;ARL8B;TGFBR1;SMPD1;FGF2;SYT11;MYH9;SMAD3;PAK1;SYT7;PRCP
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.43997362461135947,1.1069486244269287,0.34300126103404793,1.0,1.0,9/26,24.17%,HSP90AA1;TMEM106A;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,intracellular protein transmembrane transport (GO:0065002),0.4077075608670997,1.1066307148137087,0.3223981900452489,1.0,1.0,14/42,22.01%,DNLZ;RTN2;SEC61A2;TOMM20;PEX1;PEX5;PEX7;SEC61G;HSPD1;SEC62;TIMM44;SEC63;TIMM23;PEX2
prerank,regulation of response to biotic stimulus (GO:0002831),0.42214127264960016,1.1060581579813522,0.34958382877526756,1.0,1.0,6/28,8.14%,FCGR2B;TIRAP;IRF1;DHX58;XIAP;LRP8
prerank,positive regulation of protein ubiquitination (GO:0031398),0.38047710082296415,1.1060412436110203,0.32409381663113007,1.0,1.0,18/80,17.91%,ARRDC4;HDAC3;UBQLN1;PHF23;STUB1;TBC1D7;MYCBP2;PEF1;XIAP;CDK5RAP3;MALT1;FANCM;UBE2D1;NDFIP2;DERL1;UBE2L3;TOPORS;DCUN1D5
prerank,potassium ion transmembrane transport (GO:0071805),0.3644837981729381,1.1058364782585153,0.29591836734693877,1.0,1.0,20/135,15.90%,KCNG2;KCNAB2;KCNA4;KCNC1;NALCN;ATP1A3;KCNK2;KCNT2;ATP1A2;KCNC2;KCNJ10;SLC24A4;KCNQ4;KCND3;KCNH5;SLC1A3;KCNA1;KCNQ2;SLC9A7;SLC9A6
prerank,AMP metabolic process (GO:0046033),0.49904976421058383,1.1055962647322783,0.3613569321533923,1.0,1.0,3/13,13.69%,ADSL;AK4;AK3
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.50226756319611,1.1055385364543815,0.38589211618257263,1.0,1.0,1/14,0.80%,WNT5A
prerank,cobalamin metabolic process (GO:0009235),-0.3656731724187734,-1.105232658631774,0.2943396226415094,0.8404210028152713,1.0,3/17,5.76%,MMAA;ABCC1;TCN2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3423593370536485,-1.1052041711037581,0.30303030303030304,0.8377229704424355,1.0,13/25,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ADPGK;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,protein import into peroxisome matrix (GO:0016558),0.5050694039474344,1.1048284012302154,0.3385939741750359,1.0,1.0,6/12,22.01%,PEX1;PEX5;PEX7;PEX13;PEX5L;PEX2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4518762871495336,1.1045272812967235,0.3542483660130719,1.0,1.0,6/22,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,regulation of execution phase of apoptosis (GO:1900117),0.5156762795192462,1.1045025203165224,0.3703170028818444,1.0,1.0,2/11,4.16%,SIRT2;FZD3
prerank,positive regulation of MAPK cascade (GO:0043410),0.35492709856365995,1.1043632195465234,0.2605210420841683,1.0,1.0,38/245,14.28%,FSHR;PLA2G5;MST1R;IGF1;IL34;DDT;EDN3;FGFR2;FGFR1;TAOK1;GLIPR2;NRP1;FGF10;TIRAP;PRKCA;TMEM106A;EPHA8;EZH2;SLC30A10;DHX33;CD24;GPR37;ARRB1;PRXL2C;EGF;ABCA7;APP;KLHDC10;PDGFRA;ROBO1;IQGAP1;NDRG4;HTR2C;ROR2;PTPN22;LPAR1;ROCK2;TGFB1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.513890961674812,1.1041688684804465,0.3528550512445095,1.0,1.0,3/11,11.33%,SIRT7;SMARCB1;IPPK
prerank,sulfur amino acid catabolic process (GO:0000098),0.5346723067396421,1.1040777115995588,0.38724035608308605,1.0,1.0,1/10,1.95%,ADO
prerank,lymphocyte proliferation (GO:0046651),-0.35382463212940996,-1.10393368329922,0.27235772357723576,0.8391138283693208,1.0,6/22,16.70%,MEF2C;ELF4;PTPRC;LMBR1L;HELLS;MSN
prerank,protein lipidation (GO:0006497),0.3900483702138387,1.1038973962244116,0.3160220994475138,1.0,1.0,11/59,11.53%,PIGG;GPLD1;PGAP4;WIPI1;DPM2;PIGM;PIGU;ZDHHC3;GLUL;PIGA;PORCN
prerank,cation transport (GO:0006812),0.36065951588455475,1.1038660551669761,0.28024193548387094,1.0,1.0,18/167,9.53%,KCNG2;SLC4A4;CLN3;KCNA4;KCNC1;ASIC1;GRIN1;SLC22A18;SLC22A4;SCN7A;TMEM63C;CATSPER3;KCNMA1;ATP1A2;SLC39A1;KCNJ10;TRPM3;KCNQ4
prerank,response to fatty acid (GO:0070542),0.4760961722891891,1.1035983929432258,0.36662106703146374,1.0,1.0,4/17,15.21%,LPL;PID1;SOX9;PPP5C
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.41747845398814126,1.103461553577309,0.3584905660377358,1.0,1.0,13/35,16.93%,WBP2;DDX17;PMEPA1;CALCOCO1;RBFOX2;ZMIZ1;TADA3;NCOA4;EGLN2;DDX5;TRIP4;DAXX;UBR5
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5228134205494683,1.1034608890372049,0.36336779911373707,1.0,1.0,4/10,14.79%,ERRFI1;MVP;ENPP1;IMPACT
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.43639294433786074,1.1034359467106976,0.34814814814814815,1.0,1.0,6/26,13.22%,CDC23;LCMT1;CDC16;FBXO5;ANAPC11;ANAPC4
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.4865590013574187,1.1028366216347898,0.3697478991596639,1.0,1.0,5/15,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4060933332374591,-1.1026844466047592,0.3356164383561644,0.8402439281452013,1.0,1/12,3.02%,IL1R1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.36949727209590105,1.1025125000758127,0.2923076923076923,1.0,1.0,18/124,10.55%,SFRP2;WNT5A;SFRP1;DVL2;PSMD4;RAC1;FZD9;FZD3;TCF7L2;PSMB10;DVL1;GNG2;PSMD11;WNT4;AP2S1;PSME2;PSMC5;DAAM1
prerank,regulation of actin nucleation (GO:0051125),0.5057119662552725,1.1024406124916302,0.37926136363636365,1.0,1.0,2/12,3.83%,WHAMM;PICK1
prerank,regulation of chromosome segregation (GO:0051983),-0.3821660663025819,-1.1019512000053893,0.32167832167832167,0.8395826858199923,1.0,3/16,1.76%,SMC5;PUM1;CSNK2A1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5070955159110944,1.101678959244299,0.34285714285714286,1.0,1.0,8/12,24.83%,SIRT7;TGFB1;NUP214;TPR;IFI27;KHDRBS1;UHMK1;PTPN14
prerank,negative regulation of protein catabolic process (GO:0042177),0.41071984040088,1.1010712081144614,0.33488372093023255,1.0,1.0,12/40,19.24%,SIRT2;AZIN2;MAD2L1;NELL1;MDM4;CDK5RAP3;PTPN3;CYP51A1;ATRAID;BANP;FMN2;TIMP2
prerank,axonal transport of mitochondrion (GO:0019896),0.5154967146287964,1.1010523150987401,0.35639097744360904,1.0,1.0,5/11,22.76%,NEFL;MAPT;TRAK1;ACTR10;OPA1
prerank,positive regulation of hormone secretion (GO:0046887),0.4658094616068324,1.1010323205198098,0.3620218579234973,1.0,1.0,5/17,21.27%,EDN3;SOX11;VAMP8;SNX4;VAMP7
prerank,regulation of mRNA processing (GO:0050684),0.42181427069604954,1.1009010019021497,0.3546441495778046,1.0,1.0,14/32,19.61%,ZFP36L1;SLTM;RBM39;SRSF3;HNRNPK;TIA1;KHDRBS2;PTCD2;SAFB2;YTHDC1;AHCYL1;SON;SRPK1;CDK11B
prerank,mitochondrion disassembly (GO:0061726),0.42028328277852256,1.1006337748400732,0.350920245398773,1.0,1.0,13/34,19.40%,FIS1;FUNDC2;USP30;WIPI1;FBXO7;FUNDC1;SQSTM1;ATG2A;ATG3;MAP1LC3B;ATG9A;CTSK;AMBRA1
prerank,regulation of osteoblast differentiation (GO:0045667),0.3765092239843848,1.10052932110027,0.33014861995753714,1.0,1.0,15/82,9.79%,TMEM119;IGF1;FBN2;BMP6;FGFR2;NELL1;DDR2;FBXO5;SUCO;RANBP3L;WNT4;SOX9;PTCH1;SOX11;TWIST1
prerank,regulation of endopeptidase activity (GO:0052548),0.39096871001753714,1.1003049280196746,0.34577387486278816,1.0,1.0,14/59,20.46%,VTN;NRDC;SERPING1;PRELID1;SPOCK1;PSME2;HDAC1;SERPINA2;SPOCK2;SERPINE1;SERPIND1;BIRC3;TIMP2;SERPINF1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.40969577290852366,-1.1001452145089492,0.36101083032490977,0.8426568457431103,1.0,3/13,7.57%,STAT3;STAT1;TYK2
prerank,response to organic cyclic compound (GO:0014070),0.3967376796755284,1.0999329762105547,0.33962264150943394,1.0,1.0,4/52,4.31%,CDKN2D;SFRP1;ANXA1;ABCA2
prerank,extracellular transport (GO:0006858),-0.4141366858707593,-1.0995976727879049,0.3419354838709677,0.8417180176752926,1.0,11/12,52.41%,TSG101;SPEF2;ARRDC1;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3526959790281062,1.0995620592302326,0.136,1.0,1.0,179/834,18.39%,SFRP2;APLN;METTL23;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;GNL3;SIRT7;DDX17;EAPP;CRTC1;NFKB1;SMARCD3;BMP6;PARP1;ZEB2;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MED12;MED14;GLIS2;SMAD9;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;NFKB2;DDX3X;LPIN1;CCNC;OGT;CHD8;POU2F1;RFX5;CDK13;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;AKAP8L;ARNT;SMARCB1;TEAD1;HDAC5;MOSPD1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;SLC30A9;SOX9;SMARCD1;GCN1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;PER1;ECD;DHX36;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;BRD8;APP;TAF6;JUP;RBPJ;GLIS1;RFX4;PIK3R2;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;ABHD14B;CDC73;FOXJ3;ATRX;AUTS2;TGFB1;MED21;RGMA;BCLAF1;KMT2D;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;TNIP1;GABPB1;GABPB2;MEIS2;TBL1XR1;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,regulation of histone methylation (GO:0031060),0.4956173932132621,1.099524104379787,0.3709677419354839,1.0,1.0,5/13,19.34%,AASS;NNMT;JARID2;NSD1;TET1
prerank,transition metal ion transport (GO:0000041),0.4139539652440752,1.0993816011545332,0.34292565947242204,1.0,1.0,11/35,21.53%,CP;ATP2C1;SLC30A10;SLC30A9;SLC30A1;COX17;HEPH;SLC30A5;SLC11A2;FTH1;ATOX1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4623369450736682,1.0992986810708338,0.3758300132802125,1.0,1.0,5/21,14.18%,MAFG;ZFP36L1;ERRFI1;CBFB;ROCK2
prerank,regulation of muscle contraction (GO:0006937),0.4346064655545677,1.0992742087186584,0.35668789808917195,1.0,1.0,6/26,13.93%,TNNC1;TNNI1;ATP1A2;TPM1;CHRM2;KCNA1
prerank,spliceosomal snRNP assembly (GO:0000387),0.41085492589156825,1.0986576949127282,0.3422897196261682,1.0,1.0,10/38,14.40%,COIL;SMN1;GEMIN2;PRPF8;SRSF12;PRPF6;PRMT5;SART3;USP4;AAR2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.40831492814356424,1.0985731824227805,0.3595238095238095,1.0,1.0,8/37,13.73%,DNASE1L2;EXOSC7;ENTPD7;DFFB;PABPC4;HNRNPD;MTREX;SND1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4412503729922874,1.098414321298853,0.3363286264441592,1.0,1.0,4/24,8.54%,EPHA7;BAX;CDK5;DDIT3
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40072625618728025,-1.0983680864932588,0.3411371237458194,0.8427184961712433,1.0,9/13,21.77%,CAV1;RNF185;USP13;HERPUD1;RNFT1;SGTA;BAG6;NFE2L2;UBQLN2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4160103474769086,1.0978201756901538,0.3704994192799071,1.0,1.0,16/39,22.71%,GPD1L;YWHAH;SCN2B;WNK2;ANK3;SLMAP;FGF12;CAMK2D;PTPN3;FGF14;NETO1;OSR1;SCN1B;HECW2;FGF13;WNK3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3552024141920018,1.097688564993496,0.23823823823823823,1.0,1.0,92/341,18.15%,UBQLN1;MVB12A;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;RNF8;UBE2S;SPSB1;STUB1;SYVN1;XBP1;MAD2L1;UCHL1;CDC16;RNF215;FZR1;FBXL14;TNFAIP3;OTUD7A;FBXO7;COP1;SQSTM1;ANAPC2;PSMB10;DDB1;FBXO45;RFFL;TGFB1I1;FBXW5;PSMD11;RMND5A;ARRB1;UBA1;DDIT3;TRIM9;UBE3B;RNF40;RNF168;KLHL15;RNF11;VCP;CHFR;PSME2;PSMC5;UBR3;RC3H2;ZNRF3;NTAN1;VPS4B;RNF19A;KCTD2;UBE2A;ANAPC11;USP9X;WDR91;ANAPC4;RNF19B;PCNP;ZFAND2A;CDC26;ANKIB1;RNF122;RNF217;FEM1C;CBL;PSMD1;TRPC4AP;FAF1;UBE2E1;UBE2D1;ZSWIM8;NDFIP2;CLOCK;ARIH2;NEDD8;UBE2L3;PSMD6;FBXO22;SMURF1;TOPORS;USP33;TTC3;MDM2;PPP1R11;PCBP2;TBL1XR1;KLHL20;ANAPC10;RNF111
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4715842249841648,1.0975539857124845,0.37349397590361444,1.0,1.0,8/17,21.42%,SCAP;ABCA2;ERLIN2;KPNB1;MBTPS1;APOE;PRKAA1;ABCG1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.514147844256655,1.0974891248400473,0.35878962536023057,1.0,1.0,1/11,0.80%,WNT5A
prerank,protein localization to cilium (GO:0061512),0.42467229686724967,1.097109458443672,0.3333333333333333,1.0,1.0,12/32,20.65%,TUB;TCTN1;SNX10;IFT20;CSNK1D;ATP6V1D;TULP3;TTC21B;INVS;WDR35;RABEP1;EHD1
prerank,arachidonic acid metabolic process (GO:0019369),-0.31067952606979476,-1.0969882743712718,0.26119402985074625,0.844338283094884,1.0,19/35,40.01%,PNPLA8;PTGES3;MGLL;DAGLB;CYP1B1;PTGES;GPX1;TBXAS1;HPGDS;EPHX1;CYP2U1;PLA2G4A;CYP2A6;ALOX12;PLA2G4C;FAAH;PTGES2;CYP2S1;CBR1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.5129017035538912,1.0967533873610156,0.35988200589970504,1.0,1.0,5/11,14.63%,P4HA1;P4HA2;CRTAP;EGLN2;P3H2
prerank,regulation of axon extension (GO:0030516),0.41388655226324256,1.0962198881823835,0.3396901072705602,1.0,1.0,10/37,17.44%,CDKL5;DIP2B;OLFM1;ABL1;DBN1;DBNL;MAPT;SEMA3A;APOE;RUFY3
prerank,phospholipid homeostasis (GO:0055091),0.5178589676370249,1.0961472244423625,0.3784570596797671,1.0,1.0,2/11,7.81%,TLCD1;RCN3
prerank,response to ATP (GO:0033198),-0.3560673694273325,-1.0959456531114704,0.29508196721311475,0.8446365911641386,1.0,6/18,19.02%,HSP90B1;TRPC3;ABCC9;P2RX7;P2RY12;DGKQ
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5054022883919143,1.0958671132492181,0.38011695906432746,1.0,1.0,2/12,4.89%,LPL;TIRAP
prerank,Golgi to plasma membrane transport (GO:0006893),-0.2815426217216637,-1.095853384473632,0.2777777777777778,0.8421894690870263,1.0,14/47,13.27%,EXOC6B;EXOC1;PREPL;VPS35L;GOPC;KIF13A;BLZF1;OSBPL5;ARL3;VAMP2;GCC2;BBS2;GOLGA7;EXOC2
prerank,membrane organization (GO:0061024),0.3554601082153539,1.0954841339383343,0.2720883534136546,1.0,1.0,50/227,15.44%,WNT5A;CLN3;REEP4;DVL2;A4GALT;DNM1;AZIN2;BIN1;UBXN2A;ATP2C1;DMPK;SYNJ2;ACTR2;PICK1;ARPC1A;SAR1A;GAPVD1;TLCD1;NAPG;VAMP3;PLEKHA3;HGS;MFN2;MOSPD3;ARRB1;ATP10B;FNBP1;EGF;CHMP3;TOR1B;DNAJC6;AP2S1;TMEM43;ANK3;VPS33B;LEMD3;VPS4B;VTI1B;SYT1;SERP1;IGF2R;PRKCI;CHRM2;MTCH1;USO1;DNM1L;STX11;CBL;SPTBN1;VAPB
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3695221604816116,-1.0949810439757597,0.3210332103321033,0.8421321119954669,1.0,4/17,10.39%,CD46;STAT3;TLR4;MSH2
prerank,regulation of lymphocyte activation (GO:0051249),-0.4140954056038547,-1.0947860202711173,0.3434343434343434,0.8400402816309541,1.0,9/12,54.29%,PAG1;KAT2A;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,acute inflammatory response (GO:0002526),-0.3366896709317003,-1.0944303983881092,0.30638297872340425,0.8384523766339006,1.0,4/23,7.72%,IL6R;LBP;PLSCR1;ANO6
prerank,response to UV-B (GO:0010224),0.49180871092194545,1.0941803039658768,0.34277620396600567,1.0,1.0,2/12,6.84%,MFAP4;STK11
prerank,mRNA stabilization (GO:0048255),0.40486972940297106,1.0938663113810125,0.3488372093023256,1.0,1.0,14/40,21.35%,PAIP1;TIRAP;FUS;PABPC1;GDNF;HNRNPA0;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;MAPKAPK2;YBX1;ANGEL2
prerank,erythrocyte differentiation (GO:0030218),-0.2843262245546677,-1.093316606652389,0.30434782608695654,0.8391565705115631,1.0,16/44,24.13%,HIPK2;MFHAS1;MED1;KMT2E;KIT;UBA5;RPS19;UFL1;ABCB10;IKZF1;SH2B3;VEGFA;CASP3;RPS14;NCKAP1L;INHBA
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4150949775727176,1.0926743108904293,0.3489208633093525,1.0,1.0,8/34,15.77%,WNT5A;SIRT2;RORA;FLCN;ENPP1;RUNX1T1;TGFB1;TRIO
prerank,negative regulation of cell communication (GO:0010648),0.4536166833117711,1.0926045817658758,0.35224274406332456,1.0,1.0,4/21,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,protein import into peroxisome membrane (GO:0045046),0.4508126503187746,1.0921171299977888,0.36964980544747084,1.0,1.0,9/22,16.83%,FIS1;PXMP4;PEX5;PXMP2;GDAP1;PEX13;ABCD2;RAB8B;ALDH3A2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4272200562855359,1.091953989528884,0.3656716417910448,1.0,1.0,7/27,16.50%,PCYT2;LPIN1;CEPT1;LPIN3;LPIN2;CHKB;SLC27A1
prerank,protein ADP-ribosylation (GO:0006471),0.4314603707166192,1.0918567086486661,0.3639661426844015,1.0,1.0,10/28,18.69%,SIRT2;PARP1;PARP2;PARP14;PARP16;SIRT5;ZC3HAV1;TNKS;TIPARP;PARP11
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.38517364119865105,-1.0918028892164047,0.3458646616541353,0.8411976296214526,1.0,10/15,35.25%,SAMHD1;STAT2;METTL3;CNOT7;USP18;NLRC5;ISG15;PTPN2;CACTIN;MUL1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3025285476185767,-1.0913897881374637,0.2606060606060606,0.8398933800492725,1.0,16/33,24.89%,LATS1;AR;KDM4C;UBA5;CALR;RNF6;EP300;DDRGK1;AXIN1;ESR1;UFL1;KCTD6;KLK2;UFM1;NCOA2;HDAC6
prerank,positive regulation of rRNA processing (GO:2000234),0.5230418989016692,1.0913038214409132,0.39908256880733944,1.0,1.0,3/10,8.48%,SIRT7;DIMT1;BUD23
prerank,regulation of acute inflammatory response (GO:0002673),-0.35945742275810094,-1.0912128679593027,0.2839506172839506,0.8377832069987527,1.0,15/18,64.08%,PTGES;OSMR;IL6ST;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.37727711635734273,1.0910562520320126,0.34908700322234154,1.0,1.0,24/78,20.88%,UBQLN1;SIRT2;STUB1;FZR1;ZYG11B;COP1;BBS7;DVL1;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5202422872584487,1.0907656602342366,0.3819548872180451,1.0,1.0,3/10,7.29%,MIA3;CD200R1;RIPOR2
prerank,synapse assembly (GO:0007416),0.3804734168313998,1.0905734554516622,0.3595263724434876,1.0,1.0,12/67,14.38%,WNT5A;LRRC4;OBSL1;CDK5;DVL1;DSCAM;DBNL;GABRB3;NLGN3;SPOCK2;FARP1;NLGN2
prerank,calcium import into the mitochondrion (GO:0036444),-0.4348767241802729,-1.0904037167320264,0.3169230769230769,0.8376176888640943,1.0,6/10,20.10%,MICU1;MCU;MCUR1;MCUB;MAIP1;SMDT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3950656622899872,1.090282796893203,0.36990950226244346,1.0,1.0,10/44,16.81%,CDKN2D;DDX3X;CARD16;USP47;XIAP;DNAJB6;LAMTOR5;RPS6KA3;RPS6KA1;DPEP1
prerank,COPII vesicle coating (GO:0048208),0.38560315413237445,1.0900961266694942,0.3645374449339207,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,vesicle coating (GO:0006901),0.38560315413237445,1.0900961266694942,0.3645374449339207,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.38560315413237445,1.0900961266694942,0.3645374449339207,1.0,1.0,24/61,20.41%,TRAPPC10;KLHL12;SEC16A;SEC16B;PEF1;PPP6R3;TBC1D20;SCFD1;TFG;GRIA1;TMED10;CSNK1D;TRAPPC6B;USO1;CTSZ;MCFD2;F8;NSF;GORASP1;ANKRD28;SEC24D;CNIH1;STX5;PDCD6
prerank,regulation of striated muscle contraction (GO:0006942),0.4252092947288774,1.089101529335638,0.37125,1.0,1.0,8/27,21.79%,TNNI1;CALM3;ATP1A2;GRK2;ASB3;CALM1;SMAD7;CALM2
prerank,phospholipid translocation (GO:0045332),-0.3144494571028478,-1.08864919370427,0.32124352331606215,0.8404060621720228,1.0,10/28,13.16%,ATP8B1;ATP10A;ABCC1;PLSCR2;ABCA4;TMEM30A;PLSCR1;ANO6;ATP11C;ATP11A
prerank,sodium ion transport (GO:0006814),0.37277680613375824,1.0886000422765456,0.3498942917547569,1.0,1.0,15/85,16.34%,SLC4A4;ASIC1;NALCN;SLC6A11;SCN7A;CATSPER3;ATP1A2;SLC24A4;SCN2B;SCN1A;SLC6A8;SLC6A4;SLC6A15;SLC6A12;SLC6A13
prerank,adenine nucleotide transport (GO:0051503),0.4684328155160483,1.0884293211911273,0.3736111111111111,1.0,1.0,3/17,5.16%,SLC35B2;LRRC8A;SLC25A24
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4188945674048263,1.0880986050396952,0.3759036144578313,1.0,1.0,11/31,19.89%,ANK1;SCRIB;MTCL1;DLG3;RAP2A;PRKCI;DLG2;PARD3B;ERBIN;SYNJ2BP;MYO9A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.41247012738329747,-1.0878903539702747,0.34513274336283184,0.8400360060217609,1.0,4/12,13.24%,MTPN;CFL2;PLEK;PIK3CA
prerank,negative regulation of cell adhesion (GO:0007162),0.37634093786596046,1.0876364151820952,0.35027027027027025,1.0,1.0,18/72,16.76%,DACT2;EPHB2;PLXNA2;FBLN1;ADAM22;DMTN;MIA3;RIPOR2;DSCAM;PLXNA1;SPOCK1;JAM3;TGFB1;TBCD;JAG1;SERPINE1;PLXNB3;ITGB1BP1
prerank,negative regulation of gene expression (GO:0010629),0.3498598678964167,1.0874813046442238,0.27927927927927926,1.0,1.0,74/302,19.88%,SFRP2;APLN;ILF3;FCGR2B;LSM6;SFRP1;PTGER4;IGF1;PAIP2;ANXA7;NFKB1;AEBP2;EIF2AK3;CREBZF;ERP29;DDX3X;CNOT10;IGF2BP2;RBBP4;FLCN;OLFM1;PHF1;CELF1;EZH2;SFMBT2;WNT4;ATP2B1;EPRS1;RBMS3;DHX36;SOX11;LGR4;NUDT12;PUS7;JARID2;RBL2;APP;ROBO1;EIF4E2;CNOT9;YY1;MALSU1;PARK7;HDAC1;AGO3;RACK1;NPTN;PARP14;DAPK1;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2;MRPL13;DIS3L2;SHQ1;NDFIP2;NUDT16L1;FMR1;TIPARP;APOE;TLE5;PPP1R11;MECP2;MPHOSPH8;NCOR2;PRKAA1;TRIM27;SAMD4B;YTHDF2;RPS3;KLF4;DNMT3A
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.4939934651145294,1.0873457899025065,0.39603960396039606,1.0,1.0,4/13,15.32%,FCGR2B;EIF2AK3;USP19;NUPR1
prerank,regulated exocytosis (GO:0045055),0.35655020021728956,1.0871551501683108,0.3144016227180527,1.0,1.0,42/173,21.80%,MAGED2;SYT3;CLEC3B;SYT10;IGF1;APOOL;CHID1;CD63;SERPING1;CDK5;SPARC;DNAJC5;CPLX1;EGF;RAB10;APLP2;SNAP25;APP;BRPF3;VTI1B;SYT1;TMED10;NHLRC2;GTPBP2;PSAP;TGFB1;RAB31;STEAP2;F8;SERPINE1;PHACTR2;CALM1;QSOX1;PROS1;SYT4;LYN;VAMP7;SYT11;SYT12;CD9;SDF4;MYH9
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5182892462836783,1.0870876475736728,0.3714733542319749,1.0,1.0,2/10,5.61%,GALNT16;GALNT4
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4113518601889798,-1.087082404315121,0.3536977491961415,0.8400074989703468,1.0,7/12,30.59%,INPP5K;REST;JUN;PSMC3;HMGA2;TARDBP;TFAP4
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.5196205739307875,1.0869041408780737,0.37770897832817335,1.0,1.0,3/10,7.40%,CCT8;CCT6A;WRAP53
prerank,tetrapyrrole metabolic process (GO:0033013),-0.35525515894578796,-1.08670984605928,0.3114754098360656,0.8385046610088386,1.0,3/18,5.76%,MMAA;ABCC1;TCN2
prerank,positive regulation of protein catabolic process (GO:0045732),0.3746221421273916,1.0865465067568034,0.3495762711864407,1.0,1.0,22/84,17.95%,WNT5A;GPLD1;ASB5;HSP90AA1;NRDC;FZR1;SNF8;TNFAIP3;DDB1;BARD1;PACSIN3;VCP;SNX33;EGLN2;RNF41;FAF1;NKD1;NSF;TIPARP;APOE;SMURF1;SORL1
prerank,proteolysis (GO:0006508),0.3557061928744099,1.0864952070029923,0.2922922922922923,1.0,1.0,45/252,17.65%,MMP12;MMP17;XPNPEP3;CPXM1;CLN3;ATG4A;CUL7;ADAMTS7;CASP7;PCSK5;OGT;SDE2;CAPN10;PCSK2;ANPEP;THOP1;UFSP2;CAPN5;HTRA3;LAP3;ADGRV1;HM13;LRP8;PTCH1;CAPN2;PLAT;MBTPS1;ADAM33;MALT1;AFG3L2;CPXM2;CNDP2;SUFU;METAP2;ADAMTS3;CTSZ;F3;CASP2;CTSH;NEDD8;PSMD6;PARL;CAPN15;MDM2;BMP1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3090879383823052,-1.0863403575234325,0.27472527472527475,0.8369875285443367,1.0,17/30,23.49%,WAC;FHIT;RPL11;HSP90AB1;UCHL5;STYX;CAMLG;DDRGK1;TRIM39;MAP1A;GIPC1;SGTA;CCAR2;BAG6;UBXN1;NOP53;SVIP
prerank,anterograde axonal transport (GO:0008089),0.4063753256462532,1.085672869067312,0.36556603773584906,1.0,1.0,11/37,17.51%,NEFL;KIF3A;AP3B1;KIF5C;BLOC1S2;MAPK8IP3;TRAK1;DLG2;RAB21;KIF5B;AP3B2
prerank,actin crosslink formation (GO:0051764),0.4895938939059491,1.085568049841943,0.3945480631276901,1.0,1.0,3/12,9.08%,LCP1;GAS2L1;BAIAP2
prerank,regulation of innate immune response (GO:0045088),0.39088839252768737,1.0851828960323644,0.36017897091722595,1.0,1.0,10/57,8.14%,FCGR2B;POLR3D;TNFAIP3;TIRAP;IRF1;DHX58;TRAFD1;XIAP;IFI35;LRP8
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.47096098825541555,1.0851509721722516,0.3748271092669433,1.0,1.0,3/15,3.87%,WHAMM;ACTR2;ARPC1A
prerank,N-terminal protein amino acid modification (GO:0031365),0.4737716920032856,1.085026885737157,0.38028169014084506,1.0,1.0,4/14,13.29%,METAP1;NTMT1;METAP1D;METAP2
prerank,positive regulation of DNA binding (GO:0043388),0.4143818862768544,1.0846294981610385,0.37200956937799046,1.0,1.0,7/31,14.28%,IGF1;SIRT2;EGF;TWIST1;PARK7;CEBPG;TGFB1
prerank,methylguanosine-cap decapping (GO:0110156),-0.42716867297390326,-1.084543498609277,0.3633720930232558,0.8399969761410159,1.0,4/10,10.39%,DCP1A;PATL1;DCPS;LSM1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.39550742963803565,1.084453188347643,0.3572241183162685,1.0,1.0,16/46,20.88%,DUSP26;EPHB2;FBLN1;FLCN;CNKSR3;SIRPA;WNK2;LMO3;ITGB1BP1;SPRY2;TNIP1;CAMK2N1;SYNJ2BP;RANBP9;LYN;PTPRR
prerank,piRNA metabolic process (GO:0034587),-0.34993405765245245,-1.0840190306159148,0.2987551867219917,0.8390173464943597,1.0,19/19,65.05%,TDRKH;MYBL1;TEX15;EXD1;PIWIL2;TDRD9;DDX4;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,focal adhesion assembly (GO:0048041),-0.3383932738790231,-1.083936946637145,0.32558139534883723,0.8367042251117851,1.0,7/21,5.56%,SORBS1;FERMT2;PTPRK;TAOK2;CTTN;TESK2;ACTN1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3488952831110439,-1.0836900728360184,0.30985915492957744,0.834894788900332,1.0,10/20,20.48%,MICU1;LETM1;SLC8B1;MCU;MCUR1;SPG7;MCUB;MAIP1;SMDT1;STOML2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.37411833603647526,1.083672493975965,0.36245954692556637,1.0,1.0,9/68,13.29%,WNT5A;LPL;IL33;XBP1;TIRAP;TMEM106A;TWIST1;APP;TLR3
prerank,dopamine metabolic process (GO:0042417),-0.3610501072642843,-1.083483424475641,0.3582089552238806,0.8329669044709989,1.0,6/18,27.02%,MAOA;TGFB2;MAOB;GCH1;PRKN;DRD2
prerank,regulation of cell motility (GO:2000145),0.362126078631592,1.0834034237657695,0.3425076452599388,1.0,1.0,21/121,14.28%,FGF20;FGF9;RAC1;PLXNA2;MGAT3;FBLN1;MINK1;FGF10;ABL1;PLXNA1;EGF;TWIST1;PRAG1;SRCIN1;ENPP2;CFAP20;SPOCK2;NRG2;NRG1;ROCK2;TGFB1
prerank,positive regulation of response to external stimulus (GO:0032103),0.3655858712304122,1.0830376300651745,0.32719836400818,1.0,1.0,22/128,17.26%,WNT5A;LPL;PTGER4;DDT;BMP6;IL33;USF1;POLR3D;PRKCA;DHX58;IFI35;GPRC5B;GPR4;LY96;APP;USP15;CD47;TLR3;TGFB1;AGTR1;SERPINE1;TNIP1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.48305933273615764,1.0829893724123643,0.3877551020408163,1.0,1.0,4/15,9.82%,SELENOS;SYVN1;AUP1;VCP
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5013656774160636,1.0829859273255895,0.4072463768115942,1.0,1.0,6/12,18.69%,PARP1;PARP2;PARP16;TNKS;TIPARP;PARP11
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.40900071231183166,1.0829114667265478,0.36374133949191684,1.0,1.0,7/37,16.06%,AMIGO1;TENM3;IGSF21;IL1RAPL1;ALCAM;TENM4;ICAM1
prerank,regulation of transmembrane transport (GO:0034762),-0.3132638096914634,-1.0827771107395536,0.30718954248366015,0.8325335944909764,1.0,6/31,13.21%,CTTNBP2NL;SLC2A1;ACTB;KCNJ2;OCLN;NEDD4L
prerank,regulation of phagocytosis (GO:0050764),0.3901720725968264,1.0826293949880887,0.3585746102449889,1.0,1.0,9/53,16.52%,PLA2G5;FCGR2B;TUB;SIRPA;ABCA7;CD47;RACK1;IL15RA;CAMK1D
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3607367378743024,-1.0823060150346184,0.3176470588235294,0.8313769296425143,1.0,5/18,11.28%,OGA;SAMHD1;DERA;FUCA1;BPGM
prerank,cardiac muscle tissue development (GO:0048738),-0.27951918383892094,-1.0822362564818069,0.25,0.8291185425568596,1.0,13/50,17.80%,SMAD4;GJA1;MAML1;RBP4;SMAD1;BMPR1A;CACNA1G;SGCD;BMP7;TBX18;BMP4;NDUFV2;NOTCH2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.433316800286749,1.0821877672541345,0.38246505717916135,1.0,1.0,6/26,21.06%,IGF1;CHERP;STIMATE;CAMTA1;PTBP1;ATP2B4
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3703978312479957,1.0820715105021663,0.36972972972972973,1.0,1.0,14/70,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.27861200380235146,-1.0819180140246831,0.2711864406779661,0.8275855277189864,1.0,11/47,7.14%,DAB2IP;EGFR;IGF1R;ARL6IP5;TAOK2;EPHB1;PHLPP1;TGFB2;NBR1;EIF2AK2;LGALS9
prerank,regulation of synapse assembly (GO:0051963),0.3942700857394053,1.0815983711287833,0.375,1.0,1.0,15/46,19.44%,EPHB2;GPC6;MUSK;CLSTN2;APP;ROBO2;IL1RAPL1;NLGN3;GPC4;NLGN2;SLIT1;IL1RAP;SLITRK1;CLSTN3;SETD5
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.293290270097377,-1.0814829779867714,0.3333333333333333,0.8264803038110402,1.0,16/34,24.25%,FLT1;DAB2IP;ERN1;NUS1;PRKD1;SEMA6A;MT1G;RAMP2;KDR;PIK3CA;VEGFC;HSPB1;VEGFA;NR4A1;VEGFB;PGF
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.38837992669150595,1.0814310750397331,0.3572241183162685,1.0,1.0,14/52,18.18%,CLN3;EPHB2;PDPK1;ATP2C1;PIK3R1;SQSTM1;CLIP3;RACK1;PRKCI;LRP1;DPP10;SPTBN1;KIF5B;ZDHHC2
prerank,presynaptic endocytosis (GO:0140238),0.43064268625192736,1.0813308797034107,0.3547589616810878,1.0,1.0,5/24,14.38%,SYNJ2;CDK5;NLGN3;SYT1;NLGN2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.4187336486077396,1.0810854476963443,0.3671970624235006,1.0,1.0,4/28,9.15%,DLK1;TCIM;ARRB1;EGF
prerank,ubiquinone biosynthetic process (GO:0006744),0.47115593042841464,1.0810658641018756,0.38472622478386165,1.0,1.0,2/15,2.22%,COQ6;COQ8B
prerank,regulation of nervous system process (GO:0031644),0.4458028838159845,1.0807907846580824,0.3727891156462585,1.0,1.0,6/18,16.30%,NPTXR;TMEM108;APP;HTR2C;ROCK2;DLGAP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.41541092685524694,1.0800763963281645,0.3763702801461632,1.0,1.0,9/30,16.70%,DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;PARK7;ICAM1;SERPINE1;FAIM2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5088104238569187,1.0799913469711957,0.38980509745127434,1.0,1.0,4/10,24.79%,ZBTB7B;CBFB;HMGB1;RUNX1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.35795590248346315,1.0796616622873152,0.34662576687116564,1.0,1.0,41/148,18.99%,HEXIM1;PDPK1;PIP4K2B;CSNK2A2;TAF9B;USP7;BRPF1;TAF4;CDK5;RBBP4;TBP;NUAK1;BARD1;STK11;CHD5;RFFL;EHMT2;MDM4;PRMT5;CDK5RAP3;USP2;TAF6;RPS15;MTA2;BRIP1;HDAC1;RMI1;ATR;EHMT1;PIP4K2A;MRE11;CHEK2;RAD50;TP53RK;DAXX;MDM2;TOP3A;RBBP8;PRKAA1;BANP;PRKAG2
prerank,nervous system development (GO:0007399),0.34817666294914446,1.0796003303995352,0.271,1.0,1.0,77/429,16.97%,PCDHA2;DPYSL4;PCDHA11;SH3GL3;MST1R;APLP1;EPHB2;CHERP;NTF3;ZEB2;GBA2;GLIS2;NINJ2;FZD9;SDHA;OBSL1;RAPGEFL1;NELL1;CDK5;IGF2BP2;DHX30;ATXN1;ALDH1A2;HAPLN4;ADAM22;EFNB3;DVL1;ZIC3;CXCR4;KALRN;TEAD1;DSCAM;ADGRV1;SPOCK1;DPF2;VLDLR;HDAC4;DBNL;NDUFS2;JARID2;GDNF;POU6F2;COX7B;GFRA2;RBFOX2;ROBO2;ROBO1;FGF12;MOBP;SOX6;NLGN3;SPOCK2;RPS6KA3;FEZ2;CYP51A1;RBM45;FARP1;CHRM2;LSAMP;LPAR1;NRG1;ZIC2;TGFB1;NLGN2;PPP2R5D;NR2C2;ACVR1B;KCNQ2;TRAK1;AHI1;BTBD3;ITM2B;ADGRA2;TMOD2;JAG1;ALDH3A2;MSI1
prerank,phagosome maturation (GO:0090382),0.40998149667937234,1.0792908484266255,0.37777777777777777,1.0,1.0,13/35,22.41%,ATP6V0A2;RAB34;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;RAB31;ATP6V1B2;RAB7A;ATP6V1C1;PIKFYVE;RAB43
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4796899437755906,1.07921418122395,0.3871866295264624,1.0,1.0,2/14,7.27%,IGF1;CD200R1
prerank,regulation of biosynthetic process (GO:0009889),0.5093436666047982,1.0791824128455094,0.38115330520393814,1.0,1.0,1/11,4.06%,SLC25A33
prerank,zinc ion transport (GO:0006829),0.44116522719628176,1.0788958123031758,0.3719115734720416,1.0,1.0,7/21,16.89%,SLC30A10;SLC39A1;SLC30A9;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,negative regulation of MAPK cascade (GO:0043409),0.36743523984006426,1.078865322039905,0.3670886075949367,1.0,1.0,29/87,21.58%,DUSP26;FOXM1;EPHB2;UCHL1;FBLN1;FLCN;CNKSR3;SIRPA;CDK5RAP3;ABCA7;WNK2;PIK3CB;PIK3R2;DAG1;LMO3;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;SORL1;SYNJ2BP;SMPD1;RANBP9;PRDM15;LYN;IGBP1;PTPRR;FOXO1
prerank,positive regulation of immune system process (GO:0002684),0.4598857136053077,1.0787589606501484,0.39633286318758815,1.0,1.0,3/16,10.63%,ANXA1;MIA3;PIK3CB
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.49924499674351597,1.0785570447712494,0.3880368098159509,1.0,1.0,3/10,13.55%,TIRAP;IFI35;PTPN22
prerank,positive regulation of RNA metabolic process (GO:0051254),0.39729227374600706,1.078550448120306,0.3579676674364896,1.0,1.0,14/45,18.33%,SIRT7;NFKB1;DIMT1;PIK3R1;BUD23;LIN28B;SETX;TGFB1;MAP2K2;HNRNPLL;DDX5;GRSF1;ZC3H18;RBM22
prerank,vasculogenesis (GO:0001570),0.4176726062254984,1.078470617264822,0.38571428571428573,1.0,1.0,3/32,2.42%,TNNI3;CUL7;ADM
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4418126923587308,1.078421943298645,0.39225806451612905,1.0,1.0,1/22,0.80%,WNT5A
prerank,dendritic spine organization (GO:0097061),0.4190062090436991,1.0783995282600127,0.3883248730964467,1.0,1.0,4/26,6.37%,EPHB2;PICK1;CTNND2;PAK3
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.42762308626135287,1.0783138495737392,0.3961783439490446,1.0,1.0,3/25,5.76%,BAX;PPIF;FAM162A
prerank,alcohol catabolic process (GO:0046164),0.508950646978852,1.0781446602982838,0.3896296296296296,1.0,1.0,1/10,1.82%,CYP27A1
prerank,positive regulation of DNA recombination (GO:0045911),0.42329016385707086,1.0778415184741024,0.39185750636132316,1.0,1.0,8/27,19.65%,PARP1;ACTR2;FUS;WRAP53;MRNIP;MMS19;HMCES;KMT5B
prerank,DNA duplex unwinding (GO:0032508),-0.2761376278223567,-1.0777628899625433,0.2972972972972973,0.8356193341201751,1.0,20/50,20.55%,RAD23B;GTF2H1;ASCC3;RBX1;CHD1L;CUL4A;RPA1;NBN;PURA;UBB;GTF2H5;GTF2H2;XPC;ERCC3;BLM;SUPV3L1;RECQL;RTEL1;MCM6;WRN
prerank,positive regulation of response to wounding (GO:1903036),0.43305965755795806,1.0771510036917793,0.38571428571428573,1.0,1.0,3/24,6.44%,VTN;ANXA1;DMTN
prerank,establishment of apical/basal cell polarity (GO:0035089),0.47843125069742953,1.0770094406777235,0.40540540540540543,1.0,1.0,3/14,8.79%,SCRIB;RAP2A;PATJ
prerank,copper ion transport (GO:0006825),0.49761675709450504,1.0769189543030038,0.38244047619047616,1.0,1.0,6/11,23.36%,COX17;STEAP2;SLC11A2;ATOX1;STEAP3;SLC31A1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.36748453084650345,1.076915099424038,0.37029063509149623,1.0,1.0,14/71,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,import into nucleus (GO:0051170),0.37035128089888236,1.076834876040706,0.3703308431163287,1.0,1.0,22/73,21.10%,MMP12;TSC2;SMN1;NXT2;NXT1;GEMIN2;HTATIP2;KPNB1;NUP188;BACH2;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;PPP1R10;GEMIN5;HEATR3;TPR;APPL2
prerank,regulation of lipid storage (GO:0010883),0.4433893505662252,1.0765083465656295,0.3812080536912752,1.0,1.0,2/22,2.19%,LPL;NFKB1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3365214766270634,-1.076350614140372,0.358974358974359,0.837347556878325,1.0,8/22,30.79%,PDE3B;ALK;BSCL2;CCDC3;ADRA2A;CEACAM1;GPER1;ASXL3
prerank,regulation of cilium movement (GO:0003352),-0.43978697635943237,-1.0762762927499165,0.375,0.8350758381403899,1.0,9/10,52.12%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3541407498440258,1.076067299854937,0.3350151362260343,1.0,1.0,59/173,22.69%,SPTBN5;WHAMM;KDELR3;TRAPPC8;SAR1A;ANK1;TEX261;KLHL12;SEC16A;MIA3;TRIP11;SEC16B;PEF1;ERGIC2;DCTN6;LMAN2L;COPZ2;NRBP2;TBC1D20;SCFD1;CAPZA1;PGAP1;DCTN4;TFG;ANK3;DYNC1LI1;GRIA1;VTI1B;TMED10;COG3;NRBP1;TRAPPC6B;USO1;CTSZ;MCFD2;SPTBN1;VAPB;STX17;VTI1A;F8;COG8;NSF;GORASP1;SEC24D;CNIH1;STX5;PROS1;DYNLL1;ZW10;BCAP29;PDCD6;SPTBN4;ATL3;VAMP7;NAPA;ARFGAP3;ACTR10;COPG1;GOSR1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.49702401424972475,1.0759706639879543,0.38330975954738333,1.0,1.0,4/12,9.91%,CLCN2;ABCA2;KPNB1;MBTPS1
prerank,RNA splicing (GO:0008380),0.3631393446644837,1.075959160367944,0.36770833333333336,1.0,1.0,27/95,19.19%,KHSRP;LSM6;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;DHX15;USB1;SF3B2;SF3B1;DHX8;FUS;MPHOSPH10;PRPF6;PPP1R9B;DHX16;HNRNPH3;TRA2B;NOVA1;RP9;SRRM1;LUC7L3;SRPK1;NONO;BCAS2;RSRC1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3878638457499188,1.0759035120299683,0.3661814109742441,1.0,1.0,15/55,19.84%,LYVE1;GLB1;GPC6;DCN;GPC1;HGSNAT;GPC4;OMD;TGFB1;ARSB;LUM;HSPG2;CEMIP;GPC5;GUSB
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.44182694558077534,1.0756528584022529,0.3812664907651715,1.0,1.0,6/22,13.93%,NTF3;TMEM108;RAPGEF1;MAGI2;WASF1;MAPT
prerank,maturation of SSU-rRNA (GO:0030490),-0.2946585780004772,-1.0752794419344376,0.3270440251572327,0.8357387593409692,1.0,17/34,24.91%,RIOK3;RIOK2;NOL11;RPS19;RPS16;RPS28;HEATR1;NAT10;NOB1;NGDN;NOP14;WDR3;RRP36;SNU13;RPS14;TSR2;UTP3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.2987094923405029,-1.0751577158860817,0.33689839572192515,0.8336044494194014,1.0,16/29,30.79%,CAV1;RIPK1;PML;THBS1;TNFSF10;CYLD;PPP2R1B;LTBR;TNFSF12;BCL10;INHBA;RET;BID;PAK2;DEDD2;GPER1
prerank,steroid biosynthetic process (GO:0006694),0.37990727025954746,1.075079766941089,0.36899563318777295,1.0,1.0,10/56,13.04%,CYP27A1;CYP7B1;LSS;INSIG1;HSD17B4;MSMO1;SC5D;PRLR;AMACR;CYP51A1
prerank,protein localization to chromatin (GO:0071168),-0.361065919719404,-1.0747854326752782,0.3453815261044177,0.8321733769284141,1.0,3/18,1.11%,WAPL;TASOR;PPHLN1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.36086350574891846,1.074492967740957,0.35654885654885654,1.0,1.0,18/107,14.06%,TNNI3;SLC24A5;CHERP;ATP2C1;EDN3;DMPK;CXCL12;ATP2A2;SLC30A10;SLC30A9;ATP2B1;SLC24A4;SLC30A1;PTH1R;SLC39A6;HTR2C;NPTN;SLC41A1
prerank,regulation of vasculature development (GO:1901342),0.42949797704808007,1.0744907943986965,0.3844221105527638,1.0,1.0,3/26,3.79%,SFRP1;WARS1;HTATIP2
prerank,blood vessel morphogenesis (GO:0048514),0.38919283652369974,1.0744883501342408,0.3788888888888889,1.0,1.0,8/54,10.90%,TNNI3;CUL7;STRA6;ADM;CCBE1;NRP1;EFNB2;RBPJ
prerank,regulation of T cell mediated immunity (GO:0002709),-0.42696431520025124,-1.0742735428729515,0.3630952380952381,0.8313016139676647,1.0,2/10,15.98%,ZBTB1;TNFRSF1B
prerank,inhibitory synapse assembly (GO:1904862),0.4995693293447444,1.0740273233846513,0.4101040118870728,1.0,1.0,2/11,9.74%,WNT5A;GABRB3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.49058334303452406,1.0738694894363277,0.3838383838383838,1.0,1.0,4/13,11.92%,GPD1L;ABCA7;SNX33;RIC3
prerank,glycerophospholipid catabolic process (GO:0046475),0.4216646759878925,1.0734812978861752,0.3725,1.0,1.0,8/27,20.14%,PLA2G5;PRDX6;GDPD3;ENPP2;SMPD4;GDE1;PLA2G7;ABHD16A
prerank,epithelial tube morphogenesis (GO:0060562),-0.2910242809776106,-1.0730734513553646,0.2976190476190476,0.8324276859984757,1.0,11/32,16.72%,MEF2C;SLIT2;ACVR1;COL4A1;RHOB;PRKX;RASIP1;BMP4;HES1;MET;PODXL
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4567128527892653,1.0730634307981557,0.4051841746248295,1.0,1.0,8/20,18.94%,HSP90AA1;STUB1;OGT;SDCBP;NUPR1;MLKL;FLOT1;BIRC3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4226419110406068,1.0722759582422048,0.391304347826087,1.0,1.0,8/27,17.10%,NHP2;TOE1;RNASE1;LACTB2;CPSF3;RPP30;XRN1;ZC3H12C
prerank,regulation of protein secretion (GO:0050708),0.3596799047759594,1.0722636327912183,0.368474923234391,1.0,1.0,21/119,17.24%,CACNA2D2;KCNG2;IGF1;BMP6;PICK1;ERP29;ITPR1;PRKCA;KCNC2;SNAP25;MYH10;TMED10;CYP51A1;UQCC2;TGFB1;DNM1L;RHBDF1;RFX3;CLOCK;APOE;EIPR1
prerank,cellular response to acid chemical (GO:0071229),0.4167175892268699,1.0721841176542277,0.37888198757763975,1.0,1.0,7/27,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,organophosphate biosynthetic process (GO:0090407),0.4034473206129363,1.0719902061386704,0.38006952491309387,1.0,1.0,15/37,23.06%,MOCS2;PCYT2;AGPAT5;TKT;AGPAT3;GPAM;FADS1;IPPK;IPMK;IP6K1;PIP5K1A;MOCS1;FGF2;TPI1;GNPAT
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3478579894051321,1.0719415278255138,0.33804238143289606,1.0,1.0,51/214,22.16%,FSHR;PLA2G5;DUSP26;DDT;EPHA7;EPHB2;FGFR2;GLIPR2;FBLN1;NRP1;FGF10;TIRAP;PRKCA;FLCN;SLC30A10;CNKSR3;SIRPA;ARRB1;PRXL2C;ABCA7;WNK2;APP;PDGFRA;NDRG4;HTR2C;ROR2;PTPN22;TGFB1;LMO3;ICAM1;ITGB1BP1;SPRY2;APOE;TNIP1;CAMK2N1;ZDHHC17;CCL25;PRKD2;SYNJ2BP;RANBP9;PRKCZ;GCNT2;LYN;PTK2B;TGFBR3;NTRK2;PTPRR;FGF2;MTURN;HMGB1;ERBB4
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.43169111160282037,1.071887921013543,0.37806451612903225,1.0,1.0,4/23,13.29%,GUCA1B;METAP1;NMT1;METAP2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.36430052450755995,1.071820595773317,0.3827956989247312,1.0,1.0,14/73,11.01%,FCGR2B;HSP90AA1;RAC1;ACTR2;ARPC1A;WIPF3;PIK3R1;ABL1;NCKIPSD;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.42174520340066163,1.0718184183792752,0.3933002481389578,1.0,1.0,8/28,19.43%,PSRC1;RAC1;DRG1;GIT1;MAPT;NUMA1;MECP2;RPS3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3984277164589331,1.0715534177416215,0.3779342723004695,1.0,1.0,7/37,12.24%,APLN;FGF9;IGF1;MFN2;TAFA5;TPM1;SOD2
prerank,phagosome acidification (GO:0090383),0.4273885059296655,1.0715192214908784,0.37926829268292683,1.0,1.0,9/26,22.02%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;RAB7A;ATP6V1C1
prerank,protein ubiquitination (GO:0016567),0.3475436895957783,1.0714552163673814,0.261,1.0,1.0,138/471,22.22%,ARRDC4;RNF157;CUL7;CDC23;PSMD4;SELENOS;RNF138;FBXW10;ASB5;MSL2;RNF8;UBE2S;SPSB1;STUB1;TRIM7;DTX3;UBE2E2;UBE2QL1;FBXL12;SYVN1;USP7;CDC16;LZTR1;TRIM11;BRAP;FBXL14;PDZRN3;SDE2;FBXO7;FBH1;KLHL12;THOP1;FBXO31;PSMB10;DDB1;BARD1;RTF1;FBXO45;UCHL3;RRAGA;TRIM35;FBXW5;PSMD11;MYCBP2;RMND5A;NFX1;ARRB1;TRIM62;UBA1;UBE3B;RNF40;RNF168;RNF103-CHMP3;UBE2V2;TRIM41;TRIM17;CUL4B;RNF11;VCP;CHFR;UBE2Z;PSME2;PSMC5;UBR3;BCL2;PEX5;RC3H2;ZNRF3;RNF152;RNF19A;RACK1;UBE2A;ANAPC11;USP9X;CBFB;UBE2J1;CDC73;CUL5;RNF19B;PCNP;RNF220;PEX13;ATG3;RNF41;ANKIB1;RNF122;RNF217;CBL;PSMD1;TRPC4AP;KLHL13;UBE2E1;UBE2D1;VPS18;ZSWIM8;DERL1;ARIH2;TNKS;NEDD8;UBE2L3;UBR5;PSMD6;EIPR1;FBXO22;SMURF1;TOPORS;MDM2;FBXO9;KLHL20;RNF111;HLTF;USP22;TRIM27;ZNRF2;RNF167;PELI2;VCPIP1;RNF38;PSMD5;DTX2;FANCL;RAD18;KLHL9;FBXO28;PSMA4;TRIP12;HECW2;CNOT4;COMMD1;PSMA1;TRIM26;PSMC6;UBE2V1;PEX2;TRAF2;CUL9;TAF1;PJA2
prerank,regulation of chemokine production (GO:0032642),0.4050037528945402,1.0710210199459107,0.3894230769230769,1.0,1.0,3/36,2.68%,WNT5A;LPL;IL33
prerank,regulation of monocyte chemotaxis (GO:0090025),0.431816137294033,1.0706887147085653,0.40077821011673154,1.0,1.0,9/24,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;LYN;NBL1;CXCL17;HMGB1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.41771441736609555,1.070648769404955,0.36771844660194175,1.0,1.0,4/27,11.29%,WNT5A;IGF1;DDR2;PDGFRA
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3654172332179315,-1.0705941235974934,0.3411371237458194,0.8376164873066803,1.0,5/16,16.22%,SMAD4;BCOR;PAXIP1;WDR5;DNMT1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38541740144482867,1.070342964193102,0.38171428571428573,1.0,1.0,8/48,6.44%,CUL7;RAC1;CDKL5;OBSL1;NRP1;ABL1;ARHGEF7;DMTN
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4300898367432784,1.0702210027113668,0.3765586034912718,1.0,1.0,6/25,12.16%,MVB12A;VTA1;CHMP3;VCP;LEPROT;VPS4B
prerank,autophagosome assembly (GO:0000045),0.3815033020173249,1.0701932467935036,0.38895152198421645,1.0,1.0,21/52,22.68%,UBQLN1;UBXN2A;TRAPPC8;WIPI1;ATP2A2;ATG14;MFN2;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;STX17;PIK3C3;SMURF1;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,positive regulation of cell population proliferation (GO:0008284),0.34454944302168106,1.0701412051167036,0.28,1.0,1.0,62/423,14.28%,FGF20;SFRP2;FGF9;S1PR2;WNT5A;TMEM119;SFRP1;MST1R;IGF1;IL34;FOXM1;EAPP;TBRG4;BMP6;NTF3;EDN3;TSPAN31;FGFR2;FGFR1;PTHLH;XBP1;SLC25A33;FZD9;CDC123;FGF10;IL31RA;CDK13;LAMC1;DDR2;TCF7L2;CNBP;FBXO5;EZH2;PID1;SOX9;SDCBP;EFNB2;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;COX17;RBPJ;BCL2;TCIRG1;MAZ;PDGFRA;RTKN2;BMP5;CD47;NPM1;HDAC1;UBE2A;PRMT1;LAMB1;PRKCI;EMP2;FAM98A;NRG1;TGFB1
prerank,regulation of viral transcription (GO:0046782),0.39823510493636,1.0695961811482375,0.3956916099773243,1.0,1.0,6/39,8.18%,HEXIM1;TARBP2;TRIM11;POLR2B;CDK9;TRIM62
prerank,mRNA transport (GO:0051028),0.36324171548549866,1.0693124832287162,0.36174636174636177,1.0,1.0,37/101,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;ZFP36L1;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;KIF5C;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;FMR1;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,regulation of Golgi organization (GO:1903358),0.4603953633199473,1.0691897595110573,0.40261437908496733,1.0,1.0,8/17,23.45%,CAMSAP2;PDE4DIP;USP6NL;MYO5A;MAP2K2;STX5;EHD3;MAP2K1
prerank,positive regulation of synaptic transmission (GO:0050806),0.36761442435827485,1.0689977334288592,0.3837953091684435,1.0,1.0,21/72,20.58%,MPP2;EPHB2;CACNG3;SQSTM1;ZDHHC3;GRIN2A;NMU;CLSTN2;APP;NLGN3;SYT1;NPTN;NLGN2;ADCY1;CACNG4;FMR1;ZDHHC2;CLSTN3;FLOT1;PRKCZ;PTK2B
prerank,ribosomal subunit export from nucleus (GO:0000054),0.4775178668934676,1.0686796532537421,0.4005722460658083,1.0,1.0,5/13,18.76%,NOP9;RPS15;NPM1;NUP88;ABCE1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4491575728415568,1.0686225127473177,0.3829787234042553,1.0,1.0,5/20,15.44%,FASN;FAR2;HSD17B4;FAR1;SLC25A1
prerank,lipid transport (GO:0006869),-0.23923058803983288,-1.0685929205760911,0.3125,0.8412796817002499,1.0,17/97,9.63%,SLCO3A1;ABCC4;ATP8B1;OSBPL2;PITPNA;SLC25A17;CERT1;LBP;SLCO1C1;ABCA4;PITPNC1;SLCO2A1;SCARB1;GOT2;SCP2;OSBPL5;PPARD
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3992948168296049,-1.0683104097873966,0.3783783783783784,0.8397236389833512,1.0,4/12,10.73%,ELF1;ELF2;RC3H1;PTPRC
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4501054151489912,1.0681421836472211,0.3968668407310705,1.0,1.0,8/19,21.47%,CEP97;DRG1;CHMP3;VPS4B;EML3;HNRNPU;TPR;CHMP4B
prerank,bile acid metabolic process (GO:0008206),0.41638042955691895,1.0677269291128275,0.41044776119402987,1.0,1.0,5/27,11.00%,CYP27A1;GBA2;CYP7B1;HSD17B4;AMACR
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.37386658974722375,-1.066545562712703,0.35294117647058826,0.8427439841598151,1.0,4/15,16.00%,PRKCH;MED1;SFRP4;BMP4
prerank,regulation of necroptotic process (GO:0060544),0.43499366994546207,1.06654477841508,0.3958602846054334,1.0,1.0,5/23,8.75%,HSP90AA1;STUB1;FZD9;OGT;SDCBP
prerank,chromatin organization (GO:0006325),0.357494036937378,1.0665083449446047,0.39076923076923076,1.0,1.0,35/132,17.49%,HDAC3;KDM4D;MPND;SMARCD3;FAM50A;SMARCC2;GATAD1;SNAI1;RBBP4;PHF1;SETD7;EZH2;SMARCB1;HDAC5;SOX9;SMARCD1;HDAC4;JARID2;TOP1;SUV39H1;SMARCA1;MTA2;NPM1;HDAC1;EHMT1;ATRX;BAZ2B;CHD1;NUCKS1;SATB1;TCF7L1;KDM6B;DAXX;HP1BP3;PWWP3A
prerank,cAMP biosynthetic process (GO:0006171),0.507188159431634,1.0660669352025565,0.4375,1.0,1.0,3/10,16.59%,ADCY7;ADCY1;ADCY5
prerank,regulation of protein localization to cell surface (GO:2000008),0.41195701514118466,1.066031769694583,0.38868832731648617,1.0,1.0,8/33,11.92%,KCNAB2;GPD1L;ABCA2;EGF;ABCA7;LEPROT;SNX33;RIC3
prerank,positive regulation of exocytosis (GO:0045921),0.4057205366767963,1.0659539949423893,0.39903264812575573,1.0,1.0,6/35,12.16%,UNC13D;SNF8;HGS;SDCBP;RAB2B;VPS4B
prerank,response to endoplasmic reticulum stress (GO:0034976),0.36347650761410405,1.0658999887632352,0.4006243496357961,1.0,1.0,19/107,11.57%,UBQLN1;BAX;SELENOS;EIF2AK3;SYVN1;ERLEC1;ATP2A2;ITPR1;PIK3R1;SEC16A;BRSK2;RCN3;DDIT3;CDK5RAP3;VCP;MBTPS1;PIK3R2;BCL2;USP19
prerank,cell differentiation in hindbrain (GO:0021533),0.5092677216997403,1.06584825046207,0.4192592592592593,1.0,1.0,3/11,19.23%,KNDC1;FAIM2;AGTPBP1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3477323944503324,1.0657510458086812,0.3283283283283283,1.0,1.0,44/268,16.34%,KCNG2;SLC4A4;KCNAB2;KCNA4;KCNC1;ASIC1;NALCN;SLC24A5;ATP2C1;ATP1A3;SLC6A11;ATP2A2;KCNK2;SCN7A;SLC30A10;ATP6V0E2;ATP1A2;KCNC2;SLC39A1;KCNJ10;SLC24A4;TRPM3;SCN2B;KCNQ4;SLC30A1;SCN1A;SLC6A8;SLC39A6;KCND3;ATP6V0A4;KCNH5;SLC6A4;SLC1A3;KCNA1;SLC41A1;SLC6A15;SLC30A3;ABCB7;TRPC4AP;SLC6A12;KCNQ2;SLC9A7;SLC9A6;SLC6A13
prerank,sensory perception (GO:0007600),0.39057980647657314,1.0655434617329056,0.3993212669683258,1.0,1.0,6/45,9.25%,TMEM150C;OPRK1;PCDH15;ADGRV1;GNAS;TTC8
prerank,central nervous system neuron differentiation (GO:0021953),0.4098894770503906,1.065533958434264,0.38498212157330153,1.0,1.0,12/33,23.00%,GBA2;KNDC1;CHD5;SPOCK1;MAPT;FAIM2;SOX4;AGTPBP1;MDGA2;NTRK2;RYK;MAP2
prerank,cell cycle checkpoint signaling (GO:0000075),0.4982128324307014,1.0654720910810493,0.39737991266375544,1.0,1.0,5/12,19.74%,WEE1;CHFR;ZWINT;NABP2;ZW10
prerank,glial cell development (GO:0021782),0.42275918642571775,1.065412014765274,0.4050955414012739,1.0,1.0,7/25,19.15%,MYRF;PICK1;SOX11;APP;TPPP;MXRA8;SOX4
prerank,Rap protein signal transduction (GO:0032486),0.511529751406102,1.0653875607567425,0.41294298921417566,1.0,1.0,3/10,9.43%,SGSM3;RAP2A;RAPGEF1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4910513332050279,1.0652119961677828,0.3956204379562044,1.0,1.0,2/11,2.08%,GSKIP;PDK1
prerank,regulation of neuron differentiation (GO:0045664),0.3668321652492798,1.0651055099198166,0.3888888888888889,1.0,1.0,14/76,10.08%,BIN1;NTF3;FGFR1;TCF4;CASZ1;ZEB1;BRINP3;MMD;GPRC5B;ZFHX2;YWHAH;CDK5RAP3;SOX11;YWHAG
prerank,regulation of coagulation (GO:0050818),0.49920889940916907,1.0645158558535446,0.4119448698315467,1.0,1.0,1/11,1.72%,EPHB2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.4605318640266529,1.0643823491221767,0.40668523676880225,1.0,1.0,4/17,8.02%,CASK;FSTL1;SULF1;XIAP
prerank,regulation of RNA splicing (GO:0043484),0.3690730408740115,1.0643408578718505,0.3873390557939914,1.0,1.0,30/69,23.96%,AFF2;FAM50A;RBM39;PIK3R1;SRSF3;CELF1;HNRNPK;FUS;TIA1;KHDRBS2;HNRNPH3;SETX;HNRNPL;TRA2B;HNRNPLL;GRSF1;AHNAK;YTHDC1;CLK4;SON;RBM22;SRPK1;BRDT;PTBP1;CLK2;U2AF2;RRP1B;KHDRBS1;SNRNP70;CLK1
prerank,mRNA 3'-end processing (GO:0031124),0.3727092765074646,1.0641895754479542,0.38,1.0,1.0,25/78,19.58%,RPRD2;SLBP;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;CPSF7;PABPC1;APP;CSTF2T;NUDT21;CPSF3;THOC7;CDC73;THOC1;GRSF1;AHCYL1;SRRM1;CPSF6;FIP1L1;MTPAP;CSTF3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.37284534681355713,1.0640439523919691,0.40064446831364126,1.0,1.0,20/66,22.07%,SFRP2;SFRP1;NR2F2;FGFR2;CASK;SULF1;MAGED1;SPARC;SOX9;ROBO1;CDC73;TGFB1;NUPR1;APOE;SYNJ2BP;KRIT1;MTSS1;TGFBR3;PEX2;B2M
prerank,positive regulation of stress fiber assembly (GO:0051496),0.38854166952911373,1.0630498874136765,0.38329519450800914,1.0,1.0,20/44,22.50%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,ceramide metabolic process (GO:0006672),0.38208830955781237,1.0628726044817587,0.3858447488584475,1.0,1.0,10/49,14.35%,CLN6;SMPD2;ABCA2;CERS2;SGPL1;SPTSSA;TLCD3B;PLPP3;SMPD4;ST6GALNAC6
prerank,excitatory postsynaptic potential (GO:0060079),0.442771074723938,1.062855844173165,0.3894878706199461,1.0,1.0,3/19,8.22%,MPP2;GRIN1;GRIN2A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.49886113178140157,1.062592180669612,0.4026745913818722,1.0,1.0,3/10,14.84%,SOX9;SOX6;SOX5
prerank,ganglioside biosynthetic process (GO:0001574),0.46573189250252733,1.062432524265438,0.40767045454545453,1.0,1.0,5/15,14.35%,ST8SIA3;ST3GAL2;ST3GAL5;B4GALT5;ST6GALNAC6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3681307461795661,1.062281931418016,0.3923913043478261,1.0,1.0,29/76,24.34%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;CDK5RAP3;VCP;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;SMURF1;MDM2;PIAS1;SUMO2;DAB2;SMAD7;TAF1;KEAP1;PTEN;FBXW7;TRIB2
prerank,androgen receptor signaling pathway (GO:0030521),0.48985538642868914,1.0622188808170459,0.3873343151693667,1.0,1.0,5/11,16.74%,DDX17;PMEPA1;ZMIZ1;DDX5;DAXX
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49667355299102367,1.0621134465935873,0.4152542372881356,1.0,1.0,5/12,24.11%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49667355299102367,1.0621134465935873,0.4152542372881356,1.0,1.0,5/12,24.11%,FBLN1;DMTN;ITGB1BP1;AP1AR;CORO1C
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.40949947006323745,1.0618621633241012,0.4007220216606498,1.0,1.0,8/31,10.18%,CAMK2B;TANC2;CDK5;DBN1;LRP8;DHX36;DBNL;SRCIN1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.39465115058507494,1.0617914334196241,0.3969732246798603,1.0,1.0,10/37,15.32%,BAX;FIS1;FBH1;DDIT3;BCL2;NACC2;RACK1;BCLAF1;DNM1L;NUPR1
prerank,covalent chromatin modification (GO:0016569),0.47463550697963,1.0615069058687905,0.41620879120879123,1.0,1.0,6/14,19.44%,SIRT7;PARP2;PARK7;HDAC1;CHD1;SETD5
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3565465635907632,1.0610993711644965,0.3836734693877551,1.0,1.0,16/121,10.25%,VTN;IGF1;IL34;BMP6;NTF3;NRP1;FGF10;IL31RA;DLG3;ABL1;LRP8;PIBF1;GPRC5B;TEC;SRCIN1;ENPP2
prerank,platelet degranulation (GO:0002576),0.35425515507568095,1.0610596364079128,0.3662551440329218,1.0,1.0,17/118,14.28%,MAGED2;CLEC3B;IGF1;APOOL;CHID1;CD63;SERPING1;SPARC;EGF;APLP2;APP;BRPF3;VTI1B;NHLRC2;GTPBP2;PSAP;TGFB1
prerank,histone H3 acetylation (GO:0043966),-0.2862768067672015,-1.0610440263941263,0.3032258064516129,0.8572440176073195,1.0,18/40,23.87%,LEF1;KAT7;MBIP;JADE2;KAT2B;TAF12;JADE1;JADE3;WDR5;TAF5L;KAT6B;DR1;BRCA2;ING5;NAA60;TRIM16;SUPT7L;TAF6L
prerank,regulation of establishment of cell polarity (GO:2000114),0.45666794754310097,1.060507310951806,0.3816155988857939,1.0,1.0,11/16,26.58%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;GSN;RAP1B;SHTN1;ARFGEF1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3639544482610317,1.0603649356673739,0.39278131634819535,1.0,1.0,5/78,3.12%,PSRC1;CDKN2D;HEXIM1;NR2F2;MAPRE3
prerank,apical protein localization (GO:0045176),-0.41865884473313997,-1.060091918949357,0.39814814814814814,0.8578898523805142,1.0,4/10,15.14%,ATP8B1;ACTB;GOPC;MAL
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4049351937041406,-1.059992375146287,0.35668789808917195,0.8557845129216448,1.0,4/11,6.81%,YBX3;RIPK1;SLC25A4;PELI1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.4037046788805621,1.059958059770443,0.40194884287454324,1.0,1.0,12/32,22.35%,DUSP26;CALM3;MAGI2;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2;ITGA1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3354165276243187,-1.0599265612011002,0.3542600896860987,0.8535258645523174,1.0,10/22,16.11%,RAD23B;GTF2H1;RBX1;CHD1L;CUL4A;UBB;GTF2H5;GTF2H2;XPC;ERCC3
prerank,protein transport (GO:0015031),0.34603574861856545,1.0593438176914671,0.3333333333333333,1.0,1.0,85/332,18.52%,ARRDC4;IL10RA;ARL4C;ATP6V0A2;SGSM3;PICK1;ERP29;KIF3A;SAR1A;RUNDC1;RAB24;DNAJC27;RAB34;TBC1D13;NAPG;STX6;TVP23B;SNX6;MIA3;VPS26B;ATP6V0E2;STX16;RAB12;RCN3;STX2;LMAN2L;RAB5B;YWHAH;VLDLR;CHMP3;RAB10;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;RAB3B;ATP6V1G1;USP6NL;ANK3;TCIRG1;AP3B1;EVI5L;SNX33;VPS33B;TLK1;TANGO2;MON1A;NPM1;ATP6V0A4;TMED10;RAB13;SCAMP5;LRP1;RABGAP1;ATP6V1D;VMP1;USO1;SCAMP1;AP4M1;STX11;RAB31;SPTBN1;STX8;STX17;RAB8A;RAB8B;GGA2;TXNIP;ATP6V1B2;RUFY1;NSF;SYNRG;RAB21;APOE;MTTP;TBC1D9B;SNX4;TBC1D22B;ZDHHC17;LRP1B;NECAB3;RAB6A;SGSM2;TOM1
prerank,nerve growth factor signaling pathway (GO:0038180),0.5061809294233428,1.059182579459992,0.42073170731707316,1.0,1.0,3/10,11.88%,NTF3;RAPGEF1;MAGI2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5094831022775728,1.0591572769255435,0.4114977307110439,1.0,1.0,3/10,10.95%,GPLD1;IRS2;PTH1R
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.42124798069642844,1.05882103432236,0.403530895334174,1.0,1.0,5/25,10.71%,RAC1;ABCA2;LRPAP1;SDCBP;APP
prerank,positive regulation of GTPase activity (GO:0043547),0.34603556867178886,1.058317737180173,0.3775303643724696,1.0,1.0,36/188,14.05%,SFRP1;MTSS2;NTF3;CDKL5;SLC27A4;TBC1D7;SGSM3;RUNDC1;RAP1GDS1;RGS10;ARHGEF10;TBC1D13;SCRIB;FLCN;SYDE2;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;ARHGAP42;DOCK8;RAP1GAP2;RAPGEF1;RABGAP1L;ARHGAP24;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;DOCK7;RACK1;RABGAP1;ARHGAP29
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.35293604308908266,1.0582247189947498,0.4022517911975435,1.0,1.0,42/124,23.00%,IQCG;STMN4;RAC1;GPRIN1;CDK5;EPHA8;TMEM108;TTC17;CYFIP1;PPP1R9B;GDNF;APP;TPM1;LRP12;BLOC1S2;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;ARMC2;APOE;MAP4;PKD2;ATCAY;ODF2;PLEKHA1;KIFAP3;CARMIL1;ATXN10;LIMA1;LYN;ATP1B2;EHD1;RYK;HMGB1;CAMSAP1;FAM161A;MAP2
prerank,regulation of defense response (GO:0031347),0.3634230495624441,1.057848253788951,0.39576719576719577,1.0,1.0,18/76,17.19%,WNT5A;FCGR2B;NR1D2;ANXA1;TIRAP;BRD4;IRF1;DHX58;CELF1;XIAP;LRP8;PARK7;PTPN22;PTGS2;BCL6;LACC1;AGTR1;APOE
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.45637757307316207,1.057843560899762,0.41633199464524767,1.0,1.0,7/16,16.48%,DDX17;RBFOX2;TADA3;NCOA4;EGLN2;DDX5;TRIP4
prerank,protein import into nucleus (GO:0006606),0.3681460696043485,1.0577556302624618,0.40064446831364126,1.0,1.0,22/66,21.25%,MMP12;TSC2;NXT2;NXT1;KPNA3;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;NUP153;RANBP2;KPNA1;NUP35;PPP1R10;HEATR3;TPR;APPL2;CBLB
prerank,cellular response to BMP stimulus (GO:0071773),0.36712267042940383,1.0573996586605146,0.3995703544575725,1.0,1.0,22/66,22.96%,SFRP1;ADAMTS7;BMP6;SMAD9;SOX9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3;ADAMTS12
prerank,positive regulation of neuron projection development (GO:0010976),0.35934405081593074,1.05706883691896,0.3925925925925926,1.0,1.0,31/85,20.96%,WNT5A;CAMK2B;TENM3;DBN1;PLK5;LRP8;VLDLR;DHX36;RAPGEF1;DBNL;BMP5;MAGI2;NDRG4;SETX;ROR2;NPTN;PRKCI;PLPPR5;ARSB;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;SCARB2;LYN;ATP1B2;PTK2B;NTRK2;SCN1B
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4869061842606096,1.0569442364088215,0.38268156424581007,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4869061842606096,1.0569442364088215,0.38268156424581007,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4869061842606096,1.0569442364088215,0.38268156424581007,1.0,1.0,5/12,18.59%,CDC23;CDC16;ANAPC11;ANAPC4;ANAPC5
prerank,regulation of neuron migration (GO:2001222),0.4216538549236086,1.0564439418621918,0.41676942046855736,1.0,1.0,7/26,18.76%,CAMK2B;NIPBL;SRGAP2;NTNG2;ADGRG1;SEMA3A;KIF20B
prerank,histone H3-K9 demethylation (GO:0033169),0.48892459221170625,1.0559782764992864,0.3924812030075188,1.0,1.0,2/11,2.24%,KDM4D;KDM7A
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.40737328805095496,1.0558096088359028,0.398576512455516,1.0,1.0,3/33,5.06%,IL34;ZFP36L1;PRKCA
prerank,cardiac muscle cell contraction (GO:0086003),-0.3432992777511952,-1.0557255407160298,0.3286384976525822,0.8643602259450434,1.0,7/19,13.24%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;CACNA1C;CACNA1G;PIK3CA
prerank,aminoglycan catabolic process (GO:0006026),0.42111605253558426,1.0554747417574135,0.42326732673267325,1.0,1.0,8/28,19.84%,GLB1;GPC6;GPC1;HGSNAT;GPC4;HSPG2;GPC5;GUSB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.26486609137792605,-1.0553750814195366,0.3333333333333333,0.8629307879915548,1.0,22/54,22.62%,MEF2C;ANGPT1;NUS1;SIRT1;PRKD1;HIF1A;TMSB4X;NOS3;THBS1;KDR;AKT3;PLCG1;ANGPT2;RGCC;HSPB1;VEGFA;NF1;ATP5F1B;AKT1;PPARG;GATA2;STAT5A
prerank,negative regulation of apoptotic process (GO:0043066),0.3393444947255801,1.0551912361916505,0.301,1.0,1.0,84/444,17.41%,FGF20;RNF157;CDKN2D;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;CSNK2A2;NTF3;BNIP1;TAF9B;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;FZD3;NUAK2;IL31RA;MGMT;PRKCA;CARD16;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;SNX6;HNRNPK;SLC30A10;ZFAND6;IFIT3;XIAP;SOX9;NRBP2;UBE2Z;MALT1;GDNF;PRLR;KDM2B;BCL2;MAZ;BNIP2;PARK7;SOD2;DNAJB6;NPM1;HDAC1;LAMTOR5;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;NDNF;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;APOE;SON;DFFA;TOPORS
prerank,receptor catabolic process (GO:0032801),0.42661607736489177,1.0550532978334302,0.4167741935483871,1.0,1.0,12/24,24.73%,MVB12A;VLDLR;AP2S1;ZNRF3;TGFB1;SMURF1;GPRASP1;PIK3R4;UVRAG;SH3GLB1;MYLIP;RNF43
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.46513569920094644,1.0546851748819963,0.4303977272727273,1.0,1.0,4/15,11.29%,FGFR2;NIPBL;TWIST1;PDGFRA
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3486399302615139,1.0543507808213768,0.3910386965376782,1.0,1.0,31/151,18.27%,ASL;MOCS2;CSNK2A2;ELOVL1;GSTT1;TYW1;ST3GAL2;LPIN1;PCSK5;CEPT1;GPAT4;CERS2;SGPL1;LPIN3;ELOVL4;PCYT1B;SPTSSA;STARD7;LPIN2;B4GALT5;PLPP3;PAM;VAPB;CHKB;SLC44A2;SLC27A1;ALDH3A2;APOE;TNIP1;PRKD2;ASS1
prerank,ion homeostasis (GO:0050801),0.41483811204851356,1.054338612621934,0.4020100502512563,1.0,1.0,2/30,0.31%,SLC4A4;SLC4A5
prerank,regulation of neuron projection development (GO:0010975),0.34568688927370045,1.0543353483790718,0.3953488372093023,1.0,1.0,52/163,20.96%,WNT5A;CAMK2B;CDKL5;TANC2;CDK5;FBXO7;TENM3;KNDC1;PAK3;DBN1;BRSK2;CAMSAP2;PLK5;SPOCK1;EFNB2;RAPGEF1;PRAG1;NTNG2;SRCIN1;BRSK1;DENND5A;MAGI2;IL1RAPL1;NDRG4;CAMK2G;SETX;ROR2;NPTN;PRKCI;DISC1;LPAR1;PLPPR5;ARSB;SEMA3A;NDNF;CAMK1D;RIT2;PLXNB3;PTK7;APOE;RUFY3;DCC;CCDC88A;ITM2C;SCARB2;PTPRS;LYN;ATP1B2;PTK2B;CHN1;NTRK2;SCN1B
prerank,protein processing (GO:0016485),0.3565897845633253,1.0542921626558097,0.37938144329896906,1.0,1.0,20/102,17.62%,XPNPEP3;CPXM1;CLN3;MYRF;PCSK5;OGT;SDE2;PCSK2;HM13;PTCH1;AFG3L2;CPXM2;PRSS12;METAP2;ADAMTS3;F3;CASP2;CTSH;PARL;OMA1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.33940383163938437,-1.0540040199041076,0.38565022421524664,0.8646557332069181,1.0,4/20,7.06%,PRKCE;LBP;IRAK1;TLR4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.38543396733577207,-1.0537408201564527,0.38620689655172413,0.8630392079025357,1.0,5/14,16.22%,SMAD4;KMT2E;PAXIP1;WDR5;DNMT1
prerank,cytosolic calcium ion transport (GO:0060401),-0.2995401039649594,-1.0533999131375003,0.36923076923076925,0.8617825012417082,1.0,19/28,32.09%,MICU1;CACNA2D1;CACNA1C;ITPR3;SLC35G1;MCU;MCUR1;ADRA1A;MCUB;ATP2B3;MAIP1;SMDT1;ATP2A3;RYR2;MICU3;SLC8A1;JPH2;JPH4;SLC8A2
prerank,regulation of interleukin-4 production (GO:0032673),-0.33010705094283904,-1.0533809338675892,0.38202247191011235,0.8594193629316478,1.0,9/21,32.79%,LEF1;LGALS9;RARA;CEBPB;CD86;SYK;ZFPM1;HAVCR2;FCER1G
prerank,transcription by RNA polymerase III (GO:0006383),-0.3085560251272222,-1.0527946971114253,0.4068627450980392,0.858675427727979,1.0,14/27,25.76%,BRF1;GTF3C3;GTF3C2;ELL;POLR3GL;ICE1;SNAPC1;CRCP;POLR3H;GTF3C1;GTF3C5;ZC3H8;GTF3C4;POLR3G
prerank,detection of calcium ion (GO:0005513),0.4758700050610046,1.0526593583865123,0.42219020172910665,1.0,1.0,4/13,21.79%,CALM3;SYT1;CALM1;CALM2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.43473758642394805,-1.0525368443365162,0.3887240356083086,0.852285503859591,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.43473758642394805,-1.0525368443365162,0.3887240356083086,0.852285503859591,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.43473758642394805,-1.0525368443365162,0.3887240356083086,0.852285503859591,1.0,7/10,33.10%,NBN;SMARCAL1;BLM;SLX4;WRN;ERCC1;DNA2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.41505546199279864,1.0522548391652584,0.40818858560794047,1.0,1.0,5/26,4.88%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.4214618327789663,1.0522485588402426,0.42424242424242425,1.0,1.0,6/26,16.13%,PSRC1;RAC1;DRG1;KATNB1;MAPT;NUMA1
prerank,negative regulation of signaling (GO:0023057),0.4178581668587893,1.0521778248447293,0.40667490729295425,1.0,1.0,4/25,14.46%,BRAP;SRMS;IGFBP3;GLRA1
prerank,regulation of T cell activation (GO:0050863),0.38973279191772364,1.0520499154196838,0.40898876404494383,1.0,1.0,7/42,15.53%,PRELID1;ABL1;THY1;SIRPA;CD47;PTPN22;HSPD1
prerank,negative regulation of nervous system development (GO:0051961),0.4491736530672944,1.0518699922760393,0.43454790823211875,1.0,1.0,6/17,22.07%,HOOK3;ROBO2;SLIT1;SORL1;APPL2;B2M
prerank,lymphocyte differentiation (GO:0030098),-0.25548332165613014,-1.0518473859087238,0.3333333333333333,0.8520082643923379,1.0,16/68,15.12%,AXL;TOX;KAT7;KIT;KLF6;DCAF1;GPR89B;GPR89A;PLCG2;MSH2;PTPRC;LMBR1L;NHEJ1;TPD52;PTPRJ;ITGA4
prerank,regulation of urine volume (GO:0035809),0.5003872309774187,1.0514688025563008,0.43555555555555553,1.0,1.0,1/10,2.42%,ADM
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.46614481649704215,1.051335487480615,0.4191780821917808,1.0,1.0,4/15,12.08%,MAD2L1;ABL1;FBXO5;PARK7
prerank,positive regulation of cell junction assembly (GO:1901890),0.37003167298390105,1.0511336066106305,0.4011173184357542,1.0,1.0,18/56,21.65%,SFRP1;EPHB2;RAC1;NRP1;ABL1;THY1;CLSTN2;IL1RAPL1;NLGN3;NLGN2;CNTNAP2;IL1RAP;CLSTN3;NPHP1;FLOT1;DLG5;MAP4K4;PPM1F
prerank,regulation of cellular protein metabolic process (GO:0032268),0.38120701499691895,1.0511294463837257,0.4153498871331828,1.0,1.0,12/47,17.19%,NFKB1;RBM4B;RBM3;METAP1;CYFIP1;SSH1;PUM3;APP;WDR91;TGFB1;AGTR1;APOE
prerank,alpha-amino acid catabolic process (GO:1901606),0.40839860395729605,1.0509317129387483,0.4245742092457421,1.0,1.0,5/29,14.99%,HGD;ACAT1;ALDH4A1;ACADSB;FAH
prerank,epithelial structure maintenance (GO:0010669),-0.4113090427454634,-1.05066326631478,0.3980263157894737,0.8534157910391337,1.0,2/11,17.38%,RBP4;STRAP
prerank,negative regulation of neurogenesis (GO:0050768),0.39310222667856054,1.0505439979338405,0.4246737841043891,1.0,1.0,12/34,23.89%,THY1;EFNB3;MCF2;YWHAH;HOOK3;GORASP1;RUFY3;SORL1;APPL2;B2M;LRP4;PTEN
prerank,ERAD pathway (GO:0036503),0.3603689481855012,1.0503328581379519,0.39915966386554624,1.0,1.0,20/83,16.38%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLEC1;ERLIN2;BRSK2;RCN3;JKAMP;AUP1;RNF103-CHMP3;POMT2;VCP;UGGT2;USP19;UBE2J1;UBXN4;RNF121;DERL1
prerank,positive regulation of cytokine production (GO:0001819),0.3395781553140896,1.050220306754903,0.3663663663663664,1.0,1.0,49/292,15.76%,WNT5A;LPL;PTGER4;NFKB1;EIF2AK3;IL33;POLR3D;STAT6;ANXA1;XBP1;RORA;NFKB2;CCBE1;AGPAT1;TIRAP;SCRIB;TMEM106A;SULF1;IRF1;DHX58;ARNT;ZBTB7B;DHX33;DDIT3;PIBF1;XRCC6;DHX36;POLR3E;TWIST1;MALT1;APP;IRF3;PARK7;POLR2K;CEBPG;TMED10;LAMTOR5;TLR3;SCAMP5;PTPN22;ROCK2;PTGS2;TGFB1;LACC1;F3;MRE11;SPTBN1;HSPD1;PDE4B
prerank,positive regulation of kinase activity (GO:0033674),0.3546906009124176,1.0501217849770441,0.39791666666666664,1.0,1.0,24/107,17.15%,MST1R;EPHA7;EPHB2;FGFR2;MAPRE3;FGFR1;DDR1;DDR2;EPHA8;MMD;XRCC6;EPHA10;MRNIP;MUSK;JTB;PDGFRA;ALS2;IQGAP1;ROR2;MAPT;MRE11;RAD50;DAXX;EPHA5
prerank,positive regulation of viral genome replication (GO:0045070),0.41121333162133916,1.0500616708352255,0.41344956413449563,1.0,1.0,5/29,9.95%,TARBP2;DDX3X;DDB1;PPIH;PABPC1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.38856834480293406,1.050015627414597,0.4096662830840046,1.0,1.0,11/42,12.36%,RNF8;SMARCC2;CHD8;RBBP4;ACTR6;SMARCB1;ACTR8;ARID1B;SMARCA1;MTA2;HDAC1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.41716367692004924,-1.0499477910721882,0.39156626506024095,0.8531369609413695,1.0,4/10,13.00%,LRP6;PHACTR4;LIN7C;BMP7
prerank,peptidyl-glutamic acid modification (GO:0018200),0.42068707613052686,1.0498502900484694,0.40852130325814534,1.0,1.0,7/24,19.23%,PARP1;TTLL4;TPGS1;CFAP20;TTLL11;AGBL4;AGTPBP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.35644594975188665,1.049682139110992,0.41139240506329117,1.0,1.0,28/95,20.88%,ADAMTSL2;PDPK1;ZEB2;STUB1;DKK3;PMEPA1;FLCN;SNX6;STK11;HTRA3;TGFB1I1;SDCBP;SOX11;LEMD3;PEG10;TGFB1;SMAD6;VASN;MTMR4;SNW1;SPRY2;SMURF1;RNF111;TGFBR1;PPM1A;DAB2;TGFBR3;SMAD7
prerank,positive regulation of viral life cycle (GO:1903902),-0.3274610123634183,-1.0495614593209288,0.3827751196172249,0.8519086919997311,1.0,9/22,17.98%,TSG101;AXL;P4HB;KPNA6;LGALS9;VPS37B;CHMP2B;LGALS1;VPS4A
prerank,cell-cell junction assembly (GO:0007043),0.36875179599693625,1.049534028257404,0.42546245919477693,1.0,1.0,18/63,17.22%,GJB2;CTNND2;PRKCA;CLDN11;FLCN;JAM3;PATJ;CDH11;GJB6;CLDN12;JUP;TLN2;CDH18;EPB41L3;TBCD;CDH20;CDH19;CDH7
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.34115348499822956,1.0494249918118945,0.361,1.0,1.0,77/314,18.01%,UBQLN1;CDC23;SIRT2;SPSB3;KCTD5;PSMD4;SELENOS;UBXN2A;UBE2S;SPSB1;STUB1;EDEM1;FBXL12;SYVN1;MAD2L1;UCHL1;CDC16;FZR1;FBXL14;FBXO38;COP1;ERLIN2;ANAPC2;FBXO5;FBXO31;PSMB10;DDB1;FBXO45;RFFL;FBXW5;PSMD11;RMND5A;ARRB1;DDIT3;TRIM9;JKAMP;AUP1;RNF103-CHMP3;CUL4B;KLHL15;VCP;PSME2;PSMC5;UBR3;USP19;NEMF;KCTD2;UBE2A;ANAPC11;ANAPC4;UBE2J1;CUL5;PCNP;ZFAND2A;CDC26;RNF122;FEM1C;PSMD1;FAF1;UBE2E1;UBXN4;RNF121;UBE2D1;ZSWIM8;CLOCK;DERL1;DMAC2;PSMD6;SMURF1;TOPORS;MDM2;DNAJC10;FBXO9;PCBP2;TBL1XR1;KLHL20;ANAPC10
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.48286349951465296,1.0492887748889173,0.41594202898550725,1.0,1.0,6/12,26.38%,STX2;SNAP25;STX11;SNAP47;SNAP23;STX1A
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5023659412610278,1.0492358066189038,0.44328358208955226,1.0,1.0,5/10,19.44%,DIP2B;FLCN;PARK7;PRKAA1;SETD5
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.48201764803112807,1.0490195430690712,0.42302158273381296,1.0,1.0,2/11,4.89%,TNFAIP3;TIRAP
prerank,epithelium development (GO:0060429),0.35263916127093076,1.04897748398293,0.41139896373056994,1.0,1.0,22/107,18.84%,ANXA7;FGFR2;FGF10;ERRFI1;ALDH1A2;DVL1;RCN3;WNT4;SOX9;PTCH1;SOX11;DAG1;NDRG4;HNRNPH3;VDAC1;TGFB1;AHI1;ACADVL;OSR1;ANXA4;PKD2;PGK1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4552414532049006,1.0488933885931415,0.4415041782729805,0.9999409239708502,1.0,5/16,21.10%,ERLIN2;SOX9;ACADL;ACADVL;APPL2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.42687910687103103,1.0487576057504142,0.4283854166666667,0.9995815595712575,1.0,3/21,7.87%,FGF9;IGF1;MFN2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4733718688240439,1.048344245892481,0.42857142857142855,1.0,1.0,2/13,4.65%,WNT5A;AGPAT1
prerank,regulation of cell population proliferation (GO:0042127),0.3364156417792913,1.0477022452516511,0.309,1.0,1.0,136/691,19.15%,FGF20;SFRP2;FGF9;S1PR2;CDKN2D;SFRP1;MST1R;IGF1;IL34;FOXM1;SIRT2;GPLD1;GNL3;EAPP;TSC2;TBRG4;CHERP;BMP6;NTF3;EDN3;TSPAN31;CGRRF1;FGFR2;TNFRSF9;GNRH1;STAT6;FGFR1;PTHLH;WARS1;XBP1;ZFP36L1;SLC25A33;CDC123;FGF10;IL31RA;CDK13;RBBP4;CLMN;TCF7L2;CNBP;IRF1;DLG3;NUAK1;FBXO5;ALDH1A2;CELF1;EZH2;EEF1E1;STK11;HGS;CHD5;TGFB1I1;IFIT3;PODN;XIAP;IFI35;SOX9;WDR6;PPP1R9B;SDCBP;EFNB2;XRCC6;MDM4;EGF;HDAC4;SOX11;GDNF;PRLR;IRS2;WNK2;RBFOX2;COX17;APP;JUP;IGFBP3;BCL2;ADGRG1;TCIRG1;IGFBP7;MAZ;PDGFRA;RTKN2;BMP5;NACC2;MAGI2;SPEG;SOD2;CD47;NPM1;HDAC1;AGO3;AXIN2;UBE2A;PRMT1;ROR2;TNS2;CDC73;EMP2;FGFBP1;FAM98A;NRG1;RNF41;TGFB1;SLURP1;BCL6;P3H2;SMAD6;KMT2D;DIS3L2;NUPR1;CNOT6;CTSH;CTBP1;JAG1;ADAMTS1;AGTR1;ITGB1BP1;PHIP;CAPNS1;HP1BP3;MDM2;ABI1;CAMK2N1;MEIS2;PKD2;CCDC88A;CDK10;S100A13;MECP2;TGFBR1;PDCD5;ATP8A2;KIF20B;KCNH1;KSR1;SOX4
prerank,positive regulation of response to stimulus (GO:0048584),0.39212278834290687,1.047238842999192,0.4135514018691589,1.0,1.0,4/40,6.71%,WNT5A;FCGR2B;CDKN2AIP;EEF1E1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3559900757021294,1.0467768582556807,0.42452830188679247,1.0,1.0,30/91,22.18%,TCIM;CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;PSMB10;DDB1;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;MN1;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5;PSMD5;PSMA4;ATP2B4;PSMA1;PSMC6;TAF1
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.3850915002549104,-1.0466704430766751,0.3659305993690852,0.8583039888188091,1.0,6/13,42.44%,LAMP1;SYK;SPHK2;ITGB2;ITGAM;FGR
prerank,protein modification by small protein removal (GO:0070646),0.3430166631831859,1.0466480517821772,0.3901705115346038,1.0,1.0,82/252,22.11%,CCP110;COPS7A;OTULINL;PSMD4;IL33;TAF9B;USP14;USPL1;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;COPS7B;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;SENP5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB;SENP7;SMAD7;PSMA4;SMAD2;PSMA1;PSMC6;OTUD6B;TRAF2;SMAD3
prerank,glycolipid metabolic process (GO:0006664),0.3795906888003059,1.046596474494948,0.42841037204058624,1.0,1.0,10/47,14.35%,B3GALNT1;SMPD2;GBA2;GLB1;ABCA2;ST3GAL2;PGAP1;PSAP;SMPD4;ST6GALNAC6
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4516824638745309,1.0465342162154863,0.42857142857142855,1.0,1.0,5/16,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33824172239544736,1.046327895480164,0.3733733733733734,1.0,1.0,76/308,21.52%,HDAC3;WNT5A;TMEM119;PTGER4;IL33;NKX6-1;STAT6;XBP1;GLIPR2;LPIN1;AGPAT1;OGT;ALMS1;SNAI1;OLFM1;MFAP2;FBXO5;EZH2;ZBTB7B;CXCR4;TGFB1I1;MFN2;SOX9;LRPAP1;SDCBP;GNAS;EGF;PPIB;ABCA7;SOX11;TWIST1;GDNF;PRLR;TBXA2R;CPT2;LEPR;SOX6;AXIN2;B4GALT5;EHMT1;ZBED3;SCAMP5;LRP1;TGFB1;ESRRG;SOX5;RFX3;NR2C2;ACVR1B;NUMA1;VAMP8;SERPINE1;SLC27A1;ACADL;KDM6B;APOE;OMA1;BMP1;SNX4;SORL1;HMCES;S100A13;TGFBR1;FLOT1;FOXD1;ELOVL6;KMT5B;NCOA3;PLA2R1;DAB2;GCNT2;APPL2;VAMP7;FGF2;CFL1;SMAD2
prerank,membrane fusion (GO:0061025),0.39974479078208874,1.0458831496526888,0.4324644549763033,1.0,1.0,10/33,16.55%,DNM1;UBXN2A;NAPG;VAMP3;VPS33B;VTI1B;USO1;DNM1L;STX11;NSF
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4220859808735964,1.0457964208125632,0.4306748466257669,1.0,1.0,6/24,12.69%,SELENOS;SYVN1;XBP1;PARK7;CREB3;RACK1
prerank,anion transport (GO:0006820),0.4007660683208184,1.0457683684899277,0.41935483870967744,1.0,1.0,4/33,7.43%,SLC17A5;LRRC8A;VDAC2;SLC13A4
prerank,organic substance transport (GO:0071702),0.35007017334107915,1.0456574195812538,0.4124236252545825,1.0,1.0,34/121,24.23%,ARRDC4;PICK1;KIF3A;SLC22A18;SLC22A4;ABCA2;MIA3;RCN3;LMAN2L;CHMP3;ABCA7;SLC50A1;VPS33B;ABCA6;SCAMP5;SLC6A4;SLC18A1;SCAMP1;ABCD2;TXNIP;RUFY1;SNX4;LRP1B;TOM1;ABCA5;CMTM6;ABCG1;RAB7A;MYH9;SPNS2;ABCA9;PLEKHA8;ABCA1;PEX3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4469428958222365,1.0448494887045945,0.4343832020997375,1.0,1.0,3/17,13.55%,UBASH3A;THY1;PTPN22
prerank,sprouting angiogenesis (GO:0002040),-0.2590429891472983,-1.0448101815597348,0.32142857142857145,0.8614301467814076,1.0,15/51,12.02%,BMPER;ANGPT1;PARVA;RSPO3;SLIT2;PIK3R3;TEK;EPHB4;THBS1;ENG;OTULIN;RNF213;RAMP2;KDR;JMJD6
prerank,protein oxidation (GO:0018158),-0.41172547727157494,-1.044777110126305,0.3902439024390244,0.8592044517733292,1.0,5/11,30.99%,SUMF1;LOX;PRDX3;CHCHD4;TMX3
prerank,mitotic DNA replication (GO:1902969),0.5011523869343429,1.044457678920142,0.4298245614035088,1.0,1.0,1/10,1.55%,LIG1
prerank,negative regulation of cell death (GO:0060548),-0.23864623253052467,-1.0438889983707555,0.35185185185185186,0.8595901747768568,1.0,26/88,18.27%,MECOM;FERMT2;CCN2;ATG5;BNIP3L;PRKD1;BECN1;NCK1;DCPS;LRRK2;ADNP2;CD34;TM7SF3;IKBKG;DUS2;BMP7;CCN3;NENF;BNIP3;TNFRSF1B;BMP4;PINK1;KANK2;CCN5;TMEM109;CCN1
prerank,regulation of tissue remodeling (GO:0034103),0.44957193251428607,1.0437053868092996,0.4272608125819135,1.0,1.0,7/18,24.79%,DDR2;SUCO;LEPR;TGFB1;IL18;SYT7;RUNX1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.49721221888339096,1.0435929456620843,0.4254062038404727,1.0,1.0,4/10,19.20%,ERLEC1;INSIG1;UBE2J1;YOD1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35682852384436264,1.0435842423647896,0.4206602768903088,1.0,1.0,30/84,21.20%,DDX17;RBM3;PCBP4;SRSF12;PRDX6;RBM39;CELF2;SRSF3;CELF1;HNRNPK;TIA1;SRSF9;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;SNW1;FMR1;THRAP3;SON;SRPK1;CIRBP;HNRNPU;TRA2A;PTBP1;RBM7
prerank,chloride transport (GO:0006821),-0.2440154556686357,-1.043358141531952,0.30434782608695654,0.8587575860248066,1.0,27/74,23.88%,ANO4;GABRB1;SLC12A7;SLC4A10;SLC26A7;GABRG2;CLCN3;CLCN6;ANO6;ANO1;GABRA5;SLC12A4;CLIC5;GLRA2;GLRB;GABRA4;SLC12A9;ANO3;SLC12A2;GABRG1;SLC4A8;TTYH3;GABRA1;GLRA3;TTYH1;FXYD1;SLC12A8
prerank,microtubule bundle formation (GO:0001578),0.38292913414820895,1.043204246971351,0.4050925925925926,1.0,1.0,4/42,7.37%,PSRC1;MTCL1;TPPP3;GAS2L1
prerank,cellular response to unfolded protein (GO:0034620),-0.3090045230483053,-1.0431742643852688,0.36923076923076925,0.8569674375806793,1.0,10/26,19.09%,DAB2IP;ERN1;BAG3;HSF1;TM7SF3;TMBIM6;HSPA14;ABCB10;HSPA5;HSPA13
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.48759231239741024,1.0430855854545629,0.4370477568740955,1.0,1.0,3/11,12.54%,UBQLN1;PARK7;LANCL1
prerank,response to hydroxyurea (GO:0072710),-0.4128932352005729,-1.0429892381505275,0.38580246913580246,0.8551869656146284,1.0,5/11,16.92%,KAT7;SPIDR;DDI2;RTF2;BLM
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.4804489808144907,1.0422177138026067,0.4234104046242775,1.0,1.0,3/11,6.98%,FBH1;FBXO5;LIG3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.39843325756795395,1.0421583194231012,0.4315403422982885,1.0,1.0,3/34,4.76%,TNNI3;CALM3;ATP2A2
prerank,defense response to fungus (GO:0050832),0.4410055519649817,1.0421462904140548,0.41201117318435754,1.0,1.0,2/17,7.78%,RNASE7;FAM3A
prerank,lymphocyte mediated immunity (GO:0002449),-0.39705105981570704,-1.0418760174963722,0.4153846153846154,0.8561077006432715,1.0,3/12,17.35%,CD46;MSH2;GNL1
prerank,regulation of monocyte differentiation (GO:0045655),0.4725021074695537,1.0418485884747601,0.43892045454545453,1.0,1.0,2/14,4.02%,IL34;ZFP36L1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4150238708176435,1.041537611248606,0.40310077519379844,1.0,1.0,5/23,11.07%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4150238708176435,1.041537611248606,0.40310077519379844,1.0,1.0,5/23,11.07%,TFDP1;NMT1;YWHAH;YWHAG;BCL2
prerank,neuron apoptotic process (GO:0051402),0.43224254678393137,1.0414533099473366,0.40808344198174706,1.0,1.0,5/19,11.07%,CDK5;FAM162A;CIT;APP;BCL2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4488660666524262,1.0413100325820401,0.4476584022038568,1.0,1.0,7/18,18.02%,CRTC1;LRP8;CRTC3;ADCY1;CAMK1D;EPHA5;PRKD2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.350042088841773,-1.0412701381943459,0.3423076923076923,0.8555568867910288,1.0,6/17,14.29%,CACNA1D;CACNA2D1;KCNJ2;CACNA1C;CACNA1G;CACNB2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.40998967220883265,1.041061292872824,0.4226044226044226,1.0,1.0,8/28,18.18%,EPHB2;ABL1;SQSTM1;APP;YTHDF1;ADCY1;APOE;ZDHHC2
prerank,osteoclast differentiation (GO:0030316),-0.3236843715787565,-1.0408327669007684,0.3836734693877551,0.8545477462181043,1.0,6/22,15.91%,FOXP1;SBNO2;OSTM1;GLO1;SRC;TNFRSF11A
prerank,glycerolipid metabolic process (GO:0046486),-0.3987234652779883,-1.0407991296868286,0.4417910447761194,0.8523589449153334,1.0,6/11,28.66%,DGKB;DGKZ;DGKG;DGKQ;PLA2G15;PGP
prerank,cellular macromolecule catabolic process (GO:0044265),0.3758214234367161,1.0407022029937332,0.4221218961625282,1.0,1.0,9/49,10.46%,DNASE1L2;EXOSC7;NGLY1;DFFB;RAB12;MANBA;PABPC4;HNRNPD;MTREX
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4038527736423475,-1.040694502934445,0.3641791044776119,0.8480915712098135,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4038527736423475,-1.040694502934445,0.3641791044776119,0.8480915712098135,1.0,3/11,9.38%,TNRC6A;AGO2;RBM4
prerank,L-amino acid transport (GO:0015807),-0.3044099213655007,-1.0405789002502357,0.35714285714285715,0.8461886136684493,1.0,6/28,10.89%,ARL6IP5;SLC25A13;SLC3A2;SLC7A1;SLC36A4;CTNS
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2567330407378927,-1.0405712808125942,0.35135135135135137,0.8439701855909933,1.0,19/55,18.83%,CRADD;DAB2IP;CAV1;RIPK1;PML;GSDME;BECN1;BCL2L1;TPD52L1;TP53;TNFSF10;CYLD;TRIM39;FAS;TRAF7;LTBR;SIAH1;ING5;TNFSF12
prerank,positive regulation of histone modification (GO:0031058),0.39785288796974927,1.0403984931451808,0.4233055885850178,1.0,1.0,10/33,19.34%,NIPBL;CDK9;AKAP8L;ZBTB7B;ARRB1;SART3;SAP30BP;CTBP1;FMR1;TET1
prerank,L-serine metabolic process (GO:0006563),0.4991405131889915,1.0402792898038205,0.45413533834586467,1.0,1.0,1/10,2.30%,PSAT1
prerank,programmed necrotic cell death (GO:0097300),0.437161175232232,1.0401321302750206,0.4355909694555113,1.0,1.0,7/18,20.53%,PPIF;LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34481064011895124,1.0400713095138512,0.42142857142857143,1.0,1.0,21/140,16.59%,PTGER4;CCR9;ACKR2;FIS1;GRIN1;C1QTNF1;ABL1;CXCR4;CD24;BDKRB2;SELENOT;GPR4;TBXA2R;PDGFRA;HTR2C;NPTN;LPAR1;LPAR6;JPH1;AGTR1;ADCY5
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4044184439079695,1.0400347805713672,0.4571078431372549,1.0,1.0,9/30,20.71%,IGF1;FGF10;RASGEF1A;RAPGEF1;IRS2;STK19;ERBIN;LYN;ITGAV
prerank,regulation of activated T cell proliferation (GO:0046006),0.40369406184858025,1.0397658356524535,0.43014705882352944,1.0,1.0,3/30,7.55%,IGF1;SCRIB;CD24
prerank,generation of neurons (GO:0048699),0.34194165890411576,1.0393438125983747,0.40986908358509566,1.0,1.0,28/190,14.07%,WNT2B;WNT5A;RAC1;DCDC2;CDKL5;FGFR1;FZD3;NRP1;CDK5;TUBB2A;BRSK2;WNT4;CIT;SPOCK1;PRUNE1;NRBP2;SOX11;BRSK1;LRP12;SMARCA1;IL1RAPL1;DOCK7;MYEF2;USP9X;DISC1;MAPT;AUTS2;PEX13
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3865609854232434,1.0393308025388526,0.4266984505363528,1.0,1.0,8/38,12.69%,TSC2;THEM4;FLCN;DDIT3;PIK3CB;MAGI2;DAG1;RACK1
prerank,embryonic organ morphogenesis (GO:0048562),0.3803847612483469,1.0391117154038152,0.4129181084198385,1.0,1.0,8/42,12.67%,FBN2;FGFR2;NIPBL;MFAP2;MFAP5;SOX11;PDGFRA;FBN1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.32994374430324025,-1.0383855417090637,0.34782608695652173,0.84824557420147,1.0,11/22,37.79%,SORBS1;CREBL2;PPARD;CREB1;AKT1;PPARG;PPARA;SIRT4;DISP3;MLXIPL;ANGPTL3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.40140538892876076,-1.0383853532380167,0.39943342776203966,0.846013349006203,1.0,5/11,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,protein localization to cell surface (GO:0034394),0.410657945756623,1.0378226745827455,0.43017456359102246,1.0,1.0,10/26,17.33%,FGF10;PIGU;JAM3;RIC3;FBLN5;PIGK;EMP2;USP4;GGA2;SMURF1
prerank,negative regulation of axonogenesis (GO:0050771),0.4118240599673132,1.0377566028045733,0.43828715365239296,1.0,1.0,11/27,23.89%,DIP2B;THY1;EFNB3;MCF2;RUFY3;DCC;PTPRS;FGF13;MAP2;LRP4;PTEN
prerank,positive regulation of interferon-beta production (GO:0032728),0.39806589586028485,1.0376994335291656,0.434052757793765,1.0,1.0,8/33,13.29%,HSP90AA1;POLR3D;DDX3X;IRF1;DHX58;TRIM56;IRF3;TLR3
prerank,gastrulation (GO:0007369),-0.3667304721306932,-1.0376635059448076,0.3745583038869258,0.8459479189541109,1.0,1/15,0.19%,TASOR
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.437291756680173,1.037406859120543,0.43320363164721143,1.0,1.0,3/18,13.72%,LIG1;LIG3;POLD3
prerank,epidermal cell differentiation (GO:0009913),0.3823757872762004,1.0371231522383133,0.4274004683840749,1.0,1.0,7/41,18.58%,WNT5A;SCEL;ANXA1;HDAC1;TXNIP;JAG1;PIP5K1A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3400834743616037,1.0369445474311947,0.3877755511022044,1.0,1.0,85/264,22.27%,RAVER2;LSM6;DDX17;LSM7;COIL;SMN1;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;CDK13;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PRMT5;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;SRPK1;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,neuron projection organization (GO:0106027),0.45166997509250484,1.036795935346455,0.4353932584269663,1.0,1.0,4/15,15.47%,PICK1;ATP1A3;APP;ABCD2
prerank,hemopoiesis (GO:0030097),0.35585153138773284,1.0367825994224196,0.42462845010615713,1.0,1.0,8/87,5.45%,SFRP2;WNT2B;WNT5A;SFRP1;FGFR2;TIRAP;CDK13;FLCN
prerank,tRNA methylation (GO:0030488),0.39227389126596063,1.0365865803256542,0.42266824085005905,1.0,1.0,7/34,12.90%,TRMT61B;TRDMT1;WDR6;PRORP;TRMT1;METTL2B;METTL2A
prerank,cartilage development (GO:0051216),0.37300334079963154,1.036473636232372,0.4227373068432671,1.0,1.0,9/49,17.12%,WNT2B;GPLD1;SULF1;TRIP11;SOX9;SOX6;TGFB1;SOX5;OSR1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4095435458954068,1.0363956131951912,0.43478260869565216,1.0,1.0,5/25,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4329541214489227,1.036307848131935,0.4231770833333333,1.0,1.0,5/21,14.99%,LPIN1;LPIN3;LPIN2;CYP26B1;FAH
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4271859093034977,-1.0362505483820486,0.4481707317073171,0.8477500469709142,1.0,4/10,6.32%,DROSHA;TSN;AGO2;TSNAX
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.37758898150601206,1.036214772696186,0.42970521541950113,1.0,1.0,15/46,18.63%,RAC1;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;ATRN;ILK;MEGF9
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.3890999301721339,-1.036106789401554,0.4065573770491803,0.8459545607077825,1.0,10/12,30.20%,ACO2;ACO1;IDH1;ACLY;IDH2;IDH3A;IREB2;SIRT4;GLUD1;IDH3G
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.468754548270468,1.0352893394729048,0.4460856720827179,1.0,1.0,6/12,19.58%,ABCA2;ABCA7;TMED10;ROCK2;APOE;RANBP9
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.24210741378342662,-1.0352439245871234,0.36619718309859156,0.8462669647334667,1.0,24/75,27.40%,SLC12A7;ATP1B3;SLC9A2;SLC39A14;CACNA2D1;ATP1A1;KCNJ2;SLC24A2;ABCC9;SLC39A8;ATP1B1;SLC39A12;SLC12A4;SLC12A9;SLC39A10;SLC12A2;KCNJ3;KCNK9;HCN2;TRPV2;SLC12A8;KCNJ12;SLC12A6;TRPV4
prerank,regulation of B cell proliferation (GO:0030888),0.37433860629473326,1.035159604374882,0.4183082271147161,1.0,1.0,5/44,11.07%,FCGR2B;EPHB2;TIRAP;IRS2;BCL2
prerank,cellular response to hypoxia (GO:0071456),0.3438088141934517,1.035144777703412,0.4209445585215606,1.0,1.0,29/126,17.57%,CPEB1;UBQLN1;SFRP1;SIRT2;PSMD4;STUB1;RORA;ZFP36L1;CARD16;FAM162A;PSMB10;ARNT;PSMD11;TBL2;MDM4;NDRG1;TWIST1;PSME2;PSMC5;SUV39H1;AK4;BACH1;EGLN2;PTGS2;PSMD1;NDNF;PSMD6;HP1BP3;MDM2
prerank,heart development (GO:0007507),0.34384126445849333,1.0347777105175717,0.4331983805668016,1.0,1.0,32/150,20.60%,APLN;PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;NIPBL;SOX9;FLRT2;ADAP2;FGF12;BMP5;NDRG4;FBN1;AKAP13;TGFB1;FOXC2;MEGF8;KDM6B;OSR1;PKD2;TGFBR1;SCUBE1;SOX4;KDM6A;DLC1;CHD7;TGFBR3
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.4958257485405812,1.0344244273724845,0.45156482861400893,1.0,1.0,11/11,50.45%,MALT1;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;NFKBID
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.41579439954215974,-1.0344085806148213,0.41714285714285715,0.8465268329285827,1.0,4/10,17.43%,PCGF5;PRMT7;IGF2;KDM1B
prerank,histone modification (GO:0016570),0.34701039475456075,1.0342754250343158,0.4364012409513961,1.0,1.0,32/109,20.24%,SIRT2;INCENP;SIRT7;PRMT6;MIER2;PARP2;EZH2;HDAC5;EHMT2;NTMT1;HDAC4;RCOR1;BRD8;TAF6;NSD3;USP3;MTA2;PARK7;HDAC1;UBE2A;PRMT1;EHMT1;EYA2;PRMT8;NSD1;TBL1XR1;SGF29;USP22;PRMT2;CARM1;MIER1;EYA1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3934989390231597,1.0342190676167025,0.43990384615384615,1.0,1.0,9/33,19.75%,CDKN2D;WEE1;PLK5;RBL2;NACC2;CDC73;PKD2;PRMT2;KLF4
prerank,phosphatidylserine metabolic process (GO:0006658),0.39588836597213295,1.0341398567779303,0.4311163895486936,1.0,1.0,1/32,0.14%,PLA2G5
prerank,nuclear envelope organization (GO:0006998),0.4282148045990058,1.034046568603918,0.43342391304347827,1.0,1.0,5/20,11.77%,REEP4;DMPK;TOR1B;TMEM43;LEMD3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.35225751954609663,-1.0339645489777418,0.4312267657992565,0.8457387007167971,1.0,4/16,10.48%,PDS5B;RB1;PDS5A;MAU2
prerank,regulation of telomere maintenance (GO:0032204),0.4140785563948082,1.0330698447602615,0.4475703324808184,1.0,1.0,10/26,21.36%,GNL3;USP7;HNRNPD;DHX36;ATRX;MRE11;RAD50;TERF2IP;PPP1R10;SMG1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.35128998616449736,-1.0330136287971687,0.3857677902621723,0.8462743511679531,1.0,5/17,7.09%,ARL6IP5;TAOK2;RNF13;TGFB2;EIF2AK2
prerank,negative regulation of cyclase activity (GO:0031280),0.4517139294675758,1.0326217471178887,0.44382801664355065,1.0,1.0,2/14,7.66%,LTB4R2;ADGRV1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3715720749548013,1.0324945996426864,0.44407158836689037,1.0,1.0,14/52,16.69%,CUL7;KDELR3;EDEM1;SYVN1;XBP1;WIPI1;EXTL3;EXTL2;SERP1;PARP16;CTDSP2;VAPB;FKBP14;ACADVL
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3382071219513539,1.032449103066222,0.42814070351758793,1.0,1.0,29/198,14.72%,PLA2G5;DUSP28;DUSP18;XYLB;HKDC1;LPL;EPHA7;G6PC3;EPHB2;PLCH1;PIP4K2B;TAOK1;AGPAT1;CDK5;PPA2;PLPPR2;INPP5A;ACYP2;TOP1;PIK3CB;NUDT3;IPPK;ENPP1;HDHD2;PLPP3;PIP4K2A;PLPPR5;TGFB1;EPHX2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.39530619909523523,1.0324420381947905,0.43063932448733416,1.0,1.0,3/32,6.13%,PDPK1;GRIN1;THY1
prerank,response to cholesterol (GO:0070723),0.44108662235381924,1.0323105040940608,0.4418918918918919,1.0,1.0,4/17,8.42%,GPLD1;MLC1;ABCA2;PTCH1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.34583481624199297,1.031876708770217,0.43260188087774293,1.0,1.0,23/98,18.57%,EPHB2;PDPK1;FIS1;TFDP1;SLC5A3;MTCL1;MIEF2;PIK3R1;SQSTM1;NMT1;YWHAH;CLIP3;YWHAG;BCL2;ANK3;PRKCI;LRP1;DPP10;SPTBN1;ITGB1BP1;KIF5B;CEMIP;PDCD5
prerank,mRNA processing (GO:0006397),0.33765742437390434,1.0318212363011245,0.40981963927855714,1.0,1.0,95/287,22.27%,RAVER2;LSM6;LSM7;RPRD2;TBRG4;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;GEMIN2;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;CELF1;HNRNPK;AKAP8L;FUS;THOC3;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;AURKAIP1;KIN;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;GTF2H3;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CCNH;CPSF3;HNRNPA0;THOC7;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;THOC1;DDX5;YTHDC1;SNW1;CDK7;SON;SRRM1;PRPF40B;CPSF6;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;SARNP;PTBP1;SART1;SRRM2;ISY1;TCERG1;GTF2F2;HNRNPUL1;METTL14;PNN
prerank,regulation of viral genome replication (GO:0045069),0.37137649641416537,1.0314421423426408,0.43843498273878023,1.0,1.0,12/56,18.52%,ILF3;TARBP2;DDX3X;DDB1;PPIH;PABPC1;SHFL;VAPB;ZC3HAV1;OAS2;TNIP1;SRPK1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.37569433890685316,-1.031356804131327,0.3879598662207358,0.849004829895659,1.0,4/13,7.30%,LATS1;FLNA;NFKBIA;GOPC
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3662749688752909,1.0310354606341279,0.432967032967033,1.0,1.0,23/61,22.00%,GNL3;APLF;RNF8;USP7;FGF10;WRAP53;RNF168;DHX36;CEBPG;USP9X;ATRX;EYA2;MRE11;RAD50;PRKD2;MECP2;UIMC1;RPS3;PPP1R10;EYA1;FGF2;NPAS2;HMGB1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.34328393433859283,1.0308417951959026,0.43536711478800416,1.0,1.0,25/113,16.69%,LCP1;BAX;PARP1;HSP90AA1;STUB1;WARS1;DDX3X;TIRAP;SLF2;DDB1;TPPP3;DHX33;CUL4B;VCP;GTF2H3;PSMC5;PARK7;RACK1;ATR;NRG1;TGFB1;FAF1;IL5;TERF1;TPPP
prerank,nucleotide catabolic process (GO:0009166),-0.3599247922290069,-1.030753298807686,0.39453125,0.8485579339840081,1.0,9/16,30.67%,NT5C2;SAMHD1;DERA;NT5E;ITPA;GPX1;PNP;GDA;NT5C
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.383866084020972,1.030614515865875,0.4406580493537015,1.0,1.0,14/37,22.71%,S1PR2;SIRT2;CALM3;DMTN;EGF;APP;TGFB1;SPRY2;CEMIP;CALM1;PRKAG2;SMAD7;CALM2;WNK3
prerank,negative regulation of cell growth (GO:0030308),0.3430567882518363,1.0304827733022879,0.444672131147541,1.0,1.0,12/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;DIP2B;FLCN;STK11;TCHP;PPP1R9B
prerank,negative regulation of response to stimulus (GO:0048585),0.3686196018950039,1.0300186595771448,0.4380434782608696,1.0,1.0,9/60,10.88%,FCGR2B;CASK;BRAP;THY1;FBXO5;SRMS;SLC30A10;TWIST1;IGFBP3
prerank,regulation of catabolic process (GO:0009894),0.4401809781095639,1.0297052546338998,0.45081967213114754,1.0,1.0,7/18,20.98%,SNF8;HGS;FAF1;CHEK2;MDM2;ZDHHC2;ITGB1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4108150677641724,-1.0295945154241815,0.43333333333333335,0.8497049035540805,1.0,6/11,41.68%,MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,regulation of translation (GO:0006417),0.33744308928069605,1.0295268767451091,0.4397163120567376,1.0,1.0,41/173,16.79%,ILF3;MIF4GD;PAIP2;RBM4B;EIF2AK3;RBM3;PAIP1;DDX3X;CNOT10;IGF2BP2;METAP1;EIF1B;CYFIP1;EPRS1;HNRNPD;DHX36;PUM3;PUS7;APP;ZCCHC4;SHFL;EIF4E2;CNOT9;EIF4G2;NEMF;MALSU1;YTHDF3;EIF1;NPM1;RACK1;RPS6KA3;GSPT1;DAPK1;YTHDF1;PRR16;IMPACT;MRPL13;RPS6KA1;MTG2;EIF4G3;FMR1
prerank,bone development (GO:0060348),0.380255963050384,1.0292335552388305,0.43568945538818077,1.0,1.0,8/39,12.92%,PTGER4;FGFR2;SULF1;RANBP3L;GNAS;PPIB;CYP26B1;AKAP13
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3411501672156015,1.0290926194498056,0.4352226720647773,1.0,1.0,37/159,21.72%,AMIGO1;FGFRL1;LRRC4;ATP2C1;OBSL1;CLDN11;GPC6;TENM3;IGSF21;DSCAM;CDH11;CLDN12;IGSF11;ROBO2;ROBO1;PTPRF;IL1RAPL1;GPC4;NPTN;ALCAM;UNC5D;CDH18;TENM4;ICAM1;PLXNB3;CDH20;CDH19;CDH7;CDH4;SLITRK1;CNTN2;PTPRS;NEXN;CDH9;ITGB1;PCDHB16;CDH10
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.41254972738159174,1.0290437014047344,0.4312267657992565,1.0,1.0,7/23,19.74%,WEE1;PLK5;CDK5RAP3;CHFR;ZWINT;NABP2;ZW10
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3362766636798189,-1.0290428708957025,0.4,0.8492585030853065,1.0,10/20,14.38%,MORC3;PML;SKP1;SP100;SUN2;ARL2BP;TAF8;RANGAP1;BBS4;TAF3
prerank,negative regulation of biosynthetic process (GO:0009890),0.4443744378446476,1.0288019143948974,0.4314516129032258,1.0,1.0,5/16,15.47%,SLC30A10;PARK7;COA8;ABCB7;ABCD2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.35663830040723976,1.0286228352194802,0.45016077170418006,1.0,1.0,22/84,18.59%,CDC23;PSMD4;UBE2S;MAD2L1;CDC16;FZR1;ANAPC2;FBXO5;FBXO31;PSMB10;PSMD11;PSME2;PSMC5;ANAPC11;ANAPC4;CDC26;PSMD1;UBE2E1;UBE2D1;PSMD6;ANAPC10;ANAPC5
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.328956457368654,1.0283275143098898,0.324,1.0,1.0,339/1668,18.39%,SFRP2;METTL23;CBX8;CAMTA2;MMP12;HDAC3;HEXIM1;TEAD3;LAGE3;WNT5A;PTPRN;ZSCAN12;ZMYM5;WBP2;HSF2;POU6F1;ZNF418;IGF1;MED24;DUSP26;SP7;DVL2;ZNF23;MPND;FOXM1;BAX;SIRT2;ZBTB48;SIRT7;POU5F2;DDX17;CRTC1;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;AASS;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;BMP6;PARP1;ZEB2;CREBZF;IL33;USF1;NR2F2;FGFR2;MLXIP;TEF;NKX6-1;MED12;TAF9B;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;GRIN1;PCGF1;ZNF8;ZFP82;HTATIP2;XBP1;ACTR2;RORA;TFDP1;MIER2;NFKB2;CARF;DDX3X;MXI1;ABCA2;ZNF205;LPIN1;SNF8;NIPBL;CCNC;OGT;CHD8;VGLL3;POU2F1;RFX5;CDK13;SNAI1;SLTM;CDK9;ZNF692;FLCN;MRTFA;NPAT;TCF4;TCF7L2;TFCP2;ZNF276;BBS7;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;ATXN1;DVL1;ZNF35;ZIC3;CASZ1;HNRNPK;EZH2;AKAP8L;FUS;ARNT;ZBTB7B;RTF1;ZEB1;SMARCB1;CHD5;TEAD1;HDAC5;PCGF6;MOSPD1;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;PID1;MED4;ZKSCAN5;DBP;NFX1;PRPF6;ARRB1;TSHZ2;SLC30A9;SOX9;SRA1;SMARCD1;PTCH1;EHMT2;DDIT3;BRD3;PGBD1;CRTC3;SDCBP;DPF2;LPIN3;ZFHX2;XRCC6;PER1;ECD;ARID1B;DHX36;MDM4;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;TWIST1;CALCOCO1;PSIP1;PRRX1;NKRF;GTF2H3;TCEA1;HOXB8;USP2;GDNF;ATF2;POU6F2;SSBP4;RCOR1;PSMC5;ZBTB20;BRD8;ZNF445;KDM2B;APP;TAF6;JUP;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;PIK3R2;SARS1;BACH2;MAZ;NFAT5;IRF3;CAMK2D;JAZF1;BMP5;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;MTA2;E2F3;NFIX;BRIP1;BACH1;PARK7;ZNF462;PEG3;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;LPIN2;ZFP2;AGO3;CREB3;CREB3L4;ZNF383;RPS6KA3;USP9X;PROX2;SETX;SUFU;TLR3;ZBED3;CBFB;ABHD14B;CDC73;FOXJ3;ATRX;ZHX2;EBF1;AUTS2;ZIC2;TGFB1;MED21;RGMA;TRPS1;ESRRG;CAMTA1;BCL6;BAZ2B;BCLAF1;ZNF292;IMPACT;SMAD6;SOX5;KMT2D;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;SSBP2;FOXC2;CIC;HSPD1;THAP3;RPS6KA1;DDX5;TRAK1;AHI1;GTF2IRD1;MAF;SAFB2;UBE2D1;CTBP1;HOXC8;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;SERPINE1;TNKS;CBX5;KDM6B;ITGB1BP1;THRAP3;CBX7;PHIP;ZFP37;CDK7;KDM3B;MTDH;SOX13;ZBTB41;OSR1;HSBP1;APOE;ZFP90;TNIP1;TLE5;TCF7;NSD1;MDM2;GABPB1;GABPB2;ANXA4;RAD21;MEIS2;TBL1XR1;PRKD2;PKD2;RELB;ZNF177;PHF12;RBBP8;RNF111;ATN1;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GPS2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4552045511716773,1.0283253159668793,0.4511173184357542,1.0,1.0,2/13,7.66%,LTB4R2;ADGRV1
prerank,smooth muscle tissue development (GO:0048745),0.48823604230857093,1.0283130081036884,0.4556040756914119,1.0,1.0,2/10,8.42%,STRA6;PTCH1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.34205009204843373,-1.0275757024858487,0.41732283464566927,0.8514145773875491,1.0,12/18,33.13%,SIRT1;HIF1A;TRAP1;PINK1;HSPB1;NFE2L2;AKT1;PRKN;MAPK7;BAG5;NME5;HTRA2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3949596077624944,1.0273402221361525,0.4491725768321513,1.0,1.0,8/33,14.38%,LRRC4;NTF3;GRIK5;LRP8;NRG3;PSMC5;NLGN3;NLGN2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.47502665620108714,1.0272338751777745,0.47421203438395415,1.0,1.0,5/13,16.67%,PLXNA2;NRP1;PLXNA1;SEMA3A;PLXNB3
prerank,regulation of centriole replication (GO:0046599),0.439695588002299,1.027233730416677,0.4392156862745098,1.0,1.0,5/17,17.13%,MDM1;ALMS1;NPM1;SPICE1;CEP76
prerank,activation of protein kinase activity (GO:0032147),0.34512455527916247,1.026986462025732,0.45492227979274613,1.0,1.0,29/106,21.25%,WNT5A;IGF1;PDPK1;ADCY7;NTF3;TAOK1;MINK1;TIRAP;ABL1;PAK3;STK11;PIBF1;MALT1;PRLR;STRADB;PARK7;TLR3;EMP2;NRG1;ADCY1;ADCY5;ITGB1BP1;CCDC88A;PRKAR1A;NRK;PTK2B;PAK5;MAPKAP1;MAP4K4
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3322353518494156,1.0268726942317903,0.427,1.0,1.0,91/336,20.64%,WDHD1;XRCC2;APTX;LIG1;BAX;SIRT7;CDKN2AIP;PARP1;APLF;RNF8;PAXX;UBE2E2;TAOK1;NIPBL;PARP2;MGMT;USP47;ASF1A;FBH1;SLF2;ABL1;FBXO31;DDB1;BARD1;PHF1;SETD7;TDP1;FBXO45;STK11;FANCG;ZBTB38;XIAP;PLK5;UBA1;DDIT3;USP10;RNF168;KIN;CUL4B;MRNIP;VCP;CASP9;GTF2H3;ATF2;POLH;MTREX;BRSK1;SUV39H1;ENDOV;USP3;BCL2;ALKBH3;IRF3;YY1;BACH1;PARK7;NPM1;UBE2A;ATR;SETX;MMS19;HELB;BCL6;FANCA;MRE11;CASP2;CHEK2;RAD50;CBX5;FMR1;UBR5;TANK;TOPORS;NABP2;SUSD6;PWWP3A;DCUN1D5;HMCES;RBBP8;FMN2;RECQL5;ALKBH1;RPS3;VCPIP1;KMT5B;INO80;FANCL;UVRAG;LYN;MAPKAPK2;RAD18
prerank,cellular response to reactive oxygen species (GO:0034614),0.3606509181687402,1.0267468643252253,0.4489571899012075,1.0,1.0,14/59,14.79%,MAPK9;PPIF;ANXA1;TNFAIP3;PRDX5;ABL1;SIRPA;TPM1;PDGFRA;OSER1;PARK7;SETX;MAPT;IMPACT
prerank,sensory perception of light stimulus (GO:0050953),0.3479541590639499,1.0265467992863573,0.44456177402323127,1.0,1.0,10/87,14.68%,GPR179;BEST1;RDH10;PCDH15;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,cell differentiation in spinal cord (GO:0021515),0.48592311091695745,1.02642769304048,0.444947209653092,1.0,1.0,4/10,20.79%,SOX6;SOX13;SOX4;MDGA2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.47110660118782915,1.026420987130064,0.460545193687231,0.9996584500616642,1.0,6/12,21.65%,FGF9;TPM1;DOCK7;ADAMTS1;DOCK5;IGFBP5
prerank,negative regulation of reproductive process (GO:2000242),0.4316457459855682,1.0252459887767627,0.45135135135135135,1.0,1.0,2/17,5.67%,IGF1;SULF1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3070403666011313,-1.025058658135003,0.41935483870967744,0.8566575676461236,1.0,5/24,11.10%,MEF2A;MEF2C;SPAG9;RBM4;CAMK1
prerank,regulation of lymphocyte migration (GO:2000401),-0.41636190133670836,-1.0250541286622366,0.41411042944785276,0.8544916015212676,1.0,6/10,27.01%,JAM2;SLC8B1;STK10;MSN;AKT1;WASL
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4559564494872321,1.0246862182447216,0.4596888260254597,1.0,1.0,3/13,14.28%,SOX9;SRA1;TGFB1
prerank,positive regulation of DNA replication (GO:0045740),-0.3441337696442988,-1.024610107940905,0.3992932862190813,0.85363234053532,1.0,4/16,7.16%,EGFR;KAT7;BCAR3;STN1
prerank,negative regulation of innate immune response (GO:0045824),0.3886826103683766,1.0244142420961828,0.4551971326164875,1.0,1.0,7/34,12.01%,TNFAIP3;SERPING1;DHX58;TRAFD1;FAM3A;USP15;YTHDF3
prerank,motor neuron axon guidance (GO:0008045),0.4462006482122661,1.0243692002085132,0.4414668547249647,1.0,1.0,6/15,22.67%,RAC1;TMEFF1;SLIT1;SEMA3A;CHN1;EPHA4
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.40426673995379725,1.0241223771900199,0.4420654911838791,1.0,1.0,6/26,13.35%,IGF1;CAPN10;PIK3R1;CLIP3;IRS2;PRKCI
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.34163011750114125,-1.0240490902669654,0.38589211618257263,0.8531376598180964,1.0,6/18,23.74%,JAM2;SLC39A8;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.47970381920569305,1.0239098200768846,0.46747352496217853,1.0,1.0,3/11,7.40%,CCT8;CCT6A;WRAP53
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.42606714259202433,1.0233864753035302,0.45235069885641677,1.0,1.0,6/20,18.56%,UBQLN1;HSP90AA1;ZMIZ1;DAXX;DCUN1D5;TGFBR1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.397117710834668,1.0233532475970264,0.44512946979038226,1.0,1.0,6/28,9.63%,ABITRAM;GBA2;CXCL12;PAK3;DBN1;DBNL
prerank,neuron projection development (GO:0031175),0.3339256423624334,1.0231728677839034,0.450050454086781,1.0,1.0,53/168,23.00%,STMN4;EPHB2;NTF3;GPRIN1;TAOK1;CTNND2;MINK1;NEFH;CDK5;SRGAP2;PAK3;EPHA8;DBN1;TMEM108;CAMSAP2;ADGRV1;PPP1R9B;DBNL;GDNF;APP;LRP12;ALS2;BLOC1S2;MAPK8IP3;BICDL1;DOCK7;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;EPB41L3;CNTNAP2;TRIO;SLC9A6;APOE;MAP4;ATCAY;GAS7;KIF20B;SHANK1;NRK;ATXN10;LYN;NBL1;EHD1;MAP4K4;RYK;HMGB1;CAMSAP1;PAK1;EPHA4;MAP2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.42182474158282063,1.0227059907113074,0.43359375,1.0,1.0,5/21,12.27%,BRD4;FBXO5;CDC25A;VPS4B;NPM1
prerank,regulation of plasminogen activation (GO:0010755),0.4733261059156538,1.0225185246245965,0.4430379746835443,1.0,1.0,3/12,16.49%,CLEC3B;CTSZ;SERPINE1
prerank,myoblast differentiation (GO:0045445),0.4614969102982083,1.0224980693220775,0.4563953488372093,1.0,1.0,6/14,16.44%,IGF1;DDX17;TCF7L2;NRG1;DDX5;JAG1
prerank,negative regulation of hemostasis (GO:1900047),0.46513016873561064,1.0213949057602345,0.4498567335243553,1.0,1.0,4/12,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,phospholipid dephosphorylation (GO:0046839),-0.27854810622988657,-1.0212779406269348,0.4217687074829932,0.8591326690802034,1.0,7/37,5.95%,PIP4P2;INPP5F;MTMR12;MTMR10;OCRL;MTMR3;INPP5K
prerank,regulation of ruffle assembly (GO:1900027),0.41445045329004954,1.0208337600463284,0.45363408521303256,1.0,1.0,1/23,0.06%,CARMIL2
prerank,organelle fission (GO:0048285),0.4120907281770912,1.020560945873892,0.4550063371356147,1.0,1.0,6/24,14.84%,DNM1;FIS1;SEC16B;MTFR1L;GDAP1;DNM1L
prerank,positive regulation of gene expression (GO:0010628),0.32781714656508326,1.0203463514032363,0.45,1.0,1.0,94/442,19.80%,FGF20;FGF9;MAPK9;WNT5A;EPB41L4B;TMEM119;WBP2;PTGER4;IGF1;EPHB2;BMP6;EIF2AK3;IL33;RBM3;WARS1;ERP29;DDX3X;SNF8;C1QTNF1;AGPAT1;FGF10;FUBP1;SF3B1;OLFM1;TBP;PIK3R1;CELF1;ZBTB7B;NOS1AP;HGS;SEC16B;PID1;SOX9;HNRNPD;RBMS3;DHX36;EGF;SOX11;TWIST1;CALCOCO1;MUSK;ATF2;PIK3CB;APP;RBPJ;ZCCHC4;ANK3;MAZ;ROBO1;IFNGR1;YTHDF3;PARK7;POLR2K;NPM1;TADA3;AGO3;LAMTOR5;SETX;TLR3;SCAMP5;YTHDF1;PTPN22;FAM98A;ROCK2;PRR16;TGFB1;MAP2K2;EPHX2;F3;HNRNPLL;MED23;CTSH;DDX5;POLR1A;FMR1;UBR5;SPRY2;OSR1;CAMK2N1;S100A13;RBM22;METTL5;TGFBR1;PDCD5;FLOT1;PRKAA1;TAF1B;FOXD1;SOX4;RPS3;MITF;KLF4;CIRBP;GABPA
prerank,cellular response to UV (GO:0034644),0.3465458314754318,1.0203110046477835,0.4701492537313433,1.0,1.0,14/76,12.82%,MFAP4;PARP1;SDE2;CARD16;USP47;DDB1;STK11;CDC25A;DHX36;CUL4B;CASP9;YY1;NPM1;ATR
prerank,regulation of inflammatory response (GO:0050727),0.338171977259597,1.0198933590302834,0.4482412060301508,1.0,1.0,32/190,17.26%,SMPDL3B;WNT5A;LPL;PTGER4;DDT;SELENOS;IL33;NR1D2;ANXA1;RORA;TNFAIP3;BRD4;VAMP3;CELF1;SNX6;CD200R1;SIRPA;XIAP;IFI35;GPRC5B;GPR4;APP;PARK7;CD47;TLR3;PTGS2;BCL6;LACC1;AGTR1;SERPINE1;APOE;TNIP1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4038090740233854,1.0197823659038279,0.4509316770186335,1.0,1.0,7/27,11.84%,GPD1L;YWHAH;SCN2B;SLMAP;FGF12;CAMK2D;PTPN3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3243704081906435,-1.0194067391814832,0.38,0.8604130181784323,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.3243704081906435,-1.0194067391814832,0.38,0.8604130181784323,1.0,12/24,28.14%,HK1;GPI;PKM;FOXK2;ALDOA;ENO1;HK2;PFKM;GAPDH;FOXK1;ALDOC;PFKL
prerank,RNA catabolic process (GO:0006401),0.368363882796898,1.0193520413967527,0.4487034949267193,1.0,1.0,11/46,16.22%,LSM6;EXOSC7;CNOT10;PABPC4;HNRNPD;NUDT12;MTREX;AGO3;SND1;DIS3L2;NUDT16L1
prerank,amide biosynthetic process (GO:0043604),0.3661868745148003,1.0193516164617626,0.4575087310826543,1.0,1.0,8/47,13.94%,ASL;SMPD2;PCSK5;CERS2;SPTSSA;TLCD3B;PAM;SMPD4
prerank,regulation of blood coagulation (GO:0030193),0.4031183962609207,1.018649767784649,0.48194271481942713,1.0,1.0,6/27,17.19%,VTN;EPHB2;DMTN;TFPI;SERPINE1;APOE
prerank,regulation of cell migration (GO:0030334),0.3283272939318789,1.0184344611978136,0.455,1.0,1.0,91/382,21.29%,FGF20;CARMIL2;SFRP2;FGF9;CLN3;CAMK2B;SFRP1;IGF1;EPHB2;ELP6;FAM83H;NTF3;RAC1;PLXNA2;MGAT3;ANXA1;XBP1;CXCL12;MINK1;FGF10;PRKCA;SNAI1;FLCN;SULF1;CD151;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;RHOD;RFFL;PODN;PLXNA1;SDCBP;EGF;RIPOR1;SEMA3D;NTNG2;SRCIN1;ENPP2;TPM1;MAZ;PDGFRA;ROBO1;MAGI2;YTHDF3;DAG1;SOD2;RACK1;ROR2;LAMB1;RNF41;ROCK2;TGFB1;SLURP1;ARSB;SEMA3E;F3;SEMA3A;CTSH;NKD1;JAG1;SERPINE1;PLXNB3;DPEP1;SPRY2;RUFY3;MCTP1;SORL1;CEMIP;AMOT;TGFBR1;MMP14;MITF;CARMIL1;DLC1;DAB2;NEXN;GCNT2;PTK2B;TBCCD1;NF2;SMAD7;SRGAP1;ITGB1;APPL2;SGK3;DLG5;MAP4K4;FGF2
prerank,adherens junction organization (GO:0034332),-0.2655599269391418,-1.0181090241067736,0.4090909090909091,0.8619889905379889,1.0,16/48,21.26%,FERMT2;CADM2;TJP1;ACTB;CDH6;CADM1;CDH1;CSK;RAMP2;NECTIN3;NECTIN1;PIP5K1C;CADM3;NECTIN2;DCHS1;PVR
prerank,positive regulation of exosomal secretion (GO:1903543),0.4533136217599638,1.0179356460246136,0.4596888260254597,1.0,1.0,4/15,12.16%,SNF8;HGS;SDCBP;VPS4B
prerank,regulation of protein processing (GO:0070613),0.4235602251075006,1.0178490464125867,0.4680573663624511,1.0,1.0,2/21,4.19%,CLN3;CCBE1
prerank,actin polymerization or depolymerization (GO:0008154),0.36971989611932216,1.017246437740283,0.4605855855855856,1.0,1.0,17/50,21.98%,SPIRE2;RAC1;TTC17;WASF1;SVIL;SPIRE1;VILL;ABI1;GAS7;ARHGAP6;PSTPIP2;EVL;PREX1;CFL1;GSN;DIAPH1;ENAH
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.30751995882571065,-1.0171625701999512,0.4095744680851064,0.8625441691111081,1.0,8/25,12.55%,ATP1B3;SLC6A9;DMD;AKAP9;TCAF1;ACTN2;NDUFA4;ATP1B1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4683613610228445,1.0168866142913506,0.47289156626506024,1.0,1.0,1/12,1.59%,GPLD1
prerank,eye development (GO:0001654),-0.24983716136110262,-1.016586958588459,0.44642857142857145,0.862045538497528,1.0,14/54,16.74%,HIPK2;SMOC1;COL5A1;RAB18;RBP4;TGFB2;CACNA1C;HIPK1;PBX3;MEIS1;BMPR1B;PBX4;SMG9;PBX2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.39808427304795213,1.0164273443575762,0.44556962025316454,1.0,1.0,12/29,22.96%,TARBP2;DGCR8;PUS10;LIN28B;ZC3H7B;AGO3;HNRNPA2B1;ZC3H7A;SMAD2;PRKRA;SMAD3;AGO4
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.22436084772340706,-1.015907546930691,0.48,0.862000643613736,1.0,36/88,24.63%,ANGPT1;CAV1;PTPRM;STAT1;SIRT1;PRKD1;NRAS;NRP2;TEK;HIF1A;AGGF1;THBS1;AIMP1;TIE1;ECM1;KDR;CAV2;AKT3;SCG2;BMP4;VEGFC;RGCC;TNFSF12;EMC10;VEGFA;NF1;PDCL3;AKT1;ATOH8;STAT5A;NR4A1;PIK3CD;VEGFB;SEMA5A;PGF;BMP2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.37164727169303546,1.0158977361577295,0.46396396396396394,1.0,1.0,7/46,8.27%,DNLZ;FIS1;TOMM20;FBXO7;TIMM13;MFN2;AIP
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.37042761759728454,1.0158591936674781,0.45550351288056207,1.0,1.0,11/42,19.07%,PARP1;ACTR2;FBH1;FUS;WRAP53;KLHL15;MRNIP;MMS19;HELB;TERF2IP;PPP4C
prerank,regulation of proteolysis (GO:0030162),0.3708202959294968,1.015785759126838,0.4528301886792453,1.0,1.0,7/48,9.66%,CLN3;CLN6;STUB1;OGT;CDK5;AURKAIP1;PLAT
prerank,regulation of type I interferon production (GO:0032479),0.3492964624450363,1.015407908746589,0.46546227417640806,1.0,1.0,16/84,13.55%,NFKB1;POLR3D;STAT6;NFKB2;TNFAIP3;TIRAP;IRF1;DHX58;TRIM56;DHX33;XRCC6;DHX36;POLR3E;IRF3;POLR2K;PTPN22
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3546529115926716,-1.0151713519478136,0.4189723320158103,0.8620503125708298,1.0,6/16,11.38%,GBF1;TAPT1;VAPA;LRRK2;DDRGK1;GABARAPL2
prerank,oligosaccharide metabolic process (GO:0009311),0.3729389962479767,1.01492383486168,0.4690366972477064,1.0,1.0,6/46,8.34%,MAN2C1;ST8SIA3;ST3GAL2;ST3GAL3;ST6GAL2;MANBA
prerank,sulfate transport (GO:0008272),-0.35974970938964485,-1.014914569724698,0.41295546558704455,0.8606665959994204,1.0,6/14,22.89%,SLC26A7;SLC26A2;SLC26A11;SLC25A14;SLC25A30;SLC25A11
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.34888943568207037,1.0148353393158613,0.46030042918454933,1.0,1.0,14/75,17.48%,RNF157;GUCA1B;GNG7;METAP1;NMT1;ZDHHC3;PPP1R9B;RIC8B;GIT1;METAP2;ROCK2;TULP3;MRAP2;USP33
prerank,negative regulation of translational initiation (GO:0045947),-0.3736378726257075,-1.014773849659125,0.41935483870967744,0.8589839254475504,1.0,5/13,9.38%,EIF3E;EIF2AK4;AGO2;EIF2AK1;RBM4
prerank,neuron maturation (GO:0042551),0.4285751797223739,1.014026296289932,0.46070460704607047,1.0,1.0,7/18,18.42%,PICK1;EPHA8;APP;B4GALT5;MTCH1;FARP2;ADGRB3
prerank,RNA stabilization (GO:0043489),0.39167836943120204,1.01358594109533,0.46943765281173594,1.0,1.0,12/33,20.76%,TRDMT1;PAIP1;FUS;DHX36;PABPC1;GDNF;AXIN2;THRAP3;TENT5A;CIRBP;HNRNPU;YBX1
prerank,intermediate filament organization (GO:0045109),0.437636578240182,1.0135704121340592,0.4777327935222672,1.0,1.0,4/17,16.80%,NEFL;DES;DNAJB6;BFSP2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4489869229055094,1.0135665215085317,0.4832869080779944,1.0,1.0,6/14,22.82%,HDAC5;TBXA2R;ITGB1BP1;KLF4;STARD13;MEOX2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.3659569596209563,1.01336979610528,0.4647577092511013,1.0,1.0,9/55,17.07%,FOXM1;SIRT2;RAC1;SLC25A33;PID1;RNF41;SIRT5;AGTR1;PARL
prerank,nucleosome organization (GO:0034728),0.3625858312437547,1.0132229643775317,0.4663726571113561,1.0,1.0,21/55,21.67%,SMARCD3;RNF8;SMARCC2;ASF1A;ACTR6;SMARCB1;SOX9;SMARCD1;SART3;NPM1;ATRX;DAXX;BRDT;INO80;CTCF;SMARCD2;NAP1L4;ZNHIT1;VPS72;H3-3A;SRCAP
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4326940382768707,1.0130052190825545,0.4634146341463415,1.0,1.0,5/16,13.96%,OGT;ARHGAP24;PIK3CB;ALS2;AUTS2
prerank,fatty acid beta-oxidation (GO:0006635),0.36144282170801123,1.013002820572933,0.46938775510204084,1.0,1.0,15/51,16.69%,ACAD10;HADHB;ACAT1;HSD17B4;CROT;AMACR;CPT2;EHHADH;MECR;ECHDC1;ABCD2;ACOX3;ETFA;ACADL;ACADVL
prerank,regulation of cell communication (GO:0010646),0.3871480644875745,1.012948558834723,0.465311004784689,1.0,1.0,8/35,14.61%,ANXA1;NCLN;YWHAG;GRK3;IGFBP7;CAMK2D;MTCH1;GRK2
prerank,negative regulation of viral process (GO:0048525),0.35653111176507324,1.0127855282710727,0.4737417943107221,1.0,1.0,12/57,18.85%,ILF3;HEXIM1;TRIM11;TRIM35;TRIM62;CHMP3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;TRIM27
prerank,regulation of macrophage cytokine production (GO:0010935),0.4576919396163564,1.0127129566847544,0.46277372262773725,1.0,1.0,4/13,14.28%,WNT5A;GPRC5B;CUEDC2;TGFB1
prerank,negative regulation of transposition (GO:0010529),0.44895814043095084,1.0122122774263036,0.4747612551159618,1.0,1.0,1/16,1.78%,SIRT7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4636995276837156,1.0121441368400155,0.44871794871794873,1.0,1.0,6/11,18.62%,ABCA2;SOAT1;ABCA7;ITM2B;NECAB3;ITM2C
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.342605142797012,1.0119031509273355,0.46790890269151136,1.0,1.0,18/90,17.62%,HDAC3;STAT6;LPIN1;OGT;ALMS1;MFAP2;ZBTB7B;CXCR4;MFN2;GNAS;PRLR;CPT2;LEPR;EHMT1;ESRRG;ACADL;KDM6B;OMA1
prerank,regulation of translational initiation (GO:0006446),0.35645890488534876,1.0115794081408147,0.4673311184939092,1.0,1.0,15/63,16.79%,MIF4GD;PAIP2;EIF2AK3;PAIP1;DDX3X;CDC123;EIF1B;EIF4G2;YTHDF3;EIF1;NPM1;YTHDF1;IMPACT;EIF4G3;FMR1
prerank,positive regulation of vacuole organization (GO:0044090),0.47743264572062794,1.0113600306966097,0.46345029239766083,1.0,1.0,6/10,23.41%,PIP4K2B;PIP4K2A;PIP4K2C;ANXA2;RAB3GAP2;SH3GLB1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.34000364513645265,1.0113384453333452,0.4773922187171398,1.0,1.0,12/95,10.30%,WNT5A;FCGR2B;SIRT2;SELENOS;NFKB1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.37674092252446456,-1.0112968854600464,0.44680851063829785,0.8672708032424555,1.0,4/14,7.77%,PRKG1;MEF2C;SLIT2;BMPR1A
prerank,regulation of protein localization (GO:0032880),0.3576471946778949,1.0111648957572055,0.47613762486126526,1.0,1.0,11/58,12.69%,TRIM67;PARP1;HSP90AA1;STX6;DVL1;MMD;TRIM17;RABGAP1L;PLEKHM2;DNAJB6;RACK1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3437476327715959,1.0110699883661802,0.4708994708994709,1.0,1.0,15/86,10.61%,IGF1;FOXM1;EPHB2;SGSM3;LZTR1;OGT;FGF10;FLCN;SQSTM1;RASGEF1A;MFN2;RALGPS1;RAPGEF1;IRS2;DENND4C
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.29330262184143563,-1.0110347277567033,0.40540540540540543,0.865804394304658,1.0,7/30,7.62%,LATS1;SMAD4;BCL9;TWSG1;TRIM33;ITGA3;ENG
prerank,regulation of presynapse assembly (GO:1905606),0.4211758516914872,1.010675028491446,0.4566929133858268,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),0.4211758516914872,1.010675028491446,0.4566929133858268,1.0,1.0,5/18,17.96%,GPC6;APP;IL1RAPL1;GPC4;SLITRK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4110155490701135,-1.010574585905783,0.4577259475218659,0.8651066373531302,1.0,5/10,17.43%,THRA;PSMC2;TP53;ESR1;PSMC3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4373526532950223,1.0105478053970005,0.4598337950138504,1.0,1.0,3/16,10.90%,IGF1;FGFR2;RBPJ
prerank,mRNA destabilization (GO:0061157),0.37590435535332123,1.0104893905573604,0.4584795321637427,1.0,1.0,10/38,15.03%,KHSRP;PLEKHN1;ZFP36L1;CELF1;DHX36;RC3H2;YTHDF3;YTHDF1;ROCK2;DIS3L2
prerank,vascular process in circulatory system (GO:0003018),-0.3823746829578731,-1.0103788413562746,0.42955326460481097,0.8615195206234544,1.0,6/13,14.84%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,regulation of tube diameter (GO:0035296),-0.3823746829578731,-1.0103788413562746,0.42955326460481097,0.8615195206234544,1.0,6/13,14.84%,SCPEP1;NOS3;GCLM;ROCK1;NPR1;ACE
prerank,positive regulation of defense response (GO:0031349),0.3497647216565276,1.0101174906847175,0.4786680541103018,1.0,1.0,15/89,17.26%,WNT5A;LPL;PTGER4;DDT;IL33;POLR3D;IFI35;GPRC5B;GPR4;APP;CD47;TLR3;AGTR1;SERPINE1;TNIP1
prerank,iron-sulfur cluster assembly (GO:0016226),0.4065951747382243,1.0093337011307923,0.46433203631647213,1.0,1.0,6/24,14.77%,ISCA2;NUBP2;NUBP1;CIAO2A;MMS19;ABCB7
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4088469410094297,1.0089661437590896,0.46465968586387435,1.0,1.0,2/22,3.11%,CDKN2D;PRKRIP1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.33179674259428976,1.008419328035292,0.48044132397191575,1.0,1.0,82/241,23.06%,RAVER2;LSM6;LSM7;CHERP;RBM4B;RBM17;U2AF1;SRSF2;SNRNP48;PRPF8;ZCCHC8;SRSF12;PSPC1;DHX15;POLR2B;SRSF5;SF3B2;SF3B1;DHX8;SRSF3;HNRNPK;FUS;SRSF9;SF3A1;DDX46;PRPF6;SRSF1;SNRPB2;HNRNPD;PPIH;CPSF7;HNRNPM;PABPC1;MTREX;RBM10;SART3;CSTF2T;NUDT21;DHX16;POLR2K;CPSF3;HNRNPA0;HNRNPH3;RBM41;HNRNPL;TRA2B;NOVA1;HNRNPA2B1;PRPF40A;DDX5;YTHDC1;SNW1;SRRM1;PRPF40B;PCBP2;RBM22;GCFC2;NONO;CWF19L2;SNRNP27;BCAS2;FIP1L1;RSRC1;DDX42;CSTF3;U2SURP;HNRNPU;GEMIN5;TRA2A;YBX1;PTBP1;SART1;SRRM2;ISY1;GTF2F2;HNRNPUL1;METTL14;PNN;U2AF2;ZCRB1;SRSF6;ZMAT5
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4497495946590424,1.0080982241828742,0.4825662482566248,1.0,1.0,3/15,10.40%,GPLD1;ADM;IRS2
prerank,cellular potassium ion homeostasis (GO:0030007),0.4518681665963835,1.0080835153601846,0.46714285714285714,1.0,1.0,3/13,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,positive regulation of cell death (GO:0010942),0.3541102953557868,1.0079891192746546,0.47859495060373214,1.0,1.0,11/59,16.74%,WNT5A;FCGR2B;HTATIP2;CELF1;EFNB2;AXIN2;LRP1;MAPT;FAF1;SLC6A13;DAXX
prerank,carboxylic acid catabolic process (GO:0046395),0.4576166356575506,1.0075600097637771,0.47638888888888886,1.0,1.0,2/12,4.80%,PON3;RENBP
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.40615646645859405,1.0073085790314187,0.4955640050697085,1.0,1.0,6/24,10.02%,AEBP2;CREBZF;RBBP4;PHF1;EZH2;JARID2
prerank,positive regulation of secretion by cell (GO:1903532),0.34935076222473577,1.0071864942999849,0.4849137931034483,1.0,1.0,11/70,14.84%,UNC13D;IGF1;BMP6;EDN3;SOX11;MYH10;RAB2B;TMED10;TGFB1;GRK2;DNM1L
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3878985536127218,1.0071651006575493,0.4767580452920143,1.0,1.0,7/33,13.26%,GLS2;FPGS;OAT;GLUL;ALDH4A1;GCLC;DGLUCY
prerank,early endosome to Golgi transport (GO:0034498),0.47789785606120344,1.0070691992998893,0.4576523031203566,1.0,1.0,6/11,25.20%,TRAPPC10;RAB6A;STX5;EHD3;SURF4;LMAN1
prerank,carbohydrate catabolic process (GO:0016052),0.37812169230129605,1.0069940699127284,0.48777648428405124,1.0,1.0,6/38,11.10%,HKDC1;MAN2C1;MANBA;PGAM4;PGAM1;ENO2
prerank,T cell activation involved in immune response (GO:0002286),0.46056648698732633,1.0067919171939805,0.4744318181818182,1.0,1.0,1/12,0.97%,LCP1
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.26309136582229325,-1.0066616893178362,0.41216216216216217,0.8699613454882499,1.0,6/42,7.91%,DROSHA;IL6R;RNASE3;LBP;TLR4;RPS19
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.37505148100230384,-1.006658682479189,0.4358108108108108,0.8678601750221007,1.0,8/13,32.88%,DDO;MTHFS;GOT2;ACOT8;GOT1;GAD1;GLUD1;QPRT
prerank,regulation of ERBB signaling pathway (GO:1901184),0.43677598442748167,1.00655423156027,0.48106591865357645,1.0,1.0,5/15,15.82%,MVB12A;EGF;RBPJ;RHBDF1;PTPN12
prerank,positive regulation of cell cycle process (GO:0090068),0.3374847514055616,1.0063567276073069,0.4735202492211838,1.0,1.0,20/91,20.92%,IGF1;SIRT2;EDN3;MAD2L1;CDC14B;CIT;EGF;GPSM2;USP19;DYNC1LI1;SVIL;ATRX;CSPP1;CEP120;NUMA1;PHIP;RAD21;KIF20B;INO80;TPR
prerank,negative regulation of viral release from host cell (GO:1902187),0.4473895526855437,1.0062493454679637,0.4590395480225989,1.0,1.0,6/13,22.47%,TRIM11;TRIM35;CHMP3;MID2;TRIM26;TRIM8
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.37127168150235806,1.0060665700963698,0.4671280276816609,1.0,1.0,7/41,13.71%,IL34;DLG3;LRP8;GPRC5B;EGF;SRCIN1;DOCK3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4333867790740843,1.0059151356352307,0.4787234042553192,1.0,1.0,4/16,11.29%,NRP1;ABL1;PLAT;PDGFRA
prerank,negative regulation of cell motility (GO:2000146),0.3401440917405392,1.0054675747831814,0.4927685950413223,1.0,1.0,41/108,26.14%,SFRP2;SFRP1;FBLN1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;ROBO1;MAGI2;DAG1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;DPEP1;MCTP1;MITF;DLC1;NF2;SMAD7;SRGAP1;DLG5;IGFBP5;EPHA4;DPYSL3;PTEN;ADARB1;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4;GTPBP4;RECK
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.37367059148939163,1.0049799269662214,0.4727061556329849,1.0,1.0,8/38,15.95%,CENPT;UBN1;RBBP4;ASF1A;NPM1;CENPC;ATRX;HAT1
prerank,regulation of gene expression (GO:0010468),0.32179882005442406,1.0048546544556427,0.476,1.0,1.0,204/903,19.85%,FGF20;SFRP2;APLN;FGF9;KHSRP;AFF2;MAPK9;WNT5A;EPB41L4B;TMEM119;SFRP1;IGF1;DVL2;EPHB2;ANXA7;NFKB1;BMP6;FAM50A;EIF2AK3;IL33;EDN3;PCBP4;NR1D2;PCGF1;PTHLH;WARS1;ERP29;RORA;NFKB2;ZFP36L1;DDX3X;PSPC1;ZNF205;TRIM11;SNF8;C1QTNF1;NELL1;FGF10;IGF2BP2;FUBP1;FLCN;OLFM1;NPAT;CNBP;ABL1;ATXN1;PHF1;ATG14;DVL1;ZNF35;CELF1;CASZ1;HNRNPK;EZH2;FUS;ZBTB7B;NOS1AP;MAGED1;ZNF711;HGS;HDAC5;SIRPA;ADNP;SEC16B;ZBTB38;ASCC1;PID1;ZKSCAN5;ACTR8;NFX1;SFMBT2;WNT4;SOX9;DDIT3;PER1;HNRNPD;RBMS3;DHX36;EGF;PRMT5;HDAC4;TRIM17;SOX11;SAP30L;TWIST1;CALCOCO1;MUSK;FADS1;ZC3H7B;RBL2;GDNF;ATF2;POU6F2;CAVIN4;PIK3CB;APP;NSD3;RBPJ;SART3;ANK3;MAZ;ROBO1;FOXN3;IFNGR1;YY1;NUDT21;BACH1;PARK7;ZNF462;PEG3;SOX6;TADA3;HDAC1;AGO3;RACK1;HNRNPH3;LAMTOR5;HNRNPL;SUFU;PARP14;TLR3;TRA2B;PTPN22;C1D;ATRX;FAM98A;MAPT;NOVA1;ROCK2;TGFB1;ESRRG;MAP2K2;TULP3;BCL6;EPHX2;KMT2D;F3;HNRNPLL;ZUP1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;CTSH;GRSF1;AHNAK;GTF2IRD1;CHEK2;HNRNPDL;YTHDC1;NDFIP2;SBNO1;CLOCK;MEGF8;TRIP4;KDM6B;DAXX;UBE2L3;UBR5;CLK4;TIPARP;ZFP37;SPRY2;ZC3H7A;SOX13;OSR1;APOE;HP1BP3;SON;TLE5;TCF7;NFXL1;NSD1;CAMK2N1;PCBP2;PHF12;ATRAID;MECP2;GCFC2;NONO;TGFBR1;TERF2IP;PDCD5;PRKAA1;TRIM27;FOXD1;NUP35;SOX4;BRDT;YAF2;YTHDF2;RPS3;KDM6A;MITF;CDK11B;KLF4;WWC1;CARM1;GABPA;NFIA
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.34259899295392343,1.0045240807941027,0.47594142259414224,1.0,1.0,34/96,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,chromatin remodeling (GO:0006338),0.33963851283708335,1.0041902404034302,0.4754953076120959,1.0,1.0,25/100,16.74%,KDM4D;MPND;SMARCD3;SMARCC2;GATAD1;CHD8;RBBP4;SMARCB1;HDAC5;ACTR8;SOX9;SMARCD1;ARID1B;HDAC4;JARID2;TOP1;SMARCA1;MTA2;NPM1;HDAC1;ATRX;BAZ2B;SATB1;KDM6B;DAXX
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.28008248858730933,-1.0039472094559274,0.46794871794871795,0.8738443784634895,1.0,8/38,10.47%,CACNA1D;CTNNA3;CAV1;CACNA2D1;KCNJ2;CACNA1C;AKAP9;CACNA1G
prerank,fibrinolysis (GO:0042730),0.45418199864640774,1.0033017878698027,0.4751066856330014,1.0,1.0,2/13,16.49%,PLAT;SERPINE1
prerank,hexose metabolic process (GO:0019318),0.3717394103234853,1.0032999642322709,0.4667458432304038,1.0,1.0,2/39,2.71%,GALT;GALK1
prerank,positive regulation of protein kinase activity (GO:0045860),0.33194773737974287,1.0032293871310933,0.4777777777777778,1.0,1.0,33/148,19.18%,IL34;INCENP;HSP90AA1;CALM3;MAPRE3;TAOK1;DDX3X;MINK1;DDR2;DLG3;PAK3;EZH2;STK11;LRP8;MMD;GPRC5B;XRCC6;MRNIP;SRCIN1;JTB;STRADB;ALS2;IQGAP1;EMP2;PARP16;MAP2K2;SLC27A1;DAXX;CCDC88A;RASSF2;CALM1;PRKAG2;NRK
prerank,heme catabolic process (GO:0042167),-0.3595587226957969,-1.0028889438550153,0.4254545454545455,0.8727739965843813,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3595587226957969,-1.0028889438550153,0.4254545454545455,0.8727739965843813,1.0,2/14,3.81%,ABCG2;ABCC1
prerank,aerobic electron transport chain (GO:0019646),0.3493053827527633,1.0028564359210461,0.5048966267682263,1.0,1.0,11/68,10.38%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,negative regulation of programmed cell death (GO:0043069),0.32358279677651663,1.0025512856050003,0.491,1.0,1.0,74/355,19.03%,RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;TCIM;PPIF;ARAF;NFKB1;BNIP1;TAF9B;AIFM2;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;NUAK2;IL31RA;MGMT;USP47;PRDX5;PIK3R1;PRELID1;SQSTM1;BAG1;BARD1;HNRNPK;ZFAND6;IFIT3;XIAP;SOX9;UBE2Z;MALT1;GDNF;PRLR;PSMC5;BCL2;BNIP2;PARK7;NPM1;HDAC1;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;TXNDC5;SMAD6;CBL;MRE11;NUPR1;CASP2;HSPD1;RPS6KA1;CTSH;AHI1;FAIM2;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;TOPORS;ANXA4;GPX4;KLHL20;BAG4;PRKAA1;BIRC3;FMN2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2666704692317585,-1.002177170593577,0.4166666666666667,0.8726918240335984,1.0,11/39,15.19%,MAML3;MAML1;STAT3;KAT2B;TGFB2;NOS3;EP300;EPN2;CCN3;POGLUT1;SRC
prerank,mitochondrion organization (GO:0007005),0.3315575711698418,1.0021166611265888,0.5040485829959515,1.0,1.0,44/165,20.14%,BAX;DNM1;CHCHD10;BCS1L;PARP1;MSTO1;FIS1;AIFM2;USP30;MYH14;SLC25A33;TOMM20;FBXO7;TIMM13;MIEF2;SLC25A36;MFN1;COX7A2;FANCG;PID1;MFN2;AIP;MTFR1L;AFG3L2;PTCD2;PARK7;GDAP1;WASF1;MTX3;DNM1L;HSPD1;TFB1M;TRAK1;SIRT5;MTX2;VPS13D;OMA1;GABPB1;ATCAY;AGTPBP1;OXA1L;GABPA;TIMM44;TIMM22
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.4345825191013231,1.001986614874125,0.46814404432132967,1.0,1.0,4/16,14.35%,A4GALT;ST8SIA3;ST3GAL5;ST6GALNAC6
prerank,positive regulation of dendritic spine development (GO:0060999),0.41890899170071016,1.0019335060975623,0.4556135770234987,1.0,1.0,9/20,21.20%,CAMK2B;DBN1;LRP8;DHX36;DBNL;FMR1;APOE;SHANK1;DLG5
prerank,membrane assembly (GO:0071709),0.37808330146884567,1.0014860282414295,0.48296122209165687,1.0,1.0,15/34,24.28%,UBXN2A;TLCD1;STX2;ANK3;IL1RAPL1;NLGN3;EMP2;NLGN2;SPTBN1;ANXA2;FLOT1;CHMP4B;LRP4;PTEN;NRXN2
prerank,positive regulation of glucose import (GO:0046326),0.4077125996688992,1.0014677807181174,0.4642857142857143,1.0,1.0,5/21,13.35%,IGF1;CAPN10;PIK3R1;IRS2;PRKCI
prerank,polarized epithelial cell differentiation (GO:0030859),0.4592700033231957,1.0012646381679093,0.4785100286532951,1.0,1.0,3/13,9.32%,SCRIB;RAP2A;RAB10
prerank,positive regulation of hydrolase activity (GO:0051345),0.33087861270727653,1.000999880074888,0.5081799591002045,1.0,1.0,24/137,12.69%,SFRP1;CDKL5;TBC1D7;CALM3;SGSM3;RAP1GDS1;RGS10;FLCN;MTCL1;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RCN3;RAP1GAP;DOCK8;RAPGEF1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1
prerank,negative regulation of ossification (GO:0030279),0.40468811894683065,1.000528511467401,0.494750656167979,1.0,1.0,5/23,14.82%,SFRP1;SOX9;RBPJ;ENPP1;SMAD6
prerank,hemidesmosome assembly (GO:0031581),-0.3864501408758634,-0.9999245518410329,0.44761904761904764,0.8772551072282725,1.0,5/11,13.49%,DST;ITGA6;PLEC;LAMA3;ITGB4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2851115971208048,-0.9995174169958128,0.4918918918918919,0.8763673450838454,1.0,16/29,30.25%,SORBS1;CREBL2;SCARB1;CREB1;NR1H3;CNEP1R1;SREBF1;ELOVL5;CTDNEP1;NR1H2;AKT1;PPARA;SLC45A3;MFSD2A;SIRT4;MID1IP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3201342218271792,0.9993256483557849,0.517,1.0,1.0,214/1082,18.39%,PSRC1;SFRP2;METTL23;ILF3;CAMTA2;MMP12;HDAC3;LAGE3;WNT5A;PTPRN;WBP2;HSF2;SFRP1;IGF1;MED24;SP7;DVL2;MPND;FOXM1;SIRT2;ZBTB48;SIRT7;DDX17;MYRF;CRTC1;NFKB1;SMARCD3;CHCHD10;BMP6;PARP1;ZEB2;EIF2AK3;IL33;USF1;NR2F2;FGFR2;MLXIP;NKX6-1;MAPRE3;MED12;SMARCC2;MED14;GLIS2;STAT6;NR1D2;GRIN1;HTATIP2;XBP1;ACTR2;RORA;TFDP1;KMT2B;NFKB2;DDX3X;BRPF1;LPIN1;SNX5;CCNC;OGT;CHD8;POU2F1;IL31RA;RFX5;SNAI1;CDK9;FLCN;MRTFA;NPAT;TCF4;TCF7L2;ASF1A;TFCP2;DCN;NFATC2IP;CNBP;BRD4;IRF1;PIK3R1;MED13;ABL1;SQSTM1;DVL1;ZIC3;CASZ1;TRIM56;AKAP8L;ARNT;ANKRD49;ZNF711;SMARCB1;DHX33;TEAD1;TGFB1I1;HDAC5;MOSPD1;RAI1;ZBTB38;PID1;MED4;DBP;PRPF6;ARRB1;WNT4;SLC30A9;SOX9;SMARCD1;DDIT3;CRTC3;DPF2;LPIN3;XRCC6;YWHAH;PER1;HNRNPD;ECD;ARID1B;DHX36;EGF;ATMIN;HDAC4;SOX11;TWIST1;CALCOCO1;NKRF;TCEA1;GDNF;ATF2;SSBP4;PSMC5;BRD8;APP;TAF6;NSD3;JUP;RBPJ;GLIS1;RFX4;PIK3R2;MAZ;NFAT5;IRF3;BMP5;YY1;SMARCA1;ZMIZ1;E2F3;NFIX;PARK7;ZNF462;PEG3;NPM1;TADA3;HDAC1;CEBPG;LPIN2;CREB3;CREB3L4;RPS6KA3;SETX;TLR3;ZBED3;MMS19;ABHD14B;FOXJ3;ATRX;AUTS2;ZIC2;TGFB1;MED21;RGMA;ESRRG;MAP2K2;BCLAF1;THOC1;KMT2D;RGMB;RFX3;NR2C2;TCF3;SSBP2;FOXC2;THAP3;RPS6KA1;AHI1;CHEK2;BCLAF3;CLOCK;SNW1;CCNT1;JAG1;TRIP4;SERPINE1;TNKS;KDM6B;ITGB1BP1;THRAP3;PHIP;CDK7;OSR1;APOE;ZFP90;TNIP1;NSD1;GABPB1;GABPB2;MEIS2;TBL1XR1;ILK;PRKD2;PKD2;RNF111;KMT2A;BCL11B;GPS2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3449258222700221,0.9993111526597851,0.493576017130621,1.0,1.0,13/72,13.72%,COPS7A;LIG1;USP7;POLR2B;DDB1;LIG3;COPS7B;CUL4B;GTF2H3;TCEA1;POLR2K;CCNH;POLD3
prerank,cellular response to growth factor stimulus (GO:0071363),0.3265415654731634,0.9991520971008674,0.508646998982706,1.0,1.0,40/151,21.10%,WNT5A;CLEC3B;SFRP1;SIRT2;ADAMTS7;MTSS2;PDPK1;BMP6;SMAD9;ANXA1;ZFP36L1;NRP1;PLK5;WNT4;SOX9;RAPGEF1;IQGAP1;MAGI2;SOX6;RACK1;SETX;MAPT;TGFB1;SOX5;ACVR1B;PTPN12;NDNF;ITGB1BP1;SPRY2;PRKD2;TGFBR1;PDCD5;WWOX;KLF4;MAPKAPK2;EHD1;ACVR2A;NTRK2;SMAD7;APPL2
prerank,neurogenesis (GO:0022008),0.36584094719670035,0.9987858684812577,0.4872389791183295,1.0,1.0,15/43,23.94%,ANXA1;CXCR4;CIT;SPOCK1;NDUFS2;LPAR1;MAPT;TRAK1;BTBD3;BTBD1;BTBD2;RYK;METTL14;CDK5RAP2;FAT4
prerank,transport along microtubule (GO:0010970),-0.3683062450240867,-0.9986674263781563,0.4358108108108108,0.876811318473343,1.0,4/13,7.51%,COPG2;SPG11;BAG3;APBA1
prerank,muscle tissue morphogenesis (GO:0060415),-0.3289632233387117,-0.9986370224097062,0.48854961832061067,0.8748243365884156,1.0,6/16,31.43%,BMP4;TBX1;EFEMP2;BMP2;HEY2;ZFPM1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.36155150020475046,0.9985531377804133,0.4691780821917808,1.0,1.0,10/45,11.68%,RBM4B;RBM3;METAP1;ATG14;CYFIP1;PER1;PUM3;ZC3H7B;APP;NUDT21
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.41061688361089443,0.9985009222311914,0.4760672703751617,1.0,1.0,2/21,3.64%,EPHA7;GRIN1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4515647111909807,0.9983270819661773,0.46647230320699706,1.0,1.0,3/13,14.06%,NOP9;RCL1;BMS1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.4329128789771866,0.9981821755589048,0.48846675712347354,1.0,1.0,4/16,12.87%,FLCN;RRAGA;GPR137C;LAMTOR5
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.24885255229722394,-0.9981444321081706,0.48672566371681414,0.8742066957840425,1.0,17/53,17.43%,RAD23B;DAB2IP;TMF1;GNA12;HSP90AB1;UCHL5;PRKACA;PSMC2;PSMF1;DDRGK1;UBB;GABARAPL2;UBQLN4;OSBPL7;UFL1;PINK1;PSMC3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4391107419215599,0.9981146065393022,0.49358059914407987,1.0,1.0,5/14,18.45%,AK4;AK5;ENPP1;AK3;CMPK1
prerank,hippo signaling (GO:0035329),0.3981303165997896,0.9981116419275121,0.47297297297297297,1.0,1.0,3/26,7.26%,TEAD3;DVL2;TEAD1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.2676662184195019,-0.9976727366226557,0.427536231884058,0.8736022728698487,1.0,16/36,27.17%,EGFR;CAV1;NUS1;HIF1A;SCARB1;NOS3;NOSTRIN;NOSIP;GCH1;AKT1;DDAH2;CYGB;TERT;SPR;WASL;S100A1
prerank,protein homooligomerization (GO:0051260),0.3355254570694954,0.9974419885979059,0.49229188078108943,1.0,1.0,22/114,18.02%,ALOX5AP;TRMT61B;GSDMD;MPP2;ASIC1;ATL1;ALDH1A2;FUS;TK1;TIFA;KCNC2;ALS2;NACC2;SOD2;PRMT1;HPRT1;SLC1A5;AQP4;PRMT8;MLKL;SLC1A2;PKD2
prerank,gene silencing by miRNA (GO:0035195),-0.27882193162663194,-0.9971793472872233,0.4540540540540541,0.87292878779591,1.0,7/32,9.38%,CNOT1;TNRC6A;PUM1;XPO5;AGO2;LIMD1;RBM4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.457886893904222,0.9970523851258486,0.4784546805349183,1.0,1.0,3/12,8.12%,SDE2;FBXO31;PLK5
prerank,regulation of DNA repair (GO:0006282),0.366730452451159,0.9967493765219924,0.49361207897793263,1.0,1.0,19/44,21.97%,SIRT7;RNF8;USP1;FGF10;CDK9;WRAP53;RNF168;UBE2V2;POLH;CEBPG;AXIN2;EYA2;UBR5;UIMC1;RPS3;EYA1;TRIP12;NPAS2;UBE2V1
prerank,intracellular cholesterol transport (GO:0032367),-0.35402912108076445,-0.9961791271385623,0.45018450184501846,0.8736292949907856,1.0,7/15,22.90%,LRP6;OSBPL2;SERAC1;OSBP;VPS4A;LDLRAP1;STARD4
prerank,nuclear pore complex assembly (GO:0051292),-0.4076119092822847,-0.995617646745616,0.46726190476190477,0.8732733297304509,1.0,5/10,21.50%,NUP205;NUP93;NUP107;NDC1;TMEM170A
prerank,protein autoubiquitination (GO:0051865),0.35381922479836325,0.9955806866615854,0.5099557522123894,1.0,1.0,11/61,14.63%,RNF157;RNF8;STUB1;NFX1;TRIM17;RNF11;UBE2A;RNF19B;RNF220;RNF41;RNF122
prerank,response to interleukin-6 (GO:0070741),0.4827036559142016,0.995507328022004,0.48406676783004554,1.0,1.0,2/10,7.65%,NFKB1;PID1
prerank,lysosome localization (GO:0032418),0.3687842776743968,0.9953741396577535,0.48614318706697457,1.0,1.0,12/37,21.80%,KXD1;RAB34;FLCN;PLEKHM2;VPS33B;BLOC1S2;FAM98A;KIF5B;S100A13;ARL8B;MAP6;MYH9
prerank,atrial septum morphogenesis (GO:0060413),-0.4006035621381286,-0.9949912075498656,0.4735202492211838,0.8731944624814151,1.0,5/10,31.43%,TGFB2;ACVR1;NOTCH2;HEY2;ZFPM1
prerank,response to estrogen (GO:0043627),0.38348141561401905,0.9949899263125107,0.4880201765447667,1.0,1.0,6/31,15.00%,WBP2;SFRP1;CD24;SRA1;NCOA4;KMT2D
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.37751399863660967,0.9948668348860114,0.5,1.0,1.0,7/38,10.96%,BMP6;POLR3D;PRKCA;DHX58;IFI35;LY96;USP15
prerank,mitotic spindle organization (GO:0007052),0.33042767248648486,0.9946855713515464,0.5035317860746721,1.0,1.0,35/153,19.92%,B9D2;CENPT;CCDC61;INCENP;TAOK1;MAD2L1;STAG1;ARHGEF10;NEK9;WRAP73;KPNB1;DCTN6;PIBF1;PPP1CC;ABRAXAS2;VCP;MAP9;CEP126;GPSM2;DYNC1LI1;SPICE1;RCC1;CENPC;STAG2;ZWINT;OFD1;CHEK2;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,Golgi inheritance (GO:0048313),-0.3785261006737999,-0.9946806261924535,0.4550898203592814,0.8721211323448521,1.0,2/11,1.81%,GBF1;YWHAZ
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.44294576969698884,0.9944630174593492,0.49719101123595505,1.0,1.0,2/16,9.75%,CLDN11;CLDN12
prerank,glycine metabolic process (GO:0006544),-0.3631983785457707,-0.9940265296370312,0.4376899696048632,0.8720275497846126,1.0,8/12,52.15%,RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1;GLYAT
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3468737435571943,0.9937052484740023,0.5147864184008762,1.0,1.0,11/69,10.38%,NDUFAB1;UQCRC1;NDUFA7;NDUFAF1;SDHA;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;COX7B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3115976400442825,-0.9934791958131024,0.4523809523809524,0.8715443987512077,1.0,5/20,6.32%,DROSHA;PUM1;TSN;AGO2;TSNAX
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.41838142941714856,0.9934273539363506,0.5013089005235603,1.0,1.0,6/19,14.84%,CSNK2A2;FBXO7;PARK7;VDAC1;HTT;DNM1L
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4336239871719605,0.9931635223462192,0.4893917963224894,1.0,1.0,3/15,9.32%,REEP4;ATL1;RAB10
prerank,positive regulation of catalytic activity (GO:0043085),-0.26771375475616077,-0.9929750822076077,0.4523809523809524,0.8709523186151525,1.0,10/37,16.62%,XRCC4;MAPK8;CAV1;PHACTR4;NCSTN;MSH2;IGF2;NHEJ1;ABL2;APH1A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.25549476313336067,-0.9928382198177195,0.4765625,0.8693874426361567,1.0,13/48,11.74%,HIPK2;FNIP2;MCL1;PML;USP28;SIRT1;BCL2L1;HIPK1;TP53;EP300;IKBKE;MSH2;BCL2L2
prerank,histone mRNA metabolic process (GO:0008334),-0.2971746778635352,-0.9928092861050523,0.4756756756756757,0.8674550678137382,1.0,15/27,26.25%,NCBP1;TENT2;CPSF2;LSM1;SNRPB;SNRPD3;ERI1;UPF1;NCBP2;TUT1;TUT4;SNRPG;SNRPE;SNRPF;SSB
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39871318948597456,-0.9926335760199884,0.46808510638297873,0.8659355712369796,1.0,6/10,44.32%,PODXL;DPP4;WNK1;SKAP1;FERMT3;ADA
prerank,histone H4 acetylation (GO:0043967),-0.2598115917578755,-0.9925316061948783,0.45323741007194246,0.8642478240608022,1.0,22/47,22.96%,EPC1;TRRAP;LEF1;KAT7;JADE2;NAA40;EP300;JADE1;KANSL3;JADE3;WDR5;MSL3;HCFC1;ACTL6A;ING3;BRCA2;KAT8;ING5;NAA60;APBB1;RUVBL1;TRIM16
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3293055531991251,0.9923534729199843,0.5146316851664985,1.0,1.0,40/170,19.43%,KHSRP;AFF2;IGF1;EDN3;PCBP4;PTHLH;ZFP36L1;TRIM11;NELL1;IGF2BP2;FUBP1;NPAT;HNRNPK;ZNF711;SIRPA;ADNP;HNRNPD;TRIM17;GDNF;CAVIN4;ZNF445;APP;SART3;ZNF462;PEG3;C1D;NOVA1;ROCK2;ZUP1;HNRNPDL;MTMR4;MEGF8;KDM6B;APOE;PCBP2;ATRAID;FLOT1;TRIM27;SCARB2;KDM6A
prerank,embryonic heart tube development (GO:0035050),-0.357171114190621,-0.9922361488789408,0.43410852713178294,0.8630823328940683,1.0,8/14,32.34%,IFT122;ACVR1;HES1;SOX17;CITED2;TBX2;RYR2;SOX18
prerank,response to peptide (GO:1901652),0.3803802593327368,0.9921522359478105,0.49878048780487805,1.0,1.0,3/33,3.76%,MMP12;STAT6;ANXA1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4020293010071535,0.9919474454164576,0.47327249022164275,1.0,1.0,5/20,14.28%,IGF1;TWIST1;PARK7;LAMTOR5;TGFB1
prerank,regulation of ATP metabolic process (GO:1903578),0.3548626716146843,0.9919044923194721,0.5028121484814398,1.0,1.0,16/54,19.14%,FIS1;SLC25A33;OGT;RAE1;COX7A2;NUP188;PGAM1;AK4;NUP210;NUP88;UQCC2;NUP214;NUP153;RANBP2;PRKAG2;NUP35
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3386650434872755,0.9916454927680505,0.5047720042417816,1.0,1.0,25/87,20.73%,NDUFAB1;NDUFAF4;BCS1L;NDUFA7;NDUFAF1;SLC25A33;DMAC1;NDUFB6;NDUFB8;NDUFS7;NDUFB2;NDUFS2;SDHAF3;COX17;UQCC2;COA8;COX16;NDUFB4;NDUFA6;DMAC2;OMA1;NDUFA2;OXA1L;NDUFB3;NDUFA12
prerank,establishment of protein localization to organelle (GO:0072594),0.34389188588835795,0.9916069546242953,0.5021186440677966,1.0,1.0,13/72,15.33%,IL10RA;MMP12;TSC2;NXT2;NXT1;KPNB1;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1
prerank,cellular glucose homeostasis (GO:0001678),0.3644065156593553,0.9915841812875908,0.5268065268065268,1.0,1.0,9/41,15.12%,HKDC1;LRRC8A;XBP1;PIK3R1;ZBTB20;PIK3R2;RACK1;TRA2B;NUCKS1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4545678822259057,0.9915403103711458,0.47788873038516405,1.0,1.0,5/12,23.24%,UNC13A;SYT1;UNC13B;SYT7;SYT2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.32753817630470106,0.9915103287518849,0.5137614678899083,1.0,1.0,32/132,18.85%,SLC4A4;KHSRP;IGF1;GPLD1;HSP90AA1;NRDC;FLCN;DCN;ARNT;STK11;PACSIN3;PRXL2C;LIN28B;TWIST1;IRS2;ZBTB20;PIK3CB;APP;RNF152;SNX33;DAPK1;FAF1;ABCD2;TPCN1;GRSF1;ZC3HAV1;ZSWIM8;MTDH;APOE;ZC3H18;PRKAA1;TRIM27
prerank,regulation of protein ubiquitination (GO:0031396),0.333742645260646,0.9915040619233977,0.5145228215767634,1.0,1.0,27/108,19.43%,HDAC3;UBQLN1;PHF23;SIRT7;HSP90AA1;STUB1;TBC1D7;OGT;TNFAIP3;SQSTM1;MYCBP2;XIAP;ARRB1;CDK5RAP3;MALT1;PARK7;USP4;UBE2D1;NDFIP2;DERL1;DAXX;UBE2L3;SPRY2;TGFBR1;BIRC3;SOX4;RPS3
prerank,mesenchyme morphogenesis (GO:0072132),-0.34110102074702364,-0.9909212397537291,0.4621212121212121,0.864775430587408,1.0,5/17,7.77%,TGFB2;NOS3;ACVR1;ENG;BMPR1A
prerank,regulation of mRNA metabolic process (GO:1903311),0.47894078178081334,0.9906078239993034,0.4956268221574344,1.0,1.0,5/11,19.61%,SLTM;PTCD2;SAFB2;SRPK1;CDK11B
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3895087694224117,0.9905532927666826,0.49228944246737844,1.0,1.0,7/29,17.91%,ARRDC4;ABL1;FBXO5;PARK7;UBE2L3;TOPORS;DCUN1D5
prerank,mitotic recombination (GO:0006312),-0.35510731322539074,-0.9905221535208169,0.4610169491525424,0.8639745609755365,1.0,9/15,32.35%,SMC5;TEP1;RAD52;RAD51D;DMC1;NSMCE2;RAD54B;ERCC1;SMC6
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4043713118396317,0.9904225534978173,0.469910371318822,1.0,1.0,5/24,16.69%,STMN4;TPPP3;KATNB1;MAPT;TPPP
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.33906789234048257,0.990378578182061,0.5057833859095688,1.0,1.0,24/85,21.81%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1;MAGI2;ROR2;PSMD1;PSMD6;SMURF1;PRICKLE2;PSMD5;PSMA4;FZD2;PSMA1;RYK;PSMC6
prerank,regulation of interleukin-1 production (GO:0032652),0.436920291349008,0.9902444897395585,0.48951048951048953,1.0,1.0,3/15,12.75%,ANXA1;SIRPA;TMED10
prerank,regulation of fatty acid oxidation (GO:0046320),0.4281747083172665,0.9901006197868508,0.49595687331536387,1.0,1.0,6/16,21.10%,MLYCD;SOX9;ACADL;ACADVL;PRKAG2;APPL2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4061186092673095,0.989875140947304,0.49047013977128334,1.0,1.0,3/22,9.49%,ALDH1A2;GC;RBP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.39252356667282684,0.9898693178022889,0.5018963337547409,1.0,1.0,8/25,24.17%,HSP90AA1;NOS1AP;PTGS2;PKD2;ASS1;KLF4;SMAD3;INSR
prerank,protein deubiquitination (GO:0016579),0.32409403659282054,0.9895975641340347,0.5386934673366834,1.0,1.0,69/242,20.05%,CCP110;OTULINL;PSMD4;IL33;TAF9B;USP14;USP7;USP30;UCHL1;JOSD2;USP1;USP38;OGT;TNFAIP3;OTUD7A;USP24;TOMM20;USP47;PSMB10;USP42;BARD1;UCHL3;HGS;PSMD11;ACTR8;CDC25A;USP32;USP10;MDM4;ABRAXAS2;VCP;USP2;PSME2;PSMC5;USP11;USP15;USP3;USP19;YY1;TADA3;USP40;USP9X;USP4;PSMD1;USP34;USP35;UBE2D1;USP48;USP31;NEDD8;EIF3F;PSMD6;TNIP1;STAM2;USP33;MDM2;TAB1;TGFBR1;USP22;BIRC3;USP50;YOD1;UIMC1;VCPIP1;USP37;PSMD5;JOSD1;INO80;NFRKB
prerank,sphingolipid biosynthetic process (GO:0030148),0.34116050402213766,0.9895516400348424,0.521311475409836,1.0,1.0,17/71,19.12%,A4GALT;ST8SIA3;ELOVL1;SMPD2;CERS2;SGPL1;ST3GAL5;ELOVL4;SPTSSA;TLCD3B;PLPP3;SMPD4;VAPB;ALDH3A2;PRKD2;ELOVL6;SMPD1
prerank,cellular response to heat (GO:0034605),0.36902746854118745,0.9894648063676956,0.5034965034965035,1.0,1.0,11/35,20.92%,TCIM;HSP90AA1;STUB1;DHX36;VCP;MAPT;DAXX;HSBP1;CLPB;PDCD6;TPR
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29474911620114563,-0.9894382460708306,0.46153846153846156,0.8651369925295364,1.0,5/25,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.32623256730301003,0.9893898644981559,0.5232793522267206,1.0,1.0,32/161,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;KREMEN1;CSNK1A1;PSMD1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.41660415530467515,0.9892745374311126,0.49736842105263157,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,regulation of DNA recombination at telomere (GO:0072695),0.41660415530467515,0.9892745374311126,0.49736842105263157,1.0,1.0,6/19,18.57%,POLR2B;POLR2K;ATRX;TERF1;DAXX;TERF2IP
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4253503841484406,0.9888457884505567,0.4993215739484396,1.0,1.0,3/15,14.38%,CLN3;ZDHHC3;NLGN2
prerank,blood circulation (GO:0008015),0.358145889216155,0.9885580369688006,0.4881889763779528,1.0,1.0,9/49,16.76%,TNNI3;EDN3;CXCL12;SERPING1;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,PERK-mediated unfolded protein response (GO:0036499),0.47777425262666884,0.9883762388717193,0.5162287480680062,1.0,1.0,2/10,8.54%,EIF2AK3;DDIT3
prerank,modulation of chemical synaptic transmission (GO:0050804),0.33061501484225353,0.9882069636183927,0.5144927536231884,1.0,1.0,19/107,12.73%,CLN3;NPTXR;LRRC4;NTF3;UNC13A;CDK5;GRIK5;TMEM108;ATP1A2;LRP8;CPLX1;NMU;NRG3;CLSTN2;PSMC5;APP;MCTP2;NLGN3;SYT1
prerank,O-glycan processing (GO:0016266),0.3518745838190286,0.9876514755732302,0.5084175084175084,1.0,1.0,10/54,17.94%,C1GALT1C1;ST3GAL2;GALNT4;ST3GAL3;POMGNT1;B4GALT5;GXYLT1;GALNT14;GALNT15;GXYLT2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.31676686279790695,0.9872345243297376,0.569,1.0,1.0,108/497,19.43%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;PAIP2;CIART;FOXM1;SIRT2;SELENOS;ZNF568;EIF2AK3;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;DDX3X;PSPC1;NIPBL;CHD8;POU2F1;CNOT10;CDK5;IGF2BP2;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;EPRS1;DPF2;XRCC6;PER1;DHX36;HDAC4;ARID4A;TWIST1;PUS7;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;EIF4E2;FOXN3;CNOT9;NACC2;MALSU1;ENPP1;HDAC1;BCL7A;RACK1;ATR;TSC22D4;EHMT1;GCLC;CIPC;DAPK1;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;MRPL13;RFX3;CIC;CTBP1;CLOCK;SNW1;TERF1;CBX5;DAXX;FMR1;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;SAMD4B;YAF2;RPS3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.36724648377407004,0.9870145655985124,0.5047846889952153,1.0,1.0,9/38,16.70%,SFRP1;DDX3X;TNFAIP3;TMBIM1;RFFL;BMP5;ICAM1;SERPINE1;FAIM2
prerank,limb development (GO:0060173),0.3810790945775951,0.9870078658995105,0.5,1.0,1.0,8/28,21.30%,PCSK5;FGF10;PTCH1;ZNRF3;KREMEN1;MEGF8;CHD7;GLI3
prerank,smooth muscle cell differentiation (GO:0051145),-0.3821772616438385,-0.9867596645839527,0.473015873015873,0.8708059471579985,1.0,11/12,38.04%,MEF2C;TMEM204;TBX18;BMP4;MRTFB;HEY2;GATA6;EDNRB;MYOCD;APLNR;HEY1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.40628488131798135,0.98649618562589,0.4948849104859335,1.0,1.0,9/22,21.94%,EAPP;CDK13;BRD4;CDC73;THOC1;CCNT1;CCNT2;HMGN1;TCERG1
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.3184023434470208,-0.9864770045235116,0.4410480349344978,0.8695820047182433,1.0,4/20,20.32%,AKR1B1;STARD3NL;FDX1;TSPO
prerank,positive regulation of cell division (GO:0051781),0.36279948911596904,0.9861636301253118,0.49182242990654207,1.0,1.0,6/38,14.15%,SIRT2;FGFR2;CDC14B;CIT;SVIL;CSPP1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.36131575560596013,0.9860795784042674,0.4823943661971831,1.0,1.0,4/40,6.52%,GSDMD;RNASE7;TIRAP;GBP7
prerank,peptidyl-lysine modification (GO:0018205),0.33705583486730323,0.9857686492995184,0.5225130890052356,1.0,1.0,29/99,20.92%,NDUFAB1;SIRT2;SIRT7;USPL1;SAE1;RAE1;PLOD1;ETFBKMT;HDAC4;NUP188;SENP5;VPS33B;PARK7;NUP210;NUP88;PIAS3;NUP214;ATPSCKMT;SIRT5;TOPORS;NUP153;RANBP2;NUP35;PIAS1;LOXL1;SUMO2;EYA1;SENP7;TPR
prerank,positive regulation of developmental process (GO:0051094),0.32578957266855757,0.9857245762879953,0.5338725985844287,1.0,1.0,42/164,19.65%,WNT5A;TMEM119;CAMK2B;DVL2;EDN3;FIS1;FGFR1;XBP1;DCN;MIEF2;ANAPC2;FBXO5;ARHGEF7;DVL1;LRP8;SOX9;VLDLR;GDNF;ENPP2;BMP5;DAG1;SOX6;B4GALT5;RPS6KA3;ZBED3;SOX5;DNM1L;NR2C2;ACVR1B;RPS6KA1;SPIRE1;NUMA1;PHLDB1;FMR1;APOE;BMP1;SORL1;HMCES;FOXD1;SHANK1;KMT5B;NCOA3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.37484945559667765,0.9857146982521113,0.5060827250608273,1.0,1.0,6/33,6.65%,UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;EZH2
prerank,Rho protein signal transduction (GO:0007266),0.3518933714994947,0.9856793241506362,0.5106382978723404,1.0,1.0,13/53,16.48%,CDC42EP5;CDC42EP4;CTNNAL1;RHOD;RIPOR1;ADGRG1;RTKN;COL1A2;PLEKHG5;ARHGAP29;ROCK2;EPS8L1;AGTR1
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.30422602622917094,-0.9856108338950501,0.4567307692307692,0.8700808247432705,1.0,10/24,30.03%,NIBAN2;DACH1;ZRANB3;MSH2;BLM;RTEL1;MSH6;H1-0;CDKN1A;ERCC1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45838561065362404,0.9853225304795747,0.4833091436865022,1.0,1.0,2/11,2.21%,SLC25A19;DCK
prerank,positive regulation of catabolic process (GO:0009896),0.3475653557894119,0.985204622704666,0.4884488448844885,1.0,1.0,19/65,21.63%,WNT5A;ASB5;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;EGLN2;RNF41;NKD1;NSF;TIPARP;SMURF1;SORL1;STX5;HECW2;FOXO1;RAB7A
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4376268160132123,0.9842005011974865,0.48753462603878117,1.0,1.0,3/14,10.20%,STAT6;PIK3R1;PRLR
prerank,negative regulation of receptor binding (GO:1900121),0.4690684755615409,0.9839152057524305,0.5094614264919942,1.0,1.0,2/10,11.35%,ATP2A2;PTPRF
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.2237714568365127,-0.9837007520368429,0.5657894736842105,0.8736034060710474,1.0,19/70,15.68%,LNPEP;IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,double-strand break repair (GO:0006302),0.32507197740070914,0.9836593113685626,0.532258064516129,1.0,1.0,35/158,16.27%,KDM4D;XRCC2;APTX;RNF138;PARP1;APLF;HELQ;RNF8;PAXX;PARP2;PALB2;FBH1;BARD1;TDP1;LIG3;IFFO1;ACTR8;RNF168;XRCC6;SEM1;UBE2V2;VCP;MDC1;DCLRE1A;YY1;BRIP1;POLN;RMI1;TDP2;SETX;NUCKS1;MRE11;PPP5C;CHEK2;RAD50
prerank,keratan sulfate metabolic process (GO:0042339),0.3821964320811009,0.9834174599176034,0.5144230769230769,1.0,1.0,7/31,15.67%,SLC35D2;GLB1;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,myeloid cell development (GO:0061515),-0.32885575174758497,-0.9831783729158678,0.472,0.8732030668196826,1.0,8/18,24.04%,FOXP1;MED1;KIT;SRC;ABCB10;SH2B3;NRROS;NCKAP1L
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3826829614010218,0.9831248530040965,0.5018867924528302,1.0,1.0,2/29,2.68%,FASN;ELOVL1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3794595809955549,-0.9830748005580608,0.47419354838709676,0.8715589392379721,1.0,3/11,23.97%,TGFB2;GCH1;DDC
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.28251033826327115,-0.9828589863763622,0.48947368421052634,0.8702005313970085,1.0,10/29,19.16%,UBE2K;SAMHD1;IFNAR2;STAT2;HSP90AB1;CDC37;METTL3;MAVS;CNOT7;USP18
prerank,organelle organization (GO:0006996),0.31829978017574817,0.9827397881828793,0.56,1.0,1.0,109/388,21.63%,SPTBN5;IQCG;CENPT;CUL7;ATL1;TJAP1;BIN1;CHCHD10;UBXN2A;BCS1L;PARP1;EIF2AK3;MSTO1;BNIP1;TRAPPC8;KIF3A;SAR1A;SLC25A33;ANK1;OBSL1;RAB34;TNFAIP3;MAST3;MIEF2;THY1;SEC16A;SLC25A36;ARHGEF7;DMTN;MIA3;TRIP11;PDZD8;TTC17;NCKIPSD;SEC16B;FANCG;ATP8B2;PACSIN3;DES;LMAN2L;AUP1;ARHGAP21;CHMP3;TOR1B;TBC1D20;TPM1;PLEKHM2;PEX1;USP6NL;KIF5C;RAB30;PTCD2;YTHDF3;PARK7;TANGO2;VPS4B;TMED10;COG3;PRKCI;SNX11;PEX7;YTHDF1;HTT;CSNK1D;MTX3;SMPD4;PRPF40A;VMP1;DNM1L;CSNK1A1;RAB31;ARMC2;VAPB;ABCD2;STX17;TFB1M;SIRT5;VPS18;NUMA1;MTX2;PHIP;VPS13D;APOE;GORASP1;GABPB1;KLHL20;PKD2;ZFYVE16;ODF2;CDC42BPB;AGTPBP1;KIFAP3;YTHDF2;FAM174B;FGD4;RANBP9;ZW10;GABPA;TOR1AIP2;PAK5;DYNC2H1;ATL3;RHOU;CFL1;CLASP2;DIAPH1;CHMP4A;CHMP4B;RAB7A
prerank,proteasome assembly (GO:0043248),0.46059110139009096,0.9826821527522316,0.5090634441087614,1.0,1.0,5/11,21.95%,PSMD4;PSMD11;POMP;PSMD5;OTUD6B
prerank,mitotic nuclear division (GO:0140014),0.34301317375961704,0.9823230209761434,0.5167206040992449,1.0,1.0,19/71,21.47%,CCDC61;UBE2S;STAG1;ARHGEF10;WRAP73;KPNB1;PIBF1;ABRAXAS2;MAP9;SPICE1;STAG2;ZWINT;OFD1;CHEK2;BCCIP;ZW10;INO80;CLASP2;CHMP4B
prerank,atrioventricular valve development (GO:0003171),-0.34405447945269624,-0.9816212261514112,0.5074074074074074,0.8716644230001792,1.0,4/14,7.89%,TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.37858325563224854,0.9810286550274856,0.5041420118343195,1.0,1.0,8/32,15.16%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;BRSK1;FOXN3;MRE11
prerank,nucleic acid-templated transcription (GO:0097659),-0.2564827873108123,-0.980818518934561,0.4696969696969697,0.8721032993463714,1.0,25/42,35.74%,EPC1;MEF2A;RRAGC;CREBL2;POLR3A;RNPS1;MED20;DTX1;PWP1;FUBP3;NR4A2;POLR2H;BCL3;TERT;POLR2G;POLR2F;POLR2C;PAX8;POLR2E;HOXD3;POLR2J;XAB2;NFKBIB;POLR2D;E2F1
prerank,protein localization to cell junction (GO:1902414),0.4020819931419096,0.9804405748062092,0.5232120451693852,1.0,1.0,6/22,19.05%,MPP4;KIF3A;JAM3;NLGN2;JAK1;SHANK1
prerank,regulation of telomere capping (GO:1904353),0.40240896635422074,0.9803917779763416,0.5076530612244898,1.0,1.0,6/23,17.42%,PKIB;USP7;HNRNPD;RAD50;TNKS;NABP2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.41752118698322416,0.9802926704160777,0.49931224209078406,1.0,1.0,3/18,11.07%,PPIF;THEM4;BCL2
prerank,regulation of centrosome duplication (GO:0010824),0.37957187197718023,0.9797834141486956,0.522673031026253,1.0,1.0,10/29,21.47%,ALMS1;FBXW5;CHMP3;VPS4B;NPM1;SPICE1;CEP120;CEP76;TMEM67;CHMP4B
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3554565372673397,0.9793374819563724,0.49608062709966405,1.0,1.0,15/49,23.46%,PTGER4;LCMT1;DDX3X;PMEPA1;JAM3;PEX5;PARK7;IMPACT;SMAD6;SORL1;PPM1A;PRKCZ;HMGB1;RPL13A;IAPP
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.37156947917326916,0.9793031757540177,0.5231316725978647,1.0,1.0,14/35,23.86%,CALM3;NUAK1;PPP1R2;PPP6R3;MAGI2;HTT;PPP1R11;TIPRL;CALM1;CALM2;ITGA1;PPP4R4;FKBP1A;TSC1
prerank,positive regulation of mRNA processing (GO:0050685),0.40015977175312967,0.9792781046701997,0.5120101137800253,1.0,1.0,9/21,20.66%,RBM3;PRDX6;DHX36;TRA2B;CDC73;SNW1;THRAP3;CIRBP;TRA2A
prerank,circulatory system development (GO:0072359),0.32927259405900944,0.9792259339238689,0.5487179487179488,1.0,1.0,24/118,19.43%,PDLIM2;TNNI3;POU6F1;DVL2;CACYBP;PDLIM7;TSC2;STRA6;PCSK5;STK11;SOX9;ADAP2;FGF12;FBN1;AKAP13;TGFB1;FOXC2;HSPG2;KDM6B;OSR1;PKD2;TGFBR1;SOX4;KDM6A
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.36318231108948673,0.9791668276468547,0.5151515151515151,1.0,1.0,11/40,16.79%,SIRT7;USP1;CDK9;ABL1;FBXO5;UBE2V2;CASP9;POLH;MAPT;BCLAF1;FMR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3406974118531348,0.979069300667753,0.5273522975929978,1.0,1.0,10/66,10.21%,CDKN2D;UBE2E2;ANXA1;TFDP1;DDX3X;FGF10;WEE1;PLK5;RBL2;PSME2
prerank,amino sugar metabolic process (GO:0006040),-0.3946862048390367,-0.9790238313601598,0.4608695652173913,0.8751134919334225,1.0,7/10,31.55%,CSGALNACT1;ST3GAL1;GFPT1;GFPT2;ST6GAL1;SLC35A3;FN3K
prerank,epithelial cell morphogenesis (GO:0003382),0.42174863526007134,0.9789613466198753,0.5213204951856947,1.0,1.0,2/17,6.62%,DACT2;COL22A1
prerank,synaptic vesicle recycling (GO:0036465),0.3771737049420133,0.9788767449268001,0.48246674727932287,1.0,1.0,6/31,14.38%,SYNJ2;CDK5;NLGN3;SYT1;TBC1D24;NLGN2
prerank,multivesicular body assembly (GO:0036258),0.3803685374813498,0.9785064892699018,0.5109223300970874,1.0,1.0,6/30,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.359610809897255,0.9781173234586223,0.5105140186915887,1.0,1.0,4/41,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.39671717416270325,-0.9777094820281527,0.4932249322493225,0.8749342597861026,1.0,4/10,45.28%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.39671717416270325,-0.9777094820281527,0.4932249322493225,0.8749342597861026,1.0,4/10,45.28%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,mRNA export from nucleus (GO:0006406),0.33208436528666707,0.9774643454414396,0.5418821096173733,1.0,1.0,35/102,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;DDX19A;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,visual perception (GO:0007601),0.3305937431963242,0.9771186585565219,0.5306553911205074,1.0,1.0,9/84,14.68%,GPR179;BEST1;RDH10;ADGRV1;OAT;POU6F2;ZIC2;CRYBB3;EML2
prerank,mitochondrial genome maintenance (GO:0000002),0.45167952168367453,0.976889213715322,0.5065502183406113,1.0,1.0,3/11,6.34%,PARP1;SLC25A33;SLC25A36
prerank,positive regulation of positive chemotaxis (GO:0050927),0.43593486530217707,0.9765232181097216,0.51931330472103,1.0,1.0,2/15,4.50%,NTF3;CXCL12
prerank,regulation of potassium ion transport (GO:0043266),0.3747069930338622,0.976504677052508,0.51145958986731,1.0,1.0,5/31,17.25%,KCNAB2;CD63;ANK3;DPP10;KIF5B
prerank,regulation of lipid metabolic process (GO:0019216),0.33134172533481565,0.9764409844526823,0.5252100840336135,1.0,1.0,28/88,24.05%,FASN;HDAC3;SMARCD3;NR1D2;RORA;CHD9;CERS2;LSS;ABCA7;GPAM;SC5D;IRS2;CYP51A1;PSAP;TBL1XR1;GPS2;NCOR2;PRKAG2;ELOVL6;CARM1;GGPS1;NPC2;ID2;NCOA1;SP1;RXRA;TGS1;NFYA
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.34621596590936266,0.9763941663349758,0.5402425578831312,1.0,1.0,9/59,13.21%,AMIGO1;OBSL1;TENM3;IGSF21;DSCAM;IGSF11;ROBO2;ROBO1;NPTN
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.4584233917941718,0.9762025197572087,0.4963820549927641,1.0,1.0,5/11,23.39%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.4584233917941718,0.9762025197572087,0.4963820549927641,1.0,1.0,5/11,23.39%,CALM3;PKD2;CALM1;CALM2;FKBP1A
prerank,ceramide transport (GO:0035627),0.4508894966074469,0.9760425157190065,0.5257731958762887,1.0,1.0,3/12,13.84%,ABCA2;PLEKHA3;PSAP
prerank,male meiosis I (GO:0007141),0.4229565987829386,0.9757579154787568,0.5077355836849508,1.0,1.0,4/16,21.15%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,melanocyte differentiation (GO:0030318),-0.38401698649555094,-0.9756783278537043,0.4691780821917808,0.8787421663320658,1.0,3/11,3.29%,MEF2C;KIT;USP13
prerank,regulation of DNA metabolic process (GO:0051052),0.35799273498213174,0.9754875425422178,0.5240274599542334,1.0,1.0,16/44,21.97%,SIRT7;WDR18;USP1;CDK9;HNRNPD;UBE2V2;POLH;HELB;THOC1;NUCKS1;TERF2IP;MPHOSPH8;KPNA1;SUB1;SMG1;UBE2V1
prerank,cholesterol metabolic process (GO:0008203),0.3428679089139701,0.9754212994815801,0.5595238095238095,1.0,1.0,10/68,13.04%,CYP27A1;CLN6;SCAP;GBA2;LSS;SOAT1;INSIG1;MSMO1;STARD3;CYP51A1
prerank,regulation of kinase activity (GO:0043549),0.3326594271552121,0.9752356143211506,0.534446764091858,1.0,1.0,20/89,17.15%,MST1R;EPHA7;EPHB2;FGFR2;SMG8;FGFR1;DDR1;DDR2;EPHA8;EPHA10;MUSK;RBL2;IRS2;PDGFRA;ROR2;EMP2;MAPT;MRE11;RAD50;EPHA5
prerank,epithelial cell differentiation (GO:0030855),0.33385240075524564,0.9744684562625955,0.539832285115304,1.0,1.0,20/88,22.16%,ANXA7;FGFR2;ANXA1;FSTL1;SCRIB;RAB10;HDAC1;HNRNPH3;VDAC1;MAF;JAG1;ACADVL;KDM6B;ANXA4;SCUBE1;PGK1;DAB2;CTSB;PTER;ERBB4
prerank,carnitine metabolic process (GO:0009437),0.4392156855253826,0.9743888217624578,0.5030674846625767,1.0,1.0,4/12,16.67%,CROT;CPT2;BBOX1;ACADL
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.27707279872766455,-0.9741834158881075,0.5051546391752577,0.8807423475603858,1.0,6/32,7.94%,MEF2C;PREPL;RIMS2;SYN1;LRRK2;DTNBP1
prerank,macromolecule catabolic process (GO:0009057),0.3904259427838817,0.973758021563466,0.5272952853598015,1.0,1.0,7/26,20.44%,MVB12A;CLN6;UCHL3;TGFB1;SMURF1;PIK3R4;UVRAG
prerank,glycerophospholipid metabolic process (GO:0006650),0.3344478485552315,0.9736727768728229,0.5288461538461539,1.0,1.0,17/75,19.92%,PIGG;CLN3;GPLD1;DPM2;PIGM;CRLS1;PRDX6;GDPD3;CPNE7;PIGA;SMPD4;FAR1;GDE1;PIGX;PIP5K1A;PLA2G7;PAFAH1B1
prerank,regulation of cellular component size (GO:0032535),-0.27959589370812765,-0.9736724129513197,0.5025380710659898,0.8803135142730424,1.0,8/30,8.61%,PICALM;RDX;MTPN;RIN3;RARG;EPS8;EZR;RAB22A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.45112011085396886,0.9734807652210584,0.5203007518796993,1.0,1.0,4/12,16.44%,CD24;IQGAP1;MAGI2;JAG1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3723234182187598,0.9731694731314933,0.5107913669064749,1.0,1.0,8/32,12.75%,RBM4B;RBM3;METAP1;CYFIP1;PUM3;PGAM1;APP;TMED10
prerank,negative regulation of phosphatase activity (GO:0010923),-0.3055931275261062,-0.9730677052369981,0.49246231155778897,0.8801498337985499,1.0,7/25,19.70%,URI1;TGFB2;SEMA4D;PTPA;BOD1L1;SH3RF2;ZCCHC9
prerank,chromosome condensation (GO:0030261),0.3664637205968788,0.9729478441239819,0.5200945626477541,1.0,1.0,4/36,6.72%,INCENP;CSNK2A2;AKAP8L;DFFB
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.24478116105323597,-0.9729316752121797,0.47474747474747475,0.8786208806747848,1.0,11/56,10.62%,IRAK2;LBP;IRAK1;NOD1;HSP90B1;UNC93B1;TLR4;CTSL;PLCG2;UBB;ALPK1
prerank,regulation of cellular response to stress (GO:0080135),0.32429950243561334,0.972699093096998,0.5639175257731959,1.0,1.0,36/115,21.54%,CLN3;CAMK2B;HSP90AA1;AIFM2;DNAJC7;RAE1;NUAK1;ABL1;BAG1;NUP188;CASP9;HSPH1;CAMK2D;USP19;CAMK2G;DNAJB6;NPM1;NUP210;ATR;NUP88;MAPT;ROCK2;NUP214;NUPR1;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;RSL1D1;NUP35;MAPKAPK2;TPR;SMG1;NPAS2;DNAJC2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.414422051603744,0.9725056759966164,0.5080862533692723,1.0,1.0,4/17,12.24%,APLN;TAFA5;TPM1;SOD2
prerank,negative regulation of cell migration (GO:0030336),0.322833664315147,0.9720428950035791,0.5730337078651685,1.0,1.0,53/137,25.61%,SFRP2;SFRP1;RAC1;FLCN;SULF1;SRGAP2;SRGAP3;THY1;MIA3;RAP2A;PODN;TPM1;IGFBP3;ADGRG1;ROBO1;MAGI2;DAG1;NDRG4;LRP1;RNF41;SLURP1;JAG1;SERPINE1;PLXNB3;ITGB1BP1;DPEP1;MCTP1;MITF;DLC1;EVL;ATP1B2;NF2;PTPRR;SMAD7;SRGAP1;DLG5;FGF2;CLASP2;IGFBP5;PFN2;HOXA7;EPHA4;DPYSL3;PTEN;ADARB1;CORO1C;PHLDB2;CX3CL1;NAV3;DUSP3;AFDN;VCL;CLIC4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3178350395549411,0.9720078044578431,0.5645161290322581,1.0,1.0,30/182,14.47%,SFRP2;APLN;SFRP1;IGF1;ANXA7;NFKB1;ERP29;FLCN;OLFM1;CELF1;SFMBT2;WNT4;LRPAP1;SDCBP;RBMS3;SOX11;RBL2;APP;ROBO1;YY1;PARK7;HDAC1;AGO3;RACK1;PARP14;PTPN22;MAPT;ROCK2;TGFB1;MAP2K2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.31938070372054617,-0.9718655072788732,0.5058823529411764,0.879595866329553,1.0,4/19,10.83%,ABHD5;IRS1;PRKCD;DAGLB
prerank,histone mRNA catabolic process (GO:0071044),-0.34225281414006914,-0.9718494628387367,0.4844961240310077,0.8777300376784816,1.0,7/15,26.25%,TENT2;LSM1;ERI1;UPF1;TUT1;TUT4;SSB
prerank,RNA export from nucleus (GO:0006405),0.33030361133822095,0.9718411819609046,0.5515088449531738,1.0,1.0,34/100,22.88%,DDX19B;SLBP;NXT1;U2AF1;SRSF2;RAE1;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;NUP188;CPSF3;NUP210;THOC7;NUP88;HNRNPA2B1;THOC1;NUP214;YTHDC1;UPF2;SRRM1;NUP153;SMG7;RANBP2;FIP1L1;NUP35;TPR;SARNP;SMG1;U2AF2;AGFG1;NUP155;SRSF6
prerank,negative regulation of phagocytosis (GO:0050765),0.4130349633028603,0.9717125221454455,0.4966532797858099,1.0,1.0,4/17,12.69%,FCGR2B;SIRPA;CD47;RACK1
prerank,electron transport chain (GO:0022900),0.4185252115258708,0.971711175583504,0.5200553250345782,1.0,1.0,3/15,6.76%,CYB561;SDHA;POR
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.38703948069115734,-0.9716163969175721,0.48606811145510836,0.8765200279217781,1.0,5/10,29.78%,SIRT1;NOC2L;KLF15;TAF7;THAP7
prerank,negative regulation of cellular component organization (GO:0051129),0.3373723592465323,0.9714227743847239,0.5421558164354322,1.0,1.0,16/74,19.82%,CARMIL2;LCMT1;BMP6;DDX3X;PACSIN3;ABCA7;PEX5;SNX33;DNAJB6;SCAMP5;IMPACT;SPRY2;MCTP1;SORL1;CARMIL1;PRKCZ
prerank,embryonic skeletal system development (GO:0048706),0.366149631429081,0.9713710467249068,0.5119047619047619,1.0,1.0,7/35,17.12%,WNT5A;PCSK5;SULF1;SOX11;PDGFRA;MEGF8;OSR1
prerank,aortic valve morphogenesis (GO:0003180),0.37942247021123987,0.9711024411608856,0.5181159420289855,1.0,1.0,10/30,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.45680724527129196,0.9710225434413482,0.5230547550432276,1.0,1.0,4/11,14.28%,FRS2;EFNB2;SOX6;TGFB1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.44340694472758546,0.9708707540895545,0.5221112696148359,1.0,1.0,3/13,12.23%,BAX;VDAC2;BLOC1S2
prerank,regulation of apoptotic process (GO:0042981),0.31144413072325716,0.9707509254371122,0.618,1.0,1.0,146/676,19.55%,SFRP2;RNF157;HDAC3;WNT5A;CLN3;SFRP1;IGF1;GLS2;TCIM;BAX;GPLD1;PPIF;ARAF;LCMT1;NFKB1;BIN1;NTF3;HSP90AA1;PLEKHN1;SLC27A4;BNIP1;TAF9B;AIFM2;ANP32A;ANXA1;HTATIP2;XBP1;MAD2L1;FSTL1;DDX3X;FZD9;NUAK2;IL31RA;MGMT;CDK5;SCRIB;FLCN;OLFM1;USP47;PRDX5;FAM162A;PIK3R1;PRELID1;ABL1;SQSTM1;USP42;BAG1;BARD1;ARHGEF7;ARHGEF4;HNRNPK;EEF1E1;MAGED1;ZFAND6;KCNMA1;KALRN;TRIM35;IFIT3;CALHM2;MCF2;XIAP;PLK5;LRP8;SOX9;SRA1;NDRG1;CLIP3;VCP;CASP9;VAV2;UBE2Z;MALT1;GDNF;PRLR;IGFBP3;BCL2;RTKN;BNIP2;IRF3;TMEM219;HS1BP3;PARK7;NPM1;HDAC1;TNFRSF25;PLEKHG5;LANCL1;RACK1;AKAP13;RPS6KA3;SETX;GCLC;VDAC1;PRKCI;DAPK1;ANKRD13C;HTT;MTCH1;EGLN2;MTCH2;TXNDC5;BCL6;RNF122;BCLAF1;SMAD6;DNM1L;CBL;SHQ1;MRE11;NUPR1;PAWR;FAF1;CASP2;HSPD1;RPS6KA1;CTSH;TRIO;AHI1;ARHGEF6;FAIM2;DAXX;DPEP1;PHIP;SPRY2;MTDH;OSR1;SON;DFFA;TOPORS;OMA1;ANXA4;KLHL20;RASSF2;BAG4;PDCD5;PRKAA1;RSL1D1;BIRC3;FMN2;PRMT2;SMPD1;SOX4;DDX42;PLEKHG2;RPS3;FGD4
prerank,positive regulation of establishment of protein localization (GO:1904951),0.4107922814928747,0.9706477465523399,0.5079787234042553,1.0,1.0,3/18,7.40%,CCT8;CCT6A;WRAP53
prerank,neuronal action potential (GO:0019228),0.39351293089409367,0.9702861709357201,0.49874371859296485,1.0,1.0,5/22,13.93%,MYH14;SCN7A;SCN1A;ANK3;KCNA1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.3634580611639412,-0.9701727514970645,0.5218978102189781,0.8787621105577883,1.0,3/14,5.38%,ANKRD17;PUM1;ZDHHC5
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4350883931001216,0.9700998987513723,0.5229485396383866,1.0,1.0,5/13,18.18%,EPHB2;SQSTM1;APP;ADCY1;ZDHHC2
prerank,organophosphate ester transport (GO:0015748),-0.2948820801910754,-0.9698279742638428,0.47115384615384615,0.8778834565124758,1.0,6/24,8.39%,OSBPL2;PITPNA;PITPNC1;SCARB1;SCP2;OSBPL5
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4360975249077129,0.9697475362708501,0.5049928673323824,1.0,1.0,3/13,9.21%,MGAT3;RENBP;EXTL2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.445405760033648,0.9697203510589918,0.5109809663250366,1.0,1.0,4/12,16.69%,ERLIN2;PIBF1;ACADL;ACADVL
prerank,negative regulation of cellular process (GO:0048523),0.3117986363525838,0.9694598484187188,0.599,1.0,1.0,89/521,15.34%,PSRC1;SFRP2;CDKN2D;FCGR2B;SFRP1;DACT2;FOXM1;SIRT2;GPLD1;EPHB2;SIRT7;CDKN2AIP;TSC2;CHERP;EIF2AK3;CGRRF1;CASK;PLXNA2;GNRH1;PTHLH;WARS1;DDX3X;FBLN1;RBBP4;FLCN;CLMN;IRF1;DLG3;SRGAP2;FBXO5;ALDH1A2;ADAM22;VAMP3;CELF1;MIA3;EEF1E1;STK11;HGS;CHD5;RIPOR2;TGFB1I1;SIRPA;IFIT3;TCHP;DSCAM;PODN;IFI35;PLXNA1;LRPAP1;WDR6;PPP1R9B;ORC6;MDM4;SOX11;WNK2;APP;TAF6;IGFBP3;BCL2;ADGRG1;IGFBP7;BMP5;NACC2;MAGI2;MALSU1;ENPP1;SPEG;PARK7;VPS4B;SOD2;NPM1;AXIN2;RACK1;ROR2;TNS2;CDC73;PARP16;FGFBP1;RNF41;TGFB1;SLURP1;BCL6;P3H2;IMPACT;SMAD6;SLIT3;DIS3L2;NUPR1;ACVR1B
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.34632448112305825,0.9691471026974523,0.5412026726057907,1.0,1.0,20/51,22.50%,SFRP1;RAC1;ARHGEF10;NRP1;ABL1;TPM1;ARHGEF10L;CD47;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;EVL;NF2;PPM1F;PFN2;PAK1
prerank,positive regulation of intracellular transport (GO:0032388),0.3646444573837016,0.9689906596758118,0.552168815943728,1.0,1.0,13/38,20.92%,MLC1;CAPN10;STK11;RIPOR1;TBC1D20;PGAP1;NUMA1;EIPR1;RUFY3;SORL1;KIF20B;EHD1;TPR
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3671950194951576,-0.9685740071350094,0.4844290657439446,0.8795306829786074,1.0,6/12,25.44%,NFKBIA;NR1H3;NR1H2;PPARG;PPARA;ITGB3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.34609516257992357,0.9685197066071188,0.5273132664437012,1.0,1.0,17/51,21.25%,NTF3;TAOK1;MINK1;SRGAP2;DBN1;DBNL;ALS2;WASF1;EPB41L3;CNTNAP2;TRIO;SLC9A6;GAS7;KIF20B;NRK;NBL1;MAP4K4
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3597467915585475,0.9682634937414496,0.536697247706422,1.0,1.0,11/39,17.80%,TMEM150A;PIP4K2B;PIK3R1;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;PIK3C2B;PIK3C3;IP6K1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3881803749015226,0.9681467092437192,0.5157629255989912,1.0,1.0,3/23,5.69%,BAX;HSP90AA1;TIMM13
prerank,positive regulation of tissue remodeling (GO:0034105),0.464639111481335,0.9681065369761783,0.509009009009009,1.0,1.0,3/10,22.93%,TMBIM1;ROCK2;IL18
prerank,Notch signaling involved in heart development (GO:0061314),0.4496498066372716,0.967814288135904,0.5151953690303908,1.0,1.0,3/11,16.44%,SNAI1;RBPJ;JAG1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4179591031895512,0.967728683514068,0.5350756533700137,1.0,1.0,1/17,0.24%,S1PR2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.35546855470986866,0.967685190628374,0.5389830508474577,1.0,1.0,7/46,12.18%,IGF1;TNFAIP3;TCF7L2;MFN2;XRCC6;IGFBP3;NDRG4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.40619349711446673,0.9674232139090648,0.5213903743315508,1.0,1.0,4/19,10.71%,NFKB1;TMEM106A;EGF;APP
prerank,nucleosome assembly (GO:0006334),0.37051394496673473,0.9671002853224598,0.5367372353673724,1.0,1.0,9/31,16.74%,UBN1;RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;HAT1;DAXX
prerank,intracellular protein transport (GO:0006886),0.31456328578611403,0.9670094632832068,0.609,1.0,1.0,93/304,22.84%,MMP12;ARL4C;RTN2;TSC2;BCS1L;CACNG3;NXT2;NXT1;SGSM3;PICK1;ERP29;SAR1A;RUNDC1;RAB24;SNF8;DNAJC27;TBC1D13;NAPG;STX6;SEC16A;SNX6;VPS26B;RANBP3L;STX16;KPNB1;STX2;RAB5B;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;CLIP3;NUP188;KATNB1;SCFD1;USP6NL;STRADB;AP3B1;EVI5L;IPO11;VPS33B;E2F3;TLK1;NPM1;TMED10;NUP88;RABGAP1;IPO7;TGFB1;USO1;AP4M1;STX11;RAB31;NUP214;STX8;TNPO1;STX17;TRAK1;GGA2;XPO6;NSF;SYNRG;AP4E1;RAB21;SMURF1;TBC1D9B;TBC1D22B;XPO7;SORL1;NUP153;RAB6A;SGSM2;RANBP3;STX5;PPP1R10;AP4S1;OXA1L;RAB3GAP2;PDCD6;EHD1;HEATR3;TPR;APPL2;NAPA;RAB7A;ARFGAP3;GGA3;SIL1;RAB43;HERC2;SNX27;NUP155
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3154698102421724,0.9668351452548879,0.5835835835835835,1.0,1.0,54/259,16.17%,S1PR2;TMEM138;B9D2;AIF1L;CPLANE2;STK36;RAC1;IFT52;WHAMM;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;MINK1;CLUAP1;NRP1;TCTN1;BBS7;INPP5E;SRGAP2;ARHGEF7;ARHGEF4;DMTN;SNX10;RAP2A;RHOD;CDC14B;CCDC28B;CYFIP1;PIBF1;PPP1R9B;SDCBP;CFAP54;TTC8;CEP126;CC2D2A;IFT80;ABLIM2;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;EMP2;DISC1;ATP6V1D;TMEM216;RFX3;OFD1;RAB8A;RAB8B;AHI1;ARHGEF6
prerank,positive regulation of dendrite development (GO:1900006),-0.38550056220092477,-0.9668254277707725,0.5070821529745042,0.8825984520754852,1.0,6/10,16.87%,DAB2IP;COBL;ZDHHC15;BMP7;ALK;PACSIN1
prerank,cellular iron ion homeostasis (GO:0006879),-0.2427076495304999,-0.9663422611390501,0.5229357798165137,0.8819918007980193,1.0,8/55,4.52%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1
prerank,regulation of lipid kinase activity (GO:0043550),0.4446178634394664,0.9662345447316004,0.5098870056497176,1.0,1.0,5/11,17.99%,PIK3R1;RBL2;PIK3R2;WDR91;PPP2R5A
prerank,negative regulation of lyase activity (GO:0051350),0.41556679738419944,0.9660760837986507,0.5163487738419619,1.0,1.0,2/16,7.66%,LTB4R2;ADGRV1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.36783319065022313,0.9658308661124745,0.533969010727056,1.0,1.0,3/33,7.26%,APLN;GNL3;TEAD1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.31505855159182405,-0.9657441375595549,0.5022026431718062,0.8817905611288414,1.0,10/19,29.29%,MTHFR;MTHFS;SLC25A32;MTHFD1;MTHFD1L;MTRR;ALDH1L1;ALDH1L2;MTHFD2;DHFR
prerank,proteasomal protein catabolic process (GO:0010498),0.3172459838355689,0.9655507810317954,0.5941295546558705,1.0,1.0,46/201,17.98%,SIRT2;SPSB3;KCTD5;PSMD4;UBXN2A;SPSB1;STUB1;SYVN1;UCHL1;ERLEC1;COP1;PSMB10;DDB1;FBXO45;BRSK2;RFFL;FBXW5;PSMD11;RCN3;RMND5A;ARRB1;DDIT3;TRIM9;CUL4B;VCP;PSME2;PSMC5;KCTD2;UBE2A;PCNP;ZFAND2A;RNF41;RNF122;FEM1C;PSMD1;FAF1;ZSWIM8;CLOCK;DERL1;PSMD6;SMURF1;TOPORS;MDM2;PCBP2;TBL1XR1;KLHL20
prerank,positive regulation of lipid transport (GO:0032370),0.44366475803901295,0.965526314240529,0.5028985507246376,1.0,1.0,3/12,17.19%,PRELID1;LRP1;APOE
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3684388754653244,-0.9654922945035154,0.477124183006536,0.8805759928226546,1.0,6/12,31.29%,AKR1B1;STARD3NL;FDX1;TSPO;FDXR;CACNA1H
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3504039930224015,0.9653340072799056,0.5455594002306805,1.0,1.0,4/43,7.34%,IGF1;SELENOS;TNFAIP3;SIRPA
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.30134847948075927,-0.9647724096349786,0.5107296137339056,0.8808496793357925,1.0,6/20,17.14%,HSP90AB1;ANO6;NT5E;ENTPD1;TXN;P2RX7
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.32555991777081505,0.9642630597471661,0.5637305699481865,1.0,1.0,37/119,21.36%,PIGG;TMEM150A;PGAP4;PIP4K2B;SYNJ2;DPM2;PIGM;INPP5E;PIK3R1;PIGU;PLEKHA3;PITPNM3;PIGA;PIK3CB;PIK3R2;PI4KB;PIP4K2A;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;IP6K1;PITPNM2;DPM1;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A;PIGB;FGF2;SMG1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.43070838576700876,0.9641546275899656,0.5228215767634855,1.0,1.0,3/14,7.02%,PCBP4;SRSF12;SRSF9
prerank,positive regulation of nervous system process (GO:0031646),0.40992855188027505,0.9639038430383333,0.5363881401617251,1.0,1.0,5/18,16.69%,MYRF;NLGN2;TENM4;ATPSCKMT;TPPP
prerank,regulation of phospholipase C activity (GO:1900274),0.4266699299795614,0.9638619959130506,0.5338028169014084,1.0,1.0,4/15,11.29%,NTF3;FGFR1;ABL1;PDGFRA
prerank,positive regulation of RNA splicing (GO:0033120),0.37394408236883003,0.9637525619284828,0.5303398058252428,1.0,1.0,11/29,20.66%,RBM3;PRDX6;PIK3R1;SETX;TRA2B;HNRNPLL;SNW1;THRAP3;RBM22;CIRBP;TRA2A
prerank,homologous chromosome segregation (GO:0045143),0.4002453802863635,0.9632792649109857,0.5397877984084881,1.0,1.0,3/20,19.03%,SIRT7;CENPC;FMN2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.33054567029296567,0.962822584066184,0.5553168635875403,1.0,1.0,10/76,11.26%,CDC42EP5;CDC42EP4;BIN1;NTF3;NRP1;CDK5;ABL1;BAIAP2;KATNBL1;GPSM2
prerank,protein localization to kinetochore (GO:0034501),0.4287989399751392,0.9626007121756843,0.528169014084507,1.0,1.0,1/14,0.88%,CENPT
prerank,iron ion transport (GO:0006826),0.35109019843649564,0.9625824331569433,0.5420875420875421,1.0,1.0,15/47,22.41%,CP;ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ABCB7;HEPH;ATP6V1B2;SLC11A2;FTH1;STEAP3;ATP6V1C1;RAB11B
prerank,positive regulation of immunoglobulin production (GO:0002639),0.36612738265427297,0.9625765753679663,0.5334128878281623,1.0,1.0,3/31,6.58%,EPHB2;XBP1;VAMP3
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3977031097289597,0.9625100435944262,0.5297297297297298,1.0,1.0,4/18,12.17%,SIRT7;EIF2AK3;DHX33;POLR2K
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.40595920099667127,0.9615600570000068,0.5431606905710491,1.0,1.0,1/18,1.59%,GPLD1
prerank,ether lipid metabolic process (GO:0046485),0.42387227681286144,0.9611513338852705,0.5021156558533145,1.0,1.0,8/14,23.06%,PEDS1;AGMO;PEX7;FAR1;PLA2G7;PAFAH1B1;NCEH1;GNPAT
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4580999509389276,0.9609229856844614,0.5219364599092284,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),0.4580999509389276,0.9609229856844614,0.5219364599092284,1.0,1.0,3/10,15.32%,HDAC4;GIT1;NUPR1
prerank,dorsal/ventral pattern formation (GO:0009953),0.3920246364157024,0.9602894360271786,0.5214477211796247,1.0,1.0,2/20,8.42%,SFRP1;PTCH1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3290510585488008,0.9601421550060433,0.5624332977588047,1.0,1.0,20/80,22.00%,CDKN2D;EPHA7;FIS1;DDX3X;CARD16;USP47;XIAP;MALT1;DNAJB6;LAMTOR5;RPS6KA3;DAPK1;RPS6KA1;DPEP1;PDCD5;KLF4;PDCD6;IGBP1;PPM1F;HMGB1
prerank,homeostasis of number of cells (GO:0048872),0.4404166868995758,0.9601391190315409,0.5252976190476191,1.0,1.0,1/12,0.50%,OCIAD2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.38636976843391646,-0.959499696051584,0.5105105105105106,0.8938198829787948,1.0,2/10,9.42%,LGALS9;RARA
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2733439698312084,-0.9594635304558929,0.535483870967742,0.8919930282826054,1.0,10/33,25.98%,CHRM3;KCNJ2;AKAP9;ANO6;NEDD4L;P2RX7;KCNJ3;KCNQ1;KCNJ12;WNK1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3827985391009733,0.9593531484288416,0.5336721728081322,1.0,1.0,2/25,6.13%,PDPK1;THY1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4240797242601775,0.9592241474174674,0.541029207232267,1.0,1.0,6/16,21.69%,SNF8;VTA1;LEPROT;CHMP4A;CHMP4B;LEPROTL1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.30919946902182843,0.9590008864006982,0.643,1.0,1.0,87/417,19.37%,SFRP2;ILF3;HDAC3;HEXIM1;WNT5A;SFRP1;CIART;FOXM1;SIRT2;ZNF568;CREBZF;NR2F2;PRMT6;SMARCC2;GLIS2;NR1D2;DKK3;PSPC1;NIPBL;CHD8;POU2F1;CDK5;MTERF3;TCF7L2;USP47;SFMBT1;IRF1;ATXN1;SNX6;EZH2;ZEB1;HDAC5;PCGF6;ZBTB38;SFMBT2;WNT4;SOX9;DDIT3;DPF2;XRCC6;PER1;HDAC4;ARID4A;TWIST1;NKRF;JARID2;RCOR1;RBFOX2;RBPJ;SUV39H1;FOXN3;NACC2;HDAC1;BCL7A;TSC22D4;EHMT1;GCLC;CIPC;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;BCL6;BCLAF1;RFX3;CIC;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;SOX13;TLE5;MDM2;LANCL2;PHF12;MECP2;GCFC2;NONO;MPHOSPH8;NCOR2;FOXD1;PRMT2;UIMC1;YAF2
prerank,autonomic nervous system development (GO:0048483),0.4037125668002951,0.9589658691566596,0.5178571428571429,1.0,1.0,5/17,19.15%,NRP1;SOX11;GDNF;SEMA3A;SOX4
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3842645400539627,-0.9588536194335876,0.5196374622356495,0.891812038583841,1.0,5/11,11.48%,ATP6V1A;CAV1;ATG7;ATP6AP1;FAS
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.32704608280237357,-0.9588055035690246,0.5121951219512195,0.8900619413300035,1.0,7/15,23.72%,GGACT;GOT2;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3771734074669264,-0.9587580242317701,0.49299719887955185,0.8883284883143966,1.0,5/11,16.70%,RDX;EZR;VPS11;PTPN23;MSN
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4499692743343102,0.9585200688577807,0.5393586005830904,1.0,1.0,2/11,11.23%,ANXA1;RC3H2
prerank,protein catabolic process (GO:0030163),0.34204104168023397,0.9584977057559708,0.5597765363128492,1.0,1.0,9/59,9.82%,CLN6;HSP90AA1;NGLY1;DDB1;UCHL3;RAB12;MANBA;CUL4B;VCP
prerank,negative regulation of telomere maintenance (GO:0032205),0.43027703312071774,0.9580951831178277,0.5366197183098591,1.0,1.0,7/15,23.45%,PARP1;RAD50;TERF1;TNKS;TERF2IP;PINX1;ATM
prerank,regulation of dendrite development (GO:0050773),0.3560769574647719,0.957704981651856,0.5437125748502994,1.0,1.0,11/37,18.42%,CDKL5;KNDC1;DBN1;RAP2A;CAMSAP2;LRP8;VLDLR;BMP5;CAMK1D;DCC;ADGRB3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3648531235044891,0.9573583517220771,0.5356265356265356,1.0,1.0,11/32,22.82%,ANXA1;HDAC5;TBXA2R;FGFBP1;PTGS2;FOXC2;ITGB1BP1;KLF4;STARD13;FGF2;MEOX2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3276357070350018,0.9570018066524926,0.5651709401709402,1.0,1.0,25/78,21.06%,CLN3;EPHB2;PDPK1;CDK5;PIK3R1;SQSTM1;TMBIM1;PID1;CLIP3;VTI1B;PRKCI;LRP1;TGFB1;DPP10;SPTBN1;STX8;VAMP8;MRAP2;KIF5B;PPP2R5A;ZDHHC2;MMP14;DAB2;ITGB1;ATP2B4
prerank,cellular response to retinoic acid (GO:0071300),0.35643768787287583,0.9566561545941985,0.5458768873403019,1.0,1.0,14/42,25.32%,WNT5A;ZNF35;BRINP3;SOX9;SETX;SNW1;PTK7;BRINP1;LYN;PTK2B;ATM;WNT5B;WNT6;RORB
prerank,regulation of cell aging (GO:0090342),0.44775879950199937,0.9565490924654451,0.537984496124031,1.0,1.0,2/11,5.98%,FOXM1;NUAK1
prerank,positive regulation of B cell proliferation (GO:0030890),0.36912890640891827,0.956451304857831,0.541871921182266,1.0,1.0,4/29,11.07%,EPHB2;TIRAP;IRS2;BCL2
prerank,negative regulation of catabolic process (GO:0009895),0.3505060354940417,0.9562701619806485,0.5512965050732808,1.0,1.0,11/47,19.03%,SIRT2;AZIN2;MAD2L1;MDM4;HDAC4;GIT1;CYP51A1;NUPR1;PRKAA1;BANP;FMN2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.37594943391964947,-0.9562631244737004,0.49363057324840764,0.8933249795697733,1.0,5/11,9.20%,CD46;THBS1;LGALS9;BMPR1A;CD34
prerank,negative regulation of coagulation (GO:0050819),0.41990888979984986,0.9562492902290313,0.5312066574202496,1.0,1.0,4/14,17.19%,VTN;TFPI;SERPINE1;APOE
prerank,iron ion homeostasis (GO:0055072),-0.23836698400976702,-0.9562491765107113,0.51,0.8914908706944248,1.0,8/58,4.52%,ABCG2;SMAD4;PICALM;ATP6V1A;CUL1;GLRX3;ACO1;SKP1
prerank,positive regulation of filopodium assembly (GO:0051491),0.38138530744879584,0.9560942731337512,0.5317258883248731,1.0,1.0,6/24,16.79%,NRP1;PIK3R1;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30716021594350473,0.9558822276870854,0.675,1.0,1.0,145/572,22.43%,CBX8;HDAC3;HEXIM1;ZMYM5;POU6F1;DUSP26;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;IL33;NR2F2;FGFR2;NKX6-1;TAF9B;GLIS2;NR1D2;PCGF1;ZNF8;MIER2;MXI1;ZNF205;NIPBL;CHD8;SNAI1;ZNF692;FLCN;TCF7L2;CNBP;ATXN1;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;MOSPD1;MXD1;ZBTB5;CC2D1A;NFX1;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;PER1;MDM4;HDAC4;SOX11;TWIST1;USP2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;USP9X;SUFU;CBFB;CDC73;ATRX;ZHX2;TRPS1;BCL6;IMPACT;NR2C2;SATB1;TCF3;FOXC2;DDX5;GTF2IRD1;UBE2D1;CTBP1;SNW1;CBX5;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;NCOR2;TRIM27;WWOX;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;ZBTB32;SMAD7;TPR;NFATC3;GLI3;ZNF431;VPS72;SMAD2;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;HOXA7;IFI27;ID2;N4BP2L2
prerank,aerobic respiration (GO:0009060),0.3975593079597377,0.9553956505066645,0.530718954248366,1.0,1.0,4/20,9.89%,UQCRC1;NDUFS7;MDH2;MTFR1L
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4501775712484316,0.9552188116629994,0.5581039755351682,1.0,1.0,4/10,20.66%,COMT;SMOX;ALDH7A1;SLC44A1
prerank,negative regulation of cell cycle process (GO:0010948),0.3371477402665485,0.9549128092543154,0.5533769063180828,1.0,1.0,16/61,20.54%,CCP110;TFDP1;RBBP4;FBXO5;EZH2;PCGF6;AURKAIP1;EHMT2;EHMT1;TERF1;CBX5;RBBP8;YAF2;PPP1R10;E2F6;TOM1L2
prerank,regulation of cell-cell adhesion (GO:0022407),0.3551238923707461,0.9546308691550206,0.5400238948626045,1.0,1.0,10/39,20.88%,EPHA7;MINK1;TENM3;CD47;TGFB1;JAG1;ZDHHC2;NF2;PTPRR;SMAD7
prerank,hyaluronan catabolic process (GO:0030214),0.3981792003786287,0.9545118153901005,0.5387647831800263,1.0,1.0,5/18,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3844118555056347,-0.9544853567246673,0.5060240963855421,0.8946554126381557,1.0,4/11,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2128462031132255,-0.9544594492918839,0.65625,0.8928376538512605,1.0,21/105,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.36786094838426225,0.9544337270707761,0.5322777101096224,1.0,1.0,16/32,27.09%,TAOK1;CAMSAP2;CLIP3;KATNB1;EML2;TBCD;TUBB4A;FGF13;CLASP2;CAMSAP1;MAP2;NAV3;STMN1;ARHGEF2;HDGFL3;APC
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.22791603755526413,-0.9540849830872408,0.5375,0.892041150528938,1.0,18/63,18.83%,CAV1;ITGA6;AR;RIPK1;PML;FEM1B;SP100;ACVR1;THBS1;TNFSF10;CYLD;FAS;MADD;SCG2;SRC;BMP4;LTBR;TNFSF12
prerank,artery development (GO:0060840),0.3877927631929361,0.9539045074164316,0.5602094240837696,1.0,1.0,8/23,20.88%,STRA6;NRP1;ROBO2;ROBO1;HECTD1;PKD2;TGFBR1;SMAD7
prerank,platelet aggregation (GO:0070527),-0.26675201441067575,-0.9537886000399886,0.5170454545454546,0.8910110488222595,1.0,13/33,20.86%,FLNA;ACTB;ACTN1;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,regulation of cartilage development (GO:0061035),0.40820907132914136,0.9533986046125189,0.540962288686606,1.0,1.0,6/18,17.65%,PTHLH;SOX9;SOX6;TRPS1;SOX5;BMP1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.2940919150084766,-0.9533505030296352,0.5212765957446809,0.8904558475345008,1.0,6/29,6.64%,FLT1;KIT;IRS1;PRKD1;TEK;DGKZ
prerank,regulation of transport (GO:0051049),0.3582161322970363,0.9532858004182945,0.5413271245634459,1.0,1.0,7/36,11.38%,NRP1;GAPVD1;CDK5;ICA1L;MBTPS1;SCFD1;LEPR
prerank,regulation of telomerase activity (GO:0051972),-0.24330778405787926,-0.9532576929110098,0.5785714285714286,0.8888638992941754,1.0,14/45,17.46%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TP53;TCP1;PARN;NAF1;SRC;MAP3K4;PNKP;CCT2;SMG6
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.36400595667865404,0.9529733919983865,0.5598548972188634,1.0,1.0,10/35,23.07%,ATP2C1;CDH11;CDH18;CDH20;CDH19;CDH7;CDH9;PCDHB16;CDH10;CDH8
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3781524881796508,0.9527346681532884,0.5390524967989757,1.0,1.0,6/25,17.56%,IGF1;SOX11;TWIST1;PARK7;TGFB1;NSD1
prerank,inositol phosphate catabolic process (GO:0071545),0.44620135390982346,0.952613962173853,0.5440340909090909,1.0,1.0,3/12,10.73%,SYNJ2;INPP5A;NUDT3
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3835778637298551,0.9525652520785763,0.5544430538172715,1.0,1.0,4/24,12.01%,IGF1;SELENOS;IRS2;ENPP1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3805195502547406,0.9523152516372727,0.5356234096692112,1.0,1.0,3/26,5.02%,PTGER4;RAC1;ALMS1
prerank,regulation of programmed cell death (GO:0043067),0.31115853522632325,0.952258425277109,0.5991943605236657,1.0,1.0,28/161,13.35%,GLS2;BAX;LCMT1;NTF3;HSP90AA1;AIFM2;ANP32A;HTATIP2;CDK5;PRELID1;ABL1;USP42;MAGED1;PLK5;LRP8;SOX9;SRA1;NDRG1;VCP;MALT1;PSMC5;IGFBP3;RTKN;IRF3;TMEM219;HS1BP3;TNFRSF25;DAPK1
prerank,apoptotic DNA fragmentation (GO:0006309),0.41465045804916234,0.9521830225989254,0.5258855585831063,1.0,1.0,5/16,22.00%,DFFB;KPNB1;DFFA;KPNA1;HMGB1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.40880507479973105,0.9520703487026148,0.5515394912985274,1.0,1.0,7/16,20.66%,RBM3;PRDX6;TRA2B;SNW1;THRAP3;CIRBP;TRA2A
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3037581285809855,0.9517884147744391,0.787,1.0,1.0,344/1646,19.91%,PSRC1;SFRP2;ILF3;CAMTA2;HDAC3;HEXIM1;TEAD3;WNT5A;ZSCAN12;WBP2;HSF2;POU6F1;ZNF418;SFRP1;IGF1;MED24;SP7;DVL2;ZNF23;CIART;TCIM;FOXM1;SIRT2;ZBTB48;POU5F2;DDX17;MYRF;NFKB1;ZNF25;KDM7A;ZBTB46;SMARCD3;HMGB3;ZNF568;MAMLD1;PKNOX2;CC2D1B;AEBP2;ZEB2;CREBZF;USF1;NR2F2;MLXIP;TEF;NKX6-1;MAPRE3;PRMT6;MED12;NKX2-2;MAFG;SMARCC2;MED14;GLIS2;ZSCAN25;SMAD9;STAT6;NR1D2;PCGF1;ZNF8;ZFP82;HTATIP2;DKK3;RORA;TFDP1;KMT2B;NFKB2;CARF;PSPC1;BRPF1;MXI1;ABCA2;ZNF205;SNF8;NIPBL;SNX5;CCNC;OGT;CHD8;VGLL3;POU2F1;IL31RA;RFX5;SNAI1;CDK5;SLTM;MTERF3;ZNF692;NPAT;TCF4;TCF7L2;USP47;SFMBT1;TFCP2;ZNF276;BBS7;CNBP;BRD4;IRF1;MED13;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;ZIC3;SNX6;CASZ1;TRIM56;HNRNPK;EZH2;FUS;ARNT;ZBTB7B;ANKRD49;MAGED1;ZNF711;ZEB1;SMARCB1;CHD5;TEAD1;TGFB1I1;HDAC5;PCGF6;MXD1;RAI1;ZNF367;ZNF32;ZBTB5;ZBTB38;CC2D1A;ASCC1;MED4;ZKSCAN5;ACTR8;DBP;NFX1;SFMBT2;ARRB1;TSHZ2;WNT4;SOX9;SRA1;SMARCD1;DDIT3;BRD3;PGBD1;DPF2;ZFHX2;XRCC6;YWHAH;PER1;HNRNPD;ARID1B;DHX36;MDM4;EGF;PRMT5;ATMIN;ZSCAN20;HDAC4;ARID4A;SOX11;SAP30L;TWIST1;CALCOCO1;FADS1;PSIP1;PRRX1;NKRF;JARID2;HOXB8;ATF2;POU6F2;RCOR1;PSMC5;ZBTB20;ZNF445;RBFOX2;KDM2B;NSD3;ZNF260;RBPJ;GLIS1;ZKSCAN1;RFX4;SUV39H1;BACH2;MAZ;NFAT5;FOXN3;IRF3;CAMK2D;ZNF471;YY1;SMARCA1;NACC2;ZMIZ1;E2F3;NFIX;BRIP1;BACH1;PEG3;POLR2K;SOX6;SOD2;CCNH;NPM1;TADA3;TIAL1;HDAC1;CEBPG;BCL7A;ZFP2;CREB3;CREB3L4;ZNF383;RPS6KA3;TSC22D4;EHMT1;PROX2;GCLC;SUFU;CIPC;CBFB;MMS19;FOXJ3;ATRX;ZHX2;EBF1;RUNX1T1;NRG1;ZIC2;TGFB1;MED21;TRPS1;ESRRG;CAMTA1;MAP2K2;TULP3;BCL6;BAZ2B;BCLAF1;ZNF292;SMAD6;SOX5;THOC1;KMT2D;RGMB;PIAS3;CHD1;NUCKS1;TTC21B;RFX3;NR2C2;MED23;SATB1;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;FOXC2;CIC;HSPD1;RPS6KA1;DDX5;TRAK1;GTF2IRD1;MAF;CHEK2;SAFB2;CTBP1;SBNO1;HOXC8;CLOCK;SNW1;CCNT1;TRIP4;CBX5;DAXX;MBD1;UBE2L3;THRAP3;PHIP;ZFP37;KDM3B;MTDH;SOX13;ZBTB41;OSR1;APOE;ZFP90;HP1BP3;TLE5;TCF7;NFXL1;NSD1;MDM2;LANCL2;ANXA4;RAD21;MEIS2;TBL1XR1;ILK;RELB;ZNF177;PHF12;RBBP8;RNF111;PRKAR1A;MECP2;CUX1;KMT2A;BCL11B;GCFC2;NONO;TGFBR1;TERF2IP;MPHOSPH8;USP22;NCOR2;CHD2;FOXD1;KLF13;PRMT2;NUP35;SOX4;ZIC4;BRDT;UIMC1;YAF2;SETD5;MITF;CDK11B;PPM1A;KLF4;MLLT3;WWC1;CARM1;GABPA;NFIA;PRDM15;PIAS1
prerank,cellular response to lectin (GO:1990858),-0.2132384361597499,-0.951725828439552,0.6764705882352942,0.8893011070363662,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2132384361597499,-0.951725828439552,0.6764705882352942,0.8893011070363662,1.0,21/104,11.70%,KRAS;IKBKB;PSMB7;CUL1;PRKCD;RPS6KA5;RAF1;SKP1;NRAS;PSMB2;PSMD7;PSMA6;PRKACA;PSMC2;PSMD13;PSMF1;PSMC1;EP300;PLCG2;IKBKG;PSMD9
prerank,mitochondrial protein processing (GO:0034982),0.4493672843952514,0.9515167765175557,0.5406203840472673,1.0,1.0,4/11,19.78%,PMPCA;AFG3L2;OMA1;IMMP1L
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.3773580850947406,-0.9512024498333738,0.4953560371517028,0.8888487371135709,1.0,4/11,16.00%,EGFR;RIPK1;TP53;BMP4
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.38118252573437106,-0.9510296331875467,0.49127906976744184,0.8874735107027591,1.0,8/10,61.90%,GNB1;SAG;PDE6A;CNGB1;PDE6G;PDE6B;RHO;GNAT1
prerank,negative regulation of growth (GO:0045926),0.31705263979811776,0.9505220436364104,0.585291113381001,1.0,1.0,11/121,8.63%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;CGRRF1;DDX3X;FLCN;STK11;TCHP;PPP1R9B
prerank,regulation of cytokine production (GO:0001817),0.3129830786137857,0.9503928367086008,0.5948453608247423,1.0,1.0,16/126,14.57%,FCGR2B;PTGER4;IL33;ANXA1;AGPAT1;IGF2BP2;TRIM56;SIRPA;ATP2B1;PER1;LGR4;IRF3;CD47;NPTN;SCAMP5;BCL6
prerank,regulation of immune response (GO:0050776),0.31558759145810356,0.9502463926050823,0.5928934010152285,1.0,1.0,10/135,8.14%,FCGR2B;GPR108;NPDC1;ADCY7;TIRAP;IRF1;DHX58;CD200R1;XIAP;LRP8
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3111849186821937,0.9498020827151573,0.6280241935483871,1.0,1.0,36/186,17.38%,SFRP2;WNT5A;BICC1;SFRP1;DVL2;PSMD4;TSC2;DKK3;CHD8;TCF7L2;KLHL12;PSMB10;DVL1;STK11;PSMD11;SOX9;DDIT3;RBMS3;PSME2;PSMC5;LZTS2;ZNRF3;HDAC1;AXIN2;RACK1;KREMEN1;LRP1;CSNK1A1;PSMD1;CTNNBIP1;INVS;NKD1;PSMD6;SOX13;APOE;TLE5
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3995821001192909,0.9497969874636344,0.5236220472440944,1.0,1.0,2/20,2.96%,HEXIM1;NR2F2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.31794230946098195,0.9497887432673178,0.5863157894736842,1.0,1.0,14/92,10.63%,WNT5A;EPB41L4B;GPLD1;RAC1;GLIPR2;NRP1;FGF10;PRKCA;ABL1;SPARC;SOX9;EGF;ENPP2;PIK3CB
prerank,cellular protein localization (GO:0034613),0.31074282564885325,0.9497502868440861,0.6486486486486487,1.0,1.0,73/285,18.60%,WNT5A;ARL4C;CPLANE2;SGSM3;TRAPPC8;PICK1;ERP29;CD63;SAR1A;RUNDC1;RAB24;WIPI1;NIPBL;DNAJC27;FGF10;TBC1D13;NAPG;STX6;PIGU;SNX6;VPS26B;RRAGA;RAP2A;HGS;STX16;MFN2;STX2;RAB5B;JAM3;YWHAH;COPZ2;ARL5B;RABGAP1L;WLS;SCFD1;USP6NL;ATG13;AP3B1;EVI5L;VPS33B;RIC3;TLK1;NPM1;AXIN2;TMED10;FBLN5;COG3;PIGK;EMP2;RABGAP1;USP4;USO1;EPB41L3;CNTNAP2;AP4M1;STX11;RAB31;STX8;STX17;AHI1;GGA2;NSF;SYNRG;RAB21;SMURF1;TBC1D9B;TBC1D22B;ARMCX3;ATG9A;AMOT;RAB6A;SGSM2;NPHP1
prerank,protein autophosphorylation (GO:0046777),0.3153159837198181,0.9497292031395881,0.6067073170731707,1.0,1.0,22/157,11.50%,AATK;CAMK2B;PDPK1;EIF2AK3;FGFR2;CDKL5;FGFR1;TAOK1;HTATIP2;DDR1;MINK1;DDR2;ABL1;SRMS;EPHA8;STK11;SIK1;TEC;MUSK;WNK2;PDGFRA;CAMK2D
prerank,glycogen metabolic process (GO:0005977),-0.2762251140674543,-0.9496641961252252,0.5215311004784688,0.8893686244795515,1.0,7/27,20.56%,AGL;PYGB;PHKA1;GYS1;PGM2;PHKG2;GYG1
prerank,heterochromatin organization (GO:0070828),-0.3440680980024696,-0.9495293128245734,0.52,0.8878792315600729,1.0,6/14,15.01%,MECOM;SIRT1;EZH1;SETDB2;PRDM16;SMCHD1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.30931210836640327,0.9494345701363547,0.6285140562248996,1.0,1.0,32/199,15.42%,SFRP2;FCGR2B;SFRP1;PTGER4;ADM;NRDC;FLCN;PLCL2;SFMBT1;ACOT11;STK11;ADAMTS5;SOX9;PTCH1;LRPAP1;DDIT3;ATP2B1;LGR4;RBPJ;ROBO1;IFNGR1;BMP5;DOCK7;CYP51A1;NPTN;SLC6A4;NOVA1;ROCK2;TGFB1;SMAD6;VASN;FOXC2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3516697741112482,0.9489620021488234,0.5365005793742758,1.0,1.0,3/39,4.88%,SFRP2;NRP1;FGF10
prerank,negative regulation of autophagy (GO:0010507),0.33803141570474576,0.948846864335576,0.5475409836065573,1.0,1.0,11/54,16.63%,IL10RA;SIRT2;RRAGA;WDR6;NRBP2;BCL2;LEPR;EIF4G2;PTPN22;NUPR1;EIF4G3
prerank,detection of visible light (GO:0009584),-0.33347599101751224,-0.9484878425540303,0.5220588235294118,0.888940615509111,1.0,4/16,24.03%,ABCA4;GNA11;CEP250;RP1
prerank,positive regulation of ion transport (GO:0043270),0.34655097797644235,0.9483174109843634,0.5682074408117249,1.0,1.0,14/48,22.71%,GPD1L;CNKSR3;ATP2B1;CRACR2A;GDNF;RAB3B;ANK3;VAMP8;AHCYL1;KIF5B;SNX4;SCN1B;VAMP7;WNK3
prerank,maturation of LSU-rRNA (GO:0000470),0.3806127065458786,0.9478563653239247,0.5356695869837297,1.0,1.0,8/26,21.09%,NHP2;DDX18;MRPL1;RPL7L1;LAS1L;NSA2;RSL1D1;RPL7
prerank,myelination in peripheral nervous system (GO:0022011),0.42665568848665125,0.9477612572340428,0.559593023255814,1.0,1.0,2/13,4.84%,SIRT2;ARHGEF10
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3036295728246986,0.9473844665356786,0.729,1.0,1.0,198/807,22.43%,SFRP2;ILF3;CBX8;HDAC3;HEXIM1;WNT5A;ZMYM5;POU6F1;SFRP1;DUSP26;CIART;FOXM1;SIRT2;SIRT7;NFKB1;ZNF25;AASS;ZNF568;BMP6;PARP1;ZEB2;CREBZF;IL33;NR2F2;FGFR2;NKX6-1;PRMT6;TAF9B;SMARCC2;GLIS2;NR1D2;PCGF1;ZNF8;DKK3;MIER2;PSPC1;MXI1;ZNF205;NIPBL;CHD8;POU2F1;SNAI1;CDK5;MTERF3;ZNF692;FLCN;TCF7L2;USP47;SFMBT1;PRDX5;CNBP;IRF1;ATXN1;SNX6;EZH2;ZBTB7B;RTF1;ZEB1;HDAC5;PCGF6;MOSPD1;MXD1;ZBTB5;ZBTB38;NFX1;SFMBT2;WNT4;SOX9;PTCH1;EHMT2;DDIT3;SDCBP;DPF2;XRCC6;PER1;MDM4;HDAC4;ARID4A;SOX11;TWIST1;NKRF;JARID2;USP2;RCOR1;RBFOX2;KDM2B;RBPJ;GLIS1;SUV39H1;SARS1;MAZ;FOXN3;JAZF1;YY1;NACC2;MTA2;NFIX;BACH1;PEG3;HDAC1;BCL7A;USP9X;TSC22D4;EHMT1;GCLC;SUFU;CIPC;CBFB;CDC73;ZHX2;RUNX1T1;NRG1;ZIC2;TGFB1;TRPS1;BCL6;BCLAF1;IMPACT;RFX3;NR2C2;SATB1;TCF3;FOXC2;CIC;DDX5;GTF2IRD1;UBE2D1;CTBP1;CLOCK;SNW1;CBX5;DAXX;MBD1;CBX7;ZFP37;MTDH;SOX13;OSR1;HSBP1;ZFP90;TLE5;NSD1;MDM2;LANCL2;MEIS2;TBL1XR1;ZNF177;PHF12;ATN1;MECP2;CUX1;GPS2;GCFC2;NONO;MPHOSPH8;NCOR2;TRIM27;WWOX;FOXD1;PRMT2;UIMC1;YAF2;MITF;PHF21A;PPM1A;KLF4;WWC1;DNMT3A;MIER1;E2F6;DAB2;GLIS3;HNRNPU;CTCF;ZNF219;IGBP1;PHC2;ZBTB32;SMAD7;TPR;GLI3;ZNF431;VPS72;SMAD2;FOXO1;PPM1F;TCERG1;CIR1;HMGB1;PEX2;SMAD3;MTA1;TAF1;SPINDOC;HOXA7;IFI27;ID2;N4BP2L2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.37624868688113366,0.9473482878814053,0.5594660194174758,1.0,1.0,6/26,17.19%,NOS1AP;POR;GDNF;PIK3CB;PARK7;APOE
prerank,response to retinoic acid (GO:0032526),0.3339460407146744,0.9473052459106686,0.5782092772384034,1.0,1.0,10/59,17.06%,CDKN2D;WNT5A;ZNF35;BRINP3;SOX9;SETX;CTSH;SNW1;PTK7;BRINP1
prerank,gliogenesis (GO:0042063),-0.34991062482569146,-0.9471590466474643,0.5106382978723404,0.8907742111561758,1.0,5/15,13.01%,NFIB;RELN;TGFB2;CDK6;METTL3
prerank,regulation of cholesterol esterification (GO:0010872),0.460032183598337,0.947151824409427,0.5545722713864307,1.0,1.0,4/10,21.42%,ABCA2;AGTR1;APOE;ABCG1
prerank,vascular transport (GO:0010232),0.3223368374081977,0.9464568296178747,0.578556263269639,1.0,1.0,16/81,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,lipoprotein biosynthetic process (GO:0042158),0.44946586868928157,0.946283948112655,0.5527488855869243,1.0,1.0,4/11,17.19%,WIPI1;PORCN;PIK3C3;APOE
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.31654833149325523,0.9460196830200855,0.6063394683026585,1.0,1.0,37/118,22.67%,SFRP1;MYO19;FGFR2;WARS1;HTATIP2;TANC2;TNFAIP3;CDK5;KNDC1;PAK3;BRSK2;PDZD8;SPARC;RAP2A;PID1;SRCIN1;GDNF;BRSK1;DAG1;EMP2;MAPT;TGFB1;BCL6;ADGRA2;PHLDB1;PHIP;RUFY3;ADGRB3;CHN1;HECW2;FGF2;CFL1;CLASP2;ARHGAP35;CAMSAP1;PAK1;EPHA4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.3408896279775106,0.945897838191931,0.5676905574516496,1.0,1.0,4/51,4.57%,IL34;EDN3;CXCL12;MOSPD2
prerank,cellular response to mechanical stimulus (GO:0071260),0.34405183128803224,0.9457585189143317,0.5793025871766029,1.0,1.0,6/46,8.37%,PTGER4;NFKB1;MAP3K14;TMEM150C;IRF1;SOX9
prerank,negative regulation of cytokine production (GO:0001818),0.31146503957729016,0.9457296436050139,0.6223350253807106,1.0,1.0,22/163,13.55%,FCGR2B;PTGER4;CHID1;SELENOS;ADCY7;RAC1;ANXA1;TNFAIP3;DHX58;CD200R1;SIRPA;ARRB1;DDIT3;PIBF1;ATP2B1;CUEDC2;LGR4;SSC5D;SARS1;IRF3;NPTN;PTPN22
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.31030899527532857,0.9457107868625312,0.6112789526686808,1.0,1.0,51/184,21.84%,CCP110;CDC23;SIRT2;PSMD4;HSP90AA1;UBE2S;MAD2L1;ZFP36L1;CDC16;FZR1;ALMS1;ANAPC2;FBXO5;PSMB10;DDB1;CDC14B;PSMD11;PLK5;TUBA1A;PPP1R9B;YWHAG;PSME2;PSMC5;ANAPC11;ANAPC4;KCNH5;HAUS3;CSNK1D;CDC26;TUBB;PSMD1;OFD1;UBE2E1;UBE2D1;PSMD6;CEP76;ANAPC10;TUBB4A;ANAPC5;ODF2;PSMD5;DYNLL1;ZW10;PAFAH1B1;INO80;PSMA4;HECW2;APPL2;PSMA1;PSMC6;CNTRL
prerank,positive regulation of phospholipid transport (GO:2001140),0.4583944181585961,0.9454751201386814,0.5659509202453987,1.0,1.0,3/10,17.19%,PRELID1;ABCA7;APOE
prerank,potassium ion import across plasma membrane (GO:1990573),-0.25256672829542137,-0.9452065638027185,0.5704697986577181,0.8944353023283239,1.0,15/41,27.28%,SLC12A7;ATP1B3;ATP1A1;KCNJ2;ABCC9;ATP1B1;SLC12A4;SLC12A9;SLC12A2;KCNJ3;KCNK9;HCN2;SLC12A8;KCNJ12;SLC12A6
prerank,regulation of receptor binding (GO:1900120),0.45818472643274066,0.944964398649901,0.556732223903177,1.0,1.0,4/10,22.07%,ATP2A2;PTPRF;GREM2;B2M
prerank,regulation of viral release from host cell (GO:1902186),0.3881604875109073,0.9449066037549444,0.5459317585301837,1.0,1.0,5/21,9.28%,TRIM11;DDB1;TRIM35;TRIM62;CHMP3
prerank,telomere maintenance via recombination (GO:0000722),-0.36867476620025075,-0.9448876569994438,0.49279538904899134,0.8934588774399008,1.0,3/11,10.16%,SMC5;TEP1;RAD51D
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.41167122430353525,0.9445810070006533,0.5482954545454546,1.0,1.0,4/15,10.58%,SCEL;FGFR1;CELF1;UBR3
prerank,response to cAMP (GO:0051591),-0.2565913745002073,-0.9441836833649195,0.5652173913043478,0.8935421333586097,1.0,13/37,25.42%,RAPGEF3;NDUFS4;STAT1;INPP5K;EZR;AKAP9;AHR;SLC5A5;DGKQ;PDE2A;HCN2;KCNQ1;HCN1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.2852756308362389,-0.9440265079048534,0.5277777777777778,0.8921487419361339,1.0,5/27,5.16%,FLT1;KIT;IRS1;PRKD1;TEK
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.2972201138488092,-0.9440025264658277,0.5485232067510548,0.8904031667456846,1.0,10/22,19.09%,TSG101;UBAP1;VPS36;VPS37B;MVB12B;TOM1L1;PTPN23;VPS37C;VPS4A;PLAA
prerank,C-terminal protein amino acid modification (GO:0018410),0.4437805270352808,0.9439363937384295,0.5434782608695652,1.0,1.0,2/11,2.01%,GPLD1;LCMT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.4154956844126608,0.9436383164680003,0.5686813186813187,1.0,1.0,5/16,16.60%,PARP1;DHX36;HNRNPA2B1;TERF1;TNKS
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4078399943726583,0.9435894636091277,0.5555555555555556,1.0,1.0,4/17,15.88%,NKX6-1;SOX9;RFX3;AHI1
prerank,negative regulation of histone acetylation (GO:0035067),-0.3629087983671061,-0.9434495537942627,0.5114754098360655,0.8902143488504596,1.0,7/11,40.65%,SIRT1;SIN3A;NOC2L;TAF7;THAP7;BRCA1;SPI1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.25515267380119755,-0.943421529794231,0.5878378378378378,0.8884819342962746,1.0,14/39,20.86%,FLNA;ACTB;ACTN1;MEGF11;STXBP3;PLEK;FN1;TLN1;ACTG1;HSPB1;P2RY12;MYL9;FIBP;MYL12A
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.407809735089947,0.9433405726653499,0.5526675786593708,1.0,1.0,3/15,17.37%,SRM;SMOX;MOXD1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3587603739433769,0.9426225240040459,0.5524728588661038,1.0,1.0,14/33,23.91%,TCIM;EZH2;PLK5;PSME2;CDC73;MN1;INO80;ATP2B4;APPL2;TAF1;ID2;STXBP4;PTEN;FBXW7
prerank,retrograde axonal transport (GO:0008090),0.4030211947302811,0.9425301372057319,0.5615491009681881,1.0,1.0,11/16,27.83%,NEFL;TMEM108;DLG2;KIF5B;PAFAH1B1;ACTR10;DYNC1H1;FBXW11;KIF5A;KIF1A;SOD1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.42211845550373395,0.9424525296531406,0.5573997233748271,1.0,1.0,2/14,7.21%,CARD16;RFFL
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4016250379138018,0.9423267976883276,0.5320855614973262,1.0,1.0,4/18,12.16%,BRD4;FBXO5;CDC25A;VPS4B
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.31707487822751734,-0.9421103662869045,0.5513307984790875,0.890289076087534,1.0,9/18,26.33%,KAT2B;RPS13;TMBIM6;PTBP2;ESR1;RPS26;NRDE2;ZC3H12A;TERT
prerank,positive regulation of signaling receptor activity (GO:2000273),0.3512998181314513,0.9420742969143636,0.539568345323741,1.0,1.0,6/36,12.36%,EPHB2;NRP1;EGF;PARK7;NLGN3;HDAC1
prerank,melanosome organization (GO:0032438),-0.2821265018417285,-0.9418321344026428,0.5051546391752577,0.8891923253519894,1.0,10/26,27.88%,AP3D1;KIF13A;DTNBP1;HPS4;AP1M1;BLOC1S5;RAB29;SNAPIN;HPS1;RAB38
prerank,response to interferon-gamma (GO:0034341),0.3346449461810627,0.9417677740900937,0.5888767720828789,1.0,1.0,10/67,14.55%,WNT5A;GBP3;GBP7;SIRPA;EPRS1;SHFL;CD47;DAPK1;GBP6;AQP4
prerank,regulation of stem cell proliferation (GO:0072091),0.40833398958538075,0.9417334963712729,0.5495376486129459,1.0,1.0,4/17,12.58%,ZFP36L1;FBLN1;SOX11;AGO3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.3697678426460822,-0.9414961938596036,0.5096153846153846,0.8882617942777077,1.0,2/11,6.43%,RIPK1;UNC93B1
prerank,cilium organization (GO:0044782),0.30886075748028124,0.9406647558940051,0.6439317953861585,1.0,1.0,40/209,15.88%,CCP110;TMEM138;B9D2;IQCG;CPLANE2;STK36;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;TCTN1;BBS7;INPP5E;SNX10;TTC17;CDC14B;CCDC28B;PIBF1;CFAP54;TTC8;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;ATP6V1D;TMEM216;RFX3;ARMC2;OFD1;RAB8A;RAB8B;AHI1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3922373401300903,0.9405907677386768,0.5548128342245989,1.0,1.0,5/19,21.92%,IL34;JAM3;CAMK1D;MPP1;CXCL17
prerank,response to molecule of bacterial origin (GO:0002237),0.3271522867958293,0.9402758569934638,0.5701849836779108,1.0,1.0,11/69,14.82%,FCGR2B;SIRT2;IFNAR1;TNFAIP3;TIRAP;CD24;LY96;HNRNPA0;RPS6KA3;PTPN22;SMAD6
prerank,mitotic cytokinesis (GO:0000281),0.34100156299676093,0.9397939456253092,0.5790067720090294,1.0,1.0,11/47,17.34%,CUL7;INCENP;CIT;JTB;MYH10;ANK3;RTKN;SNX33;ROCK2;SPTBN1;SON
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3994240988240202,0.9395495679207849,0.5615491009681881,1.0,1.0,2/17,11.13%,NOS1AP;ANK3
prerank,cellular response to lipid (GO:0071396),0.3072402872131284,0.9395022901484483,0.6539618856569709,1.0,1.0,34/191,17.06%,WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ATP1A3;TNFAIP3;CARD16;ZNF35;SIRPA;ATP1A2;PID1;INSIG1;BRINP3;SOX9;TRIM41;LY96;TFPI;NCOA4;GIT1;SETX;CDC73;ROCK2;ADCY1;PDE4B;SNW1;SERPINE1;ADCY5;PTK7;UBE2L3;BRINP1
prerank,positive regulation of wound healing (GO:0090303),0.35035391032876606,0.9393980368558315,0.5749414519906323,1.0,1.0,7/36,16.49%,VTN;ANXA1;XBP1;DMTN;PLPP3;FOXC2;SERPINE1
prerank,mitotic sister chromatid segregation (GO:0000070),0.32036676392518265,0.9393453540672728,0.61198738170347,1.0,1.0,9/98,9.28%,PSRC1;CDC23;CSNK2A2;NIPBL;AKAP8L;WRAP73;KPNB1;PIBF1;CHMP3
prerank,ncRNA transcription (GO:0098781),0.42161815533396907,0.9389853372399255,0.559593023255814,1.0,1.0,2/13,3.66%,SIRT7;USPL1
prerank,RNA 3'-end processing (GO:0031123),0.3314347661002853,0.9389312533983923,0.5890557939914163,1.0,1.0,14/69,12.56%,RPRD2;U2AF1;SRSF2;SRSF5;SRSF3;THOC3;SRSF9;SRSF1;LIN28B;CPSF7;CSTF2T;NUDT21;CPSF3;THOC7
prerank,cardiac myofibril assembly (GO:0055003),0.4165351584282938,0.9386542912888168,0.573632538569425,1.0,1.0,3/15,11.29%,NEB;OBSL1;PDGFRA
prerank,MAPK cascade (GO:0000165),0.30382723708362414,0.9386199477634203,0.67,1.0,1.0,68/295,21.29%,FGF20;FGF9;SPTBN5;CAMK2B;PTGER4;IGF1;ARAF;PSMD4;NFKB1;NEFL;FGFR2;FGFR1;GRIN1;TAOK1;ZFP36L1;MINK1;BRAP;FGF10;IL31RA;PIK3R1;DLG3;PSMB10;RASGEF1A;PSMD11;SOX9;FRS2;EGF;PPP1CC;KL;GDNF;PSME2;IRS2;GFRA2;PSMC5;PIK3CB;PIK3R2;PDGFRA;PTPN3;NRG2;SETX;PDE6D;NRG1;TGFB1;MAP2K2;PSMD1;PPP5C;SPTBN1;CTSH;IL5;RIT2;DLG2;PSMD6;RASA3;MRAS;JAK1;CALM1;KSR1;NRK;RANBP9;PSMD5;RALGDS;MAPKAPK2;ITGAV;SPTBN4;PSMA4;MAP4K4;FGF13;FGF2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3266115981669708,0.9385967758653203,0.5732620320855615,1.0,1.0,16/69,17.58%,UBQLN1;SELENOS;STUB1;EDEM1;SYVN1;ERLIN2;JKAMP;AUP1;RNF103-CHMP3;VCP;USP19;UBE2J1;UBXN4;RNF121;DERL1;DNAJC10
prerank,positive regulation of transporter activity (GO:0032411),0.4222423845004009,0.9384163308599636,0.5549295774647888,1.0,1.0,5/13,23.82%,KCTD7;KMT2A;WNK3;RXRA;SGK1
prerank,cardiac muscle cell action potential (GO:0086001),-0.26784393904521075,-0.9381806715971177,0.5029940119760479,0.8956321262203433,1.0,8/30,12.55%,CACNA1D;CACNA2D1;ATP1A1;KCNJ2;DMD;CACNA1C;CACNA1G;ATP1B1
prerank,multivesicular body organization (GO:0036257),0.36220938395105384,0.9380582755813922,0.5693606755126659,1.0,1.0,6/31,12.16%,MVB12A;SNF8;HGS;VTA1;CHMP3;VPS4B
prerank,regulation of autophagy (GO:0010506),0.3070237713396277,0.9377161567541549,0.645937813440321,1.0,1.0,49/216,17.48%,IL10RA;UBQLN1;SIRT2;PIP4K2B;CSNK2A2;ATP6V0A2;UCHL1;SNX5;ITPR1;CDK5;SLC38A9;FLCN;DCN;ABL1;SNX6;VPS26B;ATP6V0E2;STK11;RRAGA;DDIT3;WDR6;USP10;PIK3CB;ATP6V1G1;PIK3R2;ATG13;BCL2;LEPR;RNF152;EIF4G2;LAMTOR5;PIP4K2A;VDAC1;DAPK1;PTPN22;PSAP;MAPT;ATP6V1D;PIP4K2C;DNM1L;NUPR1;TPCN1;RAB8A;MTMR4;ATP6V1B2;EIF4G3;MTDH;CAPNS1;USP33
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.33615554701663397,0.9376097172585177,0.5978021978021978,1.0,1.0,11/57,11.40%,TAOK1;FZR1;SDE2;FBXO31;CDC14B;CDK5RAP3;MRNIP;ATF2;MDC1;BRSK1;FOXN3
prerank,membrane repolarization during action potential (GO:0086011),-0.3458118917964212,-0.9375532604776377,0.5406360424028268,0.8955919281146502,1.0,3/13,12.55%,ATP1A1;KCNJ2;ATP1B1
prerank,cilium movement (GO:0003341),-0.24210084161369078,-0.9372908256765594,0.6229508196721312,0.8945346476567836,1.0,37/47,54.45%,DNAAF5;ODAD1;DNAH9;CFAP251;CCDC39;DNHD1;SPEF2;SPEF1;DNAH11;GAS8;RSPH9;CFAP61;DNAH5;ZBBX;CFAP70;CABYR;CFAP53;ROPN1L;ODAD2;CAMSAP3;ADCY10;SPAG17;ODAD3;SPA17;DNAAF2;ODAD4;TEKT2;CFAP100;DNAH17;CFAP206;CCDC40;DNAAF4;CCDC63;TTC29;CFAP91;TEKT5;DNAH1
prerank,proteoglycan metabolic process (GO:0006029),0.36730246242586095,0.9372374696212299,0.5690954773869347,1.0,1.0,3/26,6.08%,IGF1;SULF1;CHST10
prerank,histone H2B ubiquitination (GO:0033523),0.4511004662392899,0.9370983258970567,0.5476550680786687,1.0,1.0,4/10,15.71%,RNF8;RNF40;CDC73;UBE2E1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3809755007208205,-0.9368544704669087,0.5227272727272727,0.8938850629299822,1.0,5/10,22.78%,ATP5F1C;ATP5PO;ATP5PD;VPS9D1;ATP5F1D
prerank,DNA repair (GO:0006281),0.30465353596719624,0.9366006334794963,0.6736736736736737,1.0,1.0,57/284,15.30%,CDKN2D;WDHD1;XRCC2;APTX;LIG1;PARP1;APLF;RNF8;PRMT6;USP1;MPG;PARP2;MGMT;USP47;ASF1A;FBH1;MLH1;ABL1;DDB1;BARD1;TDP1;LIG3;FANCE;FANCG;ASCC1;ACTR8;SLC30A9;RNF168;UBE2V2;CUL4B;VCP;GTF2H3;MDC1;POLH;DCLRE1A;ENDOV;USP3;ALKBH3;FANCM;BRIP1;BACH1;POLN;PARK7;NPM1;FAAP100;TDP2;UBE2A;PMS2;ATR;SETX;MMS19;POLD3;FANCA;NUCKS1;MRE11;PPP5C;ASCC2
prerank,regulation of mitochondrial translation (GO:0070129),0.3819178708841073,0.9363602002213439,0.559254327563249,1.0,1.0,6/21,19.29%,TRUB2;RCC1L;MALSU1;UQCC2;MTG2;ALKBH1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.27218447925557165,-0.9361884356898742,0.5837837837837838,0.8939286811314988,1.0,14/27,30.40%,TRRAP;KAT7;KAT2B;EP300;MSL3;KAT6B;KAT8;PHF20L1;BAG6;RUVBL1;TAF6L;KAT6A;KAT5;MRGBP
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4450456147260847,0.9361393111049391,0.5641025641025641,1.0,1.0,1/10,2.58%,BMP6
prerank,protein-containing complex subunit organization (GO:0043933),0.31497011578609796,0.9357143931038816,0.619146722164412,1.0,1.0,34/109,22.05%,CHCHD10;NDUFAF1;KPNA3;NAPG;LAMC1;DMTN;VAMP3;TEAD1;SOX9;EPRS1;MDM4;PPIH;CAPZA1;AFG3L2;ADD2;WASF1;DNM1L;FANCA;IL1RAP;TUBGCP2;MDM2;TSPAN4;KMT2A;SHANK1;NUP35;KIFAP3;MITF;RANBP9;ZW10;PTK2B;GEMIN5;TPR;LLGL1;TRAF2
prerank,muscle organ development (GO:0007517),0.3373108869481414,0.935653231392577,0.5906040268456376,1.0,1.0,4/54,3.12%,FHL3;POU6F1;IGF1;NEB
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3478646537191622,0.9355778827209587,0.6064073226544623,1.0,1.0,16/45,24.19%,CAMK2B;IRF1;TRIM62;IFNGR2;IFNGR1;IRF3;CAMK2D;CAMK2G;ICAM1;OAS2;JAK1;TRIM26;B2M;TRIM8;MID1;JAK2
prerank,positive regulation of insulin secretion (GO:0032024),0.3506491702358466,0.9355155378600792,0.565680473372781,1.0,1.0,7/36,16.41%,GPLD1;LRRC8A;CAPN10;TCF7L2;IRS2;NLGN2;TRH
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3864043589458133,0.9354818309864052,0.568241469816273,1.0,1.0,6/21,23.45%,MAD2L1;FBXO5;ZWINT;ZW10;TPR;ATM
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.42049605880255136,0.935373055583987,0.5708215297450425,1.0,1.0,5/13,21.79%,CALM3;ANK3;CAMK2D;CALM1;CALM2
prerank,transport across blood-brain barrier (GO:0150104),0.3182392203699318,0.9351299921744087,0.6046511627906976,1.0,1.0,16/83,16.50%,SLC4A4;SLC29A1;SLC27A4;SLC5A3;ABCA2;SLC16A12;SLC7A2;ATP1A2;SLC22A8;SLC2A3;LEPR;LRP1;SLC1A3;SLC1A5;SLC6A13;SLC27A1
prerank,intracellular lipid transport (GO:0032365),-0.2905548779805752,-0.9350438155027956,0.5512820512820513,0.8952253077149374,1.0,7/21,19.31%,ACACA;CERT1;PRKAB2;ACACB;PRKAA2;ARV1;ABCD3
prerank,B cell homeostasis (GO:0001782),-0.38003908320838165,-0.935007058390247,0.546031746031746,0.8935259012253356,1.0,3/10,8.32%,MEF2C;PPP2R3C;CAMLG
prerank,innate immune response (GO:0045087),-0.18639232542077105,-0.9349474728302983,0.6,0.891912840107074,1.0,59/217,24.26%,ANKRD17;SETD2;MFHAS1;CAPZA2;IKBKB;FER;RNASE3;PML;LBP;IRAK1;TNK2;TRIM25;SP100;IFIH1;RNF135;TLR4;OTULIN;CYLD;PLCG2;POLR3A;CXCL16;ALPK1;IKBKG;TRIM39;ADAM15;DEFA6;PYDC1;IRAK4;S100B;RPL39;MAVS;AKAP1;SRC;SERINC3;RNF187;TRIM5;IRGM;SKP2;TRIM14;IFIT1;PGLYRP1;GCH1;NRROS;TBK1;FYN;CYBA;BST2;IFITM2;NUB1;ATAD3A;STYK1;PPARG;IFITM1;BCL10;PIK3CD;NLRC5;CX3CR1;TRIM59;TRIM28
prerank,pyroptosis (GO:0070269),0.40951394356965415,0.9348302879369049,0.5653950953678474,1.0,1.0,1/15,1.45%,GSDMD
prerank,bicellular tight junction assembly (GO:0070830),-0.24301172826099576,-0.9347036264442686,0.6076923076923076,0.8907980050088131,1.0,7/46,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2
prerank,respiratory electron transport chain (GO:0022904),-0.3291607226595618,-0.9343745340665844,0.5592592592592592,0.8898954925565625,1.0,11/14,35.18%,GPD2;SLC25A13;SDHB;ETFDH;NDUFA5;PPARGC1A;ETFRF1;ETFB;SLC25A22;UQCRFS1;SLC25A18
prerank,regulation of protein acetylation (GO:1901983),0.4317344101081264,0.9343560974035499,0.5817655571635311,1.0,1.0,4/12,18.57%,TAOK1;DDX3X;PARK7;TERF2IP
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2206907358768682,-0.9340053295658607,0.673469387755102,0.8891462866442043,1.0,19/91,10.91%,ABCG2;SMAD4;ATP6V1A;CUL1;GLRX3;SLC39A14;ACO1;SKP1;NDFIP1;ATP6AP1;MT1B;MT1X;MT1G;MT1F;MT1E;MT1M;MT1H;MT1A;SLC39A8
prerank,pteridine-containing compound metabolic process (GO:0042558),0.42222693248508014,0.9338307321346324,0.5495118549511855,1.0,1.0,4/13,18.96%,HSP90AA1;FPGS;QDPR;CALM1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4203371001801566,0.9336866968970406,0.5658263305322129,1.0,1.0,7/13,23.65%,KPNA3;KPNB1;RANBP2;KPNA1;NUP35;CBLB;NUP54
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.4294745259115058,0.9335271519871663,0.5747800586510264,1.0,1.0,1/11,1.51%,UQCRC1
prerank,regulation of TOR signaling (GO:0032006),0.3247630931801218,0.9334791675489722,0.6021621621621621,1.0,1.0,8/67,7.21%,HDAC3;ARAF;TSC2;TBC1D7;SLC38A9;FLCN;RRAGA;RFFL
prerank,regulation of histone modification (GO:0031056),0.4231983268651859,0.9333285792352801,0.5333333333333333,1.0,1.0,5/13,12.08%,CDK9;FLCN;AKAP8L;NNMT;PARK7
prerank,positive regulation of interleukin-2 production (GO:0032743),0.37179488813258826,0.9332206843357429,0.571608040201005,1.0,1.0,9/25,24.79%,ANXA1;MALT1;SPTBN1;PDE4B;PRKD2;RPS3;TRAF2;TRAF6;RUNX1
prerank,cellular protein-containing complex assembly (GO:0034622),0.308478802188969,0.9330531935046722,0.6356275303643725,1.0,1.0,43/159,22.48%,CALY;SRP19;CENPT;BBS10;PSMD4;BIN1;HSP90AA1;NDUFAF1;TBCA;TCF4;VAMP3;COX7A2;PSMD11;PSMG3;VBP1;CHMP3;AP2S1;PDE4DIP;PRLR;CENPC;MAPT;NRG1;TGFB1;SHQ1;HSPD1;POMP;TBCD;VAMP8;OMA1;DNAAF3;GPX4;NUP153;DNAI4;UVRAG;TPR;CHMP4A;CHMP4B;SMAD2;OTUD6B;TRAF2;SMAD3;DNAJB12;GTF2B
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32288463246904386,0.933045466729083,0.6036916395222585,1.0,1.0,8/75,9.15%,APLN;WNT5A;PDPK1;FGFR1;NRP1;PRKCA;ARNT;EGF
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.31807600417682036,-0.9329809172850487,0.5522388059701493,0.8901765369803928,1.0,8/16,21.40%,ABHD5;SCARB1;DAGLB;NR1H3;CNEP1R1;SREBF1;CTDNEP1;NR1H2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.44829415103811376,0.9327901602640123,0.5789473684210527,1.0,1.0,5/10,22.67%,NELL1;CDK5RAP3;ANXA2;ATRAID;EPHA4
prerank,negative regulation of bone mineralization (GO:0030502),-0.35137612522650374,-0.9326491307631333,0.540625,0.8892848013350968,1.0,3/13,10.35%,BCOR;ECM1;SRGN
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4192134951798201,0.9324685206579133,0.5576642335766423,1.0,1.0,3/14,13.28%,TRUB2;RCC1L;UQCC2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.38586181105306533,0.9323174342058678,0.5510204081632653,1.0,1.0,8/20,18.70%,ABCA2;KPNB1;MBTPS1;EPHX2;ACADL;ACADVL;APOE;TTC39B
prerank,positive regulation of cellular protein localization (GO:1903829),0.3240538187594661,0.9320698180796709,0.6160616061606161,1.0,1.0,16/69,18.71%,GNL3;EIF2AK3;GPD1L;SLC5A3;ENTR1;CDK5RAP3;ABCA7;SNX33;RIC3;PARK7;LAMTOR5;MAPT;TGFB1;NUMA1;CCDC88A;PRKAA1
prerank,cellular response to amino acid stimulus (GO:0071230),0.35275928797739375,0.9318049553687677,0.5629453681710214,1.0,1.0,7/33,14.46%,CPEB1;XBP1;SLC38A9;RRAGA;CAPN2;LAMTOR5;GLRA1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.23281202721067687,-0.931653683935684,0.6126126126126126,0.8901597470018552,1.0,17/51,17.46%,NEK7;CCT3;GNL3L;SMG5;STN1;FBXO4;TCP1;PARN;NAF1;CCT5;NAT10;SRC;MAP3K4;CCT7;PNKP;CCT2;SMG6
prerank,ventricular septum morphogenesis (GO:0060412),-0.27709549898228536,-0.9313567403574345,0.565,0.8892205746034322,1.0,9/27,17.44%,SMAD4;SLIT2;TGFB2;ACVR1;BMPR1A;TGFBR2;BMP4;HES1;HEYL
prerank,cellular defense response (GO:0006968),0.345207645438221,0.9312998087090063,0.5744186046511628,1.0,1.0,7/40,20.98%,DCDC2;CCR9;LY96;TCIRG1;LSP1;PTK2B;ITGB1
prerank,regulation of establishment of planar polarity (GO:0090175),0.3151734478489848,0.9312745559937023,0.6022964509394572,1.0,1.0,12/88,10.55%,WNT5A;DVL2;PSMD4;RAC1;FZD3;PSMB10;DVL1;PSMD11;AP2S1;PSME2;PSMC5;DAAM1
prerank,positive regulation of cell migration (GO:0030335),0.3000994930518724,0.9307215815566936,0.6863727454909819,1.0,1.0,42/253,15.68%,CARMIL2;VTN;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;GLIPR2;CXCL12;NIPBL;NRP1;FGF10;PRKCA;SNAI1;DDR2;CD151;GAB1;FBXO5;ARHGEF7;DMTN;MIA3;RHOD;SOX9;SDCBP;EGF;RIPOR1;SEMA3D;ENPP2;MAZ;PDGFRA;SOD2;RACK1;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;ACVR1B;SEMA3A;CTSH
prerank,nuclear membrane organization (GO:0071763),0.39836741741384507,0.9306745133416551,0.5571245186136072,1.0,1.0,4/19,10.12%,UBXN2A;AKAP8L;TOR1B;TMEM43
prerank,lipid droplet organization (GO:0034389),-0.29318186746462715,-0.9306408972909268,0.5606694560669456,0.8892680969783755,1.0,7/22,24.02%,RAB18;ZFYVE1;FAF2;BSCL2;CDS2;RAB3GAP1;SQLE
prerank,skeletal system morphogenesis (GO:0048705),0.3410289008587834,0.9305533018578608,0.5758293838862559,1.0,1.0,9/42,18.89%,FBN2;FGFR2;FGFR1;SOX11;PDGFRA;CYP26B1;MEGF8;TGFBR1;WWOX
prerank,cell chemotaxis (GO:0060326),0.32688876227924357,0.930219817242107,0.5844594594594594,1.0,1.0,13/60,18.58%,CCR9;ACKR2;CXCL12;NRP1;CXCR4;PDGFRA;PLEKHG5;RAB13;LPAR1;AGTR1;PLXNB3;CCL25;PIP5K1A
prerank,cell-matrix adhesion (GO:0007160),0.3177522556994129,0.9300964417525694,0.6074380165289256,1.0,1.0,15/95,13.57%,VTN;LYVE1;THBS3;RAC1;WHAMM;CD63;DDR1;THY1;ARHGEF7;RHOD;TMEM8B;ITGBL1;ECM2;FBLN5;EMP2
prerank,connective tissue development (GO:0061448),0.35203604922994536,0.9299654993261887,0.5936395759717314,1.0,1.0,6/35,14.84%,XBP1;SULF1;TRIP11;SOX9;SOX6;SOX5
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.37186939571102884,0.9299377489033638,0.5642023346303502,1.0,1.0,6/25,10.95%,NRP1;DSCAM;SDCBP;EGF;APP;PTH1R
prerank,regulation of cell cycle (GO:0051726),0.3028139711412937,0.9298974738591429,0.6863727454909819,1.0,1.0,42/271,11.88%,CDKN2D;SFRP1;FOXM1;SIRT2;TSC2;CSNK2A2;TBRG4;BIN1;WHAMM;FGFR2;FBXL12;FZD9;CDC123;FGF10;CDK5;CDK9;RBBP4;TCF7L2;IRF1;ABL1;FBXO5;BARD1;GADD45GIP1;STK11;GAS2L1;CDC14B;CDC25A;MFN2;XIAP;SIK1;SOX9;SRA1;WDR6;PPP1R9B;SDCBP;RNF40;CDK5RAP3;TMEM8B;TAF6;IQGAP1;EIF4G2;MAGI2
prerank,positive regulation of protein secretion (GO:0050714),0.32165890132635405,0.9295228826774666,0.6100966702470462,1.0,1.0,13/69,16.41%,IGF1;LRRC8A;BMP6;CAPN10;TCF7L2;WLS;IRS2;MYH10;TMED10;TGFB1;NLGN2;DNM1L;TRH
prerank,positive regulation of cellular component organization (GO:0051130),0.31213180595566037,0.9293287222073031,0.6230529595015576,1.0,1.0,25/107,19.43%,CALY;CAMK2B;BAX;WARS1;TIRAP;CD151;SLF2;ANAPC2;FRMPD4;CLIP3;VCP;PLEKHM2;PARK7;RACK1;LRP1;NRG1;TGFB1;ABCB7;FAF1;TPPP;APOE;TGFBR1;FLOT1;SMPD1;RPS3
prerank,inositol phosphate metabolic process (GO:0043647),-0.24240410133764126,-0.9291266256623937,0.5944055944055944,0.8916540803569721,1.0,12/46,13.81%,IP6K2;PPIP5K1;OCRL;PLCE1;PLCD3;INPP5D;PLCB3;MINPP1;PLCG2;INPPL1;PLCG1;PLCD1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.269685817445119,-0.9291075081242639,0.5705521472392638,0.8899682767704002,1.0,7/34,5.16%,FLT1;DAB2IP;KIT;IRS1;PRKD1;PIK3R3;TEK
prerank,histone exchange (GO:0043486),0.3482687057899665,0.9288660321171458,0.5774155995343423,1.0,1.0,6/37,13.49%,CENPT;RNF8;RBBP4;ACTR6;NPM1;CENPC
prerank,positive regulation of cation channel activity (GO:2001259),0.34082528433906595,0.9288028118347114,0.5860849056603774,1.0,1.0,8/40,18.96%,EPHB2;CALM3;ANK3;NLGN3;HTT;ATPSCKMT;PKD2;CALM1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3015178503330835,-0.928704198203937,0.5368852459016393,0.8893379459233886,1.0,11/21,31.33%,BACE2;ERAP1;BACE1;NCSTN;ADAM10;APH1A;PSEN2;SPPL3;ADAM19;RBMX;PSENEN
prerank,secondary palate development (GO:0062009),-0.3291752941253363,-0.9286294082969929,0.5082508250825083,0.8878081785801046,1.0,4/14,7.89%,SMAD4;LEF1;TGFB2;TGFBR2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3009080489408205,0.9282547854634408,0.699,1.0,1.0,50/291,17.06%,CPEB1;MAPK9;WNT5A;LPL;SFRP1;GPLD1;SELENOS;NFKB1;XBP1;RORA;ZFP36L1;TNFAIP3;TIRAP;CARD16;SLC38A9;PRDX5;DMTN;ZNF35;GNG2;RRAGA;SIRPA;PID1;INSIG1;BRINP3;KCNC2;SOX9;SSH1;DHX36;CAPN2;TRIM41;RAPGEF1;VCP;LY96;TPM1;PDGFRA;GIT1;LAMTOR5;SETX;DAPK1;CDC73;MAPT;ROCK2;GLRA1;IMPACT;PDE4B;SNW1;SERPINE1;PTK7;DPEP1;BRINP1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3234525144335902,0.9281387021670412,0.5995623632385121,1.0,1.0,16/63,19.80%,BAX;PCBP4;TFDP1;SDE2;CNOT10;FBXO31;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,cellular component assembly (GO:0022607),0.3021841712032676,0.9280041605110861,0.6823647294589178,1.0,1.0,60/253,20.62%,WNT5A;LCP1;AIF1L;CHCHD10;RAC1;NDUFAF1;KPNA3;NEFH;TLCD1;MYO1B;RBBP4;NAPG;LAMC1;DMTN;DVL1;VAMP3;RHOD;TEAD1;CYFIP1;SOX9;EPRS1;BAIAP2;MDM4;PPIH;CAPZA1;AFG3L2;ANK3;YTHDF3;NLGN3;ADD2;WASF1;YTHDF1;TGFB1;NLGN2;VMP1;DNM1L;FANCA;SPTBN1;PAWR;IL1RAP;STK25;TUBGCP2;MDM2;TSPAN4;RAD21;ILK;KMT2A;SHANK1;KIFAP3;YTHDF2;VCPIP1;QSOX1;MITF;RANBP9;ZW10;MYO9A;DCX;LIMA1;PTK2B;GEMIN5
prerank,myotube differentiation (GO:0014902),0.4024175701064307,0.927982781020695,0.5720221606648199,1.0,1.0,6/17,19.08%,IGF1;ADAMTS5;ADAM12;MYEF2;ADGRB3;KCNH1
prerank,positive regulation of autophagy (GO:0010508),-0.2185998178164947,-0.9276914552898853,0.5441176470588235,0.8884286778873736,1.0,24/81,16.81%,WAC;EIF2AK4;TFEB;FOXO3;TMEM59;BNIP3L;SH3BP4;EPM2A;SIRT1;PRKD1;LRRK2;KDR;IKBKG;ROCK1;GNAI3;PAFAH1B2;PRKAA2;BNIP3;TRIM5;TRIM65;PLK2;IRGM;UFL1;PINK1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.41027744652793807,0.9275922844928243,0.5708154506437768,1.0,1.0,1/14,1.28%,IL34
prerank,neural crest cell differentiation (GO:0014033),-0.30645962606584126,-0.9275415447764155,0.5603112840466926,0.8871452789131904,1.0,3/18,1.20%,LRP6;MEF2C;TAPT1
prerank,response to UV (GO:0009411),0.31348113539797834,0.926982489115645,0.6230200633579726,1.0,1.0,16/95,12.82%,CDKN2D;MFAP4;PARP1;USF1;USP1;SDE2;USP47;CDC25A;DHX36;CASP9;POLH;BRSK1;YY1;NPM1;UBE2A;ATR
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.31582521889279613,-0.9269695432980317,0.5454545454545454,0.8869871304448247,1.0,9/17,22.78%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;VPS9D1;ATP5F1B;DMAC2L;ATP5F1D
prerank,protein localization to vacuole (GO:0072665),-0.34027507350699493,-0.9268153368701822,0.5275080906148867,0.8856926349228106,1.0,9/13,36.56%,SH3BP4;SZT2;KPTN;MFSD1;CD81;RNF128;GLMP;ATP13A2;RTN4
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.2839024744269585,-0.9267294309622256,0.5607476635514018,0.8842094484696386,1.0,8/23,28.54%,SLC12A7;CLCN3;SLC12A4;SLC12A9;SLC12A2;SLC12A8;SLC12A6;PDK2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3822437602608064,0.9263866674267324,0.5581081081081081,1.0,1.0,4/19,9.16%,HS2ST1;EXTL3;NDST2;HS6ST2
prerank,polyamine metabolic process (GO:0006595),0.4238912498702262,0.926096577353757,0.5750350631136045,1.0,1.0,4/13,15.79%,SRM;SMS;SMOX;AMD1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.3704286329352825,0.9257750646742126,0.5840821566110398,1.0,1.0,5/25,11.50%,CALM3;ATP2A2;NOS1AP;JUP;CAMK2D
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3730160337013496,-0.9256925281784252,0.533724340175953,0.8851945780122624,1.0,2/10,3.56%,ARL6IP5;SLC25A13
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3181378570669132,0.9249408332859086,0.6370370370370371,1.0,1.0,14/83,13.58%,CDKN2D;TFDP1;CDK5;NPAT;BRD4;FBXO5;CDC25A;CUL4B;E2F3;BACH1;CCNH;RCC1;GSPT1;CUL5
prerank,positive regulation of myelination (GO:0031643),0.4297592802606959,0.9248057497214222,0.5630498533724341,1.0,1.0,3/11,16.69%,MYRF;TENM4;TPPP
prerank,positive regulation of MAP kinase activity (GO:0043406),0.325168015153317,0.9247313824385337,0.6002178649237473,1.0,1.0,9/66,11.30%,MST1R;IL34;DVL2;EDN3;FGFR1;EZH2;CD24;EGF;ROBO1
prerank,nuclear pore organization (GO:0006999),-0.3433898629662713,-0.9244308933102942,0.5154639175257731,0.8868957129757729,1.0,6/14,21.50%,NUP205;NUP93;NUP107;NUP133;NDC1;TMEM170A
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.41755259732692046,0.9241897731837417,0.596045197740113,1.0,1.0,4/14,10.53%,SCAP;SAR1A;MIA3;TBC1D20
prerank,axoneme assembly (GO:0035082),-0.25818564350139156,-0.924019453158383,0.5977011494252874,0.8863399766971604,1.0,19/30,47.99%,TOGARAM1;SPAG1;TTC12;TTLL3;CCDC39;CFAP74;RP1;SPEF1;SPAG16;GAS8;RSPH9;CFAP46;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,lysosome organization (GO:0007040),0.34806195142967405,0.9237288625960822,0.6004618937644342,1.0,1.0,7/36,16.00%,CLN3;CLN6;ATP10B;MBTPS1;HOOK3;ARSB;VPS18
prerank,negative regulation of anoikis (GO:2000811),-0.3395373792715783,-0.9231608606219527,0.5442622950819672,0.886895984554457,1.0,4/14,15.19%,CAV1;MCL1;PIK3CA;SRC
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.33614410625937763,-0.9227079280269588,0.5547945205479452,0.8864124759869138,1.0,2/14,6.01%,SHLD2;PAXIP1
prerank,neuron cell-cell adhesion (GO:0007158),0.40319094552310303,0.9224533560706126,0.5794392523364486,1.0,1.0,6/14,24.90%,NINJ2;NLGN3;NLGN2;NRXN3;NRXN2;ASTN2
prerank,skin development (GO:0043588),0.3203907901676964,0.9219432585954891,0.6196721311475409,1.0,1.0,11/65,18.79%,WNT5A;DACT2;SCEL;ANXA1;ERRFI1;COL1A2;COL5A2;TXNIP;JAG1;PIP5K1A;COL5A3
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.31844251109576216,0.9219092481584729,0.607066381156317,1.0,1.0,13/72,16.27%,DNASE1L2;PARP1;RNASE1;FBH1;DCP1B;SPO11;DDB1;CUL4B;GTF2H3;ENPP1;POLD3;MRE11;RAD50
prerank,peptidyl-arginine modification (GO:0018195),0.4010082361843825,0.9217125975658237,0.5710227272727273,1.0,1.0,4/15,15.50%,PRMT5;PARK7;PRMT1;PRMT8
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.34746765164492055,0.9216274703279976,0.5874384236453202,1.0,1.0,5/37,9.24%,CHID1;ADCY7;SIRPA;PER1;CUEDC2
prerank,cellular response to starvation (GO:0009267),0.30694237517221434,0.9212123151577662,0.6588594704684317,1.0,1.0,37/147,19.00%,SFRP1;EIF2AK3;XBP1;PICK1;WIPI1;NUAK2;SLC38A9;FLCN;NUAK1;ATG14;ATP6V0E2;RRAGA;BRSK2;GAS2L1;TBL2;SIK1;GCN1;EHMT2;RIPOR1;FADS1;ATF2;BRSK1;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;MAP1LC3B;ATP6V1D;VPS41;IMPACT;ATP6V1B2;PIK3C3;MIOS;USP33;PRKAA1;PRKAG2;PIK3R4
prerank,positive regulation of telomerase activity (GO:0051973),-0.2588636772494625,-0.921032333272999,0.601123595505618,0.8889548013089089,1.0,11/33,17.02%,NVL;NEK7;PTGES3;PARM1;HSP90AB1;TCP1;PARN;NAF1;MAP3K4;PNKP;CCT2
prerank,cellular response to fluid shear stress (GO:0071498),0.4190351220721963,0.9210147712620987,0.5690936106983655,1.0,1.0,5/12,19.97%,HDAC3;PKD2;ASS1;KLF4;MTSS1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3193118534722437,-0.9201133897929812,0.5726141078838174,0.8895972428267602,1.0,9/16,39.62%,TIPIN;RAD9B;HUS1;CLSPN;DNA2;ORC1;TIMELESS;RAD9A;CDC45
prerank,regulation of phosphorylation (GO:0042325),0.3058124122650055,0.9198674094283985,0.6482051282051282,1.0,1.0,29/120,19.68%,CDKN2D;KDM4D;SIRT2;PRKRIP1;OGT;RAE1;NRP1;FLCN;BARD1;ATG14;DSCAM;CD24;SDCBP;EGF;NUP188;PGAM1;APP;NUP210;NUP88;EMP2;NUP214;PHIP;ILK;NUP153;CCDC88A;RANBP2;PRKAG2;NUP35;DYNLL1
prerank,amide transport (GO:0042886),-0.2660205398797565,-0.9198233718890657,0.5842105263157895,0.888604832772982,1.0,9/26,22.30%,ABCG2;CERT1;SLC25A32;TAP2;SLC5A6;GLTP;ABCB9;AQP11;SLC38A5
prerank,keratan sulfate catabolic process (GO:0042340),0.4417318670599318,0.919778956704918,0.5736766809728183,1.0,1.0,3/11,15.67%,GLB1;OMD;LUM
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3139693861371859,0.9194806442708356,0.6477516059957173,1.0,1.0,31/85,24.34%,SIRT2;STUB1;ZYG11B;COP1;BBS7;DVL1;VCP;PSMC5;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;NUPR1;HECTD1;ARIH2;FMR1;FBXO22;MDM2;PIAS1;SUMO2;DAB2;SMAD7;PSMC6;TAF1;TMEM259;KEAP1;FBXW7;TRIB2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2899500876256218,-0.9194601734101716,0.5517241379310345,0.887867927066339,1.0,11/24,21.52%,MBTPS2;HIF1A;TP53;HSF1;HSPA5;CEBPB;ATF4;VEGFA;NFE2L2;CREB3L1;SESN2
prerank,endoderm formation (GO:0001706),-0.26120716310519465,-0.9190678496291395,0.5704225352112676,0.887209381127674,1.0,11/35,19.68%,SETD2;COL4A2;COL8A1;COL6A1;FN1;LAMA3;ITGA4;ITGB5;MMP2;DUSP1;SOX17
prerank,regulation of cellular response to heat (GO:1900034),0.316877691104387,0.919005548076876,0.6390658174097664,1.0,1.0,29/77,24.13%,CAMK2B;HSP90AA1;DNAJC7;RAE1;BAG1;NUP188;HSPH1;CAMK2D;CAMK2G;DNAJB6;NUP210;ATR;NUP88;MAPT;NUP214;CHORDC1;HSBP1;NUP153;BAG4;RANBP2;NUP35;MAPKAPK2;TPR;DNAJC2;HSPB8;NUP155;ATM;NUP54;NUP98
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3503276892273707,0.9189419576953072,0.594306049822064,1.0,1.0,13/33,22.82%,HDAC5;TBXA2R;JUP;TGFB1;ITGB1BP1;APOE;MECP2;KLF4;STARD13;ATP2B4;FGF2;HMGB1;MEOX2
prerank,cell-cell junction organization (GO:0045216),-0.21377133484290944,-0.9187270122634392,0.581081081081081,0.8864227882168787,1.0,18/79,16.07%,CADM2;LIMS2;TJP1;PKP4;CLDN5;CDH6;GJC1;CADM1;TGFB2;ARVCF;CDH1;CSK;OCLN;MYADM;NECTIN3;NECTIN1;TLN1;CADM3
prerank,type I interferon signaling pathway (GO:0060337),-0.24525273408460632,-0.9186936321580244,0.5901639344262295,0.883208697007632,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,cellular response to type I interferon (GO:0071357),-0.24525273408460632,-0.9186936321580244,0.5901639344262295,0.883208697007632,1.0,17/41,24.05%,IP6K2;SAMHD1;IFNAR2;STAT2;STAT1;IRAK1;SP100;TYK2;IFIT2;XAF1;IRF9;IFIT1;GBP2;BST2;IFITM2;IFITM1;EGR1
prerank,serine family amino acid catabolic process (GO:0009071),-0.38262072201653163,-0.9173775253908641,0.565597667638484,0.8849505474392273,1.0,8/10,53.11%,AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1;DAO
prerank,RNA biosynthetic process (GO:0032774),0.3484794772939733,0.9173693433671184,0.5918367346938775,1.0,1.0,7/31,14.54%,SMN1;TAF4;TBP;PRMT5;TAF6;SETX;HELB
prerank,protein tetramerization (GO:0051262),0.32081528213272104,0.9170046790575658,0.625133120340788,1.0,1.0,16/67,22.07%,FARSB;KCNC1;GRIN1;ALDH1A2;TK1;CPSF7;NUDT21;SOD2;HPRT1;AQP4;CPSF6;PKD2;OXA1L;APPL2;ACOT13;B2M
prerank,tight junction assembly (GO:0120192),-0.23530135076036574,-0.9169664151950576,0.608,0.8844290393097569,1.0,8/49,10.64%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;LSR;RAMP2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4309877602530484,0.9167812407182612,0.5733333333333334,1.0,1.0,2/10,16.50%,SLC27A4;SLC27A1
prerank,purine nucleotide metabolic process (GO:0006163),0.36985882220071914,0.91676095123044,0.6017262638717632,1.0,1.0,3/24,6.18%,ADSL;PRPSAP2;GART
prerank,regulation of stress fiber assembly (GO:0051492),0.31892441237931457,0.9164528093745992,0.6282051282051282,1.0,1.0,27/74,22.50%,SFRP1;PTGER4;RAC1;ARHGEF10;NRP1;ALMS1;PIK3R1;ABL1;TPM1;ARHGEF10L;CD47;ARAP1;LPAR1;ROCK2;PPM1E;ITGB1BP1;CCDC88A;TGFBR1;CARMIL1;DLC1;ARHGAP6;EVL;NF2;CLASP2;PPM1F;PFN2;PAK1
prerank,bile acid biosynthetic process (GO:0006699),0.36351805810091,0.916451567878961,0.5710691823899371,1.0,1.0,4/24,11.00%,CYP27A1;CYP7B1;HSD17B4;AMACR
prerank,polyol biosynthetic process (GO:0046173),0.39666773257597904,0.9163274860702171,0.5801630434782609,1.0,1.0,6/16,21.29%,CYP27A1;IPPK;ISYNA1;IPMK;IP6K1;FGF2
prerank,protein-containing complex assembly (GO:0065003),0.2986042929276807,0.9161859780412536,0.7280966767371602,1.0,1.0,73/259,20.62%,TRAPPC10;GSDMD;CHCHD10;NDUFAF1;KPNA3;CXCL12;CDC123;NAPG;LAMC1;TCF7L2;KLHL12;SEC16A;DMTN;VAMP3;TEAD1;SEC16B;PEF1;SOX9;EPRS1;MDM4;PPIH;DBNL;HGSNAT;PDE4DIP;PPP6R3;TBC1D20;SCFD1;CAPZA1;AFG3L2;TFG;GRIA1;HDAC1;ADD2;AXIN2;PYGO2;TMED10;WASF1;CDC73;CSNK1D;PYGO1;TRAPPC6B;USO1;CTSZ;DNM1L;FANCA;KMT2D;MCFD2;CSNK1A1;TCF7L1;FARP2;F8;IL1RAP;NSF;ITGB1BP1;TUBGCP2;GORASP1;TCF7;MDM2;TSPAN4;PLEKHA7;ANKRD28;KMT2A;SEC24D;SHANK1;CNIH1;KIFAP3;STX5;MITF;RANBP9;ZW10;PDCD6;PTK2B;GEMIN5
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.4098711778088057,0.9161324824679454,0.5830903790087464,1.0,1.0,4/13,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.21263243892699027,-0.9159248080273275,0.7215189873417721,0.8854651398243809,1.0,18/67,15.68%,IKBKB;PSMB7;TAPBP;PSMB2;SEC22B;PSMD7;CALR;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;IKBKG;TAP2;PSMD9;PSMD2;PSMB3;ITGB5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3151964714176829,0.9159104172478266,0.6153846153846154,1.0,1.0,16/74,16.91%,IGF1;DDX3X;TNFAIP3;TCF7L2;TMBIM1;RFFL;GDNF;BCL2;BMP5;PARK7;HTT;EYA2;ICAM1;SERPINE1;FAIM2;PHIP
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4032815759286148,0.9157742054589554,0.5706447187928669,1.0,1.0,3/15,9.21%,MGAT3;RENBP;EXTL2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.32149748122839106,-0.9156133436880824,0.575,0.8845775865351551,1.0,2/16,4.71%,ST3GAL4;IRAK1
prerank,response to reactive oxygen species (GO:0000302),0.32534094415161624,0.9154977296045237,0.6124721603563474,1.0,1.0,13/54,19.43%,MAPK9;PTPRN;APTX;PRDX5;TPM1;PDGFRA;SOD2;MAPT;COA8;STK25;APOE;PKD2;RPS3
prerank,regulation of cell growth (GO:0001558),0.29947307399760625,0.9154318644359959,0.6937751004016064,1.0,1.0,32/204,15.62%,PSRC1;SFRP2;CDKN2D;SFRP1;CDKN2AIP;EXOSC2;CGRRF1;TAF9B;SLC25A33;DDX3X;FLCN;NUBP1;USP47;RASGRP2;STK11;TCHP;SPOCK1;PPP1R9B;SDCBP;NRG3;BCL2;CAMK2D;EIF4G2;ENPP1;RACK1;RPS6KA3;EGLN2;TGFB1;BCL6;SLIT3;ACVR1B;RPS6KA1
prerank,cellular response to ketone (GO:1901655),0.34699182271779444,0.915342121285194,0.6065773447015834,1.0,1.0,7/35,16.59%,SFRP1;PTGER4;GNG2;NCOA4;ROCK2;ADCY1;ADCY5
prerank,retinoic acid metabolic process (GO:0042573),0.40784301113853444,0.9148833937252344,0.6040268456375839,1.0,1.0,2/14,12.85%,ALDH1A2;CYP26B1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.32435165544771843,0.9142711180415164,0.6088397790055249,1.0,1.0,14/54,19.80%,BAX;PCBP4;TFDP1;CNOT10;MDM4;RBL2;CNOT9;PRMT1;CNOT6;CASP2;CHEK2;MDM2;SOX4;CARM1
prerank,positive regulation of cell development (GO:0010720),-0.26120147490148893,-0.9140421141725517,0.6257309941520468,0.887028666990951,1.0,11/31,23.74%,NIBAN2;TGM2;NUMB;NUMBL;ATP6AP1;OPRM1;MME;BMP4;FAIM;BAD;CX3CR1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30204047191119254,0.9136949832666725,0.6852791878172588,1.0,1.0,33/144,18.76%,HDAC3;CSNK2A2;FIS1;TFDP1;SAR1A;SAE1;TCF7L2;MTCL1;MIEF2;PIK3R1;SEC16A;NMT1;SEC16B;YWHAH;RIPOR1;YWHAG;JUP;PIK3R2;ATG13;BCL2;ANK3;LEPROT;TGFB1;ARIH2;ITGB1BP1;UBE2L3;UBR5;RUFY3;SORL1;CEMIP;ZDHHC2;RBM22;KIF20B
prerank,neuron fate commitment (GO:0048663),0.4082747363134104,0.9136034446448499,0.5648535564853556,1.0,1.0,14/14,59.21%,TGFBR1;ID2;MYT1L;FOXN4;ISL2;EPOP;ISL1;ASCL1;PAX6;POU4F1;SHH;DLL1;DLL4;POU3F2
prerank,regulation of JUN kinase activity (GO:0043506),-0.2488995891007021,-0.9134383948857974,0.6038961038961039,0.8869672739590267,1.0,14/33,25.25%,DAB2IP;PDCD4;DVL3;MAP3K10;DUSP10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;DNAJA1;MAP3K5;PPEF2;SASH1;HIPK3
prerank,protein polyubiquitination (GO:0000209),0.29712214710842444,0.9133728768424769,0.7404809619238477,1.0,1.0,71/297,19.60%,CDC23;PSMD4;FBXW10;RNF8;UBE2S;SPSB1;STUB1;UBE2E2;UBE2QL1;FBXL12;SYVN1;CDC16;FZR1;FBXL14;TNFAIP3;FBXO38;FBXO7;THOP1;ANAPC2;FBXO31;PSMB10;BARD1;TRIM56;RFFL;FBXW5;PSMD11;RMND5A;TRIM62;UBE3B;RNF168;UBE2V2;CHFR;PSME2;PSMC5;BCL2;RC3H2;RNF152;RNF19A;UBE2A;ANAPC11;ANAPC4;CBFB;UBE2J1;RNF19B;CDC26;RNF41;ANKIB1;RNF217;PSMD1;UBE2E1;UBE2D1;HECTD1;ARIH2;TNKS;UBE2L3;UBR5;PSMD6;FBXO22;SMURF1;TOPORS;TTC3;MDM2;FBXO9;KLHL20;ANAPC10;ANAPC5;TRIM27;ZNRF2;RNF167;PELI2;PSMD5
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.3419069904089611,0.9133071259194342,0.6002386634844868,1.0,1.0,11/37,21.40%,STMN4;MAPRE3;TAOK1;GAS2L1;MAPT;PHLDB1;TPPP;PRKAA1;MAP6D1;MAP6;CLASP2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4339334400971868,0.9131702946415647,0.5589080459770115,1.0,1.0,2/10,10.20%,STAT6;PRLR
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3658204490571887,0.9127769289496452,0.5669291338582677,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3658204490571887,0.9127769289496452,0.5669291338582677,1.0,1.0,5/23,8.75%,ZEB2;FLCN;STK11;TGFB1I1;SDCBP
prerank,regulation of cell death (GO:0010941),-0.21161229065514983,-0.9125150434788992,0.7083333333333334,0.8875879676503519,1.0,25/94,18.27%,FERMT2;CCN2;ATG5;RILPL1;BNIP3L;EPHB1;PRKD1;BECN1;CDKN1B;NCK1;LRRK2;ADNP2;UBB;DUS2;BMP7;PRODH;CCN3;CHRNA7;BNIP3;CRYAB;TNFRSF1B;BMP4;CCN5;TMEM109;CCN1
prerank,inflammatory response (GO:0006954),0.29893598205155564,0.9122457148986319,0.6995967741935484,1.0,1.0,27/195,18.62%,FCGR2B;PTGER4;LTB4R2;NFKB1;ADM;RAC1;IL10RB;ANXA1;GPR68;PRDX5;CXCR4;HDAC5;IL22;NFX1;BDKRB2;HDAC4;TBXA2R;HNRNPA0;BLNK;TGFB1;ADCY1;HSPG2;AGTR1;HRH1;CCL25;RELB;SCUBE1
prerank,cellular response to glucose stimulus (GO:0071333),0.3478115217497325,0.912172008667787,0.5987730061349693,1.0,1.0,10/30,22.61%,PTPRN;XBP1;SELENOT;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4;RAB11B;UNC13B
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.21495049712422956,-0.9121067530795848,0.5975609756097561,0.8870133150328112,1.0,16/61,14.52%,PSMB7;AZIN1;CAV1;SIRT1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3553992375492332,0.9120117066553476,0.5879332477535302,1.0,1.0,5/27,16.48%,GPR4;HTR2C;LPAR1;LPAR6;AGTR1
prerank,cellular response to chemical stress (GO:0062197),0.3089760260483684,0.9116525435047017,0.6408376963350786,1.0,1.0,15/96,13.10%,SIRT2;SELENOS;PARP1;MGAT3;DDX3X;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;STX2;PARK7;SOD2;SOD3;SETX
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.33861492494460754,0.911552137460853,0.6133786848072562,1.0,1.0,11/43,19.27%,TAOK1;FZR1;CDC14B;CDK5RAP3;MRNIP;CHFR;BRSK1;FOXN3;MRE11;NABP2;UIMC1
prerank,negative regulation of protein depolymerization (GO:1901880),0.36467707874004446,0.9115246901644244,0.5946291560102301,1.0,1.0,12/24,27.09%,TAOK1;CAMSAP2;PLEKHH2;KATNB1;LIMA1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,energy reserve metabolic process (GO:0006112),0.3753037359557419,0.911480958475699,0.5903614457831325,1.0,1.0,5/19,18.99%,PID1;LEPR;GBE1;MRAP2;PRKAG2
prerank,regulation of MAP kinase activity (GO:0043405),0.3096528871082307,0.9112760062803317,0.6289308176100629,1.0,1.0,13/92,11.30%,MST1R;IL34;EDN3;FGFR1;UCHL1;SNF8;EZH2;HGS;CD24;EGF;CDK5RAP3;PIK3CB;ROBO1
prerank,regulation of macroautophagy (GO:0016241),0.3071011098226153,0.9111674967439141,0.6656441717791411,1.0,1.0,17/105,11.03%,UBQLN1;CLN3;TSC2;ATP6V0A2;UCHL1;SNX5;CDK5;SLC38A9;DCN;SNX6;VPS26B;ATP6V0E2;RRAGA;NRBP2;GPSM1;ATP6V1G1;ATG13
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4152288950191212,0.9110596254607399,0.5908440629470673,1.0,1.0,6/12,21.47%,SEC61A2;SEC61G;SEC62;SEC63;CHMP4A;CHMP4B
prerank,potassium ion export across plasma membrane (GO:0097623),0.4141889859841704,0.9108893884611031,0.5819793205317577,1.0,1.0,2/13,12.11%,KCNT2;KCND3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3205303584701577,0.9097682304418768,0.6228260869565218,1.0,1.0,24/64,25.98%,SFRP1;AJAP1;CASK;MINK1;THY1;PIK3CB;JUP;EMP2;ROCK2;SEMA3E;JAG1;CCL25;PTK2B;NF2;MAP4K4;HOXA7;TSC1;CORO1C;CX3CL1;PTPRA;DUSP3;VCL;SLC9A1;LDB1
prerank,cellular response to hormone stimulus (GO:0032870),0.3146061440218473,0.9094886359492284,0.64340239912759,1.0,1.0,15/69,16.82%,WBP2;SFRP1;XBP1;ATP1A3;ZFP36L1;GAS2L1;ATP1A2;SRA1;BRD8;ROBO2;TFPI;NCOA4;SLIT3;CTSH;UBE2L3
prerank,cellular response to oxidative stress (GO:0034599),0.3024091100254551,0.9091569902520533,0.6587383660806618,1.0,1.0,20/118,13.93%,MAPK9;SIRT2;SELENOS;PARP1;MGAT3;TXNRD1;SLC25A24;PRDX5;PRDX6;ABL1;ARNT;STX2;TPM1;PDGFRA;PARK7;SOD2;SOD3;SETX;DAPK1;MAPT
prerank,heterocycle biosynthetic process (GO:0018130),0.4047002570192942,0.909056616347376,0.611336032388664,1.0,1.0,1/14,1.75%,MOCS2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4081132233100159,0.908999980345416,0.5766526019690577,1.0,1.0,5/13,21.26%,ISCA2;CIAO2A;MMS19;NFU1;ISCA1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.36042703355093153,0.9086401541302682,0.6086956521739131,1.0,1.0,6/25,24.48%,WNT5A;MALT1;LACC1;TRAF2;B2M;TRAF6
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4370729937302492,0.9083975105936011,0.6006144393241167,1.0,1.0,4/10,18.96%,CALM3;NOS1AP;PDE4B;CALM1
prerank,cellular response to cytokine stimulus (GO:0071345),0.29283991515623636,0.9082117200021457,0.794,1.0,1.0,71/416,18.11%,IL10RA;KHSRP;WNT5A;SFRP1;IL34;ADAMTS7;GBP3;NFKB1;HSP90AA1;IFNAR1;IL10RB;STAT6;ANXA1;XBP1;RORA;ZFP36L1;CXCL12;POU2F1;IL31RA;CDK9;IRF1;PIK3R1;GBP7;ZFAND6;ZEB1;CXCR4;RIPOR2;SIRPA;PID1;IL22;LRP8;TXLNA;SOX9;DOCK8;USP10;IFNGR2;EPRS1;TEC;RAPGEF1;TWIST1;PRLR;PIK3CB;PTPN5;BCL2;NFAT5;LEPR;IFNGR1;COL1A2;IL1RAPL1;CD47;DAPK1;SMPD4;GBP6;PTGS2;TGFB1;AQP4;BCL6;CBL;F3;NPR2;PTPN12;ICAM1;IL1RAP;IL5;OXSR1;TANK;TCF7;CCL25;GREM2;JAK1;ERBIN
prerank,regulation of protein dephosphorylation (GO:0035304),0.33707211621626676,0.9081901946402053,0.6018957345971564,1.0,1.0,15/37,21.79%,CALM3;PPP1R2;PPP6R3;HTT;PPP1R16A;TGFB1;CAMTA1;PPP2R5A;TIPRL;CALM1;ARPP19;SMPD1;DLC1;PTBP1;CALM2
prerank,action potential (GO:0001508),0.33336663824105406,0.9075302958829057,0.6108597285067874,1.0,1.0,7/44,13.93%,CLN3;MYH14;SCN7A;YWHAH;SCN1A;ANK3;KCNA1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3527997132076695,0.9073616352554899,0.6114421930870083,1.0,1.0,4/31,13.04%,MOCS2;LSS;PRLR;CYP51A1
prerank,linoleic acid metabolic process (GO:0043651),0.3860881500781582,0.9072593486067645,0.5935828877005348,1.0,1.0,2/17,9.95%,ELOVL1;FADS1
prerank,UV-damage excision repair (GO:0070914),0.4137953208717549,0.9070926785859402,0.5867269984917044,1.0,1.0,6/12,25.49%,DDB1;CUL4B;POLD3;INO80;POLA1;XPA
prerank,Rac protein signal transduction (GO:0016601),0.38352665189360075,0.9069404514791284,0.583554376657825,1.0,1.0,5/18,15.66%,RAC1;CYFIP1;DBNL;WASF1;FARP2
prerank,mRNA modification (GO:0016556),0.3698427169457582,0.9067984336800675,0.5821287779237845,1.0,1.0,3/22,9.92%,TRMT61B;TRUB2;PUS7
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3614439337700067,0.9067928951254074,0.6163522012578616,1.0,1.0,7/26,24.77%,GPLD1;BRSK2;ADCY5;EPHA5;STXBP4;PPP3CB;NR1D1
prerank,regulation of defense response to virus (GO:0050688),0.4065389929983564,0.906699830258454,0.594017094017094,1.0,1.0,2/14,5.04%,TNFAIP3;PPM1B
prerank,double-strand break repair via homologous recombination (GO:0000724),0.30842542737980705,0.9065593611677978,0.6442105263157895,1.0,1.0,20/95,18.10%,KDM4D;XRCC2;RNF138;PARP1;HELQ;NIPBL;PALB2;FBH1;LIG3;SEM1;FANCM;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RAD21;RBBP8
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.31582381973628065,0.9059986595277439,0.6289445048966268,1.0,1.0,19/70,19.40%,DACT2;RAC1;ARL13B;LAMC3;NRP1;LAMC1;PIK3R1;SRGAP2;VAMP3;NTNG2;SRCIN1;ANTXR1;LAMB1;RADIL;TBCD;ATRN;ILK;MEGF9;YTHDF2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3181996790345034,-0.9059005663633876,0.587360594795539,0.900961057060433,1.0,7/16,11.55%,WBP4;SFSWAP;DCPS;SNRNP200;DDX23;WBP11;CWC15
prerank,microtubule depolymerization (GO:0007019),0.3958532623675229,0.9058522993015963,0.6151797603195739,1.0,1.0,2/17,9.89%,STMN4;KATNB1
prerank,positive regulation of apoptotic process (GO:0043065),0.29524689884793964,0.9058427274495459,0.7447447447447447,1.0,1.0,66/293,19.69%,SFRP2;SFRP1;EPHA7;BAX;SIRT2;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;DDX3X;FZD9;CDK5;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;SIK1;DDIT3;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;NUPR1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6;TLE5;OMA1;RASSF2;TGFBR1;PDCD5;PRMT2;SMPD1;SOX4;PLEKHG2;RPS3;FGD4;DLC1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.32922697838077714,-0.9056399543312162,0.605072463768116,0.9000030205182906,1.0,5/14,22.71%,IKBKG;NECTIN2;RAB29;CD81;BCL10
prerank,cellular response to drug (GO:0035690),0.3536707951628777,0.9054300613435315,0.6034271725826194,1.0,1.0,6/25,18.33%,GPLD1;RAP2A;PPM1E;PDE4B;DPEP1;RBM22
prerank,regulation of establishment of protein localization (GO:0070201),0.41204531460361893,0.9052027760865422,0.5892351274787535,1.0,1.0,3/13,14.58%,GAPVD1;SCFD1;CEP120
prerank,recombinational repair (GO:0000725),0.31042155615980904,0.9050540225767473,0.6329787234042553,1.0,1.0,19/77,19.92%,KDM4D;XRCC2;RNF138;PARP1;HELQ;PALB2;FBH1;LIG3;SEM1;YY1;POLN;RMI1;NUCKS1;MRE11;RAD50;NABP2;RBBP8;RECQL5;INO80
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.41976067315917104,0.9044561756804884,0.5830903790087464,1.0,1.0,3/12,13.43%,KDELR3;INSIG1;ANKRD13C
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3890206741971745,0.9040320849176071,0.5804195804195804,1.0,1.0,5/15,22.25%,ENTPD7;AK4;AK5;CMPK1;ENTPD5
prerank,cellular amino acid catabolic process (GO:0009063),0.31055921821471816,0.903740484722399,0.6527196652719666,1.0,1.0,14/87,15.38%,HGD;GLS2;HMGCLL1;AASS;ACAT1;BCAT2;ABAT;GLUL;ALDH4A1;ACADSB;CARNMT1;OGDH;FAH;QDPR
prerank,negative regulation of cell projection organization (GO:0031345),0.3259411684317008,0.9036594753936271,0.6161731207289294,1.0,1.0,17/48,23.90%,SPOCK1;EFNB2;YWHAH;PRAG1;DENND5A;LPAR1;SEMA3A;SPRY2;APOE;GORASP1;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;PTEN;MYLIP
prerank,regulation of filopodium assembly (GO:0051489),0.341134909261871,0.903653149620348,0.6227967097532315,1.0,1.0,8/38,16.79%,ABITRAM;NRP1;PIK3R1;DMTN;RIPOR2;ARAP1;PLPPR5;FMR1
prerank,response to muramyl dipeptide (GO:0032495),-0.34392822871707585,-0.9034692892529969,0.6163934426229508,0.9039956424981951,1.0,3/12,9.34%,VIM;NOD1;CHMP5
prerank,endocytic recycling (GO:0032456),0.3240900518167706,0.9034183941511684,0.6372767857142857,1.0,1.0,17/50,22.68%,ARL4C;RAB11FIP4;SNF8;STX6;ENTR1;RAB13;VPS39;CCDC93;EIPR1;SNX4;EHD1;CMTM6;RAB11FIP3;RAB7A;EHD3;RAB11B;SNX27
prerank,phosphate ion transport (GO:0006817),-0.3191150314396838,-0.9032895865389738,0.5852713178294574,0.9028189628828014,1.0,6/16,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.40485250603626055,0.9032271150445375,0.5997286295793759,1.0,1.0,2/15,4.33%,CDC23;CDC16
prerank,cAMP-mediated signaling (GO:0019933),-0.2769204265459093,-0.9031397767571853,0.6435185185185185,0.9015612770477466,1.0,5/24,6.44%,RAPGEF3;ADGRG6;PDE7A;RIMS2;CAP2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.33626097951450257,-0.9028862542024632,0.5533980582524272,0.900626936268404,1.0,6/12,22.89%,SLC25A3;SLC37A3;SLC20A1;SLC25A14;SLC25A30;SLC25A11
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3289254176048654,0.9028320038901688,0.6264367816091954,1.0,1.0,9/46,15.42%,CLN3;CACNG3;UNC13A;CDK5;ATP1A2;NLGN3;SYT1;NLGN2;CACNG4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3900684818436435,0.9028227888141324,0.5847797062750334,1.0,1.0,2/16,7.40%,KDM4D;WRAP53
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.38788054950313683,0.9027884727979055,0.6283422459893048,1.0,1.0,3/19,9.42%,FIS1;DMTN;STIMATE
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3709313431622865,0.9026482261081615,0.6166666666666667,1.0,1.0,2/22,2.96%,HEXIM1;NR2F2
prerank,nitrogen compound transport (GO:0071705),0.2996480558673589,0.9025906323843689,0.6860346585117227,1.0,1.0,28/141,19.36%,ARRDC4;SLC7A11;PICK1;KIF3A;SLC22A4;SLC7A2;MIA3;RCN3;LMAN2L;CHMP3;SLC6A8;VPS33B;SCAMP5;SLC6A4;SLC18A1;SLC6A15;SLC1A5;SCAMP1;SLC6A12;SLC44A2;TXNIP;SLC6A13;RUFY1;SNX4;LRP1B;TOM1;SCARB2;SLC25A47
prerank,cellular response to osmotic stress (GO:0071470),-0.2855099887281026,-0.9025161421396466,0.6,0.8999153623063311,1.0,4/21,5.58%,RCSD1;CAB39;YBX3;LRRC8D
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4018605812777477,0.9018082555787357,0.5858725761772853,1.0,1.0,1/13,0.96%,LPL
prerank,regulation of fibroblast proliferation (GO:0048145),0.3265232022077015,0.9015414057093257,0.620958751393534,1.0,1.0,4/45,5.54%,WNT5A;SFRP1;IGF1;DDR2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3226896320443148,0.9005653501773548,0.6371986222732492,1.0,1.0,9/45,14.97%,PDPK1;PIK3R1;GAB1;SLC30A10;SOX9;EGF;IQGAP1;TGFB1;CBL
prerank,rRNA methylation (GO:0031167),0.3692168902250459,0.8999645918651928,0.6091954022988506,1.0,1.0,7/22,19.51%,FBL;DIMT1;BUD23;ZCCHC4;TFB1M;METTL5;NSUN4
prerank,amyloid-beta metabolic process (GO:0050435),-0.3121278226985854,-0.8997156844529853,0.5658914728682171,0.9054166604103588,1.0,9/16,23.66%,BACE2;BACE1;NCSTN;MME;ACE;APH1A;APH1B;PSEN2;IDE
prerank,positive regulation of protein maturation (GO:1903319),0.42216168960321904,0.8995206273710881,0.5849923430321593,1.0,1.0,1/11,4.19%,CCBE1
prerank,protein import into mitochondrial matrix (GO:0030150),0.38358889229754173,0.8994326944995817,0.6338939197930142,1.0,1.0,2/18,5.24%,DNLZ;TOMM20
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.22366510494504704,-0.8992824987949388,0.6821705426356589,0.9048388123057312,1.0,8/49,9.95%,STAT3;RIPK1;LBP;NOD1;AFAP1L2;TLR4;LGALS9;RAB1A
prerank,supramolecular fiber organization (GO:0097435),0.29212605779968354,0.8990169983432348,0.772,1.0,1.0,66/333,18.81%,MYO1A;FSD1;COL27A1;STMN4;P4HA1;MFAP4;NEFL;MYO19;RAC1;WHAMM;COL4A6;COL4A5;MYO1B;PLOD1;DDR2;CD151;DBN1;COL22A1;TPPP3;RHOD;CAMSAP2;TNXB;DES;PPP1R9B;PPIB;CLIP3;P4HA2;KATNB1;RHOBTB3;HOOK3;APP;TPM1;CEP126;MYO5A;COL1A2;CRTAP;VPS4B;DNAJB6;MPRIP;USP9X;FBLN5;ZBED3;EMP2;MAPT;ADAMTS3;PXDN;P3H2;COL5A2;FAT1;LUM;GGA2;HSPG2;ITM2B;TMOD2;TPPP;BFSP2;TUBGCP2;RUFY3;COL11A1;MDM2;BMP1;SORL1;CCDC88A;TGFBR1;COL5A3;COL8A2
prerank,protein alkylation (GO:0008213),0.3710035500783775,0.8989806976856404,0.6170483460559797,1.0,1.0,8/22,19.08%,LCMT1;ETFBKMT;PRMT1;GSPT1;FAM98A;PRMT8;PCMT1;PRMT2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3375184082118841,0.8988840500798015,0.632748538011696,1.0,1.0,4/36,6.64%,WNT5A;FZD3;TCF7L2;GNG2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.36655296538365706,0.898752878954394,0.6121673003802282,1.0,1.0,4/20,14.28%,NFKB1;HM13;MBTPS1;TGFB1
prerank,establishment of mitotic spindle localization (GO:0040001),0.3489088785535641,0.8983108917258898,0.6197352587244284,1.0,1.0,10/28,23.05%,MAD2L1;KPNB1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CLASP2;CDK5RAP2
prerank,regulation of actin filament polymerization (GO:0030833),0.3121770325594248,0.8979047012306351,0.658669574700109,1.0,1.0,10/69,9.63%,CDC42EP5;CDC42EP4;ABITRAM;BIN1;GBA2;PAK3;DBN1;SSH1;BAIAP2;DBNL
prerank,stem cell development (GO:0048864),0.3907536397657706,0.8976876476037957,0.6024590163934426,1.0,1.0,4/16,14.04%,KLHL12;PEF1;SOX11;NRG1
prerank,response to peptide hormone (GO:0043434),0.3361802020757712,0.8975137556499496,0.6440677966101694,1.0,1.0,6/43,6.72%,STAT6;ANXA1;XBP1;ZFP36L1;OGT;ZBTB7B
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2926867861902039,0.8974165707924244,0.7449596774193549,1.0,1.0,45/208,19.94%,WNT5A;SLC35B2;PDPK1;MAP3K14;ATP2C1;EDAR;RORA;EDA2R;TNFAIP3;TIRAP;OTUD7A;PPM1B;CARD16;TMEM106A;BRD4;SQSTM1;ZFAND6;CC2D1A;TIFA;TRIM62;GPRC5B;USP10;PER1;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;TANK;TNIP1;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1
prerank,neuron remodeling (GO:0016322),0.4249116346210324,0.8972288967954403,0.6077265973254086,1.0,1.0,4/10,18.42%,EPHA8;APP;FARP2;ADGRB3
prerank,nucleotide-excision repair (GO:0006289),0.2998193287230981,0.8965206200878851,0.6756756756756757,1.0,1.0,17/101,13.72%,COPS7A;LIG1;PARP1;USP7;POLR2B;DDB1;LIG3;COPS7B;SLC30A9;CUL4B;GTF2H3;TCEA1;BRIP1;POLR2K;CCNH;MMS19;POLD3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2687923813795171,-0.8963211158027363,0.6398104265402843,0.9104076800063712,1.0,9/23,23.37%,DAB2IP;DVL3;MAP3K10;ARHGEF5;TNFRSF11A;MAP3K4;TAOK3;MAP3K5;SASH1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.35977343507806225,-0.8962487326936719,0.6051873198847262,0.908967441107978,1.0,3/10,11.48%,RNF13;NBR1;FAS
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.21880965176840836,-0.8958412722118726,0.6696428571428571,0.908311898483949,1.0,14/50,14.52%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3
prerank,receptor signaling pathway via STAT (GO:0097696),0.3585979616693516,0.895782628896042,0.6259351620947631,1.0,1.0,3/25,4.92%,IFNAR1;STAT6;IL31RA
prerank,protein localization to plasma membrane (GO:0072659),0.29951343951355475,0.895004053332674,0.6927772126144456,1.0,1.0,35/129,18.86%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;GORASP1;CCDC88A;ZDHHC2;PIP5K1A;FLOT1;ASB3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3426309626580001,0.8947889036530806,0.5995115995115995,1.0,1.0,7/31,19.75%,CDKN2D;WEE1;RBL2;CDC73;PKD2;PRMT2;KLF4
prerank,cardiocyte differentiation (GO:0035051),0.4266118155949632,0.8947140200115318,0.622093023255814,1.0,1.0,4/10,16.74%,SIK1;AKAP13;NRG1;KDM6B
prerank,postsynaptic membrane organization (GO:0001941),0.3831489400679981,0.8946966826205272,0.6260053619302949,1.0,1.0,5/17,17.19%,LRRC4;MUSK;NLGN3;NLGN2;APOE
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3001651412453574,0.8946182671386408,0.7009345794392523,1.0,1.0,22/110,17.95%,BBS10;BAX;LCMT1;HSP90AA1;WARS1;SAR1A;DDX3X;TIRAP;NCLN;SLF2;VCP;PEX5;PARK7;RACK1;NRG1;TGFB1;IMPACT;FAF1;FARP2;TPPP;APOE;SORL1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.36009139506877974,0.8942888385202034,0.6195928753180662,1.0,1.0,3/25,6.61%,EPHB2;ERRFI1;SNX6
prerank,monosaccharide transmembrane transport (GO:0015749),0.3933442937523195,0.8941695135231149,0.6253521126760564,1.0,1.0,2/16,11.44%,SLC5A3;SLC50A1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3101896030785828,0.8939617999212932,0.6595059076262084,1.0,1.0,16/72,17.19%,RAC1;NRP1;FLCN;ABL1;RIPOR2;ARRB1;GPR4;PRAG1;ADGRG1;ROBO1;AKAP13;LPAR1;LPAR6;EPS8L1;RIT2;APOE
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.33662208865521964,-0.8935987771314302,0.6129032258064516,0.9122355180322449,1.0,3/12,17.38%,RBP4;TLR4;STRAP
prerank,regulation of cellular component organization (GO:0051128),0.298312092644892,0.893536950293121,0.7051020408163265,1.0,1.0,33/135,21.11%,WNT5A;BBS10;TSC2;HSP90AA1;NCLN;NUBP1;ABL1;RASGRP2;STK11;CAMSAP2;PACSIN3;SPOCK1;RAB5B;NRG3;RAPGEF1;AP2S1;SETD1A;CAMK2D;PARK7;EGLN2;ROCK2;RUFY1;AGTR1;RIT2;APOE;DCUN1D5;ZFYVE16;SETD5;CDK11B;MLLT3;HNRNPU;PAK5;SGK3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3795111389008497,0.8935330876902451,0.6077127659574468,1.0,1.0,5/18,15.72%,FIS1;DCN;MIEF2;DNM1L;SPIRE1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.4338513393928272,0.8934504592688297,0.6076696165191741,1.0,1.0,3/10,20.88%,MALT1;RC3H2;SMAD7
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.31897662219135037,0.8934437198754582,0.6178128523111612,1.0,1.0,6/47,6.44%,RAC1;FBLN1;NRP1;ABL1;ARHGEF7;DMTN
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.33668811246701674,0.8934306305037157,0.6269368295589988,1.0,1.0,4/36,8.94%,HDAC3;FOXM1;SIRPA;PER1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.21721768198068028,-0.8933608282571385,0.6633663366336634,0.9111432215351158,1.0,26/53,30.52%,PSMB7;AZIN1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;OAZ1;OAZ2;PSMD2;PSMB3;PSMC3;PSMD3;PSMD8;BCKDK;ODC1;PSME3;PSMB4;PSMC4;PSMB6;PSME1;PSMB5;PSME4
prerank,T-helper cell differentiation (GO:0042093),0.38464836999093927,0.8928760229602346,0.5882352941176471,1.0,1.0,1/14,1.14%,PTGER4
prerank,cell projection assembly (GO:0030031),0.3563543244158153,0.8923782941756842,0.6086387434554974,1.0,1.0,3/22,8.36%,RAC1;NEFH;CYFIP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.41912949830084056,0.8919768847298826,0.6131934032983508,1.0,1.0,4/11,20.46%,PRKCA;ANK3;JAK1;LYN
prerank,regulation of T cell proliferation (GO:0042129),-0.21533172716880208,-0.8919426787997572,0.7472527472527473,0.9129925235913189,1.0,13/61,30.13%,CD46;SLC7A1;NCK1;SDC4;PTPRC;TNFRSF1B;CEBPB;NCKAP1L;PNP;CD80;CD274;NCK2;CD86
prerank,endochondral bone morphogenesis (GO:0060350),0.4121637793013809,0.8919374861432777,0.5953420669577875,1.0,1.0,1/11,1.00%,TMEM119
prerank,pre-miRNA processing (GO:0031054),0.3967109838594931,0.8919146198122231,0.5918079096045198,1.0,1.0,3/14,12.58%,TARBP2;LIN28B;AGO3
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3894043969089098,0.8918136756007726,0.5969101123595506,1.0,1.0,2/15,4.02%,ANXA1;ZFP36L1
prerank,regulation of protein metabolic process (GO:0051246),0.32825879852159073,0.8917794732804193,0.6396713615023474,1.0,1.0,14/44,19.75%,SNF8;HGS;SSH1;ABCA7;APP;ROCK2;FAF1;CHEK2;NEDD8;PARL;APOE;MDM2;ZDHHC2;KLF4
prerank,regulation of response to stress (GO:0080134),0.42488508588250584,0.8917316493421397,0.6024279210925645,1.0,1.0,1/10,4.10%,MLC1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.39274772329224356,0.8915556790958596,0.5961272475795297,1.0,1.0,4/14,22.93%,ANXA1;MALT1;PRKCZ;IL18
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.16960338840107678,-0.8913591982643331,1.0,0.9128109007916924,1.0,124/306,30.16%,EPC1;MEF2A;KAT7;PTMS;RPS24;ORC4;ST3GAL4;ABCF1;AGO2;RPL11;RRAGC;CREBL2;TIPIN;RPS15A;RPS23;RPL5;EEF2;RPL37A;RPL6;RPL18A;RPA1;RPL24;NBN;RPS19;RPS20;RPL38;RPL8;RPL19;RPL21;RPL3;NT5M;SRBD1;POLR3A;RPS16;REV1;RPS6;RPS18;RPL28;RPL22;RPL34;RPS13;RPLP0;EEF1A1;RPL36;RPL10;RPL32;RPS28;UPF1;RPS5;MRPL42;RPL15;RPS2;RNPS1;RPL39;RPL12;RPL27;RPS17;MRPS21;MED20;RPS26;RPS27;RPL10A;GTPBP1;MRPL52;DARS1;BLM;RPS10;MRPS18A;MRPS15;EEF1D;DTX1;RPL7A;MRPS33;ATRIP;MRPS18C;ING5;PWP1;ORC5;TBRG1;MCM6;RAD9B;MRPL27;RPL31;WRN;RFC2;RPL36A;RPL29;HUS1;FUBP3;NR4A2;RPS14;DHPS;INHBA;MRPL9;POLR2H;FAM111A;BCL3;CDK2;RPS6KB2;TSFM;RPL41;POLA2;RPL35;TERT;MRPL51;POLR2G;POLR2F;RHNO1;MRPL32;POLR2C;MRPS14;DUT;POLE2;CLSPN;PAX8;CDC7;MRPS7;KAT5;MCM4;MRPL18;IGHMBP2;MRPL43;IGF2BP3;RAD1
prerank,negative regulation of cellular component movement (GO:0051271),-0.3117543811556087,-0.8913352148813515,0.6029411764705882,0.9112594907865156,1.0,3/15,5.70%,FRMD5;ACTN1;SP100
prerank,cristae formation (GO:0042407),0.3507099122459257,0.8911646023729551,0.6142131979695431,1.0,1.0,5/27,10.62%,APOOL;ATP5PF;APOO;ATP5MC3;AFG3L2
prerank,RNA destabilization (GO:0050779),0.3788769005410525,0.8911635375360409,0.6190476190476191,1.0,1.0,9/18,22.24%,CELF1;LIN28B;YTHDF3;YTHDF1;ROCK2;ZC3H18;FTO;YTHDF2;METTL14
prerank,regulation of DNA replication (GO:0006275),-0.221101085642298,-0.8907816117148267,0.7033898305084746,0.9110874110346773,1.0,7/49,7.16%,WAPL;ANKRD17;EGFR;KAT7;RBBP6;BCAR3;STN1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3008808280959283,0.8899423478916516,0.6868475991649269,1.0,1.0,16/99,14.79%,CPEB1;SFRP1;XBP1;ZFP36L1;SLC38A9;DMTN;RRAGA;SOX9;SSH1;CAPN2;RAPGEF1;GABRB3;JUP;LAMTOR5;GLRA1;IMPACT
prerank,positive regulation of TOR signaling (GO:0032008),0.3328690854173137,0.8898382764905085,0.6332945285215367,1.0,1.0,5/40,7.73%,HDAC3;SLC38A9;FLCN;RRAGA;GPR137C
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3626476480719788,0.8898292530127545,0.6288659793814433,1.0,1.0,5/22,10.85%,EDEM1;SYVN1;MAN1A2;EDEM3;UGGT2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3330544457773151,0.889681966924593,0.6510538641686182,1.0,1.0,6/38,8.94%,RORA;TNFAIP3;OTUD7A;PPM1B;USP10;PER1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3505842790005785,0.8896320158799208,0.6228070175438597,1.0,1.0,5/28,11.07%,BAX;ITPR1;BRSK2;DDIT3;BCL2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.23343776888434437,-0.8894564148061195,0.6793893129770993,0.9128056852786838,1.0,13/43,22.64%,MEF2C;ACVR1;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;HES1;CCDC39;SOX17;MICAL2;TBX2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4010696054616089,0.8893436734611214,0.6173020527859238,1.0,1.0,4/13,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.22994722626251543,-0.8892629791863713,0.6814159292035398,0.911669935608108,1.0,17/45,24.63%,SLC25A13;MTHFR;GOT2;FOLH1;THAP4;MTHFD1;GLS;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;MTRR;DDAH2;ALDH18A1
prerank,histone deubiquitination (GO:0016578),-0.2995834591133734,-0.8892024213648801,0.6228070175438597,0.9102201880692711,1.0,4/18,5.34%,TRRAP;BRCC3;ATXN7;USP36
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2465593252999575,-0.8891544133883704,0.6648936170212766,0.9087159199987459,1.0,5/33,5.21%,FOXO3;MED1;STAT3;STAT1;HIF1A
prerank,regulation of signal transduction (GO:0009966),0.2911753414152643,0.888623762687561,0.7416750756811302,1.0,1.0,41/190,18.59%,GSKIP;CDKN2AIP;TSC2;FGFR2;DCDC2;GNG7;CD63;RORA;BRAP;OGT;NCLN;SULF1;SRMS;TMEM108;CD24;ZDHHC3;PTCH1;PRAG1;YWHAG;GDNF;APP;GRK3;RIC8B;IGFBP3;IGFBP7;GIT1;CBFB;MTCH1;TGFB1;TULP3;GRK2;NUCKS1;TCF7L1;FRRS1L;SNW1;ITGB1BP1;USP33;ZDHHC17;ILK;SYNJ2BP;CDC42SE2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.31733067398474735,-0.8885497586942576,0.5972222222222222,0.9086477935365831,1.0,5/15,24.20%,ATP1A1;KCNJ2;ATP1B1;KCNJ3;KCNQ1
prerank,regulation of synapse maturation (GO:0090128),0.4262681413635946,0.8882713494409893,0.6349206349206349,1.0,1.0,2/10,6.19%,CAMK2B;ANAPC2
prerank,protein targeting to lysosome (GO:0006622),0.36517363714606554,0.888210602658084,0.5981554677206851,1.0,1.0,8/20,22.09%,HGS;NCOA4;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.21488062066876484,-0.8880930158936576,0.7368421052631579,0.9081101921435608,1.0,23/59,27.54%,DAB2IP;IKBKB;IRAK2;RIPK1;ERC1;NFKBIA;TLR4;UBB;IKBKG;ROCK1;TNFRSF1A;RNF31;IRAK1BP1;FAIM;TBK1;AKT1;NFKBIL1;PRDX4;BCL10;BCL3;BIRC2;SHARPIN;TLR7
prerank,receptor-mediated endocytosis (GO:0006898),0.29634548292125457,0.8876207478399526,0.7274590163934426,1.0,1.0,27/132,17.97%,FCGR2B;CLN3;PDLIM7;DNM1;ADM;HSP90AA1;TMEM108;SPARC;VLDLR;DNAJC6;AP2S1;GRK3;HSPH1;NLGN3;IGF2R;PI4KB;WASF1;LRP1;GRK2;DNAJC13;RAB31;HSPG2;SNAP91;AP4E1;APOE;SORL1;LRP1B
prerank,keratan sulfate biosynthetic process (GO:0018146),0.35373555275585017,0.8876122306703531,0.6222509702457956,1.0,1.0,6/26,15.67%,SLC35D2;ST3GAL2;ST3GAL3;B4GALT5;OMD;LUM
prerank,negative chemotaxis (GO:0050919),0.3382280201299411,0.887610842543466,0.6343825665859564,1.0,1.0,8/33,15.56%,EPHA7;SEMA3D;ROBO1;UNC5C;SLIT1;SLIT3;SEMA3E;SEMA3A
prerank,regulation of isotype switching (GO:0045191),-0.32104369428283686,-0.887522122489996,0.5963636363636363,0.9077735191110883,1.0,3/14,17.03%,SHLD2;PAXIP1;SLC15A4
prerank,positive regulation of telomere capping (GO:1904355),0.384223584656789,0.8875155673572998,0.6095238095238096,1.0,1.0,4/17,17.42%,PKIB;HNRNPD;TNKS;NABP2
prerank,protein localization to chromosome (GO:0034502),-0.24799261421192131,-0.8875092322537175,0.7222222222222222,0.9062057701815878,1.0,8/34,14.89%,WAPL;XRCC4;RB1;RPA1;TPP1;MSH2;SLF1;ESR1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3755131164323485,0.8874437783839745,0.6137281292059219,1.0,1.0,3/17,6.44%,SIRT2;CALM3;DMTN
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3195759000905081,0.8872062710182743,0.6483762597984323,1.0,1.0,14/52,16.84%,DDX17;SRSF12;CELF2;CELF1;KHDRBS2;RBFOX2;HNRNPL;TRA2B;NOVA1;CELF5;DDX5;YTHDC1;FMR1;THRAP3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.3062696509946989,0.8871471803348839,0.6825568797399784,1.0,1.0,15/72,15.93%,FOXM1;BAX;PCBP4;TFDP1;CNOT10;USP10;MDM4;NDRG1;RBL2;CNOT9;PRMT1;ATRX;CNOT6;CASP2;CHEK2
prerank,autophagosome organization (GO:1905037),0.3181902110618251,0.8871179385534814,0.6522234891676169,1.0,1.0,17/50,22.68%,UBQLN1;UBXN2A;WIPI1;ATP2A2;ATG14;ATG2A;ATG13;ATG3;MAP1LC3B;VMP1;PIK3C3;ATG9A;AMBRA1;RAB7A;ATG16L2;RAB43;WIPI2
prerank,ceramide biosynthetic process (GO:0046513),0.32487034067298576,0.8869299913686973,0.6304604486422668,1.0,1.0,8/40,14.35%,ST8SIA3;SMPD2;CERS2;ST3GAL5;SPTSSA;TLCD3B;SMPD4;ST6GALNAC6
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.39921300687145356,0.88675787678693,0.5880597014925373,1.0,1.0,4/12,20.27%,SFRP1;HDAC1;NCOR2;DAB2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.29207880162737,-0.8866166099773252,0.6090909090909091,0.9067146561554226,1.0,8/19,22.61%,CAT;MAOB;NOX1;PRDX2;CYBA;GPX1;PRDX3;PRDX4
prerank,regulation of autophagosome assembly (GO:2000785),0.3422005248475767,0.8865828374028643,0.636471990464839,1.0,1.0,17/33,25.99%,PHF23;PIP4K2B;SCFD1;IFT20;FEZ2;PIP4K2A;PIP4K2C;NUPR1;RAB3GAP2;NPRL2;CHMP4A;CHMP4B;PIKFYVE;SH3GLB1;MTM1;NPRL3;TBC1D14
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.28862761518856056,-0.8863308529411159,0.6,0.9057786852113482,1.0,5/20,8.34%,PICALM;TMEM59;BCL2L1;NUMB;CSK
prerank,mononuclear cell differentiation (GO:1903131),-0.2673063023415486,-0.8859069398426511,0.6212765957446809,0.9052127726239184,1.0,8/24,22.05%,AXL;PIR;MT1G;THOC5;BMP4;IKZF1;VEGFA;PPARG
prerank,mitochondrial translation (GO:0032543),0.3010690146784905,0.8857190119247698,0.6903023983315955,1.0,1.0,25/104,20.20%,MRPL36;MTRF1L;MRPL17;NDUFA7;MRPL19;GATB;GADD45GIP1;EARS2;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;HARS1;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;IARS2;MRPS6;OXA1L;MRPS24
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.33924621938740107,-0.8856625814699874,0.595679012345679,0.9041859241183817,1.0,4/11,25.97%,TWSG1;LGALS9;VSIR;CD274
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4187664410563529,0.8856303682324027,0.6142208774583964,1.0,1.0,2/10,8.37%,FGFR2;SOX9
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3034796185243052,0.8856219848365915,0.6812366737739872,1.0,1.0,9/86,10.71%,PSRC1;CDC42EP5;CDC42EP4;BIN1;RAC1;BAIAP2;DRG1;KATNB1;APP
prerank,negative regulation of protein modification process (GO:0031400),0.30454455043600664,0.8855625978186135,0.6964477933261571,1.0,1.0,22/79,19.02%,EPHB2;WARS1;FBLN1;ATG14;SIRPA;PID1;CDK5RAP3;IGFBP3;CDYL;PARK7;CRTAP;PLPP3;ZBED3;MAPT;TGFB1;FKBP8;IMPACT;TPPP;DNAJC10;TERF2IP;PRKAA1;ARPP19
prerank,icosanoid metabolic process (GO:0006690),0.3292509051292495,0.8852453682331249,0.6339181286549708,1.0,1.0,9/40,20.61%,ALOX5AP;PON2;PON3;FADS1;PTGS2;DPEP1;GPX4;PTGS1;MAPKAPK2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2232228741682734,-0.885022007080064,0.6792452830188679,0.9041531378446671,1.0,13/54,14.52%,UBE2K;IKBKB;RIPK1;HIPK1;OTULIN;CYLD;CASP4;TAX1BP1;IKBKG;MADD;TNFRSF1A;PYDC1;RNF31
prerank,carbohydrate homeostasis (GO:0033500),-0.2104742848106626,-0.8849320098477982,0.7215189873417721,0.9027781568117468,1.0,13/67,14.55%,IGF1R;CYB5R4;STAT3;IRS1;BACE2;RBP4;INPP5K;ADIPOR1;SLC8B1;RPS6;MCU;PRKAA2;ADIPOR2
prerank,negative regulation of transport (GO:0051051),0.3182659143196907,0.8844784467383933,0.649379932356257,1.0,1.0,16/51,22.31%,FCGR2B;SIRPA;PACSIN3;EGF;ABCA7;SNX33;RACK1;SCAMP5;NRG1;NDFIP2;MCTP1;ITGAV;SYT11;RAB7A;PPM1F;PXK
prerank,positive regulation of transferase activity (GO:0051347),0.2931944959719921,0.8842068374613961,0.7139959432048681,1.0,1.0,27/142,17.95%,ARRDC4;MST1R;EPHA7;PKIB;EPHB2;HSP90AA1;FGFR2;FGFR1;DDR1;DDR2;EPHA8;WRAP53;HNRNPD;EPHA10;MUSK;PDGFRA;ROR2;HNRNPA2B1;TGFB1;MRE11;RAD50;TNKS;UBE2L3;EPHA5;TOPORS;DCUN1D5;SORL1
prerank,tryptophan catabolic process (GO:0006569),-0.35057435189253655,-0.8838932566502358,0.6233766233766234,0.9037368686275039,1.0,11/11,64.97%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3060020446863513,-0.8836710684211486,0.5993150684931506,0.9011304859840532,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,stress fiber assembly (GO:0043149),-0.3060020446863513,-0.8836710684211486,0.5993150684931506,0.9011304859840532,1.0,5/15,16.99%,SORBS1;SRC;KCTD13;ITGB5;ZYX
prerank,sphingolipid metabolic process (GO:0006665),0.2964474818403683,0.8836630897343849,0.6931106471816284,1.0,1.0,23/108,19.67%,B3GALNT1;ELOVL1;SMPD2;GBA2;GLB1;ABCA2;CERS2;SGPL1;ELOVL4;ENPP2;SPTSSA;TEX2;PLPP3;PSAP;SMPD4;ST6GALNAC6;VAPB;ALDH3A2;GALC;PRKD2;ELOVL6;SMPD1;PDXDC1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4044344666291429,0.8835334800890142,0.614138438880707,1.0,1.0,4/12,16.41%,SRM;SMS;AMD1;TRH
prerank,anterograde trans-synaptic signaling (GO:0098916),0.28873643484008044,0.8831366840440125,0.7717717717717718,1.0,1.0,41/224,18.29%,SYT10;CACNB4;GRIN1;PDE7B;OPRK1;MINK1;CDK5;HCRTR2;GRIN2A;SDCBP;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;HCRTR1;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,mitochondrion distribution (GO:0048311),0.40672407143855255,0.8831180642021765,0.6432664756446992,1.0,1.0,5/12,18.34%,MSTO1;MAPT;DNM1L;TRAK1;ATCAY
prerank,lymphocyte migration (GO:0072676),-0.2523220315654269,-0.8831006937419552,0.6721311475409836,0.900896721272805,1.0,6/32,25.67%,CCL15;S1PR1;MSN;CCL13;CKLF;RET
prerank,non-motile cilium assembly (GO:1905515),0.3387071631480921,0.8829275791480806,0.6481927710843374,1.0,1.0,7/30,14.82%,BBS10;ARL13B;PIBF1;TTC8;DISC1;CSNK1D;TMEM216
prerank,synaptic vesicle endocytosis (GO:0048488),0.3366083816375947,0.8827885331014508,0.6498237367802585,1.0,1.0,8/33,16.22%,DNM1;SYNJ2;CDK5;DNAJC6;NLGN3;SYT1;NLGN2;SNAP91
prerank,positive regulation of synapse assembly (GO:0051965),0.347318093463358,0.8827711627409585,0.6322418136020151,1.0,1.0,9/27,22.99%,EPHB2;CLSTN2;IL1RAPL1;NLGN3;NLGN2;IL1RAP;CLSTN3;DLG5;AGRN
prerank,regulation of protein transport (GO:0051223),0.3471737911249343,0.8826768815248257,0.6496894409937888,1.0,1.0,5/27,16.04%,LCP1;GAPVD1;SCFD1;RHBDF1;NDFIP2
prerank,mesenchymal cell development (GO:0014031),0.37391604816647545,0.8825200775750763,0.6330645161290323,1.0,1.0,4/18,14.04%,KLHL12;PEF1;SOX11;NRG1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.42486712517061587,0.8822309263703968,0.6034985422740525,1.0,1.0,4/10,21.08%,ATP1A2;CAMK2D;OSR1;HECW2
prerank,apical junction assembly (GO:0043297),-0.21815415332318683,-0.8815737053921694,0.7433628318584071,0.9029766542225612,1.0,16/53,29.36%,PARD3;PECAM1;CLDN5;ESAM;F11R;OCLN;RAMP2;CLDN14;RHOC;DLG1;ARL2;RHOA;STRN;CLDN1;PAK2;PKN2
prerank,defense response to bacterium (GO:0042742),-0.19469764667443007,-0.8813514756441831,0.7647058823529411,0.9019265987304113,1.0,19/105,20.09%,ANKRD17;DROSHA;IL6R;ANXA3;PRKCD;RNASE3;LBP;NOD1;TLR4;RPS19;RAB1A;DEFA6;RPL39;MAVS;IRGM;CEBPB;PLA2G6;GBP2;PGLYRP1
prerank,positive regulation of calcium ion transport (GO:0051928),0.33066069940784615,0.8813189589874131,0.648936170212766,1.0,1.0,4/36,8.98%,GRIN1;CXCL12;ATP2B1;CRACR2A
prerank,regulation of astrocyte differentiation (GO:0048710),0.396556733665001,0.8812880827288764,0.6057553956834533,1.0,1.0,1/12,2.40%,BIN1
prerank,synaptic vesicle transport (GO:0048489),0.4128531948722446,0.8811030334304316,0.6099706744868035,1.0,1.0,4/11,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,positive regulation of JNK cascade (GO:0046330),0.3075303872626896,0.8810460248664874,0.6760869565217391,1.0,1.0,9/70,10.71%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.30371060770849606,0.8809922430254079,0.6937901498929336,1.0,1.0,13/77,13.66%,IGF1;PPIF;CSNK2A2;DDX3X;FZD9;TCF7L2;PRELID1;CAAP1;BCL2;MAZ;RTKN2;PARK7;HTT
prerank,protein K48-linked ubiquitination (GO:0070936),0.3129723883125078,0.8806430221895305,0.6611842105263158,1.0,1.0,14/54,17.56%,RNF8;UBE2E2;SYVN1;TNFAIP3;FBXO38;RFFL;RNF152;UBE2A;UBE2E1;UBE2D1;ARIH2;UBR5;TOPORS;TTC3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.35182091027170775,0.8804848030008053,0.638676844783715,1.0,1.0,3/24,7.11%,VTN;ARNT;HGS
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.29538812144621324,0.8804778561487124,0.7047325102880658,1.0,1.0,35/109,24.48%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,negative regulation of JNK cascade (GO:0046329),0.34054576232272454,0.8804586305055785,0.6420047732696897,1.0,1.0,5/31,13.55%,HDAC3;MAPK8IP1;SIRPA;PER1;PTPN22
prerank,regulation of stem cell differentiation (GO:2000736),0.3044417680168793,0.8803028629598771,0.7061909758656874,1.0,1.0,25/89,21.81%,SP7;PSMD4;ABL1;PSMB10;PSMD11;PUS7;GDNF;PSME2;PSMC5;SETD1A;PDGFRA;NUDT21;CBFB;PSMD1;TCF3;JAG1;PSMD6;OCIAD1;KMT2A;YTHDF2;PSMD5;HNRNPU;PSMA4;PSMA1;PSMC6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3340965313680678,0.8798491903250569,0.6519666269368296,1.0,1.0,7/35,16.60%,CCT8;PKIB;CCT6A;DHX36;ATR;HNRNPA2B1;TNKS
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3569669531007952,0.8796556171929757,0.6484076433121019,1.0,1.0,6/22,21.79%,CALM3;HTT;VMP1;PKD2;CALM1;CALM2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.37518049910504986,0.879637331795121,0.638268156424581,1.0,1.0,9/18,23.15%,RIPOR2;RACK1;ROCK2;RUFY3;KIF20B;KRIT1;PTK2B;LLGL1;RAP1B
prerank,DNA geometric change (GO:0032392),0.3553116015551408,0.8794632476810205,0.6383526383526383,1.0,1.0,7/24,19.19%,HMGB3;ANXA1;DHX36;HNRNPA2B1;MRE11;RAD50;RECQL5
prerank,regulation of vasoconstriction (GO:0019229),0.3478831007001143,0.8792554242195109,0.6316440049443758,1.0,1.0,4/27,10.66%,ADM;BDKRB2;ATP2B1;TBXA2R
prerank,snRNA transcription (GO:0009301),0.3018600266930755,0.8790438001777358,0.6781857451403888,1.0,1.0,26/70,24.78%,RPRD2;USPL1;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,regulation of intracellular signal transduction (GO:1902531),0.28382502166941914,0.8789692566653078,0.849,1.0,1.0,113/420,22.25%,FSHR;WNT5A;ATP6AP2;ARAF;PDPK1;PIP4K2B;CSNK2A2;RAC1;TAF9B;USP7;TAOK1;PTPMT1;BRPF1;TAF4;MINK1;CDK5;RBBP4;FLCN;SYDE2;ARHGAP20;TBP;NUAK1;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;BARD1;ARHGEF7;PAK3;ARHGEF4;ZFAND6;STK11;RHOD;KALRN;RFFL;CD24;MCF2;RCN3;XIAP;EHMT2;MDM4;PRMT5;ARHGAP21;VAV2;USP2;ARHGAP24;TAF6;PIK3R2;MTA2;BRIP1;ARAP1;HDAC1;RMI1;PLEKHG5;FAM13A;ATR;AKAP13;EHMT1;PIP4K2A;PTPN22;MAPT;ARHGAP29;RNF41;AKAP12;PIP4K2C;MRE11;TRIO;CHEK2;ARHGEF6;RAD50;TP53RK;RIT2;DAXX;MDM2;FBXO9;TOP3A;PRKD2;RBBP8;RASSF2;PRKAR1A;PIP5K1A;PRKAA1;BANP;BIRC3;PRKAG2;NRK;PLEKHG2;FGD4;DLC1;WWC1;MYO9A;STARD13;ARHGAP6;LYN;CHN1;PEX5L;ITGAV;PAK5;NTRK2;NF2;PREX1;SRGAP1;TAF2;MAPKAP1;MAP4K4;RHOU;ARHGAP26;ARHGAP35;TELO2;TRAF2;TAF1;PJA2;ENTPD5
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.2639314446389925,-0.8787708700356149,0.6512820512820513,0.9064408111966373,1.0,8/25,18.27%,SMAD4;UBE2O;ENG;BMPR1A;ACVR2B;BMPR1B;BMP4;CCN1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.31543834840586915,0.8787330582144285,0.6670416197975253,1.0,1.0,18/53,21.45%,RNF8;FGF10;FBH1;EEF1E1;WRAP53;RNF168;NACC2;CEBPG;ATR;EYA2;BCLAF1;DDX5;FMR1;UIMC1;RPS3;EYA1;PLA2R1;NPAS2
prerank,ncRNA export from nucleus (GO:0097064),-0.23732302879525793,-0.8785895187343464,0.7105263157894737,0.9053306150161263,1.0,13/36,17.56%,NUP160;XPOT;NUP205;PHAX;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,glycolytic process (GO:0006096),0.3446492924688416,0.8785592628295942,0.6487804878048781,1.0,1.0,4/28,11.10%,HKDC1;PGAM4;PGAM1;ENO2
prerank,metal ion transport (GO:0030001),-0.19280586015979667,-0.8784880376675547,0.803921568627451,0.9039896666738029,1.0,25/86,21.81%,CACNA1D;NIPA2;CAV1;MRS2;SLC3A2;CACNA2D1;TRPC3;TRPC1;CACNA1C;NDFIP1;SELENOK;RAMP2;NIPA1;SLC39A8;TRPC4;CHRNA7;TRPM7;TRPC5;MAGT1;FYN;PANX1;TPT1;CALCRL;CACNG8;CAMK2A
prerank,smooth muscle contraction (GO:0006939),-0.31635253408131025,-0.8784134017444353,0.6161616161616161,0.9026124120584932,1.0,8/14,30.00%,EDNRA;SMTN;TPCN2;ROCK1;ADRA1A;MYH11;ACTA2;SLC8A1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3188776880026225,0.8777945238406576,0.6735632183908046,1.0,1.0,5/42,6.13%,SFRP1;RAC1;NRP1;ABL1;THY1
prerank,determination of left/right symmetry (GO:0007368),0.32824524395169463,0.8775897562676076,0.6595744680851063,1.0,1.0,8/36,23.23%,BBS7;ZIC3;RFX3;OFD1;MEGF8;PKD2;DAND5;KIF3B
prerank,purine-containing compound salvage (GO:0043101),0.40308229440847293,0.8774654236636171,0.6456241032998565,1.0,1.0,4/12,21.40%,DCK;HPRT1;GMPR2;ADK
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3419231711419809,-0.8774431611792376,0.6086956521739131,0.9033472973331166,1.0,2/11,1.67%,IP6K2;PPIP5K1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.38669976160467096,0.8773848967353268,0.6357243319268636,1.0,1.0,5/15,20.15%,EDEM1;RAB10;ZFAND2A;SEC61G;RAB3GAP2
prerank,response to iron ion (GO:0010039),0.3971261742088482,0.877329373177017,0.6051136363636364,1.0,1.0,4/12,22.07%,BMP6;BCL2;SLC11A2;B2M
prerank,negative regulation of nuclear division (GO:0051784),0.41006738502182855,0.8764584256891249,0.630057803468208,1.0,1.0,2/11,8.26%,FBXO5;AURKAIP1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.2963660218438268,0.8764223786216219,0.6892177589852009,1.0,1.0,22/95,20.33%,CHPF;HS2ST1;SLC35D2;ST3GAL2;GPC6;NDST2;DCN;ST3GAL3;GPC1;CHSY3;HS6ST2;B4GALT5;GPC4;OMD;LUM;HSPG2;EXT2;CEMIP;DSE;GPC5;HS3ST1;GCNT2
prerank,cellular protein modification process (GO:0006464),0.28138379935431396,0.8763287439659201,0.944,1.0,1.0,196/983,19.00%,AATK;ILF3;COPS7A;ALG5;MAPK9;B3GALNT1;CAMK2B;DUSP26;CUL7;STK36;SIRT2;SPSB3;ARAF;SIRT7;PSMD4;LCMT1;PDPK1;PDK1;COQ8B;FBXW10;CP;ASB5;ST8SIA3;PARP1;EIF2AK3;DMPK;UBE2S;SPSB1;KCTD7;CDKL5;UBE2E2;FBXL12;HUNK;FGFR1;ANXA1;TAOK1;PICK1;FSTL1;WIPI1;OBSL1;NUAK2;ST3GAL2;MINK1;FBXL14;MAP4K5;PARP2;WSB2;CDK13;PPM1B;PRKCA;CDK5;FBXO7;COP1;CDK9;LAMC1;ALG1;UBXN7;METAP1;NGLY1;PIGU;NUAK1;ABL1;FBXO31;ST3GAL3;PSMB10;DDB1;PAK3;MIA3;UCHL3;STK11;BRSK2;CKAP4;FBXW5;CDC14B;PSMD11;LTBP1;SIK1;COPS7B;MANBA;ST3GAL5;SSH1;PPP2R5E;TEC;FAM20C;PPP1CC;ABCA7;NRBP2;APLP2;CUL4B;PLAT;MBTPS1;PRAG1;PSME2;METAP1D;PPM1H;WNK2;PSMC5;BRSK1;PGAP1;APP;PTPN5;GRK3;MAPK6;IGFBP3;STRADB;IGFBP7;PTPRF;CAMK2D;PORCN;PTPN3;TLK1;PARK7;DCAF5;FBN1;B4GALT5;SERP1;RAB13;COG3;PARP14;LAMB1;METAP2;NEURL2;PRKCI;DAPK1;PIGK;PTPN22;CUL5;PARP16;DAD1;CSNK1D;STK19;ATG3;NEK3;NRBP1;ROCK2;TGFB1;KLHL5;GRK2;PPM1E;FEM1C;PPP2R5D;CSNK1A1;CTDSP2;PSMD1;RPN2;PPP5C;PPM1M;KLHL13;ACVR1B;RAB8A;UBE2E1;GALNTL5;PTPN12;SIRT5;CHEK2;ZC3HAV1;CTBP1;MTMR4;MAP3K1;CCNT1;SERPIND1;TP53RK;TNKS;PIK3C3;NEDD8;UBE2L3;STK25;TIPARP;PSMD6;PPP2CB;CDK7;MXRA8;OXSR1;APOE;FBXO22;FBXO9;ILK;KLHL20;PPP2R5A;PRKD2;JAK1;NEK1;CDK10;BTBD1;PTPRE;PTAR1;TAB1;SRPK1;B3GALNT2;TGFBR1;PHKA2;PRKAA1;CDC42BPB;ASB3;PRKAG2;PIK3R4
prerank,tRNA metabolic process (GO:0006399),0.3805627159875445,0.875983068998679,0.6421768707482993,1.0,1.0,6/17,20.86%,YARS2;AARS1;SARS1;RPP30;FARS2;DTD1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.33113274731889597,0.8759013153760254,0.6599045346062052,1.0,1.0,6/35,10.52%,EPHB2;LZTR1;FLCN;RIPOR2;MFN2;ARHGAP24
prerank,negative regulation of macroautophagy (GO:0016242),0.3480780246724489,0.875656443170182,0.6322418136020151,1.0,1.0,13/26,25.36%,PHF23;TSC2;NRBP2;SCFD1;FEZ2;NUPR1;QSOX1;SMG1;CHMP4A;CHMP4B;TSC1;MTM1;CLEC16A
prerank,regulation of JNK cascade (GO:0046328),0.29663852637390015,0.8754985705934061,0.6981132075471698,1.0,1.0,12/101,8.94%,HDAC3;FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;RAP2A;SIRPA;SDCBP;PER1
prerank,mRNA catabolic process (GO:0006402),0.31778138846382686,0.8753629198621568,0.6738636363636363,1.0,1.0,11/44,19.40%,LSM6;CNOT10;NUDT12;AGO3;XRN1;DIS3L2;DDX5;NUDT16L1;THRAP3;DHX34;YTHDF2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.32810362017063643,0.8751546870608269,0.6611177170035671,1.0,1.0,13/37,20.74%,IFT52;KIF3A;CLUAP1;KIF3C;TRIP11;IFT80;IFT20;TTC21B;TNPO1;WDR35;KIFAP3;DYNLL1;DYNC2H1
prerank,in utero embryonic development (GO:0001701),0.35387589244125356,0.8751496188914227,0.6552598225602028,1.0,1.0,3/25,5.45%,ZNF568;FGFR2;FLCN
prerank,regulation of monooxygenase activity (GO:0032768),0.3527194958139266,0.8750032383544235,0.6442786069651741,1.0,1.0,4/23,10.19%,HSP90AA1;NOS1AP;POR;GDNF
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.28672851849754705,-0.8747942142289229,0.6278026905829597,0.9081485101255103,1.0,5/19,7.89%,SMAD4;TGFB2;ACVR1;BMPR1A;TGFBR2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2501403213085265,-0.8745925852195306,0.6727272727272727,0.9055351606234622,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,tRNA export from nucleus (GO:0006409),-0.2501403213085265,-0.8745925852195306,0.6727272727272727,0.9055351606234622,1.0,12/32,17.56%,NUP160;XPOT;NUP205;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1;NUP37
prerank,pharyngeal system development (GO:0060037),-0.31076501463692446,-0.8741636605613241,0.6264150943396226,0.904964784911413,1.0,6/15,17.99%,TGFB2;BMPR1A;BMP7;BMP4;HES1;TBX1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.4091563480083643,0.8735925309480044,0.6259541984732825,1.0,1.0,1/10,2.64%,ZEB2
prerank,prostanoid metabolic process (GO:0006692),-0.32427929682147844,-0.873531559397669,0.615916955017301,0.904852526901272,1.0,5/13,25.94%,PTGES;PLAA;GSTM1;HPGDS;HPGD
prerank,positive regulation of programmed cell death (GO:0043068),0.28472284874180115,0.873486777408809,0.7947947947947948,1.0,1.0,49/272,16.17%,SFRP2;SFRP1;BAX;GPLD1;BIN1;PLEKHN1;SLC27A4;AIFM2;HTATIP2;DDX3X;FZD9;SCRIB;FLCN;OLFM1;FAM162A;ABL1;SQSTM1;BARD1;ARHGEF7;ARHGEF4;EEF1E1;KCNMA1;KALRN;TRIM35;CALHM2;MCF2;CLIP3;CASP9;VAV2;UBE2Z;IGFBP3;PLEKHG5;RACK1;AKAP13;DAPK1;HTT;MTCH1;MTCH2;BCL6;RNF122;BCLAF1;DNM1L;SHQ1;PAWR;FAF1;CASP2;HSPD1;TRIO;ARHGEF6
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.368015225461027,0.8733589641879518,0.6644562334217506,1.0,1.0,2/18,7.14%,IL34;CXCR4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.36347237908227836,0.8733035638788954,0.6361256544502618,1.0,1.0,4/20,9.58%,PPIF;NKTR;PPIB;PPIH
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3605843250108578,0.8732866371501372,0.6491228070175439,1.0,1.0,3/21,8.83%,CHPF;DCN;CHSY3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.42124674197319356,0.8732017336581643,0.6234756097560976,1.0,1.0,2/10,19.73%,ETFBKMT;OXA1L
prerank,carnitine shuttle (GO:0006853),-0.33904645305506476,-0.873128160600674,0.631578947368421,0.904211770962873,1.0,4/11,14.03%,ACACA;PRKAB2;ACACB;PRKAA2
prerank,peptidyl-threonine modification (GO:0018210),0.3057165772564903,0.8729166322237685,0.6865509761388287,1.0,1.0,18/66,18.78%,PDPK1;CSNK2A2;GALNT16;PRKCA;CDK5;GALNT4;SBK1;CIT;CAMK2D;GALNTL6;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,mitochondrion transport along microtubule (GO:0047497),-0.31657430469252185,-0.872762348527717,0.6317567567567568,0.9035475064572964,1.0,5/13,14.40%,RHOT1;HIF1A;LRPPRC;UBB;MAP1S
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.41463060838008603,0.8725934072112758,0.6407914764079148,1.0,1.0,1/10,1.15%,NPTXR
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.30326770452480056,0.8725010506475663,0.6789189189189189,1.0,1.0,6/63,11.07%,EPHB2;ANXA1;FGF10;TIRAP;IRS2;BCL2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29407050699941645,0.8724737635596517,0.7037422037422038,1.0,1.0,28/109,20.35%,PLA2G5;PIP4K2B;SYNJ2;INPP5E;PIK3R1;PLEKHA3;PITPNM3;PIK3CB;PGAP1;PIK3R2;PI4KB;PIP4K2A;LCLAT1;PIP4K2C;FIG4;SACM1L;CDS1;PIK3C2B;MTMR4;RUFY1;SLC27A1;PIK3C3;PITPNM2;PIP5K1A;PLEKHA1;PIK3R4;IMPA1;INPP4A
prerank,aortic valve development (GO:0003176),0.3337690100714592,0.872046361930041,0.663953488372093,1.0,1.0,10/34,16.44%,SNAI1;SOX9;TWIST1;ROBO2;ROBO1;ROCK2;TGFB1;SMAD6;SLIT3;JAG1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3066706473660627,0.8719110276694881,0.6883116883116883,1.0,1.0,16/67,17.79%,ABITRAM;RAC1;DCDC2;CDKL5;SGSM3;TBC1D13;DMTN;TBC1D20;USP6NL;IFT20;RABGAP1;TBC1D24;ATG3;FMR1;TBC1D9B;TBC1D22B
prerank,response to chemokine (GO:1990868),0.3919643291206699,0.8713666399915777,0.6301939058171745,1.0,1.0,3/13,8.61%,CXCL12;RIPOR2;DOCK8
prerank,apoptotic nuclear changes (GO:0030262),0.3556411569881473,0.8713062814311464,0.6524547803617571,1.0,1.0,7/24,22.00%,DFFB;KPNB1;CDK5RAP3;DFFA;KPNA1;ACIN1;HMGB1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3411199717257993,0.8711962847608488,0.6563658838071693,1.0,1.0,8/30,16.55%,RAB34;SEC16A;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF
prerank,membrane repolarization (GO:0086009),-0.30845003545811805,-0.8710726588999678,0.6587837837837838,0.9059217835003891,1.0,4/15,12.55%,ATP1B3;ATP1A1;KCNJ2;ATP1B1
prerank,positive regulation of protein metabolic process (GO:0051247),0.29257628393472496,0.8709737553691281,0.7246673490276356,1.0,1.0,29/110,21.63%,WNT5A;ASB5;ABCA2;FZR1;SNF8;TNFAIP3;DDB1;BARD1;VCP;APP;PRMT1;EGLN2;RNF41;ROCK2;TGFB1;NKD1;AGTR1;NSF;TIPARP;APOE;SMURF1;SORL1;SLC25A37;STX5;RANBP9;KLF4;HECW2;FOXO1;RAB7A
prerank,regulation of endothelial cell migration (GO:0010594),0.29558880579161456,0.8709035385584895,0.7068783068783069,1.0,1.0,23/85,21.29%,WNT5A;GPLD1;RAC1;NR2F2;NRP1;PRKCA;DCN;ABL1;SPARC;GLUL;EGF;PIK3CB;EMP2;ROCK2;FOXC2;ITGB1BP1;APOE;PRKD2;SYNJ2BP;KRIT1;PDCD6;PTK2B;FGF2
prerank,V(D)J recombination (GO:0033151),0.41055820446898195,0.870688847591586,0.6392961876832844,1.0,1.0,3/11,15.29%,LIG1;LIG3;TCF3
prerank,regulation of dendritic spine development (GO:0060998),0.36540422198626865,0.8701254033263534,0.6369593709043251,1.0,1.0,7/19,21.20%,CAMK2B;TANC2;FMR1;APOE;SHANK1;PTPRS;DLG5
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3383969326841516,-0.8699735769337889,0.631578947368421,0.9069195702820324,1.0,8/11,53.93%,PLCG2;P2RX4;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.4026112610633357,0.8698928135266495,0.6324404761904762,1.0,1.0,11/11,59.77%,RTP4;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3;LPO;PKD1L3;PKD2L1
prerank,positive regulation of peptidase activity (GO:0010952),0.36285390959118624,0.8696367090756502,0.6308100929614874,1.0,1.0,6/20,17.20%,PRELID1;RCN3;VCP;PSME2;CTSH;TANK
prerank,regulation of cellular senescence (GO:2000772),0.346407130076296,0.8695781039775071,0.6709021601016518,1.0,1.0,5/28,9.79%,NUAK1;FBXO5;SLC30A10;EEF1E1;TWIST1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.37972946884780456,0.8694623612979621,0.6589041095890411,1.0,1.0,3/15,9.95%,ZFP36L1;DHX36;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.37972946884780456,0.8694623612979621,0.6589041095890411,1.0,1.0,3/15,9.95%,ZFP36L1;DHX36;PABPC1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32507644907313527,0.8691127232421032,0.6611957796014069,1.0,1.0,8/39,19.15%,LRRC8A;CAPN10;TCF7L2;SELENOT;IRS2;NLGN2;TRH;SOX4
prerank,neurotrophin signaling pathway (GO:0038179),0.3596212696107028,0.8690898143851268,0.6454545454545455,1.0,1.0,4/21,11.88%,NTF3;FRS2;RAPGEF1;MAGI2
prerank,protein hydroxylation (GO:0018126),-0.297458325184226,-0.8690840179297202,0.6287625418060201,0.9073540240331194,1.0,9/15,25.44%,OGFOD1;VIPAS39;P3H3;ASPH;EGLN3;PLOD2;P3H1;PLOD3;HIF1AN
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.3889142141080192,0.8688968906115729,0.6566951566951567,1.0,1.0,1/13,0.91%,CLN3
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.30172359766940726,-0.8688586232084623,0.6028880866425993,0.9063338487675334,1.0,3/15,10.40%,ERN1;TSEN2;CSTF2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2879823693702562,0.8687492261981765,0.7558494404883012,1.0,1.0,26/138,15.24%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23
prerank,organelle assembly (GO:0070925),0.2805345690098806,0.8686120463577145,0.853,1.0,1.0,76/384,17.36%,TMEM138;HDAC3;B9D2;UBQLN1;CENPT;CCDC61;CPLANE2;MVB12A;STK36;UBXN2A;IFT52;DCDC2;MAPRE3;ACTR2;KIF3A;ARL13B;WIPI1;ATAT1;DDX3X;SNF8;CLUAP1;ATP2A2;TCTN1;BBS7;INPP5E;ATG14;SNX10;HGS;CDC14B;CCDC28B;PIBF1;ATG2A;CFAP54;AUP1;VTA1;TTC8;CHMP3;DBNL;CEP126;CC2D2A;ATG13;IFT80;ATXN2L;YTHDF3;CYS1;VPS4B;NPM1;CFAP20;RCC1;CPLANE1;IFT20;YTHDF1;CENPC;PDE6D;DISC1;HAUS3;CSNK1D;MAPT;ATG3;MAP1LC3B;ATP6V1D;VMP1;TMEM216;RFX3;OFD1;RAB8A;RAB8B;FARP2;AHI1;CDS1;TMOD2;TNKS;PIK3C3;TUBGCP2;STAM2;DHX29
prerank,leukocyte tethering or rolling (GO:0050901),-0.2953092712404237,-0.867901459462868,0.6451612903225806,0.9069296301915999,1.0,5/17,23.74%,JAM2;ROCK1;ITGA4;PODXL2;CX3CR1
prerank,positive regulation of protein transport (GO:0051222),0.3067926380298808,0.8678560822286314,0.7038251366120218,1.0,1.0,10/67,14.84%,CLN3;IGF1;BMP6;ATP2C1;RIPOR1;MYH10;RACK1;TMED10;TGFB1;DNM1L
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3043655772385232,-0.8678332384777437,0.6480836236933798,0.9055777966256437,1.0,6/15,25.09%,CSGALNACT1;CSPG4;DSEL;BGN;CSPG5;CHST12
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2890745659577927,-0.8678204862855734,0.65234375,0.9041163099209546,1.0,4/17,8.99%,WASF2;GMFB;BRK1;ABI2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.28381562502322377,0.8675844144027072,0.7919597989949749,1.0,1.0,28/190,12.69%,RNF157;PPIF;TSC2;GPD1L;THEM4;TBC1D7;RORA;DDX3X;TNFAIP3;OTUD7A;ITPR1;PPM1B;FLCN;RFFL;IFI35;CIT;DDIT3;USP10;PER1;ABCA7;TWIST1;PIK3CB;PIK3R2;BCL2;RTKN2;MAGI2;DAG1;RACK1
prerank,prostanoid biosynthetic process (GO:0046457),0.3758659194587088,0.8675663468044799,0.6478679504814305,1.0,1.0,1/15,0.44%,PRXL2B
prerank,antibacterial humoral response (GO:0019731),-0.30389576250910594,-0.8675215962503795,0.6606498194945848,0.9031933108595821,1.0,4/16,18.33%,RNASE3;DEFA6;RPL39;PLA2G6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.29349281673346495,0.8672021156296159,0.7230290456431535,1.0,1.0,23/100,17.57%,SIRT2;ARAF;STUB1;USP7;ZYG11B;OGT;COP1;BBS7;DVL1;SDCBP;VCP;PARK7;RNF19A;RACK1;RNF19B;CSNK1D;ANKIB1;RNF217;CSNK1A1;HECTD1;ARIH2;FBXO22;MDM2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.40744061791994723,0.8669330470404183,0.6482334869431644,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),0.40744061791994723,0.8669330470404183,0.6482334869431644,1.0,1.0,2/11,7.08%,CCT8;CCT6A
prerank,selective autophagy (GO:0061912),0.31324535593764224,0.8668075541765544,0.7044943820224719,1.0,1.0,11/56,12.08%,UBQLN1;USP30;ARL13B;SQSTM1;ATG14;ATG2A;AUP1;ATG13;PEX5;DYNC1LI1;PARK7
prerank,regulation of cellular catabolic process (GO:0031329),0.30682921038162125,0.8665162664727476,0.6967391304347826,1.0,1.0,17/62,17.48%,PIP4K2B;ITPR1;ABL1;RRAGA;DDIT3;USP10;PIK3R2;WDR91;PIP4K2A;DAPK1;PSAP;MAPT;PIP4K2C;NUPR1;RAB8A;MTMR4;USP33
prerank,transferrin transport (GO:0033572),0.33155789372816014,0.8663452166215823,0.6627634660421545,1.0,1.0,10/33,22.41%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2;STEAP3;ATP6V1C1;RAB11B
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3580256313888683,0.8661764520855266,0.6493506493506493,1.0,1.0,5/22,14.18%,IGF1;PARP1;PRKCA;CAMK2D;ROCK2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2782391363361502,0.86616104857401,0.874,1.0,1.0,61/476,12.36%,PSRC1;ILF3;WNT5A;WBP2;SFRP1;IGF1;MED24;FOXM1;ZBTB48;MYRF;NFKB1;SMARCD3;NR2F2;MAPRE3;MED12;SMARCC2;MED14;GLIS2;NR1D2;RORA;KMT2B;BRPF1;SNX5;CHD8;IL31RA;SNAI1;NPAT;TCF4;CNBP;BRD4;IRF1;MED13;ZIC3;CASZ1;TRIM56;ANKRD49;ZNF711;TEAD1;TGFB1I1;RAI1;MED4;WNT4;SOX9;DDIT3;XRCC6;YWHAH;HNRNPD;ARID1B;EGF;ATMIN;HDAC4;SOX11;CALCOCO1;PSMC5;NSD3;MAZ;SMARCA1;ZMIZ1;NPM1;TADA3;HDAC1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.35129669157350574,0.866133786302939,0.6493011435832274,1.0,1.0,9/26,19.65%,OGT;ETFBKMT;SETD1A;SUV39H1;KMT2D;ATPSCKMT;KMT2A;SETD5;KMT5B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.33299872217685,0.8656034755897415,0.6714285714285714,1.0,1.0,9/31,22.01%,DNLZ;TOMM20;PEX1;PEX5;PEX7;HSPD1;TIMM44;TIMM23;PEX2
prerank,RNA methylation (GO:0001510),0.3062824175754537,0.865360750196046,0.6891592920353983,1.0,1.0,9/60,12.90%,TRMT61B;TRDMT1;FBL;DIMT1;BUD23;WDR6;ZCCHC4;METTL2B;METTL2A
prerank,response to organonitrogen compound (GO:0010243),0.322938155592357,0.8650932532155025,0.6632064590542099,1.0,1.0,7/38,16.38%,SYVN1;ERLEC1;BRSK2;RCN3;VCP;GLRA1;DERL1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2935431247910612,0.8647977504924298,0.7154899894625922,1.0,1.0,24/93,22.50%,SFRP2;ARAF;NTF3;HSP90AA1;GPD1L;DMTN;CNKSR3;APP;CNOT9;PARK7;DOCK7;RACK1;TGFB1;SPRY2;NSD1;PRKD2;RASSF2;TERF2IP;SMAD7;SPTBN4;ATP2B4;PPM1F;PFN2;PAK1
prerank,negative regulation of cellular senescence (GO:2000773),0.3932185419993345,0.8643333528694599,0.6338028169014085,1.0,1.0,3/13,9.79%,FBXO5;SLC30A10;TWIST1
prerank,regulation of platelet activation (GO:0010543),0.35221033671072294,0.8641952320441568,0.6474530831099196,1.0,1.0,4/21,11.29%,C1QTNF1;PRKCA;TEC;PDGFRA
prerank,cell junction maintenance (GO:0034331),0.38190227737406973,0.8641100574992409,0.6339410939691444,1.0,1.0,2/14,14.38%,CHCHD10;NLGN2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.388500695589077,0.8639369027365451,0.655076495132128,1.0,1.0,2/14,14.21%,PARK7;PTGS2
prerank,regulation of mitochondrial fission (GO:0090140),0.35142635742539324,0.8637826118342671,0.6598984771573604,1.0,1.0,7/24,15.72%,MYO19;FIS1;DCN;MIEF2;MAPT;DNM1L;SPIRE1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.34617558082126865,0.8634844282393026,0.6544303797468355,1.0,1.0,5/23,19.11%,ELOVL1;FAR2;ACSL6;FAR1;ELOVL6
prerank,negative regulation of developmental growth (GO:0048640),0.3333266540947278,0.8634820379962721,0.6525,1.0,1.0,10/30,23.89%,DIP2B;PTCH1;SLC6A4;NKD1;DCC;WWC1;PTPRS;FGF13;MAP2;PTEN
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3389220035252163,-0.8629873598269802,0.6136363636363636,0.9116840371759687,1.0,4/11,15.68%,KIT;KIFC3;CCN3;ITGB5
prerank,positive regulation of protein import (GO:1904591),0.3340369066765385,0.8627984136434237,0.662962962962963,1.0,1.0,10/30,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;PDCD5;TPR;SMAD3
prerank,dephosphorylation (GO:0016311),0.28667267295648735,0.8626903561728819,0.7594291539245668,1.0,1.0,32/147,18.51%,DUSP28;DUSP18;DUSP26;PPM1B;STK11;CDC14B;PLPPR2;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;HDHD2;PLPP3;PTPN22;PLPPR5;EPHX2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PLPP4;PTPN12;PLPP5;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.29982284107620577,0.8626567910922882,0.7308900523560209,1.0,1.0,28/80,25.12%,KDELR3;BNIP1;ATP9A;PICK1;KIF3A;KIF3C;ERGIC2;COPZ2;ATP9B;SCFD1;TMED10;PLPP3;COG3;HTT;NSF;RAB6A;KIFAP3;ZW10;UVRAG;NAPA;ARFGAP3;COPG1;KIF3B;COPA;TMED7;GOLPH3L;ERGIC1;SURF4
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.23374495097385772,-0.8625668402540114,0.7555555555555555,0.9111013340397968,1.0,19/36,35.74%,CEP63;USP28;TIPIN;DOT1L;NBN;HINFP;ATRIP;ERCC6;RAD9B;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON;SETMAR;DNA2;TIMELESS;E2F1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3379481930814549,0.8624268675963951,0.681087762669963,1.0,1.0,9/28,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;RBM22;TPR;SMAD3
prerank,vasoconstriction (GO:0042310),0.4086407618077096,0.8620537803803687,0.6692307692307692,1.0,1.0,1/11,2.70%,EDN3
prerank,Ras protein signal transduction (GO:0007265),0.2873183328365289,0.8620410637509526,0.7609805924412666,1.0,1.0,32/137,19.09%,CDC42EP5;IGF1;CDC42EP4;CTNNAL1;RAC1;SGSM3;BRAP;RASGRP2;RAP2A;RHOD;KPNB1;CYFIP1;RAPGEF1;RIPOR1;DBNL;ADGRG1;RTKN;GPSM2;COL1A2;PARK7;PLEKHG5;WASF1;ARHGAP29;ROCK2;FARP2;EPS8L1;AGTR1;RIT2;MRAS;RRAS2;USP50;KSR1
prerank,positive regulation of viral process (GO:0048524),0.3054730381044518,0.8620371816833519,0.6956521739130435,1.0,1.0,13/60,18.54%,TARBP2;DDX3X;POLR2B;CDK9;DDB1;PPIH;PABPC1;TBC1D20;POLR2K;VAPB;CCNT1;SRPK1;NELFA
prerank,regulation of viral entry into host cell (GO:0046596),-0.24964675902227768,-0.8618664620307885,0.7281553398058253,0.911094742159431,1.0,11/30,22.45%,P4HB;TRIM25;LY6E;LGALS9;LGALS1;TRIM5;TRIM14;NECTIN2;HS3ST5;IFITM2;IFITM1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3487654330598405,0.8614991008992599,0.6508344030808729,1.0,1.0,11/24,25.45%,ZFP36L1;ERRFI1;CBFB;ROCK2;NUMA1;CTSK;NCOA3;HOXA7;SRSF6;RUNX1;SGPP1
prerank,regulation of multicellular organismal development (GO:2000026),0.34616589774342726,0.861237149611096,0.664179104477612,1.0,1.0,8/25,24.54%,NIPBL;CD24;DHX36;EHMT1;OAS2;TRIP12;INSR;MYSM1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.35291754476190573,-0.8611649430416564,0.6330275229357798,0.9110432474682623,1.0,6/10,37.39%,NR1H3;ELOVL5;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,Fc receptor signaling pathway (GO:0038093),0.2887368124425312,0.8610014004957335,0.7386831275720165,1.0,1.0,35/110,24.48%,MAPK9;PSMD4;PDPK1;NFKB1;RAC1;PIK3R1;PSMB10;PSMD11;TEC;VAV2;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;PSMD1;MAP3K1;PSMD6;TAB1;CALM1;PSMD5;LYN;TAB3;PSMA4;NFATC3;PSMA1;PSMC6;PAK1;MAP2K7;PSMA5;SOS1;PPP3CB;VAV3;PSMD14;TRAF6
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2314623548280224,-0.8607488855586025,0.6896551724137931,0.9105183005819173,1.0,14/39,23.62%,ANGPT1;PDCD4;TEK;THBS1;ANO6;RAMP2;KDR;PLCG1;SCG2;ITGA4;RGCC;NFE2L2;GATA2;SEMA5A
prerank,lysine metabolic process (GO:0006553),0.40675935569013416,0.8607181056166867,0.6468023255813954,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.40675935569013416,0.8607181056166867,0.6468023255813954,1.0,1.0,3/12,18.79%,AASS;OGDH;ALDH7A1
prerank,hexose biosynthetic process (GO:0019319),-0.22665459406144547,-0.8606174292824914,0.7445255474452555,0.9093431304611794,1.0,16/42,24.87%,AKR1B1;SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH
prerank,response to histamine (GO:0034776),-0.35242081552523175,-0.86056916418846,0.6391437308868502,0.907930422064352,1.0,2/10,5.29%,GABRB1;GABRG2
prerank,neuron development (GO:0048666),0.28380534630565474,0.8604876870992216,0.7553083923154702,1.0,1.0,38/141,22.15%,STMN4;GBA2;GPRIN1;XBP1;CDK5;TENM3;EPHA8;TMEM108;PPP1R9B;GDNF;APP;LRP12;BLOC1S2;BICDL1;DOCK7;TDP2;B4GALT5;RAB13;PRMT1;LAMB1;MAPT;TBC1D24;CNTNAP2;TENM4;TBCD;EPHA5;APOE;MAP4;ATCAY;ATP8A2;ATXN10;DCX;LYN;EHD1;NTRK2;RYK;HMGB1;CAMSAP1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.2581180773877837,-0.8604470237746487,0.677570093457944,0.9067205026044929,1.0,11/25,30.30%,CNNM2;CAV1;TMTC2;FAM20A;TRPM7;SELENON;CNNM4;PRKN;WFS1;SLC8A1;JPH2
prerank,pyruvate metabolic process (GO:0006090),-0.21796655831141915,-0.8603265512657068,0.7788461538461539,0.9055341486524027,1.0,16/52,19.17%,ME3;ME2;HK1;BSG;GPI;PDHX;SLC16A1;PDHA1;PKM;GLO1;ALDOA;PDHB;PCK2;PFKFB2;ENO1;HK2
prerank,plasma membrane tubulation (GO:0097320),0.3916215887126186,0.8602361233914765,0.6547788873038516,1.0,1.0,3/13,11.60%,WHAMM;PACSIN3;SNX33
prerank,early endosome to late endosome transport (GO:0045022),0.35532501029194674,0.8602056657835903,0.6472114137483788,1.0,1.0,6/20,16.64%,SNF8;HOOK3;WDR91;EMP2;STX8;PIK3C3
prerank,response to X-ray (GO:0010165),0.383326663240504,0.8601957311389075,0.6554621848739496,1.0,1.0,4/14,15.12%,ANXA1;NIPBL;XRCC6;NUCKS1
prerank,transcription preinitiation complex assembly (GO:0070897),0.3925382786392283,0.8601469037281586,0.6522988505747126,1.0,1.0,5/12,22.48%,TBP;GTF2A2;TAF1B;TAF1;GTF2B
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.32063456810020036,0.8600477693763298,0.6714456391875747,1.0,1.0,5/34,6.44%,RAC1;NRP1;ABL1;ARHGEF7;DMTN
prerank,neutrophil migration (GO:1990266),-0.21143930615492812,-0.8599630378034256,0.7341772151898734,0.9048801431296263,1.0,5/58,6.44%,GBF1;PECAM1;BSG;CCL15;TGFB2
prerank,mitochondrial translational termination (GO:0070126),0.2955320073571527,0.8596239990971399,0.7197049525816649,1.0,1.0,24/88,22.85%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.27782023575159487,-0.8594056075278912,0.6666666666666666,0.9046741634691727,1.0,5/21,17.61%,MFHAS1;ENSA;PPP1R8;PTPA;BOD1L1
prerank,zinc ion transmembrane transport (GO:0071577),0.3480727679414055,0.8591728656663601,0.6395939086294417,1.0,1.0,6/22,16.89%,SLC30A10;SLC39A1;SLC30A1;SLC39A6;SLC30A3;SLC30A5
prerank,regulation of macrophage migration (GO:1905521),-0.3493396979330071,-0.8591244533601041,0.6298507462686567,0.9037505592292094,1.0,5/10,23.74%,MTUS1;P2RY12;EMILIN1;CD81;CX3CR1
prerank,GTP metabolic process (GO:0046039),0.3752546072873829,0.8590969286430724,0.6479885057471264,1.0,1.0,4/15,13.69%,ENTPD7;MFN1;AK4;AK3
prerank,lytic vacuole organization (GO:0080171),0.3280430553697915,0.859004631202637,0.6689895470383276,1.0,1.0,6/32,16.00%,CLN3;CLN6;MBTPS1;HOOK3;ARSB;VPS18
prerank,postreplication repair (GO:0006301),-0.22867730187066307,-0.8586399120136209,0.7615384615384615,0.9033416866436226,1.0,9/45,10.39%,WDR33;UBE2N;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;MSH2
prerank,defense response to protozoan (GO:0042832),0.39159026987189377,0.8584997954717243,0.6438953488372093,1.0,1.0,4/12,23.73%,GBP7;GBP6;GBP4;LYST
prerank,tryptophan metabolic process (GO:0006568),-0.3462135543890688,-0.858494092453221,0.6603174603174603,0.9021881253872537,1.0,10/11,64.97%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3326678147879285,-0.8583886810395288,0.6463414634146342,0.9009747653449497,1.0,3/11,7.14%,MEF2C;SIRT1;LGALS9
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.24714292115156553,-0.858244388212673,0.7045454545454546,0.8998763436903405,1.0,8/33,11.54%,BMPER;TJP1;CEMIP2;SEMA6A;SMAD1;THBS1;EPN2;PKM
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.2717540399703319,-0.8581160891518548,0.6758893280632411,0.8987005458726156,1.0,3/21,1.12%,FOXP1;PRKCH;ELF1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.3254854850334813,0.85744861843667,0.669481302774427,1.0,1.0,7/31,18.56%,FGFR2;SOX11;TWIST1;PDGFRA;MEGF8;OSR1;TGFBR1
prerank,DNA double-strand break processing (GO:0000729),0.3717089908665436,0.8573034051603804,0.6644113667117727,1.0,1.0,7/18,21.07%,RNF138;BARD1;UBE2V2;MRE11;RAD50;RBBP8;EXD2
prerank,DNA metabolic process (GO:0006259),0.2793032005339411,0.8573030577382541,0.8258258258258259,1.0,1.0,62/270,21.07%,WDHD1;XRCC2;LIG1;SIRT7;DNASE1L2;HMGB3;PARP1;NTHL1;USP7;MPG;PARP2;MGMT;TCF7L2;ASF1A;CNBP;DDB1;BARD1;TDP1;DFFB;SMARCB1;LIG3;FANCG;ORC6;XRCC6;UBE2V2;VCP;GTF2H3;POLH;TOP1;ZNF445;ENDOV;USP3;ALKBH3;BACH1;PARK7;NPM1;AXIN2;UBE2A;ATR;MMS19;POLD3;HELB;FANCA;MRE11;RAD50;TERF1;TOP3B;NABP2;PWWP3A;TOP3A;RAD21;RBBP8;TERF2IP;RECQL5;ALKBH1;KMT5B;INO80;FANCL;UVRAG;RAD18;TOP2B;EXD2
prerank,response to steroid hormone (GO:0048545),0.3286515475178152,0.8570038255220257,0.676829268292683,1.0,1.0,8/31,16.82%,WBP2;ATP1A3;ABCA2;CATSPER3;ATP1A2;TFPI;TGFB1;UBE2L3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.35158193972932544,0.8565227147792274,0.6623711340206185,1.0,1.0,4/21,16.59%,ADCY7;ADCY1;NPR2;ADCY5
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.29004190949804626,0.8562963096266205,0.7317327766179541,1.0,1.0,23/94,20.07%,CCP110;B9D2;HSP90AA1;ALMS1;TCTN1;CEP97;TUBA1A;YWHAG;CC2D2A;HAUS3;CSNK1D;TUBB;TMEM216;OFD1;AHI1;CEP76;IQCB1;TUBB4A;NPHP1;ODF2;DYNLL1;PAFAH1B1;TMEM67
prerank,protein localization to membrane (GO:0072657),0.28323941510941514,0.8557493683072751,0.8050251256281407,1.0,1.0,60/187,23.65%,TMEM150A;LRRC4;PRAM1;PICK1;ANK1;RAB34;SCRIB;DLG3;THY1;SEC16A;DVL1;RAP2A;HGS;RAB12;ZDHHC3;PTCH1;RAB10;ARL5B;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;MAGI2;RAB13;EMP2;ROCK2;NLGN2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;DLG2;PACS1;SMURF1;ZDHHC2;SYNJ2BP;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2;NPC1;EHD3;RAB11B;WNK3;NUP155;AGRN;RAB40B;SH3PXD2B;SH3GLB1;NUP54
prerank,apoptotic process (GO:0006915),0.2779307485546051,0.8557141295844516,0.81067472306143,1.0,1.0,39/203,18.34%,BAX;YARS1;TSC2;PARP1;DMPK;BNIP1;AIFM2;CASP7;OGT;CDK5;FAM162A;IRF1;STK11;CXCR4;TCHP;CIT;DPF2;CASP9;APP;BCL2;BNIP2;IRF3;RNF152;TNFRSF25;KREMEN1;VDAC1;DAPK1;BCLAF1;THOC1;MAGI3;PAWR;CASP2;HSPD1;ARHGEF6;AHCYL1;MDM2;DCC;ATN1;ATCAY
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3020676795365275,0.8552171879682955,0.7192393736017897,1.0,1.0,10/57,16.59%,ADCY7;OPRK1;GPR37;GABBR1;CHRM2;LPAR1;PSAP;AKAP12;ADCY1;ADCY5
prerank,macrophage migration (GO:1905517),-0.3037572444101736,-0.8550243546634744,0.6402640264026402,0.9040711518849519,1.0,7/13,45.76%,P2RY12;CKLF;EDNRB;P2RX4;TAFA4;CCR2;CCL2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2881285315977881,0.854339654504586,0.7432150313152401,1.0,1.0,26/104,22.11%,ADAMTSL2;PDPK1;STUB1;SMAD9;PMEPA1;SNX6;HTRA3;TGFB1I1;LEMD3;MAGI2;PEG10;TGFB1;SMAD6;VASN;UBE2D1;MTMR4;SPRY2;SMURF1;SORL1;TGFBR1;PPM1A;NBL1;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4069873703673471,0.8537973026215292,0.6666666666666666,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4069873703673471,0.8537973026215292,0.6666666666666666,1.0,1.0,2/11,7.92%,SYNJ2;INPP5A
prerank,cellular response to nitrogen compound (GO:1901699),-0.28089115625569194,-0.8536561240039413,0.6666666666666666,0.9056156914304355,1.0,6/20,16.92%,RIOK3;SPIDR;DDI2;HSF1;RTF2;BLM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3443108021511343,-0.8533781880931203,0.6181818181818182,0.9032957284061379,1.0,4/10,32.25%,MYADM;WNK1;MAPK7;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3443108021511343,-0.8533781880931203,0.6181818181818182,0.9032957284061379,1.0,4/10,32.25%,MYADM;WNK1;MAPK7;MBP
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3044015617887943,0.8532909644967591,0.7009029345372461,1.0,1.0,9/52,11.37%,CSNK2A2;TFDP1;SAE1;NMT1;YWHAH;YWHAG;ATG13;BCL2;LEPROT
prerank,positive regulation of blood coagulation (GO:0030194),0.3665577839009039,0.8526160773899389,0.649402390438247,1.0,1.0,4/17,16.49%,USF1;DMTN;F3;SERPINE1
prerank,negative regulation of neuron projection development (GO:0010977),0.30407851597111635,0.8525830903302108,0.7111111111111111,1.0,1.0,19/56,23.90%,THY1;EFNB3;MCF2;SPOCK1;EFNB2;PRAG1;DENND5A;LPAR1;SEMA3A;APOE;RUFY3;DCC;ITM2C;PTPRS;EPHA4;DPYSL3;LRP4;PTEN;MYLIP
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2888730410100817,0.8524217990868427,0.7525987525987526,1.0,1.0,21/104,19.09%,CDKN2D;INCENP;CALM3;DDX3X;SNF8;ABL1;THY1;EZH2;HGS;CDC25A;CDK5RAP3;CCNH;PARP16;HTT;MAP2K2;CCNT1;SLC27A1;CDK7;BCCIP;CALM1;KSR1
prerank,peroxisome organization (GO:0007031),0.33932377256031804,0.8522313736266508,0.6741854636591479,1.0,1.0,6/25,15.47%,FIS1;SEC16B;PEX1;PEX7;DNM1L;ABCD2
prerank,toll-like receptor signaling pathway (GO:0002224),-0.1920377391448778,-0.8521615347860546,0.7924528301886793,0.9044815653314527,1.0,13/84,10.78%,IKBKB;IRAK2;RIPK1;LBP;IRAK1;HSP90B1;UNC93B1;TLR4;LGALS9;CTSL;PLCG2;UBB;IKBKG
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.3004328839781236,-0.8521370825648061,0.6512455516014235,0.9031023466475425,1.0,2/15,7.95%,LRP6;ANKRD11
prerank,regulation of dephosphorylation (GO:0035303),-0.30248151995596206,-0.8521325408289073,0.6655405405405406,0.9016631702838379,1.0,6/15,17.46%,MTMR3;SMG5;INPP5K;MTMR9;SRC;SMG6
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2903176457763458,0.8519469637137285,0.7401490947816827,1.0,1.0,22/88,22.11%,BAX;WARS1;SNF8;TIRAP;PRKCA;SLF2;HGS;SDCBP;VCP;PARK7;VPS4B;RACK1;NRG1;TGFB1;FAF1;TPPP;FLOT1;RPS3;TPR;RAB7A;PFN2;SMAD3
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.36401603251007186,0.8518515815144889,0.6662106703146374,1.0,1.0,5/18,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,protein monoubiquitination (GO:0006513),-0.2283441923029826,-0.8514328225907128,0.7757575757575758,0.9017170193025403,1.0,11/36,19.24%,WAC;RBX1;TRIM25;UBE2O;PAF1;UBE3D;UBE2D3;DTX3L;HUWE1;UBE2R2;LEO1
prerank,indolalkylamine catabolic process (GO:0046218),-0.3505523474767763,-0.8514197005084851,0.6523076923076923,0.9002967704554959,1.0,10/10,64.97%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,mismatch repair (GO:0006298),0.3363789014756104,0.851269474513517,0.6832298136645962,1.0,1.0,5/27,13.72%,LIG1;MLH1;ABL1;PMS2;POLD3
prerank,regulation of cellular component movement (GO:0051270),0.30611199742578765,0.8512421994274117,0.6930022573363431,1.0,1.0,19/49,22.49%,ZSWIM6;ABL1;MYCBP2;EGF;PRAG1;ARAP1;NRG2;YTHDF1;NRG1;ROCK2;ZSWIM8;TGFBR1;LYN;TGFBR3;IGBP1;DIAPH1;CD9;ERBB4;PKN1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.37903330885303166,0.851162604432706,0.6722689075630253,1.0,1.0,2/14,9.38%,CLN3;ABCA7
prerank,regulation of fibrinolysis (GO:0051917),0.3852314475961903,0.8511423199575364,0.6731034482758621,1.0,1.0,1/13,2.95%,USF1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.34834748496598483,0.8502222338104886,0.6718146718146718,1.0,1.0,3/23,8.05%,DDX3X;PPM1B;IFI35
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.35832952117413097,0.8497913465974094,0.6544715447154471,1.0,1.0,4/18,15.42%,CACNG3;NLGN3;NLGN2;CACNG4
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3037147326952151,-0.849513009934207,0.6827309236947792,0.902918368983765,1.0,4/14,30.01%,IL17D;CD80;CD84;PAEP
prerank,positive regulation of histone acetylation (GO:0035066),0.34757975527097323,0.8493097232944664,0.7038007863695938,1.0,1.0,3/23,8.07%,WBP2;SMARCB1;ARRB1
prerank,phospholipid catabolic process (GO:0009395),0.34036341153241234,0.8490661752441651,0.6823979591836735,1.0,1.0,6/24,19.12%,PRDX6;GDPD3;ENPP2;SMPD4;GDE1;SMPD1
prerank,protein stabilization (GO:0050821),0.2801188792603969,0.8489929379479343,0.7923387096774194,1.0,1.0,37/168,19.15%,DNLZ;IGF1;CCT8;HSP90AA1;TAF9B;SYVN1;USP7;NCLN;NAPG;PIK3R1;BAG1;SEC16A;DVL1;CCT6A;GET1;MDM4;PPIB;USP2;USP19;PARK7;CRTAP;CCNH;PLPP3;USP9X;COG3;ZBED3;COA8;HSPD1;CHEK2;RAB21;CDK7;USP33;GNAQ;RASSF2;BAG4;FLOT1;SOX4
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.40006576116415465,0.8485844435472389,0.6626865671641791,1.0,1.0,1/11,6.74%,NOS1AP
prerank,"base-excision repair, AP site formation (GO:0006285)",0.36758992831618964,0.8482133087082985,0.6719787516600265,1.0,1.0,2/17,4.62%,NTHL1;MPG
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.1853233895267005,-0.848093752188166,0.8813559322033898,0.9044720584375422,1.0,28/86,21.52%,PSMB7;BAG3;RBX1;HIF1A;PSMB2;PSMD7;ELOC;PSMA6;PSMC2;PSMD13;TP53;PSMF1;PSMC1;EP300;LIMD1;UBB;PSMD9;EGLN3;PSMD2;PSMB3;PSMC3;ATF4;VEGFA;ELOB;NFE2L2;PSMD3;HIGD1A;PSMD8
prerank,"phototransduction, visible light (GO:0007603)",-0.2978674168485368,-0.8475151943140973,0.6431095406360424,0.9042726013104962,1.0,6/14,39.16%,ABCA4;GNA11;RP1;GNB1;SAG;PDE6A
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.3564678116995637,0.8475150220938165,0.6817558299039781,1.0,1.0,2/18,4.02%,ANXA1;ZFP36L1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3486278055901302,0.8472661637714786,0.675392670157068,1.0,1.0,7/22,18.96%,CALM3;DDX3X;RAP2A;MRE11;RAD50;RASSF2;CALM1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.28816360357820003,0.8470948917589399,0.7377398720682303,1.0,1.0,15/84,15.42%,WNT5A;GPLD1;PDPK1;RAC1;FGFR1;NRP1;PRKCA;ABL1;SPARC;EGF;PIK3CB;PLPP3;ROCK2;TGFB1;FOXC2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.30527993614988846,-0.8469906830834731,0.7117437722419929,0.9025010307006538,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.30527993614988846,-0.8469906830834731,0.7117437722419929,0.9025010307006538,1.0,6/15,22.86%,AP3D1;AP3S2;DTNBP1;AP3M2;BLOC1S5;SNAPIN
prerank,translational termination (GO:0006415),0.29024636224077627,0.8468660365227628,0.7505263157894737,1.0,1.0,26/95,22.85%,MRPL36;MTRF1L;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;GSPT1;CHCHD1;MRPL13;MRRF;MRPL24;MRPL15;ABCE1;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3236357430486848,-0.8465520548599818,0.688135593220339,0.9019964545388205,1.0,4/13,13.21%,CAB39;CAV1;ACTN2;NEDD4L
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3288461229378527,-0.8464464838253903,0.645367412140575,0.9007972118095848,1.0,3/11,16.00%,TGFB2;BMPR1A;BMP4
prerank,lipid translocation (GO:0034204),0.3477106601617982,0.8464445417153186,0.6644823066841415,1.0,1.0,5/21,10.47%,ATP9A;ATP8B2;ATP10B;ABCA7;ATP9B
prerank,regulation of neurotransmitter transport (GO:0051588),0.3656637394404686,0.8462128951851166,0.6815020862308763,1.0,1.0,5/16,18.68%,CPLX1;MCTP2;FMR1;MCTP1;FLOT1
prerank,glucose import (GO:0046323),0.3867739133254401,0.846205634493591,0.6855172413793104,1.0,1.0,3/13,16.50%,SLC27A4;SLC2A3;SLC27A1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2943423352524105,0.8460303824484275,0.7459807073954984,1.0,1.0,11/73,10.02%,WBP2;AEBP2;CREBZF;RBBP4;SF3B1;TBP;PHF1;EZH2;HDAC5;HDAC4;JARID2
prerank,protein autoprocessing (GO:0016540),0.3704452128972453,0.8460102935320685,0.6728476821192053,1.0,1.0,3/17,17.62%,MYRF;AFG3L2;OMA1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3320859036663738,0.8454060521958663,0.6880290205562273,1.0,1.0,1/29,1.78%,SIRT7
prerank,regulation of rRNA processing (GO:2000232),0.3698254929421712,0.8452270967971535,0.6653061224489796,1.0,1.0,3/16,8.48%,SIRT7;DIMT1;BUD23
prerank,regulation of defense response to virus by host (GO:0050691),0.3319657656654424,0.8452176597544316,0.6855421686746987,1.0,1.0,3/30,4.85%,TARBP2;HSP90AA1;TNFAIP3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.35321850773388863,0.8452147287273085,0.6613756613756614,1.0,1.0,4/19,15.76%,DCK;HPRT1;POLD3;GMPR2
prerank,phosphorylation (GO:0016310),0.27384529389339823,0.8448380446226492,0.885,1.0,1.0,89/385,20.76%,AATK;ILF3;XYLB;MAPK9;CAMK2B;STK36;EPHA7;EPHB2;PDPK1;PDK1;COQ8B;EIF2AK3;DMPK;CDKL5;HUNK;FGFR1;TAOK1;PICK1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;NUAK1;ABL1;PAK3;STK11;BRSK2;SIK1;GNPTG;TEC;FAM20C;NRBP2;PRAG1;WNK2;TOP1;BRSK1;PIK3CB;APP;GRK3;MAPK6;IGFBP3;STRADB;CAMK2D;TLK1;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;CHEK2;CTBP1;MAP3K1;CCNT1;TP53RK;STK25;CDK7;OXSR1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PGK1;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;DGKI;PRKCZ;CDK14;LYN;PTK2B;MAPKAPK2;PAK5;ACVR2A
prerank,regulation of primary metabolic process (GO:0080090),0.28091463067013395,0.8448026068575112,0.781855249745158,1.0,1.0,39/126,24.05%,FASN;HDAC3;PSMD4;SMARCD3;NR1D2;CHD9;PSMB10;CERS2;LSS;PSMD11;ABCA7;GPAM;SC5D;PSME2;IRS2;PSMC5;CYP51A1;PSAP;ROCK2;PSMD1;PSMD6;APOE;TBL1XR1;GPS2;NCOR2;ELOVL6;PSMD5;CARM1;GGPS1;PSMA4;PSMA1;PSMC6;ID2;NCOA1;SP1;PSMA5;RXRA;TGS1;NFYA
prerank,inner dynein arm assembly (GO:0036159),-0.3439255498195086,-0.844605915107631,0.6787709497206704,0.9031956886259397,1.0,2/10,18.77%,DNAAF5;CCDC39
prerank,ventricular septum development (GO:0003281),0.3153053146993898,0.8440440555814324,0.7055288461538461,1.0,1.0,13/37,23.02%,STRA6;MDM4;SOX11;ROBO2;ROBO1;SLIT3;HECTD1;TGFBR1;SOX4;TGFBR3;SMAD7;MATR3;DAND5
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.30409257994196054,-0.84360156204112,0.6738351254480287,0.9038788130616913,1.0,2/14,2.31%,SPRED1;CAV1
prerank,monocyte differentiation (GO:0030224),-0.34604881335934795,-0.843577656768928,0.6428571428571429,0.9024996258510216,1.0,6/10,22.05%,PIR;MT1G;THOC5;BMP4;VEGFA;PPARG
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3857826034762003,0.8435004063492115,0.6881258941344778,1.0,1.0,2/12,10.19%,SOX9;GDNF
prerank,fat cell differentiation (GO:0045444),-0.20350531494633153,-0.8432125006582224,0.7692307692307693,0.9018098359973291,1.0,25/57,30.53%,MED1;BBS9;SIRT1;ERAP1;SENP2;EP300;BBS2;BBS4;TMEM120B;PRDM16;ATF5;BSCL2;CTBP2;TMEM120A;C1QTNF3;PPARG;PPARGC1A;NR4A1;NR4A2;METRNL;HMGA2;CBY1;MAFB;TRIM32;MKKS
prerank,neuron differentiation (GO:0030182),0.28086807609568964,0.8432073102911946,0.8058943089430894,1.0,1.0,16/165,12.79%,WNT2B;WNT5A;XBP1;FZD3;CDK5;TENM3;BRSK2;WNT4;SPOCK1;NRBP2;SOX11;BRSK1;SMARCA1;IL1RAPL1;TDP2;MYEF2
prerank,acylglycerol catabolic process (GO:0046464),0.3306766668473698,0.8427362592142151,0.7017766497461929,1.0,1.0,1/30,0.96%,LPL
prerank,regulation of DNA recombination (GO:0000018),-0.24479824466573424,-0.8426675480051369,0.7298850574712644,0.901535670597373,1.0,11/32,26.22%,SETD2;SHLD2;SPIDR;ZRANB3;MSH2;BLM;SMARCAD1;RTEL1;PPP4R2;MSH6;H1-0
prerank,epithelial cell development (GO:0002064),0.350877073102794,0.8424183403250062,0.6899736147757256,1.0,1.0,1/20,1.42%,DACT2
prerank,glucose homeostasis (GO:0042593),0.2910196579963641,0.8419864584572961,0.7703703703703704,1.0,1.0,11/83,12.44%,HKDC1;LRRC8A;USF1;TCF7L2;PIK3R1;STK11;SELENOT;PIK3R2;LEPR;PARK7;HECTD4
prerank,peptidyl-tyrosine modification (GO:0018212),0.29732220295087314,0.8414385067382968,0.7145993413830956,1.0,1.0,8/56,11.29%,EPHB2;FGFR2;FGFR1;DDR2;ABL1;SRMS;TEC;PDGFRA
prerank,regulation of protein modification process (GO:0031399),0.3028010013655391,0.8412213175542375,0.7261640798226164,1.0,1.0,8/50,9.42%,KDM4D;WARS1;ABCA2;CDK9;FLCN;ATG14;PPIB;PUM3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.29162934694887954,-0.8411767511192549,0.6838487972508591,0.9031803774853576,1.0,8/16,22.78%,ATP5F1C;ATP5PO;ATP5F1E;ATP5PD;STOML2;ATP5F1B;DMAC2L;ATP5F1D
prerank,regulation of cardiac conduction (GO:1903779),0.3002688239878898,0.8411397154523187,0.7385474860335196,1.0,1.0,6/54,8.60%,DMPK;ATP1A3;ATP2A2;ITPR1;ATP1A2;ATP2B1
prerank,inner mitochondrial membrane organization (GO:0007007),0.3051987591869154,0.8410269920131883,0.7164351851851852,1.0,1.0,9/47,13.79%,APOOL;MICOS10;ATP5PF;TIMM13;APOO;ATP5MC3;AFG3L2;TIMM29;MTX3
prerank,positive regulation of type 2 immune response (GO:0002830),-0.303467395024113,-0.840943036808227,0.6729559748427673,0.90224849530174,1.0,7/14,38.99%,RARA;DENND1B;CD81;CD86;CD74;RSAD2;NOD2
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.33006891195901794,0.8406575937300805,0.6822660098522167,1.0,1.0,7/29,22.00%,CXCL12;MOSPD2;CREB3;SERPINE1;PLA2G7;CXCL17;HMGB1
prerank,vasodilation (GO:0042311),0.37737009093981366,0.8405984384082018,0.6781115879828327,1.0,1.0,2/13,12.24%,KCNMA1;SOD2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.2895948613451885,-0.8393293338972226,0.6507936507936508,0.9042578717333956,1.0,5/18,16.00%,EGFR;RIPK1;TP53;ESR1;BMP4
prerank,establishment of spindle orientation (GO:0051294),0.3257310268170109,0.8389524530500344,0.6911942098914354,1.0,1.0,10/28,23.05%,MAD2L1;GPSM2;HTT;NUMA1;MAP4;ZW10;PAFAH1B1;ITGB1;LLGL1;CDK5RAP2
prerank,cilium assembly (GO:0060271),0.2723810486237822,0.8387301082685665,0.8788788788788788,1.0,1.0,69/296,20.74%,CCP110;TMEM138;B9D2;CPLANE2;STK36;BBS10;HSP90AA1;IFT52;DCDC2;ACTR2;KIF3A;ARL13B;ATAT1;CLUAP1;ALMS1;TCTN1;BBOF1;BBS7;INPP5E;CEP97;SNX10;KIF3C;TRIP11;CDC14B;CCDC28B;TUBA1A;PIBF1;CFAP54;TTC8;YWHAG;CEP126;CC2D2A;IFT80;CYS1;CFAP20;CPLANE1;IFT20;PDE6D;DISC1;HAUS3;CSNK1D;ATP6V1D;TUBB;TMEM216;TTC21B;RFX3;TNPO1;OFD1;RAB8A;RAB8B;AHI1;CEP76;DNAAF3;NEK1;IQCB1;TUBB4A;NPHP1;ODF2;WDR35;KIFAP3;DYNLL1;PAFAH1B1;TMEM67;DCX;LZTFL1;TMEM80;EXOC5;EHD1;DYNC2H1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.33293243293853014,0.8386839924063332,0.677336747759283,1.0,1.0,6/24,18.95%,PDPK1;TNFAIP3;ICAM1;NDNF;SERPINE1;KRIT1
prerank,protein phosphorylation (GO:0006468),0.2708310410806577,0.838662500175108,0.923,1.0,1.0,110/479,20.88%,AATK;ILF3;MAPK9;CAMK2B;CAMK1G;STK36;INCENP;EPHB2;PDPK1;PDK1;COQ8B;CSNK2A2;EIF2AK3;DMPK;FGFR2;CDKL5;HUNK;FGFR1;TAOK1;HTATIP2;PICK1;DDR1;NUAK2;MINK1;MAP4K5;CDK13;PRKCA;CDK5;CDK9;MAST3;DDR2;NUAK1;ABL1;SRMS;PAK3;EPHA8;STK11;BRSK2;SBK1;SIK1;CIT;TEC;FAM20C;NRBP2;PRAG1;MUSK;GTF2H3;WNK2;TOP1;BRSK1;APP;GRK3;MAPK6;IGFBP3;USP15;STRADB;PDGFRA;CAMK2D;TLK1;CCNH;ATR;RPS6KA3;TLR3;PRKCI;DAPK1;CSNK1D;STK19;NEK3;NRBP1;ROCK2;TGFB1;GRK2;CSNK1A1;ACVR1B;RPS6KA1;CHEK2;CTBP1;MAP3K1;CCNT1;CAMK1D;TP53RK;TNKS;STK25;CDK7;OXSR1;ABI1;ILK;PRKD2;JAK1;NEK1;CDK10;SRPK1;TGFBR1;PRKAA1;CDC42BPB;PRKAG2;PIK3R4;NRK;CDKL2;CDK11B;PRKCZ;CDK14;LYN;PTK2B;TGFBR3;MAPKAPK2;PAK5;ACVR2A;NTRK2;SMAD7
prerank,SNARE complex assembly (GO:0035493),0.40057528820269206,0.838079691822234,0.68188302425107,1.0,1.0,3/10,20.44%,VAMP3;VAMP8;UVRAG
prerank,inositol phosphate-mediated signaling (GO:0048016),0.3554309637860725,0.8378237887585235,0.6767411300919842,1.0,1.0,5/19,21.03%,EDN3;INPP5A;NFAT5;HRH1;NFATC3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.34289347059955105,0.8373106108318438,0.6763157894736842,1.0,1.0,10/21,27.09%,TAOK1;CAMSAP2;KATNB1;FGF13;CLASP2;CAMSAP1;NAV3;ARHGEF2;HDGFL3;APC
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.29189707834818845,-0.8372977585741846,0.6885245901639344,0.906939078618994,1.0,7/15,23.62%,PRKD1;TMSB4X;KDR;MET;HSPB1;VEGFA;SEMA5A
prerank,chemical synaptic transmission (GO:0007268),0.27244302067258064,0.8366861254117035,0.879,1.0,1.0,49/284,18.29%,SYT10;CACNB4;UNC13A;GRIN1;PDE7B;OPRK1;MINK1;CDK5;GRIK5;DVL1;HCRTR2;GRIN2A;SDCBP;DNAJC5;CPLX1;SCN2B;GABRB3;CACNB1;SNAP25;BRSK1;HCRTR1;RIC3;GRIA1;NLGN3;HTR2C;SYT1;RPS6KA3;CHRM2;SLC1A3;KCNA1;TBC1D24;GRIA2;NOVA1;NLGN2;GLRA1;KCNQ2;RPS6KA1;SYN2;DLGAP1;RIT2;DLG2;GPR176;APOE;HRH1;SLC1A2;SYNJ2BP;DTNA;PRKAR1A;GABRG3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2919128604559968,0.8365053717091092,0.7411894273127754,1.0,1.0,11/66,14.28%,HDAC3;CCT8;EIF2AK3;PIK3R1;CCT6A;CDK5RAP3;JUP;PIK3R2;PARK7;LAMTOR5;TGFB1
prerank,post-translational protein modification (GO:0043687),0.27122809822178046,0.8362489466290971,0.9019019019019019,1.0,1.0,54/332,17.27%,COPS7A;CUL7;SPSB3;PSMD4;FBXW10;CP;ASB5;SPSB1;KCTD7;FBXL12;FSTL1;OBSL1;FBXL14;WSB2;FBXO7;COP1;LAMC1;UBXN7;FBXO31;PSMB10;DDB1;MIA3;UCHL3;CKAP4;FBXW5;PSMD11;LTBP1;COPS7B;FAM20C;APLP2;CUL4B;MBTPS1;PSME2;PSMC5;APP;IGFBP3;IGFBP7;DCAF5;FBN1;RAB13;LAMB1;NEURL2;CUL5;KLHL5;FEM1C;PSMD1;KLHL13;RAB8A;SERPIND1;NEDD8;PSMD6;MXRA8;APOE;FBXO22
prerank,primary miRNA processing (GO:0031053),0.3980249723366147,0.836031401714854,0.6846846846846847,1.0,1.0,5/10,22.11%,DGCR8;PUS10;HNRNPA2B1;SMAD2;SMAD3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3335317991134672,0.8360150899254449,0.6873350923482849,1.0,1.0,8/22,21.64%,TNFAIP3;TIRAP;IFI35;PTPN22;FLOT1;LYN;APPL2;RAB7B
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.32939730856367017,0.8359215925433486,0.7023661270236613,1.0,1.0,8/26,22.22%,DDX3X;TIRAP;IFI35;TLR3;PTPN22;FLOT1;HMGB1;PJA2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.3478695826362979,0.8357228819796044,0.7,1.0,1.0,6/20,20.58%,ZFP36L1;HOXB8;PRMT1;CDC73;MEIS2;PTK2B
prerank,histone ubiquitination (GO:0016574),0.34050885137869813,0.8356368274404841,0.6816380449141347,1.0,1.0,6/21,18.64%,RNF8;RNF40;UBE2A;CDC73;UBE2E1;USP22
prerank,response to thyroid hormone (GO:0097066),-0.3187830829450578,-0.8353717831453713,0.6862068965517242,0.9094431388965296,1.0,4/13,10.85%,RDX;MED1;CTSL;LMO2
prerank,determination of bilateral symmetry (GO:0009855),0.33494039732917685,0.8350783760458067,0.7042801556420234,1.0,1.0,2/24,6.59%,BBS7;ZIC3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.376450606340916,0.8348258282255973,0.7044476327116213,1.0,1.0,5/14,21.34%,AK4;AK5;AK3;CMPK1;ME1
prerank,regulation of vasculogenesis (GO:2001212),-0.2992907710619126,-0.8346576532609252,0.6518771331058021,0.9094058179643872,1.0,6/14,28.20%,CD34;KDR;HIF1AN;CEACAM1;HEY2;RRAS
prerank,positive regulation of cell motility (GO:2000147),0.27075443843106967,0.8346030960463785,0.8515546639919759,1.0,1.0,31/205,15.68%,CARMIL2;IGF1;EPHB2;ELP6;FAM83H;NTF3;XBP1;CXCL12;PRKCA;SNAI1;CD151;RHOD;SDCBP;EGF;RIPOR1;SEMA3D;TWIST1;MAZ;PDGFRA;SOD2;CFAP20;RACK1;SPOCK2;ROR2;LAMB1;ROCK2;TGFB1;SEMA3E;F3;SEMA3A;CTSH
prerank,regulation of cholesterol transport (GO:0032374),0.3468451859157256,0.8344684698165725,0.675,1.0,1.0,5/20,20.04%,NFKB1;ABCA2;LRP1;TTC39B;ABCA5
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3258337440928384,-0.8344451450943767,0.6862745098039216,0.9083940923219774,1.0,4/12,10.85%,RDX;MED1;CTSL;LMO2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.3295061431221359,0.8344187275256658,0.6758448060075094,1.0,1.0,3/25,6.29%,DNAJC7;DNAJB5;BAG1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3469303634014098,-0.8342774524437503,0.6884735202492211,0.9073266713853307,1.0,5/10,32.06%,MTMR3;MTMR9;MFSD2A;MTMR2;PHB2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.33254358791073746,0.8341588570147862,0.6960408684546615,1.0,1.0,9/23,20.70%,TUBA1A;HOOK3;KIF5C;TUBA1B;TUBB;KIF5B;CCDC88A;MAP6D1;MAP6
prerank,mitochondrion localization (GO:0051646),0.34998257157290047,0.8337715921389426,0.7011642949547219,1.0,1.0,6/19,18.34%,MSTO1;MFN1;MFN2;ZBED3;TRAK1;ATCAY
prerank,transcription by RNA polymerase II (GO:0006366),0.27103217949025826,0.8331197843178496,0.8778778778778779,1.0,1.0,85/305,22.77%,HDAC3;TEAD3;RPRD2;NFKB1;SLBP;PARP1;TAF9B;NR1D2;XBP1;RORA;TFDP1;TAF4;POU2F1;POLR2B;CDK13;CDK9;TFCP2;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;TEAD1;SNAPC4;HDAC5;MED4;NFX1;NRBF2;CPSF7;PRRX1;GTF2H3;TCEA1;TAF6;RBPJ;CSTF2T;MAZ;NUDT21;E2F3;NFIX;POLR2K;CCNH;CPSF3;HDAC1;TSC22D1;SETX;CBFB;CDC73;NRBP1;ESRRG;GTF2E1;SOX5;NR2C2;MED23;DDX5;MAF;SNW1;CCNT1;MBD1;CDK7;NABP2;TBL1XR1;NELFA;NCOR2;INTS6;KLF13;FIP1L1;CSTF3;MLLT3;INTS2;PKNOX1;ELP2;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;INTS7;SNAPC3;GTF2F2;TAF1;GTF2B;MED17;BTF3;RPAP2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.32455443060428646,0.8330544966388119,0.6919315403422983,1.0,1.0,3/29,4.92%,IFNAR1;STAT6;IL31RA
prerank,hyaluronan metabolic process (GO:0030212),0.3339987185621754,0.8326715964335221,0.6984924623115578,1.0,1.0,5/23,21.29%,LYVE1;TGFB1;CEMIP;GUSB;FGF2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2727694948997925,0.8326645510987365,0.8126888217522659,1.0,1.0,36/166,19.78%,IGF1;GPLD1;ZEB2;HSP90AA1;RBM3;DDX3X;ZNF205;DDB1;ARNT;NOS1AP;HNRNPD;NNMT;EGF;IRS2;PTH1R;ZCCHC4;BRPF3;YTHDF3;PARK7;NPM1;PRMT1;YTHDF1;PTGS2;PRR16;FAF1;SLC27A1;FMR1;SLC25A37;PRKD2;PKD2;ASS1;METTL5;ARPP19;SOX4;KLF4;CIRBP
prerank,peptidyl-lysine methylation (GO:0018022),0.3337361420669614,0.8326561850585744,0.6915422885572139,1.0,1.0,6/26,15.49%,ETFBKMT;SETD7;EHMT2;SUV39H1;EHMT1;ATPSCKMT
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.24875939525242816,-0.8325753652916146,0.7079207920792079,0.9093549504293169,1.0,5/27,9.60%,CTNNA3;CAV1;CACNA1C;AKAP9;SRI
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.30305825191640623,0.8325740004979392,0.7144508670520231,1.0,1.0,10/48,21.79%,PDPK1;CALM3;THY1;CAMK2D;JPH1;CEMIP;CALM1;PTK2B;DIAPH1;CALM2
prerank,carboxylic acid transport (GO:0046942),0.2965081089599692,0.8325614139922067,0.7217294900221729,1.0,1.0,9/55,16.34%,SLC17A5;CLN3;SLC6A11;SLC16A12;PSAP;SLC6A15;SLC1A5;SLC6A12;SLC6A13
prerank,regulation of angiogenesis (GO:0045765),0.27220413247379127,0.8322338632433424,0.8474747474747475,1.0,1.0,45/192,21.29%,SFRP2;WNT5A;SFRP1;PDPK1;THBS2;WARS1;HTATIP2;XBP1;TNFAIP3;PRKCA;SULF1;DCN;GAB1;SPARC;HGS;GLUL;TWIST1;ATF2;JUP;SARS1;ADAM12;EMP2;ROCK2;SEMA3E;F3;CTSH;HSPG2;ADGRA2;ADAMTS1;SERPINE1;SPRY2;MTDH;PRKD2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;PDCD6;SERPINF1;ITGB1;ATP2B4;FOXJ2;FGF2
prerank,glutamate receptor signaling pathway (GO:0007215),0.31404968256468496,0.8312183405099921,0.7171129220023282,1.0,1.0,12/37,24.55%,CLN3;GRIN1;GRIN2A;APP;GRIA2;FMR1;GNAQ;PTK2B;GRIA4;GRIK2;GRIN3A;GRIK1
prerank,intracellular pH reduction (GO:0051452),0.31836047836917786,0.8310702134692658,0.7157894736842105,1.0,1.0,7/33,16.35%,ATP6V0A2;ATP6V0E2;ATP6V1G1;TCIRG1;ATP6V0A4;ATP6V1D;ATP6V1B2
prerank,collagen fibril organization (GO:0030199),0.28136059440180217,0.8309695245746228,0.7646443514644351,1.0,1.0,22/88,18.81%,COL27A1;P4HA1;COL4A6;COL4A5;PLOD1;DDR2;CD151;COL22A1;PPIB;P4HA2;COL1A2;CRTAP;ADAMTS3;PXDN;P3H2;COL5A2;LUM;COL11A1;BMP1;TGFBR1;COL5A3;COL8A2
prerank,activation of phospholipase C activity (GO:0007202),-0.24371116574197826,-0.8309154681042612,0.7277777777777777,0.9111591943178469,1.0,15/29,42.22%,EGFR;EDNRA;PLCG1;ADRA1A;P2RY12;HTR2A;BDNF;CD86;PHB2;P2RY6;LPAR2;HTR2B;ANG;TXK;RASGRP4
prerank,snRNA metabolic process (GO:0016073),0.35673986944442754,0.830888083057584,0.6950067476383266,1.0,1.0,8/17,24.58%,ZCCHC8;MTREX;INTS6;INTS2;RBM7;INTS7;INTS10;INTS9
prerank,peptidyl-proline modification (GO:0018208),0.3323125899086478,0.8306272503050208,0.699501246882793,1.0,1.0,5/25,9.58%,PPIF;NKTR;NTMT1;PPIB;PPIH
prerank,positive regulation of macrophage migration (GO:1905523),0.3469201819355613,0.8306264763561163,0.6995994659546061,1.0,1.0,1/19,1.28%,IL34
prerank,receptor metabolic process (GO:0043112),0.30335131242203367,0.8300532620968293,0.7219132369299222,1.0,1.0,16/53,23.41%,MVB12A;DNM1;ADM;GRK3;LRP1;TGFB1;GRK2;RAB31;SMURF1;PIK3R4;UVRAG;ITGB1;CD9;EHD3;RAB11B;SH3GLB1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3836602746320912,0.8299667667379453,0.6962025316455697,1.0,1.0,2/12,7.68%,EPHB2;MYCBP2
prerank,regulation of neuron death (GO:1901214),0.28472049178309594,0.8298420994546871,0.7600849256900213,1.0,1.0,16/82,18.00%,WNT5A;FCGR2B;CDK5;CD200R1;INPP5A;EFNB2;PARK7;LANCL1;EGLN2;MAPT;CTSZ;FAIM2;DAXX;DCC;SORL1;RRAS2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.37013033436871107,0.8296117953071556,0.6957123098201936,1.0,1.0,6/14,23.12%,ATR;ATRX;TNKS;NABP2;TERF2IP;PINX1
prerank,regulation of complement activation (GO:0030449),0.30657417174226154,0.8295273761005069,0.7160919540229885,1.0,1.0,2/40,5.04%,VTN;SERPING1
prerank,modified amino acid transport (GO:0072337),0.3587187625665498,0.8293488294181799,0.6763085399449036,1.0,1.0,3/15,16.34%,SLC16A12;SLC6A8;SLC6A13
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.35856789530433486,0.8292606441612842,0.6798866855524079,1.0,1.0,3/16,16.46%,PRKCA;PRMT5;MRAP2
prerank,negative regulation of synaptic transmission (GO:0050805),-0.24622209294610117,-0.829172200951725,0.735,0.9132924486657963,1.0,7/23,18.61%,ATAD1;SLC24A2;LRRK2;SHANK2;PLK2;GRIK3;PRRT1
prerank,aminoglycan metabolic process (GO:0006022),0.4035434629357167,0.8289628059751485,0.6971080669710806,1.0,1.0,1/10,2.20%,CLN6
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2950354110706325,0.8287135268215182,0.7447280799112098,1.0,1.0,10/58,10.65%,RNF8;PAXX;BARD1;LIG3;IFFO1;RNF168;XRCC6;UBE2V2;MDC1;DCLRE1A
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.2915226347278477,-0.8283699379041717,0.6955017301038062,0.9134533319313651,1.0,3/15,11.10%,RAPGEF3;EHD2;CAMK1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3426504867030727,0.8282558517166524,0.7074742268041238,1.0,1.0,8/22,20.31%,BARD1;DMTN;INSIG1;PARK7;SUFU;ITGB1BP1;BAG4;CABP1
prerank,fatty acid transmembrane transport (GO:1902001),-0.27534582705356403,-0.8281883749122083,0.7131147540983607,0.9124030129547747,1.0,5/19,14.03%,SLC2A1;ACACA;PRKAB2;ACACB;PRKAA2
prerank,response to estradiol (GO:0032355),0.3176948504373027,0.8281614769029184,0.7035236938031592,1.0,1.0,2/31,3.76%,SFRP1;ANXA1
prerank,prostaglandin biosynthetic process (GO:0001516),0.34762181956834093,0.8278455664352391,0.7110817941952506,1.0,1.0,1/18,0.44%,PRXL2B
prerank,regulation of extracellular matrix organization (GO:1903053),0.3612208132484154,0.8274107804700003,0.7097203728362184,1.0,1.0,3/15,13.61%,DDR1;DDR2;LRP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3275999613740295,0.8272622308143168,0.7146401985111662,1.0,1.0,5/27,15.53%,THY1;SIRPA;NFAT5;CD47;HSPD1
prerank,cellular response to estradiol stimulus (GO:0071392),0.34726028202779113,0.8270965952719752,0.7054161162483488,1.0,1.0,1/18,1.12%,SFRP1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3628118504843446,0.826729127080651,0.6911357340720221,1.0,1.0,4/14,17.60%,SLC25A33;EARS2;TFB1M;FASTKD1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.2972110674913569,0.826589498996765,0.732650739476678,1.0,1.0,12/52,17.25%,EPHB2;PDPK1;PIK3R1;SQSTM1;CLIP3;GPSM2;PRKCI;LRP1;DPP10;SPTBN1;NUMA1;KIF5B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38540466673755647,0.8265891374852381,0.7083946980854198,1.0,1.0,4/11,18.54%,FBXO7;PARK7;RACK1;NONO
prerank,long-term synaptic potentiation (GO:0060291),0.34409201220019214,0.8265774539044027,0.6990801576872536,1.0,1.0,5/21,20.58%,MPP2;GRIN2A;NPTN;PRKCZ;PTK2B
prerank,transcription by RNA polymerase I (GO:0006360),-0.22774551652184966,-0.825663437706853,0.8106508875739645,0.915954895625858,1.0,10/34,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,nuclear membrane reassembly (GO:0031468),0.2946797214242966,0.8255951753374074,0.7311946902654868,1.0,1.0,7/54,9.85%,REEP4;SIRT2;UBXN2A;CC2D1B;KPNB1;CHMP3;NUP188
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.35337047303498337,0.8255021587072779,0.6751336898395722,1.0,1.0,3/16,11.50%,CALM3;ATP1A2;CAMK2D
prerank,stress-activated MAPK cascade (GO:0051403),0.2960894392551007,0.8254579078520121,0.7552370452039692,1.0,1.0,5/61,4.55%,MAPK9;PTGER4;NFKB1;ZFP36L1;MINK1
prerank,muscle cell migration (GO:0014812),0.38653635948751874,0.8253059493625421,0.6862745098039216,1.0,1.0,3/10,16.76%,DDR1;PLAT;ITGB1BP1
prerank,insulin receptor signaling pathway (GO:0008286),0.28666578597792225,0.8251526715335872,0.7591397849462366,1.0,1.0,15/69,16.91%,GPLD1;ATP6V0A2;PIK3R1;GAB1;ATP6V0E2;BAIAP2;IRS2;ATP6V1G1;PIK3R2;TCIRG1;ATP6V0A4;ATP6V1D;FOXC2;ATP6V1B2;PHIP
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.31453970124337416,-0.8251364087348748,0.6936026936026936,0.9155606725432456,1.0,4/12,11.55%,SORBS1;IRS1;SIRT1;IGF2
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3304146952049283,-0.8249282989128088,0.6965944272445821,0.914576685127944,1.0,4/11,31.79%,PTPRC;AHR;CEACAM1;HFE
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.25856863806323876,-0.8248533653605341,0.7397769516728625,0.9133255221006031,1.0,15/20,41.95%,SEMA6A;SEMA7A;SEMA4D;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;SEMA3G;SEMA6B;SEMA4C;SEMA6D;SEMA4A;SEMA4G;SEMA3F
prerank,anion transmembrane transport (GO:0098656),0.2899796563597768,0.8245897729519834,0.7602150537634409,1.0,1.0,13/67,17.80%,SLC35B1;SLC25A19;LRRC8A;SLC16A12;SLC7A2;SLC13A4;SLC25A38;SLC6A8;SLC1A3;SLC25A1;SLC6A13;SLC27A1;SLC1A2
prerank,regulation of focal adhesion assembly (GO:0051893),0.29147288210577627,0.8243753813812605,0.743078626799557,1.0,1.0,6/54,6.44%,SFRP1;RAC1;NRP1;ABL1;THY1;DMTN
prerank,magnesium ion transport (GO:0015693),0.37866406509420664,0.8242591543589236,0.691285081240768,1.0,1.0,4/12,14.06%,MMGT1;NIPAL3;NIPAL2;SLC41A1
prerank,histone lysine demethylation (GO:0070076),0.3243357289503976,0.8233885450505687,0.7003841229193342,1.0,1.0,6/25,19.43%,KDM4D;KDM7A;KDM2B;KDM6B;KDM3B;KDM6A
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2964420531470994,0.8232596204727844,0.7528089887640449,1.0,1.0,16/50,23.12%,SIRT7;OGT;TNFAIP3;ABL1;SQSTM1;FBXO5;ARRB1;PARK7;USP4;SPRY2;SOX4;RPS3;SMAD7;TAF1;U2AF2;PINX1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3060529706271162,0.8231988639689266,0.7292161520190024,1.0,1.0,11/39,19.22%,ERRFI1;ARHGEF7;HGS;EGF;MVP;PTPN3;CBL;PTPN12;SPRY2;STAM2;EPN1
prerank,membrane depolarization (GO:0051899),0.317969109015245,0.8228840252108083,0.716824644549763,1.0,1.0,5/32,10.99%,CACNB4;SCN7A;ABL1;YWHAH;SCN1A
prerank,vesicle organization (GO:0016050),0.30150373559889493,0.8226757986114487,0.7453488372093023,1.0,1.0,13/46,19.06%,DNM1;SAR1A;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;SNX11;DNAJC13;VPS18;ZFYVE16;USP50
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.27165715135792057,-0.8225750337543769,0.6972477064220184,0.9163794338661803,1.0,2/18,1.25%,ANKRD17;PUM1
prerank,oxoacid metabolic process (GO:0043436),-0.2433685998952015,-0.8224002276939038,0.7386934673366834,0.9153276276756104,1.0,7/27,18.32%,DDO;BPNT2;MINPP1;THAP4;TPST2;PPA1;BPNT1
prerank,axonal transport (GO:0098930),0.3102897875186214,0.8222843058806523,0.7159763313609467,1.0,1.0,9/36,19.92%,NEFL;KIF3A;TMEM108;AP3B1;BLOC1S2;MAPT;RAB21;AP3B2;PAFAH1B1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.2380425593178585,-0.8219407248593991,0.7848837209302325,0.9148317443026471,1.0,6/30,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,microtubule nucleation (GO:0007020),-0.26848890131044306,-0.8218086782937576,0.7532467532467533,0.9137129737499528,1.0,5/19,16.85%,TUBGCP5;AKAP9;TUBGCP6;NDE1;SLAIN2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.24045692582204947,-0.8217197922819668,0.7388888888888889,0.9125186245112449,1.0,6/29,10.78%,IKBKB;RIPK1;TLR4;IKBKE;UBB;IKBKG
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.310649793868656,0.8215727409517987,0.7261904761904762,1.0,1.0,6/35,11.29%,NTF3;NRP1;CDK5;ABL1;BAIAP2;PDGFRA
prerank,mRNA methylation (GO:0080009),0.3611080887573896,0.8213760203090409,0.6994301994301995,1.0,1.0,1/15,0.77%,TRMT61B
prerank,histone H3-K4 trimethylation (GO:0080182),0.3918216509924031,0.8210730272193687,0.7182481751824817,1.0,1.0,4/11,18.37%,OGT;SETD1A;KMT2D;KMT2A
prerank,heart looping (GO:0001947),-0.21977481926246806,-0.8210078071735056,0.8027210884353742,0.9124874767301394,1.0,11/39,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,limb morphogenesis (GO:0035108),0.33799008801506886,0.8206587220238978,0.6909814323607427,1.0,1.0,5/20,16.45%,PCSK5;NIPBL;PTCH1;CYP26B1;MEGF8
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.31216052190889915,0.8203147962731554,0.7257072570725708,1.0,1.0,8/33,18.95%,PDPK1;TNFAIP3;TCF7L2;NUPR1;ICAM1;NDNF;SERPINE1;KRIT1
prerank,negative regulation of cell cycle (GO:0045786),0.285227820805368,0.8201910546472345,0.7764705882352941,1.0,1.0,14/73,17.73%,HEXIM1;NR2F2;MAD2L1;HECA;SCRIB;TRIM35;BRINP3;TAF6;PTPN3;IPO7;TGFB1;NUPR1;BRINP1;CAMK2N1
prerank,regulation of AMPA receptor activity (GO:2000311),0.32562328991761513,0.820061849032359,0.7075351213282248,1.0,1.0,7/25,19.05%,CACNG3;MINK1;NLGN3;NLGN2;CACNG4;SHISA9;SHANK1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.3188652936156171,0.82003660861825,0.702801461632156,1.0,1.0,2/30,1.24%,SFRP1;SP7
prerank,negative regulation of autophagosome assembly (GO:1902902),0.37477240404583534,0.8199369780682805,0.7064748201438849,1.0,1.0,6/13,21.47%,PHF23;SCFD1;FEZ2;NUPR1;CHMP4A;CHMP4B
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3751319685415988,0.8195311345977072,0.6980568011958147,1.0,1.0,1/11,1.32%,DDT
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.30137899211056096,0.8194988761557417,0.7302857142857143,1.0,1.0,5/41,12.62%,CHERP;GRIN1;ITPR1;GRIN2A;HTR2C
prerank,positive regulation of cell cycle (GO:0045787),0.2893367370248469,0.8190621220151426,0.7412663755458515,1.0,1.0,12/62,18.64%,PSRC1;FGFR2;MAPRE3;PRKCA;USP2;APP;USP19;NUPR1;MDM2;MEIS2;PKD2;USP22
prerank,ion transport (GO:0006811),0.2737321941748337,0.8189540773719897,0.7849794238683128,1.0,1.0,15/111,15.90%,SLC17A5;SLC24A5;LRRC8A;GRIN1;SLC20A2;TMEM63C;VDAC2;SLC39A1;SLC24A4;TRPM3;VDAC1;SLC1A3;GLRA1;SLC9A7;SLC9A6
prerank,clathrin coat assembly (GO:0048268),0.36112477616030847,0.818806864936511,0.6873239436619718,1.0,1.0,2/15,9.83%,CALY;AP2S1
prerank,steroid catabolic process (GO:0006706),0.38877006443603246,0.8187349860718672,0.7158218125960062,1.0,1.0,1/10,8.88%,YWHAH
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26715769697166253,0.818199459739714,0.8714859437751004,1.0,1.0,56/234,22.18%,WNT5A;DVL2;STK36;CRTC1;NFKB1;NKX6-1;TFDP1;NFKB2;EDA2R;TIRAP;CARD16;DDR2;SMARCB1;DHX33;HDAC5;LRP8;TRIM62;DDIT3;CRTC3;HDAC4;TRIM41;MALT1;ATF2;APP;JUP;RTKN2;PARK7;NPM1;CEBPG;LAMTOR5;PLPP3;PRKCI;ZIC2;ADCY1;TCF3;CLOCK;IL1RAP;CAMK1D;MTDH;EPHA5;PRKD2;TAB1;TERF2IP;FLOT1;TRIM27;RPS3;PRKCZ;TAB3;FZD2;MID2;RAB7B;TRIM26;UBE2V1;TRAF2;SMAD3;TAF1
prerank,positive regulation of phosphatase activity (GO:0010922),0.3383077195821066,0.8181158239777319,0.7190412782956058,1.0,1.0,2/21,3.09%,GPLD1;CALM3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3001818569741777,0.8180936920559646,0.7294520547945206,1.0,1.0,4/43,8.37%,APLN;GNL3;TEAD1;SOX9
prerank,muscle cell differentiation (GO:0042692),0.3157502040752196,0.817923541783396,0.7363304981773997,1.0,1.0,3/32,5.48%,NEB;RORA;MRTFA
prerank,T cell differentiation in thymus (GO:0033077),0.36783094344909156,0.8178965511887798,0.6924157303370787,1.0,1.0,1/14,4.02%,ZFP36L1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.31516451796802036,0.8175823081889272,0.7142857142857143,1.0,1.0,9/29,17.44%,TCF7L2;HDAC1;AXIN2;PYGO2;CDC73;PYGO1;KMT2D;TCF7L1;TCF7
prerank,positive regulation of cellular component movement (GO:0051272),0.3284370047238556,0.8173835945829918,0.7104591836734694,1.0,1.0,6/24,20.46%,STK11;TWIST1;CFAP20;SPOCK2;TGFBR1;LYN
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.20040874392831565,-0.8172940845955852,0.9142857142857143,0.9182866842536036,1.0,19/55,21.52%,PSMB7;CUL1;RBX1;SKP1;PSMB2;PSMD7;PSMA6;PSMC2;PSMD13;PSMF1;PSMC1;PSMD9;PSMD2;PSMB3;ATF5;PSMC3;AVEN;PSMD3;PSMD8
prerank,cellular response to interleukin-12 (GO:0071349),0.295587520356131,0.817075399870901,0.7411630558722919,1.0,1.0,11/48,18.03%,LCP1;SIRPA;AIP;PSME2;CAPZA1;SOD2;CD47;HNRNPA2B1;HNRNPDL;ANXA2;JAK1
prerank,regulation of MAPK cascade (GO:0043408),0.2666545523183439,0.8169255349963478,0.8143289606458123,1.0,1.0,39/157,22.00%,ATP6AP2;IGF1;EPHA7;FGFR2;FGFR1;TAOK1;MINK1;FGF10;TMEM106A;PAK3;EPHA8;DHX33;CD24;GPR37;EGF;ABCA7;PIK3R2;IQGAP1;DAG1;ROR2;LPAR1;RNF41;ROCK2;MAP2K2;RIT2;ZDHHC17;KSR1;NRK;PELI2;WWC1;PRDM15;LYN;TGFBR3;PAK5;NTRK2;MAP4K4;FGF2;RYK;HMGB1
prerank,metanephric mesenchyme development (GO:0072075),0.3911651269385887,0.8168411021977579,0.7052785923753666,1.0,1.0,3/10,18.02%,WNT4;OSR1;PKD2
prerank,translesion synthesis (GO:0019985),-0.2141413719037717,-0.8167182093632012,0.8095238095238095,0.9179571098305426,1.0,29/42,42.89%,REV3L;ZBTB1;TRIM25;RPA1;UBB;REV1;PARP10;PRIMPOL;RFC2;SPRTN;PCNA;POLE2;POLK;POLI;UBE2L6;ISG15;FAAP20;RPA3;RCHY1;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.34280909733474485,0.8166315536694416,0.7230359520639148,1.0,1.0,3/20,14.35%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,regulation of integrin activation (GO:0033623),0.3591048535754686,0.8166141626432625,0.7024793388429752,1.0,1.0,3/15,15.66%,PTGER4;JAM3;FARP2
prerank,smoothened signaling pathway (GO:0007224),0.3123349806732825,0.8165662724830485,0.727710843373494,1.0,1.0,4/32,10.88%,STK36;ARL13B;PTCH1;CC2D2A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.3705843102304527,0.8165576078722504,0.699859747545582,1.0,1.0,2/13,10.24%,NTHL1;UPP2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.32194025238591684,-0.8163991898106264,0.7092651757188498,0.9170971201168658,1.0,3/11,9.31%,SEMA6A;THBS1;EPN2
prerank,cellular response to light stimulus (GO:0071482),0.2823282430728075,0.8162993746004975,0.7620087336244541,1.0,1.0,9/66,12.82%,PARP1;SDE2;USP47;CDC25A;DHX36;CASP9;YY1;NPM1;ATR
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3206511986021652,0.8161272156194397,0.699873896595208,1.0,1.0,8/26,20.27%,SFRP1;PER1;CNOT9;HDAC1;VPS18;CLOCK;NCOR2;DAB2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3128750937860217,0.8159161847728217,0.7311435523114356,1.0,1.0,2/31,9.55%,FCGR2B;SOX11
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28329614790019525,0.8154907224780422,0.7505518763796909,1.0,1.0,16/65,19.22%,MVB12A;ERRFI1;ARHGEF7;HGS;EGF;MVP;CNOT9;PTPN3;ARAP1;CBL;RHBDF1;PTPN12;SPRY2;STAM2;CCDC88A;EPN1
prerank,protein localization to cell periphery (GO:1990778),0.2729147836352468,0.8154384348168244,0.8290946083418108,1.0,1.0,38/133,21.40%,TMEM150A;PRAM1;ANK1;RAB34;SEC16A;RAP2A;RAB12;ZDHHC3;PTCH1;RAB10;DENND4C;RAB3B;JUP;ANK3;SLMAP;MYO5A;MAP7;RAB13;EMP2;ROCK2;DPP10;EPB41L3;AP4M1;SPTBN1;RAB8A;RAB8B;MRAP2;ITGB1BP1;PACS1;SMURF1;ZDHHC2;PIP5K1A;FLOT1;RABEP1;EHD1;SPTBN4;FGF13;CLASP2
prerank,establishment of vesicle localization (GO:0051650),-0.2631452992658837,-0.8150851391213944,0.7521008403361344,0.9181433683793756,1.0,5/18,11.67%,CCDC186;SPG11;RAB27A;IKBKG;LIMK2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3053675823256866,0.8150304718374045,0.7309048178613397,1.0,1.0,10/36,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.36133082032682406,0.8149889484958542,0.7243319268635724,1.0,1.0,2/14,8.62%,WNT5A;GPRC5B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.24013921030956126,-0.8148073896092394,0.7128205128205128,0.9173199087885263,1.0,12/26,32.34%,TLR4;RARA;CDK6;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;C1QC;ZFPM1;GPR137;PTPN2
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3278896628975038,0.8139400983776163,0.7296954314720813,1.0,1.0,9/24,20.27%,DMTN;TMBIM1;PID1;TGFB1;MRAP2;ITGB1BP1;PPP2R5A;LZTFL1;DAB2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3296865431699686,0.8138103544874407,0.7214854111405835,1.0,1.0,4/22,11.33%,EIF2AK3;SMARCB1;DHX33;IPPK
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2785019538125047,0.8134929699819268,0.7927736450584485,1.0,1.0,11/87,10.46%,CDKN2D;PSMD4;ZFP36L1;USP47;FBXO5;PSMB10;WEE1;PSMD11;RBL2;PSME2;PSMC5
prerank,regulation of embryonic development (GO:0045995),0.30717945934754487,0.8133937847909553,0.7351154313487241,1.0,1.0,11/34,21.40%,NIPBL;DHX36;DAG1;B4GALT5;EHMT1;ZBED3;NR2C2;PHLDB1;TRIP12;CFL1;CLASP2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.3066979152607192,-0.8130403562747477,0.7403846153846154,0.9192530809923113,1.0,3/12,8.36%,CNOT1;CALR;ASXL1
prerank,sulfur amino acid metabolic process (GO:0000096),0.3296109809815254,0.8128867968602335,0.7183098591549296,1.0,1.0,4/24,16.81%,ADO;SMS;GCLC;DPEP1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.27983021732580565,0.8126387973694046,0.7744034707158352,1.0,1.0,25/69,24.78%,RPRD2;POU2F1;POLR2B;CDK9;TBP;GTF2A2;SNAPC4;TAF6;POLR2K;GTF2E1;CCNT1;CDK7;NABP2;INTS6;INTS2;CCNT2;INTS7;SNAPC3;GTF2F2;GTF2B;RPAP2;SP1;INTS10;INTS9;INTS13
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3618981432953657,0.812164911309891,0.7098150782361309,1.0,1.0,1/14,1.58%,BAX
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.24199209624967424,-0.8121642582401932,0.7627906976744186,0.9195649039426669,1.0,10/26,26.56%,ADIPOR1;ERLIN1;PRKAB2;NR1H3;PRKAA2;ADIPOR2;ELOVL5;NR1H2;CEACAM1;SLC45A3
prerank,cell junction organization (GO:0034330),0.28469456963270945,0.8120860376558727,0.7745415318230853,1.0,1.0,17/71,19.89%,PPFIA4;CTNND2;PAK3;DVL1;CAPZA1;APP;NLGN3;PRKCI;MAPT;TGFB1;NLGN2;VMP1;SEMA3E;RAB8B;ILK;PPFIBP1;MYO9A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3326367322094581,0.8119812841278711,0.7300131061598951,1.0,1.0,3/20,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.24129585483379767,-0.8117982105890496,0.8029556650246306,0.918848496497404,1.0,13/24,30.70%,LATS1;TMF1;UCHL5;PRKACA;UBB;PINK1;CTSC;NUB1;GPX1;PSME3;PKD1;PSME1;EFNA1
prerank,basement membrane organization (GO:0071711),0.3645933253966709,0.8108493284164218,0.6978723404255319,1.0,1.0,4/14,14.59%,FLRT2;NTNG2;LAMB1;PXDN
prerank,regulation of interleukin-8 production (GO:0032677),0.2786162316261741,0.8107763166234185,0.7689839572192514,1.0,1.0,13/69,18.02%,ANXA1;TIRAP;ARRB1;DDIT3;SSC5D;PARK7;LAMTOR5;TLR3;PTPN22;F3;SERPINE1;ANXA4;PRKD2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3205092103895437,0.810172600062936,0.7279894875164258,1.0,1.0,6/24,16.45%,NRP1;DSCAM;SEMA3D;SEMA3E;SEMA3A;MEGF8
prerank,neural tube closure (GO:0001843),0.30423781120194404,0.8096089905620603,0.7449584816132859,1.0,1.0,5/34,10.68%,DVL2;TSC2;SCRIB;DVL1;KDM2B
prerank,glycine transport (GO:0015816),-0.32026230309427145,-0.8095334460775905,0.6910569105691057,0.9218111204699356,1.0,5/10,27.84%,SLC6A9;SLC38A5;SLC6A17;SLC36A1;SLC6A5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.36514993109375266,0.809481299225535,0.7067448680351907,1.0,1.0,2/12,11.07%,TAF9B;BCL2
prerank,cardiac ventricle development (GO:0003231),0.33285552723161244,0.809373517525445,0.7301587301587301,1.0,1.0,5/20,23.02%,STRA6;MDM4;HECTD1;MATR3;DAND5
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3237538857319449,0.8093646609578262,0.7268170426065163,1.0,1.0,7/26,19.61%,PRKCA;USP2;APP;MDM2;MEIS2;USP22;PPP1R10
prerank,protein kinase A signaling (GO:0010737),0.3708040655294275,0.8090084069070539,0.7008670520231214,1.0,1.0,1/12,0.97%,LCP1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.28128939655315327,0.8083080336595627,0.7911255411255411,1.0,1.0,4/73,2.67%,SFRP2;ARAF;NTF3;HSP90AA1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3660490906408423,0.8082172497379269,0.712166172106825,1.0,1.0,5/13,23.45%,EEF1E1;ATR;DDX5;PLA2R1;ATM
prerank,regulation of axon regeneration (GO:0048679),-0.3161615025825026,-0.8081479337370855,0.7295597484276729,0.9228394185668993,1.0,4/12,16.44%,INPP5F;GRN;SCARF1;RTN4RL1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2714099713040014,0.8080185467562416,0.8106694560669456,1.0,1.0,16/101,17.09%,WNT5A;SELENOS;NFKB1;XBP1;TNFAIP3;CARD16;SIRPA;TRIM41;LY96;GIT1;PTPN22;CDC73;TGFB1;PDE4B;SERPINE1;MTDH
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3690634349705711,0.8079043293247941,0.6961483594864479,1.0,1.0,1/12,2.30%,PSAT1
prerank,iron ion transmembrane transport (GO:0034755),-0.32975288777770223,-0.8078789795870048,0.7270029673590505,0.9220001651963983,1.0,5/10,21.79%,SLC39A14;SLC39A8;SLC40A1;SLC25A28;SCARA5
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3308075145366208,0.8075474880423247,0.7230169050715215,1.0,1.0,7/21,21.65%,GPD1L;DMTN;CNKSR3;RACK1;RASSF2;SMAD7;PPM1F
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3638070199285892,0.8074028691567022,0.7379603399433428,1.0,1.0,7/14,24.31%,PPP2R2C;PPP5C;PPP2CB;PPP2R2B;PPM1F;PPP2R2A;PPP2R2D
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3726933374175563,0.8070325514123569,0.715372907153729,1.0,1.0,2/11,11.07%,TAF9B;BCL2
prerank,T cell activation (GO:0042110),-0.19458172619069022,-0.8064812793229753,0.9058823529411765,0.9231203205921072,1.0,24/69,32.34%,KIF13B;EIF2AK4;KIT;NCK1;CD44;GPR89B;GPR89A;PTPRC;LMBR1L;NHEJ1;MSN;RAB29;JAG2;DPP4;PIK3CD;RHOH;MDK;DDOST;LFNG;NCK2;NLRC3;CTPS1;CD74;PTPN2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.33916507321135364,0.8063955755613295,0.7103825136612022,1.0,1.0,5/19,19.39%,SLC35B2;ENPP1;ABHD14B;SULT1A1;PAPSS1
prerank,cellular response to virus (GO:0098586),0.3089894886206622,0.8060682800644963,0.7515375153751538,1.0,1.0,3/30,4.15%,BAX;HSP90AA1;DDX3X
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.2769502998998768,0.8059870158739825,0.7754880694143167,1.0,1.0,17/67,21.65%,SFRP1;RAC1;NRP1;ABL1;ARHGEF7;DMTN;JUP;FBLN2;ECM2;EMP2;NDNF;CCL25;ILK;CARMIL1;PTK2B;DOCK5;PPM1F
prerank,regulation of TORC1 signaling (GO:1903432),0.3104635176239513,0.805959087955024,0.743801652892562,1.0,1.0,6/33,12.87%,FLCN;STK11;RRAGA;GPR137C;RNF152;LAMTOR5
prerank,hexose transmembrane transport (GO:0008645),0.3354669651485337,0.8053542359288152,0.7152406417112299,1.0,1.0,3/21,11.44%,SLC5A3;SLC2A3;SLC50A1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.297145578364088,0.8052386346715166,0.7569124423963134,1.0,1.0,6/42,13.72%,CDKN2D;USP10;VCP;POLH;POLN;POLD3
prerank,translation (GO:0006412),0.26381178788979825,0.8051507634610012,0.871356783919598,1.0,1.0,41/208,17.26%,MRPL36;FARSB;YARS1;AIMP2;NDUFA7;WARS1;RPL22L1;YARS2;GATB;DRG2;CARS1;SARS2;GARS1;PPA2;EEF1E1;TARS1;AARS1;EPRS1;PABPC4;DRG1;MRPL47;MRPL10;RPL35A;RPS25;SARS1;RPS15;NARS1;RPL9;HARS1;GTPBP2;MRPL3;GSPT1;EEF1B2;RPL4;MRPL13;MRRF;RWDD1;MRPL24;RPL23A;RPLP2;TNIP1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3742042362960059,0.8049682235069733,0.717546362339515,1.0,1.0,2/12,10.40%,IGF1;IRS2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3756274176448686,0.8048389915059005,0.7223001402524544,1.0,1.0,3/11,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,organelle transport along microtubule (GO:0072384),0.310076458114161,0.8047808631462139,0.7318573185731857,1.0,1.0,9/31,19.92%,CLN3;ARHGAP21;BICDL1;HTT;MAPT;TRAK1;KIF5B;RAB6A;PAFAH1B1
prerank,positive regulation of actin nucleation (GO:0051127),0.3722175763741806,0.8046615883833795,0.7112375533428165,1.0,1.0,3/11,13.25%,WHAMM;CYFIP1;WASF1
prerank,meiosis I (GO:0007127),0.32698549958458534,0.8042462199199085,0.7232375979112271,1.0,1.0,4/23,21.15%,SYCP3;FOXJ3;BRDT;FOXJ2
prerank,response to ionizing radiation (GO:0010212),0.2742026456469243,0.8039763667273371,0.7895299145299145,1.0,1.0,20/70,22.17%,KDM4D;RNF8;ANXA1;COP1;STK11;RNF168;MRNIP;BRSK1;AEN;CLOCK;TANK;NABP2;PRKAA1;SMPD1;UIMC1;INO80;EYA1;INTS7;CLK2;MTA1
prerank,engulfment of apoptotic cell (GO:0043652),0.35759609355911104,0.8037912073762467,0.75,1.0,1.0,2/15,10.17%,RAC1;XKR6
prerank,neutrophil degranulation (GO:0043312),0.26039385116064107,0.8037907054245145,0.948,1.0,1.0,65/425,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,DNA damage checkpoint signaling (GO:0000077),-0.22976667796521266,-0.8036365982511101,0.7633136094674556,0.9269918087205894,1.0,14/28,31.86%,CEP63;USP28;DOT1L;NBN;HINFP;STK33;ATRIP;ERCC6;HUS1;PRPF19;RHNO1;CLSPN;RAD1;DONSON
prerank,macrophage activation (GO:0042116),0.3058150794313764,0.8036349564301439,0.7560386473429952,1.0,1.0,6/34,13.93%,TMEM106A;IFI35;CRTC3;APP;IFNGR1;MAPT
prerank,7-methylguanosine RNA capping (GO:0009452),-0.22811457327295384,-0.8035939956116348,0.8181818181818182,0.9243569010724849,1.0,20/31,34.95%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.22811457327295384,-0.8035939956116348,0.8181818181818182,0.9243569010724849,1.0,20/31,34.95%,GTF2H1;MNAT1;NCBP1;GTF2H5;GTF2H2;ERCC3;RNMT;NCBP2;CMTR1;POLR2H;POLR2G;POLR2F;ERCC2;POLR2C;GTF2F1;RAMAC;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2883206115012616,0.8035617990982634,0.7539149888143176,1.0,1.0,8/48,12.17%,WBP2;SF3B1;ASF1A;TBP;SMARCD1;ARID1B;ZMIZ1;POLR2K
prerank,cellular response to hydroxyurea (GO:0072711),-0.32580459985366844,-0.8034104657439969,0.7267441860465116,0.9233435725172857,1.0,4/10,16.92%,SPIDR;DDI2;RTF2;BLM
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.29922252289457557,0.8030093791066981,0.7467144563918757,1.0,1.0,8/35,16.67%,RAC1;PLXNA2;NRP1;SEMA3D;SEMA3E;SEMA3A;FARP2;PLXNB3
prerank,protein prenylation (GO:0018342),-0.3388977108145538,-0.8029847220181965,0.7150684931506849,0.922728777217574,1.0,4/10,27.26%,FNTA;RABGGTB;CHM;CHML
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3162716163201649,0.8028014866525104,0.71375,1.0,1.0,5/26,14.97%,ERRFI1;SNX6;EGF;APP;CBL
prerank,regulation of organelle assembly (GO:1902115),0.27990460143766227,0.8023666636297757,0.7830290010741139,1.0,1.0,17/72,17.79%,DCDC2;CDKL5;SGSM3;ALMS1;TBC1D13;TBC1D20;USP6NL;ATXN2L;NPM1;SPICE1;IFT20;RABGAP1;TBC1D24;ATG3;CEP76;TBC1D9B;TBC1D22B
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.353765641296655,0.8019692050828602,0.7220708446866485,1.0,1.0,4/15,15.93%,ATF2;MDC1;MRE11;CHEK2
prerank,synaptic vesicle localization (GO:0097479),0.36264569462704577,0.8017575962720853,0.7062146892655368,1.0,1.0,4/13,17.25%,CDK5;KIF5C;TMEM230;KIF5B
prerank,endothelial cell differentiation (GO:0045446),0.37004731407818814,0.8016859756425315,0.7217391304347827,1.0,1.0,4/12,18.62%,FSTL1;JAG1;KDM6B;SCUBE1
prerank,intracellular sterol transport (GO:0032366),-0.29328400413122635,-0.8016654567705347,0.7068403908794788,0.9237420488637189,1.0,6/13,22.90%,OSBPL2;SERAC1;OSBP;ARV1;VPS4A;STARD4
prerank,Golgi to lysosome transport (GO:0090160),0.38556881891923933,0.8015337000214513,0.721835883171071,1.0,1.0,1/11,0.91%,CLN3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3543416950246109,0.8014126519021747,0.7281976744186046,1.0,1.0,3/13,12.69%,GPR37;PARK7;RACK1
prerank,neutrophil activation involved in immune response (GO:0002283),0.2596661752281749,0.8013790183100249,0.953,1.0,1.0,65/428,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.2826314091952901,-0.8012587078216968,0.7420634920634921,0.9230773767703935,1.0,12/17,50.29%,RB1;BUB3;MTBP;MIS12;ZWILCH;BOD1;KNL1;TTK;SPDL1;CENPA;IK;CDK1
prerank,nucleic acid metabolic process (GO:0090304),0.28254537120886175,0.8008870840512988,0.7882978723404256,1.0,1.0,20/69,22.24%,DNASE1L2;POLR2B;HNRNPK;HNRNPD;HNRNPM;RBFOX2;ENPP1;POLR2K;HNRNPA0;HNRNPL;MMS19;HNRNPA2B1;RAD50;PCBP2;RECQL5;HNRNPU;PTBP1;EXD2;GTF2F2;METTL14
prerank,cation transmembrane transport (GO:0098655),0.2938926337656861,0.8004046703321916,0.7686230248306998,1.0,1.0,5/44,10.16%,SLC25A19;SLC7A2;ATP1A2;TRPM3;SLC25A38
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.34600237128217004,0.7997412907748102,0.73224043715847,1.0,1.0,3/16,13.25%,CLN3;SHFL;GSPT1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.29830923648130775,-0.7996972153777941,0.7482517482517482,0.9244506928610104,1.0,3/13,4.50%,SORBS1;IRS1;SIRT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.35302947798493345,0.7996174379765761,0.6994301994301995,1.0,1.0,3/15,13.76%,SFRP1;ZNRF3;CSNK1D
prerank,regulation of protein export from nucleus (GO:0046825),0.3257240832534819,0.7995149519384898,0.7389659520807061,1.0,1.0,4/23,12.08%,SIRT7;TCF7L2;BARD1;PARK7
prerank,endosome organization (GO:0007032),0.295660201957561,0.7991530791414921,0.7678571428571429,1.0,1.0,9/41,16.00%,DNM1;SQSTM1;SNX10;HOOK3;ALS2;SNX33;VPS33B;DNAJC13;VPS18
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.2650421766471426,-0.7987283107458034,0.7795918367346939,0.9248090330383097,1.0,11/18,30.31%,DAB2IP;MORC3;TP53;PARP10;MED25;NF1;EMD;B4GALT7;CD300A;NLRC3;TRIM32
prerank,regulation of intracellular protein transport (GO:0033157),0.3107985658245364,0.7985498938833675,0.7549591598599766,1.0,1.0,11/32,25.34%,LCP1;SIRT7;RIPOR1;TGFB1;RUFY3;KIF20B;TPR;IFI27;UHMK1;PTPN14;PRR5L
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.29251180676598293,0.798264080988226,0.764018691588785,1.0,1.0,14/43,22.35%,ERRFI1;ARHGEF7;SNX6;HGS;EGF;MVP;PTPN3;CBL;SPRY2;STAM2;EPN1;CBLB;RAB7A;ITGA1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.36909884827077777,0.7982320803707844,0.737062937062937,1.0,1.0,4/12,20.48%,LRIF1;CDYL;YTHDC1;HNRNPU
prerank,positive regulation of histone methylation (GO:0031062),0.3204529046653911,0.798227350538695,0.734955185659411,1.0,1.0,7/24,19.34%,OGT;PHF1;JARID2;AUTS2;SNW1;KMT2A;TET1
prerank,positive regulation of T cell activation (GO:0050870),0.28049655672444695,0.7980082856096283,0.778516057585825,1.0,1.0,7/62,12.26%,ANXA1;XBP1;THY1;SIRPA;DOCK8;ZMIZ1;CD47
prerank,positive regulation of T cell differentiation (GO:0045582),-0.21684837272843271,-0.7979114941770409,0.8598726114649682,0.9248754046579731,1.0,10/36,25.40%,LEF1;CD46;ZBTB1;DUSP10;NKAP;VSIR;NCKAP1L;RHOH;MDK;PNP
prerank,calcium ion transmembrane transport (GO:0070588),0.27761806028211644,0.7978835141151753,0.8128286014721346,1.0,1.0,11/86,10.62%,NALCN;SLC24A5;ATP2C1;GRIN1;ATP2A2;PMPCA;GRIN2A;ATP2B1;SLC24A4;TRPM3;AFG3L2
prerank,carboxylic acid metabolic process (GO:0019752),-0.2236613695677267,-0.7976403588074009,0.83125,0.9240065912229868,1.0,3/33,2.77%,CSGALNACT1;DDO;SLC2A1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.38309792601919573,0.7972132696761021,0.7187993680884676,1.0,1.0,1/10,2.68%,IL33
prerank,protein localization to condensed chromosome (GO:1903083),-0.30667082865204626,-0.7970880674679521,0.744408945686901,0.9236190107066721,1.0,9/12,50.29%,BUB3;MTBP;MIS12;ZWILCH;KNL1;TTK;SPDL1;IK;CDK1
prerank,protein export from nucleus (GO:0006611),0.3077061491969883,0.7970794421639497,0.7576126674786845,1.0,1.0,11/27,23.16%,RANBP3L;STRADB;TGFB1;NUP214;XPO6;SMURF1;XPO7;RANBP3;TPR;CSE1L;DUSP16
prerank,cell cycle G2/M phase transition (GO:0044839),0.265752137301646,0.7968740982541683,0.8311156601842374,1.0,1.0,28/129,20.42%,CCP110;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;AKAP8L;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.37144304925463745,0.7967016492237748,0.740029542097489,1.0,1.0,3/11,14.28%,EFNB2;DHX36;TGFB1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2652523718907367,0.7966834641884218,0.8353783231083844,1.0,1.0,29/128,21.00%,CCP110;FOXM1;LCMT1;HSP90AA1;FBXL12;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;YWHAG;BRSK1;BACH1;CCNH;HAUS3;CSNK1D;TUBB;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;DYNLL1;PAFAH1B1;CDK14;PHLDA1;TAF2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.20812518254492415,-0.7966595210988289,0.8,0.9230062154211397,1.0,16/41,31.15%,PNPLA8;MGLL;SCP2;DAGLB;CYP1B1;ACOT8;FADS2;ELOVL5;DEGS1;GPX1;FADS3;DECR2;EPHX1;SCD;GSTM2;PLA2G4A
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3424101003484471,0.7962294740626858,0.7218453188602443,1.0,1.0,4/15,17.45%,ADGRV1;SCN1A;KCNA1;COL11A1
prerank,negative regulation of T cell activation (GO:0050868),0.30200691338621066,0.7960138941658618,0.7420118343195267,1.0,1.0,3/35,13.55%,FCGR2B;RIPOR2;PTPN22
prerank,transition metal ion homeostasis (GO:0055076),0.31195619086731663,0.795994026671319,0.7431077694235589,1.0,1.0,9/28,23.52%,CP;XIAP;ABCB7;HEPH;NEO1;COMMD1;HMOX2;B2M;FBXL5
prerank,negative regulation of lipid catabolic process (GO:0050995),0.34333323064508803,0.7958225445339174,0.7418032786885246,1.0,1.0,1/17,1.59%,GPLD1
prerank,protein localization to microtubule organizing center (GO:1905508),0.3465296345868266,0.7955830808965347,0.7258522727272727,1.0,1.0,4/15,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,striated muscle cell differentiation (GO:0051146),0.345653283903313,0.7954857482573389,0.7513440860215054,1.0,1.0,5/16,16.74%,SIK1;MYEF2;AKAP13;NRG1;KDM6B
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2066980592566917,-0.7952179111050595,0.8444444444444444,0.9242191076297271,1.0,6/45,7.77%,SMAD4;TWSG1;TGFB2;ACVR1;ENG;BMPR1A
prerank,translational elongation (GO:0006414),0.26996746739983296,0.7950840165986032,0.8223615464994776,1.0,1.0,28/101,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;NEMF;RACK1;GTPBP2;MRPL3;EEF1B2;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;EEF2K;GFM2;MRPS35;MRPS28;GFM1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.26491717312451735,0.7948600332741156,0.8460754332313966,1.0,1.0,31/132,18.52%,TARBP2;COIL;SMN1;HSP90AA1;GEMIN2;SRSF5;SF3B1;CELF2;CELF1;SRSF9;PRPF6;SRSF1;PRMT5;CPSF7;SART3;RPS15;NUDT21;SETX;LUC7L2;CDC73;KHDC4;SHQ1;CELF5;YTHDC1;RPL23A;DHX29;LUC7L3;CPSF6;BRIX1;GCFC2;SRPK1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2566194235525462,0.7940136514171597,0.945,1.0,1.0,90/366,20.76%,DVL2;RBM4B;RBM3;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;METAP1;CNBP;ABL1;ATXN1;FBXO5;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;CYFIP1;EHMT2;DDIT3;HNRNPD;PRMT5;PUM3;SOX11;SAP30L;FADS1;ATF2;POU6F2;APP;NSD3;FOXN3;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;NUCKS1;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;CCDC88A;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;USP37;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;GEMIN5;YBX1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3602059448818744,0.7931521748249617,0.7200577200577201,1.0,1.0,2/13,9.55%,DDIT3;SOX11
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3121003348045949,-0.7931499149819061,0.7339449541284404,0.9263627901778596,1.0,2/11,1.97%,TOMM70;AGK
prerank,negative regulation of catalytic activity (GO:0043086),0.3173480972548832,0.7931453724694878,0.7418546365914787,1.0,1.0,2/24,6.95%,CLN3;TMBIM1
prerank,regulation of peptidase activity (GO:0052547),0.3328686933666959,0.7929780290353633,0.7304116865869854,1.0,1.0,4/19,15.68%,NRDC;RCN3;HDAC1;CTSH
prerank,regulation of cholesterol efflux (GO:0010874),0.307426863771554,0.7929276091670254,0.7572815533980582,1.0,1.0,9/30,20.04%,ABCA2;PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;TTC39B;ABCA5
prerank,positive regulation of dephosphorylation (GO:0035306),0.30913301245149605,0.7924944343630012,0.7711757269279393,1.0,1.0,9/27,21.79%,CALM3;TGFB1;CAMTA1;PPP2R5A;CALM1;SMPD1;DLC1;PTBP1;CALM2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.35759904564612877,0.7922989978811434,0.7374149659863946,1.0,1.0,3/13,11.79%,SMARCD1;ARID1B;ZMIZ1
prerank,oogenesis (GO:0048477),-0.28402981259779714,-0.7921223183517337,0.7258687258687259,0.9267037015867827,1.0,1/15,0.24%,MARF1
prerank,myoblast fusion (GO:0007520),0.3686456865577785,0.7916716379142126,0.7418397626112759,1.0,1.0,5/12,21.60%,ADAMTS5;ADAM12;ADGRB3;KCNH1;CD9
prerank,BMP signaling pathway (GO:0030509),0.2765407997626848,0.7916196280262122,0.7758433079434167,1.0,1.0,18/62,22.11%,BMP6;SMAD9;USP15;BMP5;USP9X;TGFB1;RGMA;SMAD6;RGMB;DDX5;MEGF8;SMURF1;ZFYVE16;TGFBR3;ACVR2A;SMAD7;SMAD2;SMAD3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.271318331867887,0.7912783327097057,0.795429815016322,1.0,1.0,11/67,11.01%,HSP90AA1;RAC1;SH2D2A;NRP1;SULF1;PIK3R1;CYFIP1;BAIAP2;VAV2;PIK3CB;PIK3R2
prerank,negative regulation of endocytosis (GO:0045806),0.31910453264967,0.7911995537072959,0.7417302798982188,1.0,1.0,5/24,13.39%,RAC1;PACSIN3;ABCA7;SNX33;SCAMP5
prerank,pulmonary valve morphogenesis (GO:0003184),0.3427009998959021,0.7909668266173123,0.7671601615074024,1.0,1.0,5/17,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3259621342135563,0.7908812885856115,0.7308192457737321,1.0,1.0,3/19,9.11%,CHD8;PRDX5;DHX36
prerank,UV protection (GO:0009650),0.3689220017599267,0.7907829090215333,0.7168405365126677,1.0,1.0,1/10,2.32%,MFAP4
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3401195492690897,0.790729070477238,0.7194148936170213,1.0,1.0,1/16,2.42%,ADM
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.31943210571385494,0.7904857758426171,0.7503217503217503,1.0,1.0,4/23,14.28%,IGF1;EFNB2;NRG1;TGFB1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.37566378875133366,0.7904461621876983,0.741506646971935,1.0,1.0,3/10,16.66%,CHFR;DIS3L2;NEDD8
prerank,mesonephric tubule development (GO:0072164),0.3455056711531114,0.7901209218241045,0.7318435754189944,1.0,1.0,4/15,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,neutrophil mediated immunity (GO:0002446),0.2558236184075645,0.7900993205009684,0.965,1.0,1.0,65/432,16.15%,UNC13D;KCNAB2;ATP6AP2;CCT8;GSDMD;NFKB1;HSP90AA1;RAC1;TMEM63A;ACTR2;CD63;RAB24;GLB1;DDX3X;MOSPD2;CDK13;ANPEP;PRDX6;MLEC;TMBIM1;CKAP4;COMMD3;SIRPA;KPNB1;PSMD11;MANBA;CYFIP1;RAB5B;SDCBP;XRCC6;DNAJC5;PLEKHO2;CRACR2A;RAB10;DBNL;MVP;VCP;HGSNAT;PGAM1;SNAP25;JUP;TCIRG1;SLC2A3;IQGAP1;DYNC1LI1;CD47;GGH;KCMF1;FGL2;IGF2R;CRISPLD2;PSAP;VAT1;TXNDC5;ATP6V1D;TUBB;ARSB;SCAMP1;CTSZ;DNAJC13;RAB31;PSMD1;CTSH;SLC44A2;VAMP8
prerank,regulation of mitochondrial fusion (GO:0010635),0.36872529178439245,0.7898668058871215,0.7238912732474965,1.0,1.0,3/11,17.62%,PID1;VAT1;OMA1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.31635028763501355,0.7896814472689322,0.766541822721598,1.0,1.0,8/23,23.05%,MAD2L1;GPSM2;HTT;NUMA1;ZW10;PAFAH1B1;ITGB1;CDK5RAP2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.26732885343261803,0.7894211461809594,0.8027426160337553,1.0,1.0,20/86,21.52%,BMP6;ZEB2;FLCN;SULF1;STK11;TGFB1I1;SDCBP;SOX11;RBPJ;BMP5;TGFB1;ACVR1B;NUMA1;SNW1;RNF111;TGFBR1;FOXD1;DAB2;ACVR2A;SMAD2
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30565777689551993,0.7892188032034719,0.758495145631068,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30565777689551993,0.7892188032034719,0.758495145631068,1.0,1.0,4/29,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,stem cell differentiation (GO:0048863),0.2956198703131592,0.7891588480534467,0.7648428405122235,1.0,1.0,5/39,10.02%,SFRP1;SP7;FGFR2;PSMD11;JARID2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.348460493729276,0.7886024624477915,0.7349570200573066,1.0,1.0,2/15,7.04%,DDX3X;DHX33
prerank,oligodendrocyte development (GO:0014003),0.34447190591070814,0.7884330527055994,0.7372764786795049,1.0,1.0,3/15,16.69%,MYRF;B4GALT5;TPPP
prerank,regulation of calcium ion transport (GO:0051924),0.28574762788180397,0.7883949072543575,0.7808370044052864,1.0,1.0,7/54,12.18%,CAMK2B;PACSIN3;ATP2B1;CRACR2A;EGF;BCL2;CAMK2G
prerank,negative regulation of cell differentiation (GO:0045596),0.26105045183051073,0.7880141535605883,0.8849646821392533,1.0,1.0,44/181,22.44%,SFRP2;WNT5A;SFRP1;SIRT2;ADAMTS7;PTHLH;RORA;RANBP3L;ADGRV1;SOX9;SRA1;PTCH1;TWIST1;HOXB8;BMP5;ENPP1;SUFU;CDC73;RUNX1T1;TGFB1;SMAD6;COL5A2;VASN;TRIO;JAG1;SPRY2;OSR1;MEIS2;IQCB1;GPS2;TGFBR1;YTHDF2;ABCA5;HNRNPU;PTK2B;ITGAV;SMAD7;PTBP1;ABCG1;FOXO1;SMAD3;METTL14;ID2;TMEM64
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.2648739918283141,-0.7878884564752734,0.7673469387755102,0.9323877709983809,1.0,8/18,18.89%,ITGA3;RASIP1;KANK1;KCTD13;ABL2;KCTD10;MET;CCDC125
prerank,apoptotic cell clearance (GO:0043277),0.30816132488469444,0.7877281467896282,0.7738814993954051,1.0,1.0,8/30,22.00%,RAC1;ANXA1;XKR6;LRP1;TXNDC5;RHOBTB1;ITGAV;HMGB1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.23581602122617973,-0.7876533183787636,0.8028169014084507,0.9314241812432373,1.0,9/23,23.18%,STAT1;HSP90AB1;CDC37;NR1H3;IRGM;PARP9;NR1H2;PPARG;NLRC5
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.29224848609803494,0.78762291874813,0.7708333333333334,1.0,1.0,16/41,24.13%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;LACC1;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98
prerank,sphingoid biosynthetic process (GO:0046520),0.36729154419678517,0.787609658666319,0.7283582089552239,1.0,1.0,1/11,4.31%,ABCA2
prerank,sphingosine biosynthetic process (GO:0046512),0.36729154419678517,0.787609658666319,0.7283582089552239,1.0,1.0,1/11,4.31%,ABCA2
prerank,negative regulation of RNA splicing (GO:0033119),0.3331125201610685,0.7875923226235947,0.7378768020969856,1.0,1.0,3/19,7.02%,PCBP4;SRSF12;SRSF9
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.35283348257078834,0.7875684581785074,0.7461212976022567,1.0,1.0,5/13,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,regulation of platelet aggregation (GO:0090330),0.3382183104619953,0.7875345705321357,0.7250341997264022,1.0,1.0,3/17,6.44%,C1QTNF1;PRKCA;DMTN
prerank,respiratory chain complex IV assembly (GO:0008535),0.32743451816452385,0.7875181933154393,0.736,1.0,1.0,5/21,19.73%,BCS1L;COX17;COA8;COX16;OXA1L
prerank,purine ribonucleotide catabolic process (GO:0009154),0.3325407273432203,0.7874635024444512,0.7493261455525606,1.0,1.0,4/21,13.10%,MLYCD;ACAT1;NUDT3;HPRT1
prerank,cytoskeleton organization (GO:0007010),0.2645934229773605,0.7872766145863336,0.8478260869565217,1.0,1.0,30/114,21.43%,BIN1;RAC1;ANK1;OBSL1;TNFAIP3;MAST3;THY1;DMTN;PDZD8;RHOD;NCKIPSD;LRCH3;PACSIN3;DES;RHOBTB3;TPM1;PRKCI;PRPF40A;EPB41L3;PHIP;APOE;KLHL20;CDC42BPB;FGD4;RANBP9;RHOBTB1;PAK5;RHOU;CFL1;DIAPH1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3478220484383411,0.7871422470296677,0.7341954022988506,1.0,1.0,4/14,16.76%,CD63;DMTN;EMP2;ITGB1BP1
prerank,mesonephros development (GO:0001823),0.3681364768296014,0.7867646549578428,0.7251798561151079,1.0,1.0,2/11,17.12%,FGF10;OSR1
prerank,proteoglycan biosynthetic process (GO:0030166),0.30200883590799266,0.7867105890736675,0.7701711491442543,1.0,1.0,3/31,6.08%,IGF1;EXTL3;CHST10
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.330158962581688,0.7863872497861605,0.7624309392265194,1.0,1.0,4/18,15.42%,ANXA1;FGFBP1;PTGS2;FOXC2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.33204940224515406,0.786181097244281,0.7480719794344473,1.0,1.0,7/20,19.70%,FPGS;CNDP2;GCLC;PTDSS1;SLC27A1;PTDSS2;HAGH
prerank,endodermal cell differentiation (GO:0035987),-0.23038190054423516,-0.7857670212094312,0.7951807228915663,0.9332799445051276,1.0,10/31,16.79%,SETD2;COL4A2;COL8A1;COL6A1;FN1;PAF1;LAMA3;ITGA4;ITGB5;MMP2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.2723497723319275,0.7857554095965629,0.8138297872340425,1.0,1.0,19/79,21.29%,APLN;CASK;SMAD9;SULF1;HTRA3;HGS;GPC1;LEMD3;SMAD6;UBE2D1;SPRY2;SMURF1;SORL1;PDCD6;NBL1;ACVR2A;SMAD7;ATP2B4;FGF2
prerank,cellular response to alkaloid (GO:0071312),-0.26631333237580285,-0.7856871606518531,0.779467680608365,0.9320749798232756,1.0,11/17,39.43%,TGM2;SPIDR;BLM;CASP3;RYR2;GSTM2;SLC8A1;CASP6;HTR1B;CASQ2;RAD51
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3058731527658163,0.7847744029949324,0.7538071065989848,1.0,1.0,8/26,20.58%,GRIN1;TMEM108;APP;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.3582943184829664,0.7844941674407466,0.7332382310984308,1.0,1.0,2/12,14.28%,SELENOS;TGFB1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.32357583305548787,0.7843363185833219,0.7558746736292428,1.0,1.0,2/21,6.49%,DVL2;DVL1
prerank,ncRNA processing (GO:0034470),0.2573434604137957,0.7843158006669136,0.9023162134944612,1.0,1.0,31/200,14.23%,EXOSC1;EXOSC3;TARBP2;DGCR8;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;ZCCHC8;PUS10;EXOSC8;MPHOSPH10;AARS1;LIN28B;RCL1;ESF1;RPL35A;RPS25;MTREX;SARS1;RPS15;RPL9;AGO3;RPP30;C1D;RPL4;BMS1;HNRNPA2B1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.22473531024576449,-0.7842058749778121,0.8118279569892473,0.9332782897114331,1.0,9/30,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;TTF1;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.19374110506231307,-0.7839881968312266,0.9382716049382716,0.9323330135626973,1.0,15/62,15.93%,TNRC6A;PUM1;NUP160;STAT3;NUP205;AGO2;LIMD1;NUP93;NUP42;NUP107;NUP50;NUP133;NUP85;AAAS;NDC1
prerank,response to light stimulus (GO:0009416),0.28116460155036016,0.7838922874565528,0.7832402234636872,1.0,1.0,3/55,4.61%,CDKN2D;USF1;USP1
prerank,calcineurin-mediated signaling (GO:0097720),-0.31911228368727995,-0.7835193043130181,0.7203647416413373,0.9304832911050864,1.0,3/10,15.47%,NFATC1;NFATC2;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.31911228368727995,-0.7835193043130181,0.7203647416413373,0.9304832911050864,1.0,3/10,15.47%,NFATC1;NFATC2;NFATC4
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3291238430873574,0.7832228141436625,0.7516512549537648,1.0,1.0,6/18,18.25%,HSP90AA1;NELL1;CDK5RAP3;WDR91;FAF1;ATRAID
prerank,cellular sodium ion homeostasis (GO:0006883),0.3426474809290635,0.7831737998398156,0.7510431154381085,1.0,1.0,2/15,7.53%,ATP1A3;ATP1A2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.3289881281979171,0.7830169848103303,0.7476882430647291,1.0,1.0,2/18,9.67%,RTN2;CLIP3
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3344305528355192,0.7828761277511963,0.724376731301939,1.0,1.0,1/17,2.97%,GPD1L
prerank,regulation of G0 to G1 transition (GO:0070316),0.2933957098582138,0.7824674939831963,0.7860520094562647,1.0,1.0,10/38,20.17%,TFDP1;RBBP4;EZH2;PCGF6;EHMT2;EHMT1;CBX5;RBBP8;YAF2;E2F6
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2734840160751345,0.7820964818364101,0.8254817987152034,1.0,1.0,22/75,21.15%,THBS2;SULF1;DCN;SPARC;HGS;WNT4;ATF2;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,regulation of cytoskeleton organization (GO:0051493),0.2618698368679751,0.7820282388705719,0.8485477178423236,1.0,1.0,29/108,21.89%,CLN3;RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;KATNBL1;CAPN2;RHOBTB3;IQGAP1;LRP1;MAPT;ROCK2;PHLDB1;TPPP;EPHA5;PFDN2;CCDC88A;CDK10;PRKAA1;MAP6D1;DLC1;RHOBTB1;NEXN;MAP6;DIAPH1;ARHGAP35
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3054367535353274,0.7818164297746977,0.7408312958435208,1.0,1.0,13/29,23.51%,TRAPPC10;NAPG;COPZ2;VTI1B;COG3;VTI1A;COG8;NSF;RAB6A;NAPA;COPG1;GOSR1;COPA
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3464363469624731,0.7815415314607248,0.7467625899280576,1.0,1.0,4/14,21.35%,TIRAP;HNRNPA0;MAPKAPK2;ANGEL2
prerank,aggrephagy (GO:0035973),0.31089251894390113,0.7814488182192254,0.7772277227722773,1.0,1.0,5/27,12.08%,UBQLN1;ARL13B;SQSTM1;DYNC1LI1;PARK7
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3020211304661514,0.781400522736827,0.7648484848484849,1.0,1.0,3/32,7.08%,CCT8;PKIB;CCT6A
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2562978220966415,0.7812019438976877,0.8814589665653495,1.0,1.0,42/158,23.39%,SLC35B2;MAP3K14;ATP2C1;EDAR;EDA2R;TIRAP;CARD16;TMEM106A;BRD4;CC2D1A;TIFA;TRIM62;GPRC5B;DHX36;WLS;MALT1;TFG;PLEKHG5;LAMTOR5;AKAP13;LPAR1;PPP5C;NDFIP2;SLC44A2;MTDH;ZDHHC17;S100A13;TERF2IP;TRIM27;BIRC3;PELI2;PPM1A;MIER1;TRAF3IP2;TAB3;MID2;UBE2V1;TRAF2;TRIM8;TNFRSF19;REL;FKBP1A
prerank,cortical cytoskeleton organization (GO:0030865),0.2909603298564457,0.7810991409730236,0.7827626918536009,1.0,1.0,7/41,14.73%,LCP1;RAC1;RHOD;RHOBTB3;RAB13;ROCK2;EPB41L3
prerank,calcium ion transport (GO:0006816),0.26445349228541043,0.7809570790594625,0.8527291452111225,1.0,1.0,10/113,8.98%,NALCN;SLC24A5;ORAI2;ATP2C1;CACNG3;ATP2A2;ITPR1;SLC24A4;TRPM3;CRACR2A
prerank,regulation of chromatin binding (GO:0035561),0.366847418926586,0.7806472559163168,0.7396630934150077,1.0,1.0,1/10,1.29%,KDM4D
prerank,renal system development (GO:0072001),0.2829935366466564,0.780503502942992,0.7977900552486188,1.0,1.0,9/52,18.56%,STRA6;GREB1L;PCSK5;SULF1;WNT4;PYGO2;PYGO1;AGTR1;TGFBR1
prerank,peptide metabolic process (GO:0006518),0.27043343225610444,0.7799050731647006,0.8275132275132275,1.0,1.0,10/75,11.82%,CPXM1;MGAT3;GSTT1;PCSK5;ANPEP;THOP1;DNPEP;HM13;CPXM2;CARNMT1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.24951639614731846,-0.7798813659908296,0.7905982905982906,0.9350453649906916,1.0,12/22,37.73%,PSMB7;PSMB2;PSMA6;PSMB3;NFE2L2;PSMB4;PSMB6;PSMB5;PSME4;PSMB8;PSMB9;PSMA8
prerank,muscle tissue development (GO:0060537),0.35006696460920106,0.7797335031585952,0.7408412483039348,1.0,1.0,2/13,8.42%,STRA6;PTCH1
prerank,protein K48-linked deubiquitination (GO:0071108),0.31926172605732467,0.7793897656939842,0.7403598971722365,1.0,1.0,8/23,19.59%,TNFAIP3;OTUD7A;USP34;USP33;USP50;YOD1;VCPIP1;USP37
prerank,positive regulation of reproductive process (GO:2000243),0.30357696186931216,0.7789924696886709,0.7788347205707491,1.0,1.0,4/31,15.34%,SIRT2;PGAM4;GLRA1;ACVR1B
prerank,cyclooxygenase pathway (GO:0019371),-0.3118407172341638,-0.7787054338621298,0.7734138972809668,0.9355461209934914,1.0,4/10,24.17%,PTGES3;PTGES;TBXAS1;HPGDS
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2900984424467828,0.7786205397484751,0.7707838479809976,1.0,1.0,6/37,13.72%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,brain morphogenesis (GO:0048854),-0.3004469091870808,-0.778401889069242,0.7411003236245954,0.9347191389178319,1.0,6/12,30.53%,SHANK3;BBS2;BBS4;SPEF2;VPS51;MKKS
prerank,protein targeting to membrane (GO:0006612),0.2667016455463492,0.7783544067291477,0.8263157894736842,1.0,1.0,25/83,22.95%,SRP19;FIS1;ZDHHC3;SDCBP;PXMP4;PEX5;PXMP2;GDAP1;PRKCI;PEX13;ATG3;ABCD2;RAB8B;ALDH3A2;SEC62;ZDHHC2;SEC63;RTP4;CHMP4A;CHMP4B;PEX2;SIL1;PIKFYVE;ZDHHC14;ZDHHC21
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.32121974312437734,0.7782260772905537,0.7526737967914439,1.0,1.0,6/20,20.71%,BAX;CASP9;BCL2;CASP2;DCC;ITGAV
prerank,eosinophil chemotaxis (GO:0048245),-0.2799051434880824,-0.7776599685752652,0.7310606060606061,0.9332748582280138,1.0,11/14,61.18%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil migration (GO:0072677),-0.2799051434880824,-0.7776599685752652,0.7310606060606061,0.9332748582280138,1.0,11/14,61.18%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.28737301871042714,0.777496008836259,0.7825086306098964,1.0,1.0,2/43,1.18%,FGF9;IGF1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3441180018303015,0.7770726869361836,0.7503410641200545,1.0,1.0,2/15,8.11%,GPLD1;SIK1
prerank,ureteric bud development (GO:0001657),0.32968382399591256,0.776920354967262,0.7550471063257066,1.0,1.0,4/17,18.02%,FGFR2;ROBO2;OSR1;PKD2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3122611794697627,0.7765384157762109,0.7649253731343284,1.0,1.0,3/24,10.16%,UROD;RSAD1;SLC25A38
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.19469792940905756,-0.7762964021973645,0.8979591836734694,0.9341753462835571,1.0,15/48,23.18%,SAMHD1;STAT2;SLIT2;PTPRC;METTL3;PYDC1;NR1H3;CNOT7;SH2B3;USP18;OTUD4;CCDC3;NR1H2;PPARG;NLRC5
prerank,regulation of response to oxidative stress (GO:1902882),0.3627945384981278,0.7761563882226565,0.746705710102489,1.0,1.0,1/11,3.34%,AIFM2
prerank,necroptotic process (GO:0070266),0.3362454734714134,0.7760449276816974,0.75,1.0,1.0,6/16,20.53%,LY96;TLR3;DNM1L;MLKL;IPMK;ITPK1
prerank,gluconeogenesis (GO:0006094),-0.2091516439717497,-0.7759819268604911,0.8905109489051095,0.9333395667407157,1.0,16/39,26.79%,SLC25A13;GPI;SLC39A14;RBP4;GOT2;ALDOA;PCK2;GOT1;ATF4;ENO1;PPARGC1A;SLC25A11;CRTC2;MDH1;GAPDH;ALDOC
prerank,nucleus organization (GO:0006997),0.27788535234406025,0.7759411294010848,0.7862068965517242,1.0,1.0,16/47,24.13%,REEP4;BIN1;DMPK;CHMP3;LEMD3;VPS4B;NUMA1;NUP35;TPR;SUN1;CHMP4A;CHMP4B;NUP155;SYNE1;NUP54;NUP98
prerank,negative regulation of locomotion (GO:0040013),0.36011087615153486,0.7757977452972995,0.7339055793991416,1.0,1.0,1/12,4.45%,FBLN1
prerank,T cell receptor signaling pathway (GO:0050852),0.2556364215557067,0.7757465863644909,0.867005076142132,1.0,1.0,17/138,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;RC3H2
prerank,positive regulation of behavior (GO:0048520),0.3654097911501668,0.7757382634161247,0.7272727272727273,1.0,1.0,2/10,12.46%,STRA6;CFAP20
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3712772665625492,0.775634609665262,0.754601226993865,1.0,1.0,2/10,15.38%,ASRGL1;QDPR
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3207317596931112,0.7753237730081961,0.7637795275590551,1.0,1.0,2/20,8.19%,SIK1;WNT4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2873718848996044,0.7752757733677501,0.7877030162412993,0.9998868904862158,1.0,18/41,25.79%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;SCARB2;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29038545958311396,0.7751230308383126,0.7854671280276817,0.9996771039122803,1.0,6/39,11.84%,PPIF;GPD1L;YWHAH;SCN2B;FGF12;PTPN3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3468062359294339,0.7749373034002383,0.7300435413642961,0.999524062320926,1.0,3/13,15.96%,KHSRP;NUDT21;ZC3HAV1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3201473716367641,0.7748949025820516,0.7413127413127413,0.9991627165106908,1.0,2/22,14.28%,ZBTB7B;TGFB1
prerank,protein targeting (GO:0006605),0.2560599160755699,0.7738840473182851,0.8536335721596725,1.0,1.0,32/118,22.95%,CACNG3;EDEM1;FIS1;TOMM20;FBXO7;TIMM13;ZFAND6;ZDHHC3;MFN2;AIP;SDCBP;KATNB1;PEX1;GDAP1;PRKCI;ZFAND2A;ATG3;AP4M1;SEC61G;TRAK1;AP4E1;SORL1;ZDHHC2;AP4S1;TIMM44;TIMM22;SEC63;RTP4;TIMM23;PIKFYVE;ZDHHC14;ZDHHC21
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2660968855949284,-0.7737940462500136,0.8387096774193549,0.9355728307400508,1.0,7/18,22.51%,PABPN1;MCM3AP;THOC2;NUP93;NUP133;NXF1;ZC3H11A
prerank,mammary gland epithelium development (GO:0061180),0.3439780294629633,0.7737552493229577,0.7531734837799718,0.9999253147499629,1.0,2/14,8.19%,SCRIB;WNT4
prerank,membrane protein proteolysis (GO:0033619),0.2891337302950583,0.7735200037352854,0.787515006002401,0.9998428022107447,1.0,13/37,24.87%,NFKB1;HM13;MBTPS1;AFG3L2;DAG1;TGFB1;CTSH;PARL;NAPSA;MYH9;SPPL2A;TRAF6;CLPP
prerank,regulation of GTPase activity (GO:0043087),0.2532738283796198,0.7732298453497158,0.895748987854251,0.9998374419667673,1.0,27/177,13.79%,SFRP1;CDKL5;PLXNA2;TBC1D7;SGSM3;RAP1GDS1;RGS10;FLCN;SRGAP2;THY1;ARHGEF7;RASGRP2;EZH2;RAP1GAP;PLXNA1;DOCK8;RAPGEF1;VAV2;GPSM1;TBC1D20;USP6NL;EVI5L;ALS2;ARAP1;RACK1;ADAP1;RABGAP1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.33819052754912077,0.7731212146596652,0.7780784844384303,0.9995558924221173,1.0,1/18,1.12%,SFRP1
prerank,cholesterol transport (GO:0030301),0.2832004400750901,0.772892893257988,0.8109965635738832,0.9994584950119404,1.0,11/45,22.04%,STARD5;RELCH;SOAT1;ABCA7;STARD3;APOE;ABCA5;LIMA1;NPC2;ABCG1;NPC1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31797851171696523,0.7728616811838571,0.7784974093264249,0.9990709225818982,1.0,4/21,10.62%,FIS1;RAP1GDS1;PDZD8;AFG3L2
prerank,positive regulation of binding (GO:0051099),0.26550500569009367,0.7727916534781966,0.831413612565445,0.9987488585756097,1.0,14/84,17.48%,VTN;IGF1;KDM4D;SIRT2;TCF7L2;EGF;GPSM1;APP;CEBPG;ADD2;LRP1;DERL1;APOE;USP33
prerank,protein localization to nucleus (GO:0034504),0.26026821121888005,0.7727405341288065,0.8614583333333333,0.9983905051094425,1.0,30/102,23.13%,MMP12;TSC2;CHCHD10;NXT2;NXT1;DVL1;KPNB1;ABCA7;TOR1B;NUP188;IPO11;E2F3;NUP88;IPO7;NUP214;TNPO1;TOPORS;MDM2;NUP153;BANP;PPP1R10;TOR1AIP2;HNRNPU;HEATR3;TPR;APPL2;PIKFYVE;NUP155;PINX1;CSE1L
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3201278583783045,0.7725603157052897,0.7578125,0.9982387398637299,1.0,7/22,25.60%,FBXO38;MALT1;HSPD1;TRAF2;B2M;TRAF6;STX7
prerank,primary neural tube formation (GO:0014020),0.29746098369636487,0.7724091104500855,0.7707082833133253,0.9980396515328958,1.0,3/30,5.37%,DVL2;TSC2;SCRIB
prerank,RNA modification (GO:0009451),0.2781063569219245,0.772262455691322,0.8082497212931996,0.9978000172642146,1.0,12/54,19.95%,DTWD1;ANKRD16;TRDMT1;AARS1;PUS7;TRMT1;TFB1M;QTRT2;URM1;ALKBH1;NSUN4;WDR4
prerank,tube closure (GO:0060606),0.296016913206254,0.7719585884239429,0.7793764988009593,0.9978131768892735,1.0,3/31,5.37%,DVL2;TSC2;SCRIB
prerank,tRNA processing (GO:0008033),0.2718817059831566,0.77167937995782,0.823271130625686,0.9977785134266761,1.0,16/61,21.85%,DTWD1;ANKRD16;TRDMT1;AARS1;SARS1;TRMT1;RPP30;PTCD1;QTRT2;URM1;RTCB;WDR4;RTRAF;FARS2;ZBTB8OS;TRMT6
prerank,membrane depolarization during action potential (GO:0086010),0.3058672421821596,0.771660439756981,0.7696078431372549,0.9973812527673104,1.0,5/26,10.99%,SCN7A;ATP1A2;YWHAH;SCN2B;SCN1A
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2672436633967863,0.7715303731392809,0.819935691318328,0.9971305783889131,1.0,23/72,24.48%,PSMD4;MAP3K14;NFKB2;TIRAP;PSMB10;PSMD11;MALT1;PSME2;PSMC5;TLR3;PSMD1;PSMD6;RELB;BIRC3;PSMD5;PSMA4;PSMA1;PSMC6;TRAF2;PSMA5;REL;PSMD14;TRAF6
prerank,negative regulation of TOR signaling (GO:0032007),0.29120921562318675,0.7715187896213594,0.7893491124260354,0.9967146680667184,1.0,15/36,25.84%,TSC2;TBC1D7;FLCN;STK11;RNF152;PRKAA1;PDCD6;NPRL2;SESN1;ATM;TSC1;TMEM127;NPRL3;CASTOR2;DEPTOR
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2699029323110353,0.771369119724573,0.8306538049303323,0.9965134798158581,1.0,19/68,19.58%,SMN1;SLBP;TBP;PRMT5;CPSF7;GTF2H3;CSTF2T;MAZ;NUDT21;POLR2K;CCNH;CPSF3;SETX;POLR1A;CDK7;POLR3K;TAF1B;FIP1L1;CSTF3
prerank,stress granule assembly (GO:0034063),0.31760801094479285,0.7712520322998071,0.7658473479948253,0.9962492697061885,1.0,7/20,19.78%,DDX3X;ATXN2L;YTHDF3;YTHDF1;MAPT;YTHDF2;CIRBP
prerank,positive regulation of bone resorption (GO:0045780),-0.30715643975519724,-0.7703510981378426,0.7492260061919505,0.9396224290344313,1.0,4/11,15.91%,PLEKHM1;ATP6AP1;SPP1;TNFRSF11A
prerank,skeletal muscle organ development (GO:0060538),0.3018614547358304,0.7699462928975277,0.7645600991325898,0.9976949798013952,1.0,2/26,4.00%,STRA6;MYH14
prerank,protein dephosphorylation (GO:0006470),0.2555484270390917,0.7698255964444859,0.8771750255885363,0.9974484706384186,1.0,48/135,25.66%,DUSP18;DUSP26;PPP2R2C;PPM1B;STK11;CDC14B;SSH1;PPP2R5E;PPP1CC;PPM1H;PTPN5;PTPRF;PTPN3;TNS2;PTPN22;EYA2;PPM1E;PPP2R5D;CTDSP2;PPP5C;PPM1M;PTPN12;MTMR4;PPP2CB;PPP2R5A;PTPRE;TAB1;PPM1A;PTPRS;EYA1;PTPRR;PPP2R2B;PPM1F;PPP2R2A;RPAP2;DUSP16;PTEN;PPP3CB;PPP2R5C;PPM1D;PPP4R1;PPP2R2D;MTM1;PTPN14;PTPRA;DUSP3;PTPN13;FBXW11
prerank,"phagocytosis, engulfment (GO:0006911)",0.29063375368664035,0.7689833560715469,0.8048484848484848,0.9982032038454073,1.0,2/36,2.78%,FCGR2B;RAC1
prerank,regulation of microtubule-based process (GO:0032886),-0.20924420298574709,-0.768765297090651,0.8782051282051282,0.9407315931720541,1.0,13/36,24.89%,MARK2;BICD1;MARK4;CYLD;TRIM36;ROCK1;PRKAA2;KLHL42;ATF5;TRAF3IP1;ERBB2;FAM107A;HDAC6
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2922831823935297,-0.7686268656244294,0.7364864864864865,0.9396336159699468,1.0,6/13,21.79%,NCK1;DDRGK1;PPP1R15B;UFL1;HSPA5;DNAJB9
prerank,JNK cascade (GO:0007254),0.28837258124079157,0.7684425600858583,0.7687927107061503,0.9985357432417418,1.0,3/40,4.55%,MAPK9;PTGER4;MINK1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3254146737574646,0.7684125704288797,0.7735602094240838,0.9981568084082667,1.0,5/19,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,cellular response to organic substance (GO:0071310),0.25837940906870027,0.7682645229461055,0.867983367983368,0.9979468396465432,1.0,17/116,15.82%,KHSRP;CLEC3B;SFRP1;CDK9;CXCR4;PID1;PLK5;PTPN5;ROBO2;NFAT5;IL1RAPL1;PARK7;RACK1;TGFB1;SLIT3;ACVR1B;PTPN12
prerank,estrogen metabolic process (GO:0008210),0.3360261526382101,0.7678863364002435,0.7662162162162162,0.9980842051948478,1.0,2/15,16.33%,HSD17B4;SULT1A1
prerank,regulation of T cell cytokine production (GO:0002724),0.3376213449903172,0.7678762380877456,0.7673758865248227,0.9976742502293318,1.0,5/15,24.48%,MALT1;SMAD7;TRAF2;B2M;TRAF6
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.33668120346555813,0.7669799469655227,0.763768115942029,0.9985099187369985,1.0,6/15,23.39%,LEMD3;MAGI2;ACVR1B;ACVR2A;SMAD7;FKBP1A
prerank,positive regulation of cholesterol efflux (GO:0010875),0.31568842886783227,0.7668612461427242,0.768837803320562,0.9982480674462906,1.0,6/21,18.39%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25737718310360713,-0.7666236903573869,0.8352059925093633,0.941350754941639,1.0,6/18,16.70%,RDX;EZR;VPS11;PTPN23;SRC;MSN
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3504477915633638,0.7665685186178515,0.7421652421652422,0.9982396971777339,1.0,3/13,14.97%,ERRFI1;SNX6;CBL
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.25789704740404046,0.7664598443045479,0.8714285714285714,0.9979777676496833,1.0,23/125,19.92%,B9D2;CENPT;INCENP;TAOK1;MAD2L1;NEK9;KPNB1;DCTN6;PPP1CC;CEP126;GPSM2;DYNC1LI1;RCC1;CENPC;ZWINT;TNKS;BCCIP;MAP4;MECP2;RANBP2;DYNLL1;ZW10;PAFAH1B1
prerank,glycoprotein metabolic process (GO:0009100),0.2755567304252096,0.7663464332489153,0.8134831460674158,0.9977223039540641,1.0,11/53,17.26%,ST8SIA3;ST3GAL2;MGAT4B;NGLY1;MAN1A2;MANBA;PARK7;B4GALT5;ST6GALNAC6;MAN1C1;TNIP1
prerank,regulation of chromatin organization (GO:1902275),0.3435343932467811,0.7663362377995845,0.7553648068669528,0.997315629736694,1.0,6/14,20.48%,CDK9;SETD1A;TLK1;SETD5;MLLT3;HNRNPU
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.3059839262678991,-0.7656582296816364,0.7514792899408284,0.9415397339747046,1.0,4/10,17.54%,SETD2;SETD3;SMYD2;SETD4
prerank,negative regulation of DNA replication (GO:0008156),-0.2837833840036538,-0.7656492076877783,0.7934426229508197,0.9402344744808312,1.0,2/13,10.10%,WAPL;PDS5A
prerank,microtubule anchoring at centrosome (GO:0034454),0.3715488014470822,0.7656409608923848,0.7374810318664643,0.9979010652510297,1.0,3/10,17.04%,KIF3A;HOOK3;NIN
prerank,peptidyl-serine modification (GO:0018209),0.2520861910560385,0.7654664169812737,0.8998988877654196,0.9977253505133336,1.0,30/166,16.60%,MAPK9;CAMK1G;PDPK1;CSNK2A2;GALNT16;PARP1;EIF2AK3;DMPK;PARP2;PRKCA;CDK5;MAST3;GALNT4;SBK1;NTMT1;TOP1;BRSK1;CAMK2D;TLK1;ATR;RPS6KA3;PRKCI;CSNK1D;ROCK2;GRK2;CSNK1A1;RPS6KA1;NDNF;CAMK1D;TNKS
prerank,microtubule anchoring (GO:0034453),-0.29741687640388637,-0.7653682450169738,0.7461300309597523,0.9393431419453098,1.0,3/12,12.21%,BICD1;PCM1;GCC2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3276670396297651,0.765027385457311,0.7602739726027398,0.9979033589644858,1.0,1/17,0.79%,UBQLN1
prerank,response to unfolded protein (GO:0006986),0.2807317705371408,0.7649450275913493,0.8243847874720358,0.9975807749559621,1.0,10/48,18.07%,BAX;HSP90AA1;DNAJB5;DDIT3;TOR1B;HSPH1;HSPD1;DERL1;DAXX;PACRG
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.34143400528108253,0.764722984737127,0.7646239554317549,0.9974842943009137,1.0,1/14,2.70%,EDN3
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2815535340123693,0.7642185171077789,0.7900943396226415,0.9977609368272903,1.0,6/39,13.72%,PARP1;NTHL1;DDB1;CUL4B;GTF2H3;POLD3
prerank,sodium ion homeostasis (GO:0055078),0.3148651605175047,0.76415232665129,0.7739816031537451,0.9974288692226876,1.0,2/21,7.53%,ATP1A3;ATP1A2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3541789326727446,0.7636643126813036,0.7492260061919505,0.9977028130160257,1.0,1/10,2.67%,HSP90AA1
prerank,regulation of protein import into nucleus (GO:0042306),0.28953226366228024,0.7634693363581629,0.8002392344497608,0.9975426229797202,1.0,11/36,22.11%,HDAC3;PIK3R1;JUP;PIK3R2;SUFU;TGFB1;UBR5;RBM22;CABP1;TPR;SMAD3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2544473832857025,0.763247635543739,0.8783505154639175,0.9974360066974295,1.0,28/112,21.52%,WNT5A;CLEC3B;SFRP1;CGN;SMAD9;ZFP36L1;WNT4;SOX9;USP15;COL1A2;ZMIZ1;SOX6;USP9X;TGFB1;SMAD6;SOX5;CBL;SMURF1;TGFBR1;PDCD5;WWOX;PRKCZ;GCNT2;TGFBR3;SMAD7;ITGB1;APPL2;SMAD2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.30349573618547115,0.7630678489188196,0.7861557478368356,0.9972520491524123,1.0,8/27,23.39%,CACNB4;CACNB1;CAMK2D;AHNAK;JPH1;CALM1;CALM2;FKBP1A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.35507642924733374,0.7629804227530705,0.7661764705882353,0.9969465615655253,1.0,2/11,6.77%,RENBP;GNPNAT1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.28975009021020126,0.762967878576648,0.7987804878048781,0.9965445215565016,1.0,5/34,14.46%,MPP2;GRIN1;GRIN2A;NLGN3;GLRA1
prerank,integrated stress response signaling (GO:0140467),0.3414280207540964,0.7628281927015187,0.7780938833570412,0.996324782421241,1.0,4/14,17.62%,EIF2AK3;DDIT3;IMPACT;OMA1
prerank,positive regulation of transmembrane transport (GO:0034764),0.34483871357073315,0.7627107404986608,0.7593880389429764,0.9960717459579089,1.0,2/13,9.67%,AZIN2;CLIP3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3113961462596233,0.7624999170927033,0.7798408488063661,0.9955184037747427,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3113961462596233,0.7624999170927033,0.7798408488063661,0.9955184037747427,1.0,4/21,10.07%,PARP1;DDB1;CUL4B;GTF2H3
prerank,cellular response to superoxide (GO:0071451),0.36359045800477396,0.7624453668977039,0.7544378698224852,0.9951818073038114,1.0,2/10,12.47%,SOD2;SOD3
prerank,gene expression (GO:0010467),0.2473840157836556,0.7620359700498988,0.964964964964965,0.9953365774199592,1.0,76/348,19.45%,MRPL36;FARSB;DDX17;DDX19B;SLBP;STUB1;RBM3;NXT1;U2AF1;SRSF2;WARS1;YARS2;RAE1;POLR2B;SRSF5;RBM39;CELF2;DHX8;ATXN1;SRSF3;HNRNPK;MPHOSPH10;THOC3;SRSF9;SRSF1;PABPC4;HNRNPD;DRG1;MRPL10;NUP188;RPL35A;RPS25;SARS1;RPS15;RBMS1;RBMS2;POLR2K;CPSF3;NUP210;RPL9;THOC7;HARS1;HNRNPH3;NUP88;SETX;HNRNPL;MRPL3;GSPT1;MMS19;RPL4;NOVA1;HNRNPA2B1;MRPL13;THOC1;NUP214;PPP5C;HSPD1;MRRF;YTHDC1;MRPL24;UPF2;RPL23A;RPLP2;TNIP1;SRRM1;TOPORS;SORL1;NUP153;SMG7;RANBP2;TAF1B;FIP1L1;NUP35;MRPS6;RPS3;RPL27A
prerank,protein sumoylation (GO:0016925),0.2795308458839464,0.7620277439793858,0.8293515358361775,0.9949277416853459,1.0,19/49,24.13%,SAE1;RAE1;NUP188;NUP210;NUP88;PIAS3;NUP214;TOPORS;NUP153;RANBP2;NUP35;PIAS1;SUMO2;EYA1;TPR;NUP155;UBA2;NUP54;NUP98
prerank,regulation of interleukin-17 production (GO:0032660),0.2951605978728483,0.7619005045064371,0.7524752475247525,0.9946784087277272,1.0,3/31,14.28%,ZBTB7B;DDIT3;TGFB1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.2896954074598601,-0.7617419250863848,0.778169014084507,0.9436387207351231,1.0,7/13,26.59%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;PPARA;NOS1
prerank,response to progesterone (GO:0032570),0.3208306424564943,0.7612438708678138,0.7890625,0.9951583835428488,1.0,2/18,6.78%,WBP2;CATSPER3
prerank,cell proliferation in forebrain (GO:0021846),0.34982891176029285,0.7608448661917688,0.7747747747747747,0.9952787084138612,1.0,3/10,14.58%,HOOK3;DOCK7;CEP120
prerank,striated muscle cell development (GO:0055002),-0.2693989028259679,-0.7601873844007828,0.7508417508417509,0.9446614698881907,1.0,4/14,31.69%,PGM5;TMOD1;LMOD1;SDC1
prerank,negative regulation of cell junction assembly (GO:1901889),0.30441520617704737,0.7601165975494812,0.7849740932642487,0.9958449168914375,1.0,11/25,24.80%,DMTN;ROBO2;ROCK2;SLIT1;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,inorganic anion transport (GO:0015698),0.2712495894102909,0.7600112299973729,0.8205980066445183,0.9955832687312809,1.0,7/53,14.46%,BEST1;CLCN2;SLC13A4;CLCN4;CLIC1;ENPP1;GLRA1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2615147502753621,0.7600055250818385,0.8501070663811563,0.9951708355402102,1.0,28/80,25.20%,TRAPPC10;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;DENND5A;VPS54;VTI1B;VTI1A;RAB6A;SGSM2;TRIM27;STX5;HEATR5A;RAB7A;RAB7B;EHD3;PIKFYVE;GOSR1;DENND2A;GGA1;HEATR5B;SURF4;LMAN1
prerank,positive regulation of nervous system development (GO:0051962),0.2788968972776405,0.7597640845901826,0.8257309941520468,0.995089422839441,1.0,11/42,21.20%,EPHB2;SOX11;CLSTN2;IL1RAPL1;NLGN3;NLGN2;SNW1;IL1RAP;CLSTN3;SERPINF1;DLG5
prerank,positive regulation of chemotaxis (GO:0050921),0.2757174844044882,0.7596717028271868,0.8078291814946619,0.9947959445826555,1.0,9/43,21.65%,EDN3;NRP1;DSCAM;TGFB1;F3;MEGF8;PRKD2;FGF2;PPM1F
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3627521914848418,0.7591838489371389,0.7559880239520959,0.9946500701369945,1.0,2/10,12.69%,SMPD2;RACK1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3627521914848418,0.7591838489371389,0.7559880239520959,0.9946500701369945,1.0,2/10,12.69%,SMPD2;RACK1
prerank,prostaglandin metabolic process (GO:0006693),0.2980918458302147,0.7588423587187192,0.7980535279805353,0.9947073832587059,1.0,1/26,0.44%,PRXL2B
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.23697315993086293,-0.7587391671582775,0.8444444444444444,0.9454656981917795,1.0,8/21,23.84%,SMAD4;BMPR1A;NUP93;CCN3;BMP4;TGFB3;SLC2A10;SH2B1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3463486801200332,0.7585033836452227,0.7710674157303371,0.9947511043295524,1.0,2/13,10.40%,IGF1;IRS2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.344095118593491,0.7581120209041166,0.7449567723342939,0.9948591979346282,1.0,2/13,9.15%,PIGU;EGF
prerank,sphingoid metabolic process (GO:0046519),-0.29438128981078704,-0.7579659945337665,0.7801857585139319,0.9453136987513164,1.0,3/12,16.39%,KDSR;NAAA;DEGS2
prerank,negative regulation of angiogenesis (GO:0016525),0.262539478863525,0.7579596113633085,0.8616684266103485,0.9946526712017552,1.0,24/84,21.15%,THBS2;SULF1;DCN;SPARC;HGS;ATF2;PIK3CB;SARS1;ROCK2;SEMA3E;HSPG2;ADAMTS1;SERPINE1;SPRY2;SYNJ2BP;AMOT;MECP2;PGK1;KRIT1;EPN1;KLF4;SERPINF1;ATP2B4;FOXJ2
prerank,embryonic organ development (GO:0048568),0.26659814691606815,0.7571111308705679,0.8379272326350606,0.9953554888038271,1.0,9/61,14.28%,TEAD3;STRA6;FGFR2;PCSK5;TEAD1;GDNF;RBPJ;NDRG4;TGFB1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.24508446295820052,0.7568618934063943,0.9669669669669669,0.9952882367591271,1.0,79/327,20.76%,DVL2;NR1D2;PCGF1;RORA;NFKB2;PSPC1;ZNF205;CNBP;ABL1;ATXN1;PHF1;DVL1;ZNF35;CASZ1;EZH2;FUS;MAGED1;ZBTB38;ASCC1;ZKSCAN5;ACTR8;NFX1;DDIT3;HNRNPD;PRMT5;SOX11;SAP30L;FADS1;ATF2;POU6F2;NSD3;FOXN3;ZMIZ1;BACH1;SOX6;SUFU;ATRX;ESRRG;TULP3;KMT2D;RFX3;NR2C2;MED23;TCF7L1;TCF3;ASCC2;ACVR1B;SSBP2;GTF2IRD1;CHEK2;SBNO1;CLOCK;TRIP4;DAXX;UBE2L3;ZFP37;SOX13;HP1BP3;TCF7;NFXL1;NSD1;PHF12;GCFC2;NONO;TGFBR1;TERF2IP;NUP35;SOX4;BRDT;YAF2;MITF;CDK11B;WWC1;CARM1;NFIA;CHD7;UTP4;ZNF219;YBX1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.30438109129767593,0.7566110486535894,0.7861715749039693,0.9952218601877969,1.0,6/24,22.83%,CHERP;ITPR1;HTR2C;PKD2;FGF2;IBTK
prerank,negative regulation of protein binding (GO:0032091),0.2608213302432705,0.7564269182672018,0.8452380952380952,0.9950597417422874,1.0,16/71,17.95%,BAX;ATP2A2;CARD16;DVL1;LRPAP1;PTPRF;PARK7;RACK1;DISC1;CTSZ;CTNNBIP1;PSME3IP1;ITGB1BP1;TLE5;USP33;SORL1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.349396916499482,0.7562139521464092,0.7607090103397341,0.9949521852130523,1.0,4/12,21.79%,CALM3;CAMK2D;CALM1;CALM2
prerank,peripheral nervous system development (GO:0007422),0.30720559504277845,0.75594417900788,0.7871794871794872,0.9949003492572117,1.0,3/23,10.19%,NTF3;GPC1;GDNF
prerank,substrate-dependent cell migration (GO:0006929),0.33679296253477575,0.7558631905441245,0.7805907172995781,0.9945987326820652,1.0,3/14,8.75%,NRP1;EPHA8;SDCBP
prerank,carbohydrate biosynthetic process (GO:0016051),0.3140037887963813,0.7558118961085071,0.7883116883116883,0.9942524106038924,1.0,3/21,14.35%,ST3GAL2;ST3GAL3;ST6GALNAC6
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.269797680142748,0.7557823277387118,0.8235930735930735,0.9938736951326643,1.0,10/57,12.27%,MRPL36;EBNA1BP2;GLUL;CUL4B;RBIS;RPL35A;RPS25;RPS15;MALSU1;NPM1
prerank,defense response to symbiont (GO:0140546),0.25752025429058956,0.7557206706449141,0.8604407135362014,0.9935459332885188,1.0,16/92,16.96%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2
prerank,regulation of receptor recycling (GO:0001919),0.32726981302210423,0.7556652905930802,0.772972972972973,0.9932078320968675,1.0,4/16,16.65%,SCRIB;VAMP3;NSF;ANXA2
prerank,protein homotetramerization (GO:0051289),-0.1867586628929727,-0.7556084187815522,0.9072164948453608,0.9474642593317305,1.0,15/49,25.91%,SAMHD1;OSBPL2;ACACA;KCNJ2;GLS;ACACB;GBP5;ALDOA;UPB1;MCOLN1;ALDH9A1;APIP;CBR4;HCN1;KCNJ12
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3490729540744546,0.7553291967916403,0.7746077032810271,0.9932670204451655,1.0,3/12,20.33%,THY1;FLOT1;GCNT2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2706521623491709,-0.7553272622644034,0.7925170068027211,0.9465869502638333,1.0,5/14,31.27%,LGALS9;TGFBR2;CD81;CD55;SYK
prerank,pore complex assembly (GO:0046931),-0.25029418632395994,-0.7550072990717722,0.8416988416988417,0.9457755100176786,1.0,9/19,22.04%,NUP205;ANO6;NUP93;NUP107;ADAM10;NDC1;P2RX7;TMEM170A;BAD
prerank,rRNA processing (GO:0006364),0.24865168560147313,0.7548616368673592,0.9152371342078708,0.9934925637352098,1.0,24/172,14.06%,NHP2;LSM6;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;MRPL1;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;BMS1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3244350303931424,0.7548582029595853,0.7670454545454546,0.9926679757824481,1.0,8/16,24.80%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3244350303931424,0.7548582029595853,0.7670454545454546,0.9926679757824481,1.0,8/16,24.80%,DMTN;ITGB1BP1;DLC1;ARHGAP6;CLASP2;PTEN;CORO1C;PHLDB2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3584875056171079,0.7547475900698336,0.7903726708074534,0.9924034520026846,1.0,1/10,1.57%,FOXM1
prerank,T cell mediated immunity (GO:0002456),-0.27982876153789354,-0.7546814964718529,0.8114478114478114,0.9449135280520529,1.0,2/13,6.13%,CD46;CADM1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.33910289210647215,0.7544967174103495,0.7651296829971181,0.9923309276486564,1.0,5/13,22.16%,FGFR2;RBPJ;TGFBR3;FGF2;ERBB4
prerank,response to interleukin-4 (GO:0070670),0.36399141273766683,0.7543624485251621,0.7834890965732088,0.9921111279599257,1.0,1/10,3.80%,XBP1
prerank,regulation of interleukin-2 production (GO:0032663),0.27850707573371125,0.7543232188401421,0.8142695356738392,0.9917474914838827,1.0,12/43,25.01%,ANXA1;TNFAIP3;MALT1;SPTBN1;PDE4B;PRKD2;TRIM27;RPS3;TRAF2;TRAF6;RUNX1;NAV3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.27041280236806686,-0.7542266013617829,0.7913907284768212,0.9442723273162392,1.0,4/14,14.13%,NUDT5;ENTPD1;ADPRM;ENTPD6
prerank,chondroitin sulfate metabolic process (GO:0030204),0.29098791876079294,0.7540553019112448,0.8105781057810578,0.991701763796241,1.0,7/30,21.21%,CHPF;DCN;CHSY3;ARSB;NDNF;DSE;CHST9
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2974512019967524,0.7533546906681442,0.7885085574572127,0.9922503728328951,1.0,7/29,16.00%,WBP2;UFSP2;GPAM;CNOT9;CBFB;KMT2D;VPS18
prerank,negative regulation of insulin secretion (GO:0046676),0.3309933844344385,0.7530481273978098,0.7817938420348058,0.9922572967989732,1.0,1/17,1.12%,SFRP1
prerank,receptor internalization (GO:0031623),0.27915299092879214,0.7529401471332535,0.8261363636363637,0.9919957437182336,1.0,7/44,15.11%,DNM1;ADM;ARRB1;GRK3;LRP1;GRK2;RAB31
prerank,positive regulation of chromatin organization (GO:1905269),0.35282846529037326,0.7527532220709887,0.7625178826895566,0.9918387474645471,1.0,6/12,21.66%,ATRX;TERF1;DAXX;TERF2IP;MIER1;H3-3A
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.34798398174970735,0.7527314471929457,0.8106936416184971,0.9914598968674923,1.0,6/13,20.92%,BARD1;PARK7;SUFU;NUP153;CABP1;TPR
prerank,negative regulation of transferase activity (GO:0051348),0.2993751450456624,0.7526595761604357,0.7984981226533167,0.9911482935300965,1.0,9/28,20.88%,ABL1;FBXO5;IRS2;PARK7;MAPT;TERF1;HNRNPU;NPRL2;SMAD7
prerank,mitochondrial translational elongation (GO:0070125),0.2586497469868884,0.752340563991142,0.8680042238648363,0.99118080033965,1.0,23/88,23.10%,MRPL36;MRPL17;MRPL19;GADD45GIP1;AURKAIP1;MRPL47;MRPL21;MRPL10;MRPL1;MRPL48;MRPL3;CHCHD1;MRPL13;MRPL24;MRPL15;MRPS6;OXA1L;MRPS24;MRPS5;GFM2;MRPS35;MRPS28;GFM1
prerank,nuclear migration (GO:0007097),0.3360165417563549,0.7523326748336765,0.7776183644189383,0.9907795906422128,1.0,5/13,19.92%,CLMN;HOOK3;DOCK7;CEP120;PAFAH1B1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3619858655926099,0.7521870879393112,0.7837837837837838,0.9905492813682898,1.0,2/10,11.52%,CD200R1;BMP5
prerank,protein destabilization (GO:0031648),-0.20652286070561401,-0.751538118514553,0.930635838150289,0.9467809880695182,1.0,13/32,28.80%,SIRT1;SENP2;SERF2;EP300;RNF139;IRGM;SOX17;KDM8;PRKN;RAD23A;CCDC88C;BTRC;TRIM21
prerank,response to axon injury (GO:0048678),-0.253988501660787,-0.7509616354641656,0.8188679245283019,0.9463042036160861,1.0,13/18,46.78%,RTN4RL1;P2RY12;DHFR;FLRT3;MORN4;SARM1;TYROBP;P2RX4;NREP;GAP43;APOD;TREM2;MTR
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.33067544457215137,0.7507592033440663,0.7750716332378224,0.9921249755632998,1.0,2/14,5.95%,NRP1;GAB1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.2535162855535116,0.7503831665223358,0.8833333333333333,0.9922019584442981,1.0,22/101,19.78%,CLN6;HSP90AA1;STUB1;RBM3;DDX3X;OGT;AURKAIP1;HNRNPD;ZCCHC4;YTHDF3;NPM1;YTHDF1;PRR16;TGFB1;FAF1;ASPSCR1;AGTR1;FMR1;METTL5;SOX4;KLF4;CIRBP
prerank,response to interferon-alpha (GO:0035455),-0.2564646725203743,-0.7502131459881192,0.8191489361702128,0.9460162277087201,1.0,3/16,7.09%,AXL;IFNAR2;EIF2AK2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.332456475507242,0.7499489951976965,0.8095238095238095,0.9923743741207289,1.0,3/14,13.29%,TIRAP;MALT1;TLR3
prerank,negative regulation of T cell differentiation (GO:0045581),0.3516825243474164,0.7498613069380698,0.7612403100775194,0.9920794740365302,1.0,1/10,5.88%,IRF1
prerank,positive regulation of B cell activation (GO:0050871),0.2675954514714181,0.7497591052695178,0.8445945945945946,0.991814736930568,1.0,5/50,11.07%,EPHB2;XBP1;TIRAP;IRS2;BCL2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3343445509941695,0.7495874158128648,0.7934336525307798,0.9916358973292014,1.0,2/15,10.19%,SOX9;GDNF
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.25781339846808793,0.7493322593910421,0.8560606060606061,0.991574358988786,1.0,22/72,23.46%,PFDN4;TAOK1;CAMSAP2;VBP1;SSH1;PFDN1;CLIP3;PLEKHH2;KATNB1;EML2;TBCD;APOE;PFDN2;TUBB4A;SHANK1;LIMA1;FGF13;CLASP2;PFN2;CAMSAP1;MAP2;IAPP
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.21132742806397906,-0.749047348182146,0.9135135135135135,0.9463656504707357,1.0,9/32,16.11%,GTF2H1;CAVIN1;UBTF;MNAT1;RRN3;TAF1A;GTF2H5;GTF2H2;ERCC3
prerank,membrane lipid metabolic process (GO:0006643),0.3016332287308169,0.7489427390134865,0.8025974025974026,0.9916643004541643,1.0,3/22,11.89%,SMPDL3B;AGMO;TEX2
prerank,cellular protein catabolic process (GO:0044257),0.2671769683917728,0.7488638081465163,0.847682119205298,0.9913594039569602,1.0,19/59,24.87%,ADAMTS7;RAB12;VLDLR;CAPN2;AP2S1;MALT1;TCIRG1;CTSZ;CTSH;CHEK2;MDM2;CTSK;CTSO;CTSB;RAB7A;ADAMTS12;MYLIP;SIAH2;CLPP
prerank,peptide cross-linking (GO:0018149),0.29802091815756754,0.7488349694487971,0.7975,0.9909897992881083,1.0,3/25,16.28%,ANXA1;ABCA7;NDNF
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2694213976192163,0.7484486011600432,0.8354002254791432,0.9906727904426568,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,mitotic nuclear membrane organization (GO:0101024),0.2694213976192163,0.7484486011600432,0.8354002254791432,0.9906727904426568,1.0,7/51,12.64%,REEP4;SIRT2;CC2D1B;KPNB1;CHMP3;NUP188;RCC1
prerank,organophosphate catabolic process (GO:0046434),0.35444185593230576,0.7479882342077652,0.7892376681614349,0.9908576180726368,1.0,1/11,10.25%,ENPP2
prerank,amino sugar biosynthetic process (GO:0046349),0.34642465955424623,0.7478928162446175,0.7903225806451613,0.9905855042590684,1.0,2/12,6.77%,RENBP;GNPNAT1
prerank,protein modification process (GO:0036211),0.25738417444583533,0.7478493636946913,0.865301724137931,0.9902326826686716,1.0,13/76,17.27%,ARAF;LCMT1;PARP1;UBE2S;ABL1;MANBA;PLAT;SERP1;ATG3;RPN2;NEDD8;UBE2L3;FBXO22
prerank,histone H4-K16 acetylation (GO:0043984),0.31616995115467955,0.7473616377600155,0.7769130998702983,0.9904818601102447,1.0,4/19,13.99%,MSL2;OGT;MSL1;KANSL2
prerank,dendritic cell chemotaxis (GO:0002407),0.33293571069814165,0.7472392640497186,0.7662889518413598,0.9902392035517243,1.0,14/14,66.74%,CXCR4;HMGB1;TRPM4;CCR7;CXCR2;CCR6;CCR1;CCL5;PIK3CG;CCR2;CCR5;CCL19;GPR183;TRPM2
prerank,replication fork processing (GO:0031297),0.2811028550038327,0.7469690830126504,0.8016336056009334,0.9901805289474795,1.0,8/38,15.16%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1;MRE11
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.3042341244361828,-0.7462935491835136,0.7645348837209303,0.9489773191259049,1.0,3/10,12.00%,IVD;ACAD11;ETFDH
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.28367043529619373,-0.7457578629418845,0.8,0.9484075231151765,1.0,6/11,26.82%,ASAH1;SIRT1;DGKQ;EGR1;BMP2;FGFR4
prerank,response to acidic pH (GO:0010447),0.3320026118338344,0.7455811356611165,0.7851123595505618,0.9916277351734064,1.0,4/13,25.79%,GPR4;IMPACT;RAB11B;SLC9A1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2515732538397748,0.7447841434171595,0.8610816542948038,0.9922468084234374,1.0,18/94,17.58%,BAX;GSKIP;PDK1;DDX3X;ITPR1;ABL1;STK11;BRSK2;CD24;DDIT3;CASP9;BCL2;CUL5;CASP2;DDX5;CHEK2;TOPORS;DNAJC10
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3285064999519096,0.7444665680102536,0.7935222672064778,0.9922620889331537,1.0,3/16,14.28%,SUCO;WNT4;TGFB1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2939223630757316,0.7436620403574915,0.8211068211068211,0.9929337912102191,1.0,5/26,15.82%,PDPK1;ZFP36L1;SOX9;IQGAP1;PTPN12
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3499804930780613,0.743367488514892,0.7790530846484935,0.9929194805049962,1.0,1/11,1.59%,GPLD1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3407333683938888,0.7433674419079427,0.7913043478260869,0.9925120453468079,1.0,5/12,22.96%,DCN;PIK3CB;SPRY2;ATP2B4;ADAMTS12
prerank,signal peptide processing (GO:0006465),0.34595752571521604,0.7425327410639021,0.7667638483965015,0.9931567538930871,1.0,3/11,17.07%,PCSK5;HM13;PARL
prerank,response to amino acid starvation (GO:1990928),0.25925055368363953,0.7425237235710986,0.8629550321199143,0.9927647871083936,1.0,15/72,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,regulation of microglial cell activation (GO:1903978),-0.2551093116734555,-0.7422192120233585,0.8083623693379791,0.9519490367363068,1.0,4/15,28.50%,PTPRC;GRN;TTBK1;SPHK1
prerank,negative regulation of protein transport (GO:0051224),0.2953950523101939,0.7422171768513431,0.783989834815756,0.9927309364856536,1.0,5/25,17.19%,ERP29;CYP51A1;RHBDF1;NDFIP2;APOE
prerank,high-density lipoprotein particle assembly (GO:0034380),0.352315486769191,0.7419437919345651,0.7916666666666666,0.9926846980354544,1.0,3/10,17.65%,ABCA7;APOE;BMP1
prerank,cellular response to amino acid starvation (GO:0034198),0.2593890102595136,0.7418814164182439,0.8620320855614974,0.992369069973495,1.0,15/71,16.99%,EIF2AK3;SLC38A9;FLCN;ATP6V0E2;RRAGA;GCN1;ATF2;ATP6V1G1;TCIRG1;RNF152;LAMTOR5;ATP6V1D;IMPACT;ATP6V1B2;MIOS
prerank,positive regulation by host of viral transcription (GO:0043923),0.3226203202050603,0.7417941566653845,0.8,0.9920645050071193,1.0,7/15,23.03%,SMARCB1;CHD1;NUCKS1;SNW1;CCNT1;RRP1B;SP1
prerank,cellular response to glucagon stimulus (GO:0071377),0.3176655156074964,0.7413311510867082,0.8161073825503355,0.9922758026833505,1.0,4/17,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2585646855498629,0.7412788855467618,0.8553191489361702,0.9919355387841599,1.0,23/70,24.79%,PSMD4;ABL1;PSMB10;PSMD11;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;N4BP2L2;PSMA5;YAP1;PSMD14;RUNX1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.2868629168719685,-0.7411551591761296,0.7699680511182109,0.9520724247988718,1.0,3/11,10.02%,PARP8;PARP6;PARP10
prerank,anterior/posterior axis specification (GO:0009948),0.33168269500392067,0.7411180246711087,0.7757909215955984,0.9917346429040034,1.0,2/15,9.61%,DDIT3;WLS
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.26990437455385274,0.7400855651330555,0.8337182448036952,0.9926433782407988,1.0,11/44,19.40%,KHSRP;ZFP36L1;CELF1;DHX36;PABPC1;YTHDF3;YTHDF1;ROCK2;ZC3HAV1;FTO;YTHDF2
prerank,potassium ion homeostasis (GO:0055075),0.296768239862748,0.739670990138811,0.8184110970996217,0.9927738234767912,1.0,3/23,7.53%,ATP1A3;KCNMA1;ATP1A2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.27422849867325383,0.7393108173716197,0.8268551236749117,0.9928498718373954,1.0,3/36,7.14%,WNT5A;AGPAT1;CXCR4
prerank,endodermal cell fate commitment (GO:0001711),0.3589434378470878,0.7392047387348226,0.810930576070901,0.9925846867970635,1.0,2/10,13.57%,RTF1;CDC73
prerank,artery morphogenesis (GO:0048844),0.2846093484744726,0.7387547758500063,0.8106796116504854,0.9927664502848462,1.0,7/30,20.88%,STRA6;NRP1;LRP1;JAG1;PKD2;TGFBR1;SMAD7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.33324184815966584,0.7386074206436635,0.7936962750716332,0.9925521511418193,1.0,2/13,6.77%,RENBP;GNPNAT1
prerank,positive regulation of isotype switching (GO:0045830),-0.25947016872746986,-0.7384778975311884,0.8111888111888111,0.954389783029758,1.0,2/15,6.01%,SHLD2;PAXIP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.25690555052851133,0.7379763127741754,0.8694267515923567,0.9929565651063333,1.0,24/73,24.79%,PSMD4;ABL1;PSMB10;PSMD11;DHX36;PUS7;PSME2;PSMC5;SETD1A;CBFB;PSMD1;TCF3;PSMD6;KMT2A;YTHDF2;PSMD5;PSMA4;PSMA1;PSMC6;METTL14;PSMA5;YAP1;PSMD14;RUNX1
prerank,neutrophil chemotaxis (GO:0030593),-0.18175050964705528,-0.7373914890351742,0.9722222222222222,0.9545555593509785,1.0,4/53,6.44%,GBF1;BSG;CCL15;TGFB2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.2905403220735987,0.7371519755837672,0.817625458996328,0.9935980841741143,1.0,6/31,14.82%,RANBP3L;SOX9;PTCH1;TWIST1;SUFU;SMAD6
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.21064541863404884,-0.7365954258003129,0.9017341040462428,0.9542490952298985,1.0,18/30,36.35%,LBR;HMGCS1;ACLY;FDFT1;ACAA2;ARV1;NSDHL;ACAT2;SQLE;DHCR24;PMVK;IDI1;MVK;HSD17B7;FDPS;PLPP6;DHCR7;EBP
prerank,neural crest cell development (GO:0014032),0.26614137536837323,0.7360137914596,0.8292682926829268,0.9946432719852403,1.0,9/44,15.56%,KLHL12;PEF1;SOX11;SEMA3D;GDNF;RADIL;NRG1;SEMA3E;SEMA3A
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.25917296763814707,-0.7358071176204826,0.8483754512635379,0.9539864312466236,1.0,4/15,11.54%,BMPER;TJP1;SMAD1;PKM
prerank,microglial cell activation (GO:0001774),0.3023871215129573,0.7350669078323878,0.8032128514056225,0.9954925612490267,1.0,3/21,13.93%,APP;IFNGR1;MAPT
prerank,negative regulation of establishment of protein localization (GO:1904950),0.35399367205311405,0.7350422723109545,0.7933130699088146,0.9951184310991062,1.0,5/10,25.31%,MAPT;NDFIP2;TERF1;PPM1F;WWP2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.34652835045329555,0.7350030994204139,0.8079763663220089,0.9947613101143655,1.0,5/11,20.88%,USP15;TGFB1;TGFBR1;TGFBR3;SMAD7
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3096042338399953,0.7347873343587955,0.8157216494845361,0.9946231432670452,1.0,4/18,17.54%,RGS10;CHRM2;GRK2;GNAQ
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2836326499782014,0.73474792324006,0.8136020151133502,0.994274462135246,1.0,7/27,20.26%,SNAI1;EEF1E1;TWIST1;ATR;DDX5;MDM2;PLA2R1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.34470881129133973,0.7343314105330713,0.7868613138686131,0.9943971995781826,1.0,1/10,1.59%,SIRT2
prerank,mitotic cell cycle phase transition (GO:0044772),0.2418133458343134,0.7342121927902854,0.9487951807228916,0.9941430028212416,1.0,41/203,21.47%,CCP110;CDKN2D;CDC23;FOXM1;LCMT1;HSP90AA1;UBE2S;FBXL12;CDC16;ALMS1;WEE1;BRSK2;CDC25A;TUBA1A;CUL4B;YWHAG;BRSK1;E2F3;CCNH;RCC1;GSPT1;CUL5;HAUS3;CSNK1D;TUBB;ACVR1B;OFD1;CHEK2;CDK7;CEP76;TUBB4A;ODF2;ARPP19;USP37;DYNLL1;PAFAH1B1;CDK14;PHLDA1;TAF2;CLASP2;CHMP4B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3452732236827175,0.7340496486466381,0.7981790591805766,0.9939350557364213,1.0,1/11,1.57%,FOXM1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.30626445001224983,0.7338431437323757,0.7957559681697612,0.9930121199648373,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.30626445001224983,0.7338431437323757,0.7957559681697612,0.9930121199648373,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.30626445001224983,0.7338431437323757,0.7957559681697612,0.9930121199648373,1.0,5/20,23.45%,MAD2L1;ZWINT;ZW10;TPR;ATM
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.31048334792023013,0.7338393606229028,0.8100407055630936,0.9926155460942904,1.0,6/18,26.13%,ELOVL1;ACSL6;ELOVL6;HACD2;HACD1;ACSL3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.34906307301090733,0.7335599503022885,0.803030303030303,0.9925619378386261,1.0,3/10,17.00%,DCN;PIK3CB;SPRY2
prerank,positive regulation of T cell proliferation (GO:0042102),0.2645008762326896,0.7331864112769769,0.8459821428571429,0.9926323085110746,1.0,3/55,7.55%,IGF1;ANXA1;CD24
prerank,T cell differentiation (GO:0030217),0.2723848979749673,0.7322947012295348,0.8372365339578455,0.9933723154070891,1.0,9/40,21.30%,ANXA1;ZFP36L1;LEPR;PTPN22;SOX13;TCF7;SOX4;CHD7;GLI3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.26195725896528177,0.7322657108911627,0.8489932885906041,0.993003932503584,1.0,10/50,19.43%,TCIM;DDX3X;IFI35;APP;NFAT5;RTKN2;TLR3;ILK;TERF2IP;RPS3
prerank,determination of heart left/right asymmetry (GO:0061371),-0.19095080171945616,-0.7319386718764759,0.927007299270073,0.957766695827293,1.0,11/42,22.64%,MEF2C;ENG;TGFBR2;TBX3;SETDB2;BBS4;BBS5;CCDC39;SOX17;MICAL2;TBX2
prerank,integrin-mediated signaling pathway (GO:0007229),0.254097911709178,0.7319062821941122,0.8828633405639913,0.9930487282837702,1.0,19/73,22.29%,PRAM1;FBLN1;NRP1;ABL1;THY1;TEC;ITGBL1;CD47;PLPP3;ADAMTS1;ITGB1BP1;ILK;ERBIN;DAB2;PTK2B;ITGAV;ITGB1;MYH9;ITGA5
prerank,cytoplasmic microtubule organization (GO:0031122),0.26061484477567187,0.7318160346780942,0.8585526315789473,0.9927554895604658,1.0,12/54,18.17%,FSD1;CAMSAP2;KPNB1;CLIP3;HOOK3;CEP126;VPS4B;MAPT;NUMA1;TPPP;TUBGCP2;CCDC88A
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2933648863827171,0.7318134810599701,0.8427109974424553,0.9923581656981606,1.0,3/24,13.72%,LIG1;LIG3;POLD3
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3120306255864578,0.731637374221563,0.8091922005571031,0.9921622179923726,1.0,3/17,9.79%,SNAI1;RFFL;TWIST1
prerank,regulation of pH (GO:0006885),0.3431909134172851,0.7316340218209293,0.7958883994126285,0.9917658495196937,1.0,3/11,15.89%,ATP6V0A4;LACC1;SLC9A7
prerank,zymogen activation (GO:0031638),0.2723986941654356,0.7310127367830881,0.8416763678696159,0.992142192265123,1.0,7/39,19.31%,GRIN2A;PLAT;PRSS12;CTSH;OMA1;PGK1;MMP14
prerank,sulfur compound transport (GO:0072348),0.2877477700764818,0.7307723672509466,0.8194945848375451,0.9920432268211884,1.0,3/27,7.43%,SLC35B2;SLC25A19;SLC13A4
prerank,regulation of actin filament-based process (GO:0032970),0.25427899659111913,0.7307542853781801,0.8509719222462203,0.9916671041603992,1.0,16/70,19.85%,RAC1;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;IQGAP1;LRP1;ROCK2;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1
prerank,endoderm development (GO:0007492),0.3342377884893583,0.7303546000047957,0.8147100424328148,0.9917895584263753,1.0,1/13,5.43%,LAMC1
prerank,N-glycan processing (GO:0006491),0.30995225362325707,0.7302850639941034,0.8060288335517694,0.9914772824429798,1.0,3/18,7.62%,ST8SIA3;MGAT4B;MAN1A2
prerank,RNA interference (GO:0016246),0.3137506023649862,0.7302532851147672,0.805668016194332,0.9911211428434418,1.0,3/17,12.58%,TARBP2;CELF1;AGO3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.28186393174452506,0.730197451947791,0.8268506900878294,0.9907944259424161,1.0,10/30,22.49%,SFRP1;PARK7;HDAC1;DDX5;SAFB2;NCOR2;PRMT2;DAB2;H3-3A;PKN1
prerank,bone morphogenesis (GO:0060349),0.32010057335120823,0.7299139448354457,0.7934336525307798,0.990744257543746,1.0,2/14,12.85%,FGFR2;CYP26B1
prerank,histone H3-K4 methylation (GO:0051568),0.28886470700451317,0.7288015532867147,0.831858407079646,0.9917567316403944,1.0,7/26,19.43%,KMT2B;OGT;SETD1A;DPY30;KMT2D;KMT2A;KDM6A
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.30145508410034966,0.728665870612089,0.821954484605087,0.9915257136691291,1.0,7/20,20.27%,TMBIM1;PID1;TGFB1;MRAP2;PPP2R5A;LZTFL1;DAB2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2639886012640282,0.7285510742030167,0.8573033707865169,0.9912736543883223,1.0,15/49,22.96%,PRMT6;KMT2B;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;KMT2D;KMT2A;CNOT4;RAB7B;H3-3A;MTURN;AGO4
prerank,positive regulation of macroautophagy (GO:0016239),0.2651508662479842,0.7285353487744959,0.8535754824063564,0.9908964510596985,1.0,16/48,23.41%,TSC2;PIP4K2B;DCN;GPSM1;PIP4K2A;VDAC1;HTT;PIP4K2C;VPS13D;FYCO1;SCOC;RAB3GAP2;UVRAG;SESN1;HSPB8;SH3GLB1
prerank,regulation of protein binding (GO:0043393),0.24267142766194497,0.7284548791276163,0.9065708418891171,0.9905953570573305,1.0,25/114,18.68%,VTN;BAX;CARD16;TCF7L2;DVL1;HDAC5;LRPAP1;HDAC4;APP;PARK7;ADD2;RACK1;DISC1;LRP1;CTSZ;CTNNBIP1;PRMT8;PSME3IP1;DERL1;ITGB1BP1;TLE5;USP33;SORL1;BTBD1;FLOT1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2579802972995782,0.7278602958843872,0.8683351468988031,0.9909317282145842,1.0,17/62,21.66%,PRMT6;KMT2B;HOXB8;SETD1A;DPY30;HDAC1;AGO3;PRMT1;CBFB;CDC73;KMT2D;MEIS2;KMT2A;LYN;PTK2B;CNOT4;H3-3A
prerank,negative regulation of complement activation (GO:0045916),0.3395361832562281,0.7274909292184929,0.801762114537445,0.9909644553761313,1.0,1/10,5.04%,SERPING1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2437690958200846,0.7267038087461036,0.9088082901554404,0.9915310841205999,1.0,26/122,19.78%,IGF1;NFKB1;IL33;RBM3;XBP1;DDX3X;TMEM106A;HNRNPD;EGF;IRS2;ZCCHC4;HSPH1;BRPF3;YTHDF3;NPM1;PRMT1;YTHDF1;PRR16;FAF1;FMR1;SLC25A37;PRKD2;METTL5;SOX4;KLF4;CIRBP
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.31429683335443537,0.7267028169241732,0.8333333333333334,0.991134534498516,1.0,3/16,14.54%,FBH1;KLHL15;HELB
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.31719543023705515,0.7266047825734363,0.7963483146067416,0.9908504122901675,1.0,4/15,20.27%,SMAP1;PIK3CB;SNAP91;DAB2
prerank,protein K63-linked deubiquitination (GO:0070536),0.2796944044024572,0.7261472660899034,0.8389021479713604,0.9910128165747079,1.0,8/31,19.27%,USP7;TNFAIP3;OTUD7A;ABRAXAS2;USP33;USP50;YOD1;UIMC1
prerank,response to nitric oxide (GO:0071731),0.3268981108947514,0.7255978958616326,0.811046511627907,0.9912808434775559,1.0,3/13,21.58%,KCNC2;DPEP1;FOXO1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.293548274698268,0.7248016875676451,0.8297872340425532,0.9918403380958131,1.0,5/23,19.11%,FADS1;PTGS2;EPHX2;GPX4;ELOVL6
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.31089202874174426,0.7247965434175164,0.8027586206896552,0.991448372039923,1.0,3/15,13.57%,EZH2;NPM1;CDC73
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2509625634152127,0.7246665659179622,0.8688172043010752,0.9912120287229426,1.0,14/75,19.12%,HEXIM1;PKIB;NR2F2;UCHL1;ABL1;CDK5RAP3;PIK3CB;IPO7;PKIG;SPRY2;APOE;SORL1;PRKAR1A;SMPD1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.23618639965708205,0.7238583315794646,0.9427710843373494,0.9917873035806446,1.0,13/175,7.67%,SFRP1;ADAMTS7;GBP3;PSMD4;MAP3K14;EDAR;TNFRSF9;ZFP36L1;EDA2R;PSMB10;ZFAND6;PID1;PSMD11
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.2986624346697382,0.7235627128705807,0.828125,0.9917402063489126,1.0,3/21,7.87%,EPHB2;LZTR1;MFN2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.26590829441698843,0.7233803331944402,0.85,0.9915731903282099,1.0,9/41,20.88%,THY1;ANK3;CD47;PLPP3;DENND6A;JAK1;FLOT1;GCNT2;SMAD7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.24447825519918448,0.7233772343848754,0.9064143007360673,0.9911793799255739,1.0,11/93,12.93%,FCGR2B;EDAR;TAOK1;MINK1;EDA2R;TIRAP;MAPK8IP1;SDCBP;APP;KLHDC10;PRMT1
prerank,secretory granule organization (GO:0033363),0.34233680044736414,0.7233375276872307,0.8095238095238095,0.9908249266167787,1.0,4/10,23.97%,VPS33B;BLOC1S2;LYST;ABCA1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.22251157564242885,-0.7231095955781909,0.8427947598253275,0.967512008105834,1.0,9/22,28.50%,MFHAS1;MAP3K4;EMC10;VEGFA;SASH1;ZC3H12A;BMP2;GADD45B;SPHK1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.2945197572844162,0.7230426101140817,0.8232189973614775,0.990794680097064,1.0,8/22,23.03%,ABCA2;IFNGR1;ROCK2;RANBP9;LYN;ABCG1;EPHA4;SP1
prerank,response to ketone (GO:1901654),0.29075229129951824,0.7226668926770372,0.823238566131026,0.9908331177622106,1.0,4/24,14.88%,WBP2;CATSPER3;TGFB1;SLIT3
prerank,cell junction assembly (GO:0034329),0.24415942892582732,0.722138135634274,0.8987473903966597,0.9910731331966831,1.0,31/100,24.53%,CTNND2;OBSL1;CDK5;FLCN;DSCAM;CDH11;DBNL;CAPZA1;NLGN3;SPOCK2;FARP1;TLN2;CDH18;NLGN2;VMP1;CDH20;CDH19;CDH7;ILK;SLITRK1;MYO9A;CDH9;PCDHB16;CDH10;RYK;SDK1;CDH8;PTEN;NRXN2;CDH2;FLNC
prerank,negative regulation of proteolysis (GO:0045861),0.2737345958173138,0.7220419805177773,0.8501783590963139,0.9907988073384442,1.0,4/34,11.84%,CLN3;CDK5;PLAT;PTPN3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3119164994694127,0.7219804095043283,0.8152173913043478,0.990491580121445,1.0,4/17,16.44%,SNAI1;RBPJ;TGFB1;JAG1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2546013957269176,0.7217499475704319,0.8869179600886918,0.9903731119317554,1.0,5/60,7.40%,CCT8;PKIB;HSP90AA1;CCT6A;WRAP53
prerank,B cell proliferation (GO:0042100),-0.24169415203160644,-0.721688203289107,0.845360824742268,0.9678861184404683,1.0,2/17,10.73%,MEF2C;PTPRC
prerank,vitamin D metabolic process (GO:0042359),0.32694609028589455,0.7216572080961089,0.8152327221438646,0.9900916058626066,1.0,1/13,7.82%,GC
prerank,proton transmembrane transport (GO:1902600),0.26891671420793123,0.7212786965358419,0.8317535545023697,0.990145409705974,1.0,4/36,12.68%,ATP1A3;ATP6V0E2;ATP1A2;ATP6V0A4
prerank,response to lipopolysaccharide (GO:0032496),0.23799849269611795,0.7211702379118838,0.9212678936605317,0.9898937843556533,1.0,19/138,16.49%,WNT5A;SELENOS;NFKB1;IFNAR1;XBP1;TNFAIP3;TIRAP;CARD16;SIRPA;TRIM41;LY96;HNRNPA0;GIT1;RPS6KA3;PTPN22;CDC73;SMAD6;PDE4B;SERPINE1
prerank,sister chromatid segregation (GO:0000819),-0.20616038312609564,-0.7211287292531324,0.9202453987730062,0.9671997163016546,1.0,23/31,46.53%,LATS1;RB1;NCAPG2;SMC1A;SMC4;MIS12;KIF18A;RAN;TUBG1;CENPK;KLHL22;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24771804521370203,0.7203771896412066,0.9015873015873016,0.9904348813045247,1.0,16/88,17.64%,PSMD4;FBXL12;FBXL14;FBXO38;FBXO31;PSMB10;FBXW5;PSMD11;CUL4B;PSME2;PSMC5;CUL5;PSMD1;DMAC2;PSMD6;FBXO9
prerank,B cell receptor signaling pathway (GO:0050853),0.27427425166415564,0.7201898882583678,0.8371810449574727,0.9902447583779553,1.0,4/32,14.04%,BAX;TEC;BCL2;BLNK
prerank,positive regulation of vasculature development (GO:1904018),0.2421842608691374,0.7200979018967473,0.9145569620253164,0.9899537601080652,1.0,6/94,5.95%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1
prerank,long-term memory (GO:0007616),-0.23381920830721728,-0.71996927280545,0.8962655601659751,0.9672774493427638,1.0,3/19,15.47%,EIF2AK4;CPEB3;NFATC4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.28198691731791525,0.7196485931083715,0.8281053952321205,0.9901061677192734,1.0,3/27,8.83%,CHPF;DCN;CHSY3
prerank,protein localization to Golgi apparatus (GO:0034067),0.28683026364151076,0.719443689308493,0.8475836431226765,0.9899618276587507,1.0,9/27,18.30%,OBSL1;ARL5B;RIPOR1;TMED10;IFT20;CSNK1D;VPS13D;SORL1;RAB6A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.30804093457693504,0.719359305844872,0.8206521739130435,0.9896732287745842,1.0,5/17,22.35%,CALM3;MAGI2;CALM1;CALM2;ITGA1
prerank,protein localization to centrosome (GO:0071539),0.30585602175651605,0.7192386845077113,0.8014084507042254,0.989424817436531,1.0,4/17,13.76%,SNX10;PIBF1;HOOK3;CSNK1D
prerank,endothelial cell migration (GO:0043542),0.26794693977856787,0.7183223985108952,0.8447867298578199,0.9901224295916371,1.0,7/37,16.26%,FSTL1;NRP1;ABL1;PLEKHG5;RAB13;EMP2;ADGRA2
prerank,response to glucocorticoid (GO:0051384),0.28492191317792337,0.7179838481644828,0.8250950570342205,0.9901353057857407,1.0,2/26,4.02%,ANXA1;ZFP36L1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3032542512679002,0.7179286767789743,0.8220451527224436,0.9898095096171916,1.0,1/18,0.91%,CLN3
prerank,autophagy of nucleus (GO:0044804),0.31536501811170553,0.7178685960278975,0.8196022727272727,0.9894917182429258,1.0,5/16,18.15%,WIPI1;ATG2A;ATG13;ATG3;ATG9A
prerank,"transcription, DNA-templated (GO:0006351)",0.2351675991836867,0.7176721636162223,0.9646821392532795,0.9893325345439998,1.0,54/207,22.18%,NFKB1;SMN1;PARP1;TAF9B;XBP1;TFDP1;SLC25A33;TAF4;POLR2B;CDK9;TBP;ZBTB7B;RTF1;TRIP11;GTF2A2;MED4;NFX1;PRMT5;DRG1;GTF2H3;TCEA1;TAF6;NFIX;POLR2K;CCNH;TSC22D1;SETX;CBFB;MMS19;CDC73;GTF2E1;SOX5;PPP5C;DDX5;MAF;CCNT1;MBD1;CDK7;POLR3K;TOPORS;NELFA;TAF1B;KLF13;MLLT3;PKNOX1;GLIS3;TBPL1;CCNT2;TAF2;RPAP1;EAF1;SNAPC3;GTF2F2;TAF1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.2978543476196302,0.7176349715031392,0.8294270833333334,0.988984221603655,1.0,3/21,11.50%,CALM3;ATP1A2;CAMK2D
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2946249298251455,0.7170272910583427,0.8246505717916137,0.9893302326175837,1.0,4/22,14.99%,IRF1;CBFB;BCL6;FANCA
prerank,water-soluble vitamin metabolic process (GO:0006767),0.25082886496939183,0.7169718141303938,0.8765957446808511,0.9890108133516906,1.0,9/68,12.48%,SLC25A19;FPGS;PCCB;MMAB;FLAD1;NNMT;SLC2A3;ENPP1;PCCA
prerank,ribosome biogenesis (GO:0042254),0.23532906842083212,0.7167665116487357,0.9515640766902119,0.9888748789764374,1.0,27/187,14.06%,MRPL36;EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;GLUL;CUL4B;RBIS;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;MALSU1;NPM1;RPL9;C1D;RPL4;BMS1
prerank,regulation of muscle cell differentiation (GO:0051147),0.27423421120657,0.7166395135180583,0.8525798525798526,0.9886339476660231,1.0,5/31,15.29%,FGFR2;CDK9;ABL1;BNIP2;TCF3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.23902211184034836,0.7161603754841468,0.9033915724563206,0.9887976215231957,1.0,25/108,22.11%,BAX;EIF2AK3;FIS1;DDX3X;FAM162A;VCP;CASP9;MALT1;ROBO1;RACK1;DAPK1;MTCH1;MAPT;F3;CASP2;HSPD1;PDCD5;RPS3;DLC1;PDCD6;GSN;PPM1F;HMGB1;TRAF2;SMAD3
prerank,regulation of mast cell activation (GO:0033003),-0.28737212355791664,-0.7155062326992381,0.8307210031347962,0.9712670401775485,1.0,8/10,53.76%,PLSCR1;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;CD226
prerank,negative regulation of heart contraction (GO:0045822),0.336472977081991,0.7149675363425352,0.8213256484149856,0.9897770122715153,1.0,3/11,20.90%,ATP1A2;GRK2;SPTBN4
prerank,microvillus organization (GO:0032528),0.31888125421423424,0.7146485988843098,0.8149210903873745,0.9897768464264741,1.0,2/13,7.01%,MINK1;RAP2A
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.23623012546075256,0.7145656772276441,0.9421319796954315,0.9894699671329015,1.0,29/166,16.30%,HDAC3;TEAD3;TAF9B;NR1D2;RORA;TAF4;POLR2B;CDK9;TBP;GTF2A2;TEAD1;HDAC5;NRBF2;GTF2H3;TAF6;RBPJ;MAZ;E2F3;POLR2K;CCNH;HDAC1;NRBP1;ESRRG;GTF2E1;NR2C2;MED23;TFB1M;POLR1A;SNW1
prerank,chromatin remodeling at centromere (GO:0031055),0.2744496131172077,0.7145601325706487,0.854066985645933,0.9890842714871136,1.0,4/31,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,negative regulation of type I interferon production (GO:0032480),0.2655486191661969,0.7143944991692932,0.8687572590011614,0.9888912440103836,1.0,6/40,11.61%,TNFAIP3;PPM1B;DHX58;SIRPA;IRF3;YY1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.31206304715386946,0.7142754289161585,0.8218232044198895,0.9886421080367604,1.0,6/16,20.48%,FLCN;ZBTB7B;PTGS2;SOX13;FTO;HNRNPU
prerank,regulation of cell size (GO:0008361),0.2928333605303031,0.713918418484514,0.8201811125485123,0.9886512491728696,1.0,5/23,14.28%,RAC1;RAP1GAP2;VAV2;LAMTOR5;PRR16
prerank,actomyosin structure organization (GO:0031032),0.24546715343644404,0.7138156775673393,0.8990536277602523,0.9883804564909938,1.0,17/75,21.82%,EPB41L4B;MYH14;ARRB1;CIT;MYH10;TPM1;FRMD6;ROCK2;EPB41L3;EPB41L1;TMOD2;CSRP2;CDC42BPB;ITGB1;PDLIM1;MYH9;CSRP3
prerank,blood vessel diameter maintenance (GO:0097746),0.272690590289475,0.7137750978696109,0.8614457831325302,0.9880386720305139,1.0,6/34,16.76%,EDN3;BDKRB2;GCLC;ROCK2;AGTR1;ITGB1BP1
prerank,tRNA transport (GO:0051031),0.2707215036681498,0.7135820186804875,0.868421052631579,0.9878722134794412,1.0,16/35,25.79%,RAE1;TOMM20;NUP188;NUP210;NUP88;NUP214;NUP153;RANBP2;NUP35;YBX1;TPR;NUP155;NUP54;NUP98;POM121;SEH1L
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.2732001294717386,0.7130954665975887,0.8614457831325302,0.9880270177703199,1.0,5/34,15.82%,DUSP18;PTPRF;TNS2;PTPN22;PTPN12
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2421428571527413,0.7128541938164715,0.9012474012474012,0.9879379667226403,1.0,27/88,21.74%,MYO1B;HGS;ARRB1;RAB10;DNAJC6;CLINT1;SCFD1;APP;MYO5A;TXNDC5;SCAMP1;AP4M1;AP1B1;STEAP2;VAMP8;CCDC93;AP4E1;SORL1;KLHL20;AP4S1;RABEP1;EXOC5;FTH1;VAMP7;COMMD1;NAPA;LLGL1
prerank,replicative senescence (GO:0090399),0.3206906519278104,0.7127498493425217,0.814327485380117,0.987670676644464,1.0,5/12,23.45%,ATR;CHEK2;SERPINE1;PLA2R1;ATM
prerank,ATP transport (GO:0015867),0.33943089285780614,0.7126940515068223,0.8232695139911634,0.9873532748373725,1.0,3/10,18.60%,SLC25A24;CD47;ABCC6
prerank,regulation of cellular biosynthetic process (GO:0031326),0.27588617157295175,0.7126467430385839,0.8482252141982864,0.9870249868034092,1.0,7/28,19.56%,RAC1;NOS1AP;SIRPA;CD47;SIRT5;PRKAG2;MITF
prerank,positive regulation of cell aging (GO:0090343),-0.28030447445970125,-0.7120763864540696,0.8134556574923547,0.9739690509948035,1.0,2/11,4.50%,LMNA;SIRT1
prerank,morphogenesis of an epithelium (GO:0002009),0.2860022500000607,0.7118780812587336,0.8503740648379052,0.9875310280264027,1.0,5/25,15.88%,FGFR2;SOX9;KDM2B;DAG1;AHI1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2642354563123636,-0.7117443694188095,0.8642384105960265,0.9730348607127971,1.0,11/14,60.44%,ATP6AP1;TYROBP;POU4F1;CCR1;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;IL12B
prerank,regulation of cholesterol storage (GO:0010885),0.31198678593603696,0.7115774880813607,0.8129395218002813,0.9874780289446582,1.0,1/15,0.96%,LPL
prerank,protein localization to organelle (GO:0033365),0.23526162611792076,0.710809782790148,0.9248971193415638,0.9879693046654191,1.0,30/133,19.51%,TUB;FAM83H;DDX3X;OBSL1;DVL1;TIA1;SNX10;GET1;AUP1;ABCA7;RIPOR1;TOR1B;APP;SERP1;IFT20;COG3;CSNK1D;MTCH2;ATP6V1D;TULP3;SEC61G;TTC21B;ALDH3A2;TOPORS;MDM2;SORL1;RAB6A;WDR35;BANP;STX5
prerank,copper ion homeostasis (GO:0055070),0.3009748536835971,0.7105653194092643,0.8084239130434783,0.9878632684908615,1.0,5/17,23.36%,XIAP;APP;COMMD1;ATOX1;SLC31A1
prerank,renal water homeostasis (GO:0003091),0.2859673357298524,0.7102728904734148,0.8286802030456852,0.9878113511939252,1.0,5/23,18.28%,ADCY7;AQP4;ADCY1;ADCY5;PRKAR1A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.25896216268280303,0.7101532561710434,0.8574660633484162,0.9875641027330062,1.0,9/46,18.33%,HDAC3;TCF7L2;PIK3R1;JUP;PIK3R2;TGFB1;UBR5;CPSF6;RBM22
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2817046505334995,0.7100365290413645,0.8440925700365408,0.9873005818881418,1.0,5/28,12.23%,BAX;DDX3X;ZDHHC3;BCL2;BLOC1S2
prerank,pulmonary valve development (GO:0003177),0.3032474181645391,0.7097536195331317,0.8504551365409623,0.9872493286726131,1.0,5/18,16.44%,STRA6;ROBO2;ROBO1;SMAD6;JAG1
prerank,intestinal lipid absorption (GO:0098856),0.33237084928755256,0.7094231426716003,0.8197932053175776,0.9872421182868024,1.0,11/11,66.79%,LIMA1;LDLR;CEL;FABP2;ABCG8;NPC1L1;ABCG5;AKR1C1;CD36;SOAT2;UGCG
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.23453900009637257,0.7093667831378638,0.9338085539714868,0.9869308399082307,1.0,37/145,23.12%,CCP110;PSMD4;HSP90AA1;ALMS1;USP47;BRD4;FBXO5;PSMB10;PSMD11;CDC25A;TUBA1A;YWHAG;PSME2;PSMC5;VPS4B;KCNH5;HAUS3;CSNK1D;TUBB;PSMD1;OFD1;PSMD6;CEP76;TUBB4A;MECP2;ODF2;PSMD5;DYNLL1;PAFAH1B1;PSMA4;PSMA1;PSMC6;CNTRL;NINL;CDK5RAP2;PSMA5;PINX1
prerank,positive regulation of immune response (GO:0050778),0.24709725234316773,0.709268578229274,0.8937093275488069,0.9866568912999616,1.0,4/64,8.05%,FCGR2B;POLR3D;XBP1;IFI35
prerank,epithelial cell migration (GO:0010631),0.2662751777413125,0.7091383290699435,0.8647686832740213,0.9864374269399729,1.0,4/37,6.07%,ZEB2;FSTL1;NRP1;ABL1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2518711101757499,0.7087733724942161,0.8744493392070485,0.9864599617283507,1.0,15/59,18.78%,PDPK1;CSNK2A2;PRKCA;CDK5;SBK1;CIT;CAMK2D;ROCK2;ACVR1B;TNKS;OXSR1;PRKD2;CDK10;TGFBR1;CDC42BPB
prerank,telomere capping (GO:0016233),0.31096588703062733,0.7082785147788709,0.8415977961432507,0.9866455437766889,1.0,5/16,18.57%,DCLRE1A;MRE11;RAD50;TERF1;TERF2IP
prerank,histone H3-K36 demethylation (GO:0070544),0.33338371523270544,0.7082018931031405,0.8202764976958525,0.9863492302973778,1.0,2/10,10.68%,KDM7A;KDM2B
prerank,positive regulation of translation (GO:0045727),0.23955712314728886,0.7068125657562191,0.9120762711864406,0.98757415317948,1.0,19/94,19.78%,RBM3;TRUB2;DDX3X;CDC123;CNBP;RCC1L;HNRNPD;DHX36;ZCCHC4;YTHDF3;NPM1;UQCC2;YTHDF1;PRR16;FMR1;METTL5;SOX4;YTHDF2;CIRBP
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.341493033677744,0.7067527348837053,0.8257686676427526,0.987248337889823,1.0,4/10,21.46%,CAMK2D;OSR1;HECW2;COMMD1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.3308751858083146,0.7066624636410438,0.8159771754636234,0.9869635746870239,1.0,3/11,18.96%,HSP90AA1;QDPR;CALM1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.30583546551144813,0.7063962578150945,0.8190348525469169,0.9868798945733681,1.0,1/15,2.47%,MLYCD
prerank,regulation of myoblast fusion (GO:1901739),0.3307883566926292,0.7063842656751494,0.8546762589928057,0.986507487760789,1.0,3/11,20.65%,RIPOR2;FLOT1;EHD1
prerank,negative regulation of chemotaxis (GO:0050922),-0.20193025950542634,-0.7061908202459639,0.9333333333333333,0.9778466280718408,1.0,15/31,33.03%,SLIT2;SEMA6A;THBS1;SEMA7A;SEMA4D;ANGPT2;SEMA4B;SEMA3B;SEMA5A;SEMA5B;SEMA6C;PTPN2;SEMA3G;SEMA6B;SEMA4C
prerank,negative regulation of centrosome duplication (GO:0010826),0.333306088999489,0.7060493806300121,0.8237885462555066,0.9865017426035744,1.0,4/11,23.05%,MDM1;NPM1;TMEM67;CDK5RAP2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.30876186305460623,0.705734355590753,0.8240997229916898,0.9864655463001671,1.0,4/16,13.24%,HGS;PIBF1;LEPROT;PARP14
prerank,cGMP biosynthetic process (GO:0006182),-0.2917417359327212,-0.7056369958579555,0.8318318318318318,0.9771713863793321,1.0,2/10,13.98%,GUCY1A1;NPR1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.24588180640315346,0.7052892579390565,0.8864864864864865,0.9865834997392292,1.0,12/73,15.53%,BAX;EIF2AK3;FAM162A;VCP;CASP9;ROBO1;RACK1;MTCH1;MAPT;F3;CASP2;HSPD1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.283973863662303,-0.7052807763988104,0.835195530726257,0.9762016262847766,1.0,1/10,2.31%,CAV1
prerank,microvillus assembly (GO:0030033),0.31071132418727426,0.7049704843795775,0.8309859154929577,0.9865518645799977,1.0,2/14,7.01%,MINK1;RAP2A
prerank,defense response to virus (GO:0051607),0.23762052240541265,0.7045799811586324,0.9027921406411582,0.9866183587980989,1.0,18/100,18.76%,NDUFAF4;MAP3K14;RNASE1;OPRK1;TTC4;IRF1;TRIM56;IFIT3;BCL2;SHFL;IRF3;TLR3;NT5C3A;AGBL4;MLKL;OAS2;CLPB;ABCE1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3110778484058543,0.704352885639631,0.8472032742155525,0.9865027318787816,1.0,2/15,7.50%,MLYCD;ACAT1
prerank,negative regulation of double-strand break repair (GO:2000780),0.27150849828240464,0.703805464084753,0.8238153098420413,0.9867371338235311,1.0,6/30,16.93%,FBH1;KLHL15;TWIST1;HELB;NUDT16L1;UBR5
prerank,superoxide metabolic process (GO:0006801),-0.20672323405517196,-0.7036424009131533,0.94375,0.9767389051353116,1.0,6/29,20.59%,CYB5R4;NOS3;NOX1;PRDX2;NRROS;CYBA
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.2149240076495248,-0.7034765580743155,0.9045226130653267,0.9756179966772506,1.0,9/26,28.50%,ASAH1;NOS3;CYP1B1;GCH1;AKT1;DDAH2;NOS1;SPR;SPHK1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.22221619924697522,-0.7028705697346327,0.8764478764478765,0.9736014893636729,1.0,4/21,10.43%,MCL1;BCL2L1;EYA3;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.22221619924697522,-0.7028705697346327,0.8764478764478765,0.9736014893636729,1.0,4/21,10.43%,MCL1;BCL2L1;EYA3;EYA4
prerank,cellular response to hexose stimulus (GO:0071331),0.2771619987654505,0.7026755746528729,0.8470290771175727,0.9876128491068191,1.0,6/23,19.15%,XBP1;ZBTB20;RACK1;TRA2B;PRKAA1;SOX4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2764413697378947,0.7025808426231,0.8748435544430538,0.987331059112223,1.0,5/27,13.69%,TXNRD1;RRM2B;AK4;AK5;AK6
prerank,response to lipid (GO:0033993),0.23667612567368734,0.7025070345958287,0.9269311064718163,0.987025199068325,1.0,14/105,15.68%,CDKN2D;IFNAR1;ANXA1;ABCA2;TIRAP;SOX9;LY96;VPS4B;HNRNPA0;RPS6KA3;PTPN22;TGFB1;SMAD6;CTSH
prerank,manganese ion transport (GO:0006828),0.3124850071203593,0.702452518862595,0.8163841807909604,0.9867036430416468,1.0,2/14,6.66%,ATP2C1;SLC30A10
prerank,negative regulation of developmental process (GO:0051093),0.24380357823530072,0.7023510538544586,0.9111592632719393,0.9864395984776272,1.0,11/69,17.72%,SFRP1;FOXM1;SFMBT1;THY1;SOX9;VAT1;MAPT;ROCK2;TGFB1;OMA1;DCC
prerank,odontogenesis (GO:0042476),0.266193082456473,0.7003172233075763,0.8604923798358733,0.9882996963436324,1.0,6/35,17.12%,FGFR2;COL1A2;HDAC1;AXIN2;LAMB1;OSR1
prerank,melanosome localization (GO:0032400),0.2869168132295614,0.7001751533569988,0.8414154652686763,0.9880795720161116,1.0,3/21,11.66%,BBS7;MYO5A;VPS33B
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.23376155755161832,-0.7001042824391006,0.9045643153526971,0.9752979416329446,1.0,5/19,19.65%,GNL3L;STN1;NAT10;SRC;CTC1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.25242505586620867,0.699796015462592,0.8845714285714286,0.9881471105881421,1.0,8/48,15.42%,PDPK1;FGFR1;ANXA1;PRKCA;FGFBP1;PTGS2;TGFB1;FOXC2
prerank,regulation of microtubule-based movement (GO:0060632),0.33181781316840026,0.6988734974976049,0.8251445086705202,0.9887685341000777,1.0,4/11,23.00%,NEFH;TTC21B;IGBP1;MAP2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.22904615827442099,0.6983636012565837,0.9545454545454546,0.9889345380982955,1.0,18/163,11.23%,PSMD4;PDPK1;NFKB1;PRAM1;PIK3R1;THY1;PSMB10;PAK3;PSMD11;TEC;THEMIS;MALT1;PSME2;PSMC5;PIK3CB;PIK3R2;BCL2;RC3H2
prerank,cellular respiration (GO:0045333),0.25942593565380767,0.6983523842921764,0.8866822429906542,0.9885646869861592,1.0,9/41,19.73%,UQCRC1;SDHA;NDUFS7;MDH2;MTFR1L;ETFA;COQ10A;UQCRC2;OXA1L
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.28379245498069033,-0.6983171631935309,0.8674351585014409,0.9759588345919008,1.0,8/10,43.76%,NAF1;NUFIP1;RUVBL1;PIH1D1;RUVBL2;ZNHIT3;TAF9;PIH1D2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.3035831744202988,0.6980663994684411,0.8322237017310253,0.9884859514065292,1.0,3/17,14.28%,SUCO;WNT4;TGFB1
prerank,cellular response to organic cyclic compound (GO:0071407),0.23174830643248814,0.6980542898182112,0.9420731707317073,0.9881180719844948,1.0,24/141,18.02%,SFRP1;RORA;ATP1A3;ZFP36L1;CASP7;DMTN;GNG2;ATP1A2;INSIG1;SSH1;RAPGEF1;GABRB3;JUP;TFPI;NCOA4;ROCK2;TGFB1;ADCY1;IMPACT;ADCY5;UBE2L3;TIPARP;HRH1;PKD2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.28475193690127776,-0.6970672370423443,0.8635097493036211,0.9759758694832007,1.0,5/10,29.52%,LGALS9;TGFBR2;CD81;NCKAP1L;CD55
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2673819388879672,0.6970593668567081,0.8536880290205562,0.9887825198858331,1.0,3/30,6.29%,DNAJC7;DNAJB5;BAG1
prerank,regulation of BMP signaling pathway (GO:0030510),0.24207708908471465,0.6968389974471594,0.9139433551198257,0.9886369290798486,1.0,19/73,21.52%,SMAD9;FSTL1;SULF1;HTRA3;XIAP;SOX11;RBPJ;LEMD3;SMAD6;UBE2D1;NUMA1;SMURF1;SORL1;FOXD1;PCSK6;NBL1;ACVR2A;SMAD7;SMAD2
prerank,negative regulation of DNA recombination (GO:0045910),0.255584652825983,0.6967658302978694,0.8699095022624435,0.9883358765156031,1.0,9/43,18.57%,POLR2B;FBH1;KLHL15;POLR2K;ATRX;HELB;TERF1;DAXX;TERF2IP
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.33543921923791475,0.6963233473057117,0.8320726172465961,0.988426106593069,1.0,3/10,15.57%,UPP2;DPYD;NT5C3A
prerank,regulation of nervous system development (GO:0051960),0.25835085827454796,0.6961756378951582,0.8778173190984578,0.988210263850322,1.0,4/37,15.23%,SIRT2;PRUNE1;DOCK7;TENM4
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.26772757558094756,-0.6961427556451623,0.8541666666666666,0.9755971321510528,1.0,6/11,25.30%,CAV1;ADIPOR1;PTPRT;SH2B3;VHL;BCL3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.24516464089033535,-0.6960241151004964,0.8854166666666666,0.9744246652650204,1.0,6/15,27.32%,ZFYVE27;NGF;SORT1;CASP3;DDIT4;BDNF
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.24059384505815204,-0.6958682869934595,0.8796680497925311,0.9732841089126625,1.0,8/16,29.29%,NUS1;HIF1A;SCARB1;GCH1;AKT1;TERT;S100A1;DHFR
prerank,spinal cord development (GO:0021510),-0.2640830880572903,-0.6955313474454994,0.8571428571428571,0.9722961736264493,1.0,2/12,4.40%,RELN;VIT
prerank,ether lipid biosynthetic process (GO:0008611),0.340219234572436,0.6951812994600527,0.8323076923076923,0.9889054539312414,1.0,5/10,23.38%,PEDS1;PEX7;FAR1;GNPAT;CHPT1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2745297099611112,0.694796218489614,0.8616891064871481,0.9889369211055006,1.0,7/27,20.93%,TIRAP;LY96;HSPD1;MAP3K1;TNIP1;TAB1;TAB3
prerank,modulation by symbiont of host process (GO:0044003),0.33467759862438257,0.6943547363979944,0.8386627906976745,0.9890045444502056,1.0,4/10,25.10%,HGS;PGK1;B2M;RPS27A
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.237933756680634,0.6942930312656206,0.9154175588865097,0.9886923675360341,1.0,22/80,23.03%,SMPD2;RBM3;DDX3X;ABCA2;HNRNPD;ZCCHC4;IFNGR1;YTHDF3;NPM1;RACK1;YTHDF1;ROCK2;PRR16;FMR1;METTL5;SOX4;CIRBP;ABCG1;SAMD4A;METTL14;EPHA4;SP1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.26166554143134724,0.6939717061486337,0.8713942307692307,0.9886587305064852,1.0,8/35,19.09%,PDE7B;SOX9;HTR2C;ADCY1;EPHA5;APOE;PDE9A;KSR1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2305237316731325,0.6934400788531832,0.949238578680203,0.9888603969665918,1.0,38/140,21.89%,FOXM1;RAC1;FLCN;SYDE2;ARHGAP20;ARHGAP19;SRGAP2;SRGAP3;SQSTM1;ARHGEF7;ARHGEF4;RHOD;KALRN;MCF2;ARHGAP21;VAV2;ARHGAP24;PIK3R2;ARAP1;PLEKHG5;FAM13A;AKAP13;ARHGAP29;TRIO;ARHGEF6;PLEKHG2;FGD4;DLC1;MYO9A;STARD13;ARHGAP6;CHN1;ITGAV;PREX1;SRGAP1;RHOU;ARHGAP26;ARHGAP35
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.24998413861847812,0.6932088710055523,0.8810872027180068,0.9887390434325655,1.0,7/47,16.48%,GRIN1;SLC5A3;PID1;MAPT;RNF41;TGFB1;AGTR1
prerank,relaxation of muscle (GO:0090075),-0.26125651366341124,-0.6932032781449908,0.8859934853420195,0.9733638005059765,1.0,4/13,13.24%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2551969869861394,-0.692482819466867,0.8589743589743589,0.9728001785206356,1.0,5/13,27.27%,TBC1D10A;ASPH;BAD;PERP;CYFIP2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.20483615704030395,-0.692278506008542,0.9358288770053476,0.9717293754393022,1.0,10/28,26.41%,DAB2IP;PSMC2;DDRGK1;AXIN1;RNF139;OSBPL7;PSMC3;CTSC;ECSCR;PRKN
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.22034646322180332,-0.692267553937429,0.876984126984127,0.9704610501481937,1.0,4/22,12.41%,TOX;SLC16A2;LRRK2;PTPRZ1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.28501826077648285,0.6920875687626086,0.8826666666666667,0.9895758486735268,1.0,3/19,11.79%,XBP1;XRCC6;ZMIZ1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2601795510340051,0.6917417596375186,0.8811764705882353,0.9895701243261356,1.0,7/40,15.12%,CDK9;FBH1;FANCM;ATR;ATRX;THOC1;NUCKS1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2788952095584778,0.6916744520634208,0.8573232323232324,0.989268222591731,1.0,4/23,15.32%,SIK1;HDAC4;GIT1;NUPR1
prerank,regulation of interferon-alpha production (GO:0032647),0.28191149519495895,0.6910126517897646,0.8657465495608532,0.9895894979336842,1.0,5/23,15.53%,DDX3X;DHX36;IRF3;TLR3;HSPD1
prerank,establishment of epithelial cell polarity (GO:0090162),-0.22898181236986687,-0.6909459783134702,0.8958333333333334,0.970452229562175,1.0,2/19,6.30%,PARD3;EZR
prerank,sphingosine metabolic process (GO:0006670),0.29789704490524643,0.6906217482449742,0.8612244897959184,0.9896295952632934,1.0,2/17,12.87%,ABCA2;PLPP3
prerank,regulation of histone acetylation (GO:0035065),0.2647848977720006,0.6900399905874098,0.8721893491124261,0.9898524972725183,1.0,7/33,19.44%,FLCN;HDAC5;ARRB1;PARK7;CTBP1;KMT2A;SETD5
prerank,microtubule polymerization (GO:0046785),0.2739131170925522,0.6899455584583698,0.8548185231539425,0.9895689645416585,1.0,8/28,21.40%,TPPP3;CSNK1D;MAPT;TPPP;TUBGCP2;RANBP9;FGF13;CLASP2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.2414502916275726,0.6897934898023008,0.9233296823658269,0.9893479233247923,1.0,11/64,19.11%,ELOVL1;SLC27A4;HSD17B4;FADS1;CPT2;PTGS2;ACSL6;EPHX2;ACADL;GPX4;ELOVL6
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3134906060646185,0.6893704289077874,0.8468335787923417,0.9894004268010095,1.0,2/12,10.86%,BIN1;JUP
prerank,protein acylation (GO:0043543),0.255753474518282,0.688883159721998,0.8876013904982619,0.9895364829850839,1.0,11/38,22.95%,NAT9;ZDHHC3;GLUL;PORCN;CLOCK;ZDHHC17;ZDHHC2;FOXO1;GTF2B;ZDHHC14;ZDHHC21
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.28250978833987395,0.6887469063686772,0.8450520833333334,0.98928423251938,1.0,4/20,17.54%,RGS10;CHRM2;GRK2;GNAQ
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.3206267185364785,0.6886501142024962,0.8445440956651719,0.9890059555101555,1.0,1/10,4.50%,CXCL12
prerank,regulation of centrosome cycle (GO:0046605),0.2842678507823978,0.688565795765702,0.8540609137055838,0.9887256451043349,1.0,4/21,12.27%,FBXW5;CHMP3;VPS4B;NPM1
prerank,signal transduction by p53 class mediator (GO:0072331),0.2661551358203474,0.6883958131232915,0.8678304239401496,0.9885177858191897,1.0,6/30,15.78%,STK11;USP10;MDM4;NDRG1;ATRX;DDX5
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.27705438237296004,0.6882070573275523,0.8730569948186528,0.9883388943396483,1.0,7/24,23.39%,CALM3;CAMK2D;JPH1;PKD2;CALM1;CALM2;FKBP1A
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.23526639782520875,0.6877969878781219,0.9123931623931624,0.9883882772634005,1.0,20/87,20.58%,RAC1;NEB;TAOK1;ABL1;PAK3;DMTN;RHOD;BAIAP2;RHOBTB3;PDGFRA;IQGAP1;LRP1;ROCK2;SEMA3E;EPHA5;CCDC88A;CDK10;DLC1;RHOBTB1;PTK2B
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.2882645223447655,-0.6877562973277551,0.8648648648648649,0.9722488697478554,1.0,7/10,29.78%,NAGK;ST3GAL1;GNPDA2;GNPDA1;AMDHD2;ST6GAL1;NPL
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2736591406410126,0.6875138602891286,0.8734335839598998,0.9883064000384445,1.0,4/25,16.64%,ITPR1;HTT;MAPT;RIT2
prerank,chromatin assembly or disassembly (GO:0006333),0.32866731708156166,0.6873019124112404,0.8350364963503649,0.988149469696013,1.0,2/11,11.79%,RBBP4;MTA2
prerank,response to glucagon (GO:0033762),0.28444427433619246,0.6865031337247637,0.8613989637305699,0.9885892461396624,1.0,8/19,26.13%,ADCY7;ADCY1;ADCY5;PRKAR1A;CRY1;PRKAR1B;ADCY2;PRKAR2A
prerank,monoacylglycerol metabolic process (GO:0046462),0.3106128659312121,0.686381012313556,0.8545454545454545,0.9883307561715149,1.0,1/13,3.44%,MOGAT3
prerank,response to muscle stretch (GO:0035994),-0.24779321858714518,-0.6858052955992691,0.9125874125874126,0.972864888526578,1.0,4/15,30.00%,DMD;PIK3CA;RYR2;SLC8A1
prerank,cochlea morphogenesis (GO:0090103),0.3297109922885873,0.6856151201842587,0.8364485981308412,0.9887656481766675,1.0,1/10,8.37%,SOX9
prerank,cell projection organization (GO:0030030),0.25941302472182937,0.6853248167657403,0.8759305210918115,0.9886781860791487,1.0,8/30,21.42%,RAC1;NEFH;CYFIP1;NPHP1;ATP1B2;ITGB1;RHOU;GSN
prerank,heart morphogenesis (GO:0003007),0.2442758921091296,0.6844406817708988,0.8948545861297539,0.9891913160660127,1.0,10/50,20.60%,NIPBL;OLFM1;SOX9;FLRT2;MDM4;MEGF8;TGFBR1;DLC1;CHD7;TGFBR3
prerank,regulation of inclusion body assembly (GO:0090083),-0.2663092883901802,-0.6836769857993977,0.8544303797468354,0.9736486923629136,1.0,8/11,45.88%,SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,signal transduction in response to DNA damage (GO:0042770),0.24899821381075407,0.6835400812147806,0.9046563192904656,0.989711511746416,1.0,11/49,18.46%,ABL1;USP10;MDM4;NDRG1;CASP9;BRIP1;ATR;ATRX;CHEK2;CLOCK;TIPRL
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.22702740061137977,0.6834210439597479,0.9559877175025588,0.9894426507040884,1.0,28/136,22.39%,COMMD6;GLIS2;USP7;RWDD3;TNFAIP3;TCF7L2;ARRB1;SIK1;PTCH1;DDIT3;CDK5RAP3;HDAC4;CEBPG;LRRC14;SUFU;NUPR1;CTNNBIP1;ANXA4;PKD2;ERBIN;PRMT2;KLF4;SMAD7;ZNF431;COMMD1;MTURN;TAF1;ID2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.28587070623967153,0.6827718974152157,0.843421052631579,0.9896933580916253,1.0,5/19,19.75%,WNT5A;CD24;CBFB;TLE5;KLF4
prerank,cellular response to radiation (GO:0071478),-0.18460937293304494,-0.6826498734733709,0.9806451612903225,0.9733357916945748,1.0,6/40,9.55%,SIRT1;NET1;SPIDR;SWI5;TP53;RHOB
prerank,rRNA metabolic process (GO:0016072),0.22507377537396425,0.6825705972790322,0.9604863221884499,0.9895252645691469,1.0,23/160,14.80%,EXOSC1;EXOSC3;WDR18;EBNA1BP2;EXOSC7;HELQ;EXOSC2;FBL;NOP56;EXOSC8;MPHOSPH10;RCL1;ESF1;RPL35A;RPS25;MTREX;RPS15;RPL9;C1D;RPL4;MAPT;BMS1;XRN1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.27102095599030335,-0.6825294702976681,0.8502994011976048,0.9721888761221563,1.0,5/11,31.76%,CFL2;PLEK;SEMA5A;TRPV4;STMN2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.31576262508843667,0.6820851606241596,0.8307475317348378,0.9896201336265545,1.0,2/13,8.41%,SAE1;UBA1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.31243026615236585,0.6813880616583112,0.8673621460506706,0.9899311468148737,1.0,5/12,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2633699577363855,0.6807636827940245,0.8882421420256111,0.990196166870298,1.0,7/33,13.10%,SLBP;CPSF7;CSTF2T;MAZ;NUDT21;CPSF3;SETX
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.28366298008159146,0.6804925186506265,0.8657718120805369,0.9901051132974612,1.0,6/18,20.58%,GRIN1;NLGN3;NLGN2;SHANK1;PRKCZ;PTK2B
prerank,dendrite self-avoidance (GO:0070593),0.2943498386862077,0.6798992707454319,0.8602442333785617,0.9903226571418008,1.0,4/16,20.32%,DSCAM;NPTN;CNTN2;NEXN
prerank,nucleoside phosphate catabolic process (GO:1901292),0.30349346308079256,0.6783733045553199,0.8534850640113798,0.991511344188228,1.0,2/13,12.01%,ENTPD7;ENPP1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.24745964445633598,0.6783352213494874,0.8914549653579676,0.991174374042307,1.0,11/46,21.38%,LCP1;AIP;PSME2;CAPZA1;SOD2;HNRNPA2B1;HNRNPDL;ANXA2;JAK1;TALDO1;CFL1
prerank,cytosolic transport (GO:0016482),0.22938479563353684,0.6782633925913144,0.9394250513347022,0.9908640219538238,1.0,36/108,25.13%,CLN3;SNF8;SNX5;STX6;VAMP3;SNX6;VPS26B;STX16;TMEM87B;RHOBTB3;HOOK3;DENND5A;VPS54;VTI1B;WDR91;EMP2;AP4M1;STX8;VTI1A;PIK3C3;KLHL20;RAB6A;TRIM27;STX5;HEATR5A;RAB7A;EHD3;PIKFYVE;GOSR1;CCDC91;DENND2A;EEA1;DOP1B;GGA1;HEATR5B;SNX16
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3077245108337956,0.6779028622363992,0.8394886363636364,0.9908430361932445,1.0,3/13,16.33%,ENPP1;ABHD14B;SULT1A1
prerank,membrane lipid biosynthetic process (GO:0046467),0.23877977932809563,0.6774988978134203,0.9193370165745857,0.9908858809996697,1.0,11/58,19.11%,ELOVL1;ST3GAL2;CERS2;SGPL1;ELOVL4;SPTSSA;PLPP3;VAPB;ALDH3A2;PRKD2;ELOVL6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.27495517028950267,0.6771825877276463,0.8516624040920716,0.9908422795189651,1.0,13/24,28.26%,PARP1;XRN1;TERF1;TNKS;HNRNPU;PINX1;HNRNPC;TERF2;TENT4B;ERCC4;TNKS2;HNRNPA1;EXOSC10
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24397585180997594,0.6766731698553391,0.8993288590604027,0.9909926049622355,1.0,8/50,17.73%,CDKN2D;CDC25A;CDK5RAP3;CCNH;CCNT1;CDK7;BCCIP;CAMK2N1
prerank,amino acid transport (GO:0006865),0.24491399583619897,0.6762322312470339,0.9183445190156599,0.9910568387645938,1.0,7/49,15.32%,SLC7A11;SLC38A9;SLC7A2;SLC38A10;SLC6A15;SLC1A5;SLC6A12
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2508339806997263,-0.6747193765563676,0.9006410256410257,0.97816863576881,1.0,5/13,17.80%,RREB1;NAPEPLD;BMP7;SIX1;TFE3
prerank,hydrogen peroxide catabolic process (GO:0042744),0.3144396728062857,0.6744332613175643,0.8440233236151603,0.9924650273082941,1.0,2/11,14.59%,PRDX5;PXDN
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.230377370832756,0.674012741572974,0.9303062302006336,0.9924953265735668,1.0,16/82,19.92%,CCP110;HSP90AA1;ALMS1;TUBA1A;YWHAG;NPM1;KCNH5;HAUS3;CSNK1D;TUBB;OFD1;CEP76;TUBB4A;ODF2;DYNLL1;PAFAH1B1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24449538512130703,0.6735216795507809,0.8828828828828829,0.9926214775562556,1.0,18/48,25.79%,OGT;RAE1;NUP188;PGAM1;NUP210;NUP88;NUP214;NUP153;RANBP2;PRKAG2;NUP35;TPR;NUP155;NUP54;NUP98;PNPT1;POM121;SEH1L
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.23083800430953166,0.6726841654117979,0.922422954303932,0.9930779719150352,1.0,15/76,21.84%,COMMD6;USP7;RWDD3;TNFAIP3;ARRB1;DDIT3;CDK5RAP3;LRRC14;FAF1;ANXA4;ERBIN;PRMT2;KLF4;COMMD1;MTURN
prerank,regulation of microtubule depolymerization (GO:0031114),0.26595959762817417,0.6724785206782266,0.8829516539440203,0.9929086329114051,1.0,3/25,9.89%,TAOK1;CAMSAP2;KATNB1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.28429355738334305,0.6719307715848625,0.8860244233378561,0.9930696109197282,1.0,2/18,4.31%,HSP90AA1;ABCA2
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2952773040857164,0.6715456754960728,0.8591352859135286,0.9930645111320705,1.0,3/15,20.88%,CUEDC2;TGFB1;SMAD7
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.2779884437447128,-0.6714065050011155,0.8753462603878116,0.9798831640192798,1.0,1/10,1.33%,TGFA
prerank,anterior/posterior pattern specification (GO:0009952),0.24116713911466278,0.6708232701878071,0.9063545150501672,0.9933660777463796,1.0,4/53,9.61%,ATP6AP2;PCSK5;DDIT3;WLS
prerank,cellular response to leucine starvation (GO:1990253),-0.26058009158518397,-0.6706335411130363,0.874251497005988,0.979261142874808,1.0,3/10,13.48%,EIF2AK4;RRAGB;LARS1
prerank,negative regulation of receptor internalization (GO:0002091),0.30664186191329834,0.6701310983544136,0.8619186046511628,0.993670740505595,1.0,2/12,8.75%,LRPAP1;SDCBP
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.3119186443995017,0.6698928396416871,0.85,0.9935177419268075,1.0,2/11,12.08%,CAAP1;PARK7
prerank,polyol metabolic process (GO:0019751),0.24351169050770186,0.669575826306944,0.9065743944636678,0.993424276639849,1.0,12/46,20.53%,PLCH1;SLC5A3;INPP5A;NUDT3;IPPK;ISYNA1;IPMK;IP6K1;CALM1;IMPA1;INPP4A;ITPK1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2871406242988389,0.6694505970806595,0.8694481830417228,0.9931751996557612,1.0,3/19,14.28%,SUCO;WNT4;TGFB1
prerank,positive regulation of cholesterol transport (GO:0032376),0.26478314586899254,0.6694060960789359,0.8920245398773006,0.9928484988278351,1.0,7/27,20.04%,PTCH1;ABCA7;EEPD1;LRP1;APOE;GPS2;ABCA5
prerank,NAD biosynthetic process (GO:0009435),0.2780949738926984,0.6690512169522846,0.8703956343792633,0.9928117930915867,1.0,4/20,14.21%,NNMT;NUDT12;PARP16;PTGS2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3167156641288366,0.6683089624550052,0.8671875,0.9931528255644362,1.0,2/10,18.28%,SCRIB;PRKAR1A
prerank,nitric oxide mediated signal transduction (GO:0007263),0.2873862412743162,0.66763667227667,0.8868458274398868,0.9933967225622072,1.0,3/16,17.19%,KCNC2;NDNF;APOE
prerank,negative regulation of viral genome replication (GO:0045071),0.2480547355367676,0.6671470097242644,0.8980301274623407,0.9934935158547947,1.0,7/40,18.61%,ILF3;SHFL;ZC3HAV1;OAS2;TNIP1;SRPK1;MPHOSPH8
prerank,positive regulation of locomotion (GO:0040017),0.2648059937739489,0.667087003291747,0.8813349814585909,0.9931750399221235,1.0,4/27,14.28%,TWIST1;CFAP20;SPOCK2;TGFB1
prerank,DNA recombination (GO:0006310),0.25456455921150456,0.6666796318543251,0.9143876337693222,0.9932067178200591,1.0,3/37,5.73%,XRCC2;HMGB3;FBH1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3196517898403214,0.6666043134700188,0.8746312684365781,0.9928974167406692,1.0,2/10,13.55%,MAPK8IP1;PTPN22
prerank,relaxation of cardiac muscle (GO:0055119),-0.2528839171669345,-0.6663675173230758,0.8636363636363636,0.9816138675367332,1.0,4/13,13.24%,ATP1A1;KCNJ2;ATP1B1;PIK3CA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.25190696639346927,-0.6662626300028576,0.9023569023569024,0.98041287622414,1.0,6/12,26.59%,ATP1B3;DMD;ATP1B1;FXYD1;WNK1;NOS1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2856973341163882,0.6660888298340333,0.8716577540106952,0.9930049145349044,1.0,3/16,20.99%,FANCM;RMI1;TOP2B
prerank,cytokine-mediated signaling pathway (GO:0019221),0.21565828494054817,0.6660522877218286,1.0,0.9926610066849805,1.0,68/532,17.01%,IL10RA;LCP1;CAMK2B;IL34;PSMD4;NFKB1;MAP3K14;HSP90AA1;IL33;EDAR;IFNAR1;TNFRSF9;IL10RB;STAT6;ANXA1;RORA;CXCL12;EDA2R;POU2F1;IL31RA;IRF1;PIK3R1;SQSTM1;PSMB10;ZEB1;IFIT3;PSMD11;IL22;IFI35;LRP8;TRIM62;TXLNA;AIP;IFNGR2;TEC;RAPGEF1;TWIST1;PRLR;PSME2;IRS2;PSMC5;CAPZA1;PIK3CB;BCL2;LEPR;IFNGR1;IRF3;CAMK2D;COL1A2;CAMK2G;SOD2;TNFRSF25;PTGS2;HNRNPA2B1;TGFB1;BCL6;CBL;F3;IL15RA;PSMD1;HNRNPDL;ICAM1;IL1RAP;IL5;SLC27A1;ANXA2;OAS2;PSMD6
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.24895662883465194,-0.6660221369273079,0.9288135593220339,0.9793671383435378,1.0,3/12,30.01%,IL17D;CD80;PAEP
prerank,erythrocyte development (GO:0048821),-0.27140525864128945,-0.6659851411703667,0.8812154696132597,0.9781285379815975,1.0,4/10,24.04%,MED1;ABCB10;SH2B3;NCKAP1L
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.31212618888978466,0.6654399932984891,0.8847305389221557,0.9928541144520561,1.0,1/10,6.68%,MIA3
prerank,ncRNA 3'-end processing (GO:0043628),0.29758137227704345,0.6646937535615789,0.8758915834522111,0.9931877347364062,1.0,5/14,21.77%,TOE1;PTCD1;INTS6;INTS2;INTS7
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2713527264296165,0.6646332712040024,0.8921052631578947,0.9928727805801523,1.0,3/20,14.18%,LCP1;RAB13;ROCK2
prerank,positive regulation of cartilage development (GO:0061036),0.2806982462585251,0.6645836029841973,0.8875968992248062,0.9925452186981296,1.0,4/17,17.65%,SOX9;SOX6;SOX5;BMP1
prerank,protein-DNA complex assembly (GO:0065004),0.22180595269739428,0.6645735826295076,0.9619732785200411,0.9921859876649153,1.0,21/116,17.03%,PSMD4;PARP1;TCF4;ASF1A;PSMB10;DDB1;PSMD11;SOX9;ORC6;CUL4B;GTF2H3;PSME2;PSMC5;SART3;CCNH;NPM1;ATRX;PSMD1;DAXX;PSMD6;CDK7
prerank,muscle contraction (GO:0006936),0.22102905283927807,0.6641790743362104,0.9565217391304348,0.9921830929957512,1.0,9/126,11.40%,TNNI3;TNNC1;TNNI1;NEB;MYL1;DES;BDKRB2;TPM1;SLC6A8
prerank,lipid modification (GO:0030258),0.24945719595914737,0.6631314065820102,0.9184397163120568,0.9927670690013208,1.0,10/37,21.55%,PLPPR2;PORCN;PLPP3;PLPPR5;EPHX2;PLPP4;PLPP5;DGKI;PLA2G7;MBOAT2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.28099674755104975,0.6625527637927164,0.8727524204702628,0.992942041896984,1.0,6/19,22.16%,FGFR2;RBPJ;TGFBR1;TGFBR3;FGF2;ERBB4
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2640306454587001,0.6625321134659701,0.8984771573604061,0.9925960206766935,1.0,2/26,4.91%,CHERP;ITPR1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.2525542306375883,0.6621922173772741,0.8926014319809069,0.992540250908255,1.0,5/33,19.43%,UBASH3A;THY1;PTPN22;PRKD2;RPS3
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2372654701405235,0.6616820673636871,0.9306167400881057,0.9926664322345872,1.0,13/54,21.09%,NHP2;EBNA1BP2;MRPL1;RPL35A;MALSU1;NPM1;LAS1L;RPL23A;NSA2;BRIX1;RSL1D1;HEATR3;RPL7
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.29117767057688954,0.6610452269030258,0.8614718614718615,0.9929066729804269,1.0,3/13,17.57%,SNAI1;TWIST1;MDM2
prerank,modulation by host of viral genome replication (GO:0044827),0.29980208578857737,0.6603668607899768,0.880466472303207,0.9931624608312583,1.0,6/13,22.29%,PPIB;TBC1D20;NUCKS1;FMR1;YTHDC2;IFI27
prerank,positive regulation of biosynthetic process (GO:0009891),0.24632694068072342,0.6599195932082029,0.9104651162790698,0.9932144158714685,1.0,7/40,17.19%,GRIN1;SLC5A3;SUCO;WNT4;ZBTB20;TGFB1;APOE
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.29765545204948785,0.6591488769933269,0.8840782122905028,0.9935481074687132,1.0,2/14,11.13%,WNK2;ANK3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2799356708213955,0.6590942826385124,0.884514435695538,0.993227607403747,1.0,3/18,15.41%,AQP4;RFX3;OFD1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3075347899234858,0.6590841250765083,0.8582434514637904,0.992866810207036,1.0,2/10,13.81%,JARID2;ATRX
prerank,regulation of adenylate cyclase activity (GO:0045761),0.2678216520649976,0.6576771498149913,0.8983268983268984,0.9937427340326417,1.0,2/22,7.66%,LTB4R2;ADGRV1
prerank,cholesterol biosynthetic process (GO:0006695),0.2564068369924872,0.6574945979452042,0.904126213592233,0.9935330915176616,1.0,5/31,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,centromere complex assembly (GO:0034508),0.24668092988887974,0.6572017639945911,0.9252336448598131,0.9934330411338556,1.0,4/36,13.49%,CENPT;RBBP4;NPM1;CENPC
prerank,camera-type eye morphogenesis (GO:0048593),0.316989737123382,0.6571998922904593,0.8569321533923304,0.9930635893752324,1.0,2/10,10.68%,TENM3;KDM2B
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2525645663328537,0.6569440870184177,0.9178743961352657,0.992903279402651,1.0,2/31,2.90%,BAX;STUB1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.24566718293337392,-0.6566928500057653,0.8770226537216829,0.9843585604542223,1.0,5/12,26.33%,ESR1;PPARG;ELAVL1;ZC3H12A;TERT
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.3121531198946963,0.6560537153013418,0.8801213960546282,0.9929833197400167,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.3121531198946963,0.6560537153013418,0.8801213960546282,0.9929833197400167,1.0,2/10,9.83%,VLDLR;AP2S1
prerank,negative regulation of cell activation (GO:0050866),0.29429437601674246,0.6559375262468282,0.8828571428571429,0.9927249100786785,1.0,3/14,17.19%,C1QTNF1;PDGFRA;APOE
prerank,adipose tissue development (GO:0060612),0.30639632484409973,0.6559094012918825,0.8975109809663251,0.9923786119092487,1.0,1/11,3.80%,XBP1
prerank,glucose transmembrane transport (GO:1904659),0.2809256189206507,0.6557420773347953,0.8717598908594816,0.9921642798726816,1.0,2/18,11.24%,SLC5A3;SLC2A3
prerank,neuromuscular synaptic transmission (GO:0007274),-0.21849234828028466,-0.6556700824081494,0.9221311475409836,0.983910995709195,1.0,10/18,43.44%,ERC1;FCHSD2;SLC5A7;CHRNB1;ERC2;STAC3;KIF1B;FCHSD1;TSPOAP1;CHAT
prerank,protein localization to lysosome (GO:0061462),0.26100134874567,0.6552385491464547,0.8963337547408344,0.9922512508544398,1.0,10/28,23.25%,HGS;NCOA4;LAMTOR5;AP4M1;SORL1;ZFYVE16;SCARB2;RAB7A;GGA3;LMBRD1
prerank,activation of protein kinase A activity (GO:0034199),0.2837206445380296,0.6544406175489466,0.889344262295082,0.9925824726139717,1.0,4/16,18.28%,ADCY7;ADCY1;ADCY5;PRKAR1A
prerank,RNA polyadenylation (GO:0043631),0.2607497256446207,0.6542931117951533,0.9020310633213859,0.9919704672073154,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,mRNA polyadenylation (GO:0006378),0.2607497256446207,0.6542931117951533,0.9020310633213859,0.9919704672073154,1.0,9/26,19.58%,PABPC1;APP;CPSF3;CDC73;GRSF1;AHCYL1;FIP1L1;MTPAP;CSTF3
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.315040553624524,0.6540786692099518,0.8807069219440353,0.991794090305712,1.0,4/10,26.70%,DCLRE1A;TERF2IP;RIF1;TERF2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.24797724357801634,0.6540608521987843,0.9032258064516129,0.9914428665049376,1.0,14/36,25.49%,RAB34;RAB10;ANK3;RAB31;SPTBN1;GGA2;NSF;GORASP1;RAB7A;GGA3;GOLGA4;GOLPH3L;GGA1;AFDN
prerank,regulation of interferon-gamma production (GO:0032649),0.22757352122354038,0.6538512648058927,0.9458874458874459,0.9912660906069208,1.0,9/71,15.76%,SCRIB;SIRPA;DDIT3;CD47;CEBPG;TLR3;PTPN22;HSPD1;PDE4B
prerank,histone lysine methylation (GO:0034968),0.25035020255562523,0.6534050873538602,0.8992718446601942,0.9912925888417277,1.0,8/33,19.43%,KMT2B;EZH2;EHMT2;DPY30;SUV39H1;KMT2D;KMT2A;KDM6A
prerank,regulation of protein localization to nucleus (GO:1900180),0.23798521718335663,0.6529250628457288,0.9263521288837745,0.9913397367992973,1.0,7/43,14.28%,EIF2AK3;FLCN;GLUL;CDK5RAP3;PARK7;LAMTOR5;TGFB1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.2470165599362973,0.6526338573555487,0.9137529137529138,0.9912266308702091,1.0,11/36,22.00%,NR2F2;DCN;JUP;TGFB1;APOE;SYNJ2BP;MECP2;KRIT1;ATP2B4;FGF2;HMGB1
prerank,response to growth factor (GO:0070848),0.2385653654818902,0.6525413155239099,0.9171528588098017,0.9909469269121611,1.0,8/41,20.76%,SFRP1;TBC1D7;PLK5;RACK1;ACVR1B;TGFBR1;KLF4;ACVR2A
prerank,response to laminar fluid shear stress (GO:0034616),0.31083724910095634,0.6520265917783082,0.8828967642526965,0.991037616651377,1.0,5/10,23.97%,SMAD6;ASS1;KLF4;SMAD7;ABCA1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.26741409435602054,0.6502969202784353,0.9153846153846154,0.9922325938560642,1.0,3/23,10.19%,SOX9;EGF;GDNF
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2500213972079789,0.6500315583475854,0.9207317073170732,0.9920965220495571,1.0,10/30,23.91%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PDCD5;RHOU;SH3GLB1;FBXW7
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.21910170574531512,-0.6499402637886572,0.933920704845815,0.9869851703438866,1.0,4/18,14.70%,EZR;CD34;PTPRC;HOMER3
prerank,regulation of RNA export from nucleus (GO:0046831),0.3071425910672468,0.6498429765509262,0.8850072780203785,0.9918950623608446,1.0,5/11,23.44%,AKAP8L;CPSF6;NUP153;TPR;KHDRBS1
prerank,glutathione metabolic process (GO:0006749),0.24296223347770285,0.6497042104825154,0.930715935334873,0.9916474564884092,1.0,8/38,20.02%,GSTT1;CNDP2;PARK7;GCLC;ETHE1;DPEP1;HAGH;GSTT2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.18682194508819222,-0.6490874410239774,0.9421052631578948,0.9863660155860066,1.0,4/33,7.64%,TGFA;AFAP1L2;BCAR3;DGKD
prerank,B cell activation (GO:0042113),0.22677138999013158,0.6488823394225144,0.9537444933920705,0.9919861028424368,1.0,9/68,15.53%,EPHB2;HDAC5;HDAC4;MALT1;BCL2;CEBPG;BLNK;TCF3;HSPD1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.2392840048095684,-0.6482092172295566,0.9085173501577287,0.9845181771926277,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.2392840048095684,-0.6482092172295566,0.9085173501577287,0.9845181771926277,1.0,2/12,21.55%,HOMER3;DYRK2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3055906358080804,0.6478669324126303,0.889922480620155,0.9924907493448134,1.0,1/10,8.54%,DDIT3
prerank,response to tumor necrosis factor (GO:0034612),0.219395560802789,0.6465269211404198,0.959915611814346,0.993275737923935,1.0,6/91,7.65%,SFRP1;ADAMTS7;GBP3;ZFP36L1;ZFAND6;PID1
prerank,cellular protein metabolic process (GO:0044267),0.20826632803819609,0.645961368998162,0.996996996996997,0.9933652993554579,1.0,63/396,17.62%,IGF1;MRPL36;FARSB;ARAF;LCMT1;CP;UBE2S;WARS1;FSTL1;YARS2;PCSK5;LAMC1;ABL1;MIA3;CKAP4;RAB12;LTBP1;HM13;MANBA;PABPC4;FAM20C;APLP2;MRPL10;PLAT;MBTPS1;RPL35A;RPS25;AFG3L2;APP;IGFBP3;SARS1;IGFBP7;RPS15;PAPPA;RPL9;FBN1;SERP1;HARS1;MRPL3;GSPT1;LAMB1;RPL4;SFTPA1;SFTPA2;ATG3;MRPL13;RPN2;CTSH;MRRF;CHEK2;SERPIND1;MRPL24;NEDD8;UBE2L3;RPL23A;PARL;MXRA8;APOE;RPLP2;TNIP1;FBXO22;PCMT1;OMA1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.24673952125213927,0.6446195052303544,0.9184914841849149,0.9941847645830878,1.0,2/32,7.78%,RNASE7;FAM3A
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2354999687688572,0.6440853697029928,0.9250288350634371,0.9942667067241133,1.0,10/44,20.46%,UCHL1;MAPK8IP1;CDK5RAP3;PIK3CB;PTPN22;SPRY2;APOE;SORL1;SMPD1;LYN
prerank,DNA methylation (GO:0006306),0.26359515465231276,0.643942246378073,0.8997429305912596,0.9940062391199377,1.0,4/23,13.81%,PICK1;EHMT2;EHMT1;ATRX
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.29578170352657096,0.6434948355008654,0.8803418803418803,0.993998754310242,1.0,2/12,18.27%,MIA3;ASS1
prerank,telomere maintenance (GO:0000723),0.2313586838068499,0.6434156504281884,0.937984496124031,0.9937000060893619,1.0,10/50,18.57%,ZBTB48;PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TPRKB;TERF2IP
prerank,regulation of endocytic recycling (GO:2001135),0.30745453304764564,0.6431879787138495,0.8814589665653495,0.9935319242522286,1.0,5/11,22.41%,ATP9A;EIPR1;SORL1;EHD1;RAB11B
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.26926692938427654,0.6419703743897505,0.908,0.9941549999647545,1.0,3/20,10.90%,SNAI1;OLFM1;RBPJ
prerank,androgen metabolic process (GO:0008209),-0.20640485199821118,-0.6419627523284905,0.9467680608365019,0.9877180512016802,1.0,3/18,22.19%,MED1;SPP1;SRD5A3
prerank,actin filament capping (GO:0051693),-0.21635077629552557,-0.6418906368657185,0.9315589353612167,0.9852382581156135,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,barbed-end actin filament capping (GO:0051016),-0.21635077629552557,-0.6418906368657185,0.9315589353612167,0.9852382581156135,1.0,5/18,17.39%,CAPZA2;EPS8;TRIOBP;TWF2;TWF1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.23018091603377372,0.6415040547582647,0.9367369589345172,0.9941834796930206,1.0,11/54,19.43%,SIRT7;OGT;TNFAIP3;SQSTM1;ARRB1;PARK7;USP4;PIAS3;SPRY2;SOX4;RPS3
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.2917302836623058,0.6413006415542526,0.8872620790629575,0.9939826500129311,1.0,2/12,17.51%,SOAT1;MTTP
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.2745627882072427,0.6409425667424492,0.8922651933701657,0.9939079044539174,1.0,4/16,21.29%,GDNF;PKD2;FOXD1;FGF2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.23212024980415472,0.6409261753665205,0.9283276450511946,0.9935533785097008,1.0,7/48,18.85%,SCRIB;CEBPG;TLR3;PTPN22;HSPD1;PDE4B;TRIM27
prerank,regulation of sensory perception of pain (GO:0051930),0.29943867574523986,0.6402301499716763,0.8892261001517451,0.9937582187231399,1.0,2/11,15.49%,ZFHX2;ATPSCKMT
prerank,cellular response to interleukin-1 (GO:0071347),0.21284842639921528,0.6398741069376597,0.9695121951219512,0.9936990932233545,1.0,13/143,10.46%,SFRP1;ADAMTS7;GBP3;PSMD4;NFKB1;SQSTM1;PSMB10;SIRPA;PSMD11;SOX9;USP10;PSME2;PSMC5
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2839465159398816,0.6396514245206315,0.9129213483146067,0.9935300687422949,1.0,5/14,18.99%,CPSF7;CSTF2T;NUDT21;CPSF6;FIP1L1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.23375946526157082,0.6393348688845926,0.9193370165745857,0.9934329998576004,1.0,4/49,13.24%,IGF1;IL31RA;PIBF1;PARP14
prerank,positive regulation of angiogenesis (GO:0045766),0.2115417430815972,0.6387779320598187,0.9701030927835051,0.9935295168120826,1.0,16/108,18.03%,SFRP2;WNT5A;PDPK1;XBP1;PRKCA;GAB1;TWIST1;JUP;ADAM12;F3;FOXC2;CTSH;SERPINE1;MTDH;PRKD2;JAK1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.3069857524324001,0.6384132665805596,0.8840361445783133,0.993460871972181,1.0,2/10,7.32%,SMARCB1;HDAC5
prerank,regulation of transferase activity (GO:0051338),-0.21255906256237253,-0.6379901730005143,0.9330543933054394,0.9865887188527409,1.0,9/17,37.64%,FEM1B;SMG6;FEM1A;NLRC5;PPP1R3F;SPTSSB;BAG5;JMJD8;HMBOX1
prerank,nucleotide metabolic process (GO:0009117),0.2591343658751344,0.6375501207556232,0.9051282051282051,0.9937643133165015,1.0,4/23,12.08%,DCK;AK4;AK5;PARK7
prerank,sulfur compound biosynthetic process (GO:0044272),0.2144425044308429,0.6373590756091015,0.9696969696969697,0.99356007056162,1.0,12/104,13.12%,SLC35B2;CHPF;SLC35D2;GSTT1;ST3GAL2;DCN;ST3GAL3;CHSY3;CNDP2;B4GALT5;OMD;GCLC
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3003874877777064,0.6373355518029818,0.8892261001517451,0.9932186726725215,1.0,2/11,10.25%,ARHGEF7;ENPP2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.2897533365712908,0.6369037497915754,0.9010339734121122,0.9932093730005391,1.0,4/13,24.79%,ZBTB7B;CBFB;GLI3;RUNX1
prerank,activin receptor signaling pathway (GO:0032924),0.2807516463761883,0.636897963264549,0.9066852367688022,0.9928500837947795,1.0,5/15,22.11%,ACVR1B;TGFBR1;ACVR2A;SMAD2;SMAD3
prerank,cellular response to ionizing radiation (GO:0071479),0.22817434564648129,0.6360545553827461,0.9461626575028637,0.9931442405039033,1.0,8/47,17.57%,KDM4D;NIPBL;XRCC6;ATR;NUCKS1;CLOCK;TANK;MDM2
prerank,regulation of cell morphogenesis (GO:0022604),0.24590674480558194,0.6348393544759232,0.8968058968058968,0.9937406693360356,1.0,11/30,25.96%,PDZD8;SPARC;NTNG2;PHIP;MYO9A;CFL1;CAMSAP1;STRIP1;SH3D19;ZMYM6;BCL9L
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.22399963200370424,0.6342204671197179,0.9477777777777778,0.993855363523263,1.0,11/57,22.00%,FIS1;GRIN1;DDX3X;GRIN2A;MALT1;DAPK1;PDCD5;USP50;PDCD6;PPM1F;HMGB1
prerank,regulation of hippo signaling (GO:0035330),0.27251542653322025,0.6341406259083293,0.9045020463847203,0.9935553861948851,1.0,6/17,23.31%,CIT;SOX11;WWC1;NF2;DLG5;MAP2K3
prerank,reverse cholesterol transport (GO:0043691),0.2864808106975406,0.6328052651974335,0.8758915834522111,0.9942203808279051,1.0,4/13,23.97%,APOE;ABCA5;ABCG1;ABCA1
prerank,cell cycle G1/S phase transition (GO:0044843),0.22587165638408827,0.6318237748522116,0.9523281596452328,0.9946300274115818,1.0,10/61,17.03%,CDKN2D;CDC25A;CUL4B;E2F3;CCNH;RCC1;GSPT1;CUL5;ACVR1B;CDK7
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.24871777119726113,0.6314635280545902,0.926208651399491,0.9945401995773812,1.0,4/26,12.24%,FBXO7;GPR37;PARK7;SOD2
prerank,cellular component maintenance (GO:0043954),0.2845320835086449,0.6295204308887626,0.9260869565217391,0.9956727370514743,1.0,1/12,3.83%,PICK1
prerank,mitotic chromosome condensation (GO:0007076),0.2518819128687959,0.6290891336433472,0.917189460476788,0.9956422227276667,1.0,2/26,6.66%,CSNK2A2;AKAP8L
prerank,regulation of mononuclear cell migration (GO:0071675),0.25522309085807193,0.6284325000044717,0.9037711313394018,0.9958062563715427,1.0,1/23,1.28%,IL34
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2230709293508504,0.6278362032390128,0.9575163398692811,0.9958916748110151,1.0,17/62,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.2639530445464008,0.6276230895745453,0.9110512129380054,0.9956820669605777,1.0,6/18,23.03%,ABCA2;IFNGR1;ROCK2;ABCG1;EPHA4;SP1
prerank,T cell proliferation (GO:0042098),-0.2325504253736351,-0.6273619705258866,0.9293286219081273,0.9922264252961778,1.0,3/13,16.70%,CADM1;LMBR1L;MSN
prerank,cellular response to cAMP (GO:0071320),0.24096378337091173,0.6270338833481712,0.9327731092436975,0.9957663987757855,1.0,3/30,9.43%,ZFP36L1;DMTN;RAPGEF1
prerank,regulation of anoikis (GO:2000209),0.2650558891285134,0.6265504825984026,0.9104683195592287,0.9957836645162891,1.0,6/19,22.29%,SIK1;BCL2;ANKRD13C;TLE5;ITGB1;ITGA5
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2786790450164459,0.6264540674710034,0.8950354609929078,0.9955055636364981,1.0,1/14,2.36%,DDX18
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.2906001253822603,0.6262195648951093,0.8876080691642652,0.9953106477931445,1.0,3/12,17.04%,KIF3A;HOOK3;NIN
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.22735518350493134,0.6261148734932209,0.9546998867497168,0.9950218851618637,1.0,13/51,20.88%,SMAD9;FSTL1;HTRA3;LEMD3;FBN1;SMAD6;UBE2D1;SMURF1;GREM2;SORL1;NBL1;ACVR2A;SMAD7
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.26427695042376914,0.6260558037685391,0.8985695708712613,0.9947030822555253,1.0,3/18,18.27%,MIA3;PTPN22;ASS1
prerank,synaptic vesicle membrane organization (GO:0048499),0.2669070040911551,0.6257485694505087,0.9135135135135135,0.9945769769325071,1.0,3/17,14.94%,STX2;SNAP25;STX11
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.21569556651532268,0.6254641274215355,0.9521276595744681,0.9944278474400579,1.0,11/74,15.20%,SIRT2;PSMD4;PSMB10;ARNT;PSMD11;PSME2;PSMC5;RBPJ;BACH1;EGLN2;PSMD1
prerank,regulation of phosphatase activity (GO:0010921),0.25034590937246215,0.6250792142649401,0.9246753246753247,0.9943413944324115,1.0,5/24,18.46%,PPP1R2;CDK5RAP3;PPP6R3;HTT;TIPRL
prerank,homocysteine metabolic process (GO:0050667),-0.24099297990070423,-0.6245883067510112,0.9175257731958762,0.9926944901289888,1.0,7/11,48.66%,MTHFR;MTRR;CBS;CTH;NOX4;MPST;BLMH
prerank,amyloid fibril formation (GO:1990000),0.2243341673134891,0.6233603526984408,0.9411098527746319,0.9952418693426627,1.0,19/51,25.85%,APP;USP9X;MAPT;GGA2;HSPG2;ITM2B;MDM2;SORL1;GSN;H3-3A;B2M;GGA3;FKBP1A;IAPP;SIAH2;GGA1;RPS27A;TSPAN14;FURIN
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.21771858945237613,0.6233566390260435,0.9423913043478261,0.9948823576723093,1.0,8/65,10.46%,PSMD4;USP47;PSMB10;PSMD11;CDK5RAP3;CHFR;PSME2;PSMC5
prerank,toxin transport (GO:1901998),0.2957696921798017,0.6228335819649857,0.9020217729393468,0.9948970409138389,1.0,3/10,23.17%,ANTXR1;ANTXR2;RAB40B
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.24953734919964665,0.6223384582201572,0.9267676767676768,0.9949014189615728,1.0,4/26,13.92%,FGFR1;GDNF;BCL2;EYA2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.24525028806280869,-0.6215073633138143,0.9211267605633803,0.9933426301012879,1.0,7/10,39.59%,HSP90AB1;FN1;LAPTM4B;GATA6;TSKU;TYROBP;CDH3
prerank,chondroitin sulfate catabolic process (GO:0030207),0.28347877195958815,0.6214634291043051,0.9165467625899281,0.9951879035262481,1.0,2/13,14.45%,DCN;ARSB
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.23592820004023368,-0.6214029426399603,0.9303135888501742,0.9921497582391422,1.0,3/12,16.45%,NELFB;REST;HES1
prerank,regulation of acrosome reaction (GO:0060046),0.2935140358437627,0.6212851179644687,0.9180327868852459,0.9949605366468804,1.0,1/10,14.46%,GLRA1
prerank,response to nutrient levels (GO:0031667),-0.21425446778435278,-0.6207582957548606,0.9386973180076629,0.9912814948682072,1.0,3/17,23.29%,PRKAA2;ATF4;FAM107A
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.21830281541417187,0.6194680352592432,0.9613733905579399,0.9959127261281964,1.0,17/64,21.99%,POLR2B;CDK13;CDK9;RTF1;GTF2H3;TCEA1;POLR2K;CCNH;CDC73;CCNT1;CDK7;NELFA;MLLT3;ELP2;CCNT2;EAF1;GTF2F2
prerank,sterol biosynthetic process (GO:0016126),0.23840574714408833,0.6194258604148692,0.9342891278375149,0.9955792750972923,1.0,5/33,13.04%,LSS;INSIG1;MSMO1;SC5D;CYP51A1
prerank,modulation by host of symbiont process (GO:0051851),0.23661708087954786,0.6189040784194016,0.9292682926829269,0.9955865869994565,1.0,7/31,16.32%,SMARCB1;HDAC1;CHD1;NUCKS1;SAP30BP;SNW1;CCNT1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.2525442768025103,0.6168745296445652,0.9245773732119635,0.9966710526275814,1.0,4/21,14.28%,SOX9;ENPP1;ROCK2;TGFB1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.22991855241020265,0.6165666920761143,0.9529411764705882,0.9965239373440219,1.0,8/39,21.65%,BMP6;MIA3;TGFB1;JAG1;ASS1;KLF4;NF2;PPM1F
prerank,protein depolymerization (GO:0051261),0.24461914609546193,0.6154974800756545,0.9276807980049875,0.9969230821098046,1.0,3/27,12.16%,STMN4;KATNB1;VPS4B
prerank,negative regulation of viral life cycle (GO:1903901),0.2640386116586611,0.6151090339223579,0.9262865090403338,0.9968304715370776,1.0,5/15,23.40%,TRIM11;GSN;MID2;TRIM26;IFITM3
prerank,regulation of DNA binding (GO:0051101),0.22515874183789927,0.6144642463720348,0.9571759259259259,0.9969009834464632,1.0,5/44,14.28%,IGF1;SIRT2;EGF;CEBPG;TGFB1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.21011052250311132,0.612923378388249,0.9671261930010604,0.9976163589165724,1.0,14/76,19.73%,TCIM;DDX3X;PPM1B;IFI35;APP;NFAT5;RTKN2;TLR3;PTPN22;ILK;RASSF2;TERF2IP;RPS3;PPM1A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.2527315084967314,0.6126634842232461,0.9193121693121693,0.9974458405210446,1.0,6/21,21.87%,CNOT10;CNOT9;CNOT6;SAMD4B;CNOT4;SAMD4A
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2571169376437802,0.6122586613062556,0.9308510638297872,0.9973623611173976,1.0,4/20,19.15%,DIP2B;ARRB1;PRKAA1;SOX4
prerank,endothelial tube morphogenesis (GO:0061154),0.2913535935119971,0.611812847442017,0.9010654490106544,0.9973163799989779,1.0,3/10,19.93%,RBPJ;PRKD2;STARD13
prerank,positive regulation of protein binding (GO:0032092),0.21845053101821515,0.6114663389957856,0.9672846237731734,0.9972075872652354,1.0,11/56,18.68%,VTN;TCF7L2;ABL1;APP;ADD2;LRP1;DERL1;PPP2CB;APOE;USP33;FLOT1
prerank,regulation of Notch signaling pathway (GO:0008593),0.20919871426499953,0.6110403080055691,0.9671261930010604,0.9971320488185359,1.0,14/76,19.40%,DLK1;TCIM;ARRB1;EGF;PRAG1;RBPJ;ZMIZ1;PRKCI;SNW1;JAG1;ITGB1BP1;SYNJ2BP;MMP14;YTHDF2
prerank,mesoderm formation (GO:0001707),0.26143594357907685,0.6088347253809625,0.9122340425531915,0.9982508131973222,1.0,4/17,21.52%,SNAI1;KDM6B;ITGB1;SMAD2
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.2852566449999866,0.6087915431242648,0.9115549215406562,0.9979174974393328,1.0,3/12,15.88%,SCRIB;RAB10;AHI1
prerank,heterochromatin assembly (GO:0031507),0.25383390494048236,0.6080269979986994,0.9425133689839572,0.9980469697032744,1.0,3/20,12.36%,SIRT2;SUV39H1;HDAC1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.25364800961435297,0.6076764474761791,0.9250334672021419,0.9979078011900425,1.0,4/19,21.65%,BMP6;DENND6A;FLOT1;PPM1F
prerank,positive regulation of endopeptidase activity (GO:0010950),0.2352324011095238,0.6068207813357095,0.9320148331273177,0.998126667186899,1.0,7/26,22.67%,GRIN1;PRELID1;PSME2;ROCK2;USP50;LYN;EPHA4
prerank,negative regulation of cell division (GO:0051782),0.2835704177884294,0.6064633964913334,0.9035087719298246,0.9980020092218779,1.0,2/11,16.11%,ORC6;TXNIP
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.2757736865084904,0.6061239407774378,0.9111111111111111,0.9978784971669019,1.0,2/12,11.52%,MIA3;BMP5
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.22699987624527398,-0.6061220774042458,0.9404388714733543,0.9981457487259727,1.0,3/12,16.50%,IGF1R;BNIP3;IRGM
prerank,positive regulation of superoxide anion generation (GO:0032930),0.2718152807752647,0.6059820426923925,0.9296987087517934,0.9976118438151184,1.0,2/13,14.28%,MAPT;TGFB1
prerank,positive regulation of vascular permeability (GO:0043117),0.2806470894425853,0.6045291644594352,0.9245283018867925,0.9982178224721776,1.0,1/12,2.58%,BMP6
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2649086090682714,0.6030391779771226,0.9134199134199135,0.9988339150879912,1.0,3/15,17.57%,TAF9B;BCL2;MDM2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.23980624155303984,0.6021256774514273,0.930628272251309,0.9990459997320795,1.0,5/24,16.69%,PID1;LEPR;MRAP2;COQ10A;ACADVL
prerank,negative regulation of protein secretion (GO:0050709),0.22746187229114712,0.6010420941925935,0.956271576524741,0.9993587868660118,1.0,2/38,3.84%,SFRP1;ERP29
prerank,regulation of superoxide anion generation (GO:0032928),0.265828846517071,0.6001027000262319,0.9358974358974359,0.9995701792116855,1.0,2/14,14.28%,MAPT;TGFB1
prerank,regulation of interleukin-10 production (GO:0032653),0.21703682785994535,0.5995524486749144,0.9573241061130334,0.9995507085233208,1.0,4/44,15.53%,FCGR2B;PIBF1;CD47;HSPD1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2634578217696192,0.5985508880982061,0.9241773962804005,0.9998615733693249,1.0,2/15,12.69%,SMPD2;RACK1
prerank,positive regulation of coagulation (GO:0050820),0.2885170826900923,0.5985301713896413,0.9208955223880597,0.9991573848581254,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),0.2885170826900923,0.5985301713896413,0.9208955223880597,0.9991573848581254,1.0,2/10,16.49%,DMTN;SERPINE1
prerank,carbohydrate transport (GO:0008643),0.2773347527334409,0.5981156889605016,0.9273255813953488,0.9990518290992312,1.0,1/11,11.44%,SLC50A1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.2698525222462866,0.5976427722426831,0.9215686274509803,0.998995773625737,1.0,4/13,20.27%,BMP6;TGFB1;TGFBR1;DAB2
prerank,regulation of cell projection organization (GO:0031344),0.2652588021262737,0.5969530582458995,0.9203413940256046,0.9990641515341993,1.0,3/13,19.89%,NTNG2;SPRY2;MYO9A
prerank,regulation of vacuole organization (GO:0044088),0.24769956813703872,0.5965565336966944,0.9268929503916449,0.9989461326385867,1.0,9/20,25.99%,ENO2;IFT20;ANXA2;SCARB2;NPRL2;PIKFYVE;MTM1;NPRL3;TBC1D14
prerank,cellular response to inorganic substance (GO:0071241),0.24220513263727528,0.5949143366289644,0.9498644986449865,0.9995883790826404,1.0,4/21,16.81%,KCNC2;ATRX;FMR1;DPEP1
prerank,ESCRT complex disassembly (GO:1904896),0.28702105513145876,0.5944743086037716,0.8964497041420119,0.9991401790339755,1.0,2/10,12.16%,VTA1;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.28702105513145876,0.5944743086037716,0.8964497041420119,0.9991401790339755,1.0,2/10,12.16%,VTA1;VPS4B
prerank,negative regulation of interleukin-12 production (GO:0032695),0.26722623579122035,0.5938855940090125,0.9121813031161473,0.9991415756363555,1.0,1/14,8.56%,PIBF1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.1980649688550601,0.5936993424220962,0.9877049180327869,0.9988947187184827,1.0,21/114,22.05%,PSMD4;MAP3K14;EDAR;TNFRSF9;EDA2R;PSMB10;PSMD11;PSME2;PSMC5;TNFRSF25;PSMD1;PSMD6;ILK;BAG4;BIRC3;PSMD5;PTK2B;PSMA4;PSMA1;PSMC6;TRAF2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.26516327379283233,0.5935503335611554,0.9217877094972067,0.9986204257282181,1.0,3/14,15.47%,TWIST1;IRS2;ABCD2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.28705186997553045,0.5916252792150313,0.9182763744427934,0.9993826536767692,1.0,1/10,5.93%,DHX58
prerank,nucleoside catabolic process (GO:0009164),0.2779070077592799,0.5913726073755774,0.9206349206349206,0.9991635680704466,1.0,3/11,15.57%,UPP2;DPYD;NT5C3A
prerank,regulation of response to interferon-gamma (GO:0060330),0.2638425773235774,0.5891737024346398,0.9347222222222222,1.0,1.0,4/14,19.91%,IFNGR2;IFNGR1;JAK1;PIAS1
prerank,ameboidal-type cell migration (GO:0001667),0.211317397310073,0.5889831754807707,0.9674418604651163,0.9998287923759301,1.0,13/51,22.49%,SRGAP2;SGPL1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A;MEGF8;AMOT;PDXDC1;PDLIM1;ERBB4;PKN1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2130169383364679,0.5885673420301625,0.9614949037372593,0.9993504698463148,1.0,20/50,26.21%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,regulation of gene silencing by RNA (GO:0060966),0.2130169383364679,0.5885673420301625,0.9614949037372593,0.9993504698463148,1.0,20/50,26.21%,RAE1;POLR2B;NUP188;POLR2K;NUP210;NUP88;NUP214;FMR1;NUP153;RANBP2;NUP35;TPR;H3-3A;NUP155;NUP54;NUP98;POM121;POLR2A;SEH1L;PUM2
prerank,axonemal dynein complex assembly (GO:0070286),-0.17650015708451147,-0.5881980810240046,0.99,1.0,1.0,27/27,82.39%,SPAG1;TTC12;DNAAF5;ODAD1;CCDC39;DNAH8;DNAH5;ODAD2;DRC1;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH1;DNAAF1;DNAI3;ZMYND10;CFAP73;DNAL1;DNAI4;LRRC49;DNAAF3
prerank,glucose metabolic process (GO:0006006),0.2080399385405997,0.58807755259478,0.9757442116868799,0.9992698533123404,1.0,9/58,18.84%,G6PC3;MDH2;PGAM1;IRS2;ENO2;HECTD4;SLC25A1;OMA1;PGK1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.27534172923758865,0.5869497973662641,0.934351145038168,0.9995688429520995,1.0,2/10,12.08%,GPR37;PARK7
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.2438167245912204,0.5866007800912949,0.9390243902439024,0.9994084212286695,1.0,2/19,6.77%,RENBP;GNPNAT1
prerank,negative regulation of chemokine production (GO:0032682),0.2560456192642529,0.5862639260858165,0.925035360678925,0.9992467206814989,1.0,1/14,7.34%,SIRPA
prerank,protein palmitoylation (GO:0018345),0.2256812666579358,0.5850654962186921,0.9601449275362319,0.9995558438420424,1.0,6/30,18.18%,ZDHHC3;GLUL;CLIP3;PORCN;ZDHHC17;ZDHHC2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2161728482969929,0.5842069898106683,0.9618497109826589,0.9996782010814884,1.0,3/40,10.32%,SLC7A11;SLC38A9;SLC38A10
prerank,negative regulation of hippo signaling (GO:0035331),0.27247290820959946,0.5837059641785857,0.9290882778581766,0.999619906253905,1.0,4/12,23.31%,CIT;WWC1;DLG5;MAP2K3
prerank,positive regulation of viral transcription (GO:0050434),0.23536653389575418,0.5835456259727738,0.9582822085889571,0.9993418523808312,1.0,5/25,18.54%,POLR2B;CDK9;POLR2K;CCNT1;NELFA
prerank,neural crest cell migration (GO:0001755),0.21626494488341386,0.5834860563778538,0.9673123486682809,0.9990236674831582,1.0,6/36,15.56%,NRP1;SEMA3D;GDNF;RADIL;SEMA3E;SEMA3A
prerank,protein acetylation (GO:0006473),0.22433184772731146,0.5827531913213658,0.9546568627450981,0.999061588096199,1.0,7/30,22.48%,NAT9;MAPT;HAT1;CLOCK;NAA35;FOXO1;GTF2B
prerank,cardiac muscle cell differentiation (GO:0055007),0.23988823873659687,0.5826753259576882,0.9473007712082262,0.9987430341094133,1.0,4/21,16.74%,SIK1;AKAP13;NRG1;KDM6B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2659359342468931,0.5825020919420142,0.9274074074074075,0.9984854824518546,1.0,3/12,18.66%,LIN28B;TGFB1;NCOR2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.21836682245347405,0.5823727862162866,0.966785290628707,0.9981965214157231,1.0,5/35,15.34%,ZFP36L1;BRD1;ARNT;PRMT1;ACVR1B
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.17834622243458548,-0.5820881414762802,0.9876543209876543,1.0,1.0,4/22,17.61%,IKBKB;ROCK1;PTPA;BOD1L1
prerank,glutathione biosynthetic process (GO:0006750),0.27288221712802563,0.5820840225952478,0.9136904761904762,0.99799487379916,1.0,3/11,19.70%,CNDP2;GCLC;HAGH
prerank,TOR signaling (GO:0031929),-0.17428885577342668,-0.5818953963899848,0.9757281553398058,1.0,1.0,1/26,0.08%,RICTOR
prerank,response to cytokine (GO:0034097),0.192083785179499,0.5814166326574047,0.9908814589665653,0.9980192153397204,1.0,15/141,11.98%,KHSRP;ANXA1;PRKCA;CDK9;ALDH1A2;TRIM56;CXCR4;PID1;HDAC4;APP;PTPN5;BCL2;SHFL;NFAT5;IL1RAPL1
prerank,cellular response to chemokine (GO:1990869),0.21455791277731864,0.5807794251591385,0.9657142857142857,0.9979974153889114,1.0,3/46,8.61%,CXCL12;RIPOR2;DOCK8
prerank,cranial nerve development (GO:0021545),0.27129495951289945,0.580253304458186,0.9295977011494253,0.9979329897902407,1.0,11/11,72.89%,CHD7;SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;ERBB3;TMEM126A
prerank,diol biosynthetic process (GO:0034312),0.25176951476678017,0.5777991474566522,0.9373297002724795,0.9988576715310916,1.0,2/15,15.38%,ABCA2;QDPR
prerank,regulation of interleukin-12 production (GO:0032655),0.209427021029444,0.5760391229432821,0.9747995418098511,0.9994033963888804,1.0,5/47,15.53%,TIRAP;PIBF1;CD47;TLR3;HSPD1
prerank,myofibril assembly (GO:0030239),0.21249289103577823,0.5760076001986633,0.9791666666666666,0.9990639195455661,1.0,5/42,18.74%,OBSL1;TPM1;PDGFRA;TMOD2;CSRP2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.1985347052938286,-0.5756579691868577,0.977859778597786,1.0,1.0,10/17,44.74%,CACNA2D1;AKAP9;SNTA1;KCNQ1;SCN4B;KCNE4;ANK2;KCNH2;SCN5A;GJA5
prerank,motile cilium assembly (GO:0044458),0.2602075887126752,0.5754195659191647,0.9270833333333334,0.9990165167759761,1.0,2/12,17.63%,BBOF1;DNAAF3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.21120653653196378,0.5746470675176472,0.9700460829493087,0.9990480497237992,1.0,8/40,21.29%,NTF3;FGFR1;PDGFRA;LPAR1;GNAQ;ARHGAP6;NTRK2;FGF2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.19340882632755618,-0.5744738621858854,0.9671532846715328,1.0,1.0,4/17,27.02%,ADRA1B;ADRA1A;ADRA2A;DRD2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.2742691286488285,0.5737013853448323,0.9418238993710691,0.9991670830841488,1.0,1/10,7.66%,ADGRV1
prerank,tRNA wobble base modification (GO:0002097),-0.1988948866216687,-0.5733566988340645,0.9714285714285714,1.0,1.0,11/14,49.84%,ELP3;TRMT9B;DPH3;ELP4;GTPBP3;MOCS3;KTI12;ALKBH8;ADAT2;CTU2;CTU1
prerank,chromatin assembly (GO:0031497),0.21396624955319837,0.5718250775892294,0.9596199524940617,0.9997532313642101,1.0,10/38,21.66%,RBBP4;ASF1A;SOX9;SART3;NPM1;ATRX;DAXX;CTCF;NAP1L4;H3-3A
prerank,heterotypic cell-cell adhesion (GO:0034113),0.22924696144068835,0.5711817343650738,0.9733502538071066,0.9997257022062607,1.0,3/25,10.86%,CD200R1;JAM3;JUP
prerank,regulation of oxidoreductase activity (GO:0051341),0.25773299848098713,0.5708131897446159,0.9489795918367347,0.999556507666696,1.0,1/13,6.07%,ABL1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.20228820165244565,0.5705401311873168,0.982122905027933,0.9993307787878792,1.0,10/56,20.88%,BMP6;PMEPA1;SDCBP;BMP5;TGFB1;SMAD6;TGFBR1;DAB2;ACVR2A;SMAD7
prerank,negative regulation of gluconeogenesis (GO:0045721),0.2660930371164586,0.5703006984699953,0.9336158192090396,0.9990865616310634,1.0,3/11,24.50%,SIK1;CLK2;CRY1
prerank,positive regulation of ATPase activity (GO:0032781),0.21057114924068382,0.5698877267112046,0.9711981566820277,0.9989305446567521,1.0,11/41,21.93%,FGF10;TPM1;DNAJC24;VMP1;DNAJC10;DYNLL1;TOR1AIP2;HNRNPU;ATP1B2;MSH3;PFN2
prerank,water transport (GO:0006833),0.2599341254180099,0.5696992009469776,0.9515669515669516,0.9986645557531852,1.0,1/12,14.55%,AQP4
prerank,lipid droplet formation (GO:0140042),0.2706347141461646,0.5695234908746889,0.9273301737756714,0.9984042739719033,1.0,2/10,15.93%,AUP1;CDS1
prerank,tRNA 5'-leader removal (GO:0001682),0.259418364205549,0.5677482004874663,0.9385474860335196,0.9989245519412095,1.0,2/13,13.56%,PRORP;RPP30
prerank,DNA packaging (GO:0006323),0.24224819535048528,0.5660603913112267,0.9478021978021978,0.9993527675275413,1.0,2/16,15.95%,RBBP4;HAT1
prerank,B cell differentiation (GO:0030183),0.20729902966164332,0.5660098121429984,0.9873853211009175,0.9990218757434803,1.0,6/46,15.29%,SYVN1;HDAC5;HDAC4;CEBPG;BLNK;TCF3
prerank,protein insertion into membrane (GO:0051205),0.2132392669510122,0.5659323772352945,0.9761620977353993,0.9987025848834804,1.0,9/32,22.11%,GET1;APP;SERP1;SEC61G;ALDH3A2;STX5;OXA1L;RTP4;TRAM2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.20347218919035912,-0.5658392592325167,0.978494623655914,1.0,1.0,8/14,41.52%,TSEN2;CSTF2;TSEN15;CPSF4;CPSF1;CLP1;TRPT1;TSEN54
prerank,negative regulation of TORC1 signaling (GO:1904262),0.2601963987291953,0.5657135019778822,0.9495798319327731,0.9984599658886942,1.0,2/13,11.57%,STK11;RNF152
prerank,heme biosynthetic process (GO:0006783),0.23194493092206891,0.5652030562271917,0.9669211195928753,0.9983466056161389,1.0,2/22,10.16%,UROD;SLC25A38
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2275702528731393,0.5645995383243461,0.9679075738125802,0.998285630343459,1.0,5/25,18.17%,RBPJ;CNOT9;ARAP1;CBL;CCDC88A
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.25016752108238527,0.5638782982835728,0.9584487534626038,0.9982597851705546,1.0,3/15,17.10%,LACTB2;RPP30;ZC3H12C
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.21159507119117607,0.5638193534343197,0.9774614472123369,0.9979334148734014,1.0,8/38,18.55%,CSNK2A2;SAE1;ATG13;LEPROT;ARIH2;UBE2L3;PARL;BAG4
prerank,entry into host (GO:0044409),0.2540165872028897,0.5637195096414777,0.9368575624082232,0.9976309928514565,1.0,3/13,20.71%,CXCR4;CBL;ITGAV
prerank,calcium ion transport into cytosol (GO:0060402),0.23245197718885421,0.5631839288250446,0.9489247311827957,0.9975339301338394,1.0,2/21,8.22%,GRIN1;GRIN2A
prerank,regulation of B cell apoptotic process (GO:0002902),0.26009013491146815,0.5623010980539502,0.9591240875912409,0.9975764001100571,1.0,3/12,20.46%,IRS2;BCL6;LYN
prerank,phosphate ion homeostasis (GO:0055062),0.26812235126349826,0.5602602880630703,0.9373088685015291,0.9981294580954592,1.0,1/10,12.01%,ENPP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.19169383240784257,0.5599331679234187,0.9861407249466951,0.9975629409398615,1.0,8/78,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.19169383240784257,0.5599331679234187,0.9861407249466951,0.9975629409398615,1.0,8/78,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.26951046870701667,0.5585060197303663,0.9548872180451128,0.9978495759720634,1.0,3/10,20.87%,PIBF1;PARP14;NF2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.23913706544927177,0.5583989866792325,0.9543080939947781,0.9975434681074573,1.0,1/19,2.38%,AASS
prerank,mitochondrial transcription (GO:0006390),0.26776902094915905,0.5578077346913847,0.9463487332339792,0.9974333056606396,1.0,2/10,15.73%,SLC25A33;TFB1M
prerank,glutathione derivative metabolic process (GO:1901685),0.2352420665762882,0.5574603300289888,0.9597402597402598,0.9968792303074746,1.0,1/20,4.08%,GSTT1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.2352420665762882,0.5574603300289888,0.9597402597402598,0.9968792303074746,1.0,1/20,4.08%,GSTT1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.2294100775130583,0.5572343205805581,0.9670619235836627,0.9966269671775411,1.0,6/20,24.48%,MALT1;PRKCZ;TRAF2;B2M;IL18;TRAF6
prerank,cardiac muscle cell development (GO:0055013),0.23078853694620566,0.5569874284730084,0.9610894941634242,0.996382411430499,1.0,2/20,11.29%,OBSL1;PDGFRA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.19589970565193765,-0.5564953506680022,0.9590443686006825,1.0,1.0,1/13,2.79%,STAT3
prerank,cellular response to interleukin-15 (GO:0071350),-0.19589970565193765,-0.5564953506680022,0.9590443686006825,1.0,1.0,1/13,2.79%,STAT3
prerank,macrophage chemotaxis (GO:0048246),-0.21924428822495606,-0.5545811471122053,0.953125,1.0,1.0,10/10,78.10%,CKLF;EDNRB;TAFA4;CCL2;CCL5;CCL3;LGALS3;EDN2;SAA1;CXCL17
prerank,positive regulation of interleukin-12 production (GO:0032735),0.21250803459013945,0.5533125931317255,0.972939729397294,0.9975923174103769,1.0,3/31,15.53%,TIRAP;TLR3;HSPD1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.24748341591113782,0.5516638344410963,0.9519774011299436,0.9979219243100567,1.0,1/13,7.25%,CLPTM1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.18870444643769918,0.5513978813466499,0.9904153354632588,0.9976802497588537,1.0,8/79,11.81%,FCGR2B;KIF3A;KIF3C;DCTN6;AP2S1;CAPZA1;DCTN4;DYNC1LI1
prerank,lymphocyte chemotaxis (GO:0048247),-0.15682948983607725,-0.5513417439536573,0.9935483870967742,1.0,1.0,6/34,22.73%,CCL15;CXCL16;CCL13;SLC12A2;CKLF;PIK3CD
prerank,thymus development (GO:0048538),0.24789696221562435,0.550210901087925,0.9396551724137931,0.9978168049508419,1.0,1/13,4.88%,FGF10
prerank,embryonic digit morphogenesis (GO:0042733),0.23392667682656645,0.5501889188141768,0.9665327978580991,0.9974762408841414,1.0,4/18,21.30%,TWIST1;HDAC1;OSR1;GLI3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.2570253869643814,0.5496933096657785,0.9534883720930233,0.9973446251964787,1.0,3/12,19.23%,DSCAM;NKD1;AGTPBP1
prerank,granulocyte chemotaxis (GO:0071621),0.19796513812905198,0.5495988081588434,0.9844617092119867,0.9970444158214408,1.0,3/55,9.33%,EDN3;ANXA1;PPIB
prerank,glucan biosynthetic process (GO:0009250),-0.20681253945034392,-0.5492634021491463,0.9658385093167702,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.20681253945034392,-0.5492634021491463,0.9658385093167702,1.0,1.0,4/12,27.59%,GYS1;PGM2;GYG1;PPP1R3C
prerank,mitochondrial gene expression (GO:0140053),0.20324898438131922,0.5477156451373901,0.9806157354618016,0.9974431588406115,1.0,5/42,12.81%,NDUFA7;SLC25A33;GATB;MRPL47;HARS1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.22456023839483358,0.547089999486286,0.9605095541401274,0.9973413795720749,1.0,4/22,20.33%,THY1;FLOT1;KLF4;GCNT2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.24048241647922647,0.5453023796121415,0.9596662030598053,0.9976653784210698,1.0,3/15,21.42%,APOE;ABCA5;ABCG1
prerank,positive regulation of cytokinesis (GO:0032467),0.20793363168126278,0.5421581415396902,0.9738154613466334,0.9984924561416251,1.0,4/32,14.15%,CDC14B;CIT;SVIL;CSPP1
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.20590081607030758,-0.5405707025924108,0.9654088050314465,1.0,1.0,12/12,79.43%,ANXA6;RYR2;MTLN;CASQ2;ANK2;CASQ1;TRDN;FKBP1B;UBASH3B;LIME1;DIAPH1;PTK2B
prerank,cellular response to ATP (GO:0071318),-0.1917885681865103,-0.5400946079019087,0.9779411764705882,1.0,1.0,3/14,18.46%,HSP90B1;P2RX7;P2RY12
prerank,positive regulation of neuron migration (GO:2001224),0.2500633850049809,0.5400572123855393,0.9554234769687965,0.9989160445302707,1.0,6/11,26.21%,NIPBL;SEMA3A;KIF20B;SHTN1;ARHGEF2;RAPGEF2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.2582396157230954,0.5387992646676927,0.9623493975903614,0.9990135760768311,1.0,4/10,26.00%,RAP2A;MYO9A;CDC42;OPHN1
prerank,dendritic cell migration (GO:0036336),0.23502567093630933,0.5383541794170619,0.9559228650137741,0.9988123018540732,1.0,1/16,7.14%,CXCR4
prerank,positive regulation of cellular senescence (GO:2000774),0.2581000613468285,0.5381392106004862,0.9337349397590361,0.9985474910916371,1.0,1/10,6.71%,EEF1E1
prerank,catecholamine metabolic process (GO:0006584),0.23982923154193855,0.5374604874215203,0.9717114568599717,0.9984496601614324,1.0,14/14,76.04%,COMT;DBH;DRD4;PAH;TH;ATP7A;DRD1;SNCAIP;LRTOMT;DRD3;RNF180;DRD2;PRKN;DDC
prerank,snRNA processing (GO:0016180),0.23364693832682115,0.5364997016034146,0.9573863636363636,0.9984219950852949,1.0,1/16,2.38%,TOE1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.24219925456314217,0.5361671119740364,0.9601769911504425,0.9981895717719534,1.0,1/12,5.78%,DCN
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.25727934163005034,0.5339514039934822,0.9638009049773756,0.9986071335116681,1.0,2/10,16.49%,JAM3;SERPINE1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.23823317698414143,0.5333071046513462,0.9652777777777778,0.9984808641759961,1.0,3/14,15.57%,UPP2;DPYD;NT5C3A
prerank,pentose-phosphate shunt (GO:0006098),0.2504314583881777,0.5323113964670603,0.9626972740315638,0.998472595730143,1.0,3/11,20.30%,TKT;RPIA;TALDO1
prerank,outer dynein arm assembly (GO:0036158),-0.19016825715720745,-0.5319980691161166,0.9823943661971831,1.0,1.0,14/14,81.01%,DNAAF5;ODAD1;DNAH8;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAAF1;ZMYND10;DNAL1;LRRC49
prerank,eye photoreceptor cell development (GO:0042462),0.23314190081125463,0.5309506148478732,0.9605978260869565,0.9985526522135947,1.0,2/15,17.41%,THY1;TOPORS
prerank,maturation of 5.8S rRNA (GO:0000460),0.2279173507513892,0.5298919810954242,0.9776902887139107,0.9985491185731455,1.0,4/17,17.60%,MTREX;C1D;LAS1L;NSA2
prerank,sensory perception of pain (GO:0019233),0.2174279042355016,0.5292894083240963,0.9574742268041238,0.998409806078041,1.0,1/21,4.13%,OPRK1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.17401198966142,-0.5282577943847947,0.9925373134328358,1.0,1.0,5/17,31.08%,SLC9A2;SLC12A2;HCN2;SLC8A1;SLC9A5
prerank,pigment granule transport (GO:0051904),0.2212055368795322,0.5279284878239131,0.966931216931217,0.9981460574820388,1.0,2/18,11.49%,BBS7;MYO5A
prerank,melanosome transport (GO:0032402),0.2212055368795322,0.5279284878239131,0.966931216931217,0.9981460574820388,1.0,2/18,11.49%,BBS7;MYO5A
prerank,diol metabolic process (GO:0034311),0.22428323379882012,0.5268860618837168,0.9734395750332006,0.9981192718732215,1.0,1/19,2.67%,HSP90AA1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.2514867227492373,0.5256720670856054,0.9596412556053812,0.9981416572967783,1.0,1/10,7.55%,CD24
prerank,synaptonemal complex organization (GO:0070193),-0.18971420080721313,-0.525386449183077,0.9728682170542635,1.0,1.0,9/15,52.35%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,synaptonemal complex assembly (GO:0007130),-0.18971420080721313,-0.525386449183077,0.9728682170542635,1.0,1.0,9/15,52.35%,BAG6;P3H4;SYCP2;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3
prerank,DNA replication (GO:0006260),0.17679586940401518,0.5224514883561553,0.9947698744769874,0.9987550076994116,1.0,15/105,18.10%,WDHD1;BARD1;MCMBP;ORC6;KIN;TOP1;RBMS1;BRIP1;RMI1;ATR;HELB;MRE11;RAD50;TOP3A;RBBP8
prerank,establishment of melanosome localization (GO:0032401),0.21708764244439926,0.5223417623206528,0.975130890052356,0.9984356997994175,1.0,2/19,11.49%,BBS7;MYO5A
prerank,fluid transport (GO:0042044),0.23685633934303896,0.5216072948876531,0.9745762711864406,0.9983211457513523,1.0,1/12,14.55%,AQP4
prerank,cGMP metabolic process (GO:0046068),-0.19978056596376673,-0.5207876085997144,0.9732441471571907,1.0,1.0,3/12,23.06%,GUCY1A1;NPR1;PDE2A
prerank,receptor recycling (GO:0001881),-0.20570060077222962,-0.5169961142389452,0.9682539682539683,1.0,1.0,5/10,34.25%,LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,serine family amino acid metabolic process (GO:0009069),0.21730464044178527,0.5130106122657738,0.9680998613037448,1.0,1.0,2/16,13.12%,SARS1;GCLC
prerank,inorganic ion transmembrane transport (GO:0098660),-0.1958061119205194,-0.5129320848995387,0.9930795847750865,1.0,1.0,5/12,43.97%,ABCC9;CACNA1H;KCNJ8;PKD2L1;ABCC8
prerank,negative regulation of ion transport (GO:0043271),0.2091403405992095,0.5123198549564278,0.98661800486618,1.0,1.0,6/24,22.71%,PACSIN3;WNK2;PTK2B;SYT11;PXK;WNK3
prerank,pre-replicative complex assembly (GO:0036388),0.17998115736356793,0.5118518458487259,0.9913606911447084,0.9999964682230709,1.0,6/64,10.46%,PSMD4;PSMB10;PSMD11;ORC6;PSME2;PSMC5
prerank,plasma membrane repair (GO:0001778),0.22894684872424834,0.510594194956462,0.975609756097561,0.9999910971858693,1.0,5/13,23.19%,ARL8B;SMPD1;SYT11;MYH9;SYT7
prerank,tRNA 5'-end processing (GO:0099116),0.22684068871833768,0.5103471837084896,0.976775956284153,0.9997071809877328,1.0,2/15,13.56%,PRORP;RPP30
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.22462042146438266,0.5100647858962019,0.9806896551724138,0.9994325851210111,1.0,5/14,24.26%,SUFU;FAF1;PKD2;KEAP1;G3BP2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23436361152930726,0.5093966986065276,0.9680696661828737,0.9992608736081028,1.0,3/12,19.70%,CNDP2;GCLC;HAGH
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19057396075291638,0.5088228253613241,0.9847775175644028,0.9990639536379915,1.0,9/42,26.55%,CXCL12;OXSR1;CCL25;PTK2B;CX3CL1;ACKR3;CCL14;RBM15;FOXC1
prerank,dermatan sulfate metabolic process (GO:0030205),0.22594023690820542,0.5067915597406394,0.9737991266375546,0.9992401931744211,1.0,1/13,5.78%,DCN
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.18203666611448366,0.5058695444238849,0.993421052631579,0.9991291314637131,1.0,3/57,8.56%,IGF1;IL31RA;PIBF1
prerank,telomere organization (GO:0032200),0.1856353602434443,0.5047607030633995,0.9910213243546577,0.999049856817554,1.0,8/43,18.57%,PARP1;XRCC6;ATR;POLD3;MRE11;RAD50;TERF1;TERF2IP
prerank,microtubule-based transport (GO:0099111),0.2265536723163841,0.49918754915744296,0.9751824817518249,1.0,1.0,12/12,77.36%,HTT;DYNC1I2;DNAAF4;CCDC40;DNAAF2;SPA17;SPAG17;ADCY10;ROPN1L;CABYR;DYNC1I1;SPEF2
prerank,regulation of cell development (GO:0060284),0.18578239258301285,0.4939410471461016,0.9929161747343566,1.0,1.0,9/36,24.93%,PRUNE1;DOCK7;ADGRA2;CLOCK;FBXO22;YTHDF2;FOXO1;YAP1;CX3CL1
prerank,error-free translesion synthesis (GO:0070987),-0.15755948119885094,-0.4920535150516423,0.9906103286384976,1.0,1.0,13/22,42.89%,RPA1;UBB;REV1;RFC2;SPRTN;PCNA;RPA3;RCHY1;RFC3;UBA52;RPA2;RFC4;POLD1
prerank,gas transport (GO:0015669),0.2328646748681899,0.49155839234292753,0.9852507374631269,1.0,1.0,10/10,76.73%,CA2;AQP5;AQP6;RHAG;NGB;MB;AQP1;MYC;CYGB;IPCEF1
prerank,regulation of neurogenesis (GO:0050767),0.1732645514725018,0.4909872353859938,0.9966592427616926,1.0,1.0,13/55,24.98%,PRUNE1;SOX11;HOOK3;DOCK7;SNW1;SORL1;YTHDF2;SERPINF1;APPL2;B2M;YAP1;CX3CL1;NAP1L1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.22693032015065928,0.48994900657026175,0.9801699716713881,1.0,1.0,12/12,77.32%,CENPC;SEH1L;CDT1;CHAMP1;KIF2C;NUF2;MAD1L1;RMDN1;NDC80;CENPE;BOD1;MIS12
prerank,regulation of actin filament-based movement (GO:1903115),-0.19233753829170763,-0.48982693914967396,0.9885057471264368,1.0,1.0,6/10,45.38%,SRI;PDE4D;PLN;ANK2;SCN5A;STC1
prerank,cellular response to gamma radiation (GO:0071480),0.20975155351679847,0.4892166500855336,0.9849315068493151,1.0,1.0,6/17,25.59%,XRCC6;ATR;MDM2;ATM;YAP1;MAP3K20
prerank,regulation of hemopoiesis (GO:1903706),0.23824929804807266,0.4875410136997885,0.9775112443778111,1.0,1.0,3/10,24.79%,CBFB;MYSM1;RUNX1
prerank,DNA-dependent DNA replication (GO:0006261),0.16350807074040064,0.4866285828018082,1.0,1.0,1.0,9/128,10.46%,WDHD1;SIRT7;PSMD4;PSMB10;MCMBP;PSMD11;ORC6;PSME2;PSMC5
prerank,cellular response to interleukin-2 (GO:0071352),0.22622559789090455,0.4848339903759683,0.9799713876967096,0.9998001716585719,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.22622559789090455,0.4848339903759683,0.9799713876967096,0.9998001716585719,1.0,11/11,77.39%,JAK1;PTK2B;IL2;IL2RB;SHC1;IL2RG;STAT5B;IL2RA;JAK3;SYK;STAT5A
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.19622506541309104,-0.4847625756794399,0.9915254237288136,1.0,1.0,1/10,2.90%,SACS
prerank,photoreceptor cell development (GO:0042461),-0.17454069726951715,-0.48456932252376517,1.0,1.0,1.0,5/14,28.07%,ARL3;VEGFA;RP1;CEP290;MFSD2A
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.1957213182939041,0.4779236484068302,0.9823008849557522,1.0,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.1957213182939041,0.4779236484068302,0.9823008849557522,1.0,1.0,5/22,22.95%,ZDHHC3;CLIP3;ZDHHC2;ZDHHC14;ZDHHC21
prerank,midbody abscission (GO:0061952),0.20462119607726356,0.47747349643900855,0.9825268817204301,1.0,1.0,6/17,26.29%,CHMP3;VPS4B;CHMP4A;CHMP4B;PDCD6IP;MITD1
prerank,DNA methylation or demethylation (GO:0044728),0.20115036092932542,0.4771025613444276,0.9879839786381842,0.9994392552818534,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,DNA alkylation (GO:0006305),0.20115036092932542,0.4771025613444276,0.9879839786381842,0.9994392552818534,1.0,3/19,13.81%,EHMT2;EHMT1;ATRX
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.1627406580878072,0.47655053365123473,0.9989350372736954,0.9991828339035151,1.0,9/76,17.53%,OPRK1;GPR4;PTH1R;HTR2C;CHRM2;LPAR1;LPAR6;AGTR1;HRH1
prerank,response to gamma radiation (GO:0010332),0.1896414718836028,0.47272557632525414,0.9922978177150192,0.9994782844502159,1.0,8/24,25.94%,XRCC6;ATR;MDM2;PRKAA1;ATM;YAP1;MAP3K20;DCUN1D3
prerank,cilium-dependent cell motility (GO:0060285),-0.14569300300236387,-0.4707508302345388,0.9953703703703703,1.0,1.0,8/22,34.46%,CFAP44;CCDC39;EFHC2;EFHC1;DNAH2;DNAH8;GAS8;RSPH9
prerank,thyroid hormone generation (GO:0006590),-0.1904343459703741,-0.4679762667425765,0.9883040935672515,1.0,1.0,10/10,80.97%,SLC5A5;FOXE1;DIO2;TG;TPO;DUOX1;IYD;CPQ;DUOX2;CTSK
prerank,negative regulation of axon extension (GO:0030517),0.18118633231028114,0.46728595125196454,0.9949044585987261,0.9999270825764965,1.0,4/30,15.56%,DIP2B;SEMA3D;SEMA3E;SEMA3A
prerank,aorta morphogenesis (GO:0035909),0.19904146509931803,0.46529294253747777,0.9931787175989086,0.9998725165086542,1.0,3/17,16.44%,RBPJ;LRP1;JAG1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.19935235014811975,0.46469788728026196,0.9811574697173621,0.9996039019444636,1.0,4/18,23.91%,FBN1;TLR3;TCTA;FBXW7
prerank,ureteric bud morphogenesis (GO:0060675),0.19669918500406933,0.4558116987384527,0.9889042995839112,1.0,1.0,3/16,21.29%,GDNF;PKD2;FGF2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.19981722525857512,0.45188441030294674,0.9896602658788775,1.0,1.0,2/14,17.37%,SLC6A4;MOXD1
prerank,sulfation (GO:0051923),0.21329483397150223,0.4478732859375069,0.98796992481203,1.0,1.0,11/11,78.69%,SULT1A1;UST;SULT2A1;CHST4;SULT1C4;SULT1C2;SULT6B1;SULT2B1;CHST5;SULT4A1;HS3ST5
prerank,regulation of osteoclast differentiation (GO:0045670),-0.12690929662455214,-0.44770785866157553,1.0,1.0,1.0,33/33,87.34%,TLR4;CEBPB;PRXL2A;GPR137B;TMEM178A;MAFB;GPR137;FSTL3;LILRB3;CARTPT;MTOR;LRRC17;POU4F1;BGLAP;CCR1;IL4;TNFSF11;OCSTAMP;CSF1;IL23A;TNF;IL23R;CCL3;IL12B;GPR55;UBASH3B;POU4F2;IFNG;CAMK4;TRAF6;TCTA;TLR3;FBN1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.1741991269624082,0.4470937509162632,0.9963547995139733,1.0,1.0,1/29,1.88%,NOP9
prerank,cellular glucan metabolic process (GO:0006073),0.20541068108681904,0.4426975545476404,0.9925595238095238,1.0,1.0,2/11,18.99%,GBE1;PRKAG2
prerank,DNA strand elongation (GO:0022616),0.18572550288224854,0.43387597967960784,0.9934980494148244,1.0,1.0,3/18,16.27%,POLD3;MRE11;RAD50
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.17386392166708511,-0.4267160447191532,1.0,1.0,1.0,10/10,82.63%,PTPRC;SH2B3;MAPK7;SIGIRR;MAP2K5;PALM3;APOA1;IRAK3;KLF4;TLE5
prerank,neuron projection regeneration (GO:0031102),0.2013552002477365,0.4242543911033893,0.9882525697503671,1.0,1.0,1/10,12.38%,MAPK8IP3
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.16490431380553638,-0.4161058537358933,1.0,1.0,1.0,3/10,28.82%,ANO6;NCKAP1L;CD300A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.18145212661469518,0.41610101948920547,0.9971949509116409,1.0,1.0,3/16,21.29%,FGFBP1;AGTR1;FGF2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.18882056533193303,0.41523504123584426,0.9941944847605225,1.0,1.0,6/13,28.71%,NFAT5;ZDHHC21;TRAF6;FUT9;RELA;ETS1
prerank,cardiac cell development (GO:0055006),0.19107400665369412,0.41297414637462276,0.9942938659058488,1.0,1.0,11/11,80.91%,JAG1;CXADR;NOTCH1;ALPK2;MYH6;TCAP;ALPK3;TTN;SLC8A1;MYH11;VEGFA
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.1299237962677482,-0.4047653466555022,1.0,1.0,1.0,6/20,34.38%,ADRA1B;ADRA1A;ADRA2A;DRD2;PDE4D;ADRB2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.1705220346943243,0.4022163359088107,0.9986876640419947,1.0,1.0,2/19,17.19%,RIC3;APOE
prerank,tRNA wobble uridine modification (GO:0002098),-0.14360254310241616,-0.3986991890683604,1.0,0.9996202493122808,1.0,1/14,3.41%,ELP3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.19120845433218792,0.39697819117954725,0.9924698795180723,1.0,1.0,3/10,24.20%,ATRX;INO80;SSBP1
prerank,negative regulation of T cell proliferation (GO:0042130),0.1544127345474567,0.3953168838614866,0.9987421383647799,1.0,1.0,1/28,5.37%,SCRIB
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.17859384808537354,0.38981148508170765,0.9958791208791209,1.0,1.0,12/12,82.15%,CHEK2;RAD17;NAE1;TOPBP1;TICRR;CDC6;HUS1B;ORC1;SETMAR;CLSPN;HUS1;STK33
prerank,atrial septum development (GO:0003283),0.1773270405317819,0.3874846353167278,0.9986282578875172,1.0,1.0,1/13,9.14%,MDM4
prerank,cellular copper ion homeostasis (GO:0006878),0.16910112204118344,0.3845112311331119,0.9985775248933144,1.0,1.0,3/14,23.36%,APP;ATOX1;SLC31A1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.13576960437469254,0.38266754314994234,1.0,1.0,1.0,4/53,17.53%,ANXA1;HTR2C;CHRM2;HRH1
prerank,mitotic cytokinetic process (GO:1902410),0.14932418657885896,0.36006920352189015,1.0,1.0,1.0,4/20,21.47%,CHMP3;VPS4B;CHMP4A;CHMP4B
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.1562889622501886,0.34832635541787643,1.0,1.0,1.0,2/15,21.30%,HSPH1;GLI3
prerank,sarcomere organization (GO:0045214),0.12467792369466443,0.31751977406657167,1.0,0.9999507527016968,1.0,25/27,64.16%,TPM1;CSRP2;CSRP3;WDR1;CSRP1;ANKRD1;MYOZ1;MYH3;TNNT1;LMOD2;TNNT2;MYOZ2;SYNPO2L;MYH6;OBSCN;TCAP;MYLK3;MYPN;CAPN3;CASQ1;TTN;KRT19;MYOM2;SIX4;TNNT3
